world
health
china
offic
first
viru
behind
number
pneumonia
wuhan
citi
eastern
china
popul
epidem
mainli
limit
china
becom
truli
global
pandem
confirm
accord
univers
dashboard
inform
nation
intern
health
diseas
us
brazil
russia
widespread
confirm
true
number
like
consider
govern
initi
outbreak
wuhan
nearbi
quarantin
roughli
million
peopl
provinc
quarantin
slowli
watch
see
whether
rise
us
new
outbreak
countri
confirm
death
toll
china
march
govern
took
unpreced
step
extend
entir
countri
shut
ban
govern
shut
nonessenti
least
nine
johnson
outlin
flexibl
plan
would
see
reopen
june
depend
current
threat
march
prime
minist
johnson
put
say
polic
power
fine
peopl
gather
two
outsid
nonessenti
peopl
main
coronaviru
fever
dri
cough
stay
home
seven
day
least
one
person
quarantin
day
four
day
later
prime
minist
health
secretari
test
posit
viru
johnson
spent
three
night
intens
care
stay
prime
minist
countri
resid
recov
return
work
street
morn
march
offici
declar
outbreak
pandem
outbreak
around
clock
deepli
concern
alarm
spread
sever
alarm
inact
although
public
health
emerg
intern
concern
reluct
call
pandem
pandem
word
use
lightli
carelessli
word
caus
unreason
fear
unjustifi
accept
fight
lead
unnecessari
suffer
death
quick
note
name
although
popularli
coronaviru
offici
name
diseas
viru
diseas
sever
acut
respiratori
syndrom
coronaviru
diseas
wuhan
market
wild
bat
illeg
known
jump
thought
first
peopl
infect
diseas
group
primarili
made
market
contract
contact
hunt
anim
sourc
still
unknown
although
strong
team
wuhan
institut
virolog
detail
paper
show
new
genet
per
cent
ident
coronaviru
found
bat
studi
march
genet
coronaviru
per
cent
similar
human
viru
earli
howev
appear
peopl
link
wuhan
market
suggest
initi
rout
human
infect
predat
market
wuhan
market
shut
inspect
clean
alreadi
start
spread
beyond
market
western
pacif
offic
diseas
evid
appar
medic
staff
infect
larg
group
known
infect
caus
respiratori
ill
rang
common
much
seriou
case
coronaviru
epidem
sever
acut
respiratori
syndrom
first
southern
china
went
affect
caus
current
outbreak
initi
unknown
health
strain
coronaviru
five
day
later
govern
genet
sequenc
viru
develop
diagnost
viru
often
mild
common
fever
dri
cough
lead
seriou
respiratori
tract
ill
pneumonia
bronchiti
particularli
danger
older
peopl
health
case
studi
earli
found
per
cent
peopl
confirm
experienc
mild
per
cent
sever
condit
five
per
cent
peopl
critic
suffer
respiratori
failur
septic
shock
multipl
organ
failur
studi
per
cent
confirm
although
actual
death
rate
probabl
much
lower
mani
peopl
infect
viru
test
felt
initi
brunt
epidem
peak
outbreak
countri
saw
singl
day
health
acknowledg
within
provinc
sinc
march
howev
countri
seen
remark
slowdown
march
china
new
viru
countri
new
elsewher
world
least
china
outbreak
china
outbreak
rest
world
confirm
least
us
seen
highest
number
countri
slow
test
confus
approach
crisi
confirm
confirm
russia
mortal
rate
particularli
low
true
death
toll
countri
statist
includ
peopl
directli
seen
highest
number
confirm
mostli
north
countri
countri
countri
eas
first
time
nine
grip
signific
outbreak
countri
confirm
govern
shut
nonessenti
peopl
leav
buy
food
go
work
confirm
rate
lower
mani
social
stay
place
countri
slowli
start
reopen
confirm
first
countri
partial
lift
number
new
rise
sharpli
peopl
infect
global
peopl
per
cent
peopl
confirm
although
true
number
coronaviru
much
confirm
highest
death
toll
total
peopl
test
diseas
march
prime
minist
johnson
led
first
daili
coronaviru
press
confer
say
govern
advis
avoid
nonessenti
social
contact
travel
possibl
march
extend
includ
shutdown
day
shut
notic
vulner
son
key
permit
remain
school
transport
current
run
reduc
tube
bu
rail
servic
meant
key
seen
per
cent
reduct
passeng
sinc
march
weekend
mani
flout
social
prime
minist
coronaviru
peopl
leav
essenti
work
food
medic
care
vulner
person
exercis
polic
abil
fine
compli
new
prime
minist
address
nation
govern
mobil
send
messag
everyon
must
stay
current
live
alon
seven
day
develop
fever
persist
dri
cough
two
common
coronaviru
peopl
live
togeth
advic
entir
household
member
either
strategi
part
govern
delay
phase
plan
flatten
peak
viru
reduc
burden
key
part
plan
shield
vulner
peopl
older
underli
health
million
peopl
vulner
sent
peopl
leav
contact
food
medic
left
prime
minist
shield
last
long
order
ensur
peak
outbreak
imperi
colleg
place
long
prime
minist
johnson
would
place
least
june
critic
govern
stanc
go
far
enough
place
even
restrict
south
extrem
comprehens
test
mani
popul
govern
ramp
antibodi
eventu
abl
detect
previous
expos
viru
although
seriou
accuraci
current
avail
first
suggest
per
cent
around
per
cent
across
coronaviru
mani
flu
common
cold
although
certain
common
flu
usual
seen
peopl
confirm
rare
suffer
runni
nose
common
fever
dri
cough
earli
diseas
nearli
per
cent
experienc
fever
dri
cough
govern
anyon
high
temperatur
new
continu
cough
stay
home
seven
day
live
peopl
entir
household
isol
day
first
onset
less
common
per
cent
peopl
diseas
experi
fatigu
third
peopl
cough
sputum
thick
mucu
within
includ
short
breath
muscl
pain
sore
loss
smell
tast
accord
tend
appear
five
six
day
vaccin
around
corner
market
notori
slow
process
potenti
vaccin
pass
multipl
test
safeti
effect
know
vaccin
safe
need
manufactur
scale
high
enough
use
across
world
like
vaccin
around
lot
work
done
develop
vaccin
pharmaceut
firm
tri
build
flu
vaccin
turn
someth
suitabl
treat
one
univers
extern
spike
viru
way
target
requir
coalit
epidem
prepared
billion
support
develop
new
coronaviru
number
daili
mani
take
tent
eas
daili
coronaviru
death
toll
sinc
march
sinc
visit
small
construct
reopen
remain
close
june
countri
welcom
back
countri
exercis
walk
outdoor
sinc
shop
worship
start
reopen
per
cent
capac
remain
close
foreign
remain
least
june
howev
prime
minist
johnson
construct
start
work
reproduct
number
remain
countri
posit
begin
get
primari
back
june
outdoor
space
worship
open
extra
hygien
social
order
prevent
deadli
second
wave
ramp
test
commun
depart
health
social
care
contact
invit
take
part
initi
studi
track
coronaviru
transmiss
receiv
nose
throat
swab
test
whether
current
viru
provid
monthli
blood
find
proport
popul
studi
set
extend
peopl
next
contact
trace
underway
unlik
south
china
use
combin
credit
card
data
inform
reli
wireless
technolog
trace
peopl
locat
idea
person
cross
someon
test
posit
coronaviru
instantli
alert
let
request
wire
scienc
editor
articl
reflect
latest
spread
essenti
sourc
inform
make
sens
world
constant
transform
wire
convers
technolog
everi
aspect
cultur
busi
scienc
design
uncov
lead
new
way
think
new
new
nast
aerosol
scientist
tech
one
world
infecti
new
coronaviru
air
anyon
breath
enough
peopl
indoor
consider
risk
seem
caught
day
organ
fact
skip
usual
morn
workout
join
aerosol
tri
warn
make
big
zoom
laid
case
tick
grow
list
call
cruis
choir
rehears
peopl
got
sick
even
across
room
contagi
person
main
safeti
keep
distanc
peopl
frequent
travel
larg
immedi
fell
ground
say
infecti
air
like
culprit
unmov
go
call
direct
take
gather
viru
abund
air
meanwhil
peopl
fall
ill
everi
video
call
rose
one
point
rever
atmospher
physicist
meet
tri
explain
far
infecti
differ
size
potenti
travel
one
abruptli
cut
tell
wrong
rude
argu
physic
spent
two
differ
branch
air
pollut
came
soot
ash
organ
readili
accept
physic
mani
size
aloft
travel
far
though
say
appli
respiratori
word
appli
smaller
trap
jargon
two
zoom
liter
understand
one
call
end
sat
back
heavili
feel
old
frustrat
coil
bodi
go
run
pound
footfal
footfal
pavement
felt
alreadi
made
entertain
us
stranger
medic
establish
often
seen
epistem
trespass
use
persev
skeptic
outright
reject
time
howev
much
ego
stake
begin
global
pandem
terribl
time
get
fight
inkl
verbal
spar
symptom
bigger
outdat
scienc
underpin
public
health
polici
get
first
crack
mysteri
commun
fail
badli
spent
first
mani
career
air
pollut
chang
late
sent
child
day
care
winter
runni
chest
flu
swept
despit
staff
rigor
disinfect
common
actual
air
pick
introductori
medic
satisfi
curios
accord
medic
canon
nearli
respiratori
transmit
whenev
sick
person
bacteria
spray
gun
quickli
fall
stick
surfac
within
blast
radiu
alight
nose
mouth
hand
face
caus
infect
thought
break
droplet
rule
measl
tuberculosi
transmit
differ
way
travel
insid
microscop
stay
suspend
travel
longer
spread
contagi
peopl
simpli
distinct
droplet
transmiss
enorm
combat
lead
precaut
wash
frequent
soap
water
fight
infecti
air
enemi
expens
isol
medic
drew
line
micron
unit
measur
equal
meter
definit
infecti
particl
smaller
diamet
aerosol
anyth
bigger
droplet
found
number
us
diseas
control
prevent
list
fulcrum
dichotomi
one
liter
tini
problem
physic
wrong
much
obviou
everyth
knew
move
air
realiti
far
much
afloat
depend
heat
humid
see
wrong
number
found
disturb
error
meant
medic
commun
distort
pictur
peopl
get
sick
long
respiratori
requir
close
contact
spread
yet
small
space
lot
happen
sick
person
cough
onto
face
emit
small
inhal
shake
hand
use
rub
nose
one
transmit
viru
technic
hard
separ
see
one
caus
infect
blame
close
though
size
play
yet
seen
main
decid
collect
data
air
day
frequent
found
flu
viru
air
often
small
enough
stay
aloft
enough
make
peopl
major
news
instead
major
medic
manuscript
even
ran
new
ad
evid
idea
influenza
peopl
via
one
nich
publish
journal
royal
societi
interfac
consist
recept
work
world
alway
domain
pure
medic
concern
one
rare
peopl
tri
straddl
divid
definit
fring
help
overcom
resist
tri
time
time
figur
flaw
figur
come
alway
got
stuck
medic
simpli
state
fact
without
citat
air
eventu
got
tire
tri
research
life
mysteri
fade
background
paper
cross
desk
lab
research
univers
hong
li
made
name
first
outbreak
investig
outbreak
apart
complex
provid
evid
coronaviru
convinc
public
health
commun
risk
calculu
eventu
decid
work
math
li
eleg
person
heavi
open
mouth
small
account
much
infect
li
team
therefor
public
health
establish
backward
flu
respiratori
must
spread
instead
expos
fallaci
boundari
gone
step
trace
number
back
document
help
feel
surg
excit
journal
review
li
paper
mask
repli
wrote
work
huge
import
dogma
infecti
diseas
even
compos
note
li
work
far
theoret
later
govern
cut
travel
citi
wuhan
desper
attempt
contain
respiratori
diseas
burn
megalopoli
pandem
shut
countri
countri
told
peopl
wash
scrub
maintain
social
distanc
say
anyth
indoor
day
zoom
meet
got
anoth
aerosol
scientist
call
atmospher
chemist
univers
colorado
boulder
becom
recommend
peopl
stay
apart
one
anoth
far
tell
social
guidelin
base
actual
possibl
transmiss
definit
would
involv
none
add
told
boundari
two
link
guidelin
built
incorrect
definit
error
arcan
detail
sit
heart
flaw
guidanc
find
origin
suddenli
prioriti
hunt
help
knew
one
tech
scholar
special
histori
tuberculosi
influenza
bring
board
graduat
student
know
good
particular
form
team
agre
interest
wrote
think
go
find
hous
graduat
student
question
covid
dealt
dissert
big
longer
conduct
research
advis
would
devot
spring
dissert
noth
els
quest
team
far
unearth
layer
archaeolog
site
make
pot
wrote
studi
citat
type
scholast
detect
work
blood
stray
buri
dig
li
left
variou
find
dead
tri
anoth
tack
everyon
agre
tuberculosi
plug
tuberculosi
search
scroll
scroll
document
tuberculosi
prevent
aerosol
size
book
written
engin
firth
contagion
air
hygien
lead
time
would
acquir
book
interlibrari
loan
pandem
shut
longer
option
open
track
first
edit
rare
book
seller
hefti
expens
side
project
essenti
one
univers
came
digit
copi
michigan
dig
manuscript
found
man
end
career
rush
research
read
earli
work
one
wife
physician
air
plot
curv
show
oppos
graviti
evapor
respiratori
coupl
made
possibl
predict
time
would
take
particl
given
size
travel
someon
mouth
ground
accord
bigger
sank
within
smaller
stay
air
curv
drawn
foreshadow
idea
dichotomi
one
around
book
long
still
hook
dissert
help
restless
daughter
navig
remot
kindergarten
covid
close
school
often
late
night
everyon
gone
bed
return
take
detail
day
night
read
ultraviolet
insid
came
measl
measl
viru
must
air
struck
knew
measl
get
diseas
later
part
medic
rhetor
understand
certain
take
hold
spring
turn
summer
investig
found
influenti
chief
epidemiologist
newli
establish
brought
gospel
person
cleanli
obsess
made
bedrock
us
public
health
polici
view
transmiss
retrograd
see
slide
back
toward
ancient
irrat
terror
bad
miasma
theori
littl
interest
theoret
time
grow
increasingli
preoccupi
threat
biolog
warfar
worri
carpet
us
march
start
war
report
simultan
belief
infect
work
foundat
understand
physic
curiou
thought
kept
report
look
health
work
mine
mucu
nose
throat
except
good
filter
bigger
smaller
howev
slip
deep
caus
irrevers
damag
someon
turn
rare
nasti
pathogen
potent
agent
mass
infect
wrote
thing
would
formul
liquid
smaller
small
enough
bypass
bodi
main
curiou
inde
made
return
book
day
later
written
industri
hygien
inspir
investig
role
particl
size
likelihood
natur
respiratori
design
studi
bacteria
bug
hardi
land
grew
small
lesion
expos
similar
bacteria
either
fine
smaller
coars
bigger
mist
got
fine
treatment
fell
ill
upon
autopsi
clear
receiv
coars
blast
wors
day
work
back
forth
move
forward
backward
time
got
later
shift
tone
wrote
toward
end
career
admit
wrong
infect
big
part
mind
one
final
work
hospit
exhaust
air
tuberculosi
ward
guinea
build
top
floor
month
month
guinea
came
tuberculosi
still
public
health
skeptic
experi
team
ad
anoth
time
includ
kill
air
guinea
stay
healthi
first
incontrovert
evid
human
even
public
health
big
ignor
follow
year
month
later
late
engin
speech
public
health
thank
illumin
inadequ
respons
grow
epidem
tuberculosi
problemat
worri
smaller
head
someth
snap
place
shot
forward
time
first
tuberculosi
guidanc
document
investig
learn
tuberculosi
curiou
invad
subset
human
promiscu
emb
size
infect
along
respiratori
must
thought
insid
conflat
pluck
size
particl
tuberculosi
context
make
stand
gener
definit
spread
threshold
got
left
behind
see
idea
respir
stay
infecti
phenomenon
time
blind
repetit
error
sank
medic
canon
respond
multipl
comment
june
meet
rest
team
share
found
almost
believ
someon
crack
oh
gosh
came
final
answer
get
bottom
myth
first
step
public
health
doctrin
would
mean
convinc
two
world
power
health
wrong
error
dig
past
campaign
went
public
open
letter
public
health
along
without
ventil
spread
would
undermin
even
vigor
test
trace
social
news
made
strong
backlash
promin
public
health
rush
defend
twitter
epidemiologist
professor
mason
univers
will
buy
idea
peopl
get
covid
breath
close
rang
way
public
health
peopl
use
word
weight
term
approach
someth
toss
around
haphazardli
day
later
scientif
brief
especi
poorli
stuck
rule
peopl
wear
indoor
keep
distanc
misinform
make
difficult
protect
updat
forbid
portabl
spar
social
media
work
behind
rais
awar
around
talk
atmospher
chemist
san
ear
promin
public
health
within
white
hous
covid
task
forc
two
sent
director
nation
allergi
infecti
one
trajectori
particl
height
averag
person
mouth
went
farther
farther
later
speak
audienc
medic
school
admit
distinct
bottom
line
much
aerosol
thought
declin
stori
still
droplet
dogma
earli
group
letter
scienc
urg
everyon
get
page
infecti
move
start
threshold
provid
clear
effect
advic
public
day
guidanc
acknowledg
spread
emphas
winter
talk
publicli
organ
final
everyon
alway
wear
mask
indoor
wherev
spread
interview
maria
van
chang
organ
commit
guidanc
scientif
evid
chang
attent
transmiss
reason
ventil
viru
van
term
specif
mean
medic
commun
instead
pose
biggest
think
decis
public
health
respons
cost
peopl
know
need
protect
yet
time
rethink
old
dichotomi
accord
van
formal
review
diseas
transmiss
li
whose
work
inspir
given
sliver
hope
tragedi
alway
us
someth
lesson
peopl
final
start
learn
transmiss
complic
less
scari
mani
respiratori
wildli
measl
contagi
percent
suscept
peopl
expos
someon
viru
evid
shown
coronaviru
often
peopl
long
viru
effect
immedi
vicin
contagi
person
say
time
aw
lot
textbook
pathogen
respiratori
know
rout
infect
catastroph
cost
zero
influenza
million
year
kill
global
next
bring
particularli
deadli
flu
li
effect
global
respons
allow
good
ventil
emerg
central
pillar
public
health
polici
develop
would
hasten
end
pandem
beat
back
futur
get
glimps
futur
need
peek
li
gym
medicin
day
pandem
li
convinc
univers
hong
spend
budget
ventil
rather
mass
covid
test
owner
gym
calcul
ventil
consult
redesign
workout
outsid
near
kept
perman
open
date
one
caught
covid
gym
li
univers
school
total
cours
gym
small
univers
fact
scar
epidem
quick
recogn
aerosol
transmiss
li
swift
well
odd
ultim
public
health
tilt
peopl
closer
quietli
page
section
coronaviru
text
viru
spread
via
well
note
new
york
time
perhap
biggest
news
pandem
news
confer
big
declar
pay
attent
easi
pay
attent
help
note
time
li
two
aerosol
editori
top
medic
journal
transmiss
beg
journal
came
team
final
post
paper
error
public
preprint
server
earli
made
similar
guidanc
inhal
top
list
diseas
though
news
confer
press
releas
cours
even
got
car
pick
daughter
gymnast
alon
first
time
day
red
light
suddenli
burst
sob
unabl
stop
hot
stream
pour
face
exhaust
relief
triumph
final
thought
get
right
light
turn
away
someday
would
sink
today
pick
dinner
eat
someth
approach
normal
life
us
know
think
articl
submit
letter
editor
mail
stori
origin
technica
sourc
technolog
news
tech
polici
analysi
wire
parent
compani
gain
grim
mileston
nation
death
toll
roughli
popul
voic
state
pandem
take
turn
wors
menac
coronaviru
variant
b
first
seen
delta
world
health
spread
rapidli
around
globe
us
even
contagi
worrisom
variant
first
seen
variant
alpha
percent
transmiss
origin
coronaviru
wuhan
china
start
delta
percent
contagi
delta
variant
low
earli
rose
earli
june
delta
variant
account
percent
year
alpha
outspread
viru
becom
predomin
strain
us
expect
delta
take
place
us
diseas
control
prevent
offici
delta
variant
concern
right
unit
delta
percent
doubl
everi
two
former
commission
food
drug
administr
face
nation
probabl
go
becom
domin
strain
unit
mean
go
see
sharp
mean
go
take
think
risk
realli
spike
new
epidem
head
fall
worri
new
data
delta
caus
sever
addit
spread
peopl
earli
suggest
delta
variant
associ
nearli
doubl
risk
infect
end
alpha
variant
data
correspond
lancet
say
need
data
confirm
good
news
fulli
protect
delta
end
public
health
post
data
two
pfizerbiontech
vaccin
percent
effect
symptomat
infect
delta
variant
meanwhil
data
two
vaccin
percent
effect
notabl
one
shot
either
vaccin
protect
offer
percent
efficaci
symptomat
delta
import
skip
second
dose
data
likewis
two
pfizerbiontech
vaccin
percent
effect
delta
variant
two
vaccin
percent
anoth
analysi
two
pfizerbiontech
vaccin
percent
effect
hospit
two
vaccin
percent
effect
hospit
control
defeat
still
concern
pace
vaccin
significantli
us
mani
far
behind
goal
get
percent
least
one
vaccin
low
vaccin
among
spike
delta
director
hospit
center
vaccin
develop
concern
told
extrem
worri
delta
variant
right
crunch
time
get
fulli
five
six
delta
press
brief
last
week
top
infecti
diseas
expert
made
similar
plea
point
rapid
spread
delta
variant
let
happen
unit
power
argument
get
stori
origin
first
data
new
delta
variant
trickl
earli
martin
immedi
convinc
third
wave
professor
public
health
school
hygien
tropic
medicin
particularli
saw
delta
r
number
averag
number
peopl
one
infect
person
go
infect
viru
see
much
transmiss
variant
june
public
health
strateg
respons
director
told
new
variant
left
spread
uninhibit
r
number
five
inevit
new
steadili
sinc
earli
would
begin
rise
june
number
daili
cross
seen
sinc
earli
still
full
third
wave
look
differ
last
two
delta
variant
consid
virul
previous
success
vaccin
campaign
broken
seemingli
inevit
link
current
rate
remain
low
new
hospit
june
rate
per
new
height
second
wave
rate
per
new
johnson
govern
current
intend
end
restrict
exactli
mean
new
public
health
almost
imposs
predict
due
immun
viru
popul
third
wave
differ
situat
complex
model
professor
clinic
microbiolog
univers
lot
peopl
alreadi
infect
unvaccin
peopl
lot
young
peopl
addit
intens
care
report
fragment
pictur
across
make
far
difficult
form
coher
strategi
third
wave
alreadi
north
west
new
last
seven
day
still
see
rel
littl
transmiss
fine
morgan
consult
intens
care
medicin
univers
hospit
realli
well
north
west
see
scoop
curv
hospit
climb
big
concern
morgan
variat
make
hard
public
mental
toll
repeat
accept
potenti
threat
third
wave
one
two
case
togeth
extent
realli
hard
peopl
get
narr
vaccin
campaign
gone
well
yet
still
ongo
risk
vaccin
popul
remark
effici
june
per
cent
countri
receiv
least
one
dose
vaccin
remain
proport
peopl
martin
professor
medicin
epidemiolog
univers
percentag
elderli
mount
full
immun
respons
vaccin
effect
begin
wear
receiv
jab
earli
week
minist
covid
vaccin
deploy
nine
ten
peopl
elig
vaccin
accept
one
howev
still
one
tenth
receiv
jab
remain
unvaccin
either
want
turn
sort
medic
reason
everyon
older
age
cover
still
unvaccin
peopl
case
continu
climb
viru
eventu
reach
vulner
come
potenti
caus
new
spike
one
peopl
fulli
still
capabl
delta
variant
extent
studi
even
peopl
receiv
two
vaccin
still
transmiss
within
result
govern
need
look
way
threat
third
wave
old
vulner
need
happen
absolut
minimum
joint
committe
vaccin
look
much
long
tradit
peopl
benefit
vaccin
influenza
partli
want
get
primarili
want
infect
lot
sinc
first
wave
array
new
dispos
fight
viru
past
year
recoveri
trial
program
march
clinic
investig
provid
vital
inform
work
morgan
latter
inform
import
streamlin
care
intens
result
convalesc
plasma
aspirin
colchicin
artifici
elderli
mount
immun
respons
viru
via
intraven
drip
shown
effect
lifesav
help
dampen
deadli
storm
wide
drive
forc
behind
mani
latter
treatment
avail
variou
antibodi
newli
recent
result
new
data
recoveri
time
inform
longer
term
viru
especi
long
covid
impact
younger
previous
healthi
particularli
hard
risk
third
wave
assess
evid
persist
brain
chronic
infect
caus
structur
higher
risk
muscl
dementia
psychiatr
even
among
third
wave
almost
certainli
look
differ
inevit
previou
two
result
feel
come
like
moral
ethic
rather
medic
necess
think
wave
one
wave
two
clear
huge
wave
morgan
differ
think
medic
ethic
moral
societ
societi
ethic
wire
tomorrow
essenti
sourc
inform
make
sens
world
constant
transform
wire
convers
technolog
everi
aspect
cultur
busi
scienc
design
uncov
lead
new
way
think
new
new
nast
health
tech
one
promin
annual
explor
technolog
medicin
year
main
includ
artifici
intellig
remot
surgic
ongo
fight
data
statist
base
publicli
avail
data
time
public
inform
date
visit
coronaviru
hub
follow
live
page
recent
inform
year
wire
health
tech
confer
took
place
last
month
effort
adapt
current
rang
latest
medic
technolog
remot
surgic
technolog
issu
everyon
mind
year
research
combat
special
featur
offer
overview
main
mani
wire
health
tech
recur
theme
technolog
help
fight
coronaviru
given
rise
current
school
hygien
tropic
medicin
unit
kingdom
spoke
global
respons
issu
paramount
import
context
note
accord
research
lancet
peopl
becom
far
volatil
lot
polit
opinion
poll
use
much
stabl
ago
knew
agre
less
confid
around
frequent
offer
posit
news
overal
pictur
gener
trend
peopl
becom
littl
confid
ago
accord
prof
public
health
pervas
vaccin
past
see
remain
confid
skeptic
strongli
believ
safe
highest
rate
finland
strongli
believ
signific
drop
confid
confid
across
globe
pandem
current
situat
prof
surround
becom
even
volatil
whole
environ
trust
distrust
around
covid
vaccin
gotten
togeth
resist
even
covid
vaccin
danger
antivaccin
give
scienc
human
face
prof
need
bring
togeth
scientif
technolog
valuabl
lose
human
face
bring
back
togeth
scientif
perspect
misinform
problem
relationship
problem
cultur
revolut
say
need
chang
need
get
back
human
face
scientif
medic
field
prof
public
health
advisor
chair
global
public
health
depart
univers
spoke
next
fight
situat
prof
certain
key
countri
need
take
put
stop
spread
viru
effici
think
crucial
thing
get
test
sort
need
test
turnaround
time
less
test
wide
avail
strategi
point
point
use
think
new
tri
elimin
viru
get
rid
put
place
reimport
vice
chancellor
univers
global
health
equiti
went
speak
curb
spread
new
coronaviru
first
step
identifi
came
stop
spread
expert
clear
idea
establish
best
strategi
spread
importantli
howev
accord
prof
made
sure
keep
daili
news
regard
local
spread
viru
good
bad
w
hen
need
popul
someth
protect
usual
trust
money
technolog
countri
pandem
take
peopl
limit
human
contact
carri
lack
appropri
imperi
colleg
spoke
technolog
help
current
electron
engin
fast
access
test
technolog
origin
purpos
help
peopl
understand
health
genet
predispos
make
wire
research
technolog
detect
turnaround
time
govern
order
million
state
effect
took
pandem
us
get
technolog
prepar
medicin
hospit
system
way
bulldoz
covid
prof
research
import
step
health
particularli
peopl
mental
health
would
anxious
wait
isol
test
panel
discuss
joshi
director
artifici
intellig
government
unit
respons
nation
health
went
stress
advanc
technolog
help
better
understand
patholog
identifi
peopl
ad
allow
provid
help
faster
like
affect
infect
new
joshi
view
technolog
therefor
offer
holist
view
person
health
statu
beyond
panel
discuss
recent
find
vaccin
new
two
tal
chief
medic
offic
therapeut
prof
cofound
test
candid
use
genet
inform
rather
viral
base
train
immun
system
new
vaccin
versu
better
number
fundament
way
first
start
genet
inform
compon
speed
get
clinic
clinic
chanc
two
lead
leverag
point
think
second
one
biolog
precis
make
protein
otherwis
character
biolog
process
lot
differ
lot
go
wrong
genet
inform
way
cell
make
wrong
bit
biolog
fidel
higher
likelihood
translat
kind
immun
respons
want
tal
think
last
element
flexibl
platform
us
littl
bit
beyond
covid
infrastructur
rel
small
quick
space
tremend
agil
usual
time
wire
confer
clinic
candid
similar
sinc
two
similar
question
creat
sens
competit
two
accord
context
pandem
valid
question
two
viru
clock
ad
candid
demonstr
safeti
efficaci
would
ideal
situat
world
need
one
compani
succeed
viru
truli
stay
previou
research
one
vaccin
becom
necessari
long
agre
way
whole
industri
best
perform
collabor
import
see
peopl
team
collabor
nation
health
pfizer
univers
sever
collabor
transpar
develop
vaccin
peopl
see
data
almost
come
peopl
understand
phase
trial
work
phase
trial
work
even
phase
everyon
see
transpar
fashion
perform
prof
two
sens
transpar
regard
develop
new
pharmaceut
essenti
long
run
express
hope
persist
pandem
whether
candid
vaccin
develop
rush
distribut
sooner
rather
later
prof
pandem
find
better
effici
method
proceed
clinic
less
reliabl
one
one
import
aspect
instead
skip
cut
decid
parallel
usual
vaccin
develop
phase
studi
mayb
later
phase
studi
decid
whether
would
phase
studi
base
cost
risk
base
tradit
way
vaccin
best
way
tradit
way
mani
wire
health
tech
around
fight
technolog
improv
patient
eric
founder
director
research
technolog
make
medicin
humanist
main
object
ai
medicin
improv
accuraci
improv
diagnos
diseas
care
known
precis
medicin
ai
medic
practic
bring
includ
free
file
inform
digit
pay
attent
medicin
erod
terribl
rush
job
talk
see
number
enough
need
gift
time
ai
give
back
peopl
feel
rush
feel
rush
either
want
spend
time
less
time
comput
keyboard
nation
institut
health
research
institut
ophthalmolog
univers
colleg
spoke
soon
use
ai
diagnos
treat
retin
set
eye
lead
vision
loss
made
similar
point
argument
mani
peopl
affect
eye
often
sheer
amount
wait
diagnosi
treatment
peopl
essenti
go
blind
seen
earli
enough
new
particular
ai
least
role
problem
eye
hospit
ai
technolog
train
system
diagnos
retin
correctli
specialist
studi
natur
medicin
eye
hospit
build
new
care
research
center
integr
advanc
technolog
clinic
ai
help
link
variou
health
data
therefor
offer
bigger
pictur
person
overal
health
statu
health
mark
slack
chief
medic
offic
cofound
surgic
spoke
potenti
surgic
system
help
carri
minim
invas
keyhol
surgeri
keyhol
surgeri
better
open
surgeri
huge
keyhol
surgeri
slack
present
larg
wound
follow
open
surgeri
go
back
hospit
small
wound
almost
none
go
back
larg
wound
fifth
go
back
oper
theater
get
wound
infect
roughli
reduc
keyhol
surgeri
rather
open
surgeri
mark
prof
biochemist
founder
innov
institut
technolog
spoke
revolutionari
potenti
gene
new
technolog
taken
medic
research
world
technolog
molecular
surgeri
way
alter
way
allow
precis
correct
genet
allow
genet
materi
live
way
help
help
treat
sever
blood
sickl
cell
diseas
treatment
eye
even
muscular
scientist
besid
technolog
potenti
treat
diseas
come
handi
new
even
come
diagnost
tool
help
identifi
much
talk
potenti
technolog
advanc
think
deliveri
control
cours
safeti
effect
access
extraordinari
realli
excit
time
work
field
live
latest
regard
novel
coronaviru
click
revolution
interact
new
technolog
actual
adopt
clinic
practic
uptak
mobil
health
slow
spotlight
well
futur
hold
coronaviru
pandem
month
ask
resid
medic
tackl
endur
articl
back
previou
potenti
offer
handl
caus
sever
respiratori
ill
peopl
one
two
caus
learn
receiv
weekli
roundup
coronaviru
news
sign
half
us
new
aim
keep
number
week
half
us
coronaviru
nine
percent
receiv
least
one
dose
vaccin
keep
vaccin
rise
instanc
offer
peopl
get
next
year
super
bowl
cruis
woman
million
state
lotteri
open
resid
receiv
least
one
newli
mask
peopl
forgo
mask
mani
unfortun
easier
unvaccin
peopl
go
one
way
around
vaccin
verif
set
system
like
complic
messi
way
let
peopl
know
receiv
diplomaci
start
stall
deal
govern
suppli
million
coronaviru
vaccin
start
summer
unlik
mani
prime
minist
sign
advanc
purchas
viru
control
stick
point
pfizer
legal
liabil
sever
side
effect
concern
indemn
given
vaccin
though
seem
like
agre
pfizerbiontech
one
robust
vaccin
eu
would
donat
meanwhil
us
yet
ship
million
send
amid
string
regulatori
logist
state
emerg
around
world
institut
curb
prime
minist
extend
countri
state
emerg
june
eight
countri
due
host
month
despit
mount
opposit
though
new
japan
still
midst
anoth
wave
vaccin
remain
among
among
recent
public
health
amid
new
viru
night
discov
cluster
three
without
known
curfew
mask
mandat
among
week
spring
presid
jail
enforc
sophist
new
fine
good
day
gadget
game
earli
outsid
bowl
look
roughli
within
shape
everyth
ink
cartoon
game
alik
bowl
ball
design
legend
mo
secur
home
without
unnecessari
system
still
investig
potenti
therapeut
recent
us
find
treat
two
multipl
anoth
repurpos
oral
treat
peopl
earli
come
covid
fact
kick
high
gear
mani
either
enough
draw
meaning
bigger
final
yield
given
diseas
unlik
go
away
complet
even
widespread
across
globe
know
treat
effect
receiv
weekli
roundup
coronaviru
news
sign
fall
record
us
new
drive
peopl
get
coronaviru
case
us
sinc
march
say
countri
unlik
see
surg
summer
thank
rise
vaccin
date
percent
receiv
least
one
shot
presid
recent
outlin
aggress
plan
reach
goal
percent
least
partli
get
jab
convinc
well
chanc
year
free
free
super
mani
peopl
receiv
shot
rang
promis
free
beer
chanc
win
million
seem
work
exampl
percent
governor
five
peopl
would
win
million
lotteri
us
first
shipment
surplu
us
sent
first
shipment
need
outlin
share
surplu
rest
world
first
million
sent
world
health
organ
initi
world
first
prioriti
south
southeast
go
made
white
hous
white
hous
made
clear
attach
rise
across
world
need
better
equit
vaccin
distribut
increasingli
urgent
week
vaccin
china
sent
shot
easi
store
make
signific
dent
demand
eu
summer
travel
despit
week
seven
eu
region
digit
green
certif
whether
someon
fulli
test
neg
within
past
certif
free
use
eu
path
toward
summer
travel
uniformli
smooth
across
contin
week
travel
catch
surpris
countri
amber
destin
rather
green
mean
would
need
quarantin
day
upon
return
switch
stem
part
concern
bring
countri
return
home
decis
come
shortli
would
launch
new
global
pandem
radar
system
track
covid
new
whole
famili
enjoy
tough
especi
everyon
differ
adapt
game
make
possibl
everyon
play
video
togeth
came
would
consid
technolog
dinosaur
mani
way
advanc
market
today
work
equit
regardless
skin
color
gender
disabl
statu
today
advanc
meet
whether
plan
bask
sun
cool
indoor
summer
favorit
board
play
get
spirit
pandem
commun
us
last
fall
across
countri
sick
remot
learn
wari
send
back
take
class
plan
stick
even
pandem
though
white
isolationist
divers
swath
took
opportun
learn
last
year
often
help
tech
virtual
especi
base
cultur
racial
key
set
know
pulmonari
taken
eight
ill
part
screen
project
last
year
duke
univers
team
seek
valid
new
test
found
two
ago
clinic
infecti
show
novel
coronaviru
process
leap
anim
world
peopl
viru
covid
probabl
new
viru
accident
bystand
whose
various
turn
evid
flu
caus
diseas
soon
know
clear
covid
canin
viral
caus
covid
belong
separ
genera
coronaviru
famili
nevertheless
world
absolut
sure
found
much
sooner
covid
suppos
need
faster
detect
possibl
novel
pathogen
lie
conceal
lab
freezer
sinc
earli
much
work
still
novel
coronaviru
human
find
academ
public
colin
j
exasper
assist
professor
univers
medic
center
princip
investig
consortium
viral
emerg
research
initi
show
us
notif
system
human
diseas
broken
effort
repair
diseas
detect
one
day
paper
unit
kingdom
prime
minist
johnson
govern
creat
new
global
pandem
radar
track
covid
built
known
genom
covid
within
need
build
system
diseas
surveil
fit
centuri
data
rapid
genom
respons
johnson
littl
disagr
better
faster
surveil
fact
first
independ
review
covid
crisi
two
johnson
announc
global
alert
system
meek
scath
report
independ
panel
pandem
prepared
respons
covid
centuri
moment
key
element
pandem
prevent
new
global
system
surveil
base
full
transpar
digit
accid
made
close
togeth
june
global
govern
tradit
global
health
health
world
health
assembl
gather
jointli
set
polici
world
health
organ
current
presid
johnson
made
announc
summit
assembl
prep
host
meet
pandem
world
turn
attent
rapid
identif
whichev
one
come
next
good
yet
world
alreadi
mani
surveil
covid
global
outbreak
alert
respons
network
kind
listen
network
new
hub
pandem
intellig
berlin
global
influenza
surveil
respons
system
network
made
nation
philanthrop
surveil
nation
health
network
research
infecti
new
agenc
zoonot
emerg
intern
digit
health
artifici
intellig
research
collabor
region
diseas
surveil
six
cover
middl
east
version
health
us
intern
deep
breath
array
academ
nonprofit
detect
malaria
tuberculosi
fungal
wildlif
short
world
need
anoth
surveil
system
plethora
one
reason
foundat
recent
pandem
prevent
institut
instead
creat
hub
data
rather
new
one
much
detail
new
effort
govern
think
along
similar
effort
philanthrop
trust
concept
organ
link
provid
resourc
data
analysi
infrastructur
along
oper
day
johnson
made
announc
director
state
plan
would
creat
system
local
intern
let
get
success
system
world
go
new
detect
respons
network
need
made
scope
way
end
anoth
system
power
pinpoint
risk
spin
risk
play
epidemiologist
senior
scholar
center
health
secur
think
issu
decad
sinc
work
administr
ye
better
pandem
predict
discuss
least
long
laid
last
year
propos
nation
center
epidem
forecast
foreign
ventur
capit
firm
wrote
pandem
predict
justifi
research
necessarili
step
away
public
servic
need
give
diseas
financi
support
work
advanc
formal
feder
call
work
nation
weather
servic
alreadi
propos
read
right
peopl
five
day
presid
joe
inaugur
new
administr
nation
center
epidem
forecast
outbreak
analyt
march
million
part
rescu
plan
come
us
agenc
intern
effort
dovetail
hing
data
abund
data
granular
data
centuri
inaccuraci
weather
forecast
butt
made
reliabl
endeavor
radar
weather
power
graphic
understand
repres
help
us
scan
horizon
alreadi
exist
read
one
mobil
data
purchas
search
use
repres
inform
fuel
predict
public
health
yet
good
job
data
get
even
rich
global
south
problem
wors
much
heterogen
underli
variou
data
help
countri
ring
alarm
let
alon
contribut
global
forecast
even
matter
move
paper
digit
hard
see
skip
end
advanc
radar
system
without
first
basic
jurisdict
big
undertak
take
test
instanc
would
desir
plug
diagnost
done
health
care
sort
whether
wave
respiratori
common
viru
new
strain
mani
peopl
lack
access
health
care
diagnost
data
limit
predict
power
hand
peopl
use
sewag
sampl
detect
without
intrud
individu
privaci
forc
construct
record
data
anoth
gap
alreadi
exist
human
diseas
wildlif
livestock
separ
run
differ
unit
one
system
ring
alarm
bell
oversight
sinc
mani
zoonot
begin
leap
revel
two
ago
coronaviru
carri
dog
found
old
throat
peopl
point
came
light
belatedli
academ
project
get
notif
system
indic
anyon
set
anyth
new
track
viru
go
keep
eye
canin
know
viru
recombin
way
transmit
seen
realli
limit
way
know
potenti
threat
health
secur
global
final
question
pandem
radar
face
colonialist
model
resourc
commod
global
south
use
benefit
global
diseas
surveil
midst
concern
spread
avian
flu
stop
send
collect
within
flu
surveil
network
nation
say
world
govern
time
experienc
bird
flu
possibl
leverag
inequ
affluent
use
develop
vaccin
inexpens
compet
buy
product
would
without
immedi
crisi
fade
thank
complex
negoti
countri
underli
issu
viral
sovereignti
never
realli
went
away
surfac
epidem
earli
day
covid
possibl
fresh
attent
need
global
surveil
becom
moment
global
south
get
assist
deserv
collect
data
benefit
well
realli
need
broadli
distribut
surveil
system
local
collect
inform
relev
ownership
data
advoc
commun
need
v
assist
professor
northeastern
univers
emerg
lab
someth
built
easili
narrow
window
right
basic
whole
planet
need
solv
binari
never
mani
peopl
shot
obtain
vaccin
come
lack
sick
leav
would
let
risk
side
effect
meet
elig
criteria
earli
day
suppli
limit
becom
clear
binari
anoth
enorm
group
peopl
receiv
shot
immun
manufactur
adequ
take
make
sure
organ
tamp
overact
immun
rheumatoid
arthriti
lupu
altern
undermin
abil
defend
hand
research
past
find
result
receiv
covid
creat
mani
defens
healthi
peopl
contract
diseas
despit
fulli
protect
must
continu
behav
though
never
result
seek
extra
third
hope
act
booster
studi
annal
intern
medicin
team
univers
school
medicin
experi
peopl
live
organ
sought
third
shot
immun
second
none
high
antibodi
fact
six
antibodi
respons
third
shot
saw
improv
antibodi
consid
import
though
made
small
group
someth
typic
thought
weak
studi
point
way
peopl
rejoin
societi
help
explain
rare
breakthrough
occur
small
fraction
fulli
peopl
cluster
breakthrough
last
month
among
peopl
work
new
york
basebal
team
underli
link
found
hope
l
studi
senior
author
professor
surgeri
lot
transplant
excit
vaccin
got
check
suboptim
show
someth
done
minut
third
understand
possibl
sticki
regulatori
worth
look
first
chronic
immun
complic
team
among
first
tackl
issu
last
one
day
food
drug
administr
emerg
use
pfizer
group
put
call
social
media
peopl
enrol
trial
would
keep
track
health
document
almost
peopl
first
week
almost
registri
march
group
first
data
among
transplant
percent
detect
one
dose
pfizer
discouragingli
low
contrast
everi
particip
clinic
antibodi
product
day
first
dose
vaccin
accord
data
academ
studi
antibodi
two
transplant
social
media
first
group
good
bad
news
good
studi
group
percent
first
dose
second
bad
percent
antibodi
group
academ
team
think
problem
soon
avail
univers
medic
center
new
york
take
care
kidney
transplant
worri
sever
qualifi
yet
vaccin
pass
immun
sever
still
came
covid
worri
nephrolog
depart
staff
kidney
transplant
receiv
antibodi
test
two
second
shot
end
march
went
test
percent
antibodi
disappoint
immunolog
sens
purpos
vaccin
induc
bodi
develop
protect
along
immun
system
infect
drug
transplant
take
keep
donat
suppress
antibodi
product
goal
work
vaccin
intend
design
blunt
immun
respons
new
pathogen
typic
biggest
pathogen
expos
speak
new
kidney
assist
professor
medicin
first
author
account
regimen
design
prevent
antibodi
product
import
say
new
territori
order
get
author
peopl
immun
covid
vaccin
clinic
broad
assumpt
among
would
less
respons
vaccin
attempt
gather
data
run
spring
first
defin
vaccin
effect
continu
vulner
patient
transplant
peopl
low
antibodi
covid
vaccin
instanc
analysi
preprint
yet
journal
peopl
blood
bone
marrow
two
covid
percent
made
immun
suppress
drug
blame
immun
statu
one
particular
blood
cancer
known
chronic
lymphocyt
leukemia
even
less
like
make
immun
respons
percent
detect
even
though
take
low
feel
tell
whole
stori
senior
author
analysi
transplant
infecti
physician
univers
medic
center
frustrat
risk
still
good
immun
technic
protect
covid
know
protect
antibodi
look
healthi
far
rang
person
drop
still
yet
defens
bodi
creat
immun
make
memori
b
vaccin
clinic
attempt
measur
cell
creat
effect
defens
viru
clinic
whether
someon
serious
ill
diseas
alon
miss
import
immun
respons
tri
use
respond
vaccin
someon
make
princip
investig
studi
recruit
peopl
rang
immun
order
studi
covid
vaccin
respons
worri
drive
vaccin
hesit
vaccin
work
think
littl
account
immun
system
even
done
far
clear
immun
respons
depend
age
patient
type
immun
deficit
type
transplant
receiv
specif
take
length
time
sinc
transplant
last
dose
host
likelihood
abund
antibodi
product
higher
instanc
take
treat
chronic
inflammatori
transplant
cancer
done
team
show
better
antibodi
product
one
two
separ
preprint
done
univers
school
medicin
st
san
wide
rang
depend
drug
regimen
patient
provid
clue
vulner
get
closer
kind
immun
protect
otherwis
healthi
peopl
receiv
covid
one
thing
tell
suppress
gotten
yet
consid
hold
medicin
h
j
kim
studi
senior
author
assist
professor
immunolog
univers
obvious
hold
risk
go
flare
make
vaccin
side
effect
wors
make
vaccin
less
effect
realli
tricki
situat
legal
current
advis
seek
extra
covid
vaccin
author
one
two
let
enter
us
market
team
studi
prescrib
third
found
third
way
studi
specifi
team
track
evid
medic
literatur
support
util
addit
instanc
govern
third
dose
anyon
us
understood
second
dose
season
flu
vaccin
hepat
b
vaccin
creat
immun
necessari
gather
data
sure
team
trial
seek
third
would
enrol
track
formal
way
despit
allur
higher
protect
urg
start
third
take
third
risk
third
dose
activ
immun
system
caus
either
overt
reject
sort
subclin
thing
start
develop
littl
organ
import
peopl
go
get
third
either
part
research
collabor
yield
one
recent
nation
let
get
back
everyday
life
illumin
immun
system
interact
still
well
understood
benefit
pandem
whatev
need
protect
year
later
multipl
effect
age
older
elig
get
shot
easier
come
reflect
increas
hope
recent
relax
fulli
peopl
forgo
indoor
outdoor
mani
public
transit
decis
prove
make
new
charg
alreadi
social
awkward
year
lone
isol
limit
outsid
world
becom
even
fraught
one
recent
walk
neighbor
stop
away
sidewalk
dug
back
us
put
anyway
gave
embarrass
apologet
head
thought
better
public
health
wake
celebratori
sticker
button
got
shot
sprung
easi
dismiss
vaccin
swag
opportunist
profit
small
joy
afford
vaccin
serv
import
year
face
first
line
protect
deadli
diseas
refus
wear
one
polit
signal
see
anoth
unmask
person
trust
year
unrel
divis
honor
system
riski
proposit
widespread
attent
obscur
fact
peopl
take
protect
actual
number
peopl
refus
compli
actual
small
lee
professor
health
commun
h
school
public
health
percent
say
get
vaccin
though
taken
johnson
johnson
vaccin
million
peopl
us
number
still
rise
though
pace
ago
backfir
open
scorn
got
vaccin
perhap
deserv
peopl
vaccin
much
easier
come
wear
pin
sticker
new
social
norm
public
support
public
confus
live
area
percent
popul
walk
room
full
feel
lot
better
take
mask
lot
swag
cute
afford
way
commemor
begin
end
year
pick
enamel
pin
small
ador
vaccin
merch
printabl
sticker
well
digit
post
vaccin
statu
social
media
want
check
local
apparel
shop
tri
avoid
sport
scold
aggress
think
execut
director
center
commun
alreadi
feel
around
vaccin
polit
come
job
work
encourag
peopl
adopt
healthi
pandem
includ
vaccin
incred
chang
quickli
even
year
half
old
new
pandem
flexibl
adapt
move
forward
ambigu
harder
err
side
caution
still
mani
mask
mandat
remain
clear
public
transport
health
care
larg
peopl
congreg
indoor
ambigu
learn
navig
respect
comfort
languag
consent
feel
comfort
take
mask
feel
comfort
whichev
way
choos
talk
vaccin
stay
respect
rememb
valid
peopl
mask
mayb
want
risk
unvaccin
young
spoke
mani
continu
wear
especi
health
care
crowd
even
relax
wear
mask
mean
person
unnecessarili
paranoid
believ
scienc
mask
wear
necessarili
go
away
continu
even
peopl
around
us
prevent
measur
take
peopl
get
pandem
great
shape
back
relat
stori
neighbor
mask
confus
spoke
situat
bad
uncomfort
felt
time
actual
good
thing
cautiou
peopl
person
public
health
us
focu
fight
peopl
right
think
take
time
get
discomfort
perfectli
fine
even
mani
us
confus
guidanc
necessarili
mean
wrong
wear
wear
help
move
us
closer
goal
reduc
believ
guidanc
ground
scienc
director
urban
health
master
public
health
program
northeastern
univers
good
amount
recent
research
come
show
far
effect
even
initi
evid
start
relax
fulli
pandem
yet
peopl
let
guard
soon
anoth
surg
commun
import
vaccin
honest
transpar
way
address
tri
reduc
divis
around
greater
likelihood
abl
put
pandem
behind
us
angri
disappoint
actual
let
use
opportun
talk
pretti
much
everywher
look
devic
import
least
basic
understand
think
magnet
stuck
refriger
exampl
nope
actual
quit
complic
basic
magnet
electromagnet
electr
posit
neg
creat
electr
move
electr
charg
magnet
field
make
electr
move
batteri
wire
wire
one
end
batteri
electr
current
flow
move
want
see
electr
current
magnet
field
next
put
wire
top
magnet
compass
see
needl
point
new
direct
make
magnet
field
even
wrap
wire
around
someth
made
iron
electromagnet
build
whole
consid
magnet
stuck
look
batteri
electr
current
creat
magnet
field
honest
start
get
complic
order
figur
solid
object
magnet
field
go
atom
matter
made
made
three
act
tini
littl
character
term
magnet
moment
ye
even
neutral
neutron
magnet
moment
total
magnet
moment
atom
vector
sum
within
exampl
let
consid
two
differ
two
atom
left
magnet
opposit
essenti
cancel
make
magnet
field
overal
pretti
small
right
magnet
direct
add
low
magnet
moment
produc
signific
magnet
field
ferromagnet
iron
nickel
cobalt
ceram
pure
ferromagnet
materi
make
someth
magnet
grab
iron
nail
act
bar
magnet
turn
one
fairli
easili
small
piec
iron
nearbi
interact
magnet
caus
magnet
align
region
magnet
domain
get
magnet
point
direct
iron
act
make
happen
simpl
use
anoth
magnet
strong
magnet
near
unalign
forc
line
actual
possibl
find
ground
ferromagnet
call
strong
magnet
lightn
grab
bunch
metal
stuff
around
hous
probabl
steel
alloy
made
iron
aluminum
copper
brass
oh
cast
iron
pot
cours
made
iron
iron
steel
import
rememb
interact
ferromagnet
inde
magnet
human
steel
iron
spoon
would
stick
head
silver
would
peopl
spoon
make
metal
center
diseas
control
prevent
list
three
covid
given
emerg
use
author
unit
agenc
specif
free
iron
nickel
cobalt
lithium
rare
earth
carbon
list
show
three
contain
form
sodium
sodium
chlorid
sodium
acet
one
potassium
chlorid
potassium
sodium
mean
kind
metal
associ
professor
chemistri
physic
potassium
sodium
metal
solid
form
solid
solut
told
wire
individu
dispers
solut
liquid
compos
mostli
water
spars
individu
potassium
sodium
addit
activ
vaccin
solut
basic
bodi
need
work
properli
get
exercis
cours
neither
potassium
sodium
ferromagnet
caus
magnet
interact
normal
someon
spoon
head
prove
magnet
get
stick
human
skin
sweat
us
littl
sticki
us
object
larg
flat
surfac
greater
contact
area
skin
like
stay
stuck
let
take
iron
ferromagnet
materi
mani
peopl
put
bodi
everi
day
breakfast
ye
actual
iron
prove
classic
scienc
experi
tri
get
favorit
cereal
grind
put
cup
water
put
magnet
magnet
attract
iron
cereal
pull
super
strong
magnet
work
much
iron
abl
harvest
type
cocoa
cereal
found
hous
put
aluminum
foil
magnet
easili
remov
iron
afterward
metal
good
matter
much
cereal
eat
make
receiv
weekli
roundup
coronaviru
news
sign
us
reach
goal
vaccin
week
white
hous
us
fall
short
presid
get
percent
least
partial
million
peopl
fulli
percent
peopl
older
holiday
say
us
hit
initi
later
us
among
peopl
accord
recent
associ
press
analysi
thank
part
misinform
vaccin
us
particularli
south
feder
local
work
help
boost
recent
lotteri
peopl
gotten
presid
travel
north
yesterday
encourag
peopl
yet
get
spread
across
us
around
gain
momentum
us
gamma
first
brazil
japan
delta
first
gamma
dramat
contagi
research
slightli
resist
delta
meanwhil
percent
contagi
alpha
variant
first
thought
caus
diseas
though
still
effect
delta
variant
behind
recent
wave
extrem
brutal
grow
concern
potenti
virul
version
delta
strain
known
delta
plu
spike
protein
mutat
found
beta
variant
first
south
indic
delta
plu
found
nearli
dozen
us
declar
variant
concern
move
freeli
home
abroad
open
long
year
plu
insid
mani
head
world
summer
peopl
get
back
take
move
freeli
within
suffer
reduc
subsequ
financi
transit
across
countri
come
creativ
way
lure
peopl
back
onto
name
lower
intern
travel
us
exampl
relax
travel
allow
peopl
fulli
travel
us
without
countri
per
guidanc
fulli
travel
freeli
domest
abroad
long
take
week
court
end
conservatorship
life
past
even
spoke
gave
tornado
histori
tore
peopl
surviv
massiv
cloud
race
toward
per
hour
writer
alway
get
want
world
chang
peopl
perman
work
remot
accord
one
economist
percent
like
take
place
remot
percent
beforehand
respons
spate
serv
new
class
perman
remot
potenti
nomad
offer
live
home
school
move
place
place
truth
know
remot
world
peopl
start
return
return
better
sens
miss
earli
day
pandem
us
limit
test
capac
symptomat
peopl
recent
travel
close
contact
someon
travel
confirm
year
later
clear
proport
viral
high
presymptomat
asymptomat
make
difficult
trace
transmiss
studi
clinic
infecti
june
blood
collect
march
found
nine
peopl
five
us
mean
viru
like
present
us
late
suspect
probabl
confirm
suggest
probabl
multipl
prior
initi
st
infecti
diseas
research
medic
school
involv
studi
indic
probabl
use
serolog
find
potenti
even
similar
way
nation
health
across
us
recruit
us
research
aim
collect
health
data
lot
peopl
mani
ultim
goal
make
medicin
studi
therefor
along
gather
medic
histori
blood
across
us
earli
upa
public
health
recruit
test
longitudin
epidemiologist
school
public
health
us
team
look
previous
collect
see
whether
present
would
target
line
investig
help
us
put
togeth
puzzl
earli
day
help
us
understand
improv
upon
prepared
futur
across
countri
simultan
detect
us
team
partnership
group
quest
diagnost
sent
clinic
lab
antibodi
test
two
sampl
one
target
protein
genom
one
target
viral
spike
protein
peopl
gave
blood
march
posit
direct
toward
nine
test
posit
posit
particip
taken
collect
two
first
offici
case
report
state
found
peopl
collect
offici
averag
two
g
detect
talk
potenti
infect
sometim
even
prior
corrobor
extend
studi
led
diseas
control
found
blood
collect
michigan
island
prior
reason
conclus
base
fact
unlik
caught
first
case
mani
khan
univers
particip
work
found
small
number
rel
larg
sampl
test
possibl
number
antibodi
true
situat
low
preval
fals
someth
wrestl
sequenti
test
strategi
two
subsequ
quantif
simul
ran
predict
use
indic
unlik
due
error
evid
pursu
futur
accord
st
neutral
mix
serum
isol
blood
live
viru
see
strongli
suggest
neutral
test
would
realli
seal
deal
mean
us
import
rememb
small
sampl
happen
countri
time
st
mani
call
sens
need
improv
surveil
detect
infecti
catch
earli
realli
small
view
happen
scientist
two
new
although
neither
proven
caus
ill
spread
peopl
one
studi
anim
host
one
viru
anoth
studi
found
coronaviru
like
stem
dog
first
time
canin
coronaviru
shown
infect
research
clearli
desper
evalu
critic
regard
frequenc
coronaviru
transmiss
potenti
spread
ralph
baric
virologist
univers
north
chapel
hill
involv
either
studi
dog
studi
clinic
infecti
stem
question
gray
infecti
diseas
epidemiologist
duke
univers
earli
pandem
whether
alreadi
peopl
one
day
spark
graduat
student
coauthor
design
test
would
detect
previous
unknown
team
use
diagnost
test
screen
nasal
taken
pneumonia
eight
percent
evid
prior
exposur
novel
coronaviru
seven
scienc
previous
undetect
viru
pretti
high
preval
gray
remark
gray
sent
viru
expert
anim
state
univers
found
viru
actual
genom
felin
coronaviru
anoth
part
similar
porcin
coronaviru
major
genom
similar
two
previous
isol
dog
abl
grow
viru
canin
cell
canin
thought
peopl
never
clear
viru
pneumonia
yet
known
viru
capabl
person
person
adult
immun
system
react
realli
evid
right
viru
caus
sever
ill
press
releas
find
viru
key
found
canin
found
infect
studi
determin
mutat
necessari
jump
rule
possibl
point
new
coronaviru
becom
preval
human
pathogen
coronaviru
abl
infect
human
speak
virologist
univers
medic
care
say
paper
proven
mean
would
need
infect
human
viru
order
show
pneumonia
experi
would
uneth
instead
test
see
common
viru
pneumonia
use
anim
test
pig
studi
preprint
march
sinc
journal
new
coronaviru
serum
three
came
hospit
univers
abl
grow
viru
monkey
genom
analysi
close
known
pars
four
beta
gamma
thought
infect
scienc
one
hong
thought
viru
outbreak
swine
us
sinc
shown
infect
human
well
danger
caus
signific
true
coronaviru
isol
never
trigger
univers
virologist
benjamin
scienc
feel
much
comfort
wild
world
taken
togeth
suggest
like
higher
previous
thought
think
look
find
cross
speci
everywher
univers
virologist
involv
work
scienc
goal
move
forward
gray
press
releas
seek
caus
ill
peopl
like
miss
import
anim
begin
adapt
peopl
intermingl
open
good
screen
earli
warn
new
viru
becom
futur
pandem
viru
scientist
citi
contain
sudden
coronaviru
surg
russia
saint
record
death
count
sever
despit
global
spread
highli
contagi
vaccin
brought
numer
mostli
wealthi
rise
delta
variant
first
new
viru
alreadi
nearli
four
million
would
impos
new
nation
variant
shut
week
transport
normal
bustl
nearli
desert
peopl
order
stay
home
except
essenti
multipl
suspens
travel
arrang
respons
minist
suspens
would
give
time
consid
make
bubbl
predepartur
test
two
new
appli
five
million
peopl
along
live
nearbi
shock
sudden
outbreak
citi
return
rel
normal
struggl
get
back
last
year
work
bakeri
central
today
anoth
kick
slowli
get
highest
citi
pandem
still
world
health
organ
number
new
sinc
decreas
delta
variant
new
previous
bring
viru
control
current
lot
concern
delta
variant
chief
told
press
confer
delta
transmiss
far
least
spread
rapidli
among
unvaccin
russia
host
saint
countri
highest
daili
death
count
citi
sinc
start
citi
alreadi
six
due
host
next
viru
last
seen
explos
new
sinc
driven
delta
variant
spread
nonetheless
brought
end
mandatori
outdoor
year
rule
first
devast
first
wave
decis
came
despit
announc
major
coronaviru
cluster
student
trip
holiday
island
peopl
order
end
outdoor
eas
indoor
dine
peopl
test
scrap
coronaviru
health
minist
week
countri
use
pfizerbiontech
gave
adequ
protect
delta
delta
contagi
say
per
cent
popul
would
need
jab
order
contain
target
even
signific
vaccin
sever
shown
slightli
less
effect
delta
still
highli
effect
second
one
world
success
vaccin
seen
link
variant
surg
sinc
drop
requir
wear
public
day
four
day
new
day
health
ministri
revers
head
pandem
respons
ash
rise
yet
parallel
rise
latest
surg
alarm
rate
least
delta
variant
unpreced
diseas
control
prevent
one
per
cent
fulli
ratio
latest
news
live
get
news
around
world
watch
live
news
follow
us
tri
tell
us
think
learn
pediatr
infecti
diseas
hospit
medic
research
institut
new
public
health
crise
threaten
world
emerg
spread
novel
coronaviru
sever
acut
respiratori
syndrom
coronaviru
viru
bat
yet
unknown
intermediari
wuhan
provinc
china
around
coronaviru
diseas
date
diseas
inhal
contact
infect
incub
period
usual
fever
cough
sore
throat
breathless
fatigu
malais
among
diseas
mild
peopl
usual
elderli
progress
pneumonia
acut
respiratori
distress
syndrom
organ
dysfunct
mani
peopl
asymptomat
case
fatal
rate
rang
diagnosi
demonstr
viru
respiratori
special
molecular
common
laboratori
includ
normal
low
white
cell
elev
protein
tomograph
chest
scan
usual
abnorm
even
mild
diseas
treatment
essenti
support
role
antivir
yet
establish
prevent
home
isol
suspect
mild
strict
infect
control
includ
contact
droplet
viru
faster
two
middl
east
respiratori
syndrom
coronaviru
lower
fatal
global
impact
new
epidem
yet
novel
coronaviru
sever
acut
respiratori
syndrom
corona
viru
rapidli
spread
origin
wuhan
citi
provinc
china
rest
world
till
around
coronaviru
diseas
till
date
fortun
far
infrequ
affect
futur
cours
viru
unknown
articl
bird
eye
view
new
viru
sinc
knowledg
viru
rapidli
updat
posit
sens
rang
diamet
spike
surfac
give
crown
appear
electron
microscop
henc
name
coronaviru
four
corona
name
circul
gener
caus
mild
respiratori
two
past
two
wherein
crossov
anim
sever
diseas
first
instanc
new
coronaviru
genera
origin
bat
cross
via
intermediari
host
palm
civet
provinc
china
viru
sever
acut
respiratori
syndrom
coronaviru
affect
peopl
mostli
china
hong
mortal
rate
almost
decad
later
middl
east
respiratori
syndrom
coronaviru
bat
origin
dromedari
intermedi
host
affect
peopl
fatal
rate
wuhan
capit
citi
provinc
major
transport
hub
china
local
sever
pneumonia
unknown
caus
mani
initi
common
exposur
wholesal
market
live
surveil
system
put
place
outbreak
respiratori
sent
refer
china
notifi
outbreak
world
health
organ
sea
food
market
close
viru
coronaviru
homolog
bat
coronaviru
similar
environment
sea
food
market
test
posit
viru
number
increas
exponenti
exposur
live
anim
market
suggest
fact
transmiss
first
fatal
case
massiv
migrat
new
year
epidem
china
japan
south
quick
success
peopl
wuhan
transmiss
million
popul
wuhan
lock
entri
exit
region
soon
lock
extend
provinc
outsid
china
histori
travel
china
suggest
local
transmiss
differ
put
screen
detect
symptomat
peopl
china
isol
test
soon
appar
infect
asymptomat
peopl
onset
therefor
wuhan
special
china
peopl
symptomat
otherwis
isol
test
continu
increas
exponenti
epidem
doubl
time
fact
china
definit
confirm
includ
neg
pend
molecular
clinic
radiolog
lead
increas
singl
day
china
intern
convey
cruis
ship
diamond
princess
coast
japan
import
note
number
new
reduc
china
late
exponenti
south
infect
critic
condit
china
till
seen
sudden
spurt
mostli
one
case
travel
back
expos
larg
number
school
birthday
parti
citi
hotel
mani
possibl
underestim
infect
dead
due
surveil
test
though
bat
intermediari
anim
cross
uncertain
current
suscept
infect
larg
sneez
symptomat
occur
asymptomat
peopl
onset
shown
higher
viral
nasal
caviti
throat
differ
viral
burden
symptomat
asymptomat
peopl
infecti
long
last
even
clinic
recoveri
peopl
act
super
citizen
confer
infect
peopl
resort
upon
return
infect
spread
deposit
viru
remain
viabl
day
atmospher
less
minut
common
sodium
hypochlorit
hydrogen
peroxid
infect
acquir
either
inhal
touch
touch
nose
mouth
viru
present
stool
contamin
water
suppli
subsequ
transmiss
via
oral
rout
per
current
inform
transmiss
pregnant
fetu
howev
neonat
diseas
due
post
natal
transmiss
incub
period
median
receptor
receptor
viru
respiratori
mucosa
basic
case
reproduct
rate
rang
variou
comparison
pandem
flu
clinic
vari
rang
asymptomat
state
acut
respiratori
distress
syndrom
organ
dysfunct
common
clinic
includ
fever
cough
sore
throat
headach
fatigu
headach
myalgia
breathless
conjunct
thu
indistinguish
respiratori
subset
end
first
week
diseas
progress
pneumonia
respiratori
failur
death
progress
associ
extrem
rise
inflammatori
median
time
onset
dyspnea
hospit
acut
respiratori
distress
syndrom
need
intens
care
admiss
affect
seri
includ
acut
lung
injuri
shock
acut
kidney
injuri
recoveri
median
durat
hospit
stay
advers
death
common
elderli
underli
fatal
fatal
rate
adult
rang
overal
case
fatal
rate
rang
interestingli
diseas
outsid
provinc
milder
wuhan
similarli
sever
case
fatal
rate
outsid
china
milder
either
due
select
bia
wherein
wuhan
includ
sever
due
predisposit
popul
viru
due
higher
express
respiratori
mucosa
diseas
significantli
milder
adult
seri
admit
hospit
china
median
age
mo
infect
link
famili
member
histori
provinc
china
either
asymptomat
mild
diseas
sever
critic
seen
common
fever
cough
symptomat
therapi
one
case
sever
pneumonia
dysfunct
child
similarli
neonat
mild
suspect
case
defin
one
fever
sore
throat
cough
histori
travel
china
persist
local
transmiss
contact
similar
travel
histori
confirm
infect
howev
asymptomat
even
without
fever
confirm
case
suspect
case
posit
molecular
diagnosi
specif
molecular
respiratori
throat
swab
nasopharyng
swab
sputum
bronchoalveolar
lavag
viru
stool
sever
blood
must
multiplex
current
avail
includ
commerci
avail
present
suspect
case
appropri
sampl
sent
refer
nation
institut
virolog
epidem
commerci
becom
laboratori
usual
non
specif
white
cell
count
usual
normal
low
lymphopenia
lymphocyt
count
associ
sever
diseas
platelet
count
usual
normal
mildli
low
gener
elev
usual
normal
high
level
indic
bacteri
prothrombin
time
creatinin
elev
high
associ
sever
chest
usual
bilater
normal
earli
diseas
sensit
specif
gener
ground
glass
sub
segment
consolid
abnorm
asymptomat
clinic
evid
lower
respiratori
tract
involv
fact
abnorm
use
diagnos
suspect
neg
molecular
diagnosi
mani
posit
molecular
repeat
test
differenti
diagnosi
respiratori
viral
influenza
respiratori
syncyti
viru
human
non
coronaviru
atyp
bacteri
possibl
differenti
clinic
routin
lab
therefor
travel
histori
becom
import
howev
epidem
travel
histori
becom
essenti
support
first
step
ensur
adequ
isol
later
prevent
transmiss
mild
ill
home
danger
usual
hydrat
nutrit
fever
cough
routin
use
confirm
provis
oxygen
nasal
face
mask
high
flow
nasal
cannula
ventil
mechan
ventil
even
extra
corpor
membran
oxygen
support
renal
replac
therapi
suspect
proven
role
unproven
current
intern
consensu
advoc
use
recommend
short
term
therapi
dose
detail
critic
care
manag
treatment
antivir
use
base
experi
histor
control
studi
better
given
alon
case
seri
infect
wuhan
oxygen
given
ventil
mechan
ventil
extracorpor
membran
oxygen
continu
renal
replac
therapi
intraven
therapi
antivir
therapi
given
durat
ventil
median
mechan
ventil
median
case
seri
basic
treatment
need
intens
care
anecdot
experi
use
broad
spectrum
anti
drug
manag
evid
therapi
antivir
drug
avail
russia
china
intraven
chloroquin
plasma
addit
tradit
find
place
sinc
time
infect
prevent
crucial
sever
viru
make
prevent
difficult
name
nonspecif
diseas
infect
even
onset
incub
period
transmiss
asymptomat
peopl
long
incub
period
tropism
mucos
conjunctiva
durat
ill
transmiss
even
clinic
confirm
suspect
mild
ill
home
ventil
home
good
sunlight
allow
destruct
viru
wear
simpl
surgic
mask
practic
cough
hygien
wear
surgic
mask
room
patient
use
hand
hygien
everi
risk
transmiss
outbreak
affect
till
date
almost
china
infect
doctor
first
viru
import
protect
ensur
continu
care
prevent
transmiss
infect
droplet
pathogen
categori
b
infecti
highli
pathogen
china
nation
health
commiss
infect
control
categori
cholera
plagu
separ
togeth
neg
pressur
gener
equip
undergo
regular
decontamin
prefer
sodium
hypochlorit
provid
fit
test
protect
transmiss
taken
aerosol
gener
intub
suction
develop
isol
afebril
two
consecut
neg
molecular
sampl
interv
recommend
differ
pandem
flu
resum
afebril
h
day
ill
neg
molecular
prerequisit
commun
level
peopl
avoid
crowd
postpon
nonessenti
travel
ongo
transmiss
practic
cough
hygien
sleev
tissu
rather
practic
hand
hygien
frequent
everi
min
respiratori
use
surgic
use
mask
healthi
peopl
public
shown
protect
respiratori
viral
current
howev
china
public
wear
public
especi
crowd
larg
scale
entertain
china
consid
legisl
prohibit
sell
trade
wild
intern
respons
dramat
initi
massiv
travel
china
peopl
china
china
clinic
isol
test
even
asymptomat
howev
rapid
world
wide
spread
viru
travel
extend
whether
lead
viral
spread
candid
vaccin
time
write
articl
risk
coronaviru
extrem
low
chang
next
henc
follow
take
travel
histori
respiratori
intern
travel
past
well
contact
sick
peopl
travel
set
system
triag
respiratori
ill
outpati
depart
give
simpl
surgic
mask
wear
use
surgic
examin
practic
hand
hygien
govern
isol
test
time
hospit
commerci
test
yet
avail
admit
sever
pneumonia
acut
respiratori
distress
syndrom
travel
histori
contact
droplet
isol
regular
decontamin
done
test
etiolog
multiplex
logist
permit
pathogen
refer
test
keep
recent
global
spread
intern
travel
stop
spread
fals
inform
diseas
tri
allay
panic
anxieti
new
viru
outbreak
econom
medic
public
health
infrastructur
china
extent
especi
time
alon
tell
viru
impact
futur
zoonot
origin
like
continu
therefor
apart
curb
outbreak
made
devis
comprehens
prevent
futur
zoonot
natur
remain
neutral
regard
jurisdict
institut
natur
remain
neutral
regard
jurisdict
institut
cell
infect
yellow
artifici
variant
easili
nation
photo
year
pandem
natur
key
help
keep
flood
coronaviru
research
continu
coverag
import
go
natur
news
worker
dose
vaccin
woman
one
vaccin
dose
nearli
halv
transmiss
singl
dose
vaccin
made
either
pfizer
person
risk
much
half
accord
analysi
unit
shown
reduc
seriou
ill
abil
prevent
coronaviru
transmiss
unclear
public
health
someon
infect
dose
either
vaccin
r
j
preprint
knowledg
hub
assess
often
viru
household
team
found
peopl
least
day
still
test
posit
viru
viral
transmiss
lower
transmiss
first
person
test
posit
two
similar
yet
peer
person
unit
martin
citi
covid
toll
vast
dealt
blow
peopl
low
socioeconom
statu
crowd
lack
health
care
inabl
work
greater
especi
among
peopl
age
accord
research
th
school
public
health
boston
g
e
scienc
team
found
sever
dispar
high
posit
test
inadequ
therefor
base
case
curb
epidem
appropri
mani
hospit
per
peopl
wealthi
strike
outsid
affluent
area
locat
data
mobil
team
found
peopl
suppos
stay
home
possibl
peopl
outsid
peopl
swab
mobil
test
track
pandem
hidden
regular
random
sampl
popul
quickli
resurg
even
young
riley
imperi
colleg
test
nose
throat
randomli
select
riley
scienc
studi
found
time
infect
rate
dip
low
test
popul
around
earli
height
unit
kingdom
first
wave
climb
peak
final
round
earli
second
wave
highest
among
young
age
among
age
older
younger
peopl
probabl
drove
resurg
age
reflect
data
routin
surveil
infect
younger
age
say
studi
benefit
commun
test
provid
earli
warn
even
low
cell
infect
red
artifici
credit
nation
photo
predict
vaccin
success
without
larg
vaccin
protect
product
key
viral
protein
studi
insight
confirm
speed
develop
trigger
divers
immun
manufactur
antibodi
bind
block
infecti
activ
kill
immun
predict
vaccin
success
easili
judg
candid
identifi
immun
import
vaccin
barney
graham
us
nation
institut
allergi
infecti
gave
rang
vaccin
expos
k
preprint
viral
genet
materi
highest
recogn
viral
spike
protein
molecul
vaccin
immun
correl
strongli
vaccin
protect
effect
yet
peer
parallel
studi
way
compar
immun
peopl
one
peopl
infect
despit
vaccin
protect
help
assess
futur
without
run
costli
clinic
senior
facil
receiv
counti
covid
outbreak
vaccin
test
vaccin
staff
new
march
unvaccin
worker
care
home
test
posit
time
home
receiv
second
dose
vaccin
vast
major
receiv
second
shot
worker
infect
us
diseas
control
prevent
report
peopl
care
home
infect
outbreak
mortal
rep
estim
vaccin
effect
among
staff
respect
past
second
dose
even
effect
hospit
although
one
resid
variant
outbreak
known
link
transmiss
immun
cell
infect
pink
credit
scienc
photo
previou
shorten
covid
infect
relat
reduc
durat
accord
analysi
spike
protein
power
peopl
rare
predat
pandem
bind
spike
search
possibl
link
protect
univers
studi
antibodi
infect
statu
local
two
preprint
team
found
peopl
rare
work
viru
high
two
categori
associ
recoveri
specul
protect
provid
respons
previou
infect
yet
peer
volunt
doctor
woman
common
asthma
medicin
shave
day
covid
clinic
trial
peopl
risk
seriou
found
asthma
medic
durat
diseas
asthma
drug
inexpens
wide
avail
steroid
butler
univers
test
peopl
principl
collabor
group
preprint
either
age
old
risk
randomli
assign
either
receiv
drug
serv
control
group
none
took
placebo
knew
receiv
took
twice
daili
two
end
three
day
use
steroid
yet
peer
man
dose
amir
covid
vaccin
scheme
vaccin
keep
worri
coronaviru
peopl
receiv
pfizer
vaccin
case
new
first
unit
kingdom
determin
effect
team
led
stern
univers
shay
research
institut
gan
breakthrough
among
sever
hundr
peopl
preprint
multitud
coronaviru
found
us
threat
unclear
multitud
coronaviru
found
us
threat
breakthrough
peopl
receiv
one
two
vaccin
number
unvaccin
age
date
infect
comparison
found
partial
peopl
slightli
like
unvaccin
studi
breakthrough
peopl
receiv
vaccin
eight
variant
first
south
one
infect
unvaccin
variant
suggest
vaccin
less
effect
variant
infect
low
rise
studi
say
suggest
vaccin
kept
variant
check
yet
peer
rapid
test
school
quick
show
valu
stop
covid
detect
coronaviru
lead
transmiss
accord
million
coronaviru
coronaviru
test
antigen
bolster
less
effect
chain
reaction
eyr
peto
hospit
test
data
collect
l
w
lee
preprint
studi
includ
data
one
million
peopl
posit
coronaviru
million
peopl
come
contact
team
use
data
perform
estim
sensit
rapid
nearli
led
infect
contact
team
found
peopl
higher
infecti
peopl
lower
variant
first
unit
kingdom
transmiss
yet
peer
sputnik
v
vaccin
caus
common
cold
shuttl
genet
materi
sputnik
v
vaccin
match
coronaviru
variant
first
south
evad
sputnik
v
vaccin
sputnik
v
nation
epidemiolog
microbiolog
trigger
product
protein
spike
viru
infect
host
worri
ineffect
lee
school
medicin
mount
new
york
citi
blood
serum
peopl
sputnik
v
preprint
test
serum
benign
make
spike
found
certain
team
found
inhibit
spike
variant
first
south
effect
overcom
spike
variant
first
unit
kingdom
emerg
new
requir
develop
new
gener
say
yet
peer
cell
blue
artifici
infect
scienc
photo
new
coronaviru
muscl
asid
potent
coronaviru
blunt
antibodi
respons
trigger
earli
collect
spot
pair
share
sever
affect
spike
protein
viru
infect
us
half
better
gaug
threat
univers
laboratori
abil
elud
preprint
peopl
receiv
two
either
pfizer
vaccin
averag
three
time
less
potent
found
yet
peer
rare
covid
hold
key
rare
covid
hold
key
duke
univers
north
separ
investig
x
n
j
team
pit
variant
three
peopl
vaccin
peopl
vaccin
made
peopl
laboratori
resist
inhibit
three
strain
viru
antibodi
potenc
similar
variant
first
unit
kingdom
current
highli
effect
suggest
like
remain
variant
team
vaccin
prepar
vaccin
site
trigger
vaccin
last
vaccin
immun
respons
least
six
vaccin
made
shown
effect
learn
whether
vaccin
last
protect
univers
school
medicin
studi
collect
peopl
receiv
vaccin
earli
phase
test
n
n
j
three
test
still
coronaviru
six
second
dose
vaccin
exampl
age
group
inhibit
version
laboratori
whether
vaccin
last
six
screen
peopl
air
travel
new
variant
coronaviru
variant
strain
previous
team
led
de
univers
south
ministri
health
variant
three
peopl
flew
de
preprint
variant
spike
protein
viru
infect
variant
studi
say
help
escap
peopl
immun
find
yet
peer
play
roughli
peopl
receiv
least
one
dose
guy
nation
race
vaccin
unvaccin
mani
peopl
stall
infect
even
among
unvaccin
one
vaccin
world
reach
popul
peopl
age
elig
test
rippl
effect
widespread
vaccin
tal
institut
technolog
test
march
peopl
preprint
commun
relationship
vaccin
rate
three
rate
posit
test
day
found
older
peopl
receiv
vaccin
infect
risk
among
proport
percentag
warn
previous
infect
even
though
studi
includ
low
infect
yet
peer
purpl
artifici
speckl
human
cell
green
credit
photo
march
new
coronaviru
spur
antibodi
peopl
infect
coronaviru
variant
first
south
effect
previous
suggest
work
rang
coronaviru
first
wave
coronaviru
peak
second
wave
peak
driven
recent
discov
variant
variant
partial
resist
previous
rais
effect
current
de
univers
south
health
research
institut
test
blood
plasma
peopl
south
infect
one
two
natur
team
found
plasma
second
wave
time
effect
variant
laboratori
dish
plasma
first
found
plasma
neutral
effect
similar
vaccin
protect
coronaviru
studi
pfizerbiontech
vaccin
pictur
highli
protect
infect
march
studi
sharpli
cut
infect
full
vaccin
risk
coronaviru
infect
roughli
accord
studi
us
receiv
shown
made
highli
effect
protect
peopl
ill
learn
whether
shield
peopl
becom
infect
first
place
mark
us
diseas
control
prevent
studi
test
nearli
peopl
whose
work
high
risk
infect
g
mortal
rep
studi
vaccin
viral
test
week
consid
fulli
two
second
dose
immun
effect
protect
peopl
infect
singl
dose
effect
caution
infect
vaccin
difficult
state
effect
infect
high
woman
babi
wuhan
china
first
march
coronaviru
last
immun
system
disabl
viru
last
least
nine
infect
everyon
detect
wang
union
medic
colleg
took
blood
peopl
randomli
select
wuhan
china
first
place
known
wide
affect
z
lancet
team
took
three
separ
time
cours
citi
june
team
test
indic
person
infect
found
popul
infect
viru
around
infect
peopl
produc
entir
studi
conclud
peopl
wuhan
still
suscept
infect
mass
vaccin
campaign
achiev
herd
cell
artifici
infect
nation
photo
march
infect
peopl
spot
togeth
process
cell
infect
multipl
distinct
viral
genet
materi
mix
copi
data
ben
univers
sever
aros
recombin
common
b
preprint
virolog
recombin
lineag
distinguish
becom
domin
strain
late
countri
team
found
evid
four
eight
spread
contain
version
spike
gene
protein
viru
enter
host
carri
variant
version
spike
underli
variant
enhanc
transmiss
howev
stress
evid
recombin
led
import
way
discoveri
immedi
cours
pandem
yet
peer
vaccin
hous
march
older
peopl
higher
risk
get
covid
analysi
million
coronaviru
test
natur
infect
reinfect
peopl
protect
significantli
age
older
steen
serum
data
chain
reaction
method
infect
c
h
lancet
team
peopl
test
posit
coronaviru
one
two
infect
march
team
found
initi
infect
protect
repeat
infect
approxim
signific
differ
reinfect
men
protect
reduc
age
older
need
worker
dose
vaccin
made
march
emerg
covid
vaccin
prowess
lead
vaccin
offer
limit
protect
coronaviru
variant
first
south
variant
known
first
south
late
link
reduc
efficaci
johnson
johnson
anoth
unintent
test
variant
effect
univers
south
south
trial
vaccin
univers
n
j
trial
involv
around
peopl
age
test
neg
randomli
assign
receiv
either
jab
vaccin
offer
protect
overal
develop
mild
moder
variant
sever
hospit
either
group
small
size
trial
conclud
vaccin
efficaci
cell
blue
artifici
yellow
credit
photo
march
one
mutat
explain
coronaviru
variant
lone
mutat
explain
coronaviru
variant
unit
kingdom
taken
hold
around
late
found
variant
southeast
nearli
steadili
rise
proport
north
elsewher
eight
viru
spike
protein
viru
enter
host
clear
explain
rapid
better
understand
shi
weaver
univers
medic
branch
bevi
one
individu
spike
well
one
carri
eight
preprint
mutat
replic
quickli
upper
respiratori
airway
spread
readili
contribut
behaviour
say
outsiz
effect
transmiss
make
one
watch
close
yet
peer
least
horsesho
bat
viru
close
relat
isol
one
march
small
piec
land
bat
trove
new
bat
provinc
southern
china
yet
close
relat
pandem
shi
first
medic
univers
academi
medic
china
studi
urin
mouth
taken
live
bat
h
preprint
trap
bat
nearli
two
dozen
speci
area
cover
roughli
less
size
san
team
coronaviru
new
close
relat
one
isol
bat
genom
pandem
viru
make
known
rel
known
rel
coronaviru
genom
isol
bat
suggest
close
relat
continu
circul
bat
highli
preval
say
yet
peer
intens
care
unit
peopl
earli
deadli
viral
variant
spread
across
unit
march
viral
variant
deadli
form
infect
coronaviru
variant
higher
risk
die
peopl
infect
regardless
age
sex
health
school
hygien
tropic
medicin
studi
health
peopl
test
posit
preprint
found
three
peopl
within
month
test
posit
previous
viral
variant
five
test
posit
risk
death
age
presenc
health
men
higher
risk
die
unit
kingdom
domin
variant
spread
wide
across
without
control
variant
caus
deadli
pandem
previous
viru
green
artifici
infect
host
ami
photo
march
worrisom
coronaviru
variant
hope
better
infect
coronaviru
variant
mount
immun
respons
fend
multipl
first
variant
south
late
sinc
link
found
sever
less
effect
nation
institut
communic
south
assess
antibodi
mount
peopl
infect
admit
hospit
preprint
team
found
antibodi
similar
peopl
infect
team
pit
peopl
infect
form
use
coronaviru
spike
protein
infect
abl
inactiv
form
spike
protein
found
variant
brazil
suggest
base
genet
sequenc
protect
peopl
multipl
coronaviru
say
yet
peer
suggest
immun
artifici
fend
new
photo
march
provid
rescu
rampant
coronaviru
coronaviru
seem
elud
import
laboratori
recent
discov
partial
evad
respons
vaccin
previou
infect
rais
less
effect
origin
strain
viru
alba
la
institut
immunolog
whether
help
evad
compon
immun
system
particularli
import
reduc
sever
infecti
preprint
team
collect
either
infect
ancestr
strain
receiv
coronaviru
vaccin
test
abil
recogn
protein
four
variant
first
south
four
thank
viral
protein
unaffect
suggest
target
peopl
surround
worker
cemeteri
march
new
viral
variant
coronaviru
variant
citi
drive
citi
second
wave
first
wave
pandem
experienc
one
world
highest
infect
infect
lead
predict
immun
caus
new
tail
novel
coronaviru
variant
period
rise
citi
link
variant
character
variant
imperi
colleg
viral
collect
human
n
r
preprint
variant
alter
among
spike
protein
previous
link
transmiss
immun
spread
possibl
effect
second
wave
variant
time
transmiss
abl
evad
immun
previou
yet
peer
attend
class
st
cathol
school
la
j
march
classroom
mean
covid
school
person
adult
risk
implement
appropri
control
accord
larg
survey
unit
univers
survey
late
earli
half
million
peopl
live
half
school
person
either
j
preprint
found
live
especi
went
school
like
report
test
posit
found
elimin
risk
entir
least
seven
mitig
list
includ
wear
enter
increas
space
yet
peer
dose
pfizerbiontech
vaccin
march
one
dose
vaccin
silent
covid
coronaviru
four
time
less
frequent
receiv
singl
dose
promin
vaccin
unvaccin
univers
almost
taken
without
preprint
studi
test
least
day
one
dose
vaccin
pfizer
new
york
citi
infect
rate
contrast
unvaccin
infect
rate
team
note
evid
infect
well
vaccin
lower
coronaviru
infect
unvaccin
although
result
reach
statist
signific
would
suggest
asymptomat
infect
less
like
infect
peopl
unvaccin
becom
yet
peer
person
pfizerbiontech
covid
vaccin
test
fli
pfizer
vaccin
highli
effect
sever
accord
analysi
one
million
peopl
health
peopl
part
nationwid
campaign
unvaccin
twin
age
sex
resid
match
number
medic
n
n
j
found
day
second
shot
pfizer
vaccin
effect
effect
sever
diseas
consist
across
age
peopl
age
older
strikingli
close
efficaci
clinic
despit
base
less
stringent
divers
peopl
multipl
health
studi
cover
period
variant
wide
vaccin
effect
pfizerbiontech
vaccin
asymptomat
coronaviru
well
trial
pfizer
vaccin
curb
covid
lead
vaccin
highli
effect
whether
caus
evid
yet
control
viral
abil
prevent
diseas
want
know
whether
prevent
peopl
get
infect
even
show
public
health
track
effect
vaccin
made
pfizer
alreadi
part
studi
immun
v
j
hall
preprint
test
regularli
regardless
vaccin
effect
symptomat
asymptomat
period
begin
first
dose
grew
shortli
second
dose
vaccin
find
first
evid
pfizer
vaccin
block
transmiss
say
studi
yet
peer
laboratori
one
variant
partial
immun
respons
pfizerbiontech
viral
variant
less
suscept
covid
vaccin
contain
worrisom
variant
partial
blunt
immun
protect
promin
recent
rais
possibl
potent
less
effect
older
viru
work
contain
signatur
spike
shi
univers
medic
branch
sever
one
troubl
variant
known
first
south
n
j
team
pit
viru
blood
serum
peopl
receiv
two
vaccin
made
pfizer
vaccin
viru
effect
strain
viru
evas
abil
trio
portion
spike
protein
adher
host
howev
clear
whether
make
vaccin
less
effect
care
worker
vaccin
second
jab
better
protect
wide
use
vaccin
effect
second
two
given
long
wait
rather
short
one
find
decis
space
vaccin
univers
pharmaceut
firm
given
peopl
interv
test
efficaci
strategi
pollard
univers
data
peopl
half
receiv
vaccin
half
placebo
lancet
team
found
greater
six
longer
gap
better
vaccin
effect
receiv
second
dose
less
first
effect
whose
second
dose
first
team
found
singl
dose
vaccin
efficaci
first
day
worker
person
viral
variant
longer
fuel
variant
quick
suggest
variant
first
unit
kingdom
transmiss
time
insid
host
spread
rapidli
number
roughli
contagi
coronaviru
grad
th
school
public
health
boston
daili
peopl
infect
infect
preprint
team
long
viru
amount
viru
present
time
peopl
infect
averag
day
day
peopl
littl
differ
peak
viru
two
hint
easili
peopl
catch
infect
rel
long
time
therefor
infect
number
longer
quarantin
warrant
infect
variant
yet
peer
cluster
artifici
credit
eye
photo
robin
flock
new
us
covid
newli
coronaviru
unit
share
similar
mutat
signific
chang
yet
rang
geograph
seem
share
certain
possibl
evid
aid
transmiss
state
univers
health
center
new
variant
robin
e
b
preprint
chang
spike
protein
viru
bind
lineag
first
spot
preval
risen
unit
new
start
six
pelican
bluebird
unit
mutat
spot
spike
mutat
near
portion
spike
protein
must
cut
allow
viral
particl
infect
cell
say
laboratori
determin
mutat
find
yet
peer
infus
often
use
treat
rheumatoid
arthriti
peopl
clinic
trial
surviv
drug
lifelin
peopl
drug
save
peopl
whose
immun
gone
overdr
coronaviru
drug
need
invas
ventil
accord
larg
peopl
sever
show
evid
widespread
inflamm
drug
design
dampen
immun
respons
previou
clinic
peopl
infect
martin
univers
peopl
similar
number
receiv
drug
recoveri
collabor
group
preprint
studi
hospit
oxygen
evid
inflamm
nearli
take
steroid
report
peopl
receiv
left
hospit
within
day
take
drug
analysi
provid
top
team
roughli
half
peopl
unit
kingdom
would
benefit
yet
peer
wait
receiv
vaccin
sport
complex
spur
antibodi
surg
covid
shot
either
pfizer
vaccin
strong
immun
respons
variant
accord
peopl
made
pfizer
new
york
citi
highli
effect
origin
form
cancer
research
center
collect
blood
ten
peopl
collect
addit
studi
receiv
singl
dose
one
two
l
preprint
defend
infect
origin
version
first
wuhan
china
concern
new
variant
first
south
inocul
nine
ten
origin
viru
although
highli
variabl
five
peopl
neutral
follow
singl
shot
vaccin
howev
viru
approxim
red
infect
human
photo
nimbl
leap
straight
bat
found
bat
jump
directli
peopl
without
need
evolut
intermedi
anim
univers
north
chapel
hill
mice
human
lung
tissu
infect
tissu
variou
two
close
relat
isol
bat
effici
multipli
lung
tissu
natur
suggest
bat
directli
infect
peopl
potenti
caus
next
use
anim
model
show
oral
antivir
drug
known
significantli
reduc
infecti
lung
tissu
say
drug
current
clinic
use
prevent
diseas
well
treat
peopl
within
day
two
exposur
blue
artifici
infect
human
cell
transmiss
electron
photo
covid
lose
new
coronaviru
small
genom
lead
viral
protein
frequent
target
evolut
stretch
organ
genom
chang
delet
univers
school
medicin
genom
genom
region
protein
spike
k
r
scienc
viru
spike
protein
invad
analysi
crop
distinct
genom
region
spike
arisen
independ
multipl
time
show
evid
spread
one
person
power
antibodi
latch
onto
spike
team
antibodi
collect
peopl
disabl
viral
person
intens
care
unit
one
man
covid
therapi
worrisom
viral
treatment
spur
infect
man
immun
man
admit
hospit
cancer
ill
treatment
probabl
immun
system
man
two
antivir
drug
later
two
convalesc
plasma
blood
peopl
day
univers
viral
man
ill
kemp
natur
viral
blood
littl
treatment
cours
convalesc
plasma
domin
particular
pair
spike
protein
main
target
immun
one
potenc
convalesc
plasma
yet
reduc
viru
infect
second
mutat
infect
potenti
viral
evolut
convalesc
plasma
use
cautious
treat
peopl
immun
yellow
artifici
infect
human
photo
person
covid
contagi
hint
amount
person
bodi
major
factor
whether
like
transmit
viru
accord
studi
nearli
infect
peopl
close
peopl
give
anyon
els
becom
understand
school
hygien
tropic
medicin
peopl
index
recent
mild
team
peopl
live
otherwis
close
contact
index
lancet
infect
di
index
viru
close
contact
rel
high
viral
load
measur
amount
viru
bodi
much
like
pass
viru
low
viral
load
index
like
transmit
viru
cough
suggest
trace
peopl
high
viral
especi
import
saya
health
care
worker
dose
sputnik
v
russia
sputnik
v
vaccin
high
vaccin
cold
effect
symptomat
accord
interim
clinic
trial
nearli
group
typic
caus
mild
common
cold
sputnik
v
vaccin
nation
center
epidemiolog
microbiolog
two
carri
genet
spike
protein
latch
onto
host
use
two
help
increas
immun
respons
data
roughli
receiv
initi
jab
one
type
day
later
booster
jab
second
type
viru
team
studi
receiv
two
placebo
lancet
start
day
first
jab
symptomat
mild
vaccin
group
placebo
group
moder
evid
vaccin
offer
protect
day
first
dose
say
research
confirm
earli
green
blue
artist
illustr
bind
coronaviru
photo
antibodi
onto
covid
viru
heel
antibodi
effect
close
relat
walker
compani
new
isol
immun
person
infect
viru
relat
c
g
scienc
structur
one
particularli
effect
lab
antibodi
disabl
varieti
relat
given
mice
stop
respiratori
found
surfac
rang
similar
dub
receptor
heel
close
relat
suggest
vulner
make
analysi
found
first
phase
pandem
risk
death
higher
would
absenc
keep
us
fed
face
highest
covid
death
risk
essenti
higher
first
pandem
accord
analysi
death
univers
san
state
data
peopl
age
estim
mani
among
pandem
would
without
onslaught
preprint
team
found
scenario
higher
food
agricultur
higher
transport
logist
higher
nonessenti
highest
risk
includ
agricultur
peopl
pack
prepar
good
shipment
risk
vari
race
scenario
mortal
pandem
higher
peopl
age
descent
overal
higher
food
farm
say
essenti
receiv
free
person
protect
equip
easi
access
test
yet
peer
health
worker
home
older
peopl
republ
dose
vaccin
vaccin
viral
lead
vaccin
work
new
rapidli
spread
compani
collect
blood
peopl
receiv
compani
vaccin
k
preprint
vaccin
bodi
make
coronaviru
spike
protein
prime
immun
system
produc
prevent
infect
blood
peopl
viru
covid
variant
elud
immun
covid
variant
elud
immun
expos
blood
viral
mimic
rang
coronaviru
form
first
found
unit
kingdom
anoth
first
south
effect
variant
first
found
unit
kingdom
older
form
viru
effect
even
effect
enough
provid
protect
test
booster
enhanc
immun
coronaviru
yet
peer
health
worker
dose
jack
covid
lose
potenc
new
viral
coronaviru
reduc
protect
effect
two
lead
univers
new
york
citi
blood
receiv
two
either
vaccin
z
wang
preprint
carri
prompt
human
make
spike
protein
viru
infect
bodi
gener
immun
recogn
spike
second
jab
studi
sever
antibodi
block
effect
carri
certain
spike
protein
widespread
viru
effect
block
team
test
seen
coronaviru
first
unit
kingdom
brazil
south
least
one
easili
viru
wide
suggest
emerg
mean
need
updat
yet
peer
version
articl
gave
incorrect
time
window
antibodi
develop
turquois
red
purpl
white
attach
region
domain
new
coronaviru
spike
unsung
viral
featur
lead
covid
usual
region
key
protein
import
chink
viru
block
viru
bodi
potent
new
pathogen
studi
target
region
viru
spike
protein
domain
previou
act
spike
particularli
region
domain
univers
blood
peopl
recogn
preprint
prove
potent
block
infect
recogn
one
found
coronaviru
first
unit
kingdom
south
carri
weaken
effect
yet
peer
green
lurk
studi
particip
intestin
day
onset
c
immun
rememb
covid
least
half
year
immun
system
make
fend
new
coronaviru
least
six
initi
often
wane
follow
infect
rais
immun
viru
rapidli
univers
new
york
citi
collect
blood
peopl
month
infect
viru
c
natur
team
memori
b
immun
would
stimul
product
viru
studi
team
found
coronaviru
spike
protein
declin
six
memori
b
specif
make
spike
protein
constant
infect
found
half
persist
protein
potenti
provid
continu
sourc
stimul
immun
use
treat
rheumatoid
arthriti
shown
promis
treat
sever
two
prevent
covid
two
dampen
bodi
immun
respons
save
peopl
sever
peopl
grave
ill
tissu
damag
immun
respons
show
activ
regul
protein
studi
effect
activ
imperi
colleg
test
block
protein
immun
use
detect
c
preprint
team
gave
intens
care
organ
support
ventil
oxygen
receiv
receiv
receiv
neither
drug
treatment
reduc
death
rate
nearli
control
group
among
receiv
yet
peer
man
new
potenti
covid
vaccin
durabl
immun
candid
vaccin
younger
older
peopl
make
coronaviru
accord
earli
trial
vaccin
develop
johnson
johnson
new
brunswick
new
jersey
harmless
viru
inject
make
spike
protein
prevent
test
vaccin
safeti
peopl
age
j
n
j
almost
studi
age
potent
viru
day
singl
low
dose
jab
separ
arm
trial
regimen
trigger
develop
age
older
day
vaccin
side
effect
larg
mild
moder
least
day
efficaci
vaccin
mutat
immun
respons
covid
hand
help
escap
immun
respons
mount
subset
infect
vast
major
unlik
much
effect
viru
biolog
identifi
potenti
import
bloom
cancer
research
center
studi
isol
blood
serum
peopl
j
preprint
new
covid
undermin
scrambl
find
new
covid
undermin
scrambl
find
team
test
respons
viru
spike
protein
sampl
protein
carri
differ
region
receptor
bind
domain
host
major
target
test
reduc
abil
bind
tightli
spike
protein
chang
indic
reduct
abil
disabl
effect
vari
substanti
peopl
consequenti
locat
steep
drop
potenc
coronaviru
south
brazil
carri
mutat
yet
peer
scan
lung
person
immun
gone
wild
tie
covid
lung
damag
sever
respiratori
seem
result
activ
specif
immun
caus
inflamm
northwestern
univers
fluid
peopl
sever
pneumonia
infect
r
grant
natur
high
certain
type
cell
class
immun
found
nearli
alveolar
type
immun
cell
tini
air
viru
rel
high
express
involv
inflamm
suggest
viru
infect
respond
inflammatori
attract
turn
produc
protein
make
inflammatori
persist
lung
inflamm
lead
traitor
link
covid
normal
attack
sometim
rogu
instead
besieg
bodili
immun
new
studi
grow
bodi
research
tie
poor
peopl
lee
school
medicin
new
york
citi
studi
autoantibodi
blood
serum
collect
peopl
hospit
particularli
interest
protein
stabil
structur
part
integr
tini
blood
block
lung
injuri
hallmark
immun
evad
covid
immun
evad
found
level
averag
higher
eventu
differ
statist
signific
preprint
research
necessari
establish
clear
causal
link
viru
rel
rare
yet
peer
nurs
person
intens
care
unit
appl
valley
quick
treatment
blood
risk
sever
covid
clinic
trial
older
earli
dose
blood
plasma
peopl
prevent
progress
sever
plasma
peopl
treatment
plasma
mix
plasma
need
given
earli
diseas
cours
effect
polack
infant
rigor
clinic
trial
assess
effect
treatment
plasma
within
symptom
onset
includ
peopl
age
least
one
condit
diabet
r
n
j
sever
studi
receiv
plasma
placebo
group
team
found
donor
plasma
higher
associ
greater
reduct
risk
sever
diseas
provid
evid
respons
therapeut
sampl
taken
covid
evid
new
coronaviru
variant
swift
independ
analys
found
new
variant
unit
kingdom
inde
transmiss
imperi
colleg
nearli
variant
variant
concern
collect
unit
kingdom
earli
team
roughli
late
e
preprint
variant
frequenc
time
roughli
transmiss
found
viral
link
new
variant
rose
yet
peer
separ
team
use
genom
data
analys
variant
spread
last
school
hygien
tropic
medicin
new
variant
transmiss
n
preprint
found
evid
variant
concern
sever
peer
review
covid
test
help
curb
trade
away
degre
reliabl
speed
prove
valuabl
tool
hit
hard
diseas
fast
coronaviru
ca
fast
coronaviru
ca
one
week
univers
san
test
peopl
citi
g
di
studi
two
test
typic
two
four
day
unit
rapid
test
viral
return
roughli
one
hour
rapid
test
made
park
rapid
test
peopl
test
posit
high
viru
within
two
posit
result
receiv
phone
call
isol
swift
respons
meant
peopl
less
like
spread
infect
result
approxim
posit
rapid
antigen
confirm
mean
author
disclos
nonfinanci
support
relat
vaccin
silver
spring
bill
vaccin
work
quickli
ward
vaccin
recent
us
provid
protect
within
two
first
dose
accord
larg
clinic
us
food
drug
administr
author
vaccin
made
shortli
thereaft
hospit
boston
el
colleg
medicin
vaccin
trial
enrol
half
receiv
two
placebo
half
receiv
two
vaccin
day
apart
l
r
n
j
vaccin
effect
symptomat
preliminari
analysi
one
dose
vaccin
provid
defenc
asymptomat
diseas
write
trial
sever
placebo
half
receiv
vaccin
experienc
side
effect
second
dose
seriou
side
effect
rare
frequent
placebo
group
coronaviru
test
high
proport
detect
covid
end
first
nine
went
undetect
everi
person
confirm
diseas
despit
nationwid
surveil
adopt
strategi
test
contact
trace
case
isol
keep
coronaviru
check
assess
institut
epidemiolog
public
health
transmiss
late
june
found
nation
test
campaign
peopl
time
countri
g
natur
show
low
rate
posit
test
alway
equat
high
rate
suggest
mani
peopl
seek
medic
advic
need
implement
aggress
effici
test
peopl
suspect
surveil
use
tool
fight
pandem
say
close
part
effort
halt
spike
limit
valu
curb
analysi
data
substanti
cut
viral
transmiss
school
univers
peopl
shut
brought
margin
linger
rel
effect
specif
reduc
spread
pinpoint
use
univers
number
new
either
first
eas
j
scienc
team
countri
seven
common
combin
two
data
found
larg
effect
viral
spread
close
quick
success
make
imposs
team
disentangl
effect
type
close
restrict
order
littl
reduc
transmiss
cell
infect
red
artifici
credit
nation
infect
link
sever
usual
fight
infect
occasion
immun
system
erron
attack
bodi
even
immun
system
new
show
explain
peopl
sever
reaction
infect
ring
yale
school
medicin
new
studi
peopl
found
serious
ill
high
autoantibodi
activ
e
wang
preprint
bodi
immun
abil
fight
infect
central
nervou
system
heart
liver
connect
singl
autoantibodi
common
enough
use
distinguish
peopl
uninfect
peopl
say
divers
explain
variou
diseas
follow
person
care
drug
duo
peopl
sever
combin
shave
one
day
recoveri
peopl
us
nation
health
treatment
peopl
linger
effect
world
health
organ
test
part
combin
therapi
univers
medic
center
gave
drug
roughli
peopl
moder
sever
c
n
j
peopl
control
group
receiv
placebo
team
long
took
recov
enough
go
without
sustain
medic
took
median
time
recoveri
seven
day
eight
day
took
peopl
edg
invas
ventil
median
recoveri
time
fell
day
alon
day
jab
save
covid
vaccin
probabl
first
get
next
queue
limit
suggest
elderli
univers
colorado
boulder
effect
roll
vaccin
variou
age
given
prioriti
k
preprint
influenc
rate
viral
spread
popul
speed
vaccin
deliveri
effect
protect
team
found
give
peopl
older
age
save
number
prevent
mani
peopl
possibl
get
infect
younger
age
accord
peopl
infect
receiv
vaccin
cut
say
test
histori
recent
infect
yet
peer
natur
killer
cell
artifici
activ
coronaviru
vaccin
last
given
vaccin
still
high
potent
coronaviru
four
first
firm
vaccin
effect
gaug
whether
protect
us
nation
institut
allergi
infecti
blood
studi
receiv
two
vaccin
one
month
apart
n
j
latch
key
protein
peak
second
jab
fell
slightli
subsequ
four
first
jab
blood
still
disabl
viru
none
experienc
seriou
side
show
vaccin
provid
durabl
antibodi
respons
pinch
protect
new
coronaviru
suffici
protect
accord
studi
infect
studi
found
immun
contribut
immun
viru
particularli
antibodi
low
data
say
asymptomat
covid
data
say
asymptomat
covid
easi
way
predict
immun
respons
provid
protect
infecti
diseas
dan
medic
school
boston
sought
understand
immun
defend
rhesu
team
collect
infect
gave
uninfect
k
natur
recipi
infect
host
immun
activ
natur
killer
higher
greater
protect
lower
reduc
immun
reinfect
fell
contribut
coronaviru
red
artifici
help
sens
smell
often
smell
sniff
rise
covid
case
fast
cheap
test
person
abil
smell
help
stop
accord
peopl
infect
lose
sens
smell
statist
true
even
feel
ill
distinct
symptom
parker
univers
colorado
boulder
model
whether
mass
test
loss
smell
help
quash
epidem
b
preprint
team
smell
test
everi
three
day
prevent
spike
popul
peopl
assum
least
infect
peopl
experienc
detect
loss
smell
would
effect
surveil
mass
aeroplan
author
disclos
test
compani
author
disclos
founder
compani
yet
peer
purpl
artifici
cover
surfac
human
let
coronaviru
give
slip
mutat
viru
escap
recognit
sever
design
natur
immun
bloom
cancer
research
center
everi
possibl
mutat
prevent
bind
three
one
two
cocktail
made
new
york
n
preprint
affect
protein
segment
domain
viru
bind
enter
found
one
mutat
viru
escap
recognit
antibodi
cocktail
escap
one
three
wide
infect
peopl
one
preval
anoth
found
taken
mink
peopl
work
mink
yet
peer
sensit
covid
test
yield
fals
method
chain
reaction
test
coronaviru
genet
materi
nose
throat
swab
survey
peopl
singl
peopl
like
receiv
fals
gener
hospit
boston
test
peopl
thought
infect
c
open
forum
infect
di
nearli
test
neg
second
test
done
within
receiv
second
test
test
posit
initi
test
either
one
day
less
symptom
onset
day
suggest
test
like
yield
fals
neg
peopl
test
earli
late
cours
test
neg
especi
viru
widespread
heritag
theme
park
provinc
china
wear
face
tradit
yang
news
avoid
covid
bewar
nearest
studi
transmiss
china
provinc
found
like
spread
coronaviru
sun
nation
health
univers
shanghai
china
data
peopl
infect
close
infect
peopl
k
sun
scienc
team
found
peopl
live
togeth
risk
transmiss
extend
famili
transmiss
risk
lower
still
social
commun
public
transport
everi
extra
day
contact
rais
transmiss
risk
team
analysi
actual
risk
viral
spread
within
whose
spent
time
normal
home
togeth
social
commun
transmiss
fell
cross
section
human
b
cell
artifici
credit
immun
coronaviru
persist
beyond
immun
system
memori
new
coronaviru
least
six
coronaviru
reinfect
rapidli
antibodi
rais
immun
dwindl
within
recoveri
infect
la
institut
immunolog
immun
respons
blood
peopl
rang
studi
least
j
dan
preprint
team
found
immun
vari
wide
sever
immun
memori
persist
least
among
persist
immun
memori
b
antibodi
product
pathogen
two
import
class
cell
memori
memori
yet
worker
mink
outbreak
mink
coronaviru
rapidli
mink
coronaviru
mink
genet
analysi
infect
coronaviru
breed
mink
vison
across
unit
sinc
univers
colleg
studi
viral
isol
l
van
dorp
preprint
team
least
seven
separ
viru
peopl
infect
mink
found
arisen
independ
least
twice
suggest
viru
rapidli
new
frequent
genom
encod
spike
protein
use
infect
say
evid
mink
affect
abil
spread
peopl
back
yet
peer
yellow
swarm
human
cell
purpl
ward
deadli
season
among
common
cold
peopl
shield
infect
recent
infect
season
univers
blood
collect
pandem
peopl
e
preprint
team
found
studi
recogn
season
coronaviru
recogn
probabl
respons
infect
went
catch
infect
similar
neither
recogn
offer
protect
infect
quick
covid
catch
peopl
infecti
rapid
antigen
coronaviru
faster
standard
diagnost
assess
antigen
tell
high
accuraci
like
infecti
fast
coronaviru
ca
fast
coronaviru
ca
detect
specif
surfac
univers
hospit
berlin
perform
seven
commerci
avail
rapid
antigen
appli
rang
peopl
alreadi
test
posit
respiratori
chain
reaction
test
v
preprint
five
sensit
antigen
presenc
test
viral
genet
materi
rang
equival
million
million
per
swab
high
viral
first
week
peopl
like
spread
viru
yet
peer
nurs
person
coronaviru
mutat
one
person
bodi
new
coronaviru
bodi
infect
man
eventu
kill
show
evid
li
hospit
boston
cours
man
disord
medic
regimen
includ
power
b
n
j
roughli
day
man
first
test
posit
viru
back
despit
antivir
man
infect
return
twice
five
first
diagnosi
genom
analysi
man
infect
multipl
time
instead
viru
quickli
woman
face
mask
church
mysteri
one
nation
low
covid
death
first
larg
antibodi
viru
infect
peopl
surprisingli
high
figur
view
small
number
covid
presenc
histori
infect
viru
trust
research
blood
donat
late
scienc
base
estim
peopl
histori
team
estim
antibodi
preval
similar
estim
level
lost
peopl
earli
wherea
lost
end
month
write
sharp
contrast
antibodi
preval
coronaviru
effect
yellow
artifici
isol
first
person
unit
known
coronaviru
mutat
weaken
widespread
variant
new
coronaviru
potenti
evad
immun
respons
peopl
mount
start
pandem
viral
taken
infect
peopl
univers
snell
san
mutat
protein
viru
invad
e
c
preprint
antibodi
bridg
coronaviru
vaccin
world
benefit
antibodi
bridg
coronaviru
vaccin
world
benefit
mutat
protein
receptor
bind
domain
recogn
host
key
target
viru
mutat
independ
least
twice
laboratori
found
mutat
hinder
activ
potent
block
viru
among
mutat
blood
peopl
well
yet
peer
uninfect
found
recogn
blood
peopl
never
caught
viru
particularli
like
harbour
explain
infect
either
mild
ill
none
unclear
whether
previou
infect
one
season
caus
common
cold
sever
crick
institut
blood
infect
new
viru
k
w
scienc
collect
either
pandem
viru
global
team
found
roughli
uninfect
adult
recogn
uninfect
age
age
group
season
common
blood
uninfect
peopl
block
new
coronaviru
lab
artifici
credit
vaccin
coronaviru
potent
vaccin
candid
made
tini
artifici
power
lead
protect
immun
king
univers
design
microscop
mimic
structur
viru
c
cell
fuse
spike
protein
part
viru
infect
human
outsid
team
mice
vaccin
produc
compar
greater
produc
peopl
mice
receiv
vaccin
produc
ten
time
spike
protein
mani
vaccin
vaccin
produc
strong
respons
special
immun
help
mount
fast
defenc
infect
groceri
among
found
new
mani
carri
coronaviru
much
bank
frequent
touch
us
citi
reveal
posit
genet
materi
materi
present
small
picker
univers
repeatedli
public
p
preprint
rubbish
bin
liquor
store
frequent
coronaviru
contamin
infect
risk
touch
one
low
team
found
percentag
posit
one
postal
district
peak
roughli
day
spike
district
sampl
heavili
touch
provid
warn
surg
write
yet
peer
conduct
coronaviru
test
campaign
analysi
nearli
peopl
coronaviru
spread
fast
often
new
coronaviru
effici
us
previou
research
sometim
without
warn
transmiss
accord
intens
us
diseas
control
prevent
us
test
posit
recent
c
g
mortal
rep
least
week
enrol
daili
coronaviru
test
peopl
live
infect
conserv
estim
diseas
spread
test
posit
household
studi
eventu
test
posit
almost
doubl
one
previou
estim
one
half
household
infect
first
test
posit
test
posit
five
day
less
first
infect
person
home
feel
rank
coronaviru
countri
talli
among
age
use
reveal
total
number
peopl
univers
data
across
natur
found
among
peopl
younger
risk
die
age
pattern
consist
across
mani
peopl
coronaviru
mani
peopl
coronaviru
team
statist
percentag
peopl
indic
previous
expos
viru
estim
infect
fatal
rate
proport
peopl
die
infect
studi
combin
infect
fatal
death
statist
estim
begin
billion
peopl
studi
infect
south
infect
rate
highest
method
use
estim
mani
peopl
infect
carri
larg
antibodi
saya
medic
team
woman
even
peopl
becom
serious
ill
diseas
mount
vigor
antibodi
linger
bodi
antibodi
defenc
coronaviru
remain
strong
least
three
infect
accord
studi
peopl
mostli
mild
moder
school
medicin
mount
new
york
citi
blood
peopl
infect
scienc
infect
peopl
moder
high
blood
block
viru
team
subset
two
later
found
antibodi
stabl
least
three
five
symptom
onset
modest
declin
say
like
shield
peopl
dog
fur
farm
china
show
pass
anim
spread
coronaviru
small
foxlik
raccoon
dog
infect
spread
among
institut
deliber
infect
nine
raccoon
dog
new
coronaviru
c
infect
di
six
shed
viru
sever
day
later
three
uninfect
put
next
infect
two
got
infect
none
visibl
sick
slightli
suggest
spread
undetect
fur
china
million
raccoon
dog
live
captiv
coronaviru
pandem
sever
acut
respiratori
syndrom
isol
raccoon
dog
first
peopl
health
care
worker
new
collect
sampl
basketbal
score
coronaviru
basketbal
unit
provid
poorli
understood
phase
life
cycl
behaviour
newli
infect
hiatu
us
basketbal
play
staff
repeatedli
check
version
highli
sensit
chain
reaction
method
use
assess
person
viral
intens
test
rare
chanc
monitor
viral
infect
peopl
yet
never
felt
th
school
public
health
boston
test
peopl
involv
season
preprint
studi
viral
peak
three
day
test
posit
found
two
given
within
two
day
indic
whether
person
viral
level
rise
fall
inform
influenc
treatment
yet
peer
strategi
covid
test
multipl
peopl
combin
one
batch
viru
trial
shown
test
highli
effici
even
theori
mathemat
strategi
transform
coronaviru
test
mathemat
strategi
transform
coronaviru
univers
test
nose
throat
either
five
eight
individu
one
group
sampl
n
preprint
group
test
posit
everi
constitu
sampl
test
neg
method
would
check
everi
sampl
individu
peopl
household
univers
care
home
hospit
tend
get
test
togeth
increas
likelihood
posit
yet
peer
drug
protein
inflamm
extend
peopl
moder
accord
rigor
promis
drug
save
studi
drug
bodi
immun
respons
found
prevent
peopl
moder
deal
blow
hypothesi
peopl
sever
immun
system
excess
inflammatori
respons
suggest
link
grave
ill
overli
vigor
immun
defenc
link
associ
high
protein
immun
system
death
need
ventil
peopl
stone
gener
hospit
boston
tri
dampen
inflamm
peopl
treat
drug
activ
j
h
stone
n
j
trial
peopl
moder
diseas
team
found
statist
signific
reduct
need
ventil
among
receiv
studi
rule
possibl
trial
statist
power
uncov
spark
univers
seep
surround
daili
univers
covid
explos
outbreak
among
young
peopl
us
univers
town
spilt
surround
commun
lead
two
peopl
local
care
long
young
easili
cascad
commun
older
popul
scenario
confirm
la
cross
three
boost
covid
older
peopl
boost
covid
older
medic
foundat
la
cross
peopl
la
cross
counti
spike
month
class
c
preprint
team
found
overwhelm
major
two
viral
spread
first
three
peopl
age
young
peopl
infect
variant
suggest
viru
spread
student
took
place
indoor
outdoor
one
made
way
two
care
eight
home
infect
two
yet
peer
use
coronaviru
test
bari
coronaviru
test
predict
outbreak
peopl
infect
specif
town
citi
use
assess
whether
epidem
common
test
measur
infect
person
viral
load
indic
amount
viru
bodi
hay
th
school
public
health
boston
use
show
viral
popul
correl
rate
viral
spread
popul
j
hay
preprint
earli
epidem
averag
infect
person
recent
expos
viru
therefor
high
viral
load
later
epidem
averag
infect
person
viru
longer
low
viral
result
snapshot
distribut
random
sampl
popul
reveal
whether
popul
rise
say
add
method
less
suscept
simpli
count
daili
yet
peer
health
worker
market
new
sampl
rapid
antigen
rapid
coronaviru
effect
antigen
coronaviru
provid
within
market
equal
effect
detect
specif
surfac
easi
use
inexpens
produc
univers
medic
center
use
commerci
avail
rapid
antigen
peopl
alreadi
test
posit
coronaviru
standard
chain
reaction
test
highli
sensit
slow
j
van
beek
preprint
sensit
viru
time
wherea
least
sensit
test
came
peopl
tend
high
coronaviru
caution
rapid
antigen
less
effect
presenc
viru
peopl
low
viru
find
yet
peer
arriv
swimsuit
weather
necessarili
lead
drop
transmiss
coronaviru
season
temperatur
arriv
spring
summer
slow
transmiss
say
studi
earli
surviv
longer
outsid
bodi
cold
dri
air
warmer
humid
give
chanc
infect
peopl
winter
spring
summer
research
given
mix
pictur
whether
new
coronaviru
similar
see
affect
viru
spread
china
medic
school
boston
model
data
china
collect
c
rep
data
includ
case
weather
inform
domest
travel
model
took
account
team
found
weather
alon
explain
variabl
viru
spread
continu
china
tropic
well
cold
white
converg
coronaviru
particl
artist
impress
credit
one
way
build
antibodi
work
rang
potent
immun
stop
new
coronaviru
recogn
viral
keep
import
compon
immun
system
attack
promis
experiment
team
led
institut
technolog
determin
eight
attach
spike
protein
viru
gain
foothold
host
c
natur
reveal
divid
sever
class
accord
part
spike
protein
region
allow
evad
one
class
antibodi
unlik
foil
offer
littl
defenc
blood
bear
season
protect
sever
univers
new
york
citi
collect
peopl
unit
kingdom
preprint
studi
test
posit
one
season
human
caus
common
cold
coronaviru
deadli
older
male
new
data
reveal
coronaviru
deadli
older
male
new
data
reveal
team
found
serum
sampl
disabl
least
one
coronaviru
block
viru
abil
infect
human
lab
dish
serum
disabl
hybrid
viru
carri
spike
protein
crucial
player
viru
invas
host
suggest
major
role
peopl
fare
wors
say
yet
peer
pictur
endur
longer
less
intens
peopl
less
tightli
dens
brace
long
coronaviru
new
coronaviru
gener
keep
small
viru
time
spread
crowd
differ
tend
intermingl
ultim
peopl
rel
isol
univers
spread
variou
size
popul
b
natur
model
output
known
data
individu
infect
crowd
wuhan
less
dens
team
model
rel
short
intens
rel
uncrowd
stick
rather
freeli
crowd
howev
peopl
like
cope
last
longer
appli
model
predict
rel
even
popul
expect
explos
dens
settl
urban
expect
protract
guest
analysi
famili
reunion
coronaviru
spread
among
peopl
live
close
coronaviru
famili
girl
gave
new
coronaviru
holiday
hous
confirm
seed
investig
diseas
control
prevent
girl
expos
june
rapid
test
infect
famili
extend
stay
hous
n
g
mortal
rep
famili
neither
wore
distanc
peopl
hous
teenag
girl
either
test
posit
coronaviru
classifi
probabl
six
hous
outdoor
kept
distanc
six
four
took
coronaviru
test
test
neg
none
fell
medic
worker
new
sampl
massiv
effort
strike
new
coronaviru
differ
starkli
accord
studi
far
carri
data
univers
data
almost
peopl
well
close
nearli
r
scienc
incid
two
steadili
age
peopl
age
older
contrast
unit
incid
age
age
mortal
age
markedli
lower
unit
perhap
say
peopl
live
old
age
tend
rel
wealthi
die
studi
found
peopl
like
infect
within
age
group
especi
true
suggest
among
contribut
viral
immun
trait
allow
viral
reinfect
wane
antibodi
poorli
immun
respons
put
peopl
risk
reinfect
one
case
march
resid
sever
pneumonia
test
posit
new
coronaviru
individu
spent
one
month
hospit
test
neg
individu
test
posit
milder
short
breath
immun
respons
coronaviru
vaccin
immun
respons
coronaviru
analysi
univers
j
preprint
two
separ
infect
team
found
second
infect
individu
produc
low
time
person
similar
respons
first
infect
explain
individu
second
infect
team
measur
individu
protect
infect
person
lower
potent
version
first
infect
version
second
say
provid
use
antibodi
protect
reinfect
research
yet
peer
volunt
toni
resid
beach
dose
experiment
vaccin
viral
varieti
higher
widespread
mutat
infecti
human
viral
chang
examin
peopl
mutat
amino
acid
sequenc
viru
spike
protein
viru
infect
alter
known
common
north
elsewher
spring
nearli
isol
carri
alter
covid
one
million
peopl
mani
die
covid
one
million
peopl
mani
die
determin
effect
chang
two
independ
mutat
shi
univers
medic
branch
one
set
j
preprint
ralph
baric
univers
north
hill
j
preprint
found
viru
lack
mutat
replic
effici
human
airway
baric
team
found
spread
faster
use
studi
transmiss
neither
find
peer
vaccin
promis
older
peopl
one
promin
candid
high
new
univers
school
medicin
studi
respons
peopl
age
vaccin
firm
base
us
nation
institut
allergi
infecti
e
j
n
j
vaccin
piec
version
sever
immun
fight
infect
disarm
microb
second
dose
vaccin
antibodi
similar
side
effect
gener
mild
hospit
new
process
test
time
via
reveal
silent
hospit
staff
hospit
test
posit
new
coronaviru
sever
later
either
hospit
woman
work
ward
test
posit
although
neither
v
di
test
neg
return
work
test
posit
roughli
first
posit
test
neither
higher
viru
analysi
institut
integr
biolog
new
infect
second
time
genet
differ
first
viru
infect
evid
infect
anew
rather
leftov
suggest
asymptomat
often
care
person
unit
hospit
region
immun
breakdown
link
dire
sever
young
healthi
peopl
link
dysfunct
accord
survey
nearli
peopl
crucial
mount
defenc
influenza
univers
new
york
citi
peopl
sever
look
specif
trigger
product
q
scienc
team
found
studi
unabl
manufactur
second
studi
sever
ill
peopl
bastard
univers
unknown
attack
bodi
p
bastard
scienc
found
peopl
sever
target
activ
gener
popul
laboratori
confirm
suggest
use
cemeteri
brazil
ground
right
peopl
via
extrem
infect
level
quell
citi
much
popul
citi
two
million
peopl
brazil
state
infect
new
coronaviru
proport
high
enough
spread
sabino
univers
brazil
blood
collect
blood
bank
august
l
f
buss
preprint
proport
test
posit
estim
popul
infect
earli
august
epidem
peak
say
high
proport
viru
herd
immun
term
scenario
enough
peopl
immun
infect
control
team
estim
sever
potenti
bia
fals
fals
antibodi
test
yet
peer
red
artifici
isol
person
good
time
help
immun
system
control
age
older
infect
new
coronaviru
tend
mount
immun
respons
respons
associ
sever
help
explain
diseas
older
peopl
particularli
immun
system
adapt
branch
specif
three
principl
la
institut
immunolog
studi
adapt
immun
respons
peopl
whose
rang
mild
fatal
c
r
cell
mani
peopl
coronaviru
mani
peopl
coronaviru
team
found
peopl
whose
immun
rapidli
launch
entir
adapt
immun
system
sever
diseas
peopl
three
arm
ramp
product
simultan
respons
particularli
common
among
older
peopl
indic
import
passeng
coronaviru
evid
strongli
least
one
member
marri
coupl
fli
unit
hong
infect
two
flight
led
poon
univers
hong
school
hygien
tropic
medicin
studi
four
peopl
flight
e
infect
di
two
husband
wife
busi
class
crew
one
busi
class
one
whose
cabin
assign
unknown
travel
canada
unit
flight
test
posit
new
coronaviru
soon
hong
flight
test
posit
shortli
team
found
viral
four
ident
viru
close
genet
rel
north
preval
hong
one
viru
crew
flight
say
add
previou
spread
genet
trigger
unit
japan
hong
monk
tie
hong
hong
seed
local
transmiss
viru
one
person
anoth
accord
analysi
viru
earli
spread
analysi
found
viral
spread
social
spread
within
famili
examin
coronaviru
hong
late
late
univers
hong
found
evid
multipl
one
infect
person
viru
least
six
c
natur
four
hong
thought
trigger
biggest
cluster
led
anoth
link
templ
one
monk
found
transmit
anyon
team
found
analysi
downstream
link
spread
social
household
plasma
donat
peopl
help
treat
ben
via
immun
natur
immun
caus
common
cold
last
infect
accord
studi
antibodi
three
immun
protect
reinfect
matter
although
often
reduc
second
infect
van
univers
coronaviru
blood
taken
everi
ten
start
w
natur
last
miseri
coronaviru
last
miseri
coronaviru
team
use
rise
antibodi
indic
infect
least
common
june
season
pattern
suggest
follow
found
earli
first
infect
often
guid
make
treat
new
method
everi
mutat
crucial
protein
use
evad
antibodi
inform
develop
antibodi
immun
system
fend
bind
import
region
spike
protein
inactiv
viral
make
attract
time
accumul
interfer
antibodi
bind
allow
viral
escap
immun
univers
medic
center
bloom
cancer
center
detail
map
far
prevent
bind
ten
human
j
preprint
team
use
inform
design
three
antibodi
two
laboratori
viru
develop
escap
antibodi
bind
yet
peer
staffer
mask
prevent
spread
new
via
us
spread
coronaviru
infect
new
coronaviru
viru
least
anoth
twelv
peopl
accord
analysi
among
result
woman
presumpt
infect
us
diseas
control
prevent
three
salt
lake
counti
mortal
three
first
known
case
staff
member
two
gone
work
even
though
person
household
shown
infect
whose
rang
either
mild
among
close
test
posit
six
three
one
babi
infect
close
test
mean
associ
alight
train
angel
via
nearli
half
coronaviru
transmiss
peopl
yet
feel
transmiss
occur
day
onset
person
univers
studi
transmiss
infect
person
uninfect
person
team
time
person
initi
infect
onset
person
spread
infect
someon
els
l
preprint
found
roughli
transmiss
onset
around
took
place
day
follow
say
underscor
import
mass
test
contact
trace
physic
prevent
transmiss
presymptomat
peopl
well
least
two
day
first
sign
cough
fever
fatigu
loss
smell
howev
blue
orang
artifici
infect
goldsmith
surpris
host
new
discov
nearli
two
dozen
previous
unknown
role
infect
mostli
genom
known
hold
make
spike
protein
viral
infect
varieti
viral
becom
activ
insid
uncertain
whether
viru
identifi
institut
scienc
bound
insid
infect
finkel
natur
scan
turn
previous
unknown
entir
new
extend
known
control
product
known
viral
role
mani
unknown
progress
report
coronaviru
pandem
progress
report
coronaviru
predict
sever
immun
like
action
peopl
eventu
develop
sever
go
becom
mildli
ill
accord
analysi
data
peopl
aid
earli
identif
peopl
like
becom
critic
compris
import
part
bodi
rapid
respons
infect
damag
uninfect
tissu
chun
yale
univers
new
use
machin
learn
analys
blood
plasma
taken
peopl
l
preprint
sever
immun
associ
found
higher
plasma
peopl
later
critic
ill
whose
ill
becom
sever
subsequ
analysi
health
peopl
high
associ
mortal
yet
peer
child
hospit
show
uniqu
immun
infect
new
coronaviru
show
ill
struck
sever
form
caus
multipl
organ
failur
even
death
begun
teas
biolog
rare
devast
condit
inflammatori
syndrom
childhood
ill
diseas
understand
biolog
profil
petter
institut
diseas
mild
c
r
cell
found
diseas
lower
immun
chemic
inflamm
studi
two
caus
common
cold
deficit
condit
saya
woman
care
ward
power
new
evid
link
steroid
treatment
lower
sever
ill
less
like
die
given
peopl
accord
analysi
hospit
five
steroid
cut
peopl
examin
effect
gener
univers
data
seven
clinic
seven
studi
use
peopl
critic
ill
react
work
group
j
includ
peopl
across
team
statu
day
randomli
assign
take
either
steroid
placebo
risk
death
took
steroid
took
placebo
say
part
standard
treatment
peopl
sever
worker
equip
mink
farm
robin
first
mink
pass
investig
dutch
mink
found
first
transmiss
among
mink
first
late
medic
use
genom
track
among
mink
b
b
preprint
team
test
found
evid
infect
genet
analysi
mink
spread
viru
back
peopl
mink
unit
say
uncheck
spread
lead
becom
reservoir
human
yet
peer
ambul
person
hospit
persist
rather
sweep
survey
iceland
new
coronaviru
endur
bodi
four
infect
evid
suggest
import
immun
quickli
pathogen
immun
system
fight
intrud
know
whether
peopl
gener
reinfect
know
long
decod
measur
blood
roughli
peopl
test
posit
viru
f
n
j
roughli
peopl
viru
antibodi
rose
two
diagnosi
level
durat
show
viru
infect
popul
leav
iceland
vulner
second
wave
infect
even
develop
potent
new
coronaviru
sever
care
mount
antibodi
respons
viru
age
deadli
coronaviru
close
answer
deadli
coronaviru
close
six
residenti
nurs
public
health
test
staff
infect
n
preprint
five
later
team
test
mani
peopl
particular
potent
block
viru
team
found
roughli
proport
staff
form
coronaviru
almost
staff
peopl
age
caution
clear
whether
viru
guard
reinfect
yet
human
cell
purpl
artifici
infect
viral
yellow
credit
august
test
summer
avoid
rigor
test
four
overnight
medic
center
report
four
staff
test
arriv
l
l
mortal
rep
shortli
arriv
viru
assign
small
spent
first
day
camp
staff
one
camper
test
posit
camp
isol
test
neg
peopl
camper
cohort
test
neg
viru
quarantin
say
viru
spread
beyond
three
infect
child
temperatur
check
primari
school
credit
august
infect
hard
age
less
like
younger
older
accord
studi
nearli
infect
peopl
age
kelli
duke
univers
school
medicin
north
studi
young
close
contact
person
infect
j
h
hurst
preprint
roughli
studi
test
posit
either
infect
age
infect
studi
age
age
age
feel
ill
milder
older
younger
studi
infect
infect
sibl
close
contact
infect
adult
viru
spread
child
account
say
yet
peer
medic
worker
sampl
test
taxi
driver
hong
august
sex
immun
respons
drive
men
high
immun
respons
explain
men
like
die
yale
univers
school
medicin
new
studi
immun
men
infect
mild
moder
natur
male
typic
immun
respons
infect
femal
explain
sever
diseas
often
men
natur
sex
gender
neither
binari
fix
team
found
gener
men
higher
certain
known
blood
contrast
respons
immun
known
men
men
increas
symptom
sever
time
associ
weak
respons
associ
inflammatori
studi
take
sex
account
treat
peopl
august
reinfect
confirm
first
time
genet
man
hong
ill
march
infect
differ
variant
new
coronaviru
sever
later
first
evid
reinfect
genet
analysi
ethic
trace
ethic
trace
infect
mount
immun
respons
think
probabl
durabl
protect
unclear
case
reinfect
would
signal
immun
wane
previous
found
relat
instead
shed
viru
genet
univers
hong
man
test
posit
later
via
unit
kingdom
k
infect
di
genet
second
infect
viru
genet
distinct
one
respons
initi
man
never
second
infect
immun
system
fresh
batch
orang
artifici
visibl
scan
electron
microscop
photo
august
given
nose
protect
mice
show
nasal
shield
new
coronaviru
effect
form
diamond
univers
school
medicin
st
candid
vaccin
spike
protein
viru
invad
cell
gave
vaccin
mice
human
vaccin
expos
mice
infecti
viru
harbour
small
viral
contrast
mice
vaccin
insert
exposur
measur
viral
evid
nasal
vaccin
entir
ward
infect
first
hospit
medic
univers
china
anoth
vaccin
spike
protein
l
natur
found
nasal
vaccin
rhesu
mulatta
infect
say
vaccin
given
nose
allow
peopl
vaccin
purpl
artifici
infect
human
cell
green
credit
photo
august
coronaviru
mutat
tie
less
sever
mutat
east
earli
pandem
link
milder
unmut
version
earli
cluster
variant
miss
chunk
two
determin
chang
delet
immunolog
network
peopl
infect
carri
delet
infect
normal
b
e
young
lancet
none
peopl
whose
mutat
supplement
oxygen
peopl
whose
mutat
carri
delet
sinc
march
possibl
owe
viru
respons
outbreak
sever
acut
respiratori
syndrom
acquir
similar
delet
gene
suggest
import
adapt
version
articl
variant
miss
chunk
collect
winc
test
site
herald
via
august
unpreced
map
key
viral
first
time
shape
spike
part
intact
decor
surfac
lock
onto
host
gain
entri
first
spike
express
check
medic
research
council
laboratori
molecular
biolog
collect
viral
infect
determin
shape
spike
electron
microscopi
z
natur
pandem
play
beyond
pandem
play
close
determin
spike
protein
adopt
either
close
confirm
open
one
bind
receptor
structur
viral
help
explain
block
infect
august
furnish
first
evid
protect
massiv
outbreak
us
fish
boat
crew
alreadi
new
coronaviru
provid
say
first
direct
evid
protect
peopl
viral
infect
immun
system
attack
viru
previou
research
determin
whether
shield
reinfect
explos
new
coronaviru
help
end
pandem
explos
new
coronaviru
help
end
univers
school
medicin
test
crew
us
fish
vessel
viru
preprint
ship
departur
test
crew
found
neg
outbreak
hit
ship
soon
left
test
crew
infect
none
infect
test
shown
three
crew
departur
infect
provid
statist
signific
evid
acquir
infect
protect
reinfect
say
yet
peer
health
worker
sampl
coal
miner
test
credit
august
fast
test
quick
cheap
painless
test
spit
use
mass
yale
school
medicin
new
simpl
saliva
test
address
grow
demand
extens
test
lift
c
b
f
preprint
nose
throat
swab
saliva
test
less
invas
need
train
profession
use
scarc
store
extract
viral
valid
test
posit
nose
throat
neg
estim
us
unit
food
drug
administr
author
test
emerg
cell
infect
goldsmith
august
immun
reaction
common
provid
immun
recogn
caus
common
cold
respond
coronaviru
respons
found
peopl
never
expos
nevertheless
immun
memori
recogn
viru
la
institut
immunolog
found
recogn
particular
sever
j
scienc
team
similar
activ
respond
add
weight
hypothesi
immun
cold
contribut
sever
support
august
antibodi
blend
viral
mixtur
two
human
new
coronaviru
promis
anim
treat
immun
attach
disabl
new
york
made
cocktail
two
bind
gave
cocktail
rhesu
mulatta
becom
mildli
ill
infect
rush
studi
coronaviru
short
suppli
rush
studi
coronaviru
short
found
took
placebo
receiv
antibodi
combin
less
like
develop
pneumonia
less
lung
damag
true
took
either
dose
viru
preprint
unlik
golden
infect
becom
acut
ill
viru
lost
less
weight
even
weight
control
given
antibodi
cocktail
dose
viru
yet
peer
boy
camp
screen
august
outbreak
prevent
spread
new
coronaviru
least
staff
test
posit
overnight
camp
us
state
depart
public
health
outbreak
two
day
first
arriv
june
c
mortal
rep
staff
test
neg
viru
day
arriv
mix
sleep
wear
found
nearli
staff
mani
test
posit
two
leav
camp
half
age
outbreak
includ
larg
number
sleep
cabin
describ
daili
vigor
sing
cheer
volunt
new
york
inject
part
vaccin
trial
credit
vaccin
candid
experiment
coronaviru
vaccin
complet
infect
receiv
prevent
dan
beth
deaco
medic
center
boston
gave
rhesu
mulatta
singl
dose
one
n
b
natur
vaccin
compris
respiratori
viru
one
seven
spike
vaccin
nearli
made
power
immun
block
infect
trigger
immun
expos
potent
lung
infect
six
six
receiv
nasal
infect
five
associ
protect
infect
staff
member
disinfect
hotel
china
coronaviru
quarantin
news
servic
via
immun
viru
found
unexpos
prepar
attack
new
coronaviru
peopl
expos
first
immun
respons
mostli
immun
offer
anoth
possibl
rout
immun
univers
hospit
berlin
blood
react
spike
protein
j
natur
five
coronaviru
still
five
coronaviru
still
team
found
studi
well
healthi
blood
expos
specul
reactiv
healthi
past
relat
remain
unclear
whether
offer
protect
allow
viru
elud
help
viru
thwart
potent
immun
blood
mani
peopl
recov
disabl
new
coronaviru
recogn
new
coronaviru
spike
protein
viru
infect
hope
use
univers
new
york
citi
version
vesicular
stomat
viru
livestock
make
spike
protein
grew
viru
presenc
preprint
spike
protein
acquir
escap
recognit
rang
six
coronaviru
still
race
solv
six
coronaviru
still
race
team
found
infect
peopl
around
world
although
low
treatment
multipl
differ
part
spike
protein
stop
viru
resist
suggest
yet
peer
power
china
campaign
seen
pattern
china
key
metric
serial
interv
shrank
drastic
soon
new
coronaviru
arriv
find
success
china
test
isol
serial
interv
averag
time
onset
chain
peopl
infect
pathogen
benjamin
cowl
univers
hong
spread
china
found
serial
interv
plummet
day
day
period
start
scienc
say
earli
isol
transmiss
would
otherwis
later
infecti
period
lead
spread
viru
result
either
infect
peopl
earli
symptomat
phase
serial
interv
shrank
suggest
serial
interv
distribut
use
real
time
track
transmiss
found
dog
infect
compar
dog
infect
mirror
dog
like
infect
peopl
accord
survey
northern
studi
univers
bari
took
nose
throat
rectal
dog
northern
march
e
preprint
live
infect
peopl
sever
affect
test
posit
viral
viru
blood
found
around
dog
evid
previou
among
dog
compar
among
peopl
time
test
suggest
unusu
infect
yet
peer
yellow
artifici
infect
viru
school
secondari
school
infect
new
coronaviru
remov
day
fulli
two
secondari
school
ministri
health
result
outbreak
found
staff
becom
infect
c
among
close
peopl
infect
school
outbreak
mount
evid
coronaviru
health
advic
caught
mount
evid
coronaviru
health
advic
caught
viru
spread
probabl
heavi
use
suspens
requir
wear
face
school
result
space
squar
per
sever
ill
peopl
yield
divers
trove
power
divers
group
block
new
coronaviru
abil
infect
even
appli
low
interfer
hostil
tri
enter
target
ho
univers
colleg
new
york
citi
studi
plasma
five
peopl
sever
l
natur
sprint
solv
coronaviru
protein
disarm
sprint
solv
coronaviru
protein
disarm
prove
highli
effect
infect
cell
small
dose
one
golden
attach
varieti
coronaviru
spike
protein
therapi
made
fasten
onto
spike
protein
multipl
difficult
viru
evad
girl
credit
viral
help
target
amount
viral
nose
throat
person
infect
new
coronaviru
help
decid
best
treat
accord
analysi
taken
hospit
univers
hospit
viral
load
amount
viru
standard
volum
materi
taken
peopl
infect
preprint
two
distinct
earli
diseas
peopl
high
viral
tend
declin
gradual
diseas
later
stage
typic
inflamm
declin
viral
thu
serv
cue
start
treat
infect
peopl
found
correl
viral
load
sever
diseas
suggest
good
predictor
patient
outcom
research
yet
peer
hospit
time
via
antivir
peter
within
infect
key
neutral
effect
new
coronaviru
fall
low
within
infect
accord
comprehens
studi
block
pathogen
antibodi
often
wane
take
gambl
antibodi
coronaviru
take
gambl
antibodi
king
colleg
concentr
infect
peopl
day
j
preprint
preprint
yet
peer
team
peak
antibodi
product
peopl
sever
higher
peopl
mild
peopl
antibodi
fall
month
sometim
nearli
undetect
rais
durabl
design
promot
product
posit
trial
rais
top
vaccin
lead
vaccin
candid
immun
respons
viru
side
effect
accord
preliminari
data
phase
safeti
studi
vaccin
us
nation
institut
allergi
infecti
prompt
human
make
viru
spike
protein
gener
immun
respons
coronaviru
vaccin
world
make
enough
coronaviru
vaccin
world
make
enough
kaiser
health
research
institut
gave
two
four
apart
one
three
differ
vaccin
l
n
j
side
effect
mild
although
three
got
highest
dose
experienc
wors
high
produc
immun
capabl
viru
well
block
infect
phase
trial
test
whether
vaccin
prevent
set
begin
late
sever
telltal
immun
signatur
peopl
seriou
find
inform
develop
diseas
ten
immun
bad
idea
ten
immun
bad
terrier
univers
blood
peopl
infect
j
scienc
mild
moder
sever
diseas
produc
antivir
inflammatori
found
blood
specif
taken
suggest
reduct
blood
hallmark
sever
counter
inflamm
increas
help
peopl
diseas
queue
coronaviru
test
viru
us
invas
new
coronaviru
spread
across
much
interior
unit
along
peopl
move
state
state
us
coastal
seed
perhap
accord
northeastern
univers
boston
studi
air
traffic
commut
data
understand
coronaviru
took
hold
unit
j
preprint
team
found
sever
coastal
intern
travel
drove
introduct
viru
new
york
begun
earli
ethic
trace
ethic
trace
mani
domest
rather
intern
sourc
first
wave
spread
across
countri
late
earli
march
larg
undetect
say
yet
peer
unit
hospit
mark
via
massiv
effort
link
phone
credit
card
data
identifi
nearli
coronaviru
link
outbreak
popular
district
south
note
cluster
among
peopl
club
district
lee
nation
univers
medic
use
mobil
phone
locat
data
credit
card
payment
inform
identifi
peopl
spent
time
near
c
r
kang
infect
di
late
earli
undergo
test
late
test
peopl
effort
turn
sever
even
along
transmiss
chain
worker
sampl
de
campaign
provid
free
test
pablo
univers
soar
even
test
weekli
safe
reopen
residenti
need
test
everi
two
yale
school
public
health
new
effect
varieti
test
number
would
aris
among
semest
preprint
never
coronaviru
crisi
never
coronaviru
one
scenario
assum
five
new
would
week
infect
student
would
infect
test
posit
would
isol
team
found
test
everi
two
day
rapid
rel
cheap
test
would
keep
around
semest
cost
us
per
student
per
term
howev
test
weekli
would
result
explos
growth
transmiss
rate
higher
keep
manag
would
requir
daili
test
would
doubl
stress
prevent
social
therefor
remain
essenti
yet
peer
one
nation
wildli
dispar
local
infect
effort
identifi
peopl
infect
new
coronaviru
found
roughli
show
marina
institut
health
test
peopl
randomli
select
across
produc
bodi
immun
system
respons
coronaviru
infect
lancet
studi
larg
geograph
preval
peopl
central
test
posit
less
coastal
whose
coronaviru
strategi
work
best
hunt
effect
whose
coronaviru
strategi
work
best
hunt
effect
peopl
test
posit
around
one
three
asymptomat
basi
estim
roughli
one
million
peopl
previous
infect
coronaviru
gone
undetect
show
tissu
left
person
presenc
multipl
immun
cell
right
credit
link
immun
respons
death
studi
peopl
mismatch
viral
bodi
inflamm
organ
damag
suggest
immun
rather
viru
respons
death
kill
uncertainti
abil
choos
kill
uncertainti
abil
choos
immun
system
organ
damag
seen
sever
univers
detail
map
bodi
along
inflamm
injuri
preprint
survey
anatom
found
littl
correl
viru
inflamm
viru
inflam
wherea
contain
high
yet
peer
health
worker
test
new
via
june
test
frequenc
test
sensit
stop
quickli
spiral
control
frequent
test
larg
peopl
new
coronaviru
even
rel
insensit
reli
techniqu
quantit
chain
reaction
detect
genet
materi
expens
slow
return
gaug
import
test
sensit
mina
h
school
public
health
boston
effect
widespread
test
viral
spread
larg
group
peopl
b
preprint
first
test
coronaviru
unit
first
test
coronaviru
unit
found
weekli
surveil
test
pair
case
isol
would
limit
outbreak
even
test
method
less
sensit
contrast
surveil
test
done
everi
day
would
allow
total
number
climb
almost
high
test
yet
peer
viru
artist
impress
protein
spike
dark
blue
infect
host
design
june
fine
detail
map
viral
protein
protein
new
coronaviru
latch
feat
protein
crucial
bind
human
help
avoid
second
coronaviru
wave
help
avoid
second
coronaviru
cell
viral
protein
spike
tightli
receptor
surfac
mani
human
bloom
cancer
research
center
singl
amino
acid
time
key
segment
spike
produc
protein
n
preprint
mani
bind
receptor
least
well
protein
coronaviru
caus
current
team
pinpoint
amino
impair
spike
protein
bind
abil
knowledg
help
develop
neutral
viru
abil
infect
yet
peer
orang
artist
impress
bind
human
june
strike
share
infect
peopl
never
show
classic
peopl
infect
fell
ill
respiratori
fever
accord
survey
peopl
peopl
make
region
coronaviru
outbreak
foundat
marcello
health
protect
agenc
studi
peopl
close
contact
infect
person
show
evid
secur
effect
show
evid
secur
half
infect
p
preprint
respiratori
cough
fever
age
person
age
odd
becom
ill
enough
requir
intens
care
die
inform
outbreak
yet
peer
june
host
aid
viral
trawl
monkey
genom
system
hand
help
new
coronaviru
infect
peopl
help
track
health
effect
coronaviru
crisi
peopl
help
track
health
effect
coronaviru
discoveri
host
aid
viral
activ
aid
develop
new
reveal
peopl
suscept
broad
institut
yale
school
medicin
new
use
alter
cultur
monkey
viral
infect
death
j
preprint
team
survey
found
code
sever
known
assist
coronaviru
among
pathway
involv
cell
growth
death
inhibit
pathway
cell
death
yet
peer
boy
mother
grandfath
wear
infect
hong
peter
june
youth
shield
infect
close
age
much
less
like
catch
new
coronaviru
infect
household
yang
univers
yang
center
diseas
control
prevent
china
viral
transmiss
infect
peopl
close
contact
q
jing
lancet
di
isol
infect
quarantin
peopl
age
risk
infect
member
household
risk
peopl
age
risk
peopl
age
found
peopl
least
infecti
suggest
viral
spread
within
limit
provid
infect
peopl
isol
wear
protect
hospit
peopl
june
one
billion
peopl
face
risk
sever
host
common
health
boost
person
risk
becom
serious
ill
infect
new
coronaviru
analysi
extent
vulner
group
world
popul
least
one
underli
condit
risk
sever
clark
school
hygien
tropic
medicin
preval
diabet
cardiovascular
predispos
peopl
infect
sever
clark
lancet
health
data
team
billion
peopl
elev
risk
sever
ill
estim
nearli
million
peopl
underli
would
requir
hospit
use
assess
mani
peopl
need
vaccin
usag
spotti
among
peopl
board
ferri
june
swiss
survey
less
suscept
elderli
less
like
age
show
evid
past
infect
accord
survey
peopl
geneva
geneva
univers
test
peopl
age
older
produc
immun
system
prevent
reinfect
new
coronaviru
lancet
spread
coronaviru
scienc
still
clear
spread
coronaviru
scienc
still
found
one
age
test
posit
although
live
someon
age
older
live
anoth
person
test
say
low
preval
less
suscept
infect
wherea
low
preval
elderli
stem
less
exposur
viru
immun
june
karaok
aid
coronaviru
often
link
mani
peopl
breath
heavili
togeth
karaok
gym
session
accord
survey
univers
japan
least
five
infect
peopl
event
venu
di
mani
nurs
care
littl
half
took
place
music
coronaviru
slow
spread
coronaviru
slow
spread
one
concert
exampl
sourc
infect
peopl
audienc
team
probabl
time
half
age
red
new
coronaviru
bud
infect
nation
infect
june
mice
aid
quest
short
cut
gener
mous
harmless
viru
make
suscept
viru
human
cell
one
surfac
mice
differ
version
make
impervi
infect
mice
carri
human
version
suscept
infect
scarc
rush
studi
coronaviru
short
suppli
rush
studi
coronaviru
short
develop
wide
avail
mous
model
team
led
diamond
univers
st
anoth
first
hospit
medic
univers
china
use
gene
therapi
deliv
human
gene
lung
mice
exposur
mice
lost
weight
team
success
ill
mice
therapeut
cell
group
use
mice
test
experiment
vaccin
sever
j
sun
cell
clad
garb
protect
buri
dead
cemeteri
june
massiv
number
viral
seed
new
coronaviru
unit
kingdom
time
mostli
despit
earli
infect
china
peopl
unit
kingdom
understand
outbreak
team
led
univers
univers
nearli
preprint
virolog
help
avoid
second
coronaviru
wave
help
avoid
second
coronaviru
team
track
number
time
viru
unit
kingdom
spread
insid
countri
genom
analysi
found
although
say
number
preliminari
probabl
underestim
roughli
slightli
less
peopl
come
china
less
yet
peer
june
viru
pair
human
invad
found
second
protein
enter
human
potenti
offer
new
target
protein
spike
known
attach
human
protein
viru
enter
two
found
human
protein
viral
invas
profil
killer
complex
biolog
coronaviru
pandem
profil
killer
complex
biolog
coronaviru
univers
fragment
spike
protein
bind
l
preprint
team
technic
univers
j
l
preprint
show
antibodi
block
infect
human
grown
team
found
mice
entri
central
nervou
system
suggest
block
interact
viru
provid
way
combat
coronaviru
studi
peer
turkey
care
space
adher
credit
omer
june
peopl
feel
fine
unknowingli
spread
massiv
coronaviru
test
campaign
found
evid
infect
peopl
never
show
pass
viru
global
outbreak
repeatedli
test
peopl
high
risk
infect
test
posit
admit
hospit
either
test
neg
decis
stop
coronaviru
test
project
decis
stop
coronaviru
test
roughli
peopl
test
earli
infect
van
tan
univers
clinic
research
unit
ho
chi
citi
found
hospit
stay
n
v
v
infect
di
nasal
infect
asymptomat
studi
lower
viral
infect
peopl
felt
ill
point
highli
like
two
asymptomat
sourc
infect
least
two
peopl
power
tool
resound
success
thwart
new
coronaviru
accord
two
independ
differ
imperi
colleg
use
data
model
viral
transmiss
flaxman
natur
team
found
combin
viru
spread
million
epidem
start
earli
whose
coronaviru
strategi
work
best
hunt
effect
whose
coronaviru
strategi
work
best
hunt
effect
countri
taken
enough
halt
epidem
restrict
contact
especi
effect
reduc
transmiss
univers
growth
rate
time
china
unit
four
appli
prevent
viral
spread
natur
analysi
across
avert
roughli
million
team
found
requir
peopl
stay
home
whether
infect
effect
stem
viral
doctor
peopl
cloth
enter
june
pose
modest
risk
household
minor
role
within
univers
viru
includ
least
one
infect
person
preprint
team
found
viral
frequent
touch
door
taken
bathroom
team
grow
infecti
viru
air
design
pick
fine
respiratori
aerosol
test
neg
viral
although
say
method
use
result
suggest
direct
transmiss
coronaviru
exampl
probabl
main
rout
infect
howev
transmiss
possibl
rout
infect
yet
peer
woman
train
station
mask
guard
spread
new
robin
june
blood
type
influenc
two
human
gene
make
peopl
suscept
lung
failur
associ
univers
hospit
roughli
peopl
peopl
respiratori
failur
peopl
diseas
preprint
sever
like
carri
either
two
gene
peopl
without
diseas
coronaviru
mysteri
coronaviru
mysteri
variant
swath
genom
blood
analysi
found
peopl
blood
type
risk
lung
failur
blood
wherea
type
blood
extent
studi
second
variant
chromosom
near
six
one
molecular
receptor
viru
enter
human
studi
yet
peer
june
drug
potenc
prevent
infect
larg
clinic
trial
found
evid
drug
peopl
world
treatment
agent
prevent
diseas
univers
randomli
assign
peopl
take
either
placebo
within
day
exposur
r
n
j
studi
contact
infect
peopl
hous
infect
person
use
controversi
drug
coronaviru
despit
safeti
use
controversi
drug
coronaviru
despit
safeti
peopl
given
within
given
placebo
differ
statist
signific
take
drug
side
effect
take
note
import
caveat
studi
avail
peopl
unless
therefor
asymptomat
unaccount
fora
scientist
st
russia
infect
new
june
antibodi
viru
preval
antibodi
underestim
share
popul
infect
take
gambl
antibodi
coronaviru
take
gambl
antibodi
respons
pathogen
attack
immun
produc
linger
blood
provid
record
infect
univers
san
identifi
potenti
sourc
bia
detect
presenc
new
coronaviru
preprint
antibodi
blood
peopl
sever
diseas
make
small
fraction
infect
peopl
higher
bodi
peopl
mild
say
detail
assess
well
antibodi
detect
previou
infect
peopl
mild
yet
peer
green
artifici
infect
human
june
posit
coronaviru
test
guarante
unlik
spread
new
coronaviru
eight
day
sinc
accord
monkey
univers
canada
seed
cultur
monkey
human
test
posit
j
infect
di
found
collect
eight
day
person
infect
suggest
peopl
test
posit
viral
necessarili
still
test
posit
viral
feel
ill
need
strictli
isol
team
nose
bodi
entri
point
nose
probabl
start
point
decis
stop
coronaviru
test
project
decis
stop
coronaviru
test
boucher
ralph
baric
univers
north
chapel
hill
track
eas
new
coronaviru
variou
cell
respiratori
tract
found
gradient
infect
upper
lower
respiratori
tract
easili
infect
nasal
caviti
least
easili
infect
deep
j
cell
gradient
neatli
onto
distribut
express
protein
enter
specul
viru
foothold
nose
respiratori
tract
breath
say
support
use
prevent
nasal
man
face
mask
protect
coronaviru
lost
opportun
stop
viral
spread
unit
analysi
find
first
commun
spread
new
coronaviru
unit
machin
learn
help
get
aid
need
machin
learn
help
get
aid
need
late
wide
genom
analysi
silent
spread
state
analysi
outbreak
origin
travel
even
though
quickli
infect
arriv
china
done
extens
contact
trace
stop
univers
trigger
outbreak
instead
team
found
evid
viru
spread
state
china
preprint
yet
peer
four
arriv
arriv
actual
sourc
opportun
stop
viru
take
hold
unit
high
portion
extrem
high
level
viral
seed
new
coronaviru
across
accord
genom
analysi
world
health
organ
wrong
danger
must
revers
world
health
organ
wrong
danger
must
stern
univers
peopl
across
miller
preprint
yet
peer
show
infect
peopl
next
wave
power
viral
analysi
found
unit
carri
viru
us
respons
disproportion
share
viral
spread
one
possibl
explan
entri
peopl
us
expos
escap
infect
often
age
much
less
like
becom
infect
new
coronaviru
larg
systemat
review
journal
viner
univers
colleg
screen
provid
data
met
criteria
inclus
includ
peer
r
viner
preprint
coronaviru
chase
new
diagnost
fight
pandem
coronaviru
chase
new
diagnost
fight
infect
show
less
like
get
infect
contact
infect
person
analysi
smaller
part
spread
viru
popul
evid
find
weak
enough
research
determin
whether
infect
less
like
pass
infect
studi
yet
peer
man
mourn
cemeteri
rio
de
buda
trump
drug
benefit
anoth
drug
us
presid
trump
antimalari
drug
treatment
studi
nearli
peopl
found
benefit
drug
link
instead
elev
risk
death
abnorm
heart
hospit
heart
vascular
center
boston
health
peopl
studi
drew
data
r
lancet
roughli
receiv
relat
drug
chloroquin
one
pair
antibiot
block
inform
fuel
spread
misinform
block
inform
fuel
spread
peopl
take
peopl
four
treatment
arm
like
die
hospit
like
develop
disord
heartbeat
arrhythmia
say
peopl
enrol
clinic
take
separ
trial
drug
recoveri
peopl
nation
allergi
infecti
studi
peopl
enrol
trial
found
took
median
recoveri
time
day
day
took
placebo
j
h
n
j
note
lancet
retract
controversi
paper
protect
new
coronaviru
vaccin
viru
coronaviru
develop
next
coronaviru
develop
next
dan
medic
school
boston
compos
j
scienc
type
vaccin
recipi
make
pathogen
turn
immun
six
base
coronaviru
protein
spike
test
rhesu
mulatta
mount
antibodi
respons
similar
seen
peopl
team
gave
coronaviru
mild
ill
viral
multipl
gener
lower
unvaccin
probabl
immun
kept
viru
yellow
infect
human
potent
human
inspir
vaccin
typic
work
bodi
immun
respons
fend
particular
viru
stimul
protect
antibodi
respons
guarante
vaccin
everi
diseas
coronaviru
time
think
next
epidem
coronaviru
time
think
next
epidem
univers
new
york
citi
studi
peopl
infect
found
viru
fraction
strongli
block
coronaviru
human
f
preprint
work
yet
peer
sever
diseas
higher
potent
averag
peopl
whose
ill
milder
everi
particip
capabl
make
suggest
vaccin
design
elicit
potent
univers
resist
reinfect
infect
new
coronaviru
reinfect
although
long
protect
unclear
fight
coronaviru
misinform
epidem
fight
coronaviru
misinform
need
know
whether
peopl
infect
infect
address
issu
dan
medic
school
boston
gave
coronaviru
nine
rhesu
mulatta
mild
appetit
loss
well
viru
scienc
roughli
one
month
later
gave
anoth
dose
viru
follow
two
team
low
rapidli
viral
almost
none
mount
antibodi
respons
second
dose
suggest
immun
fought
seat
next
child
school
viru
heart
brain
found
new
coronaviru
heart
brain
autopsi
slowdown
quest
determin
coronaviru
autopsi
slowdown
quest
determin
coronaviru
princip
consid
respiratori
diseas
infect
peopl
experi
stroke
univers
medic
center
peopl
found
viru
abund
present
lower
liver
heart
brain
blood
v
g
n
j
genet
activ
team
found
three
known
encourag
infect
highli
activ
kidney
addit
analysi
peopl
viru
kidney
explain
kidney
damag
seen
peopl
antibodi
new
coronaviru
older
antibodi
discov
blood
person
help
fight
chloroquin
search
coronaviru
chloroquin
search
coronaviru
coronaviru
outbreak
distant
rel
viru
respons
current
pandem
antibodi
report
univers
pinto
natur
antibodi
immun
molecul
viral
protein
spike
use
enter
human
team
structur
analysi
locat
spike
distinct
attach
site
person
two
combin
one
two
better
block
viru
antibodi
sip
beer
togeth
reopen
outdoor
seat
dog
catch
coronaviru
first
two
dog
coronaviru
probabl
caught
infect
say
studi
infect
hong
analysi
viral
genet
dog
ident
infect
peopl
probabl
spread
new
china
viru
probabl
spread
new
china
studi
dog
live
peopl
h
c
sit
natur
two
german
shepherd
caught
diseas
team
viral
dog
live
viru
one
neither
dog
notic
studi
evid
dog
pass
infect
dog
promis
vaccin
lung
experiment
vaccin
pneumonia
strong
immun
respons
nation
institut
allergi
infecti
montana
gilbert
univers
design
vaccin
new
coronaviru
spike
protein
invad
host
n
van
preprint
rhesu
mulatta
vaccin
give
high
viru
coronaviru
vaccin
world
make
enough
coronaviru
vaccin
world
make
enough
prevent
viru
enter
much
lower
viral
lung
tissu
unvaccin
suggest
vaccin
stop
viru
multipli
two
three
control
pneumonia
none
research
yet
peer
clinic
trial
vaccin
lift
spell
surg
peopl
nation
infect
rate
stood
roughli
well
short
herd
immun
old
new
old
new
pasteur
institut
coronaviru
outbreak
h
scienc
found
march
reduc
viral
spread
team
time
relax
popul
would
popul
would
need
immun
immun
alon
control
epidem
result
herd
immun
prevent
second
wave
end
board
bu
new
york
choir
practic
singl
ill
person
choir
practic
state
led
probabl
infect
choir
counti
public
health
mount
numer
local
ill
even
choir
practic
march
l
mortal
rep
one
symptomat
person
practic
later
test
posit
peopl
attend
ill
confirm
addit
ill
probabl
coronaviru
agre
coronaviru
sat
sang
long
viral
transmiss
event
import
close
keep
viru
bay
like
enter
lower
risk
death
diseas
accord
studi
infect
univers
data
age
turn
test
posit
coronaviru
fulli
preprint
studi
yet
peer
zoom
call
theori
realiti
zoom
call
theori
age
one
nation
survey
overal
hospit
rate
infect
much
lower
around
least
one
infect
parent
whose
often
child
new
york
citi
infect
high
york
citi
march
correl
home
highest
number
past
three
understand
vari
substanti
citi
th
school
public
health
boston
coronaviru
test
came
citi
give
birth
preprint
coronaviru
spread
easili
peopl
coronaviru
spread
easili
peopl
team
postal
infect
estim
diseas
preval
citi
inform
locat
data
reveal
number
daili
peopl
take
found
link
infect
rate
number
taken
probabl
essenti
prevent
viru
spread
saya
cell
green
artifici
heavili
infect
viru
pink
bodi
sweep
antibodi
respons
coronaviru
peopl
infect
new
coronaviru
make
sever
viru
find
lead
effect
sensit
determin
alreadi
infect
univers
hong
determin
target
immun
help
fight
infect
take
gambl
antibodi
coronaviru
take
gambl
antibodi
team
found
peopl
viral
healthi
peopl
pandem
preprint
three
distinguish
infect
peopl
healthi
effort
develop
diagnost
viral
protein
spike
yet
peer
suggest
import
immun
high
risk
death
minor
ethnic
troubl
white
face
substanti
higher
risk
die
white
peopl
health
socioeconom
explain
small
part
higher
risk
highli
vulner
highli
vulner
sweep
studi
kind
ben
univers
medic
million
e
preprint
analysi
yet
peer
medic
diabet
link
higher
risk
death
new
preval
peopl
belong
minor
ethnic
small
part
risk
preval
social
low
incom
say
urgent
need
better
protect
peopl
minor
ethnic
person
taken
train
carri
strong
antibodi
respons
common
peopl
everyon
new
coronaviru
accord
studi
peopl
diseas
antibodi
suggest
coronaviru
vastli
exceed
offici
antibodi
suggest
coronaviru
vastli
exceed
offici
school
medicin
mount
new
york
citi
found
studi
infect
eventu
suggest
immun
reinfect
unknown
length
time
preprint
immun
respons
slow
studi
produc
detect
one
month
first
feel
ill
team
found
person
age
sex
affect
chanc
studi
test
posit
viral
two
end
mean
presenc
viral
good
indic
whether
bodi
viru
studi
yet
peer
even
use
new
test
detect
coronaviru
test
system
detect
new
coronaviru
hour
without
need
special
equip
train
personnel
fight
coronaviru
fight
broad
institut
sought
develop
test
would
simpler
current
procedur
expens
lab
equip
scarc
team
protocol
access
cooker
piec
kitchen
equip
commonli
avail
less
us
j
preprint
test
avail
paper
similar
use
pregnanc
yet
peer
team
test
use
fast
diagnosi
speedi
techniqu
synthet
use
yeast
creat
synthet
version
genom
much
quickli
achiev
untap
potenti
us
provid
coronaviru
untap
potenti
us
provid
genom
compos
protocol
univers
dozen
genom
convert
n
natur
team
insert
yeast
saccharomyc
complet
viral
team
built
live
convert
synthet
genom
back
human
synthet
took
week
make
techniqu
use
assembl
rapidli
studi
biolog
effect
new
wear
face
return
school
shanghai
credit
tang
news
stop
epidem
china
two
show
easi
evid
valu
school
travel
pain
curb
coronaviru
epidem
foundat
univers
shanghai
found
stringent
peopl
shanghai
wuhan
cut
per
day
roughli
per
day
j
scienc
drastic
social
enough
bring
epidem
control
two
team
work
shanghai
school
alon
would
stop
epidem
lower
number
new
per
day
epidem
peak
reliev
stress
need
alert
fear
second
coronaviru
wave
china
eas
need
alert
fear
second
coronaviru
wave
china
studi
lai
univers
quick
detect
isol
infect
peopl
effect
china
lai
natur
even
place
number
would
restrict
travel
social
three
number
infect
peopl
china
time
higher
viral
enzym
aid
hunt
key
enzym
action
provid
experiment
therapi
attack
shown
earli
trial
speed
recoveri
peopl
compound
action
viral
enzym
team
led
institut
biophys
chemistri
use
techniqu
microscopi
map
shape
enzym
copi
viru
genet
materi
h
preprint
peer
post
say
lead
identif
new
antivir
reveal
separ
team
led
eric
shanghai
institut
china
structur
link
snippet
molecul
w
yin
scienc
help
design
power
block
activ
queue
train
china
immun
system
abnorm
respons
immun
respons
respons
respiratori
accord
analysi
infect
peopl
find
idea
immun
system
help
peopl
school
medicin
mount
new
york
citi
found
infect
produc
unusu
low
antivir
infect
respiratori
cell
activ
gener
immun
higher
infect
peopl
uninfect
suggest
immun
imbal
low
reduc
cell
abil
limit
viral
replic
activ
immun
young
immun
like
becom
infect
close
contact
infect
person
accord
studi
peopl
china
peopl
volunt
infect
school
public
health
center
diseas
control
prevent
nearli
peopl
close
infect
peopl
q
lancet
di
team
found
close
younger
age
infect
roughli
popul
overal
work
first
post
preprint
march
found
origin
respons
close
lead
larg
target
cell
viral
red
connect
blue
target
invad
host
immun
new
coronaviru
human
one
protein
found
mani
human
littl
known
crucial
learn
medic
school
institut
technolog
boston
broad
institut
studi
airway
peopl
influenza
c
g
k
cell
influenza
viru
invad
respiratori
tract
coronaviru
spread
easili
peopl
coronaviru
spread
easili
peopl
team
found
peopl
flu
normal
help
fend
switch
host
protein
result
bodi
viral
attack
drive
activ
gene
dri
genet
test
part
use
store
sampl
extract
viral
overcom
difficulti
team
led
lea
jay
univers
procedur
viral
without
highli
sought
preprint
peer
post
dri
swab
procedur
correctli
viral
peopl
known
convent
extract
posit
say
protocol
enabl
massiv
use
genet
test
worker
test
peopl
throat
scarc
resourc
credit
hospit
viral
new
coronaviru
travel
air
spread
way
small
infect
lan
wuhan
univers
china
test
concentr
fine
two
treat
peopl
natur
team
elev
viral
small
toilet
use
staff
viral
staff
low
undetect
found
patient
presenc
viral
potenti
spread
way
say
suggest
routin
disinfect
better
ventil
help
control
viru
spit
solut
test
person
saliva
accur
whether
infect
find
make
viru
wide
test
coronaviru
infect
long
swab
rub
back
throat
short
suppli
prompt
peopl
cough
sneez
potenti
barrag
viral
yale
school
public
health
new
collect
saliva
throat
peopl
preprint
peer
post
team
test
detect
viru
detect
saliva
saliva
test
two
felt
fine
neg
throat
actual
human
cell
blue
artifici
infect
yellow
credit
intens
test
small
town
mani
silent
larg
proport
peopl
accord
research
small
town
first
death
lead
ban
movement
town
end
public
commerci
two
imperi
colleg
almost
everi
resid
viral
begin
end
team
found
peopl
infect
town
fever
e
preprint
peer
post
statist
signific
differ
potenti
infecti
asymptomat
presymptomat
key
role
transmiss
difficult
control
diseas
without
strict
social
vaccin
candid
earli
success
anim
experiment
vaccin
infect
viru
team
led
union
medic
colleg
rhesu
mulatta
three
vaccin
compris
chemic
q
preprint
peer
post
eight
intent
expos
four
given
high
dose
vaccin
detect
viru
throat
seven
day
exposur
receiv
lower
dose
vaccin
coronaviru
infect
viru
much
lower
expos
receiv
vaccin
month
compani
vaccin
receiv
approv
start
human
safeti
man
intens
care
unit
hong
stem
viral
spread
without
harsh
spread
combin
intens
surveil
social
without
sever
use
wuhan
coronaviru
outbreak
travel
citi
attempt
control
spread
viru
hong
includ
widespread
test
contact
infect
peopl
school
univers
hong
earli
march
wore
mask
public
b
j
cowl
lancet
public
health
combin
public
govern
kept
viru
spread
rel
low
hong
period
end
march
team
vaccin
viral
key
portion
coronaviru
protein
form
basi
safe
effect
bristl
spini
spike
portion
spike
domain
molecul
found
surfac
mani
human
viral
particl
gain
entri
research
institut
spike
bind
domain
b
preprint
peer
post
respons
immun
made
recogn
coronaviru
prevent
spike
red
particl
receptor
unlik
make
host
suscept
coronaviru
infect
one
main
safeti
ski
seed
coronaviru
ski
bring
coronaviru
late
decod
test
among
iceland
high
risk
exposur
viru
china
f
n
j
peopl
test
earli
infect
team
viral
peopl
test
posit
found
probabl
alpin
ski
second
half
march
randomli
select
found
infect
say
analysi
contain
viru
test
contact
trace
success
worker
dress
shift
intens
care
unit
de
relief
social
unleash
viru
like
surg
current
accord
grad
marc
th
school
public
health
boston
spread
temper
unit
team
predict
spread
coronaviru
scienc
found
effici
influenza
viru
exampl
peak
number
social
peak
number
without
social
leav
high
proport
peopl
suscept
infect
lead
spike
diseas
viral
transmiss
late
human
immun
cours
viru
like
caus
repeat
wintertim
common
techniqu
speed
diagnosi
standard
method
sequenc
day
detect
viru
test
protocol
broad
institut
team
everi
sampl
test
would
tag
uniqu
sequenc
would
serv
biolog
j
l
preprint
peer
post
common
research
around
world
use
analys
mani
one
anticip
clinic
test
method
million
per
day
site
far
effici
output
current
test
version
includ
name
paper
correspond
author
viral
enzym
structur
possibl
detail
crystal
structur
one
key
enzym
proteas
viru
need
replic
within
yang
univers
china
structur
protein
data
bank
two
ago
sinc
use
help
identifi
inhibit
proteas
z
natur
team
screen
reveal
sever
power
viral
whose
safeti
alreadi
test
work
hollow
proteas
found
similar
hollow
rais
singl
compound
help
treat
wide
varieti
key
two
blue
red
artist
impress
hollow
candid
green
bind
z
absent
suggest
mysteri
immun
infect
mani
peopl
high
viru
recent
studi
present
low
foreign
microb
bodi
immun
system
usual
help
fight
invad
team
led
fan
univers
shanghai
china
measur
novel
coronaviru
mild
f
peer
post
especi
age
never
high
suggest
immun
rid
viral
load
infect
peopl
start
feel
highest
peopl
soon
appear
accord
two
separ
research
univers
hong
hospit
china
saliva
peopl
infect
team
found
studi
viral
peak
shortli
feel
ill
one
week
viral
person
bodi
excret
sneez
say
high
onset
suggest
viru
easili
peopl
even
rel
mild
k
lancet
infect
di
consist
anoth
studi
nose
throat
peopl
viral
symptomat
similar
one
asymptomat
patient
l
n
j
howev
anoth
studi
found
peopl
milder
admiss
hospit
much
lower
viral
sever
lancet
infect
di
first
hospit
univers
china
poon
univers
hong
say
suggest
viral
predict
whether
infect
peopl
develop
sever
blue
viru
nation
infect
comparison
subtl
reli
test
quantit
chain
reaction
determin
whether
person
infect
team
led
yale
school
public
health
new
nine
wide
use
test
found
reliabl
detect
viru
c
b
f
preprint
peer
post
found
one
made
us
diseas
control
prevent
anoth
hong
univers
third
berlin
best
came
low
viru
bat
harbour
pool
relat
pandem
close
relat
viru
caus
pandem
horsesho
bat
readi
jump
mayb
even
univers
viru
sever
acut
respiratori
syndrom
f
preprint
peer
post
analysi
horsesho
bat
host
expand
lineag
infect
team
ancestor
split
ago
close
relat
bat
viru
though
two
highli
similar
genet
infect
mysteri
anim
sourc
coronaviru
analysi
lineag
readi
jump
directli
bat
first
hop
anoth
speci
expos
rather
spread
straight
bat
cut
spread
face
effect
block
spread
season
respiratori
suggest
prevent
transmiss
one
caus
common
cold
benjamin
cowl
univers
hong
ill
infect
season
sit
booth
place
sampl
devic
n
h
l
natur
coronaviru
coars
finer
aerosol
wear
mask
reduc
detect
viral
droplet
carri
wherea
breath
spread
aerosol
diamet
five
say
surgic
reduc
transmiss
season
version
articl
reduc
detect
viral
help
foil
viru
lama
help
fight
sever
infect
team
led
institut
univers
isol
two
llama
bind
spike
use
enter
preprint
peer
post
one
antibodi
coronaviru
respons
middl
east
respiratori
syndrom
second
sever
acut
respiratori
syndrom
antibodi
llama
antibodi
human
hybrid
viru
respons
data
suggest
use
coronaviru
march
debilit
ralli
dose
serious
ill
experienc
strike
improv
blood
diseas
accord
two
separ
research
extract
plasma
compon
blood
peopl
blood
coronaviru
save
yang
nation
engin
technolog
research
center
combin
wuhan
china
gave
plasma
ten
sever
ill
peopl
sixth
day
treatment
viru
undetect
seven
ten
experienc
signific
side
effect
k
preprint
peer
post
group
led
lei
third
peopl
hospit
china
gave
plasma
five
critic
ill
peopl
c
j
five
within
ten
day
plasma
three
longer
would
tri
treat
health
directli
march
viral
point
potenti
list
human
affect
viru
guid
potenti
infect
team
led
univers
san
human
produc
one
made
coronaviru
e
preprint
peer
post
identifi
human
physic
interact
coronaviru
human
viral
candid
potenti
disrupt
test
antivir
activ
urg
institut
unit
unit
unit
essenti
roundup
scienc
news
opinion
analysi
everi
full
access
articl
via
essenti
roundup
scienc
news
opinion
analysi
everi
natur
brief
newslett
scienc
free
daili
coronaviru
one
know
one
seven
known
infect
affect
caus
fever
sometim
gastrointestin
world
health
organ
declar
coronaviru
situat
global
emerg
pandem
pandem
like
end
say
possibl
viru
becom
endem
stick
around
less
lethal
form
know
exactli
viru
bat
though
underway
trace
back
common
dri
cough
fever
short
breath
includ
diarrhea
loss
smell
tast
peopl
develop
sever
blood
diseas
mild
fatal
say
definit
less
like
die
men
know
older
peopl
especi
underli
health
risk
fare
better
diseas
sever
long
road
recoveri
peopl
experienc
brain
fog
heart
spate
away
peopl
long
enough
slow
spread
viru
near
groceri
store
food
go
walk
diseas
control
prevent
away
enforc
mani
throughout
pandem
roll
back
safe
still
avoid
travel
especi
airplan
still
tri
figur
exactli
viru
air
especi
dens
navig
life
amidst
pandem
public
health
made
foolproof
way
calcul
risk
way
avoid
spread
follow
public
health
much
know
far
like
get
coronaviru
air
surfac
bad
idea
regularli
clean
disinfect
remot
one
import
cours
wash
want
soap
disinfect
make
wear
mask
doubl
public
social
hard
maintain
area
stock
rememb
equal
layer
dispos
surgic
mask
beneath
fabric
face
cover
make
cloth
outer
need
two
rubber
mutat
time
spread
person
person
novel
coronaviru
except
recent
sever
new
seem
infecti
good
news
far
still
effect
enough
protect
new
caus
alarm
boost
genet
trace
effect
vaccin
continu
import
ever
abid
social
time
especi
mani
peopl
assumpt
neg
test
safe
gather
know
last
fall
event
white
hous
need
test
keep
viru
spread
even
test
necessarili
account
moment
definit
treatment
chloroquin
malaria
drug
presid
trump
evid
viabl
treatment
drug
treat
diseas
antivir
help
though
expens
hope
research
find
old
effect
treat
therebi
drug
discoveri
process
though
drug
research
proven
pretti
time
gener
help
blood
promis
though
know
exactli
effect
get
need
challeng
food
drug
administr
emerg
use
investig
rare
peopl
seem
strong
natur
place
ai
use
acceler
everyth
diagnosi
drug
discoveri
import
rememb
find
time
lot
dubiou
whatev
pleas
tri
drink
us
first
two
pfizerbiontech
blazingli
fast
scientif
achiev
consid
use
train
immun
system
recogn
fight
though
seriou
advers
mani
peopl
experi
side
effect
typic
day
two
feverlik
fact
author
emerg
use
bear
fate
ongo
use
use
teen
underway
late
third
vaccin
johnson
johnson
though
vaccin
use
short
time
due
rare
blood
shot
back
use
outweigh
number
ongo
good
thing
need
mani
inocul
everyon
alway
possibl
prove
even
better
alreadi
new
research
begun
figur
updat
concern
two
larg
order
peopl
get
vaccin
get
effici
possibl
two
three
use
us
right
pfizerbiontech
requir
two
must
cold
two
complic
distribut
issu
suppli
far
mani
difficulti
elig
appoint
idea
set
mass
vaccin
even
would
fulli
address
equiti
access
distribut
disproportion
favor
peopl
time
access
often
need
top
import
build
trust
among
especi
within
histor
born
brunt
medic
racism
pandem
truli
end
even
peopl
need
take
everyon
need
access
rais
famili
live
alon
best
isol
home
keep
space
clean
whether
sick
healthi
import
look
mind
know
viru
person
person
someon
germi
dust
diseas
vector
spread
exponenti
first
rate
slow
time
especi
addit
taken
flatten
curv
explor
possibl
viru
return
season
common
cold
flu
season
pandem
curb
spread
work
futur
flu
wors
use
strict
south
curv
earli
thank
widespread
test
trace
though
come
us
later
spur
increas
still
lot
us
learn
far
inform
censorship
misinform
proven
build
use
fulli
understand
coronaviru
need
know
spread
lot
either
locat
data
track
spread
viru
work
put
contact
trace
system
place
mitig
concern
contact
trace
would
infring
privaci
appl
system
would
track
coronaviru
notifi
peopl
expos
without
thermal
detect
potenti
wearabl
sewag
surveil
prove
help
code
moment
citi
state
skeptic
digit
trace
peopl
trace
instead
feder
level
talk
nation
pandem
predict
agenc
studi
covid
get
ahead
futur
vaccin
becom
widespread
question
keep
track
receiv
vaccin
way
verifi
immun
work
even
mani
exist
alreadi
sourc
controversi
video
stream
live
golden
age
digit
entertain
cope
cabin
fever
work
medit
get
realli
bread
bake
everyon
els
mayb
movi
theater
near
access
roof
realli
feel
ambiti
alway
whatev
promis
tri
avoid
even
lucki
enough
work
home
product
offic
adjust
right
gear
good
connect
make
world
differ
art
zoom
recommend
commit
home
offic
invest
stand
desk
even
treadmil
desk
social
import
stave
isol
home
right
gear
help
joke
sens
go
long
way
parent
worth
affect
child
goe
without
say
pandem
done
number
everyon
mental
health
relax
calm
find
therapist
work
crazi
time
especi
light
end
tunnel
come
focu
import
gentl
world
begin
reopen
bit
bit
small
help
unemploy
death
rose
last
spring
evid
pandem
affect
everyon
way
hit
vulner
without
connect
home
peopl
without
home
shelter
nation
mani
divid
societi
much
make
well
abl
prevent
get
sick
particularli
distress
see
diseas
disproportion
impact
color
realiti
much
data
fulli
reveal
two
mani
unequ
impact
pandem
hot
dens
global
south
even
silicon
valley
big
tech
shadow
bare
scrape
everi
industri
pandem
take
busi
assembl
embrac
technolog
necessari
surviv
essenti
crisi
spur
new
basic
sick
pay
reopen
fear
face
difficult
pro
sport
patio
dine
everyon
tri
come
way
keep
safe
come
new
way
make
put
work
tech
whose
home
workplac
accordingli
us
work
remot
return
offic
like
wo
look
never
go
back
offic
go
back
reopen
class
remain
hot
topic
across
countri
alik
switch
remot
learn
last
spring
challeng
one
exactli
much
risk
resum
person
made
slapdash
basi
mani
hybrid
model
went
fulli
remot
though
digit
divid
tough
school
open
class
adopt
new
facial
recognit
thermal
ventil
face
slew
set
good
learn
environ
home
whether
higher
educ
colleg
experi
anyth
usual
whether
learn
mani
last
fall
pandem
actual
make
higher
educ
access
long
probabl
seen
citi
street
unpollut
sky
pandem
effect
climat
chang
uniformli
posit
good
probabl
wo
last
plastic
make
comeback
trump
administr
roll
back
renew
energi
industri
take
seriou
hit
coronaviru
tend
higher
wors
air
pollut
mention
deal
natur
much
harder
face
pandem
seen
wildfir
hurrican
pandem
potenti
opportun
boost
small
remak
big
better
experi
way
make
breath
better
way
urban
crime
provid
import
inform
help
increas
safeti
equit
even
pandem
still
doubt
pandem
taken
toll
urban
life
one
exampl
mass
transit
lifeblood
new
york
seriou
mani
pandem
extent
left
fend
last
spring
confus
governor
differ
path
toward
winter
piecem
disast
amid
rise
covid
northeast
west
coast
form
unpreced
region
unit
figur
test
work
contact
trace
first
day
offic
presid
singl
prioriti
administr
tackl
pandem
mark
mani
hope
new
phase
nation
pandem
polici
presid
trump
feder
govern
speak
unifi
voic
real
toll
pandem
rather
take
decis
action
mitig
effect
despit
expert
advic
contrari
presid
express
eager
get
peopl
back
work
came
white
hous
date
back
threat
pandem
fell
short
prepared
concern
presid
contract
coronaviru
woefulli
situat
public
health
receiv
weekli
roundup
coronaviru
news
sign
target
million
day
today
day
presid
administr
meet
goal
million
coronaviru
within
first
day
yesterday
white
hous
loan
combin
million
vaccin
canada
vaccin
author
use
yet
us
million
emerg
use
made
good
progress
presid
last
week
make
avail
least
even
quickli
alreadi
open
anyon
age
older
abl
sign
start
march
number
outlin
expand
elig
howev
concern
system
leav
behind
disabl
express
anger
way
vulner
forgotten
peopl
amend
school
pave
way
morn
say
univers
stay
apart
one
anoth
rather
chang
allow
mani
resum
class
week
administr
would
put
billion
toward
screen
classroom
mani
inch
closer
week
new
jersey
increas
indoor
capac
new
york
open
season
still
warn
would
mistak
nation
daili
case
averag
fall
hospit
nationwid
averag
number
gone
least
percent
worryingli
michigan
particular
see
dramat
increas
surg
affirm
agenc
vaccin
safe
dozen
shot
amid
caus
blood
add
new
warn
label
vaccin
guard
potenti
rare
complic
lead
blood
bleed
brain
howev
remain
staunch
insist
scienc
vaccin
safe
overal
say
shot
prevent
much
ill
death
announc
would
resum
vaccin
immedi
johnson
would
receiv
shot
order
encourag
public
build
vaccin
trust
imper
region
yet
anoth
went
back
week
german
extend
current
curb
viru
rapid
suddenli
went
dark
new
book
day
bedtim
fantasi
make
get
whop
billion
greenhous
ga
releas
everi
year
zero
bill
new
book
avoid
climat
disast
press
face
planet
innov
fix
bike
ride
run
weekend
check
roundup
best
wireless
work
gum
court
system
pandem
complic
uphold
public
access
fair
open
often
struggl
even
much
countri
went
remot
limit
best
turn
video
phone
unpredict
virtual
make
harder
commun
remot
elimin
access
access
particularli
peopl
go
virtual
pose
peopl
without
reliabl
home
particularli
among
histor
receiv
weekli
roundup
coronaviru
news
sign
johnson
johnson
vaccin
approv
panel
review
efficaci
safeti
johnson
johnson
vaccin
last
step
whether
approv
shot
decis
week
review
found
vaccin
percent
effect
protect
peopl
moder
sever
even
effect
protect
sever
diseas
j
j
deliv
around
million
us
end
addit
two
expect
appli
emerg
use
author
us
pfizer
told
us
week
major
boost
vaccin
next
five
say
overcom
percent
us
fulli
almost
percent
receiv
first
dose
vaccin
news
last
week
continu
look
whether
reduc
transmiss
protect
week
two
new
yet
peer
reduc
viral
spread
say
realist
tell
us
exactli
much
reduc
transmiss
good
news
show
work
well
moment
public
health
say
stay
mask
vigil
even
pfizer
work
modifi
better
protect
new
version
vaccin
design
target
variant
first
found
south
readi
human
test
pfizer
explor
third
booster
dose
specif
target
vaccin
distribut
week
initi
distribut
equit
around
world
sent
first
ivori
coast
import
step
global
vaccin
distribut
receiv
vast
major
fund
eu
china
russia
begun
vaccin
diplomaci
even
face
domest
eu
underway
acceler
vaccin
region
met
week
import
speed
vaccin
product
deliveri
idea
vaccin
make
tourism
travel
possibl
summer
video
come
long
way
still
need
celebr
gossip
get
famou
peopl
sex
get
sold
take
place
keep
famou
peopl
sordid
celebr
fixer
center
almost
great
time
buy
winter
gear
sale
season
best
live
without
smell
mani
becom
awar
smell
past
year
lost
sens
smell
sometim
smell
actual
decept
common
lose
sens
smell
say
least
experi
scent
tast
food
way
health
safeti
condit
miss
ga
abl
tell
food
emerg
worri
variant
come
pivot
moment
cours
pandem
public
health
tri
decid
receiv
first
distribut
us
mani
arisen
new
epidemiolog
import
far
unappreci
wrinkl
pathogen
like
opportun
develop
result
guard
emerg
new
danger
consid
move
higher
risk
die
front
vaccin
still
puzzl
streak
new
aros
variant
fluke
viru
track
somehow
gradual
accumul
person
person
popul
abrupt
suit
new
left
worri
singl
person
activ
infect
someon
bodi
arm
race
develop
viru
immun
system
time
allow
viru
evad
success
stack
longer
infect
person
viru
add
earli
pandem
suspect
peopl
particularli
prone
kind
extend
ill
peopl
thought
stop
shed
infecti
viru
around
day
time
infect
numer
outlier
tend
involv
peopl
immun
woman
infect
viru
nurs
home
kind
cancer
limit
antibodi
product
end
coronaviru
least
day
infecti
least
viru
mutat
rapidli
certainli
pretti
stabl
cours
normal
shorter
bout
covid
studi
post
yet
formal
journal
found
littl
viral
mutat
gener
sampl
peopl
diseas
time
close
less
reassur
michigan
man
cancer
medic
suppress
immun
system
b
normal
produc
four
track
found
spike
protein
princip
target
covid
unchang
howev
observ
elsewher
viru
unrel
spike
studi
woman
nurs
home
mark
genom
evolut
continu
turnov
domin
viral
viru
definit
spike
protein
cours
group
write
new
journal
medicin
month
detail
trajectori
viru
man
disord
case
found
acceler
evolut
viru
individu
mani
spike
protein
peopl
clear
without
major
wrote
case
potenti
persist
infect
acceler
viral
evolut
associ
state
phenomenon
immun
system
immun
function
evolv
astoundingli
high
rate
make
even
harder
bodi
keep
bind
neutral
viru
mechan
allow
individu
last
longer
morph
herp
simplex
viru
evolv
unusu
need
better
understand
exactli
vulner
infect
categori
wide
rang
differ
risk
persist
virologist
univers
term
includ
peopl
born
rare
diminish
abil
fight
well
take
allow
transplant
quell
link
persist
persist
viral
evolut
compel
enough
consid
vaccin
prioriti
panel
us
diseas
control
prevent
peopl
phase
third
vaccin
due
receiv
time
cancer
coronari
heart
diseas
obes
among
decis
meant
address
particular
peopl
immun
system
left
possibl
help
prevent
develop
new
would
make
pandem
even
wors
alreadi
reason
even
though
hand
directli
relev
case
public
health
consult
whether
wise
move
peopl
phase
least
need
better
potenti
us
govern
help
organ
viral
program
tri
captur
sequenc
data
pandem
fall
short
percent
us
percent
littl
bit
patchi
univers
michigan
medic
school
team
around
percent
sequenc
variant
data
us
vast
countri
peopl
spend
lot
time
effort
task
better
viral
evolut
help
clarifi
question
exactli
sick
like
monitor
acknowledg
understand
epidemiolog
clinic
signific
work
meanwhil
viru
still
rampant
mutat
even
person
person
associ
potenti
viral
evolut
focu
retreat
alway
mean
defeat
emerg
sever
worrisom
new
coronaviru
new
spread
faster
immun
anoth
possibl
current
repriev
temporari
public
health
urg
prepar
possibl
new
wave
driven
alreadi
us
nearli
everi
state
accord
data
us
diseas
prevent
doubl
number
two
real
number
like
far
higher
much
higher
one
way
tell
version
coronaviru
caus
infect
sequenc
genom
countri
easi
us
superpow
academ
massiv
commerci
capac
crank
rapid
clip
feder
govern
respons
much
pandem
includ
plan
mobil
corp
surveil
well
end
last
year
final
got
green
light
roll
addit
sinc
us
viral
per
week
say
still
close
enough
run
time
catch
congress
bill
provid
necessari
infus
fund
build
genom
surveil
system
us
along
know
worri
discov
expand
territori
across
us
right
see
doubl
everi
day
comput
biologist
institut
la
part
team
rapid
spread
lineag
still
sometim
variant
studi
post
month
team
viral
lineag
collect
around
countri
found
variant
like
us
month
first
calcul
fast
variant
spread
percent
faster
us
though
yet
journal
data
first
hard
evid
forecast
project
would
becom
domin
variant
us
late
march
seen
last
basic
way
thought
would
lee
vice
presid
scienc
helix
coauthor
studi
helix
san
test
lab
partnership
one
three
commerci
contract
conduct
genom
surveil
technic
helix
viral
materi
nasal
compani
test
coronaviru
quirk
test
design
helix
easili
flag
like
contain
uniqu
quirk
mani
helix
three
viru
genom
one
gene
viru
spike
protein
variant
delet
section
gene
test
person
infect
still
come
back
posit
miss
gene
signal
gene
dropout
gene
target
failur
short
use
wide
area
innocu
delet
way
know
sure
alarm
late
helix
send
everi
sampl
back
find
gene
dropout
everi
day
turn
lee
southern
gene
longer
feasibl
sequenc
least
two
repres
percent
helix
see
percent
new
lee
six
ago
less
percent
depart
health
respond
wire
fate
state
next
bellweth
come
rest
us
accord
preval
still
countri
helix
data
hot
begin
emerg
govern
make
come
day
regard
critic
slow
spread
contagi
effect
phase
circul
earli
us
preciou
time
tri
bring
current
transmiss
vaccin
mani
peopl
possibl
two
metric
dictat
whether
us
big
spike
due
new
race
time
even
bigger
wave
saw
winter
possibl
open
everyth
right
almost
happen
team
found
plenti
circul
far
either
two
suspect
best
immun
evas
discov
south
brazil
respect
accord
data
hand
us
far
mostli
peopl
recent
return
travel
thing
worri
one
peopl
look
virologist
state
univers
health
center
normal
famili
start
last
spring
combin
cooper
director
center
evolutionari
biolog
medicin
univers
microbi
set
genom
surveil
coronaviru
randomli
collect
around
state
watch
anyth
unusu
exactli
batch
mutat
seen
closer
saw
mutant
close
genet
lineag
though
lineag
quit
young
date
back
begin
data
grow
common
everi
use
around
world
next
day
univers
new
found
variant
state
meanwhil
cooper
scour
look
genet
alter
amino
acid
coronaviru
spike
protein
found
new
north
eight
phylogenist
get
viral
famili
tree
order
enlist
help
emma
univers
within
week
team
emerg
seven
new
us
mutat
pattern
exampl
converg
evolut
preprint
post
pretti
strong
indic
adapt
even
yet
know
adapt
cooper
coauthor
studi
yet
tend
use
singular
word
coronaviru
bug
accur
way
think
popul
popul
state
constant
new
person
person
genet
track
minut
follow
famili
tree
identifi
link
one
anoth
enough
viral
zoom
compar
fast
differ
grow
one
branch
take
indic
genet
acquir
provid
kind
competit
advantag
bunch
differ
independ
acquir
mutat
start
take
well
converg
seven
cooper
compani
appear
becom
common
recent
percent
transmiss
still
much
understand
first
emerg
spread
faster
mutat
viru
behavior
case
major
concern
first
abroad
holiday
travel
famili
us
spread
farther
faster
domest
even
basic
real
preval
new
variant
hard
answer
nation
still
far
behind
discov
tip
iceberg
cooper
current
us
percent
coronaviru
accord
wire
analysi
data
comparison
percent
world
leader
percent
good
news
done
elsewher
world
find
viru
settl
genet
hunt
advantag
upon
run
good
mani
better
left
deck
sens
cooper
converg
actual
friend
roster
pay
attent
good
surveil
test
vaccin
tri
number
placement
use
make
easier
develop
arsen
effect
whatev
yet
chang
fact
us
still
disastr
unprepar
spot
wire
previous
scale
nation
network
patchwork
industri
helix
front
public
health
patient
data
logist
agre
standard
time
money
viral
sequenc
gener
far
fund
seven
tune
million
helix
medic
test
quest
diagnost
million
million
public
health
week
administr
provid
much
infus
ramp
nation
capac
per
week
would
put
us
track
captur
percent
new
coronaviru
provid
continu
declin
threshold
estim
countri
need
hit
order
detect
new
variant
percent
total
declin
say
whether
agenc
set
specif
current
consensu
us
global
optim
rate
genom
surveil
wrote
wire
brief
white
hous
test
czar
johnson
pilot
tide
congress
trillion
rescu
plan
hous
version
bill
asid
billion
genom
surveil
realli
great
interest
congress
invest
lane
coauthor
new
report
center
health
secur
effect
surveil
program
look
short
term
need
money
buy
hire
train
personnel
run
build
public
health
sort
clean
interpret
genom
data
produc
surveil
much
bigger
barrier
side
addit
peopl
comput
firepow
suggest
public
health
partner
depart
energi
around
countri
process
increas
genom
data
capac
countri
need
put
effici
recommend
fund
go
toward
character
studi
perform
right
old
scienc
still
larg
appli
whoever
variant
hold
onto
studi
huge
effect
human
health
govern
want
step
make
sure
done
safe
public
eye
longer
term
us
invest
congression
fund
nation
pandem
predict
agenc
safeguard
even
covid
crisi
build
capac
whatev
way
done
highest
prioriti
know
know
go
keep
come
long
transmiss
pop
anywher
right
countri
new
variant
idea
see
stori
correct
helix
spun
independ
compani
subsidiari
previou
version
stori
incorrectli
state
helix
san
test
lab
san
compani
headquart
san
receiv
weekli
roundup
coronaviru
news
sign
advisori
panel
us
first
vaccin
soon
night
independ
advisori
panel
gave
pfizer
vaccin
green
light
later
work
quickli
issu
shot
emerg
use
author
truck
full
leav
pfizer
plant
head
distribut
around
us
start
soon
offici
advisori
committe
immun
emerg
today
next
vaccin
make
arm
need
told
senat
transport
subcommitte
provid
locat
prioriti
vaccin
even
holiday
ship
season
record
meanwhil
administ
vaccin
us
part
prepar
encourag
skeptic
get
board
pandem
grim
week
coronaviru
us
continu
get
hospit
rose
countri
hit
grim
mileston
total
number
number
us
servic
peopl
combat
world
war
day
us
set
new
record
day
total
death
pearl
harbor
director
like
exceed
next
respons
mani
new
new
curfew
expand
mask
mandat
new
york
citi
away
indoor
dine
new
temporarili
suspend
nonessenti
allevi
strain
state
plan
put
place
would
allow
ration
determin
care
base
likelihood
surviv
necessari
part
challeng
public
health
know
sum
differ
spread
unclear
effect
without
inform
essenti
everyon
best
doubl
rise
us
rise
even
infect
enviabl
low
japan
urg
peopl
travel
new
year
time
customari
mani
return
south
whose
low
two
new
per
day
struggl
contain
new
swell
militari
personnel
assist
health
care
handl
russia
saw
daili
death
week
well
order
lift
next
week
remain
high
govern
cultur
stay
curfew
go
effect
excit
week
pfizerbiontech
vaccin
go
rapidli
seem
like
go
effect
next
get
game
without
break
bank
librari
card
help
part
biolog
entiti
especi
reduc
temperatur
warm
aliv
hot
cold
corps
close
encount
fire
writer
sought
understand
flesh
warm
winter
check
gift
guid
peopl
perpetu
mean
test
posit
receiv
test
come
back
either
posit
neg
say
benefit
approach
account
sensit
differ
much
viru
detect
even
way
analyz
impact
use
sampl
posit
presenc
viru
patient
viral
load
cours
day
peopl
receiv
posit
actual
end
ill
receiv
neg
fact
viru
sick
yet
one
mani
test
effect
way
curb
need
know
accord
world
health
organ
larg
famili
caus
ill
rang
common
cold
sever
middl
east
respiratori
syndrom
sever
acut
respiratori
syndrom
novel
coronaviru
new
strain
previous
gener
human
popul
acquir
immun
new
coronaviru
peopl
contract
viru
experi
mild
peopl
develop
sever
even
coronaviru
first
citi
wuhan
provinc
china
sinc
first
china
spread
around
world
least
suspect
viru
anim
popul
like
bat
transfer
via
secondari
sourc
includ
respiratori
fever
cough
short
breath
breath
sever
infect
caus
pneumonia
sever
acut
respiratori
syndrom
kidney
failur
even
fatal
prevent
spread
coronaviru
avoid
infect
wash
regularli
cover
mouth
nose
sneez
cook
meat
thoroughli
peopl
stay
home
avoid
spread
viru
mani
medic
advis
peopl
without
stay
home
avoid
larg
prevent
spread
diseas
temporarili
shut
well
travel
part
widespread
effort
slow
reduc
spread
viru
provid
thorough
treatment
allow
medic
govern
time
develop
implement
public
health
best
flatten
curv
graphic
represent
reduc
exponenti
spread
viru
urg
peopl
stay
vaccin
yet
nation
institut
health
unit
work
phase
clinic
trial
investig
vaccin
design
protect
coronaviru
diseas
kaiser
health
research
institut
step
research
work
hard
develop
vaccin
soon
possibl
alreadi
human
though
like
mani
vaccin
avail
good
news
healthi
young
peopl
colleg
univers
low
risk
viru
milder
howev
carrier
viru
without
even
know
still
take
necessari
protect
prevent
spread
viru
vulner
best
social
colleg
univers
student
especi
intern
abroad
lot
inform
consid
want
make
sure
stay
inform
mani
top
around
world
encourag
stay
home
mani
class
shift
virtual
us
top
academ
across
countri
univers
among
mani
make
tough
close
cancel
class
decis
move
virtual
instruct
made
lightli
presid
statement
goal
minim
need
gather
larg
spend
time
close
proxim
dine
residenti
best
social
best
right
univers
written
graham
chancellor
educ
call
univers
radic
chang
way
summer
amid
widespread
concern
viru
affect
exam
perform
suggest
altern
assess
via
video
dissert
social
institut
typic
grade
entir
social
term
one
refer
consciou
effort
reduc
close
contact
peopl
hope
stymi
commun
transmiss
viru
tiffani
atlant
appropri
social
distanc
three
six
apart
lieu
handshak
hug
elbow
bump
fist
bump
physic
contact
short
whenev
possibl
contact
peopl
limit
public
go
dinner
find
altern
way
workout
instead
go
gym
chat
phone
mani
peopl
find
creativ
way
stay
social
via
virtual
realm
limit
contact
particular
central
peopl
social
network
inform
fun
keep
toilet
roll
instead
footbal
interact
even
join
fun
legend
martin
pink
hold
solitari
impromptu
social
media
read
help
bedtim
whose
close
offer
help
housebound
peopl
social
media
support
health
fight
coronaviru
collect
sang
music
togeth
comfort
consid
past
great
continu
work
histor
plagu
creativ
product
pestil
everywher
provid
leviti
perspect
great
work
even
inspir
turbul
time
live
exampl
sir
newton
made
social
work
end
would
turn
greatli
impact
human
understand
way
world
work
outbreak
plagu
newton
return
famili
home
long
time
work
alon
variou
mind
breakthrough
regard
natur
motion
graviti
time
tell
particular
moment
best
today
import
best
remain
common
sens
wash
hand
wash
techniqu
humor
written
underneath
tradit
graphic
soap
water
keep
sens
humour
tough
time
save
saniti
keep
moral
among
exampl
catch
video
danc
went
viral
take
moment
enjoy
creativ
geniu
forget
asid
regular
hand
wash
hand
key
protect
infect
creativ
continu
respons
outbreak
exchang
studi
abroad
affect
delay
start
class
spring
break
mode
instruct
part
exchang
studi
abroad
program
monitor
make
sure
receiv
colleg
univers
class
entir
technolog
help
around
world
continu
outbreak
well
class
proceed
univers
shut
learn
help
limit
exposur
affect
colleg
univers
temporarili
shift
class
platform
requir
log
remot
conduct
class
virtual
start
outbreak
ground
china
japan
templ
univers
fort
state
univers
sam
state
univers
migrat
class
came
quarantin
around
unit
prepar
familiar
video
zoom
event
outbreak
confin
home
zoom
scholast
make
avail
free
start
elementari
school
educ
near
futur
becom
avail
free
higher
educ
zoom
applic
essenti
help
connect
learn
anoth
help
trend
media
charter
us
provid
free
servic
zoom
eric
yuan
given
mani
start
decid
offer
zoom
access
unit
addit
fill
form
school
zoom
associ
school
domain
gain
unlimit
temporari
meet
accord
site
set
process
overnight
free
basic
avail
request
south
logist
get
student
find
storag
student
enrol
program
coronaviru
want
request
credit
back
account
part
educ
neg
impact
viru
want
check
colleg
univers
registrar
exampl
room
board
rest
year
hous
inform
calcul
still
come
addit
affect
coronaviru
longer
abl
afford
certain
financi
aid
author
adjust
cost
attend
famili
contribut
accord
us
depart
educ
howev
option
continu
platform
find
way
offer
recent
concern
pay
right
temporarili
reduc
student
loan
interest
crisi
us
depart
educ
recent
statement
new
polici
borrow
feder
loan
repay
forbear
interest
temporari
polici
report
carolin
kelli
check
student
loan
provid
defer
payment
find
inform
univers
financi
aid
move
quickli
storag
bee
safe
wine
cellar
offer
one
month
free
storag
space
colleg
free
month
storag
administr
lock
minimum
rental
term
commit
size
rental
valid
student
id
student
store
storag
unit
day
commit
hammer
stay
inform
abroad
advis
pay
attent
specif
destin
countri
offici
health
inform
sign
news
relev
technolog
help
stay
inform
studi
abroad
depart
advisor
provid
inform
necessari
contact
local
embassi
advic
us
diseas
control
prevent
local
state
health
depart
updat
daili
key
get
accur
inform
need
local
embassi
consul
link
reput
news
continu
curb
spread
viru
use
effect
exampl
high
school
junior
mercer
island
outsid
late
coronaviru
yet
outsid
china
spread
viru
thought
would
cool
pull
inform
coder
mainli
creat
someth
would
show
data
accur
possibl
lot
misinform
updat
site
daili
incom
correspond
around
world
updat
site
real
time
today
digit
age
matter
countri
find
tech
savvi
student
abl
find
appropri
inform
protect
viru
lot
inform
import
make
sure
reliabl
reput
includ
diseas
control
prevent
site
specif
coronaviru
world
health
organ
coronaviru
need
need
recent
mani
taken
extrem
contain
slow
spread
viru
limit
travel
return
home
soon
possibl
mani
work
evacu
intern
abroad
region
outbreak
home
countri
return
home
soon
possibl
contact
local
embassi
stay
potenti
travel
awar
peopl
abroad
stay
quarantin
standard
period
regardless
whether
expos
show
prepar
accordingli
govern
univers
travel
around
world
make
tough
limit
travel
respect
across
world
travel
curb
spread
coronaviru
leader
union
would
propos
ban
nonessenti
travel
bloc
list
offici
govern
unit
state
depart
new
report
staff
main
student
abroad
enrol
class
local
colleg
univers
stay
connect
stay
safe
make
sure
utmost
interrupt
continu
attend
class
unless
instruct
otherwis
becom
unsaf
enrol
made
avail
stay
inform
coronaviru
affect
news
public
health
pay
attent
news
know
better
forget
practic
social
proper
final
doubt
stay
home
studi
comfort
couch
need
know
accord
world
health
organ
larg
famili
caus
ill
rang
common
cold
sever
middl
east
respiratori
syndrom
sever
acut
respiratori
syndrom
novel
coronaviru
new
strain
previous
gener
human
popul
acquir
immun
new
coronaviru
peopl
contract
viru
experi
mild
peopl
develop
sever
even
coronaviru
first
citi
wuhan
provinc
china
sinc
first
china
spread
around
world
least
suspect
viru
anim
popul
like
bat
transfer
via
secondari
sourc
includ
respiratori
fever
cough
short
breath
breath
sever
infect
caus
pneumonia
sever
acut
respiratori
syndrom
kidney
failur
even
fatal
prevent
spread
coronaviru
avoid
infect
wash
regularli
cover
mouth
nose
sneez
cook
meat
thoroughli
peopl
stay
home
avoid
spread
viru
mani
medic
advis
peopl
without
stay
home
avoid
larg
prevent
spread
diseas
temporarili
shut
well
travel
part
widespread
effort
slow
reduc
spread
viru
provid
thorough
treatment
allow
medic
govern
time
develop
implement
public
health
best
flatten
curv
graphic
represent
reduc
exponenti
spread
viru
urg
peopl
stay
vaccin
yet
nation
institut
health
unit
work
phase
clinic
trial
investig
vaccin
design
protect
coronaviru
diseas
kaiser
health
research
institut
step
research
work
hard
develop
vaccin
soon
possibl
alreadi
human
though
like
mani
vaccin
avail
good
news
healthi
young
peopl
colleg
univers
low
risk
viru
milder
howev
carrier
viru
without
even
know
still
take
necessari
protect
prevent
spread
viru
vulner
best
social
colleg
univers
student
especi
intern
abroad
lot
inform
consid
want
make
sure
stay
inform
mani
top
around
world
encourag
stay
home
mani
class
shift
virtual
us
top
academ
across
countri
univers
among
mani
make
tough
close
cancel
class
decis
move
virtual
instruct
made
lightli
presid
statement
goal
minim
need
gather
larg
spend
time
close
proxim
dine
residenti
best
social
best
right
univers
written
graham
chancellor
educ
call
univers
radic
chang
way
summer
amid
widespread
concern
viru
affect
exam
perform
suggest
altern
assess
via
video
dissert
social
institut
typic
grade
entir
social
term
one
refer
consciou
effort
reduc
close
contact
peopl
hope
stymi
commun
transmiss
viru
tiffani
atlant
appropri
social
distanc
three
six
apart
lieu
handshak
hug
elbow
bump
fist
bump
physic
contact
short
whenev
possibl
contact
peopl
limit
public
go
dinner
find
altern
way
workout
instead
go
gym
chat
phone
mani
peopl
find
creativ
way
stay
social
via
virtual
realm
limit
contact
particular
central
peopl
social
network
inform
fun
keep
toilet
roll
instead
footbal
interact
even
join
fun
legend
martin
pink
hold
solitari
impromptu
social
media
read
help
bedtim
whose
close
offer
help
housebound
peopl
social
media
support
health
fight
coronaviru
collect
sang
music
togeth
comfort
consid
past
great
continu
work
histor
plagu
creativ
product
pestil
everywher
provid
leviti
perspect
great
work
even
inspir
turbul
time
live
exampl
sir
newton
made
social
work
end
would
turn
greatli
impact
human
understand
way
world
work
outbreak
plagu
newton
return
famili
home
long
time
work
alon
variou
mind
breakthrough
regard
natur
motion
graviti
time
tell
particular
moment
best
today
import
best
remain
common
sens
wash
hand
wash
techniqu
humor
written
underneath
tradit
graphic
soap
water
keep
sens
humour
tough
time
save
saniti
keep
moral
among
exampl
catch
video
danc
went
viral
take
moment
enjoy
creativ
geniu
forget
asid
regular
hand
wash
hand
key
protect
infect
creativ
continu
respons
outbreak
exchang
studi
abroad
affect
delay
start
class
spring
break
mode
instruct
part
exchang
studi
abroad
program
monitor
make
sure
receiv
colleg
univers
class
entir
technolog
help
around
world
continu
outbreak
well
class
proceed
univers
shut
learn
help
limit
exposur
affect
colleg
univers
temporarili
shift
class
platform
requir
log
remot
conduct
class
virtual
start
outbreak
ground
china
japan
templ
univers
fort
state
univers
sam
state
univers
migrat
class
came
quarantin
around
unit
prepar
familiar
video
zoom
event
outbreak
confin
home
zoom
scholast
make
avail
free
start
elementari
school
educ
near
futur
becom
avail
free
higher
educ
zoom
applic
essenti
help
connect
learn
anoth
help
trend
media
charter
us
provid
free
servic
zoom
eric
yuan
given
mani
start
decid
offer
zoom
access
unit
addit
fill
form
school
zoom
associ
school
domain
gain
unlimit
temporari
meet
accord
site
set
process
overnight
free
basic
avail
request
south
logist
get
student
find
storag
student
enrol
program
coronaviru
want
request
credit
back
account
part
educ
neg
impact
viru
want
check
colleg
univers
registrar
exampl
room
board
rest
year
hous
inform
calcul
still
come
addit
affect
coronaviru
longer
abl
afford
certain
financi
aid
author
adjust
cost
attend
famili
contribut
accord
us
depart
educ
howev
option
continu
platform
find
way
offer
recent
concern
pay
right
temporarili
reduc
student
loan
interest
crisi
us
depart
educ
recent
statement
new
polici
borrow
feder
loan
repay
forbear
interest
temporari
polici
report
carolin
kelli
check
student
loan
provid
defer
payment
find
inform
univers
financi
aid
move
quickli
storag
bee
safe
wine
cellar
offer
one
month
free
storag
space
colleg
free
month
storag
administr
lock
minimum
rental
term
commit
size
rental
valid
student
id
student
store
storag
unit
day
commit
hammer
stay
inform
abroad
advis
pay
attent
specif
destin
countri
offici
health
inform
sign
news
relev
technolog
help
stay
inform
studi
abroad
depart
advisor
provid
inform
necessari
contact
local
embassi
advic
us
diseas
control
prevent
local
state
health
depart
updat
daili
key
get
accur
inform
need
local
embassi
consul
link
reput
news
continu
curb
spread
viru
use
effect
exampl
high
school
junior
mercer
island
outsid
late
coronaviru
yet
outsid
china
spread
viru
thought
would
cool
pull
inform
coder
mainli
creat
someth
would
show
data
accur
possibl
lot
misinform
updat
site
daili
incom
correspond
around
world
updat
site
real
time
today
digit
age
matter
countri
find
tech
savvi
student
abl
find
appropri
inform
protect
viru
lot
inform
import
make
sure
reliabl
reput
includ
diseas
control
prevent
site
specif
coronaviru
world
health
organ
coronaviru
need
need
recent
mani
taken
extrem
contain
slow
spread
viru
limit
travel
return
home
soon
possibl
mani
work
evacu
intern
abroad
region
outbreak
home
countri
return
home
soon
possibl
contact
local
embassi
stay
potenti
travel
awar
peopl
abroad
stay
quarantin
standard
period
regardless
whether
expos
show
prepar
accordingli
govern
univers
travel
around
world
make
tough
limit
travel
respect
across
world
travel
curb
spread
coronaviru
leader
union
would
propos
ban
nonessenti
travel
bloc
list
offici
govern
unit
state
depart
new
report
staff
main
student
abroad
enrol
class
local
colleg
univers
stay
connect
stay
safe
make
sure
utmost
interrupt
continu
attend
class
unless
instruct
otherwis
becom
unsaf
enrol
made
avail
stay
inform
coronaviru
affect
news
public
health
pay
attent
news
know
better
forget
practic
social
proper
final
doubt
stay
home
studi
comfort
couch
year
ago
data
genet
earli
wuhan
scientif
cloud
research
origin
intrigu
new
inform
discern
viru
bat
anoth
anim
new
analysi
varieti
wuhan
initi
link
anim
administr
viru
known
studi
neither
hypothesi
pathogen
famou
wuhan
lab
rais
origin
recov
far
great
piec
sleuth
work
sure
significantli
understand
origin
evolutionari
biologist
univers
involv
bloom
virologist
cancer
research
center
wrote
new
report
delet
suspici
like
obscur
exist
wrote
paper
yet
scientif
bloom
belong
outspoken
group
research
pandem
letter
enough
inform
determin
whether
like
lab
leak
spread
coronaviru
leapt
contact
infect
anim
outsid
genet
viral
hold
crucial
speci
anoth
anim
like
bat
preciou
earli
pandem
take
closer
origin
bloom
genet
data
variou
research
came
across
march
studi
includ
inform
genet
collect
wuhan
univers
sequenc
read
archiv
us
govern
nation
librari
bloom
wuhan
month
result
item
found
puzzl
went
back
collect
scientist
fu
hospit
wuhan
search
medic
literatur
bloom
eventu
found
anoth
studi
post
march
fu
new
experiment
test
scientif
journal
three
studi
wrote
nasal
taken
suspect
earli
epidem
portion
genet
materi
publish
actual
fish
instead
number
bloom
sourc
miss
includ
explan
sequenc
read
archiv
disappear
archiv
bloom
figur
mani
cloud
sequenc
file
cloud
basic
format
bloom
code
miss
sequenc
wuhan
suddenli
sequenc
told
recov
cloud
new
data
bloom
back
earli
pandem
combin
earli
make
progress
build
famili
tree
bat
viru
challeng
still
limit
number
studi
come
wholesal
market
wuhan
outbreak
market
actual
three
extra
miss
collect
later
later
look
found
bat
support
idea
earli
lineag
viru
pass
bloom
found
cloud
lack
extra
three
similar
bat
fish
market
bloom
time
market
awhil
wuhan
beyond
market
repres
full
divers
alreadi
loos
late
mayb
pictur
present
earli
wuhan
somewhat
report
bloom
acknowledg
conclus
would
confirm
analysi
viru
work
studi
better
understand
origin
add
bloom
addit
data
play
big
role
effort
clear
valuabl
inform
went
miss
first
place
request
send
sequenc
read
archiv
nation
librari
medicin
archiv
remov
last
summer
post
march
subsequ
withdrawn
investig
june
spokeswoman
nation
investig
name
told
archiv
would
ad
differ
bloom
everi
yet
find
obvious
rule
web
page
somewher
abl
find
obviou
test
studi
produc
immedi
respond
inquir
bloom
find
studi
give
contact
inform
anoth
coauthor
fu
skeptic
anyth
sinist
behind
remov
realli
understand
virologist
univers
note
test
paper
list
individu
wuhan
found
although
full
longer
archiv
key
inform
public
year
away
format
hard
find
rel
obscur
paper
realli
say
remov
bloom
acknowledg
interview
say
practic
consequ
remov
peopl
notic
note
govern
order
destruct
number
earli
viru
bar
public
coronaviru
without
part
still
hope
hear
crucial
understand
motiv
certainli
strang
face
valu
realli
explan
regardless
bloom
discov
order
reconstruct
origin
potenti
matter
ideal
need
tri
find
mani
earli
possibl
think
studi
look
everywher
delta
variant
coronaviru
respons
one
everi
five
unit
preval
doubl
last
two
health
delta
one
sever
concern
diseas
control
prevent
world
health
organ
spread
rapidli
appear
unit
surpris
tick
case
fall
unclear
much
problem
delta
caus
still
swift
rise
jeopard
nation
progress
beat
back
pandem
delta
variant
current
threat
us
attempt
elimin
nation
lead
infecti
diseas
expert
brief
good
news
author
unit
work
variant
let
use
crush
outbreak
common
delta
formerli
known
transmiss
variant
yet
spread
easili
origin
strain
viru
alpha
variant
first
public
health
delta
percent
contagi
alpha
though
precis
infecti
evid
variant
abl
partial
evad
made
bodi
coronaviru
infect
vaccin
variant
render
certain
antibodi
less
effect
caus
sever
ill
recent
studi
instanc
found
peopl
infect
delta
variant
roughli
twice
like
infect
alpha
remain
sever
diseas
piec
think
one
question
realli
yet
director
center
infecti
diseas
research
polici
univers
common
variant
percent
first
unit
march
although
alpha
remain
preval
variant
delta
spread
quickli
earli
delta
percent
unit
accord
earli
variant
percent
earli
june
figur
percent
day
ago
estim
hit
percent
delta
variant
unlik
pose
much
risk
peopl
fulli
fulli
would
larg
worri
k
dean
brown
univers
school
public
one
recent
studi
pfizerbiontech
vaccin
percent
effect
protect
symptomat
diseas
delta
nearli
match
percent
effect
alpha
variant
singl
dose
vaccin
percent
effect
delta
studi
found
fulli
well
new
phase
epidem
peter
dean
nation
school
tropic
medicin
colleg
medicin
howev
protect
singl
dose
low
cours
consid
high
risk
delta
like
infect
larg
unvaccin
peopl
pandem
wane
unit
declin
case
averag
roughli
day
sinc
march
director
brief
demonstr
extraordinari
progress
made
formid
foe
delta
account
increas
percentag
yet
clear
whether
drive
total
number
higher
think
go
see
anoth
big
nation
surg
unit
enough
vaccin
prevent
vaccin
highli
uneven
lower
certain
demograph
delta
fuel
south
lag
among
young
peopl
less
like
still
lot
suscept
viru
window
start
go
infecti
diseas
epidemiologist
univers
even
certainli
nation
probabl
get
back
see
last
winter
still
prolong
path
pandem
doldrum
alreadi
encourag
famili
get
vaccin
like
slow
spread
reduc
odd
new
even
danger
emerg
encourag
peopl
trust
cogniz
new
continu
occur
transmiss
infecti
diseas
epidemiologist
mason
univers
realli
local
nation
global
vaccin
senat
hear
combat
last
month
senat
rand
whether
nation
health
fund
research
china
research
know
natur
anim
infect
senat
nation
top
infecti
diseas
expert
flatli
claim
senat
due
respect
entir
complet
incorrect
ever
fund
research
wuhan
institut
exchang
bit
scientif
jargon
heart
traction
recent
usual
peopl
suggest
coronaviru
rather
explan
favor
uproar
drawn
attent
back
debat
among
whether
certain
research
riski
bird
flu
us
govern
oversight
certain
pathogen
scientif
commun
say
polici
overli
restrict
enforc
far
debat
higher
littl
research
leav
us
unprepar
futur
littl
attent
safeti
increas
experiment
pathogen
escap
lab
accid
caus
outbreak
balanc
research
prove
immens
intens
polit
rhetor
lab
leak
theori
push
detail
scienc
polici
go
make
harder
get
back
seriou
debat
marc
epidemiologist
th
school
public
health
govern
transpar
support
learn
first
time
move
one
organ
anoth
make
bacteria
produc
human
insulin
start
worri
accident
creat
deadli
way
scientist
give
organ
new
stage
evolutionari
grown
unfamiliar
host
speci
first
replic
well
new
help
adapt
gradual
improv
decad
ago
use
serial
passag
procedur
known
learn
new
influenza
evolv
flu
start
sometim
manag
mutat
form
spread
among
one
univers
medic
center
design
identifi
genet
essenti
success
jump
peopl
bird
flu
replic
transfer
new
new
soon
becom
better
news
broke
late
controversi
explod
research
reckless
fear
would
copi
work
accident
releas
new
pandem
strain
year
later
us
depart
health
human
meet
consid
research
name
took
hold
scientif
grown
increasingli
ever
sinc
horribl
imprecis
term
senior
scholar
center
health
never
pose
existenti
threat
instead
provid
huge
human
found
yellow
fever
viru
chicken
lost
abil
caus
diseas
discoveri
led
vaccin
yellow
fever
likewis
herp
gain
new
function
cancer
treatment
bird
flu
rais
certain
pose
tini
real
risk
danger
us
would
influenza
later
govern
roll
new
polici
framework
research
enhanc
potenti
pandem
rule
umbrella
sever
carri
special
review
grant
research
credibl
sourc
potenti
futur
human
pandem
scientif
review
agenc
gave
green
light
two
influenza
restart
debat
whether
polici
thorough
last
month
senat
brought
one
research
studi
done
ralph
baric
univers
north
natur
medicin
work
data
sent
shi
director
wuhan
institut
virolog
baric
built
new
coronaviru
one
work
done
north
lab
neither
shi
lab
chimer
viru
pathogen
parent
viru
baric
work
baric
wrote
last
month
work
involv
differ
strain
beta
coronaviru
one
consid
low
risk
particular
strain
paper
similar
research
potenti
prepar
mitig
futur
must
weigh
risk
danger
polici
signific
shortcom
accord
member
us
nation
scienc
advisori
board
microbiologist
univers
grant
process
part
nation
scienc
foundat
pentagon
includ
danger
research
need
oversight
even
question
privat
research
fund
govern
process
screen
research
meet
advisori
board
lack
inform
two
research
editor
chief
journal
virolog
scientist
work
herp
viru
fellow
member
board
made
strong
case
lack
transpar
process
board
told
committe
made
decis
process
use
whether
go
right
proceed
research
clearli
defin
secreci
screen
process
worrisom
part
govern
oversight
potenti
danger
research
accord
virologist
univers
vaccin
infecti
diseas
organ
research
unit
time
clear
decid
accept
gain
function
star
chamber
natur
process
biggest
problem
molecular
biologist
one
vocal
lab
leak
theori
advoc
control
research
danger
even
bigger
issu
research
simpli
screen
accord
polici
establish
nation
institut
allergi
infecti
run
ideal
solut
would
creation
independ
bodi
provid
oversight
danger
pathogen
research
similar
nuclear
regulatori
commiss
radioact
unit
forc
law
contrast
everi
aspect
research
enforc
exampl
human
vertebr
radioact
none
research
need
independ
regul
legal
oppos
flexibl
pose
law
cumbersom
slow
one
point
evolut
biolog
warfar
exampl
congress
possess
smallpox
rule
languag
ban
possess
vaccin
genet
similar
viru
tri
fix
took
forev
current
polici
offer
much
guidanc
work
differ
research
none
us
govern
dictat
world
embrac
abl
sit
everyon
shoulder
even
fall
short
research
stop
unit
better
world
leader
research
countri
set
exampl
unit
suffici
central
realli
matter
iron
pandem
put
hold
question
coronaviru
influenc
shape
debat
bloom
virologist
cancer
research
center
pandem
idea
new
viru
sweep
world
caus
million
felt
hypothet
plausibl
seen
viru
think
realli
care
kind
research
lead
sort
mishap
futur
bloom
discov
new
variant
sweep
countri
variant
known
alpha
becom
common
new
well
becom
domin
variant
unit
ever
swift
success
left
wonder
variant
world
new
studi
one
secret
success
alpha
first
line
immun
defens
give
variant
time
multipli
impress
physician
virologist
yale
school
medicin
involv
new
studi
success
viru
get
beyond
first
defens
system
success
better
viru
report
post
yet
scientif
set
apart
variant
surg
genet
look
spread
faster
lot
attent
nine
alter
spike
protein
coronaviru
invad
one
viru
bind
tightli
potenti
improv
success
alpha
human
immun
respons
virologist
univers
colleg
grew
human
lung
infect
found
lung
alpha
made
drastic
less
protein
host
immun
found
alpha
defens
normal
switch
quieter
infect
immun
system
import
alarm
bare
ring
presenc
alpha
variant
make
invis
investig
alpha
invis
coronaviru
replic
insid
infect
found
make
lot
extra
time
viru
gene
chart
molecular
biologist
univers
san
coauthor
new
previou
research
found
viral
protein
onto
human
protein
essenti
cell
releas
face
evid
togeth
argu
alpha
variant
mutat
product
lot
swarm
human
product
full
immun
respons
viru
attack
better
odd
make
infect
cell
gradual
remov
howev
infect
alarm
system
come
back
immun
respons
hell
loos
immun
respons
final
peopl
infect
alpha
robust
reaction
would
shed
mucu
make
alpha
even
better
spread
show
sens
would
see
evid
support
conclus
exampl
run
standard
test
measur
number
one
thing
concern
test
team
similar
variant
first
south
known
beta
one
first
known
delta
preliminari
beta
delta
drive
infect
sign
flood
independ
immun
system
turn
immun
respons
differ
way
king
immunologist
univers
new
south
involv
studi
understand
viru
would
help
design
better
current
crop
direct
immun
system
recogn
spike
peopl
recov
natur
shown
immun
learn
recogn
viral
number
togeth
coronaviru
new
need
take
caution
actual
dampen
immun
quit
tricki
enterpris
becom
possibl
learn
king
afternoon
among
tabl
cloth
telephon
fresno
biggest
outdoor
flea
market
prescript
sold
sold
steroid
sever
antiparasit
drug
chloroquin
malaria
presid
j
trump
last
year
make
regular
market
well
sham
herbal
consum
protect
repeatedli
sever
well
vitamin
expens
peptid
sold
altern
well
reliabl
scientif
unproven
often
social
media
mani
peopl
immigr
across
countri
high
access
health
care
low
turn
unregul
medicin
expens
inaccess
languag
cultur
disappoint
surpris
peopl
live
poverti
line
spent
larg
money
unproven
rai
interim
head
fresno
counti
health
depart
peopl
desper
misinform
time
context
interpret
medic
evid
trend
new
case
report
woman
emerg
room
fresno
poison
chloroquin
bought
flea
market
label
red
subsequ
went
market
three
smaller
found
differ
unsaf
food
drug
administr
real
eye
open
pandem
mani
shut
health
care
turn
percent
peopl
unit
lack
health
insur
proport
far
higher
among
undocu
mistrust
speak
languag
treat
curtli
harsh
polit
rhetor
direct
central
commun
govern
tri
get
rid
us
advoc
commun
group
indigen
peopl
mani
commun
treat
penicillin
mix
herbal
bought
sell
bought
peopl
taken
advantag
care
need
receiv
unproven
specialti
woman
fresno
recent
husband
fallen
sick
breath
walk
go
hospit
undocu
check
never
left
took
well
clinic
doctor
gave
inject
peptid
woman
anonym
immigr
prepar
bill
includ
cost
syring
cabinet
kitchen
mobil
home
know
exactli
still
sting
price
tri
act
strong
husband
grew
sicker
despit
famili
fund
left
care
month
well
enough
return
presid
coalit
fresno
build
health
sever
spent
vitamin
peptid
covid
poor
yet
cash
unproven
unregul
danger
even
health
risk
lead
peopl
postpon
seek
help
deadli
treatment
one
reason
black
peopl
covid
twice
rate
white
peopl
unit
limit
patient
treatment
worri
toxic
drug
page
specialist
univers
school
medicin
central
gone
emerg
room
hospit
often
mention
home
seek
care
upset
tell
taken
page
upset
system
easier
get
help
nontradit
regular
health
care
unabl
unwil
talk
medic
peopl
turn
instead
advic
home
exampl
page
peopl
unit
south
exchang
herbal
zinc
vitamin
chlorin
dioxid
tie
respiratori
liver
regen
integr
medicin
clinic
affluent
area
northern
fresno
social
media
advertis
peptid
therapi
broad
rang
photograph
get
vaccin
write
doubl
efficaci
clinic
support
claim
highli
effect
anoth
post
march
photograph
show
intraven
line
doctor
arm
caption
vitamin
c
along
peptid
therapi
limit
influenza
corona
viru
peptid
therapi
author
unit
treat
condit
past
year
agenc
feder
trade
commiss
crack
make
unsupport
suppos
vitamin
c
anyon
decept
relat
treatment
cure
prevent
subject
sent
public
warn
letter
lawyer
respond
sever
g
work
clinic
declin
comment
colleagu
want
speak
anoth
doctor
intent
take
care
patient
came
last
year
tri
along
host
standard
use
treat
fault
use
experiment
help
peopl
recov
viru
everyth
possibl
keep
outsid
hospit
distress
intub
medic
wipe
fresno
san
valley
lot
peopl
valley
take
care
poor
us
govern
spent
billion
last
year
make
covid
vaccin
effort
led
least
five
highli
effect
record
time
pour
billion
area
research
fight
viru
earli
cours
infect
potenti
save
mani
new
program
depart
health
human
speed
clinic
promis
drug
goe
well
first
readi
end
year
antivir
program
support
research
entir
new
coronaviru
caus
futur
number
influenza
hepat
c
simpl
pill
despit
year
research
pill
treat
someon
coronaviru
infect
havoc
oper
warp
speed
trump
administr
program
research
far
money
develop
gap
new
program
tri
director
nation
institut
allergi
infecti
key
backer
program
forward
time
pick
antivir
pharmaci
soon
test
posit
coronaviru
develop
wake
morn
feel
well
sens
smell
tast
go
away
get
sore
throat
interview
call
doctor
say
covid
need
prescript
support
research
antivir
experi
fight
three
ago
institut
research
led
first
antivir
proteas
block
essenti
viru
protein
keep
viru
bay
earli
found
antivir
cure
hepat
c
close
percent
time
pill
influenza
cut
time
recov
infect
reduc
bout
flu
land
someon
start
pandem
test
peopl
sever
mani
show
benefit
hindsight
choic
work
mistak
know
best
time
tri
block
coronaviru
first
day
diseas
viru
rapidli
immun
system
yet
mount
peopl
crush
infect
recuper
immun
system
instead
damag
mani
peopl
hospit
coronaviru
replic
taper
drug
replic
earli
infect
well
fail
trial
later
far
one
antivir
clear
benefit
peopl
origin
potenti
cure
drug
shorten
cours
given
intraven
first
far
antivir
drug
gain
full
approv
treat
perform
left
mani
world
health
organ
work
effect
peopl
take
cours
pill
formul
compound
work
oral
surviv
passag
mouth
stomach
circulatori
around
world
test
alreadi
known
work
pill
form
one
compound
univers
test
influenza
equin
enceph
partnership
team
carri
mice
impress
bring
drug
human
clinic
thought
molecul
realli
amaz
vice
presid
infecti
diseas
vaccin
research
trial
howev
effect
diseas
scrap
trial
see
yeah
virologist
univers
north
surpris
would
make
dramat
improv
someon
outcom
sick
sever
day
second
studi
last
fall
time
test
drug
peopl
recent
trial
recruit
higher
risk
infect
older
peopl
obes
diabet
trial
deliv
clear
year
govern
hand
mani
small
incom
administr
design
new
program
antivir
week
saw
first
depart
health
human
would
purchas
million
cost
billion
provid
current
trial
author
food
drug
administr
govern
seek
similar
two
far
along
clinic
accord
chief
scienc
offic
administr
respons
hope
get
antivir
end
fall
help
us
close
chapter
epidem
govern
consid
compound
alreadi
proven
safe
effect
treatment
hepat
c
earli
work
test
peopl
current
run
clinic
drug
govern
radar
pfizer
molecul
initi
design
earli
potenti
drug
drug
sat
shelf
last
spring
decid
modifi
structur
would
work
new
coronaviru
proteas
pfizer
effort
molecul
known
drug
design
taken
intraven
pfizer
structur
work
pill
mice
given
drug
oral
high
enough
bodi
block
coronaviru
pfizer
clinic
trial
march
studi
safeti
peopl
move
test
next
acknowledg
drive
peopl
need
gain
access
soon
test
posit
test
go
link
treatment
histori
antivir
research
guid
first
probabl
offer
modest
benefit
diseas
would
good
start
dealt
never
hit
home
run
first
time
bat
line
drive
wall
start
would
realli
good
govern
spend
billion
research
carri
block
coronaviru
way
interfer
essenti
viral
make
imposs
copi
viru
next
gener
arriv
mani
say
research
good
invest
help
pandem
potenti
provid
first
line
defens
next
one
mark
director
therapeut
translat
medic
program
support
research
work
caus
dengu
fever
west
fever
caus
eastern
equin
enceph
alway
threat
think
go
need
presid
abrupt
order
us
intellig
investig
coronaviru
mani
posit
reflect
push
recent
inform
work
viru
lab
wuhan
china
answer
time
frame
presid
long
steer
clear
debat
influenti
late
becom
open
viru
two
vocal
argument
natur
laboratori
leak
new
ad
third
point
view
resound
undecid
begin
lot
pressur
speak
tie
trump
immunologist
yale
univers
littl
ration
discuss
go
begin
still
larg
lean
toward
theori
infect
perhap
bat
anoth
anim
rais
food
spread
viru
outsid
lab
direct
evid
lab
leak
theori
isol
viru
infect
lab
china
integr
role
joint
inquiri
world
health
organ
made
dismiss
lab
leak
theori
difficult
accept
journal
scienc
month
typic
speak
topic
publicli
new
scientif
result
confid
new
discoveri
conclus
one
letter
bloom
evolut
cancer
research
center
case
still
confid
time
went
clear
say
anyth
agre
idea
viru
definit
zoonosi
anim
two
letter
presid
intellig
redoubl
deliv
report
within
day
releas
report
gener
welcom
sustain
search
warn
arriv
time
soon
ever
end
process
would
know
much
know
w
virologist
mailman
school
public
health
univers
one
first
us
visit
china
earli
consult
public
health
lack
long
coronaviru
known
seemingli
nowher
seiz
govern
agre
host
scientif
mission
came
fire
studi
intern
access
data
addit
mission
mandat
investig
research
earli
day
even
biolog
warfar
program
produc
viru
march
letter
possibl
evid
suggest
view
evolut
capabl
brew
new
pandem
viru
bat
mani
anim
infect
two
swap
genet
materi
process
find
anim
recogn
spread
among
abl
reconstruct
evolutionari
potenti
human
pathogen
still
pattern
probabl
one
mani
major
human
health
exampl
like
origin
earli
west
got
infect
infect
thought
soon
conclud
someth
similar
case
coronaviru
first
came
light
citi
wuhan
home
wuhan
institut
virolog
studi
collect
southern
top
lab
famili
citi
epidem
well
coincid
wuhan
urban
center
new
york
citi
steadi
flow
china
mani
larg
deal
wildlif
brought
across
china
beyond
wild
kept
close
quarter
opportun
jump
speci
speci
sometim
result
danger
lead
new
lab
research
anoth
coronaviru
led
epidem
soon
found
viru
bat
well
civet
sold
discoveri
anim
potenti
speci
line
start
new
take
mani
reduc
risk
get
infect
studi
gotten
sick
infect
experiment
exampl
research
nation
institut
virolog
got
infect
coronaviru
mother
pandem
new
front
debat
lab
secur
one
turn
question
whether
sometim
anim
outweigh
potenti
work
help
guard
futur
kind
research
controversi
research
king
colleg
govern
pandem
result
lab
leak
number
outsid
virologist
medic
school
coauthor
letter
would
collect
grown
coloni
somehow
never
publish
even
sens
hold
onto
viru
felt
least
possibl
lab
leak
trump
administr
viru
cast
shadow
idea
lab
pin
joint
inquiri
china
even
govern
repeatedli
tri
bend
investig
time
possibl
lab
leak
tri
prepar
ground
speak
openli
seri
open
collect
known
group
took
express
joint
inquiri
uncertainti
viru
without
overtli
sell
lab
leak
theori
tone
professor
medicin
univers
minut
went
far
path
think
lab
leak
go
crucifi
march
team
report
four
possibl
lab
leak
without
substanti
data
back
conclus
highli
decid
push
back
letter
feel
realli
time
speak
get
scienc
behind
go
see
clear
case
lab
leak
complet
littl
evid
either
almost
tossup
marc
epidemiologist
th
school
public
health
coauthor
letter
made
comfort
talk
yet
know
pandem
happen
recent
former
new
york
time
journalist
dismay
learn
two
coronaviru
wuhan
institut
virolog
carri
modest
level
safeti
known
interview
time
fact
proof
spread
lab
certainli
rais
possibl
must
consid
level
research
would
add
difficulti
face
tri
pin
clear
evid
coronaviru
infect
staff
higher
secur
staff
regularli
give
blood
studi
later
genet
materi
record
number
remain
unpersuad
possibl
lab
leak
pathway
remain
least
like
origin
peter
virologist
allianc
work
frequent
wuhan
hand
great
deal
evid
origin
wildlif
previous
repeatedli
infect
peopl
highli
expos
work
wildlif
trade
wildlif
month
genet
earli
wuhan
wild
brought
anim
citi
suppos
came
wildlif
trade
pretti
simpl
straightforward
bat
outsid
lab
hard
find
airtight
proof
pathway
die
take
fairli
good
evid
two
caus
bat
four
infect
remain
mysteri
sometim
get
lucki
sometim
take
coronaviru
first
author
knew
littl
well
work
pregnant
clinic
small
steadili
grow
bodi
evid
safe
effect
pregnanc
preliminari
two
provid
addit
encourag
pfizerbiontech
produc
robust
immun
pregnant
like
provid
least
protect
two
danger
coronaviru
accord
studi
jama
pass
protect
breast
milk
research
second
studi
journal
obstetr
gynecolog
found
evid
either
pfizer
placenta
pregnanc
shift
framework
let
protect
pregnant
peopl
vaccin
let
protect
pregnant
peopl
vaccin
miller
expert
medicin
northwestern
univers
coauthor
placenta
studi
think
realli
power
covid
seriou
pregnanc
research
shown
instanc
pregnant
coronaviru
like
admit
intens
care
unit
requir
mechan
ventil
die
viru
symptomat
similar
age
diseas
control
prevent
least
made
avail
pregnant
peopl
mani
receiv
jama
studi
beth
deaco
medic
center
boston
medic
school
studi
blood
receiv
pfizer
vaccin
march
receiv
vaccin
pregnant
neither
pregnant
blood
protect
coronaviru
immun
complex
involv
bind
block
viru
help
bodi
recogn
viru
destroy
infect
produc
similar
three
antibodi
coronaviru
found
particular
note
fact
produc
high
prevent
viru
enter
pregnant
nonpregn
clearli
work
peopl
immunologist
yale
univers
involv
research
quit
protect
found
breast
milk
umbil
cord
blood
collect
deliveri
vaccin
pregnant
peopl
peopl
actual
transfer
immun
collier
beth
first
author
realli
encourag
ad
benefit
protect
fetu
reason
get
measur
immun
two
concern
first
first
south
three
produc
antibodi
vaccin
although
antibodi
especi
origin
strain
viru
accord
studi
immun
although
asterisk
antibodi
reduc
severalfold
dan
studi
author
virologist
beth
johnson
johnson
vaccin
includ
studi
overal
good
news
ad
data
substanti
benefit
pregnant
found
percent
pregnant
fever
second
vaccin
dose
percent
nonpregn
observ
sever
side
studi
continu
immun
epidemiolog
still
confirm
collier
second
studi
research
team
northwestern
univers
ann
h
hospit
gave
birth
receiv
either
pfizer
vaccin
pregnanc
remaind
receiv
coronaviru
like
show
injuri
abnorm
unvaccin
found
data
build
upon
data
come
safeti
pregnant
peopl
miller
translat
data
placenta
see
injuri
impact
vaccin
realli
fantast
acknowledg
author
recent
studi
third
trimest
pregnanc
mani
health
care
among
first
peopl
elig
miller
collect
data
receiv
johnson
johnson
vaccin
ongo
work
miller
publish
preliminari
data
soon
ad
help
peopl
make
best
decis
nation
guardsman
colorado
first
known
case
unit
contagi
new
variant
news
unsettl
variant
begin
surg
unit
although
know
yet
around
countri
includ
south
brazil
abl
immun
system
well
new
come
wors
time
nation
start
surg
would
dwarf
previou
distribut
power
made
pfizerbiontech
botch
chao
particular
lead
fourth
wave
alreadi
strain
health
care
system
happen
becom
predomin
version
viru
unit
account
nearli
surg
fear
end
mere
blip
countri
nationwid
total
daili
new
fall
percent
horrif
pretti
virologist
research
la
actual
lot
better
viru
still
see
potenti
sourc
troubl
come
particularli
one
batter
brazil
grow
rapidli
us
take
stock
past
better
understand
nation
variant
point
combin
social
perhap
season
wane
bought
crucial
time
million
get
credit
good
dose
serendip
unlik
powerless
think
got
lucki
honest
epidemiologist
yale
univers
vaccin
end
new
troubl
came
light
fret
competit
play
discov
variant
grow
common
laboratori
variant
dodg
antibodi
treatment
work
well
previou
viru
perhap
unit
drastic
surveil
mutat
last
week
viru
almost
percent
posit
test
intern
clearer
pictur
watch
variant
turn
weak
competitor
sharpli
march
still
preval
northern
virtual
southern
state
never
found
foothold
elsewher
countri
percent
viru
test
countri
percent
went
knockout
bye
bye
variant
side
countri
variant
spread
quickli
new
york
formid
adversari
grown
percent
collect
lab
came
fact
edg
nearli
everi
variant
far
congression
hear
p
director
diseas
control
prevent
made
percent
countri
realli
see
push
decis
emma
epidemiologist
univers
new
york
turn
moder
contagi
older
viru
much
initi
success
luck
overal
boom
last
fall
otherwis
gone
unclear
edg
realli
hard
say
right
virologist
univers
vaccin
infecti
diseas
organ
need
research
figur
come
stage
competit
lab
mice
cocktail
six
idea
see
one
win
virologist
univers
san
first
scientist
discov
michigan
one
saw
surg
spring
found
hook
younger
peopl
contact
sport
transmiss
viru
behavior
normal
much
problem
martin
epidemiologist
univers
rest
countri
peopl
natur
cautiou
toll
viru
thought
percent
contagi
previou
viru
mode
spread
differ
least
partial
indoor
dine
mask
transmiss
jump
mask
still
stop
spread
still
much
viru
necessarili
ascrib
behavior
evolutionari
biologist
univers
respiratori
sometim
go
season
clear
coronaviru
cycl
would
declin
middl
winter
feel
mayb
even
ignor
puzzl
yet
spread
wide
unit
rapidli
domin
south
late
last
year
first
unit
still
percent
get
ahead
think
realli
much
transmiss
advantag
epidemiologist
th
school
public
variant
brazil
got
slow
start
unit
make
percent
countri
believ
matter
time
variant
becom
one
preval
medic
epidemiologist
evolutionari
biologist
univers
past
four
rais
whether
worth
fret
differ
rather
rein
split
hand
lost
perspect
catnip
curiou
mind
unit
ampl
suppli
power
make
academ
concern
caus
worri
averag
person
slightli
less
effect
south
brazil
prevent
sever
diseas
known
imposs
situat
worsen
percent
peopl
unit
fulli
protect
wane
winter
one
world
one
come
promin
low
unit
behav
yet
inevit
aris
viru
rampant
lot
evolut
happen
yet
man
heart
diseas
diabet
went
south
hospit
cough
fever
worri
covid
nurs
insid
nose
sampl
went
small
devic
cartridg
machin
size
quad
test
avail
around
countri
detect
coronaviru
two
influenza
respiratori
syncyti
viru
littl
later
blake
patient
result
flu
rememb
give
fist
bump
ye
covid
flu
chief
emerg
medicin
medic
center
news
patient
wife
happili
treatment
offer
right
away
relief
satisfi
patient
situat
somewhat
unusu
past
winter
given
unit
mani
shock
absenc
flu
season
countri
reopen
say
flu
make
comeback
autumn
even
grow
number
peopl
get
covid
still
new
everi
day
unit
signific
number
peopl
resist
take
health
system
south
coronaviru
day
antigen
detect
made
viru
accord
senior
execut
director
organ
process
quad
use
emerg
antigen
quad
test
viru
genet
materi
chain
reaction
short
method
far
accur
antigen
approach
patient
use
cumbersom
across
differ
laboratori
amaz
technolog
quad
test
use
system
made
compani
receiv
emerg
author
food
drug
administr
late
last
year
flu
season
nonexist
univers
confluenc
precipit
return
fall
school
use
perhap
lack
recent
immun
system
exposur
flu
peopl
get
sick
fall
ad
want
know
flu
coronaviru
laboratori
anoth
big
boom
test
whose
team
run
two
million
coronaviru
sinc
begin
pandem
even
peopl
go
wonder
breakthrough
case
addit
look
influenza
coronaviru
time
receiv
emerg
use
author
test
coronaviru
influenza
influenza
b
recent
variou
combin
well
look
dozen
differ
respiratori
simultan
technolog
multiplex
especi
help
peopl
weak
immun
allow
discern
pathogen
make
person
sick
late
start
right
compani
test
coronaviru
well
bacteria
simultan
recent
bought
compani
machin
screen
one
multipl
alway
lead
simpl
treatment
howev
person
infect
multipl
simultan
common
sometim
multiplex
detect
viral
infect
miss
bacteri
one
griffin
chief
infecti
new
york
patient
carri
influenza
viru
test
posit
bacterium
pneumococcu
exampl
initi
thought
everi
time
viru
would
abl
stop
treat
viru
effect
antivir
therapi
avail
griffin
know
often
need
continu
sometim
multiplex
sensit
enough
rule
bacteri
test
still
grappl
mani
test
differ
burn
question
everi
compani
panel
best
one
two
four
mark
miller
chief
medic
offic
rel
young
healthi
need
quad
test
know
start
influenza
exampl
underli
chronic
sick
benefit
test
differ
decid
whether
need
admit
pandem
peopl
alway
curiou
know
exact
pathogen
caus
respiratori
accord
head
clinic
develop
medic
diagnost
think
alway
percept
oh
whatev
go
kill
us
terribl
toll
need
actual
know
ever
next
time
world
outbreak
deadli
new
pathogen
must
act
readi
restrict
travel
mandat
even
anyon
extent
threat
accord
pair
new
world
health
intend
address
past
year
led
million
trillion
econom
million
peopl
extrem
poverti
current
public
privat
protect
peopl
devast
pandem
one
pandem
centuri
moment
without
chang
prevent
futur
one
advanc
month
meet
govern
assembl
written
donat
countless
midst
pandem
interview
comb
gather
data
seek
counsel
public
privat
around
existenti
threat
order
chemic
nuclear
weapon
must
respons
highest
polit
leadership
rather
health
often
among
least
power
govern
last
year
countri
govern
provid
predict
sustain
nation
prepared
member
clark
former
prime
minist
new
author
one
media
confer
lead
last
chang
open
question
clark
group
independ
panel
pandem
prepared
respons
pointedli
note
sinc
pandem
produc
vast
major
never
sit
close
gather
dust
un
govern
johnson
anoth
author
report
presid
outbreak
current
intern
health
enforc
mechan
h
presid
institut
berlin
led
second
major
review
creation
intern
pandem
treati
would
establish
live
includ
quickli
provid
rapid
access
earli
investig
respons
equit
distribut
medicin
around
note
earli
coronaviru
pandem
mani
formal
warn
known
public
health
emerg
intern
concern
unfortun
acronym
often
pronounc
fake
one
note
whether
propos
chang
phemic
prove
stir
remain
seen
independ
panel
warn
declar
least
week
instead
mani
chose
wait
see
take
concert
action
intens
care
fill
clark
group
polit
leadership
surveil
place
coronaviru
outbreak
would
becom
pandem
digit
scrape
social
media
new
better
incorpor
offici
panel
delv
individu
report
blame
would
use
approach
lead
group
commiss
studi
high
medium
low
covid
death
previous
outbreak
control
report
success
quickli
across
multipl
govern
meticul
isol
peopl
viru
expos
worst
fragment
health
scienc
highest
death
brazil
unit
serious
pandem
action
panel
key
came
differ
independ
panel
pandem
prepared
respons
intern
health
govern
suppos
prepar
report
serv
constrain
rather
facilit
rapid
action
note
assess
highli
prepar
framework
high
death
earli
group
spent
found
mani
simpli
variou
even
awar
group
vital
would
requir
latest
set
took
decad
final
instead
one
committe
major
increas
account
though
pandem
treati
period
review
prepared
would
involv
independ
panel
intern
council
led
state
keep
attent
health
overse
program
would
contribut
base
abil
would
promis
quick
contend
new
outbreak
give
incent
report
go
polit
creat
someth
catastroph
mark
one
panel
stem
part
experi
lead
presid
emerg
program
relief
known
global
fund
fight
tuberculosi
malaria
led
intern
review
gener
new
rather
improv
increas
complic
damag
global
sometim
outbreak
led
creation
health
program
agenc
role
health
crise
well
provid
technic
guidanc
report
month
note
new
program
receiv
increasingli
posit
feedback
partner
health
humanitarian
outbreak
two
differ
basic
former
intern
presid
without
member
independ
panel
one
trenchant
respons
note
mark
improv
quickli
agenc
declar
intern
emerg
biggest
fear
upper
hand
viru
would
leav
low
behind
becom
pandem
go
fight
bit
avert
panel
slew
urgent
world
entir
popul
within
good
vaccin
pipelin
commit
make
least
billion
avail
global
effort
provid
equit
throughout
world
group
goe
handl
among
hesit
get
coronaviru
vaccin
physician
adolesc
medicin
divis
hospit
new
york
get
fill
often
alreadi
vaccin
would
prefac
messag
antimask
worri
accord
recent
across
countri
share
percent
say
would
get
right
away
express
anxieti
vaccin
seriou
safeti
thu
far
lee
presid
academi
pediatr
recent
emerg
use
approv
pfizerbiontech
vaccin
critic
import
step
lifesav
despit
evid
vaccin
safeti
sever
spoke
past
week
similarli
hesit
get
shot
skeptic
overal
fear
relat
new
vaccin
unknown
futur
johnson
pound
ridg
put
messag
fast
want
lawyer
see
know
age
receiv
vaccin
compens
spoke
concern
vaccin
affect
puberti
futur
fertil
book
author
whose
though
husband
got
vaccin
affect
fertil
grow
wrong
decis
go
bad
want
either
turn
around
adulthood
ask
teen
worri
biolog
mechan
would
make
vaccin
wors
relat
puberti
chang
immun
respons
side
effect
profil
vaccin
pfizerbiontech
covid
vaccin
extrem
effect
zero
breakthrough
among
receiv
professor
yale
school
medicin
wrote
articl
time
vaccin
fertil
even
vaccin
inadvert
got
pregnant
noth
even
support
link
infertil
covid
vaccin
two
year
age
group
total
understand
fear
realli
basi
molli
pregnant
second
child
anxiou
give
daughter
vaccin
even
though
chose
get
shot
pregnanc
daughter
never
bare
sick
know
allerg
mass
work
higher
concern
allerg
reaction
vaccin
avers
respons
shot
oppos
would
wait
avail
theoret
moment
pediatrician
research
school
medicin
northwestern
univers
kind
convers
present
feasibl
vaccin
especi
experi
fear
farfetch
scienc
data
abstract
vaccin
effect
weigh
viru
presid
put
sever
diseas
benign
diseas
spoke
hope
vaccin
becom
realiti
young
rather
idea
becom
less
hesit
especi
whose
talk
best
approach
teen
alik
practic
would
feel
comfort
get
pediatrician
offic
close
doctor
know
larg
vaccin
site
convent
center
pharmaci
way
mani
last
week
presid
shift
administr
vaccin
strategi
away
mass
vaccin
toward
local
order
get
younger
peopl
vaccin
still
unclear
mani
encourag
requir
middl
get
vaccin
school
fall
though
alreadi
must
covid
vaccin
want
return
biggest
vaccin
old
enough
opinion
forget
check
teen
hear
vaccin
well
mani
need
parent
consent
get
vaccin
crowd
alreadi
elig
vaccin
tell
want
know
want
want
abl
get
back
school
go
without
worri
viru
loom
want
return
semblanc
normal
mix
coupl
far
alon
alway
go
get
vaccin
percent
medic
auditor
husband
disast
insur
adjust
pass
honest
think
worst
covid
behind
us
good
administr
get
percent
adult
summer
reluct
men
get
shot
imped
get
far
higher
rate
percentag
men
even
though
divid
roughli
even
nation
overal
popul
trend
worrisom
mani
especi
vaccin
dip
bit
us
gender
gap
mani
reflect
role
specif
receiv
earli
vaccin
prioriti
polit
cultur
long
stand
embrac
prevent
care
often
gener
gap
even
time
higher
men
among
divis
realiti
disproportion
role
societi
matter
herd
immun
alison
associ
professor
nurs
univers
expert
vaccin
hesit
fret
race
polit
parti
religion
occup
group
mani
overlap
gender
specif
target
men
counti
percent
gotten
first
shot
percent
men
scrambl
figur
concern
embark
target
outreach
among
men
chief
scienc
offic
counti
depart
public
health
particular
concern
black
men
percent
black
counti
percent
receiv
least
one
dose
vaccin
percent
men
percent
white
men
accord
recent
data
avail
earli
month
fulli
understand
one
vaccin
import
addit
protect
famili
earli
vaccin
gender
larg
got
first
make
proport
age
group
mani
health
care
given
vaccin
prioriti
account
health
care
percent
public
unit
show
unpaid
labor
life
instanc
lost
major
food
retail
health
care
govern
among
done
work
shift
remot
school
sick
combin
vaccin
motiv
two
way
seek
protect
rest
famili
desper
get
back
work
forc
inde
drove
job
last
year
lead
econom
recoveri
roughli
half
million
labor
forc
march
part
school
across
much
countri
addit
disproportion
sever
essenti
pilar
assist
professor
sociolog
univers
gender
disproportion
unpaid
older
addit
motiv
get
vaccin
mani
way
pattern
gender
come
prevent
health
care
averag
like
get
annual
men
even
health
like
men
get
prevent
like
engag
hurt
health
heavi
drink
smoke
illicit
drug
use
overweight
men
less
like
visit
regularli
go
emerg
room
crisi
get
basic
dental
care
accord
feder
data
except
histor
influenza
vaccin
much
higher
among
percent
percent
though
gap
coronaviru
vaccin
latest
express
gender
gap
long
prevent
health
care
seek
health
polici
research
clinic
professor
tuck
school
busi
say
even
context
gener
male
health
care
recalcitr
specif
vaccin
male
arm
sign
cumbersom
men
less
patienc
system
larg
taken
place
process
find
easier
sinc
tend
get
health
care
inform
figur
access
men
difficulti
appoint
come
coronaviru
subject
rampant
misinform
medic
advic
dynam
work
men
sens
necessarili
suscept
health
care
told
weather
year
sens
omnipot
public
health
academ
long
concern
effect
men
get
health
care
fear
vaccin
notabl
male
servic
branch
militari
percent
vaccin
defens
depart
turn
avoid
link
masculin
men
strong
invinc
help
w
springer
associ
professor
depart
sociolog
univers
new
jersey
done
research
trait
cultur
lead
men
avoid
import
health
care
order
act
masculin
vaccin
avail
everyon
interest
watch
vaccin
uptak
like
reflect
social
cultur
gender
health
cultur
idea
real
men
need
prevent
health
care
stage
us
health
data
polit
far
like
men
regist
demonstr
across
countri
far
less
like
embrac
men
listen
femal
recent
preprint
studi
colleg
saint
watch
men
featur
ident
inform
vaccin
among
watch
posit
male
narrat
femal
narrat
got
far
mix
respons
version
video
vaccin
intent
mix
vaccin
propens
conserv
actual
vaccin
intent
spell
victori
wife
subtli
joust
influenc
son
vaccin
decis
son
wife
take
shot
would
rather
got
shot
hope
consid
decis
benefit
son
even
often
life
men
find
cover
extent
peopl
live
social
set
men
benefit
higher
coverag
among
howev
still
trump
card
work
would
son
get
travel
togeth
possibl
protect
dad
ventil
struggl
life
last
hospit
long
island
infus
blood
plasma
experiment
treatment
hard
get
gain
attent
time
littl
els
petit
drew
hospit
gave
retir
counti
medic
infus
pale
yellow
stuff
liquid
gold
terrifi
earli
pandem
idea
plasma
save
took
life
evid
work
trump
administr
elit
medic
plasma
stori
time
mani
million
involv
collect
administr
put
face
later
one
went
donat
plasma
end
year
good
evid
convalesc
plasma
mani
prestigi
medic
quietli
abandon
drop
demand
dip
blood
march
new
york
blood
center
cancel
appoint
need
year
ago
die
covid
alarm
rate
feder
govern
made
big
bet
plasma
one
knew
treatment
would
work
biolog
plausibl
safe
much
els
tri
told
plasma
distribut
thank
feder
program
govern
bet
result
blockbust
treatment
even
decent
one
give
countri
educ
test
medic
treatment
middl
emerg
medic
scienc
messi
slow
treatment
often
difficult
let
govern
gave
plasma
mani
outsid
clinic
trial
took
long
time
measur
effect
eventu
emerg
suggest
right
plasma
help
enough
evid
show
countri
broad
costli
plasma
campaign
littl
effect
especi
peopl
whose
diseas
advanc
enough
land
three
feder
health
former
commission
food
drug
administr
peter
top
regul
h
lane
clinic
director
nation
health
acknowledg
evid
plasma
limit
data
strong
hard
think
enthusiast
see
continu
use
lane
recent
outpati
trial
plasma
lack
use
centuri
diphtheria
flu
fall
ill
new
coronaviru
last
year
around
world
turn
old
unit
two
mount
new
york
citi
methodist
first
plasma
within
march
doctor
set
mount
plasma
program
hospit
tri
experiment
treatment
blood
carri
rel
low
risk
harm
new
viru
spread
quickli
natur
much
better
manufactur
mount
prepar
infus
plasma
photograph
home
port
send
mount
call
idea
plasma
taken
scienc
class
sinc
high
school
histori
previou
diseas
form
group
grew
eventu
health
advocaci
organ
survivor
corp
donat
session
group
turn
peopl
fli
go
donat
plasma
realli
beauti
thing
see
around
time
shoe
wholesal
counti
spread
word
plasma
within
orthodox
commun
sever
knew
long
orthodox
peopl
get
test
coronaviru
show
donat
exhaust
laugh
two
month
acceler
plasma
use
help
million
feder
clinic
run
expand
access
program
across
countri
govern
agre
cover
administr
plasma
red
cross
blood
news
got
none
flashi
media
attent
later
summer
govern
disclos
much
would
invest
turn
signific
accord
contract
us
govern
million
red
cross
blood
sinc
last
convalesc
plasma
program
intend
meet
urgent
need
potenti
therapi
earli
pandem
health
depart
spokeswoman
statement
avail
spring
turn
summer
trump
administr
plasma
unproven
drug
promis
solut
administr
million
advertis
campaign
implor
donat
plasma
help
save
blitz
includ
promot
radio
coalit
organ
collect
plasma
begin
take
shape
feder
major
anthem
regular
continu
day
nonprofit
blood
plasma
collect
collabor
fight
group
includ
mitr
corpor
nonprofit
organ
receiv
million
govern
grant
promot
plasma
donat
around
sometim
conflict
blood
plasma
immedi
plasma
develop
treatment
nation
exactli
get
along
peter
lee
corpor
vice
presid
research
virtual
scientif
forum
march
organ
develop
locat
tool
group
potenti
compani
took
role
neutral
intermediari
lee
compani
provid
access
advertis
agenc
look
feel
fight
us
campaign
includ
video
august
author
plasma
emerg
use
pressur
presid
j
trump
feder
move
news
confer
agenc
commission
substanti
exagger
data
although
later
correct
follow
critic
scientif
recent
interview
trump
involv
plasma
author
made
topic
discuss
one
scienc
medicin
behind
happen
polit
issu
oppos
medic
scientif
one
author
away
clinic
system
access
even
fall
winter
use
plasma
accord
nation
usag
data
provid
blood
year
unit
day
plasma
per
commun
serv
plasma
readili
avail
treatment
health
system
give
two
plasma
standard
practic
system
medic
director
infect
prevent
acknowledg
plasma
miss
hit
last
year
bigger
access
antivir
drug
flood
mani
rural
desper
treat
anyth
safe
fall
evid
show
plasma
miracl
earli
infecti
societi
plasma
use
outsid
clinic
trial
societi
restrict
advic
say
plasma
use
highli
trial
earli
strong
evid
benefit
author
plasma
appli
peopl
earli
cours
diseas
make
regul
retrospect
slow
adapt
known
previou
diseas
plasma
treatment
like
work
best
given
earli
high
somehow
realli
take
serious
perhap
lesson
histori
actual
teach
someth
today
sever
medic
larg
stop
give
plasma
rush
univers
medic
center
found
mani
alreadi
plasma
would
superflu
clinic
longer
routin
plasma
lack
convinc
evid
efficaci
accord
critic
care
year
mount
stop
give
plasma
outsid
clinic
trial
track
scientif
literatur
sort
pile
benefit
scienc
process
old
hypothes
favor
better
hypothesi
mani
initi
promis
fail
clinic
way
call
rescind
plasma
emerg
author
act
chief
scientist
agenc
presid
usual
scientif
emerg
pandem
drain
valuabl
time
attent
pandem
someth
learn
prior
seriou
unintend
way
inadequ
outbreak
plasma
agenc
forgot
past
scant
evid
plasma
help
curb
pandem
clutch
promin
medic
continu
focu
narrow
immunologist
univers
mani
test
plasma
sick
earli
consist
clinic
trial
found
give
plasma
earli
older
peopl
reduc
progress
analysi
clinic
program
found
given
plasma
high
concentr
better
receiv
treatment
still
march
trial
plasma
peopl
yet
sever
ill
agenc
unlik
medic
commun
plasma
limit
benefit
even
fight
us
begun
shift
focu
clinic
research
page
convalesc
plasma
domin
favor
news
major
conclud
plasma
littl
broadli
promot
plasma
test
lab
thought
potent
version
plasma
clinic
research
page
neg
fight
us
still
run
feder
govern
tell
hero
insid
keep
fight
urg
donat
plasma
even
though
blood
stop
plasma
earli
turn
attent
done
plasma
last
spring
increas
accept
orthodox
commun
set
inform
run
orthodox
rapid
test
doubl
infus
feder
sinc
commun
el
san
work
divis
insur
match
right
peopl
underli
health
treatment
believ
plasma
lot
substant
word
came
back
tomorrow
jelli
work
better
jelli
save
woman
stricken
sever
vomit
confus
weak
one
arm
earli
month
hospit
see
someon
found
sever
larg
blood
block
drain
blood
brain
condit
disabl
kill
procedur
suction
huge
brain
find
new
patient
one
six
brain
within
two
johnson
johnson
coronaviru
vaccin
one
devast
led
us
health
recommend
use
vaccin
ad
sinc
one
man
compani
clinic
anoth
woman
receiv
vaccin
author
gener
sever
origin
young
woman
initi
heparin
standard
sinc
learn
actual
worsen
rare
disord
affect
small
peopl
receiv
johnson
johnson
sever
last
around
world
littl
inform
condit
recogn
immedi
fli
blind
base
hematolog
societi
specialist
care
patient
digniti
health
st
rose
hospit
campu
us
decis
call
suspens
use
vaccin
intend
give
time
learn
rare
disord
caus
assess
whether
link
vaccin
inform
recogn
treat
paus
last
least
next
expert
diseas
control
prevent
meet
review
data
decid
whether
resum
vaccin
director
top
us
health
sought
reassur
public
paus
extend
week
reason
safeguard
assess
risk
johnson
johnson
vaccin
use
unit
safe
given
mani
million
gotten
without
world
relentless
epidem
even
temporarili
stop
use
highli
effect
vaccin
mani
deploy
fraught
decis
public
health
fear
move
messag
erod
trust
global
even
vaccin
huge
peopl
die
needlessli
compani
unit
johnson
johnson
provid
percent
covid
vaccin
suppli
afford
suspens
plenti
vaccin
pfizerbiontech
fill
gap
mani
stop
limit
use
anoth
effect
vaccin
one
made
link
similar
rare
million
receiv
johnson
johnson
vaccin
far
eight
problem
seven
three
mostli
million
peopl
receiv
vaccin
sever
limit
use
older
mani
involv
younger
suspect
rare
vaccin
intens
reaction
patient
immun
system
activ
blood
compon
unusu
syndrom
extens
leav
patient
low
platelet
tendenc
bleed
time
peopl
mani
younger
known
say
far
unabl
identifi
underli
make
peopl
statement
johnson
johnson
safeti
peopl
use
number
one
prioriti
strongli
support
awar
extrem
rare
event
ensur
correct
diagnosi
appropri
treatment
expedit
health
care
continu
believ
posit
profil
vaccin
compani
letter
new
journal
medicin
causal
link
establish
vaccin
sens
hobbl
global
vaccin
campaign
pandem
rare
rare
side
effect
price
must
pay
even
difficult
accept
sever
unpredict
blood
brain
especi
young
healthi
peopl
devast
complic
chief
medic
advis
pandem
administr
ad
one
woman
three
hospit
one
intens
care
even
though
small
devast
complic
believ
make
decis
believ
rational
least
call
quick
paus
see
alert
peopl
sometim
minor
littl
abdomin
discomfort
sudden
wind
stroke
mayb
lot
peopl
spectrum
diseas
public
sever
short
breath
leg
abdomin
pain
help
identifi
reason
paus
let
know
drug
heparin
standard
treatment
blood
given
heparin
circumst
make
wors
known
whether
heparin
initi
given
use
blood
urgent
need
blood
keep
grow
new
keep
form
vaccin
similar
condit
worsen
rapidli
real
issu
long
take
make
mind
go
advisori
panel
rest
world
watch
j
j
hope
go
import
part
respons
ad
want
rush
hope
make
reason
amount
time
anoth
first
six
condit
healthi
woman
went
emerg
room
felt
ill
abdomin
pain
three
day
case
letter
editor
new
journal
medicin
platelet
count
low
blood
abnorm
scan
found
extens
blood
abdomen
anoth
scan
found
given
heparin
hemorrhag
learn
receiv
johnson
johnson
vaccin
two
stop
heparin
gave
differ
blood
thinner
along
intraven
immun
globulin
treatment
disord
platelet
count
wrote
patient
critic
ill
time
report
young
woman
fight
life
ventil
accord
speak
independ
repres
patient
famili
declin
request
team
studi
blood
fall
place
problem
knew
receiv
vaccin
mostli
young
switch
heparin
anoth
follow
guidanc
provid
similar
inform
condit
possibl
connect
johnson
johnson
vaccin
emerg
number
food
drug
administr
weekend
person
told
one
avail
help
line
kept
open
thought
emerg
hung
back
ask
reach
johnson
johnson
vaccin
inform
avail
person
told
provid
advic
patient
spokeswoman
look
ensur
call
assist
receiv
help
seek
pharmacist
hospit
report
diseas
control
prevent
earli
agenc
ask
case
week
agenc
declin
comment
whether
spokeswoman
meet
advisori
panel
johnson
johnson
safeti
expert
agenc
data
young
woman
meet
statement
say
meet
first
time
learn
case
state
previous
told
public
feder
state
hospit
intervent
radiologist
tube
blood
young
woman
brain
use
devic
suction
blood
form
later
procedur
condit
patient
brain
transfer
hospit
still
ventil
prognosi
uncertain
life
life
entir
famili
life
pandem
us
bring
million
back
argument
mani
make
offic
essenti
collabor
innov
say
fresh
keen
decis
make
born
chanc
spontan
true
colleagu
cain
miller
gender
futur
work
dug
question
found
evid
back
argument
opposit
true
offic
creativ
creat
inhospit
environ
mani
peopl
long
offic
often
wors
mani
mani
peopl
color
peopl
peopl
peopl
shi
lose
peopl
lose
divers
come
peopl
divers
remot
work
howev
enabl
bubbl
peopl
vari
peopl
comfort
speak
meet
feel
abl
particip
virtual
set
session
slack
uncov
mani
peopl
otherwis
meet
work
one
big
countri
mass
experi
work
home
even
viru
million
entir
funni
thing
work
realli
well
mani
mani
home
school
constantli
worri
get
sick
mani
good
product
balanc
corpor
cultur
hard
chang
tend
stick
know
wari
peopl
work
home
indefinit
lot
trust
peopl
make
usual
peopl
visibl
peopl
make
peopl
day
long
day
zoom
fun
relat
even
purpos
colleagu
weaver
hardli
first
time
human
face
coronaviru
pandem
last
time
emerg
one
found
evid
human
coronaviru
epidem
swept
east
ago
find
use
drug
develop
first
time
peopl
found
evid
anoth
coronaviru
deep
time
ancient
carl
colleagu
scienc
desk
told
us
pandem
big
east
left
mark
plagu
region
find
prophesi
fate
get
coronaviru
control
soon
disturbingli
coronaviru
time
peopl
still
live
small
instead
big
point
potenc
contagion
make
us
worri
evolutionari
biologist
univers
led
studi
go
right
go
human
genom
known
crucial
fight
evid
rapid
evolut
peopl
specif
mutat
would
like
surviv
coronaviru
infect
without
would
probabl
east
found
domin
time
went
evolutionari
chang
time
carl
sign
kind
evolut
expect
hit
massiv
pandem
select
time
surviv
find
big
tri
design
help
us
fight
way
current
pandem
abl
get
manipul
even
better
job
fight
new
coronaviru
carl
vaccin
go
counti
statelet
us
know
deal
pandem
send
us
respons
featur
upcom
get
brief
articl
part
debat
newslett
sign
receiv
year
half
later
still
know
certain
pandem
begin
outbreak
earli
day
assum
viru
anim
person
late
possibl
meat
market
wuhan
china
citi
million
first
known
covid
time
us
intellig
investig
anoth
explan
viru
accident
idea
conspiraci
theori
becom
plausibl
hypothesi
viru
peopl
late
wuhan
lancet
paper
viru
come
bat
perhap
way
anoth
anim
wuhan
meat
market
remain
reason
assumpt
made
kind
transmiss
known
zoonot
respons
human
infecti
mani
two
paper
probabl
one
two
wuhan
institut
virolog
wuhan
center
diseas
control
conduct
world
extens
research
bat
collect
cave
often
yield
import
virologist
wuhan
institut
shi
abl
trace
broke
back
coloni
horsesho
bat
shi
went
publish
import
earli
research
long
though
intim
studi
caus
believ
shi
team
respons
accident
controversi
studi
univers
north
lab
use
data
shi
nation
health
engin
coronaviru
capabl
human
airway
argu
type
research
known
use
potenti
riski
stir
specul
whether
shi
lab
part
vehement
theori
told
time
last
week
lab
never
enhanc
virul
natur
event
possibl
last
zero
infect
wuhan
institut
wuhan
center
likewis
china
refus
allow
independ
investig
made
difficult
valid
white
hous
stood
way
part
desir
draw
attent
govern
financi
wuhan
institut
research
vaniti
certainli
seriou
think
possibl
even
probabl
explan
one
microbiologist
call
thorough
investig
viru
sinc
last
mani
necessarili
reason
doubt
natur
origin
theori
took
shi
discov
sourc
discov
away
diseas
first
broke
virologist
coronaviru
expert
univers
aphor
anim
one
expect
sound
know
thing
told
post
zoonosi
hors
lab
leak
zebra
virologist
similarli
convinc
viru
natur
origin
think
peopl
lot
peopl
look
somebodi
told
though
uncertainti
complet
yale
immunologist
told
time
littl
evid
either
almost
tossup
well
stay
way
madden
aspect
stori
despit
big
fuss
made
right
side
still
incred
thin
scienc
journalist
former
time
report
told
post
debat
unearth
ever
new
hard
evid
lab
leak
theori
back
letter
scienc
magazin
call
transpar
independ
investig
week
later
wall
street
journal
accord
us
intellig
three
wuhan
institut
sought
medic
care
consist
common
season
ill
lab
leak
theori
interest
cautionari
tale
polit
polar
crise
unit
one
theori
republican
senat
cotton
china
hawk
loyal
alli
former
presid
trump
china
lie
viru
come
short
order
trump
administr
campaign
suggest
pandem
plot
derail
inquiri
viru
gave
rise
fals
consensu
press
understand
public
health
crisi
initi
confus
journalist
side
certainti
ought
side
uncertainti
fals
certainti
outset
dogma
question
far
long
even
consensu
around
aerosol
transmiss
suggest
introspect
scienc
possibl
peopl
valu
certainti
bender
vice
far
scienc
commun
abl
bridg
two
success
public
health
crisi
gener
disconnect
disastr
one
consequ
lab
leak
theori
becom
polit
footbal
us
scienc
float
polit
must
hope
least
find
way
public
health
exceedingli
high
find
concret
evid
event
pass
directli
bat
human
understand
manag
interfac
need
significantli
lab
caus
pandem
becom
critic
understand
chain
prevent
happen
point
view
us
debat
pleas
note
name
age
locat
respons
includ
next
newslett
lab
leak
theori
new
york
time
covid
hypothesi
know
natur
media
lab
leak
fiasco
slow
bore
even
one
insight
lab
leak
theori
hold
foreign
polici
southeast
larg
worst
coronaviru
pandem
first
year
infecti
take
hold
region
suffer
new
rest
world
west
come
probabl
look
beech
southeast
bureau
chief
time
told
delta
variant
across
globe
particular
face
frighten
hospit
capit
full
enough
peopl
involv
fight
covid
medic
die
fast
enough
combat
spread
region
kind
fell
necessarili
easi
econom
advantag
join
global
initi
rich
enough
secur
western
last
year
region
hub
vaccin
contract
pharmaceut
firm
king
experi
make
month
mani
vaccin
scale
back
vaccin
use
pandem
tighten
polit
control
tamp
dissent
emerg
ostens
pandem
use
stop
speak
today
far
cri
earli
pandem
explain
region
rel
success
peopl
use
luck
one
possibl
answer
say
come
bat
southwestern
china
home
speci
think
carri
coronaviru
coronaviru
region
possibl
peopl
within
region
expos
version
coronaviru
total
made
less
prone
suffer
sever
initi
outbreak
recent
get
antibodi
coronaviru
came
back
fact
say
peopl
need
test
confirm
vaccin
efficaci
test
mislead
clinic
alreadi
shown
author
unit
trigger
strong
antibodi
respons
everyon
peopl
immun
take
certain
get
reliabl
answer
test
peopl
would
get
specif
kind
test
right
time
take
test
soon
reli
one
wrong
easi
given
array
avail
believ
still
vulner
notour
colleagu
advic
still
part
slow
wade
agenc
use
antibodi
immun
decis
drawn
critic
provid
inform
test
health
care
result
mani
still
unawar
antibodi
vaccin
go
counti
statelet
us
know
deal
pandem
send
us
respons
featur
upcom
get
brief
midnight
offici
cours
coronaviru
pandem
life
back
way
us
mysteri
deadli
ill
call
lift
nearli
state
pandem
signific
emot
psycholog
mileston
state
experienc
nation
endur
today
vari
wide
outright
jubil
continu
frustrat
keep
place
mani
much
chang
today
still
wear
even
least
part
lot
past
year
half
say
noth
sky
heat
drought
state
coronaviru
give
littl
perspect
short
coronaviru
pandem
today
goe
live
pacif
time
tell
us
want
see
sign
today
read
everi
edit
grew
orang
counti
graduat
state
bay
area
alway
see
follow
along
suprem
court
nativ
serv
tribal
part
coronaviru
relief
congress
march
tribal
nativ
establish
manag
almost
million
part
nativ
settlement
act
tribal
lower
challeng
govern
decis
alloc
million
law
act
meet
definit
justic
write
major
decis
argument
wrote
regardless
whether
feder
court
today
feder
govern
almost
half
centuri
justic
g
g
brett
ami
justic
opinion
justic
dissent
justic
wrote
satisfi
statutori
definit
elig
special
provid
unit
statu
justic
dissent
case
v
reserv
anoth
decis
found
evid
coronaviru
epidem
swept
east
ago
devast
enough
leav
evolutionari
imprint
peopl
aliv
new
studi
ancient
coronaviru
plagu
region
mani
say
find
dire
pandem
brought
control
soon
vaccin
make
us
worri
evolutionari
biologist
univers
led
studi
journal
current
biolog
go
right
go
look
back
far
histori
famili
past
three
infect
caus
sever
respiratori
diseas
indic
speci
bat
infect
peopl
usual
caus
mild
directli
observ
becom
human
indirect
estim
gain
new
roughli
regular
rate
genet
variat
possibl
determin
common
recent
mild
cross
speci
barrier
date
back
far
point
coronaviru
trail
went
cold
appli
new
method
search
instead
look
effect
human
drive
enorm
chang
human
genom
mutat
viral
infect
well
mean
differ
life
death
offspr
lifesav
mutat
exampl
allow
peopl
chop
apart
viru
evolv
chang
shape
overcom
host
spur
host
evolv
even
lead
random
new
mutat
provid
resist
viru
becom
common
one
gener
next
gene
turn
becom
one
version
gene
larg
peopl
know
like
signatur
rapid
evolut
recent
human
genom
genet
variat
order
reconstruct
histori
array
pandem
struck
whether
ancient
left
distinct
mark
peopl
across
differ
around
world
look
combin
known
crucial
east
found
domin
version
strong
signal
peopl
east
ancient
whatev
east
limit
region
around
world
find
signal
postdoctor
research
univers
coauthor
new
tri
estim
long
ago
east
coronaviru
took
advantag
fact
domin
version
gene
gain
harmless
random
time
found
number
meant
rapidli
time
signal
absolut
expect
chanc
antivir
sometim
ago
like
cours
surpris
find
sinc
east
time
live
dens
instead
form
small
evolutionari
geneticist
univers
colleg
involv
new
studi
found
work
compel
quit
convinc
someth
think
possibl
yet
make
firm
estim
long
ago
ancient
epidem
took
place
time
complic
thing
whether
thousand
person
think
someth
confid
look
fight
new
coronaviru
want
scrutin
respons
ancient
epidem
actual
point
us
molecular
adjust
immun
respons
viru
agre
say
new
studi
get
special
attent
know
import
nice
thing
evolut
paus
use
johnson
johnson
vaccin
continu
week
day
expert
diseas
control
prevent
determin
time
assess
possibl
link
rare
seriou
decis
reinstat
vaccin
pain
nation
global
erod
public
confid
vaccin
gener
slow
desper
rural
homebound
peopl
vaccin
consid
ideal
peopl
one
shot
easili
ship
made
pfizerbiontech
must
kept
low
vaccin
paus
us
health
care
realli
devast
medic
school
told
panel
lose
johnson
johnson
vaccin
even
temporarili
big
blow
stop
pandem
especi
paus
first
us
health
led
johnson
johnson
delay
vaccin
sever
pois
start
week
contin
rare
sometim
fatal
similar
blood
disord
sever
limit
reject
widespread
use
vaccin
recommend
worrisom
variant
viru
suspend
use
johnson
johnson
vaccin
would
purchas
union
would
consid
new
technolog
employ
johnson
johnson
mani
follow
unit
lead
come
grace
lee
univers
expert
panel
although
committe
respons
unit
feel
weight
burden
global
respons
impact
potenti
worsen
advisori
group
emerg
meet
review
reason
paus
six
rare
sever
blood
brain
one
receiv
johnson
johnson
vaccin
although
unclear
whether
vaccin
respons
addit
panel
learn
problem
seventh
woman
receiv
vaccin
author
man
receiv
clinic
seven
million
peopl
unit
receiv
johnson
johnson
shot
percent
usual
end
vote
whether
use
vaccin
case
panel
declin
vote
sever
whether
limit
use
vaccin
older
mani
done
say
enough
inform
assess
potenti
fink
offici
food
drug
administr
differ
strategi
panel
suggest
vaccin
go
back
use
continu
studi
potenti
risk
provid
inform
consid
whether
accept
vaccin
current
think
risk
inclus
warn
fink
panel
without
full
understand
potenti
one
rare
condit
caus
neurolog
damag
risk
covid
messag
panel
would
send
suspens
use
advisori
committe
immun
panel
independ
advis
vaccin
disord
concern
vaccin
differ
much
typic
blood
develop
peopl
everi
year
seven
experienc
brain
notabl
low
level
blood
help
form
normal
respons
recent
given
birth
increas
risk
common
blood
one
known
take
hormon
treatment
far
evid
birth
control
rais
risk
blood
larg
danger
bodi
rare
combin
sever
low
stood
safeti
signal
known
far
way
predict
whether
individu
condit
similar
one
link
covid
vaccin
affect
rel
young
vaccin
wide
use
found
aberr
respons
vaccin
set
cascad
bleed
special
blood
detect
confirm
diagnosi
us
test
posit
johnson
johnson
use
ferri
human
creat
immun
coronaviru
suspect
aspect
technolog
role
blood
disord
emphas
condit
rare
quirk
biolog
like
certain
peopl
bad
reaction
vaccin
vaccin
alon
respons
would
mani
made
pfizerbiontech
employ
genet
materi
use
world
count
vaccin
fight
pandem
mani
restrict
use
older
stop
altogeth
peopl
still
elig
fear
vaccin
author
unit
although
compani
appli
permiss
distribut
johnson
johnson
vaccin
unit
march
first
case
blood
brain
march
million
age
rang
receiv
panel
known
background
low
brain
known
central
venou
sinu
thrombosi
gener
popul
younger
note
enough
data
precis
estim
often
two
base
rough
disord
receiv
johnson
johnson
vaccin
least
three
time
often
would
accord
safeti
expert
come
rate
would
becom
clearer
get
better
pictur
go
right
believ
extrem
rare
yet
certain
possibl
syndrom
easili
one
associ
vaccin
p
director
white
hous
news
confer
pandem
panel
discuss
note
risk
window
condit
among
vaccin
still
open
new
emerg
nearli
million
peopl
receiv
shot
within
last
two
six
sever
within
two
dissemin
health
inform
diagnosi
treatment
condit
awar
would
spread
among
emerg
peopl
receiv
vaccin
key
point
heparin
common
treatment
harm
note
peopl
condit
soon
possibl
seriou
invas
remov
larg
blood
panel
reiter
two
pfizerbiontech
avail
neither
associ
problem
paus
would
stop
peopl
unit
news
confer
white
hous
pandem
paus
would
gener
interrupt
momentum
countri
vaccin
campaign
short
term
expect
impact
daili
transit
johnson
johnson
pfizer
enough
pfizer
vaccin
suppli
continu
even
acceler
current
pace
public
health
repeatedli
disord
rare
johnson
johnson
far
outweigh
advers
effect
potenti
devast
fatal
blood
brain
public
consid
risk
unaccept
even
extrem
safeti
bar
set
high
given
healthi
peopl
seemingli
greater
vulner
younger
peopl
disord
particular
concern
risk
sever
ill
covid
lower
older
peopl
suggest
older
peopl
younger
peopl
less
gain
lose
johnson
johnson
curiou
influenza
pandem
northeastern
peopl
around
world
one
almost
exclus
affect
peopl
younger
discov
anoth
odditi
explain
first
virtual
ident
strain
peopl
born
immun
younger
peopl
earth
steadi
genet
sinc
continu
mutat
frozen
lab
often
found
sensit
temperatur
someth
use
vaccin
promin
virologist
peter
wrote
virologist
former
member
academi
told
introduct
viru
inde
thought
due
vaccin
challeng
sever
thousand
militari
live
viru
first
time
scienc
pandem
tri
prepar
second
time
whether
deal
pandem
scientif
govern
obstruct
keep
us
know
sure
whether
viru
came
wild
directli
lab
wuhan
genet
experiment
involv
know
alreadi
research
histori
lab
around
world
provid
plenti
proceed
caution
class
troubl
safeti
success
new
alway
translat
coronaviru
anim
human
without
involv
research
groundwork
potenti
disast
laid
learn
essenti
outbreak
consid
fairli
benign
caus
minor
moder
even
five
southern
china
govern
cover
threat
diseas
spread
summer
peopl
kill
abl
suppress
infect
peopl
spread
visibl
sick
make
easier
identifi
isol
peopl
close
call
roughli
percent
case
fatal
rate
rais
next
coronaviru
pandem
scientif
shi
virologist
wuhan
institut
virolog
horsesho
bat
like
primari
host
anim
bat
field
studi
often
assum
spread
palm
ador
small
mammal
sometim
sold
wildlif
though
suspect
bat
directli
infect
human
lung
without
need
intermediari
anim
shi
lab
sometim
work
bat
bat
bat
sinc
rais
natur
continu
mutat
random
remov
genom
genet
code
recombin
constant
trial
error
emerg
allow
infect
new
order
anticip
tri
steer
process
sometim
research
genet
manipul
see
becom
articl
natur
medicin
two
major
coronaviru
world
shi
ralph
baric
professor
univers
north
chapel
hill
wrote
coronaviru
work
carri
baric
laboratori
took
spike
protein
key
use
unlock
infect
horsesho
bat
viru
combin
human
viru
mice
chimer
viru
infect
human
suggest
bat
capabl
without
mutat
adapt
second
time
sinc
shi
bat
coronaviru
abil
lab
directli
infect
human
airway
kind
genet
manipul
alreadi
rais
especi
unit
flu
genet
materi
influenza
viru
deadli
gener
yet
spread
among
peopl
new
spread
air
among
humanlik
uproar
defens
coronaviru
experi
shi
peter
whose
organ
allianc
work
close
million
last
decad
us
govern
would
allow
focu
risk
would
move
viru
candid
pathogen
clear
present
danger
worri
viru
nobodi
predict
trajectori
virologist
pasteur
institut
histori
provid
plenti
reason
everi
case
sinc
origin
epidem
due
lab
six
three
twice
singl
month
lab
one
instanc
mother
lab
worker
diseas
devast
livestock
massiv
crisi
drainag
pipe
leak
lab
highest
rate
last
known
person
smallpox
someon
infect
lab
incid
first
survey
work
danger
diseas
control
prevent
across
six
often
categori
safeti
reserv
tuberculosi
instanc
exposur
lab
benign
flu
viru
sampl
deadli
discov
danger
later
june
mistakenli
sent
improperli
anthrax
bacteria
potenti
least
work
without
protect
gear
one
month
later
live
smallpox
viru
found
storag
room
nation
string
unit
new
research
moratorium
seriou
scientif
safeti
would
soon
public
list
run
intern
societi
infecti
unexplain
pneumonia
wuhan
china
connect
first
citi
market
scientist
post
genom
viru
soon
open
depositori
confirm
coronaviru
govern
viru
spread
among
three
day
later
complet
wuhan
citi
million
week
paper
lancet
medic
journal
bat
like
sourc
viru
note
outbreak
local
bat
hibern
season
bat
sold
found
market
reason
intermediari
occur
far
sourc
outbreak
thousand
horsesho
bat
mask
palm
across
china
often
cramp
unsanitari
make
prone
vehicl
probabl
use
travel
sinc
first
market
live
wild
sold
wildlif
trade
immedi
media
china
among
first
skeptic
spread
diseas
bat
happen
start
wuhan
home
wuhan
institut
virolog
one
top
bat
coronaviru
research
world
wuhan
diseas
control
prevent
bat
research
hundr
market
promin
open
letter
lancet
decri
conspiraci
suggest
natur
origin
consid
origin
question
much
whether
gotten
lab
happen
whether
gotten
would
handl
wuhan
lock
appar
relat
viru
awar
shi
natur
found
viru
whose
genom
sequenc
percent
ident
previous
horsesho
bat
comb
genom
found
exact
match
bat
coronaviru
cave
unexplain
outbreak
pneumonia
among
collect
bat
guano
mine
three
six
former
scienc
teacher
twitter
pseudonym
found
master
thesi
well
thesi
fu
current
director
center
diseas
control
prevent
master
thesi
ill
direct
transmiss
coronaviru
horsesho
bat
thesi
cautiou
still
outbreak
notabl
reveal
team
wuhan
institut
virolog
collect
bat
cave
dissert
note
four
test
blood
crucial
name
chang
link
previou
fatal
outbreak
possibl
coronaviru
origin
paper
interview
march
shi
fungu
pathogen
shi
confirm
inde
paper
natur
final
addit
uncov
team
genet
possibl
bat
coronaviru
link
miner
still
acknowledg
less
forthcom
disclosur
viru
two
connect
deadli
outbreak
shift
inconsist
whether
subject
manipul
creat
distant
cousin
mean
unlik
produc
offspr
either
recent
evolut
wild
manipul
role
outbreak
rais
shi
exampl
group
link
mine
uncov
genom
wuhan
institut
virolog
inform
bat
least
recent
discov
bat
went
offici
explan
taken
subject
hack
explain
never
secur
way
respons
independ
made
harder
rule
worri
lab
accid
viru
collect
wild
experi
lab
taken
would
less
evid
help
connect
possibl
lab
prematur
clear
howev
asymptomat
one
transmiss
chain
viru
circul
quietli
event
secreci
led
frantic
exampl
viru
lab
littl
sens
sinc
one
thing
usual
involv
lethal
known
cure
vaccin
protect
employ
much
mundan
shi
scientif
work
depend
bat
work
associ
endeavor
paper
shi
live
bat
coronaviru
sampl
bind
human
lung
cell
show
intermedi
necessari
direct
human
infect
controversi
experi
group
includ
baric
shi
carri
found
anoth
bat
coronaviru
suspect
infect
difficult
cultiv
chimer
one
spike
infect
human
airway
shi
lab
peopl
live
within
two
bat
found
six
test
posit
bat
coronaviru
past
infect
six
seen
bat
peopl
total
see
bat
fli
close
suggest
exposur
great
risk
research
howev
alway
incorpor
articl
note
caution
wuhan
institut
virolog
hood
wear
later
year
stori
shi
handl
bat
bat
fece
bare
expos
arm
person
team
bat
bite
jab
needl
post
later
remov
shi
job
danger
everyon
thought
chanc
directli
small
wrote
ordinari
protect
taken
unless
bat
known
carri
viru
infect
repeat
someth
similar
ted
video
accord
post
simpler
protect
unmask
surgic
mask
bare
appropri
bat
usual
intermedi
shi
research
institut
done
strict
accord
lab
test
annual
wuhan
reportedli
research
staff
reput
adventur
scientif
discoveri
paper
team
caught
bat
provinc
post
video
bat
studi
viru
previous
made
field
forget
person
protect
equip
splash
bat
urin
accident
get
bat
blood
skin
accord
post
yet
world
health
organ
agenc
ever
work
bat
lab
march
wuhan
lab
new
locat
near
market
report
move
given
govern
lack
candor
lab
bat
around
near
market
time
research
intern
bat
field
research
unit
told
alway
respir
bat
standard
practic
wild
idea
suggest
field
research
set
outbreak
wang
virologist
base
frequent
work
shi
hypothesi
bat
behind
epidem
told
natur
small
chanc
pandem
seed
research
inadvert
get
infect
unknown
viru
bat
creat
risk
sale
wildlif
urban
peter
organ
lancet
letter
natur
member
investig
committe
last
fall
conspiraci
theori
suggest
live
bat
scienc
work
wrote
tweet
later
collect
bat
send
lab
releas
bat
catch
evid
contrari
assist
research
told
report
shi
took
role
feed
bat
away
anoth
news
report
team
led
one
doctor
collect
full
rack
bag
dozen
live
bat
test
back
lab
academi
list
wuhan
institut
least
dozen
bat
institut
appli
patent
bat
cage
shi
bat
time
would
done
cave
recent
anoth
video
surfac
reportedli
live
bat
ago
mani
virolog
tri
set
bat
coloni
meanwhil
intermediari
anim
yet
found
despit
test
around
wuhan
last
month
former
commission
food
drug
administr
failur
ad
evid
lab
leak
although
look
wildlif
southern
transmiss
intermediari
anim
necessari
sinc
interact
bat
villag
field
widespread
bat
need
intermediari
anim
spread
research
even
settl
whether
palm
civet
spread
bat
know
palm
outbreak
market
transmiss
possibl
howev
widespread
infect
civet
found
urban
sometim
peopl
wild
know
infect
last
year
kill
million
caught
peopl
possibl
initi
intermediari
anim
cute
littl
risk
lab
lot
specul
result
genet
engin
hypothesi
base
genom
analysi
alon
suspicion
grown
opaqu
respons
share
direct
lab
shi
stanc
group
coauthor
baric
transpar
definit
accept
report
respons
group
request
see
lab
throughout
wuhan
suspect
viru
loos
local
govern
least
one
health
care
worker
communist
parti
continu
promin
scientist
travel
wuhan
rais
circumstanti
evid
doubt
claim
instanc
viru
made
suspect
evid
viru
natur
lot
attent
drawn
unusu
featur
spike
protein
cleavag
site
viru
better
infect
human
cell
one
sever
odd
weird
enough
even
greatli
doubt
lab
involv
told
see
fact
even
beyond
cleavag
site
viru
never
seen
evolut
random
accumul
weird
novel
research
shi
scientif
combin
would
incongru
work
usual
examin
one
element
viru
time
find
element
made
comput
instanc
see
wrong
simultan
power
sourc
cabl
electr
outlet
test
one
individu
varieti
unusu
paper
even
put
asid
direct
engin
regular
lab
work
wuhan
rais
wuhan
institut
live
bat
coronaviru
infect
human
lab
level
dentist
offic
protect
gear
lab
usual
option
level
often
control
seal
ventil
work
area
rest
build
lin
associ
professor
told
actual
scandal
print
viru
capabl
human
work
low
safeti
tri
cultur
bat
lab
creat
even
awar
tri
fail
cultiv
one
strain
inadvert
cultur
anoth
one
even
know
even
possibl
lin
told
coexist
singl
sampl
quietli
recombin
give
rise
someth
novel
undetect
even
sloppi
get
expos
pathogen
know
lancet
letter
consider
anyth
natur
sinc
open
lab
involv
one
emeritu
virologist
univers
four
honorari
lean
toward
believ
lab
accid
convinc
viru
brought
lab
work
told
wall
street
journal
sloppi
individu
brought
ad
admit
someth
stupid
colorado
state
univers
anoth
signatori
recent
told
news
much
coincid
ignor
theori
like
came
lab
peter
virologist
wrote
flu
pandem
lot
disturb
inform
surfac
sinc
lancet
letter
investig
come
director
center
infect
immun
univers
coauthor
influenti
articl
natur
medicin
favor
natur
origin
march
skeptic
peopl
look
bat
told
scienc
report
g
last
month
view
medic
lab
help
clarifi
last
shi
possibl
exist
anyon
associ
institut
gotten
infect
sampl
handl
bat
ad
recent
test
institut
staff
show
past
infect
found
zero
infect
rule
possibl
hard
see
care
scientist
dismiss
even
possibl
zero
infect
would
mean
singl
case
among
peopl
institut
even
though
studi
found
percent
wuhan
popul
team
inform
wuhan
detail
patient
data
someth
standard
outbreak
origin
investig
leav
lot
open
lot
due
zoonot
reason
doubt
lab
involv
mayb
look
human
histori
better
period
comparison
time
sinc
molecular
biolog
like
caus
pandem
tie
research
two
sinc
swine
flu
rare
event
pandem
one
consid
potenti
investig
plane
crash
fli
usual
safe
crash
happen
say
mechan
pilot
usual
lead
terror
rare
rather
investig
possibl
unusu
figur
prevent
similar
biggest
question
read
locat
outbreak
thousand
known
viral
yet
close
lead
research
curios
around
locat
wave
away
explan
set
howev
wuhan
institut
virolog
sinc
research
agricultur
environment
microbiolog
differ
name
focu
coronaviru
research
wuhan
metropoli
popul
new
york
citi
rural
outpost
near
bat
shi
outbreak
never
kind
thing
happen
wuhan
central
china
lab
popul
lower
likelihood
bat
coronaviru
exposur
use
wuhan
much
lower
likelihood
contact
bat
due
urban
set
still
locat
proof
either
plausibl
research
rule
week
bloom
associ
professor
cancer
research
center
told
set
partial
earli
wuhan
genet
remov
genom
archiv
substanti
evid
wuhan
prior
market
outbreak
earli
recent
investig
winter
found
mani
earli
connect
market
acknowledg
case
far
market
origin
locat
plausibl
outbreak
someplac
els
wuhan
simpli
big
citi
test
blood
across
china
especi
near
wildlif
bat
would
help
limit
govern
carri
research
much
evid
withheld
hard
say
anyth
certainti
even
genuin
investig
would
face
never
even
still
learn
biggest
one
due
bat
coronaviru
outbreak
one
way
anoth
research
show
bat
abil
jump
warn
govern
need
weigh
work
bat
field
lab
especi
sinc
public
health
much
prevent
pandem
effect
institut
rigor
surveil
threaten
known
thrive
better
prepar
react
quickli
transpar
first
sign
outbreak
research
weight
toward
respons
rather
predict
overlap
ident
find
danger
viru
cave
dish
use
bit
poke
bear
tri
research
bat
done
care
bat
studi
research
done
caution
bat
seriou
threat
human
bat
occur
strict
regul
young
investig
report
long
cover
lab
wrote
feder
govern
danger
compar
found
research
lab
even
alway
impos
analysi
research
inadvert
spark
research
still
worth
move
outsid
dens
china
vital
lab
safeti
outbreak
surveil
argu
china
respons
pandem
scientif
led
imperil
hard
see
angri
make
intransig
alreadi
understand
wari
demon
especi
given
racism
would
state
benefit
lab
accid
anthrax
bacteria
soviet
union
lead
western
accept
soviet
govern
turn
help
lead
better
safeti
would
benefit
authoritarian
better
path
forward
one
true
global
base
mutual
benefit
reciproc
despit
current
assum
govern
want
go
especi
given
public
interest
person
despit
power
research
govern
need
look
big
pictur
seek
comiti
truth
instead
embarrass
develop
framework
goe
beyond
blame
china
sinc
rais
truli
global
realiz
next
big
thing
simpli
mean
take
great
care
lot
small
coronaviru
arriv
unit
first
infect
confirm
resid
state
recent
return
wuhan
china
soon
viru
countri
studi
new
evid
base
analysi
blood
seven
peopl
five
infect
well
first
confirm
suggest
viru
exampl
earli
although
first
case
state
confirm
month
new
studi
flaw
adequ
address
possibl
caus
common
quirk
use
addit
travel
inform
explain
test
interest
paper
idea
everyon
true
go
undiagnos
immunologist
univers
small
number
test
posit
made
difficult
sure
true
infect
methodolog
error
hard
know
real
signal
accur
howev
underscor
notion
poor
test
unit
earli
pandem
without
test
see
go
epidemiologist
school
public
health
lead
author
studi
lot
infect
go
surpris
undocu
earli
pandem
evolutionari
biologist
univers
alreadi
knew
case
excess
mortal
recent
model
roughli
march
given
horribl
state
test
never
doubt
miss
earli
transmiss
studi
journal
clinic
infecti
blood
peopl
found
nine
peopl
donat
blood
march
last
year
came
blood
donat
date
first
diagnosi
consist
anoth
studi
coronaviru
blood
donat
earli
enrol
nation
health
project
us
includ
million
peopl
unit
order
increas
represent
research
half
peopl
studi
pandem
viru
would
infect
peopl
low
preval
odd
antibodi
test
mistakenli
sampl
fals
tri
minim
possibl
two
antibodi
sequenc
first
test
possibl
coronaviru
second
slash
number
team
blood
cold
flu
season
found
none
test
posit
coronaviru
still
possibl
fals
josh
chief
execut
us
fact
would
fals
pretti
unlik
done
contact
ask
travel
histori
would
continu
analyz
addit
estim
coronaviru
exact
month
probabl
came
us
still
unknown
essenti
puzzl
right
studi
one
piec
puzzl
wide
use
coronaviru
design
nearli
everyon
receiv
vaccin
even
encourag
inocul
peopl
first
shot
one
vaccin
second
shot
differ
one
govern
reveal
chancellor
receiv
two
differ
grow
interest
tri
approach
necess
particular
vaccin
ran
short
caution
rais
safeti
shot
peopl
alreadi
receiv
first
us
far
reluct
encourag
health
interest
possibl
give
differ
person
signific
common
rais
call
heterolog
new
idea
experi
fight
hand
long
give
peopl
two
slightli
differ
gener
immun
respons
perhap
stimul
slightli
differ
immun
system
teach
recogn
differ
pathogen
argument
one
one
three
virologist
medicin
well
argument
practic
covid
area
go
need
actual
data
addit
potenti
immunolog
match
flexibl
vaccin
uneven
limit
immunologist
univers
clinic
current
underway
determin
whether
univers
test
differ
pfizerbiontech
trial
us
nation
health
recent
trial
mix
booster
test
combin
sputnik
v
vaccin
shot
sputnik
somewhat
base
approach
first
second
differ
still
earli
promis
preliminari
last
month
instanc
team
peopl
receiv
dose
vaccin
dose
pfizer
vaccin
robust
immun
regimen
elicit
immun
respons
two
vaccin
whether
better
two
pfizer
vaccin
yet
data
studi
match
increas
odd
mild
moder
side
effect
fever
fatigu
data
suggest
regimen
wrote
although
possibl
side
effect
sign
strong
immun
respons
side
effect
fade
within
say
expect
data
show
approach
safe
learn
never
say
never
realli
hard
ration
new
risk
associ
realli
basic
tri
test
immunolog
approach
immunologist
imperi
colleg
varieti
degre
match
vaccin
earli
day
vaccin
number
canada
peopl
receiv
one
dose
vaccin
link
rare
blood
disord
receiv
differ
vaccin
second
shot
respons
shot
south
last
week
health
care
receiv
first
dose
vaccin
receiv
pfizer
shot
second
vaccin
advisori
panel
pfizer
use
us
food
drug
administr
conserv
agenc
peopl
got
one
dose
either
pfizer
vaccin
receiv
second
dose
except
origin
vaccin
avail
imagin
allow
kind
strategi
without
properli
clinic
trial
data
fierc
protect
medic
privaci
even
spokesman
vaccin
part
set
abnorm
bleed
mani
suspend
use
shot
march
use
later
review
union
drug
got
shot
mani
peopl
deepli
skeptic
vaccin
campaign
first
vaccin
chancellor
possibl
abl
encourag
mani
peopl
get
told
vaccin
commiss
anyon
receiv
first
shot
follow
either
pfizer
relax
advic
month
got
vaccin
day
ago
perhap
reliev
peopl
get
one
clear
shot
consider
nation
pride
work
german
saw
problem
curiou
expert
advic
receiv
presid
would
done
stage
pandem
us
extrem
cautiou
million
leap
mostli
normal
summer
hold
back
afraid
get
surg
pandem
mani
say
fear
ventur
back
normal
lifesom
peopl
still
public
transport
away
end
remot
work
keep
home
concern
safeti
percent
fourth
return
learn
white
polic
nearli
percent
rise
pandem
mani
older
peopl
say
earli
pandem
former
presid
trump
frequent
use
racist
languag
countri
ahead
mani
tri
find
way
feel
comfort
much
possibl
public
wear
mask
act
shield
attract
unwant
attent
larg
like
lieu
still
riski
take
young
daughter
son
game
whenev
go
follow
new
rule
social
six
stop
spread
arm
length
keep
get
afraid
lieu
safe
jeff
polit
partner
leadership
organ
still
anxiou
get
back
plane
sinc
day
march
woman
intern
airport
spit
go
back
came
feel
helpless
never
felt
someth
shake
made
feel
cancer
someth
radioact
cycl
pandem
seem
viru
full
retreat
us
stock
readi
read
live
still
live
notabl
new
plagu
year
time
covid
wright
staff
writer
new
yorker
panoram
histori
pandem
review
book
us
realli
govern
disast
premonit
pandem
stori
lewi
account
mostli
botch
respons
new
republ
crisi
moment
case
studi
polici
imagin
life
line
young
come
age
pandem
colleagu
emma
six
young
graduat
earli
medic
school
surg
new
york
citi
last
spring
time
excerpt
grief
expand
book
new
yorker
essay
father
death
earli
pandem
review
us
gather
dispar
navig
pandem
shot
arm
brown
graphic
novel
histori
germ
theori
got
vaccin
vaccin
go
counti
statelet
us
know
deal
pandem
send
us
respons
featur
upcom
get
brief
morn
us
feder
health
paus
use
johnson
johnson
vaccin
six
blood
one
second
critic
two
ad
list
seventh
woman
receiv
vaccin
author
man
receiv
clinic
eight
blood
million
peopl
unit
receiv
vaccin
without
seriou
advers
yet
determin
extent
vaccin
respons
investig
vaccin
made
caus
similar
extrem
rare
public
health
peopl
covid
far
outweigh
sever
last
week
restrict
use
vaccin
older
rare
blood
disord
younger
peopl
chose
use
agenc
decid
renew
johnson
johnson
vaccin
author
unit
number
small
inde
risk
blood
vaccin
yet
determin
risk
extrem
low
risk
get
unit
far
far
overal
risk
one
case
per
million
higher
safeti
expert
risk
age
rang
least
three
time
rate
would
normal
figur
rough
peopl
receiv
johnson
johnson
vaccin
within
past
three
contact
experi
sever
abdomin
pain
leg
pain
short
breath
see
peopl
particularli
young
ask
recent
receiv
covid
vaccin
administr
chief
scienc
advis
news
brief
concern
mild
first
day
vaccin
common
harmless
side
effect
brought
immun
system
product
defens
peopl
receiv
vaccin
month
two
ago
issu
rais
mean
anyth
six
within
pretti
tight
window
six
day
peopl
receiv
shot
clinic
go
wide
use
keep
track
medic
experienc
peopl
receiv
unusu
larg
cluster
turn
decid
paus
trial
stop
use
vaccin
investig
common
typic
reveal
medic
matter
coincid
investig
vaccin
pose
risk
write
new
guidanc
receiv
paus
time
advis
recogn
treat
instanc
food
drug
administr
diseas
control
prevent
paus
alreadi
advic
among
temporarili
stop
use
vaccin
health
news
confer
feder
govern
review
would
like
take
matter
day
advisori
panel
extend
paus
make
recommend
vaccin
least
week
gather
inform
unit
receiv
johnson
johnson
vaccin
one
man
receiv
clinic
trial
rare
disord
blood
within
two
vaccin
seven
eight
condit
cerebr
venou
sinu
thrombosi
form
drain
blood
brain
similar
disord
say
intens
reaction
vaccin
immun
system
activ
blood
compon
form
normal
repair
wound
addit
abnorm
bleed
disord
immun
thrombot
thrombocytopenia
peter
unusu
combin
bleed
set
red
flag
possibl
safeti
far
found
way
predict
develop
disord
underli
condit
indic
identifi
common
underli
trait
help
determin
risk
enabl
establish
peopl
receiv
j
j
blood
clot
gelatin
blob
blood
block
circul
form
respons
mani
cancer
genet
certain
sit
bed
rest
covid
trigger
seriou
form
sometim
break
travel
rare
brain
unit
peopl
year
develop
blood
leg
bodi
accord
data
blood
occur
us
popul
everi
day
sever
million
peopl
day
get
occur
coincid
unrel
roughli
one
peopl
affect
blood
clot
vein
everi
disord
concern
vaccin
much
differ
typic
blood
addit
brain
cerebr
venou
sinu
thrombosi
short
notabl
low
level
left
prone
abnorm
johnson
johnson
compani
awar
extrem
rare
disord
peopl
blood
combin
low
small
number
receiv
vaccin
addit
health
compani
statement
made
decis
delay
vaccin
news
confer
similar
johnson
johnson
use
carri
human
begin
process
gener
immun
coronaviru
yet
known
whether
technolog
vaccin
set
immun
reaction
peopl
condit
rare
say
like
individu
biolog
trait
yet
unknown
immun
month
investig
similar
cerebr
venou
thrombosi
link
low
disord
rare
side
effect
vaccin
earli
yet
know
johnson
johnson
vaccin
respons
type
rare
blood
vaccin
seek
medic
assist
number
possibl
swell
leg
persist
abdomin
pain
sever
persist
blur
vision
tini
blood
skin
beyond
area
inject
set
vagu
almost
immedi
emerg
experienc
surg
worri
fit
german
say
vaccin
must
blood
detect
tri
stop
growth
intraven
immun
globulin
help
elimin
misguid
caus
us
feder
health
advis
common
blood
thinner
heparin
choos
altern
instead
reason
disord
close
rare
syndrom
heparin
possibl
heparin
make
wors
caus
tremend
harm
treatment
begin
soon
possibl
condit
worsen
know
yet
seven
eight
among
peopl
got
j
j
vaccin
involv
howev
number
small
imposs
draw
firm
whether
use
risk
factor
us
health
know
vaccin
initi
greater
risk
blood
associ
vaccin
although
involv
men
receiv
closer
investig
turn
get
vaccin
overal
among
health
care
men
say
evid
say
whether
men
like
affect
blood
found
similar
peopl
receiv
pfizerbiontech
platelet
howev
small
receiv
pfizerbiontech
one
recipi
physician
brain
hemorrhag
platelet
us
health
yet
indic
link
last
colleagu
smith
coronaviru
time
explain
viru
situat
us
newslett
past
talk
nation
outlook
commonli
use
terribl
lousi
aw
rang
today
tone
differ
nation
pictur
uniformli
good
right
countri
per
day
sinc
test
wide
avail
continu
declin
rapidli
fall
differ
declin
recent
declin
lot
declin
everywher
larg
percentag
peopl
feel
extrem
hope
moment
although
someth
short
home
free
see
troubl
case
data
begin
bubbl
look
map
today
see
small
reason
concern
realli
small
cours
case
tell
whole
stori
pandem
worri
lag
vaccin
south
warn
lead
covid
surg
summer
howev
surg
grave
last
summer
say
mani
peopl
big
mysteri
direct
wrote
today
morn
newslett
delta
variant
first
doubl
last
month
day
experi
soon
rise
us
increas
remind
progress
pandem
even
extrem
progress
equal
ultim
victori
mani
estim
coronaviru
last
least
year
one
sure
colleagu
carl
know
stack
protect
earli
encourag
draw
blood
vaccin
measur
immun
target
coronaviru
drop
gradual
possibl
slow
rate
declin
vaccin
protect
remain
strong
long
time
peopl
previous
infect
receiv
vaccin
enjoy
even
durabl
covid
last
longer
alreadi
found
differ
vari
effect
includ
pfizerbiontech
base
made
china
prove
somewhat
less
know
lose
effect
search
biolog
reveal
protect
vaccin
longer
enough
hold
back
coronaviru
possibl
certain
level
threshold
blood
level
good
shape
greater
risk
emerg
recent
acceler
research
lead
spread
carri
blunt
effect
author
point
still
smatter
work
differ
august
new
york
citi
central
park
celebr
two
lift
viru
across
us
pandem
begin
love
send
first
life
look
someth
life
someth
particip
send
us
photograph
brief
descript
event
felt
brief
pleas
includ
name
live
use
photo
submiss
upcom
vaccin
go
counti
statelet
us
know
deal
pandem
send
us
respons
featur
upcom
get
brief
promis
return
normal
within
reach
percent
get
least
one
dose
covid
vaccin
one
month
deadlin
close
us
reach
presid
goal
close
quit
new
york
time
analysi
current
rate
vaccin
nation
ultim
fall
short
object
roughli
percent
partli
vaccin
rate
daunt
task
peopl
becom
pool
will
shrink
nudg
nation
toward
target
presid
yesterday
laid
aggress
campaign
super
bowl
free
percent
popul
independ
day
would
phenomen
progress
begin
year
vaccin
move
glacial
pace
yesterday
percent
receiv
least
one
promis
nation
figur
worri
issu
uneven
vaccin
rate
among
alreadi
percent
mark
probabl
reach
nation
target
exampl
show
rate
unlik
reach
much
higher
percent
earli
mani
deep
south
mountain
west
limit
access
shot
hesit
fallen
far
behind
unlik
reach
percent
spring
hide
local
exampl
less
percent
peopl
receiv
first
lag
hope
continu
vaccin
peopl
warn
take
make
conveni
persuad
fallen
behind
get
colleagu
soon
retir
time
scienc
desk
one
last
wrote
renown
transplant
surgeon
contract
covid
last
march
continu
perform
surgeri
even
new
york
citi
make
way
flood
would
die
get
got
sick
marathon
runner
initi
worri
quickli
put
ventil
sepsi
save
wait
list
surgic
clung
would
soon
abl
save
transplant
surgeon
watch
oper
past
magician
instead
cancer
entir
organ
affect
part
rest
back
place
team
remov
six
girl
abdomin
cancer
august
stay
hospit
oper
experi
ordeal
someth
metaphor
past
year
almost
capsul
whole
pandem
whole
sieg
get
idea
realli
aw
diseas
least
good
end
see
vaccin
go
counti
statelet
us
know
deal
pandem
send
us
respons
featur
upcom
get
brief
sudden
sharp
rise
coronaviru
mani
amount
continent
third
wave
world
health
organ
portent
troubl
contin
whose
immun
vaccin
arm
unit
test
posit
risen
last
seven
day
eight
surg
percent
new
steadili
climb
south
four
nine
third
wave
sharp
increas
covid
rise
loos
complianc
social
increas
travel
along
arriv
winter
season
southern
believ
spread
new
coronaviru
first
south
surg
rise
less
percent
global
coronaviru
contin
percent
total
almost
certainli
sever
sinc
vast
major
contin
never
formal
regist
threat
third
wave
real
rise
region
director
statement
crucial
get
arm
high
risk
fall
serious
ill
die
mani
vigor
vaccin
track
fulli
reopen
mani
face
huge
challeng
continent
popul
billion
peopl
million
receiv
least
one
dose
seven
million
fulli
one
biggest
million
peopl
receiv
two
run
first
global
facil
work
ensur
equit
distribut
hesit
afflict
rare
blood
inocul
capac
democrat
republ
donat
million
rise
overwhelm
alreadi
creaki
health
care
struggl
limit
intens
care
oxygen
forestal
crisi
signific
vaccin
coverag
releas
keep
vulner
critic
care
news
health
social
media
sound
alarm
anoth
variant
coronaviru
time
delta
much
contagi
perhap
lethal
variant
seen
far
easi
understand
new
viru
continu
emerg
rise
mani
whether
new
pose
uniqu
substanti
risk
still
unknown
concern
misunderstand
risk
pose
caus
confus
coronaviru
spread
global
genom
viru
affect
viru
fit
abil
reproduc
spread
weaken
viru
measur
effect
make
viru
becom
fit
less
fit
delta
first
variant
beat
certain
alpha
variant
first
domin
gamma
variant
first
domin
brazil
uniqu
coronaviru
viral
fit
everi
flu
season
flu
circul
wide
variant
anoth
necessarili
mean
infecti
deadli
peopl
becom
infect
true
past
year
half
human
behavior
far
import
shape
cours
pandem
mani
way
viru
mutat
increas
fit
much
focu
viru
spike
allow
coronaviru
invad
viru
sustain
allow
viru
replic
easili
evad
immun
system
exampl
even
allow
viru
persist
longer
nasal
impact
given
mutat
substanti
laboratori
research
sometim
earli
particular
mutat
incorrect
first
variant
note
last
winter
viru
spike
protein
made
viru
contagi
subsequ
research
case
even
time
new
chang
spike
protein
mani
presum
variant
virul
concern
whether
variant
biolog
transmiss
sever
ill
rigor
variant
transmiss
base
larg
widespread
variant
variant
contagi
higher
proport
new
delta
common
variant
account
percent
new
percent
new
unit
us
agre
suffici
declar
variant
transmiss
contagi
clear
delta
fitter
domin
variant
determin
transmiss
abil
viru
one
person
anoth
measur
infect
requir
peopl
uneth
peopl
contribut
rise
travel
failur
mask
adher
physic
import
right
insuffici
vaccin
often
consid
public
discuss
huge
infect
necessarili
particular
variant
larg
part
contain
crowd
poor
public
health
peopl
infect
coronaviru
highli
like
infect
variant
area
right
mani
import
understand
peopl
infect
necessarili
develop
sever
diseas
die
frequent
coronaviru
essenti
get
coronaviru
effect
sever
diseas
death
delta
alway
prevent
make
substanti
impact
reduc
viru
spread
risk
seriou
health
peopl
unvaccin
great
risk
infect
harm
variant
pandem
time
peopl
want
immedi
question
mutat
mean
provid
correct
requir
research
littl
evid
viru
endless
trajectori
transmiss
virul
today
still
end
made
pfizerbiontech
set
persist
immun
reaction
bodi
protect
coronaviru
add
grow
evid
peopl
need
long
viru
evolv
much
beyond
current
peopl
need
even
viru
make
signific
transform
good
sign
durabl
immun
vaccin
immunologist
univers
st
led
studi
journal
studi
consid
coronaviru
vaccin
made
johnson
johnson
immun
respons
less
durabl
produc
last
month
peopl
immun
recogn
viru
lie
quiescent
bone
marrow
least
eight
infect
studi
anoth
team
memori
b
continu
matur
strengthen
least
year
immun
last
possibl
lifetim
peopl
infect
coronaviru
later
unclear
whether
vaccin
alon
similarli
team
sought
address
question
look
sourc
memori
lymph
immun
train
recogn
fight
infect
vaccin
special
structur
germin
center
lymph
structur
elit
school
b
boot
camp
becom
increasingli
sophist
learn
recogn
divers
set
viral
genet
rang
longer
practic
like
abl
thwart
viru
emerg
everyon
alway
viru
show
b
thing
pepper
immunologist
univers
go
protect
ongo
evolut
viru
realli
encourag
infect
coronaviru
germin
center
vaccin
educ
place
lymph
within
reach
peopl
eight
histori
infect
viru
two
pfizerbiontech
vaccin
peopl
team
extract
lymph
three
four
five
seven
first
painstak
work
heroic
studi
immunologist
yale
kind
care
analysi
difficult
team
found
first
dose
vaccin
germin
center
still
highli
activ
number
memori
coronaviru
declin
fact
continu
almost
four
vaccin
good
sign
germin
typic
peak
one
two
immun
wane
usual
four
six
much
left
immunologist
univers
germin
still
go
lot
declin
peopl
note
know
persist
germin
base
anim
research
new
studi
first
show
peopl
suggest
vast
major
peopl
long
term
least
coronaviru
older
peopl
weak
immun
take
suppress
immun
need
peopl
later
never
need
long
protect
last
hard
predict
absenc
immun
theori
immun
last
lifetim
viru
clearli
anyth
would
actual
requir
booster
would
base
wane
immun
see
happen
peopl
infect
coronaviru
see
major
boost
antibodi
like
memori
b
produc
mani
evolv
good
news
booster
vaccin
probabl
effect
prior
infect
peopl
give
anoth
chanc
engag
massiv
respons
memori
b
immun
system
vaccin
probabl
better
actual
infect
repertoir
memori
b
produc
vaccin
divers
infect
suggest
protect
better
natur
immun
persist
immun
reaction
alon
oppos
made
tradit
johnson
johnson
unfair
comparison
johnson
johnson
vaccin
given
singl
dose
j
j
booster
mayb
induc
kind
respons
q
almost
immedi
coronaviru
coop
end
mask
requir
common
fulli
gym
new
say
peopl
fulli
must
still
wear
mask
anyon
possibl
know
coop
requir
show
vaccin
statu
board
ask
board
interview
approv
live
build
coronaviru
mani
mask
fulli
peopl
fulli
must
still
wear
build
good
posit
polic
base
honor
system
dan
presid
residenti
new
york
properti
manag
busi
keep
medic
let
say
build
decid
doorman
ask
proof
vaccin
coop
actual
refus
answer
question
lie
doorman
stop
go
apart
think
peopl
want
put
doorman
posit
smith
real
estat
lawyer
partner
offic
law
firm
smith
bar
theoret
board
ask
board
interview
avoid
question
say
follow
guidanc
physician
instead
make
safe
feel
step
lobbi
gym
without
mask
unlik
whether
feel
safe
enough
go
equinox
get
subway
certain
person
next
feel
confid
surround
wear
loosen
continu
requir
wear
common
one
space
remain
close
forese
futur
though
playroom
still
elig
vaccin
unlik
reopen
near
outbreak
delta
variant
spread
rapidli
strict
greater
surround
nation
first
sinc
earli
sudden
rise
concern
among
state
new
south
contact
target
isol
would
enough
keep
contagi
variant
initi
resist
full
strict
necessari
found
sever
addit
transmiss
around
citi
among
peopl
infecti
state
premier
viru
simpli
move
quickli
popul
past
day
cluster
airport
limousin
driver
citi
five
million
nearli
come
day
want
impos
unless
absolut
told
news
confer
unfortun
shorter
would
enough
regain
control
transmiss
delta
variant
spread
far
faster
coronaviru
unless
stay
step
ahead
viru
easili
get
control
peopl
across
metropolitan
area
leav
exercis
seek
medic
attent
care
buy
food
carri
essenti
end
one
mani
throughout
region
continu
struggl
coronaviru
mainli
new
slow
short
suppli
outsid
unit
extra
feder
govern
demand
complac
peopl
remain
unvaccin
nationwid
quarter
receiv
even
one
dose
accord
new
york
time
particular
concern
hair
salon
saw
least
infecti
wholesal
deliveri
driver
test
posit
sever
day
transport
fish
across
everi
coronaviru
infect
unit
nearli
five
asymptomat
went
undetect
accord
new
studi
nation
studi
previou
scope
contagion
much
widespread
earli
vast
gap
viru
test
mani
countri
disproportion
high
infect
rate
among
black
peopl
mani
million
unit
far
three
million
public
health
base
yearlong
studi
blood
collect
peopl
mostli
earli
studi
scienc
translat
medicin
found
percent
carri
suggest
infect
coronaviru
point
studi
potenti
million
undiagnos
addit
million
unit
data
last
summer
diseas
control
prevent
similarli
detail
vast
new
studi
account
quickli
viru
spread
countri
globe
j
director
nation
institut
statement
institut
one
sever
whose
lead
effort
studi
transmiss
viru
would
help
public
health
assess
futur
protect
peopl
coronaviru
transmiss
would
provid
clariti
vaccin
time
studi
weight
race
black
highest
rate
coronaviru
blood
percent
five
time
rate
white
percent
found
rate
higher
studi
rang
age
wide
gap
known
time
asymptomat
retrospect
understand
pandem
futur
pandem
prepared
top
offici
senior
coauthor
studi
third
dose
vaccin
univers
strong
immun
respons
clinic
trial
find
vaccin
option
third
end
exampl
extend
immun
date
vaccin
given
two
typic
four
new
data
detail
preprint
manuscript
yet
peer
came
studi
among
receiv
clinic
trial
last
year
past
march
given
third
dose
roughli
analys
third
dose
viru
point
higher
seen
month
second
dose
encourag
sign
third
shot
would
like
bring
greater
protect
effect
two
wane
time
posit
boost
turn
necessari
prof
pollard
research
led
vaccin
news
confer
think
encourag
data
preprint
show
use
would
effect
immun
respons
yet
know
whether
booster
hope
protect
lead
last
least
year
yet
evid
know
coronaviru
acceler
need
booster
third
necessari
come
avail
sever
limit
especi
enough
suppli
give
first
vulner
month
nation
health
begun
new
clinic
trial
peopl
fulli
three
author
unit
goal
test
whether
booster
shot
vaccin
made
increas
viru
initi
later
vaccin
author
sinc
last
use
unit
alreadi
enough
three
author
meet
demand
shot
backbon
struggl
program
provid
poor
account
percent
ship
middl
last
first
separ
studi
new
version
vaccin
design
protect
beta
variant
viru
first
seen
south
studi
origin
version
vaccin
effect
variant
professor
pollard
studi
would
compar
effect
third
dose
origin
vaccin
new
return
nation
end
week
wave
brought
highest
death
toll
pandem
loom
seri
sent
migrant
capit
citi
scrambl
get
reminisc
neighbor
migrant
exodu
last
garment
industri
million
peopl
percent
countri
remain
open
instruct
limit
minimum
almost
public
transport
either
alreadi
expect
larg
confin
first
day
govern
hard
though
strictli
remain
seen
govern
armi
polic
border
guard
strict
spread
viru
sporad
reduc
movement
tri
keep
much
economi
open
wave
bare
percent
popul
forc
take
drastic
countri
highest
daili
toll
sinc
pandem
test
posit
rate
percent
offici
total
nearli
viru
though
believ
true
much
current
gradual
govern
stop
long
distanc
last
week
seven
surround
aim
avert
surg
shop
close
limit
full
initi
last
one
week
transport
except
govern
instruct
garment
factori
arrang
transport
previou
public
transport
shut
slow
spread
viru
factori
arrang
transport
accus
order
walk
twice
day
get
latest
ferri
peopl
tri
cross
river
southern
embattl
health
minist
resign
day
tabloid
newspap
steami
embrac
one
senior
appar
violat
respons
coronaviru
pandem
latest
member
prime
minist
johnson
govern
accus
strict
rest
countri
understand
enorm
everybodi
countri
made
made
video
statement
even
us
make
got
stick
got
resign
initi
step
back
johnson
least
one
conserv
member
parliament
demand
resign
full
doubl
polit
elit
posit
becom
letter
prime
minist
wrote
last
thing
would
want
privat
life
distract
attent
focu
lead
us
crisi
marri
famili
three
johnson
former
chancellor
exchequ
replac
swift
fall
grace
ambiti
cabinet
minist
becom
familiar
figur
long
pandem
fixtur
street
news
often
public
abid
tri
curb
spread
end
failur
live
undid
sun
later
video
surveil
camera
offic
embrac
kiss
friend
colleg
day
still
indoor
social
peopl
differ
peopl
stay
two
apart
avoid
contact
sinc
acknowledg
sorri
let
peopl
street
initi
prime
minist
accept
apolog
consid
matter
scandal
becom
someth
lightn
rod
controversi
two
ago
former
chief
advis
johnson
post
text
prime
minist
johnson
hopeless
pin
much
blame
chaotic
handl
pandem
say
set
compet
program
spread
viru
move
elderli
peopl
nurs
flatli
came
fire
year
ago
drive
visit
north
countri
step
anoth
six
johnson
labour
parti
tri
make
polit
issu
johnson
govern
act
faster
latest
episod
right
resign
labour
leader
twitter
johnson
sack
one
marri
nonexecut
director
health
depart
previous
work
fashion
retail
husband
placement
surveil
camera
offic
done
clandestin
catch
minist
privat
news
broke
polit
surviv
furor
work
johnson
messi
privat
life
recent
marri
third
letter
resign
johnson
build
network
field
handl
flood
covid
drug
mitig
effect
covid
protect
gear
task
deal
challeng
greater
face
johnson
wrote
fight
covid
risen
challeng
everi
coronaviru
infect
unit
nearli
five
asymptomat
went
undetect
accord
new
studi
nation
studi
previou
scope
contagion
much
widespread
earli
vast
gap
viru
test
mani
countri
disproportion
high
infect
rate
among
black
peopl
mani
million
unit
far
three
million
public
health
base
yearlong
studi
blood
collect
peopl
mostli
earli
studi
scienc
translat
medicin
found
percent
carri
suggest
infect
coronaviru
point
studi
potenti
million
undiagnos
addit
million
unit
data
last
summer
diseas
control
prevent
similarli
detail
vast
new
studi
account
quickli
viru
spread
countri
globe
j
director
nation
institut
statement
institut
one
sever
whose
lead
effort
studi
transmiss
viru
would
help
public
health
assess
futur
protect
peopl
coronaviru
transmiss
would
provid
clariti
vaccin
time
studi
weight
race
black
highest
rate
coronaviru
blood
percent
five
time
rate
white
percent
found
rate
higher
studi
rang
age
wide
gap
known
time
asymptomat
retrospect
understand
pandem
futur
pandem
prepared
top
offici
senior
coauthor
studi
mount
base
camp
acclimat
extrem
altitud
head
summit
world
highest
peak
fell
ill
cough
quickli
expedit
compani
hire
help
princ
climb
hospit
capit
test
posit
spent
week
hospit
six
day
home
back
base
camp
experienc
commun
short
suppli
pandem
expedit
compani
stood
lose
princ
climb
bodi
still
fight
viru
like
first
person
stand
pinnacl
led
princ
dawn
end
climb
season
earli
month
least
infect
peopl
mountain
five
top
accord
expedit
person
social
media
former
presid
associ
issu
research
accord
govern
never
tourism
call
one
pneumonia
patient
ad
noth
new
dri
mountain
tourism
depart
posit
even
peopl
mountain
rare
event
great
expens
effort
made
train
travel
tri
summit
climber
ness
climber
wrote
social
media
last
day
today
test
hope
leav
hospit
soon
ness
wrote
post
photo
mask
hospit
one
world
struggl
dire
coronaviru
outbreak
shortag
access
climb
season
underway
even
govern
wealthi
less
percent
popul
fulli
strong
play
covid
situat
close
pandem
billion
climb
tarnish
imag
tourist
destin
invit
whose
demand
climb
year
climb
season
expedit
rampant
crowd
base
camp
drew
record
foreign
year
true
number
far
higher
sinc
expedit
hide
govern
made
prepar
avoid
mountain
test
mask
medic
personnel
base
camp
readi
swoop
pick
infect
often
bring
medic
personnel
antigen
test
regularli
isol
anyon
test
test
neg
start
trek
base
camp
like
infect
mountain
though
possibl
initi
compel
expedit
proceed
even
first
coronaviru
base
camp
last
week
first
week
laid
percent
govern
receiv
million
support
staff
rope
soon
fix
place
food
cook
ga
makeshift
citi
color
stay
day
adjust
altitud
wait
window
clear
weather
make
expedit
new
york
time
least
three
four
peopl
expedit
group
eventu
infect
stay
base
expedit
send
back
attempt
summit
talli
far
higher
time
compani
expedit
end
climber
three
base
camp
capit
written
tourism
depart
govern
extend
two
singh
director
gener
tourism
depart
inform
appeal
expedit
sent
offic
extend
climb
extend
climb
basi
covid
whether
base
camp
contract
isol
pup
higher
intern
mountain
team
fell
sick
foreign
scale
almost
half
abandon
either
cyclon
simper
climber
new
peak
accord
wife
anna
keel
mountain
guid
know
covid
mountain
simper
learn
infect
test
posit
day
later
expedit
compani
hotel
day
wife
still
ness
climber
bout
social
media
base
camp
hospit
advis
return
mountain
flew
home
expedit
taken
three
plan
cost
plu
hospit
expect
get
money
test
posit
base
camp
train
four
climb
world
highest
suffer
decid
proceed
top
covid
must
care
came
mind
covid
would
difficult
breath
altitud
mountain
beauti
flower
kill
must
come
admir
go
complet
helpless
whatev
mountain
fate
mount
base
camp
acclimat
extrem
altitud
head
summit
world
highest
peak
fell
ill
cough
quickli
expedit
compani
hire
help
princ
climb
hospit
capit
test
posit
spent
week
hospit
six
day
home
back
base
camp
experienc
commun
short
suppli
pandem
expedit
compani
stood
lose
princ
climb
bodi
still
fight
viru
like
first
person
stand
pinnacl
led
princ
dawn
end
climb
season
earli
month
least
infect
peopl
mountain
five
top
accord
expedit
person
social
media
former
presid
associ
issu
research
accord
govern
never
tourism
call
one
pneumonia
patient
ad
noth
new
dri
mountain
tourism
depart
posit
even
peopl
mountain
rare
event
great
expens
effort
made
train
travel
tri
summit
climber
ness
climber
wrote
social
media
last
day
today
test
hope
leav
hospit
soon
ness
wrote
post
photo
mask
hospit
one
world
struggl
dire
coronaviru
outbreak
shortag
access
climb
season
underway
even
govern
wealthi
less
percent
popul
fulli
strong
play
covid
situat
close
pandem
billion
climb
tarnish
imag
tourist
destin
invit
whose
demand
climb
year
climb
season
expedit
rampant
crowd
base
camp
drew
record
foreign
year
true
number
far
higher
sinc
expedit
hide
govern
made
prepar
avoid
mountain
test
mask
medic
personnel
base
camp
readi
swoop
pick
infect
often
bring
medic
personnel
antigen
test
regularli
isol
anyon
test
test
neg
start
trek
base
camp
like
infect
mountain
though
possibl
initi
compel
expedit
proceed
even
first
coronaviru
base
camp
last
week
first
week
laid
percent
govern
receiv
million
support
staff
rope
soon
fix
place
food
cook
ga
makeshift
citi
color
stay
day
adjust
altitud
wait
window
clear
weather
make
expedit
new
york
time
least
three
four
peopl
expedit
group
eventu
infect
stay
base
expedit
send
back
attempt
summit
talli
far
higher
time
compani
expedit
end
climber
three
base
camp
capit
written
tourism
depart
govern
extend
two
singh
director
gener
tourism
depart
inform
appeal
expedit
sent
offic
extend
climb
extend
climb
basi
covid
whether
base
camp
contract
isol
pup
higher
intern
mountain
team
fell
sick
foreign
scale
almost
half
abandon
either
cyclon
simper
climber
new
peak
accord
wife
anna
keel
mountain
guid
know
covid
mountain
simper
learn
infect
test
posit
day
later
expedit
compani
hotel
day
wife
still
ness
climber
bout
social
media
base
camp
hospit
advis
return
mountain
flew
home
expedit
taken
three
plan
cost
plu
hospit
expect
get
money
test
posit
base
camp
train
four
climb
world
highest
suffer
decid
proceed
top
covid
must
care
came
mind
covid
would
difficult
breath
altitud
mountain
beauti
flower
kill
must
come
admir
go
complet
helpless
whatev
mountain
fate
mani
south
vaccin
rate
lag
significantli
behind
nation
averag
particularli
among
older
trend
public
health
percent
older
still
percent
nation
accord
new
york
time
percent
state
popul
fulli
percent
one
latest
resort
dangl
financi
get
arm
strategi
debat
effect
wisdom
monetari
hold
lotteri
feder
coronaviru
relief
lotteri
unveil
last
week
jazz
band
state
song
sunshin
governor
bel
reveal
giant
check
amid
money
would
go
adult
receiv
least
one
dose
vaccin
state
would
give
away
total
million
cash
month
registr
lotteri
shot
million
week
program
see
well
work
quit
frankli
success
vaccin
rate
share
popul
lower
everi
state
six
bottom
eight
south
includ
administr
made
concert
push
overcom
vaccin
hesit
particularli
south
week
first
ladi
encourag
peopl
get
presid
mobil
vaccin
site
north
mike
five
peopl
would
win
million
last
state
would
focu
smaller
gift
select
expand
outreach
access
want
peopl
way
accomplish
way
make
sure
return
normalci
abl
safe
gather
mark
director
univers
michigan
center
insur
design
interview
compel
case
open
peopl
fulli
peopl
need
reach
get
independ
polit
affili
shown
like
buy
lotteri
physician
studi
consum
health
care
behavior
three
earli
determin
effect
make
vaccin
avail
skew
vaccin
without
realli
want
see
michigan
versu
north
first
lotteri
draw
part
similar
vaccin
push
everi
week
give
away
million
scholarship
adult
get
new
howev
pace
slip
sinc
brown
million
giveaway
spokesman
brown
night
shot
inocul
less
peopl
reach
target
least
percent
receiv
least
one
take
shot
campaign
part
strategi
includ
smaller
vaccin
lift
vaccin
rate
individu
strategi
singularli
massiv
impact
wholli
revers
vaccin
rate
strategi
littl
energi
overal
effort
mountain
west
one
unit
along
south
lag
far
behind
nation
vaccin
percent
peopl
receiv
least
one
dose
far
among
bottom
five
nation
accord
new
york
time
montana
bit
better
remain
well
nation
averag
percent
none
five
track
meet
presid
goal
least
partli
percent
white
hous
acknowledg
week
presid
expect
nation
whole
meet
region
say
spars
brand
polit
conservat
common
among
rural
stori
countri
unvaccin
mountain
west
divid
larg
two
say
kind
absolut
definit
montana
state
medic
offic
rampant
misinform
difficult
chang
logist
difficulti
provid
conveni
access
small
wide
scatter
beneath
exampl
nativ
montana
initi
hesit
white
rural
less
counti
eastern
montana
health
counti
scene
lengthi
standoff
antigovern
militia
montana
day
life
philosophi
pretti
much
govern
intervent
way
medic
director
counti
health
center
critic
access
facil
nurs
percent
elig
counti
fulli
rate
montana
accord
state
center
nurs
home
accus
employe
old
peopl
facil
receiv
littl
support
local
counti
health
depart
administ
vaccin
peopl
show
get
difficult
peopl
unless
make
trip
surround
counti
get
home
church
church
leadership
voic
strong
support
vaccin
even
recent
survey
found
half
mormon
hesit
unwil
get
factor
among
mormon
state
one
nation
highest
infecti
specialist
univers
hospit
salt
lake
citi
lot
fertil
whether
affect
menstruat
current
evid
impact
lower
immun
gener
accord
district
director
southeastern
public
health
mani
peopl
told
busi
fit
eight
dot
sever
hit
pandem
hard
peopl
person
affect
highli
get
vaccin
one
counti
fulli
half
older
accord
time
say
mani
peopl
state
rural
simpli
see
walker
chief
execut
bee
critic
access
hospit
rural
health
health
care
tri
win
appeal
sens
tri
realli
push
get
sick
regardless
whether
flu
covid
laid
bed
day
wors
go
happen
take
care
hour
two
away
medic
facil
got
famili
go
take
care
ranch
oftentim
get
peopl
secretari
state
j
speak
interview
meet
presid
macron
unit
page
determin
resist
possibl
world
order
would
profoundli
illiber
natur
first
visit
secretari
live
nine
youth
high
school
purpos
contain
china
tri
hold
china
back
come
free
open
intern
order
stand
altern
either
order
world
chao
inevit
conflict
almost
inevit
us
domin
challeng
deliv
peopl
hope
peopl
around
world
order
reinforc
model
recent
intern
rise
found
presid
macron
think
exactli
way
need
bring
practic
pleasur
back
evid
meet
day
foreign
minist
secretari
dear
toni
welcom
home
oh
ye
sacr
home
age
experi
berlin
unit
better
friend
world
would
say
thing
turn
allianc
emot
evid
come
someth
pretti
basic
know
throw
lot
kind
say
rote
best
work
actual
give
mean
liberti
equal
fratern
tri
give
mean
freedom
speech
tri
give
mean
human
tri
give
mean
democraci
continu
ultim
obvious
cultur
histori
mani
come
basic
set
closer
deepli
felt
person
call
unit
renew
bond
stand
togeth
time
coronaviru
pandem
rise
china
present
imper
work
togeth
converg
littl
surpris
macron
made
sever
recent
import
strateg
presid
j
trump
tradit
trade
aggress
us
alli
express
relief
presid
turn
foreign
polici
back
familiar
experi
trump
left
ever
follow
macron
conciliatori
unit
toward
china
tabl
arm
control
unit
eve
group
month
macron
unless
map
problem
china
part
geographi
atlant
clear
jab
independ
strategi
tend
play
well
macron
run
next
year
end
larg
wealthi
make
clear
saw
china
russia
repress
aggress
ideolog
say
china
system
relev
militari
secur
china
belt
road
initi
built
across
elsewher
expand
econom
secur
influenc
sign
leav
beholden
often
deepli
administr
attempt
counter
china
strategi
build
back
better
world
program
made
clear
interview
better
option
low
offer
someth
posit
affirm
china
offer
posit
affirm
well
think
contrast
clear
china
alway
attach
use
coerciv
tool
west
contrast
one
billion
vaccin
end
pandem
polit
six
nuclear
agreement
reviv
nuclear
deal
trump
abandon
progress
nuclear
program
becom
insurmount
obstacl
continu
spin
sophist
higher
higher
get
point
difficult
practic
matter
return
origin
nuclear
deal
put
date
day
administr
walk
away
nuclear
get
closer
news
confer
day
seriou
persist
nuclear
program
nuclear
capabl
remain
nation
meet
next
week
new
foreign
minist
yair
one
aim
tri
rebuild
littl
bit
trust
confid
point
exist
actual
move
forward
last
peac
administr
strongli
trump
administr
four
recent
war
well
west
bank
ad
know
think
seen
evid
substitut
deal
issu
protect
presid
vice
presid
elect
year
amid
pandem
heavi
burden
secret
servic
nearli
test
posit
coronaviru
watchdog
group
group
respons
ethic
former
presid
j
trump
hold
larg
campaign
secret
servic
data
feder
govern
part
public
request
freedom
inform
act
march
march
year
accord
group
data
includ
infect
govern
disclos
percentag
total
number
secret
servic
contract
viru
test
posit
includ
special
uniform
divis
staff
work
administr
profession
technic
accord
group
secret
servic
main
feder
law
enforc
agenc
protect
us
polit
presid
throughout
pandem
vice
presid
trump
penc
public
health
trump
famili
made
repeat
make
million
year
group
post
group
blame
former
presid
ride
vehicl
secret
servic
protect
treatment
coronaviru
infect
last
danger
trump
immedi
respond
request
comment
night
spokeswoman
secret
servic
statement
agenc
distribut
protect
gear
robust
program
ad
agenc
mission
signific
public
interact
public
health
crisi
fulli
prepar
staf
success
meet
last
secret
servic
divis
experienc
coronaviru
outbreak
accord
sever
peopl
matter
time
outbreak
least
fourth
strike
agenc
sinc
pandem
least
uniform
secret
servic
test
posit
viru
sever
agenc
go
final
trump
presid
viru
west
wing
sever
top
test
posit
hope
advis
white
hous
press
secretari
two
chad
trump
wear
sicker
last
white
hous
publicli
acknowledg
time
accord
sever
peopl
familiar
condit
time
blood
oxygen
fear
verg
presid
knock
talk
get
white
hous
blitz
persuad
peopl
around
countri
get
speech
north
came
govern
shift
strategi
mass
vaccin
effort
top
local
eye
toward
younger
access
reluct
get
among
import
crowd
green
road
commun
center
white
hous
sent
big
road
recent
well
first
ladi
vaccin
travel
least
five
week
travel
schedul
point
husband
last
weekend
predominantli
neighborhood
vice
presid
kamala
husband
barbershop
week
learn
turn
away
messag
clear
avail
benefici
mobil
vaccin
mani
extend
take
advantag
free
vaccin
flurri
travel
sens
urgenc
pace
slow
white
hous
countri
like
fall
short
goal
partial
percent
warn
rise
danger
delta
variant
contagi
version
coronaviru
first
week
variant
percent
new
know
go
well
variant
know
go
happen
got
get
young
peopl
talk
knock
north
mani
administr
face
percent
state
partial
percent
receiv
least
one
shot
accord
state
depart
health
human
white
hous
help
convinc
age
come
wisdom
certainli
seen
vaccin
unit
medic
director
vaccin
univers
north
chapel
speed
would
need
treat
outreach
polit
campaign
tall
order
front
us
think
walk
walk
think
say
impervi
viru
get
sick
rio
professor
medicin
infecti
diseas
expert
univers
administr
stick
rather
top
govern
think
good
messeng
rio
want
govern
tell
get
vaccin
want
doctor
want
fireman
goe
church
need
rio
work
commun
instrument
get
know
one
way
address
vaccin
hesit
individu
recommend
vaccin
offer
vaccin
come
use
speech
acknowledg
distrust
black
commun
coronaviru
past
year
track
rise
social
media
infam
studi
health
men
infect
syphili
treat
note
peopl
color
receiv
half
roughli
six
million
feder
run
mass
vaccin
close
racial
gap
save
push
run
reluct
among
mani
cite
varieti
religi
distrust
focu
young
accord
report
diseas
control
prevent
younger
well
black
peopl
lower
less
educ
health
insur
vaccin
express
least
interest
get
report
made
clear
would
need
help
listen
commun
center
faith
gener
first
ladi
vaccin
site
line
park
lot
mobil
clinic
health
care
wait
see
easi
driver
receiv
jab
vaccin
keep
drink
sex
lousi
secret
rise
senior
new
buffet
adolesc
want
know
equal
say
health
care
although
mother
strongli
vaccin
father
angrili
sue
mother
shot
keep
secret
father
mother
plausibl
vaccin
crucial
broad
immun
coronaviru
normal
school
work
though
covid
author
young
mani
worri
side
effect
frighten
new
get
thema
recent
poll
kaiser
famili
foundat
found
three
intend
allow
immedi
mani
say
wait
safeti
data
prod
school
mandat
mani
eager
get
see
unlock
pandem
crackl
hold
hard
requir
parent
consent
vaccin
age
carv
homeless
covid
crisi
seek
relax
medic
consent
permit
obtain
vaccin
sexual
fall
district
council
allow
young
get
without
parent
consent
new
jersey
new
york
pend
would
allow
young
consent
one
would
permit
young
consent
covid
opposit
direct
although
south
consent
perform
certain
medic
necessari
without
parent
permiss
even
younger
bill
legislatur
would
explicitli
bar
give
covid
shot
without
parent
consent
age
medic
consent
linn
counti
order
obtain
parent
consent
covid
shot
anyon
accord
nation
confer
state
work
legisl
prevent
public
covid
issu
consent
covid
provid
fresh
context
legal
ethic
medic
disagre
arbit
age
capabl
make
health
determin
get
want
wear
mask
mother
beach
last
name
withheld
famili
privaci
shot
effect
daughter
reproduct
system
mispercept
public
health
repeatedli
bodi
well
bodi
legal
famili
unfold
vaccin
medic
tri
determin
proceed
young
teen
covid
shot
without
parent
legal
gray
zone
vaccin
sterl
famili
physician
health
system
parent
send
consent
form
covid
vaccin
author
emerg
use
health
system
parent
present
patient
get
palm
beach
counti
fulli
long
shot
mother
absolut
subject
open
marina
social
life
five
throw
parti
go
pandem
teen
social
base
vaccin
statu
see
post
social
media
woohoo
got
see
ask
travel
lot
sure
covid
get
shot
marina
search
way
without
consent
found
way
vaccin
inform
site
run
kelli
site
state
consent
link
straightforward
inform
advic
engag
someon
ask
need
abl
consent
vaccin
clinic
open
bu
rout
help
begin
freshman
year
site
two
ago
well
covid
daughter
pediatr
neurosurgeon
intellectu
properti
lawyer
know
neither
vaccin
schedul
automat
talk
teen
issu
decid
help
help
understand
vaccin
consent
want
abl
say
hey
right
ad
health
depart
middl
name
surreptiti
got
vaccin
school
board
school
inform
would
offer
covid
mother
gave
permiss
father
forbad
upset
school
nurs
without
approv
state
learn
old
enough
consent
anyway
worst
figur
school
would
turn
took
note
mother
consent
say
noth
stuck
pickl
school
fall
semest
father
begun
administr
issu
afraid
furiou
tell
school
disciplin
stain
record
psychologist
professor
pediatr
univers
school
medicin
point
ironi
adolesc
legal
make
choic
strenuous
public
health
development
even
younger
least
good
weigh
vaccin
say
necessarili
great
mani
young
make
around
contracept
sexual
note
mani
way
complex
fraught
get
vaccin
say
even
wari
jay
lee
famili
physician
chief
medic
offic
share
commun
health
network
orang
counti
say
would
rather
risk
child
covid
get
new
vaccin
valid
lee
point
wait
see
child
sick
good
strategi
covid
flu
senior
clinic
manag
ore
area
provid
larg
health
care
system
girl
covid
vaccin
clinic
school
oppos
vaccin
get
without
know
legal
age
consent
saw
readi
home
abl
return
night
without
extrem
reliev
daughter
beach
mother
grant
permiss
vaccin
shot
gave
stream
lot
older
peopl
famili
risk
catch
covid
possibl
die
want
get
vaccin
around
safe
go
much
risk
either
although
tri
instil
vaccin
confid
well
much
object
recent
h
pediatr
professor
univers
medic
colleg
told
patient
whose
mother
consent
get
covid
vaccin
turn
three
henc
got
birthday
sent
messag
say
birthday
gift
new
york
citi
fulli
tourism
reviv
critic
driver
economi
make
urgent
plea
start
rush
million
feder
aid
citi
tourism
promot
agenc
compani
aggress
campaign
overcom
new
york
imag
origin
epicent
coronaviru
pandem
unit
hope
lure
million
citi
overnight
stay
day
memori
day
labor
intern
travel
still
close
vast
major
domest
higher
spend
foreign
pandem
virtual
citi
boom
tourism
industri
forc
mani
big
shut
welcom
need
creat
urgenc
visit
chief
execut
compani
agenc
northeast
peopl
keen
eager
return
citi
look
sign
right
time
sign
come
form
citi
biggest
advertis
campaign
nation
theme
time
new
york
citi
still
product
start
two
otherwis
gone
elsewher
oversea
consid
spend
time
money
new
york
first
video
ad
quickli
unmask
new
play
new
york
botan
garden
beach
summer
summer
time
tell
whole
world
citi
build
recoveri
us
mayor
bill
de
tourism
across
five
return
fuel
recoveri
even
agenc
attract
increasingli
success
citi
high
million
peak
tourism
industri
employ
one
everi
citi
accord
state
comptrol
compani
anyon
away
visitor
higher
valu
overnight
valu
oversea
tend
stay
longer
spend
money
almost
citi
biggest
foreign
china
brazil
still
unit
year
lead
sourc
intern
canada
unit
kingdom
start
resum
travel
freeli
unit
soon
agenc
start
restart
intern
travel
compani
revis
project
year
slightli
million
previou
estim
million
agenc
rise
million
surpass
million
due
part
demand
elimin
mani
pandem
plung
infect
high
rate
lead
part
campaign
compani
team
pitch
citi
destin
give
away
citi
effort
made
possibl
alloc
pandem
aid
citi
receiv
rescu
plan
act
congress
spring
money
agenc
budget
fund
citi
outlook
citi
hotel
industri
extend
busi
rosi
accord
alison
senior
director
consult
research
firm
forecast
project
new
york
hotel
industri
fulli
recov
even
end
hotel
busi
new
york
mani
especi
hotel
occup
mani
new
york
last
fill
week
group
still
lose
money
averag
room
rate
charg
night
averag
oper
week
end
june
occup
rate
avail
hotel
new
york
percent
percent
compar
week
yet
reopen
promin
near
center
close
hotel
industri
express
optim
recoveri
tourism
citi
busi
fare
much
build
back
south
dan
area
gener
manag
new
york
ad
progress
seen
real
sustain
feel
good
new
york
come
along
one
open
book
percent
pace
sharp
increas
sinc
end
march
demand
remain
high
broadway
provid
addit
boost
everyth
broadway
go
shot
arm
new
york
realli
go
help
sooner
return
sooner
hotel
get
back
gradual
year
question
market
slowli
presid
hotel
council
union
hotel
pandem
devast
industri
union
reason
hope
wait
come
back
return
work
warn
web
site
function
bookshelf
servic
nation
librari
medicin
nation
treasur
island
marco
c
di
c
di
updat
diseas
highli
contagi
infecti
diseas
sever
acut
respiratori
syndrom
coronaviru
catastroph
effect
world
result
million
consequenti
global
health
crisi
sinc
era
influenza
pandem
identifi
etiolog
epidemiolog
clinic
radiolog
latest
avail
treatment
manag
differ
avail
prevent
interprofession
team
improv
care
commun
care
coronaviru
improv
educ
diseas
highli
contagi
infecti
diseas
sever
acut
respiratori
syndrom
coronaviru
catastroph
effect
world
result
million
consequenti
global
health
crisi
sinc
era
influenza
pandem
first
predominantli
respiratori
viral
ill
first
wuhan
provinc
china
late
rapidli
across
world
short
span
time
compel
world
health
organ
declar
global
pandem
march
sinc
declar
global
pandem
mani
overwhelm
mani
pandem
loss
due
rippl
effect
global
economi
even
though
substanti
progress
clinic
research
led
better
understand
manag
limit
spread
viru
becom
issu
increas
concern
wreak
havoc
across
world
mani
endur
second
third
wave
viral
ill
mainli
due
emerg
mutant
viru
new
human
prone
genet
evolut
develop
time
result
differ
ancestr
sever
cours
pandem
among
consid
concern
given
impact
public
health
lineag
variant
first
unit
kingdom
late
subsequ
lineag
south
third
brazil
earli
recent
lineag
despit
unpreced
speed
vaccin
develop
prevent
robust
global
mass
vaccin
emerg
new
overturn
signific
progress
made
far
limit
transmiss
review
articl
comprehens
describ
etiolog
epidemiolog
clinic
diagnost
latest
novel
therapeut
manag
review
briefli
overview
differ
efficaci
differ
avail
prevent
appear
electron
microscop
term
crown
due
presenc
spike
envelop
subfamili
famili
order
four
genera
genu
divid
five
genom
character
shown
bat
probabl
gene
contrari
avian
speci
seem
repres
gene
becom
major
respiratori
diseas
larg
famili
caus
respiratori
enter
hepat
neurolog
differ
anim
speci
cattl
bat
yet
cross
speci
caus
ill
rang
common
cold
sever
date
seven
human
capabl
new
millennium
gener
suggest
popul
healthi
respons
acut
respiratori
novel
belong
subgenu
sever
acut
respiratori
syndrom
coronaviru
middl
east
respiratori
syndrom
coronaviru
previous
mortal
respect
round
ellipt
often
pleomorph
form
diamet
approxim
sensit
ultraviolet
heat
regard
although
high
temperatur
replic
speci
viru
current
inactiv
temperatur
must
well
viru
c
convers
resist
lower
even
effect
ether
ethanol
disinfect
acid
chloroform
except
character
new
isol
atyp
pneumonia
visit
wuhan
nucleotid
ident
bat
human
henc
intern
committe
taxonomi
genom
amino
although
origin
current
unknown
wide
anim
zoonot
transmiss
genom
analys
suggest
probabl
strain
found
bat
genom
comparison
human
sequenc
known
anim
inde
reveal
high
homolog
bat
similar
advanc
bat
intermedi
recent
report
possibl
inconclus
clearli
specifi
origin
viru
howev
report
circul
earli
report
sever
possibl
hypothes
origin
viru
includ
origin
viru
anim
transmiss
viru
intermedi
host
subsequ
passag
prone
genet
evolut
result
multipl
differ
ancestr
period
genom
viral
fundament
import
especi
global
pandem
set
detect
new
genet
notabl
genet
evolut
minim
initi
emerg
global
domin
variant
associ
transmiss
without
abil
caus
sever
ill
anoth
variant
transmiss
infect
mink
associ
transmiss
sinc
multipl
consid
concern
due
potenti
caus
enhanc
transmiss
virul
reduct
neutral
natur
infect
vaccin
abil
evad
detect
decreas
therapeut
vaccin
effect
continu
emerg
multipl
independ
establish
classif
system
distinguish
concern
interest
concern
interest
defin
specif
genet
associ
caus
enhanc
transmiss
virul
reduct
neutral
natur
infect
vaccin
abil
evad
detect
decreas
effect
therapeut
vaccin
epidemiolog
updat
seven
interest
name
alia
alia
three
world
health
organ
emerg
viral
seriou
public
health
risk
past
two
sever
sever
acut
respiratori
syndrom
coronaviru
influenza
middl
east
respiratori
syndrom
coronaviru
signific
impact
global
health
sinc
declar
global
pandem
viru
respons
spread
million
million
global
us
experienc
highest
number
relat
fact
third
lead
caus
death
us
heart
diseas
cancer
approxim
death
epidemiolog
updat
lineag
spread
lineag
around
world
current
estim
global
case
fatal
rate
howev
case
fatal
rate
affect
includ
age
underli
sever
ill
significantli
impact
medic
risk
infect
sever
diseas
howev
age
underli
medic
obes
cardiovascular
diseas
chronic
kidney
diseas
diabet
chronic
lung
diseas
smoke
cancer
solid
organ
hematopoiet
stem
cell
transplant
risk
sever
infect
percentag
hospit
six
time
higher
medic
without
medic
base
analysi
confirm
notabl
studi
percentag
ill
time
higher
medic
without
medic
data
regard
male
risk
sever
ill
mortal
due
femal
retrospect
cohort
studi
march
mortal
rate
us
acut
care
includ
confirm
infect
higher
mortal
rate
male
femal
racial
ethnic
sever
infect
mortal
relat
differ
ethnic
racial
ethnic
minor
higher
percentag
relat
white
base
recent
analysi
larg
administr
includ
approxim
march
high
percentag
relat
among
racial
ethnic
driven
higher
risk
exposur
risk
sever
diseas
us
note
peopl
black
ethnic
minor
risk
die
infect
relat
death
highest
among
anoth
analysi
risk
among
sexual
minor
underli
medic
increas
risk
sever
preval
sexual
minor
heterosexu
within
gener
popul
within
specif
gener
descript
viral
structur
genom
essenti
pathogenesi
genom
structur
organ
approxim
length
structur
tail
make
among
upon
entri
host
replic
viral
synthesi
transcript
complex
organ
via
synthesi
convers
transcript
termin
transcript
regulatori
open
read
work
product
atyp
genom
least
six
present
among
product
proteas
main
proteas
well
one
two
known
synthesi
modif
nonstructur
besid
encod
structur
spike
membran
envelop
accessori
proteic
differ
possess
uniqu
structur
accessori
pathogenesi
relat
function
structur
exampl
outlin
role
block
host
innat
immun
respons
among
structur
envelop
crucial
role
viru
pathogen
viral
assembl
releas
among
structur
spike
compos
two
compos
viral
surfac
link
host
pathogenesi
phylogenet
similar
compos
four
main
structur
spike
envelop
e
glycoprotein
n
membran
protein
along
nonstructur
accessori
surfac
spike
glycoprotein
crown
outer
surfac
cleavag
amino
n
termin
subunit
incorpor
viru
host
cell
carboxyl
c
termin
subunit
fusion
peptid
domain
cytoplasm
domain
respons
membran
fusion
subunit
divid
domain
domain
viral
entri
host
cell
potenti
target
neutral
respons
fundament
peptid
domain
pathogenesi
infect
bind
site
human
enzym
inhibit
system
previous
increas
risk
hospit
sever
diseas
gain
entri
bind
spike
protein
abundantli
respiratori
epithelium
type
alveolar
epitheli
besid
respiratori
epithelium
express
upper
esophagu
ileum
myocardi
proxim
tubular
kidney
bladder
viral
attach
process
prime
spike
protein
subunit
host
serin
proteas
cell
entri
subsequ
viral
replic
assembl
summari
spike
bind
receptor
spike
protein
amino
acid
site
polybas
site
function
human
enzym
proteas
process
exposur
fusion
therefor
fusion
viral
cell
necessari
passag
viru
enter
respiratori
primarili
consid
viral
respiratori
ill
caus
agent
predominantli
respiratori
system
pathogenesi
induc
pneumonia
best
two
earli
late
phase
earli
phase
viral
replic
result
direct
tissu
damag
late
phase
infect
host
trigger
immun
respons
recruit
recruit
tumor
necrosi
factor
sever
immun
system
storm
releas
high
especi
circul
caus
local
system
inflammatori
respons
vascular
permeabl
subsequ
develop
pulmonari
edema
sever
multipl
result
direct
viral
injuri
perivascular
inflamm
lead
deposit
b
due
bind
viru
c
activ
pathway
activ
vascular
permeabl
enhanc
epitheli
cell
contract
caus
swell
disturb
intercellular
besid
bind
receptor
releas
activ
matur
lung
inflamm
fibrosi
effect
extrapulmonari
organ
respiratori
system
princip
target
affect
major
organ
gastrointestin
tract
cardiovascular
renal
central
nervou
system
organ
dysfunct
gener
possibl
either
one
combin
direct
viral
toxic
ischem
injuri
vascul
thrombosi
immun
system
new
pathogenesi
variat
viral
pathogenesi
especi
viral
entri
host
essenti
target
vaccin
sera
three
mutat
common
affin
spike
protein
ace
viral
attach
subsequ
entri
host
along
domin
neutral
target
antibodi
product
respons
two
recent
preprint
singl
mutat
alon
affin
approxim
ten
time
ancestr
strain
interestingli
bind
affin
variant
variant
much
lower
analysi
lung
tissu
test
posit
typic
diffus
alveolar
damag
addit
frequent
presenc
type
hyperplasia
airway
inflamm
hyalin
alveolar
percent
note
larg
vessel
platelet
posit
fibrin
present
brain
histopatholog
studi
brain
acut
injuri
cerebrum
cerebellum
notabl
enceph
specif
brain
seen
addit
analysi
brain
tissu
show
cytoplasm
viral
stain
heart
analysi
cardiac
tissu
autopsi
test
posit
presenc
viral
genom
within
myocardium
kidney
histopatholog
analysi
kidney
confirm
diffus
proxim
tubular
injuri
loss
brush
border
vacuolar
degener
necrosi
addit
electron
microscopi
tubular
epithelium
tract
endoscop
posit
stain
viral
protein
gastric
duoden
rectal
epithelium
cytoplasm
numer
plasma
interstiti
edema
seen
lamina
stomach
duodenum
rectum
liver
prospect
case
seri
studi
histopatholog
exam
major
deceas
hepat
steatosi
liver
chronic
congest
differ
necrosi
note
nodular
prolifer
clinic
sever
ill
clinic
laboratori
radiograph
hemodynam
organ
function
nation
health
five
distinct
sever
respiratori
failur
worsen
alreadi
respiratori
pictur
diagnosi
set
clinic
ventilatori
criteria
chest
chest
radiograph
scan
lung
bilater
lung
fulli
lobar
lung
collaps
clinic
radiolog
pulmonari
edema
heart
failur
fluid
overload
berlin
definit
three
base
degre
refer
paramet
ratio
avail
ratio
suggest
prospect
observ
studi
mortal
mechan
similar
risk
mortal
sever
extrapulmonari
although
ill
predominantli
respiratori
system
consid
system
viral
ill
given
multipl
organ
dysfunct
associ
detail
clinic
histori
regard
onset
durat
travel
histori
exposur
peopl
infect
underli
medic
drug
histori
treat
typic
clinic
suspici
fever
cough
sore
throat
loss
tast
smell
malais
promptli
test
besid
symptomat
atyp
anyon
known
exposur
test
infect
even
absenc
test
test
laboratori
viral
ill
commonli
pneumonia
radiolog
fundament
role
diagnost
process
manag
includ
chest
lung
chest
tomographi
avail
regard
time
choic
pulmonari
type
consid
base
clinic
chest
tomographi
lung
examin
lung
progress
diseas
focal
interstiti
pattern
white
lung
evid
subpleur
consid
natur
zero
radiat
use
diagnost
modal
patient
set
mechan
ventil
prone
main
summari
cours
ill
possibl
identifi
first
phase
focal
fix
b
phase
numer
increas
b
white
lung
small
subpleur
thicken
evid
posterior
earli
pandem
understand
therapeut
manag
limit
urgenc
mitig
new
viral
ill
experiment
drug
sinc
due
intens
clinic
global
signific
progress
made
led
better
understand
manag
develop
novel
therapeut
vaccin
develop
unpreced
manag
varieti
therapeut
avail
includ
antivir
avail
emerg
use
author
manag
clinic
util
specif
base
sever
ill
certain
risk
clinic
cours
ill
phase
earli
phase
replic
soon
onset
antivir
like
effect
stage
viral
replic
later
phase
ill
driven
state
induc
releas
coagul
system
activ
state
combin
help
combat
state
antivir
summari
latest
potenti
therapeut
author
clinic
use
manag
antibodi
develop
durat
long
immun
unclear
nevertheless
role
therapeut
manag
extens
ongo
clinic
ventil
manag
oxygen
associ
respiratori
insuffici
close
continu
puls
supplement
oxygen
supplement
via
nasal
cannula
mask
must
maintain
oxygen
satur
improv
clinic
oxygen
satur
supplement
oxygen
continu
period
reassess
clinic
improv
worsen
oxygen
satur
nasal
cannula
posit
pressur
ventil
acut
respiratori
failur
respiratori
failur
common
complic
adult
convent
oxygen
therapi
help
address
oxygen
demand
enhanc
respiratori
support
nasal
cannula
posit
pressur
ventil
intub
invas
mechan
ventil
extracorpor
membran
oxygen
nasal
cannula
posit
pressur
ventil
enhanc
respiratori
support
avail
acut
respiratori
failur
instrument
invas
mechan
ventil
care
select
studi
effect
convent
oxygen
therapi
mechan
ventil
use
mechan
ventil
improv
prognosi
convent
oxygen
therapi
use
associ
dispers
air
especi
use
good
interfac
fit
thu
low
risk
nosocomi
transmiss
infect
howev
treatment
associ
greater
risk
use
neg
pressur
ventil
intub
lung
protect
invas
mechan
base
sever
import
impos
public
health
infect
control
prevent
decreas
transmiss
crucial
step
contain
global
pandem
vaccin
prevent
infect
across
world
extraordinari
clinic
pandem
develop
novel
unpreced
speed
contain
viral
ill
vaccin
immun
system
lead
product
vaccin
ongo
multin
pivot
efficaci
trial
age
older
regimen
trial
vaccin
given
day
apart
protect
safeti
profil
similar
viral
base
vaccin
efficaci
trial
use
vaccin
prevent
vaccin
anoth
phase
trial
receiv
two
base
vaccin
given
day
apart
efficaci
ill
safeti
note
besid
transient
local
system
base
vaccin
efficaci
trial
use
vaccin
prevent
vaccin
third
vaccin
vaccin
prevent
receiv
base
placebo
control
phase
trial
singl
dose
vaccin
efficaci
us
data
yet
interim
analysi
ongo
control
trial
clinic
efficaci
symptomat
accept
safeti
profil
vaccin
emerg
use
author
prevent
mani
across
world
yet
receiv
approv
use
us
addit
mani
seven
indigen
russia
china
emerg
use
author
prevent
mani
around
earli
diseas
nonspecif
differenti
diagnosi
includ
possibl
wide
rang
infecti
noninfecti
vascul
respiratori
suspect
rapid
antigen
detect
adopt
common
respiratori
noninfecti
efficaci
avail
prevent
three
novel
vaccin
vaccin
target
spike
protein
main
site
rais
regard
efficaci
new
prognosi
larg
depend
variou
includ
patient
age
sever
ill
present
quickli
treatment
respons
treatment
previous
current
estim
global
case
fatal
rate
howev
case
fatal
rate
affect
age
underli
sever
ill
prospect
cohort
studi
includ
critic
ill
mortal
higher
mortal
note
elderli
diabet
obes
sever
system
viral
ill
base
involv
multipl
major
organ
interprofession
team
includ
public
health
nurs
staff
even
potenti
ill
work
collabor
openli
inform
bring
posit
individu
well
societi
whole
level
covid
corona
replic
rohan
singh
clinic
present
rohan
singh
made
structur
rohan
singh
made
transmiss
cycl
rohan
singh
made
genom
rohan
singh
made
book
distribut
creativ
common
attribut
intern
licens
use
duplic
adapt
distribut
reproduct
medium
format
long
give
appropri
credit
origin
author
sourc
link
provid
creativ
common
licens
made
brows
activ
record
turn
record
back
nation
center
inform
us
nation
librari
medicin
pike
impact
factor
impact
coronaviru
diseas
epidemiolog
clinic
manag
public
health
respons
view
intern
agenc
research
cancer
institut
virolog
medic
colleg
editor
latest
provid
loop
research
reflect
situat
time
research
topic
suggest
research
topic
coronaviru
diseas
pandem
citi
wuhan
china
quickli
spread
variou
mani
posit
popul
second
popul
difficulti
transmiss
sever
acut
respiratori
syndrom
coronaviru
among
popul
multipl
would
highli
necessari
handl
current
outbreak
includ
comput
model
statist
quantit
analys
control
spread
well
rapid
develop
new
treatment
ministri
health
famili
welfar
rais
awar
recent
outbreak
taken
necessari
control
spread
central
state
take
sever
sever
wartim
achiev
goal
moreov
govern
throughout
countri
march
reduc
transmiss
viru
outbreak
inextric
link
economi
nation
dramat
industri
peopl
current
cautiou
engag
busi
affect
acut
respiratori
syndrom
coronaviru
coronaviru
diseas
first
wuhan
citi
china
later
spread
mani
china
world
health
organ
posit
death
toll
far
confirm
infect
declar
public
health
emerg
intern
concern
first
posit
case
state
subsequ
number
drastic
rose
accord
press
releas
council
medic
research
total
suspect
sent
nation
institut
virolog
relat
test
laboratori
among
test
posit
distribut
posit
list
tabl
map
figur
nearli
recent
affect
screen
posit
among
foreign
confirm
respect
date
impos
social
curfew
order
march
day
start
march
extend
owe
increas
number
posit
extend
third
time
current
eight
union
six
union
addit
health
ministri
red
orang
green
infect
report
across
nation
nineteen
respect
complet
contain
commun
transmiss
govern
privat
across
countri
involv
test
per
report
test
till
date
per
thousand
peopl
tabl
current
statu
posit
coronaviru
diseas
figur
distribut
posit
coronaviru
diseas
display
geograph
recent
outbreak
sever
similar
previou
middl
east
respiratori
syndrom
china
respect
coronaviru
respons
affect
respiratori
tract
caus
major
diseas
wherea
far
particular
treatment
avail
treat
current
search
cure
evid
point
similar
human
coronaviru
even
though
new
coronaviru
famili
suggest
immun
viru
easi
rapid
spread
among
human
contact
infect
person
transmiss
two
possibl
viral
load
quantiti
viru
rel
higher
especi
nose
throat
immedi
develop
bind
affin
host
cell
higher
tabul
tabl
provid
tabl
coronaviru
diseas
sever
acut
respiratori
per
offici
govern
make
outbreak
specif
crisi
import
extrem
sever
neighbor
posit
protect
deadli
viru
govern
taken
necessari
strict
health
check
nation
test
whether
peopl
enter
countri
viru
differ
rescu
surveil
wish
return
china
lesson
learn
outbreak
first
lack
clariti
inform
china
global
stand
econom
growth
outbreak
china
catastroph
led
health
care
medic
china
abil
counter
pandem
much
lower
recent
studi
affect
famili
visit
wuhan
market
china
suggest
spread
without
believ
phenomenon
normal
mani
popul
second
popul
difficulti
treat
sever
countri
minim
amount
number
nation
would
catastroph
would
difficult
identifi
infect
come
contact
would
necessit
multipl
handl
outbreak
comput
model
well
statist
quantit
analys
rapidli
develop
new
drug
vast
popul
medic
system
grossli
inadequ
studi
shown
owe
inadequ
medic
care
nearli
million
peopl
die
everi
year
engag
trade
nearbi
china
financi
year
region
trade
nearli
billion
account
total
global
trade
valu
billion
outbreak
transmiss
would
significantli
affect
economi
outbreak
china
profoundli
affect
economi
especi
electron
logist
trade
china
current
close
statement
incom
decreas
owe
assum
impact
economi
high
neg
impact
instanc
number
china
much
higher
travel
season
effect
tourism
industri
declin
yearli
rail
passeng
road
passeng
traffic
respect
moreov
world
economi
ago
world
current
much
interrel
hurt
market
impact
oil
retail
industri
perspect
consum
seem
high
advers
effect
consumpt
suppli
like
affect
turn
would
impact
suppli
demand
variou
necessari
product
clearli
base
due
effect
tourism
retail
lost
around
billion
billion
lost
global
level
estim
impact
point
possibl
spread
fulli
time
rather
ambigu
imprecis
interim
econom
assess
provid
brief
role
china
global
suppli
chain
commod
japan
south
suscept
advers
effect
close
china
declin
car
monthli
declin
china
even
industri
product
affect
far
sever
thu
major
econom
impact
labor
mobil
lack
work
global
suppli
chain
less
consumpt
tourism
less
demand
commod
market
global
level
turn
need
adequ
industri
type
corpor
need
suppli
chain
product
line
economi
via
demand
consum
end
amidst
sever
sustain
economi
impact
intern
monetari
fund
cut
financi
crisi
owe
advers
effect
sever
global
suppli
chain
drop
previous
nevertheless
roughli
china
consider
posit
growth
among
major
easi
way
decreas
infect
avoid
viru
exposur
peopl
avoid
travel
highli
affect
viru
practic
proper
hygien
avoid
consum
food
home
necessari
prevent
wear
mask
regular
hand
wash
direct
contact
infect
practic
ministri
health
famili
welfar
rais
awar
recent
outbreak
taken
necessari
action
control
besid
diseas
alert
polici
surveil
clinic
manag
infect
prevent
control
sampl
collect
transport
discharg
suspect
confirm
travel
china
fever
difficulti
breath
sore
throat
cough
breathless
visit
nearest
hospit
health
checkup
seven
differ
new
order
screen
monitor
china
affect
addit
travel
advisori
request
cessat
travel
affect
anyon
travel
histori
includ
china
sinc
would
control
room
set
govern
director
gener
health
done
travel
advisori
aircraft
inform
addit
travel
advisori
provid
link
known
tradit
form
yoga
naturopathi
homeopathi
powder
promis
effect
dengu
past
outbreak
ministri
press
note
advisori
coronaviru
use
improv
immun
current
accord
prescrib
combin
sever
prophylaxi
infect
collabor
conduct
therapeut
trial
close
use
diagnos
chronic
myeloid
leukemia
melanoma
respect
addit
beta
test
screen
test
posit
platform
need
confirm
confirmatori
neg
requir
test
rapid
found
satisfactori
rapid
test
antibodi
test
later
flow
method
limit
rapid
test
antibodi
rapid
test
diagnost
new
coronaviru
rapid
test
v
antibodi
detect
card
test
vanguard
diagnost
rapid
test
limit
detect
kit
addit
equip
diagnost
step
technolog
aspect
union
health
ministri
mobil
applic
work
android
mobil
applic
user
awar
network
alert
peopl
possibl
enorm
global
health
threat
major
caus
death
advers
socioeconom
effect
continu
therefor
potenti
treatment
need
first
take
necessari
prevent
reduc
viral
transmiss
second
ministri
provid
use
convent
prevent
treatment
increas
immun
help
reduc
sever
viral
infect
elderli
increas
life
expect
recent
report
director
would
undergo
convalesc
plasma
complet
convalesc
plasma
therapi
highli
provid
moder
success
roll
health
month
special
product
govern
establish
research
develop
rapid
diagnost
test
low
cost
addit
serum
institut
vaccin
infect
obtain
appropri
vaccin
highli
screen
red
zone
stop
transmiss
viru
medic
colleg
sampl
kiosk
collect
without
direct
exposur
contact
defens
research
develop
organ
collect
sampl
collect
kiosk
swab
collect
test
diagnost
facil
facil
use
massiv
screen
least
red
zone
without
need
person
protect
equip
broaden
research
shift
toward
test
mass
popul
medic
publicli
avail
studi
data
found
involv
design
studi
acquisit
analysi
interpret
data
draft
manuscript
involv
interpret
data
entir
studi
manuscript
declar
research
absenc
commerci
financi
potenti
conflict
acknowledg
ministri
health
famili
welfar
council
medic
research
publicli
provid
would
use
opportun
thank
manag
provid
necessari
encourag
carri
work
situat
coronaviru
diseas
avail
wee
global
emerg
wuhan
coronaviru
new
york
time
avail
council
medic
research
govern
avail
updat
ministri
health
famili
welfar
avail
novel
home
ministri
health
famili
welfar
goi
avail
bureau
curfew
march
avail
n
coronaviru
full
list
mark
red
avail
smith
global
infecti
diseas
role
risk
percept
commun
manag
soc
abstract
full
text
scholar
coronaviru
diagnost
epidemiolog
transmiss
j
abstract
full
text
scholar
n
r
tan
z
bibi
novel
coronaviru
biggest
global
health
learn
j
ahead
print
abstract
full
text
scholar
v
respiratori
hospit
age
rural
northern
j
infect
abstract
full
text
scholar
aa
shastri
j
respiratori
acut
lower
respiratori
tract
infect
tertiari
care
hospit
western
multiplex
real
time
j
abstract
full
text
scholar
tai
w
l
x
pu
j
character
domain
novel
coronaviru
implic
develop
protein
viral
attach
inhibitor
vaccin
cell
ahead
print
abstract
full
text
scholar
l
f
liang
l
h
hong
z
viral
load
upper
respiratori
infect
n
j
abstract
full
text
scholar
prepared
respons
sever
acut
respiratori
syndrom
outbreak
updat
avail
scholar
coronaviru
diseas
diseas
control
prevent
avail
coronaviru
scare
east
due
daili
avail
epidem
aftermath
china
polit
perspect
nation
press
us
avail
scholar
w
c
mao
j
health
societi
economi
china
case
comparison
studi
j
environ
public
health
abstract
full
text
scholar
b
novel
new
infect
abstract
full
text
scholar
yuan
h
yang
j
famili
cluster
pneumonia
associ
novel
coronaviru
transmiss
studi
famili
cluster
lancet
abstract
full
text
scholar
press
inform
bureau
press
inform
bureau
avail
l
r
ga
k
within
nation
epidemiolog
transit
across
global
burden
diseas
studi
lancet
abstract
full
text
scholar
coronaviru
hit
growth
target
second
case
financi
express
avail
scholar
cheng
e
tan
w
coronaviru
china
overtak
econom
impact
sever
avail
march
child
p
r
l
win
trillion
decathlon
go
gold
avail
scholar
k
j
foster
g
research
perspect
market
econom
psycholog
need
full
text
scholar
c
coronaviru
oil
price
crash
j
full
text
scholar
p
p
coronaviru
mean
global
economi
busi
review
avail
march
scholar
coronaviru
world
economi
risk
econom
outlook
avail
march
intern
monetari
fund
chapter
support
peopl
pandem
fiscal
monitor
intern
monetari
fund
avail
j
v
p
shree
antivir
activ
extract
dengu
viru
evalu
j
ahead
print
abstract
full
text
scholar
advisori
corona
viru
homoeopathi
prevent
corona
viru
use
symptomat
manag
corona
viru
infect
press
inform
bureau
avail
n
wig
n
combin
therapi
amongst
symptomat
coronaviru
diseas
protocol
restrict
public
health
emerg
use
j
abstract
full
text
scholar
p
prophylaxi
lancet
infecti
di
ahead
print
abstract
full
text
scholar
health
c
r
acid
base
avail
mobil
avail
abstract
v
coronaviru
outbreak
tradit
cure
council
modern
econom
time
avail
aa
nucleotid
life
abstract
full
text
scholar
da
silva
convalesc
plasma
possibl
treatment
j
arm
ahead
print
abstract
full
text
scholar
vaccin
develop
therapeut
avail
must
prepar
second
wave
natur
avail
inspir
south
test
built
avail
n
hospit
south
collect
avail
sampl
collect
kiosk
defenc
research
develop
avail
g
peopl
power
slow
coronaviru
natur
abstract
full
text
economi
safeti
doss
rise
impact
front
march
accept
copyright
doss
articl
distribut
creativ
common
attribut
licens
use
distribut
reproduct
permit
provid
origin
author
copyright
owner
origin
public
journal
accord
accept
academ
practic
use
distribut
reproduct
permit
compli
correspond
c
doss
research
topic
viral
concern
emerg
danger
resist
immun
current
prevent
coronaviru
diseas
moreov
concern
transmiss
virul
import
effici
public
health
vaccin
increas
global
respons
must
time
scienc
addit
track
emerg
new
sever
acut
respiratori
syndrom
coronaviru
four
major
global
respons
concern
tabl
involv
scientif
new
determin
whether
lose
efficaci
decid
whether
new
warrant
restor
efficaci
reduc
likelihood
concern
emerg
intern
research
respons
new
gener
relat
world
health
organ
track
viral
ongo
aim
detect
new
quickli
assess
possibl
effect
mani
research
viru
public
global
initi
influenza
data
collabor
track
way
viru
order
help
monitor
respond
pandem
import
increas
collect
viru
evalu
framework
continu
identifi
assess
concern
framework
enhanc
surveil
research
interest
concern
evalu
effect
diagnost
therapeut
assist
global
decis
make
regard
concern
transmiss
revers
case
mani
alpha
variant
concern
viral
increasingli
common
variant
gamma
variant
caus
sever
diseas
even
previous
infect
although
definit
inform
beta
variant
less
easili
convalesc
plasma
infect
previou
serum
prototyp
viru
vaccin
preliminari
evid
base
data
post
vaccin
reduc
efficaci
mild
moder
diseas
addit
respons
mani
delta
continu
emerg
far
good
evid
current
concern
evad
import
vaccin
effect
prevent
sever
diseas
tabl
key
five
select
fact
key
amino
spike
protein
independ
variou
world
converg
incorpor
select
cover
sever
anim
provid
import
inform
clinic
data
continu
determin
whether
lose
efficaci
clinic
data
sought
care
observ
versu
placebo
one
vaccin
versu
anoth
differ
vaccin
differ
vaccin
suppli
deliveri
capac
limit
instead
oper
determin
order
peopl
make
first
vaccin
avail
target
popul
basi
provid
use
inform
efficaci
major
especi
true
undergo
random
larg
enough
allow
assess
hard
end
hospit
sever
random
use
vaccin
deploy
compar
effect
earli
second
second
efficaci
reliabl
assess
overal
perhap
respect
certain
common
random
assign
vaccin
date
locat
built
public
health
becom
elig
vaccin
accord
vaccin
prioriti
randomli
assign
receiv
longer
shorter
gap
receiv
one
vaccin
anoth
strategi
allow
mani
undergo
random
littl
cost
vaccin
program
littl
disturb
vaccin
capac
figur
opposit
extrem
trial
size
known
potenti
prevent
even
exposur
rel
small
prophylaxi
provid
import
vaccin
efficaci
rel
efficaci
differ
observ
attempt
estim
vaccin
effect
prone
bia
nevertheless
sever
popul
care
design
observ
distribut
viral
among
unvaccin
yield
fairli
reliabl
rel
vaccin
efficaci
variou
account
potenti
confound
level
vaccin
correl
rel
preval
across
observ
detect
loss
protect
concern
previous
infect
lack
precis
either
vaccin
uptak
variant
preval
low
high
statist
stabil
provid
adequ
potenti
design
way
least
limit
confound
still
assess
concern
vaccin
efficaci
durabl
vaccin
efficaci
effect
concern
select
sentinel
reduc
select
capac
mani
world
unselect
vaccin
breakthrough
infect
unvaccin
use
assess
influenc
particular
genom
antigen
interest
vaccin
efficaci
use
ie
siev
analys
vaccin
deploy
import
relev
particular
viral
lead
strain
select
formul
reliabl
immun
serv
correl
protect
yet
known
effect
vaccin
surrog
end
prove
reliabl
predict
effect
vaccin
incid
outcom
breakthrough
provid
support
regulatori
action
regard
new
candid
howev
includ
potenti
depend
immun
protect
viral
strain
choic
studi
end
ie
infect
symptomat
infect
sever
diseas
although
reluct
deploy
base
new
clear
evid
origin
fail
reluct
allow
circul
new
time
plan
develop
protect
well
emerg
includ
effect
vaccin
modif
vaccin
suppli
ie
new
antigen
vaccin
alreadi
shown
effect
previous
viral
address
abil
elicit
previous
immunolog
respons
previous
neutral
impli
wane
effect
although
reliabl
predict
vaccin
efficaci
strike
well
provid
suffici
support
regulatori
exampl
magnitud
immun
respons
one
concern
person
receiv
vaccin
prototyp
viru
person
receiv
origin
vaccin
known
effect
assess
sever
concern
prototyp
viru
help
determin
whether
one
vaccin
ultim
polyval
vaccin
consensu
recent
regulatori
guidanc
convent
larg
clinic
probabl
necessari
order
introduc
concern
among
immun
complic
direct
food
drug
administr
agenc
anim
use
provid
support
effect
deploy
safe
effect
address
intern
pandem
new
effect
previou
viral
singl
dose
avoid
design
complet
new
leverag
intern
regard
antigen
new
still
yield
reliabl
interpret
effici
manner
random
effect
immunolog
clinic
end
placebo
ethic
perhap
vaccin
suppli
limit
young
even
infect
probabl
progress
seriou
diseas
requir
addit
practic
prevent
unidentifi
trial
confound
studi
viral
breakthrough
infect
support
multipl
analys
assess
influenc
viral
vaccin
efficaci
unbias
inform
efficaci
particip
assess
vaccin
efficaci
local
preval
viral
receiv
prioriti
access
trial
shown
accept
safeti
profil
efficaci
tabl
new
appropri
use
activ
compar
still
yield
import
howev
valid
trial
activ
compar
vaccin
use
control
depend
abil
previou
activ
compar
provid
reliabl
efficaci
activ
compar
vaccin
viral
current
present
engag
complet
new
address
new
cycl
begin
anew
even
necessit
vaccin
antigen
sequenc
develop
deploy
account
possibl
multipl
circul
area
one
vaccin
later
dose
anoth
would
concern
sinc
begin
pandem
select
advantag
gener
favor
transmiss
concern
resist
natur
immun
would
probabl
supplant
previous
immun
evas
capabl
fit
transmiss
given
emerg
even
broadli
hard
implic
vaccin
deploy
major
immun
viral
replic
presenc
partial
immun
rapid
transmiss
high
viru
crowd
live
develop
least
partial
escap
human
immun
use
convalesc
plasma
limit
undemonstr
efficaci
contribut
evolut
concern
evad
antibodi
partial
effect
therefor
encourag
viral
evolut
addit
number
infect
greater
chanc
new
concern
aris
henc
effect
public
health
social
use
target
use
effect
reduc
infect
transmiss
help
limit
viral
evolut
limit
transmiss
gener
popul
extrem
import
emerg
addit
roll
slowli
partli
product
capac
vaccin
nation
mani
probabl
limit
even
late
current
main
strategi
protect
critic
sever
diseas
like
develop
older
like
transmit
viru
vulner
health
care
essenti
contain
spread
viru
gener
popul
balanc
protect
diseas
target
prevent
spread
strateg
decis
inform
reliabl
complet
diseas
elimin
effici
understand
transmiss
target
deploy
around
smallpox
togeth
public
health
vaccin
certain
demograph
high
incid
infect
rather
high
risk
seriou
diseas
slow
transmiss
reduc
risk
develop
addit
concern
although
strategi
work
adequ
vaccin
unavail
target
exampl
certain
deploy
ring
vaccin
strategi
effect
target
global
relev
especi
consist
high
low
transmiss
concern
emerg
corner
world
spread
quickli
converg
note
concern
variou
world
modif
target
vaccin
meet
need
one
countri
elsewher
therefor
vaccin
develop
vaccin
modif
vaccin
deploy
intern
intern
help
accru
throughout
essenti
need
new
scientif
understand
risk
novel
genet
variat
antigen
escap
open
frequent
scientif
discuss
necessari
identifi
concern
requir
attent
criteria
assess
appropri
given
like
effect
well
support
develop
evalu
new
time
deploy
process
build
global
framework
use
period
select
influenza
figur
decis
make
includ
need
involv
data
data
evolutionari
biolog
clinic
anim
data
pertin
immun
continu
vaccin
efficaci
face
viral
possibl
wane
immun
meet
effici
requir
enhanc
surveil
continu
data
viral
correspond
link
clinic
inform
new
viral
variant
serum
requir
use
standard
refer
evalu
collabor
open
discuss
data
help
foster
consist
thought
public
new
help
maintain
appropri
confid
use
develop
test
deploy
present
public
health
emerg
new
great
progress
made
understand
diseas
protect
even
though
help
bring
pandem
control
necessari
plan
unsatisfactori
intern
research
data
prioriti
efficaci
equit
access
effect
utmost
import
sustain
respons
built
weak
immun
respons
two
vaccin
sever
acut
respiratori
syndrom
coronaviru
sever
coronaviru
diseas
transplant
receiv
two
nation
author
health
recommend
use
third
dose
report
humor
respons
group
consecut
transplant
mean
age
men
given
three
messeng
vaccin
group
includ
first
two
given
month
apart
third
dose
day
second
dose
time
transplant
initi
vaccin
due
use
acid
mammalian
target
spike
protein
assess
use
assay
biolog
pharmaci
enterpris
antibodi
express
ratio
sampl
signal
cutoff
signal
ratio
accord
law
anonym
retrospect
studi
institut
review
board
approv
preval
confid
interv
first
dose
second
dose
third
dose
third
dose
figur
among
seroneg
third
dose
seroposit
third
dose
mean
ratio
seroposit
third
dose
still
seroposit
later
antibodi
third
dose
month
third
dose
p
antibodi
respons
older
higher
degre
lower
glomerular
filtrat
rate
antibodi
respons
see
supplementari
appendix
avail
full
text
letter
write
receiv
three
vaccin
seriou
advers
administr
third
dose
acut
reject
studi
administr
third
dose
vaccin
transplant
significantli
immunogen
vaccin
howev
larg
proport
remain
risk
barrier
vaccin
univers
hospit
letter
june
vaccin
human
type
vector
sever
acut
respiratori
syndrom
coronaviru
spike
protein
intern
phase
trial
randomli
assign
adult
ratio
receiv
singl
dose
viral
placebo
primari
end
vaccin
efficaci
moder
coronaviru
diseas
onset
least
day
least
day
administr
among
popul
test
neg
safeti
popul
includ
receiv
receiv
placebo
moder
onset
least
day
administr
vaccin
group
placebo
group
efficaci
confid
interv
least
day
administr
efficaci
vaccin
efficaci
higher
onset
day
onset
day
despit
south
viru
variant
vaccin
efficaci
moder
onset
least
day
least
day
administr
respect
efficaci
respect
higher
placebo
gener
mild
moder
transient
incid
seriou
advers
balanc
two
three
vaccin
group
none
placebo
group
singl
dose
symptomat
asymptomat
infect
effect
diseas
hospit
death
safeti
similar
phase
fund
research
develop
ensembl
number
sinc
sever
acut
respiratori
syndrom
coronaviru
pandem
high
morbid
mortal
new
rapidli
prevent
coronaviru
diseas
unpreced
vaccin
human
type
spike
protein
vaccin
safe
induc
durabl
immun
induc
durabl
protect
low
preclin
challeng
initi
clinic
data
singl
dose
viral
safe
induc
excel
humor
cellular
immun
standard
freezer
refriger
transport
storag
use
ongo
phase
trial
ensembl
evalu
safeti
efficaci
singl
dose
viral
prevent
infect
report
primari
ongo
phase
pivot
trial
brazil
chile
south
unit
provid
written
inform
consent
trial
declar
good
clinic
practic
intern
council
protocol
avail
full
text
articl
institut
review
accord
local
independ
data
safeti
board
continu
safeti
enhanc
respiratori
trial
collabor
sponsor
research
develop
affili
prevent
part
pharmaceut
johnson
johnson
oper
warp
speed
rapid
respons
team
advanc
research
develop
author
nation
health
prevent
network
depart
defens
trial
design
data
analysi
data
interpret
sponsor
collect
interpret
data
data
avail
vouch
accuraci
complet
data
fidel
trial
protocol
medic
fund
sponsor
draft
trial
parallel
includ
age
age
older
respect
good
stabl
health
associ
risk
sever
safeti
review
data
safeti
board
addit
includ
respect
age
stabl
elig
criteria
provid
supplementari
section
supplementari
appendix
avail
basi
infect
trial
provid
supplementari
section
randomli
assign
ratio
use
randomli
receiv
either
salin
placebo
random
interact
system
stratifi
accord
trial
site
age
group
presenc
absenc
associ
risk
sever
placebo
day
concentr
viral
per
millilit
dose
viral
singl
intramuscular
inject
health
care
worker
unawar
group
infect
questionnair
fig
supplementari
appendix
trial
staff
nasal
test
use
food
drug
administr
emerg
use
author
assay
local
laboratori
subsequ
confirm
central
n
trial
entri
day
accord
key
secondari
efficaci
base
central
confirm
owe
high
incid
time
taken
central
confirm
central
confirm
time
primari
analysi
supplementari
analysi
whether
central
confirm
therefor
advers
advers
lead
withdraw
trial
throughout
trial
safeti
subpopul
approxim
see
data
solicit
local
system
advers
electron
diari
day
administr
unsolicit
advers
day
two
primari
end
efficaci
vaccin
first
occurr
central
confirm
moder
onset
least
day
administr
least
day
administr
popul
see
potenti
moder
least
three
classifi
independ
clinic
sever
adjud
committe
whose
unawar
group
committe
basi
clinic
judgment
singl
low
measur
classifi
sever
unless
clinic
consist
sever
classif
case
secondari
exploratori
end
supplementari
full
analysi
set
includ
underw
random
receiv
dose
trial
vaccin
placebo
popul
compris
receiv
dose
trial
vaccin
placebo
seroneg
unknown
time
vaccin
placebo
protocol
like
affect
vaccin
efficaci
day
day
analysi
onset
least
day
administr
least
day
administr
respect
popul
main
popul
efficaci
analys
safeti
analys
full
analysi
set
safeti
null
hypothesi
efficaci
would
higher
primari
end
point
truncat
sequenti
probabl
ratio
signific
level
sampl
size
reduc
approxim
basi
high
incid
trial
primari
analysi
trigger
posit
recommend
data
safeti
board
median
data
null
hypothesi
primari
end
secondari
null
hypothesi
use
lower
limit
vaccin
efficaci
multipl
type
error
control
fig
exact
use
analysi
vaccin
efficaci
associ
confid
interv
account
time
cumul
incid
time
use
evalu
onset
vaccin
efficaci
vaccin
efficaci
time
data
end
frequenc
seriou
advers
tabul
full
analysi
set
frequenc
sever
solicit
unsolicit
advers
tabul
safeti
trial
enrol
date
present
analysi
total
underw
random
receiv
vaccin
placebo
popul
includ
receiv
receiv
placebo
fig
demograph
balanc
across
two
tabl
total
median
day
rang
least
later
recruit
age
older
shorter
durat
subgroup
tabl
safeti
subpopul
includ
vaccin
group
placebo
group
period
administr
vaccin
placebo
solicit
advers
placebo
age
age
older
figur
vaccin
group
pain
common
local
reaction
common
system
headach
fatigu
myalgia
nausea
advers
least
grade
consid
possibl
relat
placebo
list
tabl
seriou
advers
exclud
relat
vaccin
placebo
seven
seriou
advers
consid
relat
vaccin
group
tabl
imbal
venou
vaccin
group
placebo
group
underli
medic
tabl
regard
seizur
vaccin
group
placebo
group
tinnitu
causal
relationship
determin
vaccin
group
placebo
group
consid
unrel
trial
intervent
tabl
relat
vaccin
group
wherea
relat
placebo
group
transvers
sinu
thrombosi
cerebr
hemorrhag
case
syndrom
seen
vaccin
popul
central
confirm
symptomat
onset
least
day
administr
moder
vaccin
group
placebo
group
vaccin
efficaci
confid
interv
tabl
primari
end
point
diseas
onset
least
day
administr
moder
vaccin
group
placebo
group
vaccin
efficaci
tabl
cumul
incid
first
occurr
moder
two
trial
approxim
day
administr
vaccin
placebo
earli
onset
protect
vaccin
figur
vaccin
group
day
continu
accru
placebo
group
led
increas
vaccin
efficaci
time
fig
efficaci
diseas
onset
least
day
administr
similar
across
age
efficaci
diseas
onset
day
administr
higher
among
older
among
younger
tabl
discrep
probabl
durat
smaller
sampl
size
number
primari
similar
number
symptomat
defin
accord
definit
tabl
thu
primari
analys
symptomat
vaccin
efficaci
analys
two
primari
end
secondari
end
central
confirm
less
percentag
analys
posit
confid
similar
tabl
tabl
full
analysi
set
gener
lower
popul
includ
day
administr
immun
build
tabl
regard
vaccin
efficaci
diseas
onset
least
day
administr
diseas
onset
least
day
administr
tabl
separ
approxim
day
administr
vaccin
efficaci
longer
day
post
calcul
analysi
vaccin
efficaci
asymptomat
infect
includ
newli
posit
result
day
ie
seroneg
result
avail
day
seroposit
day
result
avail
day
therefor
preliminari
analysi
total
asymptomat
vaccin
group
placebo
group
vaccin
efficaci
vaccin
efficaci
medic
intervent
rang
tabl
two
onset
least
day
administr
group
placebo
group
led
hospit
vaccin
efficaci
fig
onset
least
day
administr
vaccin
group
placebo
group
vaccin
efficaci
moder
receiv
frequent
receiv
placebo
fig
total
mean
score
infect
questionnair
lower
among
vaccin
among
placebo
day
symptom
onset
lower
day
symptom
onset
lower
day
symptom
onset
among
onset
moder
ill
least
day
administr
fig
vaccin
efficaci
diseas
consist
high
across
suffici
analysi
tabl
basi
interim
data
uniqu
infect
refer
sequenc
mutat
predominantli
unit
variant
predominantli
south
wherea
brazil
refer
sequenc
refer
sequenc
mutat
lineag
despit
high
preval
variant
south
trial
vaccin
efficaci
moder
diseas
diseas
onset
day
administr
moder
diseas
diseas
onset
day
administr
figur
tabl
south
onset
least
day
administr
vaccin
group
placebo
group
five
trial
placebo
group
south
meaning
vaccin
efficaci
among
defin
accord
sex
race
ethnic
group
fig
tabl
lower
point
estim
vaccin
efficaci
among
age
older
analysi
onset
least
day
administr
moder
among
vaccin
among
placebo
analysi
onset
least
day
administr
fig
efficaci
time
base
analysi
similar
among
age
older
without
two
age
older
vaccin
group
placebo
group
vaccin
efficaci
intern
phase
ensembl
trial
efficaci
singl
dose
vaccin
efficaci
moder
diseas
onset
least
day
administr
diseas
onset
day
administr
number
primari
similar
number
accord
definit
estim
essenti
symptomat
higher
efficaci
vaccin
efficaci
diseas
onset
least
day
administr
diseas
onset
least
day
onset
efficaci
evid
day
administr
moder
diseas
day
administr
diseas
efficaci
continu
increas
approxim
administr
especi
evid
wane
efficaci
note
among
approxim
among
find
consist
persist
humor
immun
phase
consist
high
overal
individu
suffici
analysi
particularli
import
sever
diseas
effect
individu
health
care
efficaci
hospit
regard
onset
least
day
administr
vaccin
group
placebo
group
regard
onset
least
day
administr
vaccin
group
placebo
group
although
hospit
local
practic
resourc
avail
clear
clinic
consist
across
moreov
ident
manag
would
appli
group
placebo
group
countri
five
relat
placebo
group
vaccin
group
reduct
incid
death
high
efficaci
hospit
substanti
reduc
effect
diseas
individu
dramat
decreas
burden
health
care
breakthrough
less
sever
placebo
ill
milder
vaccin
data
consist
higher
efficaci
influenza
vaccin
sever
attenu
influenza
among
preliminari
analysi
provid
least
protect
serolog
confirm
asymptomat
infect
effect
incid
symptomat
asymptomat
infect
vaccin
use
reduc
viru
spike
protein
known
particular
mutat
associ
reduc
neutral
main
concern
first
brazil
south
unit
trial
south
variant
wherea
variant
lineag
carri
mutat
brazil
sampl
howev
despit
high
preval
concern
vaccin
efficaci
high
find
vaccin
base
origin
strain
elicit
efficaci
new
south
brazil
probabl
limit
occur
induc
function
show
decreas
potenc
new
person
commun
g
alter
addit
spike
protein
seen
phase
shown
accord
contribut
high
efficaci
diseas
hospit
death
south
rel
variant
symptomat
infect
similar
among
younger
older
among
without
subgroup
analysi
age
older
vaccin
efficaci
symptomat
diseas
onset
least
day
administr
similar
defin
accord
presenc
absenc
regard
onset
least
day
administr
vaccin
efficaci
lower
among
among
without
find
imprecis
owe
shorter
subgroup
furthermor
cumul
incid
among
vaccin
age
older
similar
overal
trial
popul
similar
vaccin
efficaci
vaccin
efficaci
hospit
among
vaccin
age
older
find
consist
trial
confirm
phase
show
accept
safeti
profil
transient
lower
older
younger
resolv
quickli
sever
grade
uncommon
seriou
advers
rare
data
current
trial
robust
safeti
data
key
strength
trial
vaccin
efficaci
ethnic
geograph
divers
popul
well
associ
risk
sever
limit
trial
rel
short
vaccin
urgent
need
vaccin
data
suggest
wane
protect
compar
initi
placebo
receiv
protocol
amend
trial
time
extraordinarili
high
incid
infect
lower
vaccin
efficaci
associ
higher
incid
situat
combin
emerg
viral
comparison
vaccin
trial
robustli
simpl
regimen
high
three
consist
found
earli
increas
protect
sever
trial
found
singl
dose
symptomat
particularli
efficaci
diseas
hospit
death
consid
rel
resist
antibodi
neutral
predomin
safeti
similar
seen
previou
phase
schedul
favor
storag
vaccin
provid
major
deploy
effect
vaccin
sever
acut
respiratori
syndrom
coronaviru
infect
sever
coronaviru
diseas
whether
vaccin
would
reduc
transmiss
household
set
context
data
household
transmiss
evalu
inform
data
address
link
data
see
section
supplementari
appendix
avail
full
text
letter
risk
secondari
infect
defin
posit
test
day
posit
test
index
case
among
unvaccin
household
infect
receiv
least
one
dose
vaccin
day
test
posit
risk
among
unvaccin
household
unvaccin
infect
fit
adjust
age
sex
person
index
case
index
patient
household
contact
geograph
region
calendar
week
index
case
depriv
composit
score
socioeconom
household
type
size
consid
time
effect
among
index
time
date
posit
household
unvaccin
index
secondari
descript
data
regard
index
household
provid
summari
section
secondari
accord
vaccin
statu
index
patient
shown
tabl
overal
likelihood
household
transmiss
approxim
lower
index
day
test
posit
unvaccin
index
similar
two
index
data
set
receiv
first
dose
vaccin
assess
infect
among
household
accord
time
vaccin
index
patient
protect
effect
vaccin
least
day
posit
test
supplementari
appendix
includ
data
inform
among
index
like
less
sever
less
infecti
involv
activ
use
serolog
test
shown
higher
household
transmiss
bia
occur
case
ascertain
household
unvaccin
respect
time
vaccin
index
consist
previou
data
regard
time
individu
protect
thu
support
overal
misclassif
index
secondari
determin
basi
test
howev
misclassif
would
tend
attenu
protect
effect
vaccin
data
inform
reduct
transmiss
viru
receipt
two
vaccin
import
consid
alongsid
evid
inform
j
health
unit
kingdom
hall
colleg
institut
health
unit
j
health
unit
household
transmiss
evalu
surveil
system
public
health
research
ethic
govern
group
data
collect
link
digit
data
law
gener
data
protect
regul
articl
e
regul
health
servic
control
patient
inform
letter
june
mass
vaccin
coronaviru
diseas
commenc
vaccin
effect
need
assess
rang
across
divers
noncontrol
set
studi
data
health
care
organ
use
evalu
effect
newli
period
unvaccin
ratio
accord
demograph
clinic
studi
includ
infect
sever
acut
respiratori
syndrom
coronaviru
symptomat
hospit
sever
ill
death
vaccin
effect
outcom
one
minu
risk
ratio
studi
group
includ
vaccin
effect
studi
day
first
dose
day
second
dose
infect
confid
interv
symptomat
hospit
sever
diseas
respect
effect
death
day
first
dose
effect
specif
assess
infect
symptomat
consist
across
age
potenti
slightli
lower
effect
multipl
studi
nationwid
mass
vaccin
set
vaccin
effect
wide
rang
find
consist
vaccin
newli
sever
acut
respiratori
syndrom
coronaviru
begin
mani
world
clinic
coronaviru
rang
clinic
consid
gold
standard
intervent
effect
notabl
sampl
size
subgroup
analysi
restrict
inclus
criteria
highli
set
replic
mass
vaccin
exampl
phase
trial
vaccin
includ
randomli
assign
group
permit
vaccin
efficaci
small
number
moreov
chronic
includ
stabl
import
see
whether
vaccin
program
suboptim
adher
vaccin
logist
influenc
vaccin
effect
analys
thu
meet
urgent
need
evalu
effect
across
divers
wide
rang
midst
imperfect
adher
vaccin
mainten
data
health
care
organ
evalu
vaccin
effect
five
infect
symptomat
hospit
sever
ill
death
observ
data
set
effect
time
defin
age
sex
data
health
four
health
care
million
popul
descript
data
use
studi
provid
supplementari
appendix
supplementari
avail
full
text
articl
inform
access
well
studi
provid
supplementari
studi
institut
review
board
studi
exempt
requir
inform
design
observ
studi
emul
target
trial
causal
effect
vaccin
elig
criteria
includ
age
older
previous
posit
test
member
health
care
organ
previou
intern
variabl
probabl
exposur
high
high
variabl
feasibl
high
variabl
infect
risk
among
health
care
administr
staff
popul
live
area
health
care
system
preced
day
indic
start
symptomat
diseas
preclud
vaccin
nurs
home
medic
confin
home
health
care
day
period
newli
ratio
unvaccin
person
end
follow
occurr
outcom
event
death
unrel
vaccin
unvaccin
vaccin
control
end
studi
period
newli
elig
inclus
studi
even
previous
select
vaccin
associ
probabl
vaccin
infect
sever
age
sex
sector
gener
ultraorthodox
neighborhood
resid
sinc
diseas
activ
vaccin
uptak
vari
greatli
across
defin
histori
influenza
vaccin
preced
pregnanc
potenti
risk
factor
sever
associ
rate
vaccin
owe
vaccin
pregnant
total
number
diseas
control
prevent
risk
sever
see
supplementari
addit
inform
match
process
protocol
statist
analysi
plan
avail
five
interest
infect
confirm
posit
test
symptomat
hospit
admiss
sever
accord
nation
health
criteria
death
follow
supplementari
analysi
addit
outcom
infect
without
imperfect
proxi
asymptomat
infect
sinc
mild
tabl
miss
data
smoke
statu
index
balanc
match
use
plot
mean
variabl
standard
continu
unvaccin
differ
less
consid
surviv
unvaccin
consid
three
day
first
dose
vaccin
day
first
dose
administr
second
dose
occur
day
first
dose
day
second
dose
end
period
use
estim
daili
outcom
comput
probabl
risk
outcom
period
still
risk
begin
period
calcul
risk
vaccin
vaccin
vaccin
effect
one
minu
risk
ratio
vaccin
effect
analys
outcom
across
two
period
immedi
first
dose
immun
gradual
main
analys
risk
ratio
close
period
secondari
analys
consid
day
day
day
day
avoid
potenti
select
bia
main
analys
restrict
whose
data
uncensor
begin
period
see
supplementari
sensit
analysi
day
second
dose
vaccin
among
receiv
second
dose
sensit
analysi
hazard
ratio
day
infect
addit
sensit
analysi
assess
potenti
select
bia
due
inform
analysi
data
subsequ
day
ie
period
littl
vaccin
effect
plu
median
time
diagnosi
outcom
calcul
confid
percentil
bootstrap
method
analys
use
r
version
elig
studi
unvaccin
figur
younger
elig
popul
overal
lower
preval
chronic
smaller
pool
potenti
unvaccin
older
vaccin
owe
high
vaccin
older
popul
tabl
fig
shown
tabl
well
balanc
studi
fig
miss
data
smoke
statu
index
analysi
figur
data
unvaccin
receiv
mean
day
rang
per
symptomat
ill
hospit
sever
death
sever
diseas
death
increas
time
diagnosi
median
time
day
respect
see
fig
day
receiv
second
dose
vaccin
receiv
day
figur
cumul
incid
includ
tabl
vaccin
effect
main
time
period
day
first
dose
vaccin
effect
infect
confid
interv
symptomat
ill
hospit
sever
ill
death
period
day
first
dose
effect
respect
period
start
day
second
dose
vaccin
effect
symptomat
ill
hospit
sever
diseas
respect
daili
valu
one
minu
hazard
ratio
infect
outcom
includ
figur
consist
gradual
daili
increas
vaccin
vaccin
effect
infect
defin
age
sex
consist
similar
effect
across
age
slightli
lower
effect
among
multipl
vaccin
effect
asymptomat
infect
proxi
period
day
first
dose
day
first
dose
day
second
dose
tabl
fig
figur
magnif
cumul
incid
curv
symptomat
ill
outcom
show
diverg
start
around
day
shown
comparison
curv
analysi
minim
age
sex
separ
sensit
analys
vaccin
effect
across
addit
cumul
effect
start
day
lower
across
effect
condit
receipt
second
dose
vaccin
higher
uncondit
day
first
figur
show
sensit
analysi
data
enrol
delay
number
day
vaccin
date
depend
outcom
similar
main
analysi
tabl
analys
studi
tabl
life
tabl
variou
studi
effect
novel
nationwid
mass
vaccin
set
vaccin
effect
period
start
day
second
dose
infect
symptomat
hospit
sever
effect
day
one
dose
day
gradual
shift
first
second
vaccin
infect
symptomat
hospit
sever
death
first
primari
end
point
trial
vaccin
symptomat
trial
studi
cumul
incid
symptomat
unvaccin
diverg
around
day
first
vaccin
efficaci
symptomat
start
day
second
dose
trial
studi
efficaci
first
dose
second
dose
trial
studi
differ
reflect
high
level
transmiss
studi
affect
equal
first
day
administr
first
dose
elimin
distort
effect
vaccin
period
day
effect
effect
infect
day
studi
rel
similar
effect
cohort
anoth
health
care
organ
use
differ
studi
design
infect
among
day
first
dose
infect
day
trial
vaccin
efficaci
sever
entir
studi
period
base
studi
sever
group
unvaccin
group
result
effect
day
first
dose
day
day
second
larg
sampl
size
studi
us
estim
vaccin
effect
specif
trial
suffici
power
evalu
trial
efficaci
among
age
older
older
day
second
dose
abl
studi
granular
age
vaccin
effect
similar
age
older
younger
age
time
trial
vaccin
efficaci
one
accord
specif
obes
hypertens
provid
clariti
regard
effect
multipl
vaccin
effect
relat
variou
found
effect
slightli
lower
among
higher
make
present
studi
uniqu
effect
vaccin
practic
applic
first
rare
combin
rich
medic
background
data
test
infect
outcom
patient
data
commun
symptomat
outcom
inpati
data
repositori
half
popul
daili
two
second
rapid
pace
high
uptak
vaccin
high
diseas
vaccin
campaign
hand
rapid
pace
vaccin
campaign
frequent
data
unvaccin
especi
among
age
often
day
match
correspond
reduct
averag
period
regard
possibl
resist
studi
period
increas
share
day
data
extract
thu
studi
averag
effect
vaccin
multipl
although
provid
specif
effect
estim
variant
plateau
later
cumul
incid
curv
vaccin
effect
variant
observ
consist
previou
antibodi
variant
rare
time
data
observ
studi
studi
affect
residu
confound
due
unvaccin
especi
behavior
therefor
rigor
match
wide
rang
confound
causal
effect
vaccin
variou
match
process
found
consist
pattern
similar
day
day
first
dose
onset
vaccin
effect
thu
serv
neg
control
period
figur
fig
tabl
similar
despit
temporari
increas
among
unvaccin
first
day
first
vaccin
dose
like
stem
fact
choos
specif
day
feel
well
time
vaccin
similar
studi
known
risk
sever
tabl
fig
evid
exchang
ie
absenc
confound
howev
rigor
match
process
came
cost
final
cohort
approxim
otherwis
met
studi
elig
criteria
limit
match
age
sex
would
insuffici
elimin
earli
confound
fig
popul
high
intern
variabl
probabl
vaccin
outcom
health
care
confin
home
medic
nurs
home
avoid
residu
confound
although
trial
less
like
includ
healthi
enough
compli
vaccin
plan
exclud
health
care
assess
possibl
select
bia
stem
inform
wherebi
feel
well
around
time
vaccin
sensit
analysi
kept
unvaccin
group
period
time
set
differ
outcom
fig
tabl
analysi
similar
main
analysi
bia
small
date
onset
avail
analysi
instead
infect
date
set
date
swab
collect
first
posit
test
given
like
time
gap
onset
swab
collect
diverg
cumul
incid
infect
unvaccin
slightli
parallel
underestim
vaccin
effect
time
window
sinc
estim
actual
narrow
window
vaccin
activ
test
highli
access
done
without
referr
matter
estim
potenti
time
gap
thu
vaccin
effect
underestim
small
effect
sever
longer
median
kept
mind
fig
day
hospit
day
sever
day
studi
high
effect
vaccin
symptomat
noncontrol
set
similar
vaccin
efficaci
trial
studi
effect
high
seriou
hospit
sever
ill
death
furthermor
benefit
magnitud
time
strengthen
expect
newli
help
mitig
profound
global
effect
pandem
interim
phase
trial
sever
acut
respiratori
syndrom
coronaviru
vaccin
efficaci
coronaviru
diseas
durabl
protect
current
unknown
describ
bind
healthi
adult
ongo
phase
stratifi
accord
age
day
second
dose
day
antibodi
activ
high
age
day
bind
measur
assay
spike
geometr
mean
confid
interv
age
age
age
older
nearli
detect
activ
neutral
inhibitori
dilut
respect
sensit
neutral
detect
activ
respect
lower
age
age
older
age
figur
see
supplementari
appendix
avail
full
text
letter
bind
day
day
calcul
use
exponenti
decay
model
steadi
decay
rate
time
day
calcul
use
model
day
decay
decreas
time
antibodi
two
day
day
neutral
day
day
neutral
measur
chang
inform
criterion
correct
small
sampl
size
best
fit
bind
neutral
exponenti
decay
respect
see
supplementari
appendix
consist
convalesc
symptom
antibodi
best
correl
vaccin
efficaci
current
known
second
dose
three
distinct
serolog
ongo
immun
beyond
well
effect
booster
dose
extend
durat
breadth
activ
viral
data
show
antibodi
persist
thu
support
use
vaccin
institut
allergi
infecti
univers
school
medicin
ga
mat
compani
b
e
r
graham
c
lin
dell
j
lai
g
univers
school
medicin
c
j
luke
h
health
research
institut
school
medicin
compani
studi
studi
letter
data
phase
clinic
messeng
efficaci
prevent
symptomat
sever
acut
respiratori
syndrom
coronaviru
infect
day
second
dose
vaccin
efficaci
day
second
dose
vaccin
pfizer
sinc
nationwid
surg
coronaviru
diseas
note
infect
food
drug
administr
emerg
use
author
two
vaccin
across
unit
start
vaccin
campaign
develop
receiv
one
univers
san
univers
health
vaccin
health
care
addit
low
threshold
test
symptomat
asymptomat
health
care
undergo
weekli
test
assay
nasal
option
test
program
asymptomat
health
care
assay
nasal
program
detect
asymptomat
data
format
electron
employe
health
record
system
exempt
institut
review
board
approv
total
health
care
receiv
first
dose
vaccin
receiv
second
dose
among
health
care
uniqu
test
posit
least
day
vaccin
major
test
posit
within
first
first
dose
health
care
test
posit
posit
test
day
second
dose
health
care
test
posit
day
second
vaccin
test
posit
day
second
vaccin
tabl
total
health
care
receiv
second
dose
previous
correspond
posit
rate
cohort
absolut
risk
test
posit
vaccin
among
health
care
among
higher
possibl
elev
risk
includ
avail
regular
test
asymptomat
symptomat
region
surg
southern
vaccin
demograph
trial
health
care
cohort
health
care
younger
overal
higher
risk
exposur
clinic
addit
cutoff
initi
vaccin
well
surg
test
asymptomat
includ
vaccin
singl
screen
asymptomat
vaccin
trial
second
dose
rariti
posit
test
day
administr
second
dose
vaccin
encourag
efficaci
outsid
trial
set
data
underscor
critic
import
continu
public
health
mitig
physic
daili
symptom
screen
regular
test
even
high
incid
vaccin
herd
immun
e
san
health
san
school
medicin
univers
san
health
san
currier
school
medicin
r
j
san
health
san
ca
letter
march
pandem
known
coronaviru
pandem
ongo
global
pandem
coronaviru
diseas
sever
acut
respiratori
syndrom
coronaviru
viru
first
wuhan
china
world
health
organ
declar
public
health
emerg
intern
concern
later
declar
pandem
march
june
million
confirm
million
confirm
make
one
histori
sever
highli
variabl
rang
unnotic
sever
ill
like
elderli
well
underli
medic
peopl
breath
air
small
risk
breath
highest
peopl
close
proxim
longer
particularli
indoor
transmiss
occur
splash
nose
mouth
rare
via
peopl
remain
contagi
day
spread
viru
even
develop
prevent
includ
social
wear
face
public
ventil
hand
wash
cover
one
mouth
sneez
peopl
expos
symptomat
sever
wide
distribut
sinc
current
focu
work
underway
develop
inhibit
viru
travel
workplac
hazard
busi
numer
work
increas
test
capac
trace
infect
pandem
sever
global
social
econom
disrupt
global
recess
sinc
great
depress
led
widespread
suppli
panic
agricultur
disrupt
food
howev
greenhous
numer
educ
public
partial
fulli
close
mani
misinform
social
media
mass
media
polit
pandem
rais
racial
geograph
discrimin
health
equiti
wealth
inequ
balanc
public
health
individu
although
exact
origin
viru
still
unknown
first
outbreak
wuhan
china
late
mani
earli
link
peopl
wholesal
market
wuhan
possibl
transmiss
alreadi
happen
world
health
organ
diseas
short
coronaviru
diseas
viru
outbreak
known
sever
acut
respiratori
syndrom
coronaviru
newli
discov
viru
close
relat
bat
pangolin
current
scientif
consensu
viru
like
zoonot
origin
bat
anoth
mammal
despit
subject
signific
amount
specul
conspiraci
rapidli
grow
echo
global
geopolit
notabl
unit
china
issu
known
person
later
discov
fallen
ill
person
visibl
later
wet
market
cluster
howev
case
infect
earli
cluster
month
found
link
market
molecular
clock
analysi
index
case
like
infect
viru
offici
case
refer
number
peopl
test
whose
test
confirm
posit
accord
offici
mani
earli
offici
test
mild
analysi
earli
phase
outbreak
per
cent
undocu
sourc
per
cent
sever
varieti
mani
like
consider
greater
preliminari
found
per
cent
peopl
test
major
infect
cluster
test
posit
screen
pregnant
new
york
citi
blood
found
posit
antibodi
indic
base
conserv
show
mild
detect
studi
receiv
substanti
press
coverag
without
first
pass
peer
review
analysi
earli
age
china
rel
low
proport
clear
whether
young
peopl
less
like
infect
less
like
develop
seriou
seek
medic
attent
test
retrospect
cohort
studi
china
found
like
infect
initi
basic
reproduct
number
subsequ
analysi
per
cent
confid
interv
vari
across
confus
effect
reproduct
number
commonli
r
account
effect
social
herd
immun
effect
r
close
mani
mean
spread
diseas
time
stabl
decreas
plot
weekli
new
world
top
five
current
mean
total
per
popul
select
activ
per
popul
select
offici
gener
refer
peopl
test
posit
accord
ignor
peopl
die
without
test
convers
peopl
underli
lead
statist
versu
season
averag
indic
excess
mortal
mani
includ
due
strain
elect
surgeri
first
confirm
death
wuhan
first
death
outsid
china
first
death
outsid
unit
per
cent
peopl
contract
recov
otherwis
time
onset
death
usual
day
typic
day
june
million
peopl
risk
mortal
tend
underli
immun
system
seriou
heart
lung
sever
obes
elderli
age
older
multipl
use
quantifi
mortal
vari
region
time
test
volum
system
qualiti
treatment
govern
respons
time
sinc
initi
outbreak
popul
age
sex
overal
health
includ
suspect
regardless
whether
person
test
result
higher
includ
ratio
number
divid
number
within
given
time
interv
base
univers
statist
global
ratio
percent
june
number
region
plot
weekli
due
world
top
five
current
mean
per
popul
select
offici
death
actual
death
toll
death
pandem
show
increas
alon
data
true
number
includ
rang
million
economist
well
million
institut
health
metric
evalu
march
diseas
control
prevent
unit
provid
two
confirm
laboratori
test
clinic
epidemiolog
diagnosi
laboratori
confirm
inconclus
avail
note
laboratori
test
typic
death
us
nation
center
health
statist
implement
mortal
statist
would
use
death
certif
probabl
like
note
like
follow
underli
caus
upon
death
certif
select
caus
death
result
underli
caus
often
formal
public
two
mani
detail
laboratori
confirm
mortal
code
provision
code
unless
state
probabl
suspect
note
distinguish
infect
crucial
metric
sever
diseas
infect
fatal
ratio
cumul
number
diseas
divid
cumul
number
infect
asymptomat
undiagnos
measur
specif
date
frequent
refer
metric
infect
fatal
rate
clarifi
express
percentag
decim
refer
metric
infect
fatal
risk
review
articl
natur
number
exclud
elderli
care
found
median
rang
systemat
review
journal
epidemiolog
new
sever
includ
elderli
care
studi
found
across
reflect
correspond
age
composit
popul
pattern
infect
due
low
younger
age
age
progress
higher
older
age
age
age
age
report
world
health
organ
analysi
hazard
elderli
fatal
infect
two
magnitud
like
risk
fatal
automobil
accid
far
danger
season
influenza
anoth
metric
death
rate
case
fatal
ratio
diseas
divid
metric
mislead
delay
symptom
onset
death
test
particularli
sever
august
earli
stage
pandem
fatal
base
surveil
calcul
crude
give
rise
wide
variabl
countri
less
variabl
rang
mild
sever
ill
common
includ
headach
loss
smell
tast
nasal
congest
runni
nose
cough
muscl
pain
sore
throat
fever
diarrhea
breath
peopl
infect
differ
chang
time
three
common
one
respiratori
symptom
cluster
cough
sputum
short
breath
fever
symptom
cluster
muscl
joint
pain
headach
fatigu
cluster
digest
abdomin
pain
vomit
diarrhea
peopl
without
prior
ear
nose
throat
loss
tast
combin
loss
smell
associ
peopl
show
develop
mild
moder
mild
pneumonia
develop
sever
dyspnea
lung
involv
suffer
critic
respiratori
failur
shock
dysfunct
least
third
peopl
infect
viru
develop
notic
point
time
asymptomat
tend
get
test
spread
diseas
infect
peopl
develop
later
presymptomat
mild
spread
viru
common
delay
moment
person
first
becom
infect
appear
first
median
delay
four
five
day
symptomat
peopl
experi
within
two
seven
day
exposur
almost
experi
least
one
symptom
within
day
diseas
mainli
via
respiratori
rout
peopl
inhal
infect
peopl
releas
breath
talk
cough
sneez
sing
infect
peopl
like
transmit
physic
close
howev
infect
occur
longer
particularli
indoor
infect
earli
three
day
appear
peopl
infecti
prior
onset
first
week
infect
peopl
remain
contagi
day
peopl
spread
diseas
even
asymptomat
infecti
rang
size
remain
suspend
air
long
time
remain
fall
ground
variou
droplet
technic
gener
way
lead
confus
around
terminolog
addit
research
tradit
understand
respiratori
transmit
respiratori
fluid
travel
far
land
mucou
nose
mouth
infect
highest
concentr
peopl
close
proxim
easier
viral
transmiss
peopl
physic
close
transmiss
occur
longer
mainli
poorli
small
remain
suspend
air
broad
famili
known
viru
singl
linear
segment
infect
avian
speci
livestock
companion
human
capabl
caus
rang
common
cold
sever
middl
east
respiratori
syndrom
fatal
rate
seventh
known
coronaviru
infect
peopl
origin
prevent
reduc
infect
includ
get
home
wear
mask
public
crowd
keep
distanc
ventil
indoor
potenti
exposur
wash
soap
water
often
least
twenti
good
respiratori
hygien
touch
nose
mouth
unwash
phase
sever
efficaci
high
symptomat
june
updat
author
least
one
nation
regulatori
author
public
use
two
nine
convent
academi
medic
covaxin
five
viral
vector
sputnik
light
sputnik
v
johnson
johnson
two
protein
subunit
verif
total
march
updat
vaccin
variou
develop
clinic
research
phase
phase
phase
develop
union
pfizer
vaccin
vaccin
vaccin
us
secretari
health
human
notic
declar
public
readi
emerg
prepared
act
medic
cover
vaccin
use
treat
diagnos
cure
prevent
mitig
transmiss
viru
therefrom
declar
liabil
neglig
manufactur
vaccin
neglig
health
care
provid
wrong
dose
absent
will
misconduct
declar
effect
unit
vaccin
effect
accord
studi
percent
high
percent
specif
effect
treatment
cure
coronaviru
diseas
diseas
viru
thu
cornerston
manag
support
care
treatment
reliev
fluid
therapi
oxygen
support
prone
support
affect
vital
mild
support
care
medic
reliev
fever
bodi
cough
proper
intak
rest
nasal
breath
good
person
hygien
healthi
diet
us
diseas
control
prevent
recommend
suspect
carri
viru
isol
home
wear
face
mask
peopl
sever
need
treatment
hospit
low
oxygen
use
strongli
reduc
risk
death
ventil
ultim
admiss
intens
care
unit
mechan
ventil
support
breath
extracorpor
membran
oxygen
use
address
issu
respiratori
failur
still
consider
sever
experiment
activ
studi
clinic
thought
promis
earli
pandem
later
research
found
ineffect
even
harm
despit
ongo
research
still
enough
evid
recommend
earli
treatment
nevertheless
unit
two
avail
earli
use
thought
high
risk
progress
sever
diseas
antivir
avail
us
canada
sever
howev
peopl
need
mechan
ventil
altogeth
world
health
organ
due
limit
evid
efficaci
sever
spread
global
current
preval
share
infecti
mutat
speed
scale
key
mitig
due
natur
pandem
risk
exponenti
growth
mitig
effect
transmiss
must
broken
quickli
possibl
screen
contain
b
health
care
must
avail
provid
need
infect
c
must
place
allow
effect
b
control
outbreak
screen
contain
suppress
mitig
screen
done
devic
thermomet
detect
elev
bodi
temperatur
associ
infect
contain
earli
outbreak
trace
isol
infect
well
introduc
stop
diseas
spread
longer
possibl
contain
diseas
move
mitig
stage
taken
slow
spread
mitig
effect
system
societi
combin
contain
mitig
time
suppress
extrem
revers
pandem
reduc
basic
reproduct
number
less
part
infecti
diseas
outbreak
tri
delay
decreas
epidem
peak
known
flatten
epidem
curv
risk
health
time
nonpharmaceut
manag
outbreak
includ
person
prevent
hand
hygien
wear
face
commun
physic
mass
gather
commun
engag
encourag
accept
particip
well
environment
surfac
clean
particularli
focu
clean
rather
transmiss
hygien
drastic
outbreak
taken
china
sever
outbreak
appar
entir
impos
strict
travel
adopt
varieti
limit
spread
viru
south
mass
screen
infect
provid
financi
support
infect
larg
face
mask
product
hoard
medic
great
unit
show
mitig
stop
epidem
spread
suppress
revers
epidem
growth
major
optim
mitig
reduc
peak
demand
half
still
result
health
suppress
prefer
need
long
viru
human
popul
vaccin
becom
avail
transmiss
otherwis
quickli
relax
intervent
suppress
pandem
consider
social
econom
contact
trace
import
method
health
determin
sourc
infect
prevent
transmiss
use
locat
data
mobil
purpos
privaci
amnesti
intern
hundr
issu
statement
call
kind
surveil
sever
mobil
voluntari
use
dozen
expert
work
log
user
proxim
near
someon
subsequ
posit
appl
jointli
initi
contact
trace
base
technolog
cryptographi
system
intend
allow
creat
offici
coronaviru
eventu
goal
integr
function
directli
android
mobil
us
provid
increas
capac
need
fundament
outbreak
respons
measur
region
offic
primari
shift
multipl
laboratori
toward
test
elect
whenev
possibl
separ
isol
posit
increas
intens
care
train
personnel
increas
number
avail
addit
attempt
maintain
physic
protect
provid
virtual
due
capac
standard
suppli
print
materi
nasal
ventil
one
exampl
hospit
urgent
ventil
valv
supplier
unabl
deliv
local
receiv
legal
due
patent
infring
print
hundr
overnight
build
day
ventil
current
undergo
test
seek
approv
around
world
open
sourc
local
sew
print
million
face
protect
made
medic
made
surgic
power
hand
novel
ear
ventil
ventil
base
retrospect
analysi
start
number
gradual
reach
least
wuhan
central
hospit
sent
bronchoalveolar
lavag
fluid
bal
sampl
unresolv
clinic
case
compani
vision
citat
vision
inform
wuhan
central
hospit
test
show
new
coronaviru
pneumonia
cluster
unknown
caus
doctor
provinci
hospit
inform
wuhan
test
report
wuhan
central
hospit
compani
state
erron
posit
result
caus
group
wuhan
central
hospit
alert
relev
hospit
result
eight
li
later
polic
spread
fals
anoth
doctor
ai
fen
rais
alarm
even
wuhan
municip
health
commiss
notic
variou
medic
treatment
pneumonia
unknown
caus
next
day
wuhan
municip
health
commiss
made
first
public
announc
pneumonia
outbreak
unknown
caus
confirm
trigger
investig
follow
day
offic
china
inform
pneumonia
unknown
caus
wuhan
investig
start
accord
offici
earli
mostli
link
wholesal
market
sold
live
howev
director
center
diseas
control
prevent
anim
collect
market
test
neg
viru
market
sourc
initi
outbreak
march
report
potenti
zoonot
sourc
viru
human
via
intermedi
anim
host
like
explan
direct
bat
next
like
introduct
food
suppli
chain
anoth
possibl
explan
total
pneumonia
unknown
receiv
inform
nation
health
commiss
outbreak
associ
one
market
wuhan
new
type
coronaviru
isol
earli
outbreak
number
doubl
approxim
everi
seven
half
day
earli
viru
spread
new
year
migrat
wuhan
transport
hub
major
rail
interchang
genet
sequenc
data
china
nearli
new
one
day
two
peopl
one
retrospect
offici
studi
march
found
peopl
alreadi
would
later
infect
report
lancet
human
transmiss
strongli
person
protect
equip
health
test
viru
essenti
due
pandem
potenti
lancet
would
publish
first
studi
explicitli
warn
inevit
independ
major
global
call
public
health
confirm
across
declar
outbreak
public
health
emerg
intern
concern
pandem
march
south
japan
increas
first
confirm
two
china
march
china
countri
march
unit
china
highest
number
confirm
world
research
major
new
york
came
rather
directli
china
countri
prior
found
person
viru
person
unit
diseas
june
day
without
local
case
offici
citi
singl
case
two
june
june
offici
confirm
went
wholesal
market
june
spread
viru
still
despit
mani
made
progress
spread
one
case
offici
three
patient
travel
outsid
citi
day
contact
peopl
attent
state
special
meet
one
ten
peopl
around
world
infect
time
million
peopl
infect
million
confirm
earli
outbreak
uniqu
variant
north
region
twelv
human
variant
report
say
variant
combin
previous
respons
prime
minist
order
countri
world
produc
mink
fur
cull
mink
popul
mani
million
pfizer
trial
candid
vaccin
show
effect
viru
later
day
fast
track
applic
vaccin
virologist
us
nation
institut
allergi
infecti
director
pfizer
vaccin
spike
protein
use
infect
viru
left
long
vaccin
protect
level
protect
initi
like
go
front
unit
million
confirm
make
countri
larg
margin
public
diseas
control
prevent
current
viral
infect
via
confirm
laboratori
test
howev
true
number
eight
time
number
report
true
number
viru
infect
around
million
us
public
health
new
variant
discov
south
east
predominantli
kent
variant
variant
concern
spike
protein
make
viru
infecti
mani
servic
suspend
carri
freight
border
close
peopl
variant
first
discov
around
world
south
japan
canada
iceland
china
variant
first
return
brazil
team
world
health
organ
would
arriv
wuhan
month
ascertain
origin
determin
intermedi
origin
reservoir
follow
day
two
bar
enter
china
accord
countri
viru
vaccin
effect
variant
clinic
trial
south
china
vaccin
effect
brazil
clinic
trial
march
sever
iceland
stop
vaccin
due
sever
blood
cerebr
venou
sinu
thrombosi
addit
use
one
batch
vaccin
well
march
agenc
found
link
thrombu
blood
clot
clinic
import
lead
sever
resum
vaccin
march
us
govern
introduc
vaccin
allow
abil
board
cruis
well
june
million
due
million
due
pandem
mani
area
restrict
free
movement
set
border
nation
includ
contain
known
recommend
regroup
rebal
protect
health
exhaust
achiev
balanc
normal
life
pandem
consist
strict
person
hygien
effect
contact
trace
isol
ill
march
billion
peopl
form
billion
peopl
first
week
half
world
popul
late
around
million
peopl
limit
unit
kingdom
around
million
peopl
nearli
million
peopl
per
cent
popul
form
unit
around
million
peopl
million
peopl
south
billion
peopl
updat
except
north
although
like
despit
first
area
world
hit
outbreak
earli
respons
particularli
fare
compar
well
china
initi
sever
outbreak
respons
larg
diseas
sinc
march
japan
pandem
direct
side
effect
mental
health
accord
report
countri
nation
polic
agenc
state
pandem
mental
health
due
isol
famili
among
confirm
asymptomat
medic
observ
asymptomat
prior
march
mean
march
larg
put
control
china
minor
sinc
million
peopl
countri
china
accord
china
state
council
come
two
one
produc
first
case
order
nationwid
entir
popul
start
march
unlock
begin
june
six
account
around
half
june
activ
first
time
august
us
record
singl
day
set
new
record
almost
day
august
case
fatal
rate
rel
low
global
need
updat
number
confirm
number
confirm
world
behind
unit
number
total
confirm
mark
confirm
cross
total
number
confirm
slow
pace
ministri
scienc
mathemat
simul
pandem
correctli
decreas
activ
start
second
wave
hit
sever
strain
late
govern
new
per
day
first
confirm
accord
ministri
health
medic
educ
two
peopl
day
earli
govern
includ
cancel
cultur
sport
higher
educ
trillion
equival
us
combat
viru
presid
quarantin
affect
outbreak
would
limit
travel
march
although
heavi
traffic
ahead
new
year
continu
open
march
spread
viru
china
ten
back
outbreak
sever
govern
date
parliament
shut
test
posit
viru
march
march
govern
hundr
singl
day
countri
sinc
outbreak
least
twelv
sit
former
govern
diseas
march
march
fifti
new
everi
hour
one
new
death
everi
ten
due
accord
offici
five
time
us
affect
countri
financi
abil
respond
viral
outbreak
shop
shop
across
countri
reach
low
new
earli
new
peak
june
rais
fear
second
wave
presid
million
alreadi
becom
infect
consider
higher
offici
count
data
suggest
peopl
nearli
tripl
offici
date
confirm
spread
south
china
nation
health
agenc
signific
increas
confirm
larg
gather
church
visit
wuhan
suspect
origin
outbreak
updat
among
church
per
cent
south
declar
highest
level
alert
confirm
south
militari
base
three
viru
south
consid
world
screen
popul
viru
isol
infect
peopl
trace
quarantin
screen
includ
mandatori
new
intern
mobil
applic
test
viru
avail
next
day
increas
test
capabl
allow
peopl
test
everi
day
despit
earli
presid
moon
respons
crisi
south
consid
success
outbreak
without
entir
march
south
case
total
four
march
begin
new
oversea
two
per
media
south
receiv
viru
test
assist
differ
persist
local
greater
area
continu
found
led
director
say
june
countri
second
wave
although
offici
disagre
assess
march
number
new
greater
china
world
health
organ
consid
activ
pandem
south
wors
outbreak
march
within
confirm
case
last
countri
report
least
one
case
least
one
death
apart
citi
march
million
peopl
august
climb
among
younger
across
voic
worst
hit
area
viru
exceed
million
although
origin
thought
pandem
first
case
confirm
later
discov
person
near
test
posit
viru
old
key
event
spread
diseas
countri
annual
assembl
open
door
church
peopl
least
half
contract
viru
march
prime
minist
order
closur
nonessenti
public
march
presid
macron
mandatori
home
confin
polici
extend
least
updat
confirm
fourth
number
confirm
close
due
case
becom
countri
pandem
process
surpass
russia
new
total
confirm
million
count
addit
govern
current
nation
would
remain
place
outbreak
confirm
spread
two
test
posit
rise
sharpli
govern
suspend
china
declar
state
emerg
unassoci
cluster
later
start
confirm
council
new
contain
outbreak
peopl
eleven
differ
northern
prime
minist
cont
outbreak
entri
exit
provid
suspens
work
sport
alreadi
order
march
govern
order
full
closur
nationwid
hundr
major
sport
behind
close
march
sport
suspend
complet
least
one
month
march
prime
minist
cont
order
stoppag
nearli
commerci
activ
except
march
colleg
anaesthesia
analgesia
resuscit
intens
care
medic
ethic
regard
triag
march
china
countri
world
pandem
march
russia
sent
nine
militari
medic
equip
march
updat
confirm
larg
number
region
report
combin
larg
elderli
popul
inabl
test
viru
date
high
fatal
rate
countri
seven
day
six
govern
restrict
contain
rise
presid
feder
gener
come
due
spread
coupl
day
prior
filippo
presid
nation
feder
doctor
complet
peninsular
nation
due
pandem
day
million
confirm
second
wave
viru
stop
viru
first
confirm
spread
german
tourist
test
posit
la
canari
genet
analysi
shown
least
viru
commun
transmiss
march
confirm
countri
march
march
begin
follow
day
nonessenti
order
remain
home
next
day
late
march
commun
countri
medic
live
retir
experienc
especi
high
infect
march
offici
death
toll
china
peopl
viru
time
countri
singl
day
daili
death
toll
govern
fell
first
time
june
first
day
without
state
alarm
end
june
howev
number
number
barcelona
led
reimposit
nation
mostli
open
per
constitut
public
health
agenc
autonomi
polit
interfer
agenc
polici
strategi
put
place
longer
period
time
base
assumpt
viru
would
start
spread
shorter
new
york
time
outbreak
far
econom
impact
reduc
continu
go
work
shop
countri
week
highest
per
per
million
per
day
end
june
longer
excess
mortal
devolut
unit
kingdom
meant
four
differ
respons
govern
behalf
lift
govern
social
quarantin
march
lack
intens
respons
face
public
march
prime
minist
johnson
advis
nonessenti
travel
social
contact
suggest
peopl
work
home
avoid
march
govern
order
leisur
close
soon
possibl
prevent
unemploy
march
johnson
multipl
peopl
nonessenti
travel
outdoor
activ
unlik
previou
enforc
polic
dispers
nonessenti
order
close
promis
vaccin
trial
begun
govern
million
toward
research
number
temporari
critic
care
built
first
oper
nightingal
hospit
nine
day
would
transfer
first
three
would
first
access
vaccin
due
prior
contract
trial
success
million
would
avail
first
western
countri
approv
pfizer
vaccin
viru
would
immedi
avail
use
unit
kingdom
would
begin
vaccin
viru
less
week
state
individu
signific
allerg
reaction
vaccin
anaphylactoid
reaction
take
pfizer
vaccin
protect
first
north
unit
north
saint
confirm
case
march
north
confirm
case
million
confirm
unit
sinc
result
countri
per
mani
gone
undetect
diseas
control
march
total
million
unit
third
total
popul
us
world
confirm
caus
death
us
behind
heart
diseas
cancer
us
life
expect
first
half
first
case
presid
trump
declar
us
outbreak
public
health
emerg
china
initi
us
respons
pandem
otherwis
slow
system
stop
travel
test
b
meanwhil
trump
optimist
accus
sever
viru
pandem
confirm
south
brazil
confirm
case
south
least
one
case
infect
rapid
increas
brazil
declar
south
pandem
brazil
record
singl
day
total
almost
total
number
almost
brazil
countri
number
follow
russia
unit
brazil
number
russia
new
confirm
previou
total
number
presid
controversi
viru
littl
flu
frequent
speak
prevent
attitud
toward
outbreak
former
us
presid
trump
trump
later
test
posit
viru
june
govern
brazil
conceal
actual
activ
stop
total
number
june
brazil
health
ministri
took
offici
reflect
total
live
june
number
previou
last
offici
june
seven
eight
million
one
week
specif
brazil
one
surg
case
toward
million
brazil
briefli
phase
vaccin
suicid
volunt
earli
death
toll
total
number
million
wors
unit
pandem
confirm
spread
first
confirm
case
first
confirm
case
end
within
three
viru
spread
throughout
contin
last
sovereign
state
free
viru
case
commun
transmiss
although
test
capac
limit
unit
rather
china
viru
earli
june
face
third
wave
covid
rise
pandem
shook
world
economi
especi
sever
econom
damag
unit
consensu
report
intellig
contain
manag
viru
nationalist
global
turn
inward
protect
sometim
cast
blame
furthermor
inflam
partisanship
around
world
bitter
explod
scapegoat
help
first
includ
disrupt
intern
trade
format
result
pandem
mani
entri
either
recent
affect
togeth
willing
travel
neg
econom
social
impact
travel
sector
rais
effect
travel
contain
spread
studi
scienc
found
travel
modestli
affect
initi
spread
unless
combin
infect
prevent
control
consider
reduc
travel
use
earli
late
phase
epidem
travel
wuhan
unfortun
came
late
union
idea
free
travel
zone
owe
effect
wuhan
sever
diplomat
staff
area
primarili
charter
home
nation
provid
clearanc
canada
unit
japan
sri
among
first
plan
evacu
brazil
new
peopl
march
south
south
test
neg
viru
wuhan
four
left
behind
mitig
risk
would
evacu
china
us
would
evacu
aboard
cruis
ship
diamond
princess
canada
ship
earli
march
govern
march
unit
partial
withdraw
due
pandem
june
unit
un
comprehens
respons
unit
confer
trade
develop
slow
respons
especi
regard
un
global
open
humanitarian
access
world
vulner
conflict
lead
involv
global
pandem
sever
solidar
respons
fund
rais
money
pandem
respons
un
suppli
chain
task
forc
solidar
trial
investig
potenti
treatment
diseas
program
distribut
billion
vaccin
free
reduc
cost
end
begun
sever
risen
government
restrict
pandem
studi
found
larg
protest
like
directli
increas
spread
outbreak
major
threat
global
economi
one
estim
expert
univers
st
gave
billion
impact
world
suppli
chain
last
two
global
stock
fell
due
signific
rise
number
outsid
china
due
mount
outbreak
us
stock
post
sinc
dow
fall
drop
sinc
financi
crisi
three
major
end
week
per
cent
scope
china
sovereign
credit
rate
neg
outlook
stock
due
coronaviru
fall
march
global
insur
industri
absorb
us
billion
exceed
atlant
hurrican
season
suggest
pandem
like
go
histori
disast
ever
human
histori
tourism
one
worst
affect
due
travel
public
travel
advic
travel
numer
due
lower
demand
region
cruis
line
industri
hard
hit
sever
train
ferri
close
intern
mail
stop
due
reduc
transport
suspens
domest
servic
retail
sector
impact
global
store
temporari
declin
per
cent
north
middl
east
saw
per
cent
drop
per
cent
drop
foot
traffic
shop
march
shop
mall
around
world
addit
sanit
instal
thermal
check
temperatur
cancel
million
lost
global
million
lost
unemploy
insur
econom
impact
mass
unemploy
pandem
rais
mass
evict
crisi
analysi
aspen
institut
million
risk
evict
end
accord
report
yelp
us
close
sinc
start
pandem
stay
shut
perman
accord
unit
econom
commiss
estim
recess
leav
million
peopl
extrem
poverti
would
situat
without
pandem
accord
world
bank
million
peopl
global
fall
extrem
poverti
due
intern
labour
organ
inform
incom
first
nine
work
across
world
per
cent
trillion
amidst
outbreak
outbreak
blame
sever
suppli
stem
global
usag
equip
fight
panic
sever
led
groceri
food
toilet
paper
bottl
water
disrupt
factori
logist
spread
panic
found
stem
threat
scarciti
fear
unknown
cope
behaviour
social
psycholog
social
influenc
trust
technolog
industri
particular
electron
good
accord
demand
person
protect
equip
risen
hundredfold
lead
twenti
time
normal
price
suppli
medic
four
six
shortag
person
protect
equip
warn
endang
health
impact
outbreak
viru
shortag
raw
materi
use
price
illeg
street
pandem
global
food
trigger
new
food
crisi
head
world
food
face
multipl
within
short
senior
unit
addit
million
peopl
starv
total
million
end
earli
organ
petroleum
steep
declin
oil
due
lower
demand
china
price
west
intermedi
went
neg
fell
record
low
minu
barrel
due
take
deliveri
incur
storag
june
posit
rang
barrel
west
trade
cultur
heritag
profoundli
affect
pandem
well
employ
march
across
world
perform
cultur
indefinit
close
continu
digit
live
stream
holi
week
occur
last
week
penitenti
season
lent
mani
older
stay
home
rather
attend
mass
made
avail
via
radio
live
stream
televis
though
made
worship
cathol
dioces
st
peter
squar
religi
limit
public
health
ministri
cancel
affect
outbreak
later
close
entri
foreign
well
holi
limit
around
select
contrast
usual
number
million
pandem
signific
disrupt
sport
calendar
sinc
second
world
war
major
sport
leagu
premier
leagu
major
leagu
basebal
season
season
season
arctic
winter
outbreak
summer
japan
origin
start
intern
committe
entertain
industri
affect
mani
music
concert
song
contest
due
howev
host
mani
larg
broadway
suspend
larg
number
peopl
work
learn
home
via
led
sever
new
zoom
fatigu
declin
demand
formal
cloth
fashion
focu
cloth
upper
bodi
lower
bodi
gener
visibl
term
wide
use
numer
spread
mani
turn
humour
distract
amid
uncertainti
pandem
affect
polit
multipl
caus
legisl
multipl
due
spread
viru
although
broad
support
among
social
polit
controversi
mani
intellectu
opposit
social
come
primarili
although
heterodox
march
unit
de
appeal
global
respons
pandem
un
member
statement
support
appeal
june
un
secur
council
resolut
support
govern
china
unit
minist
cabinet
offic
gove
handl
pandem
number
communist
parti
china
handl
quarantin
china
sign
discont
respons
outbreak
move
intend
protect
gener
secretari
xi
controversi
us
intellig
commun
china
intent
number
govern
transpar
howev
pandem
tortur
pandem
detain
independ
earli
march
govern
eu
lack
solidar
ambassador
eu
china
bilater
eu
march
phone
call
prime
minist
cont
presid
armi
send
militari
disinfect
medic
equip
presid
foreign
minist
di
express
gratitud
aid
russia
sent
cargo
plane
medic
aid
unit
kremlin
spokesman
offer
assist
us
us
medic
equip
gain
momentum
abl
reciproc
necessari
earli
eu
offer
help
send
medic
personnel
disinfect
offici
apolog
countri
outbreak
unit
adopt
social
common
wealthi
univers
health
care
univers
child
care
sick
leav
higher
public
health
polit
believ
trump
loss
presidenti
elect
begin
sever
us
busi
restrict
person
movement
associ
simultan
essenti
form
gener
strike
earli
trump
famili
mani
govern
countri
polit
defend
militari
exercis
war
exercis
sinc
end
cold
war
reduc
scale
campaign
nuclear
disarma
gener
secretari
exercis
say
us
mani
oper
govern
heavili
affect
viru
two
dozen
parliament
fifteen
current
former
polit
infect
presid
wrote
public
letter
world
help
march
say
struggl
fight
outbreak
due
lack
access
intern
unit
militari
intervent
march
declar
diplomat
japan
south
due
pandem
south
japan
ambigu
passiv
quarantin
japan
anyon
come
south
would
quarantin
two
south
societi
initi
presid
moon
respons
crisi
mani
either
call
moon
impeach
prais
respons
emerg
legisl
respons
pandem
express
concern
allow
strengthen
grip
power
presid
temporari
emerg
pandem
parliament
allow
prime
minist
rule
decre
indefinit
suspend
parliament
well
punish
spread
fals
inform
viru
govern
handl
crisi
turkey
opposit
govern
allegedli
spread
fake
news
pandem
govern
respons
polic
relat
pandem
pandem
agricultur
food
hit
time
hunger
undernourish
rise
world
million
peopl
alreadi
go
hungri
base
latest
un
econom
recess
trigger
pandem
lead
anoth
million
peopl
possibl
mani
million
go
hungri
mainli
due
lack
access
food
link
fall
lost
rise
food
alreadi
suffer
high
acut
food
insecur
longer
issu
access
food
alon
increasingli
one
food
product
pandem
alongsid
travel
movement
aid
greatli
impact
food
product
result
sever
forecast
un
crisi
hunger
pandem
without
intervent
million
peopl
die
hunger
peopl
per
day
die
link
hunger
end
pandem
conjunct
locust
sever
ongo
arm
form
worst
seri
sinc
great
famin
affect
per
cent
global
popul
way
risk
three
dozen
scenario
million
peopl
forecast
famin
increas
million
due
pandem
pandem
sever
impact
educ
global
temporarili
close
educ
mani
switch
educ
approxim
billion
affect
due
school
respons
pandem
accord
march
close
per
cent
world
student
popul
school
impact
econom
societ
shed
light
social
econom
student
debt
digit
learn
food
insecur
homeless
well
access
health
care
hous
disabl
impact
sever
citat
higher
educ
polici
institut
report
discov
around
mental
health
result
pandem
alongsid
satisfact
access
mental
health
despit
director
polici
advocaci
institut
still
unclear
normal
resum
regard
educ
live
situat
pandem
mani
global
health
beyond
diseas
led
reduct
hospit
per
cent
hospit
heart
attack
unit
per
cent
head
cardiolog
univers
worri
peopl
die
home
go
hospit
concern
peopl
append
seek
time
treatment
medic
impact
peopl
variou
sever
mark
reduct
spread
sexual
attribut
social
engag
casual
sex
similarli
transmiss
influenza
respiratori
significantli
pandem
pandem
neg
impact
mental
health
global
loneli
result
social
depress
domest
violenc
june
us
advers
mental
health
serious
consid
tri
kill
past
month
disrupt
pandem
numer
posit
effect
environ
climat
global
reduct
modern
human
activ
consider
declin
travel
larg
drop
air
pollut
water
pollut
mani
china
percent
reduct
carbon
percent
reduct
nitrogen
one
earth
scientist
save
least
two
posit
effect
environ
includ
toward
sustain
energi
transit
relat
environment
protect
union
trillion
budget
propos
billion
recoveri
plan
next
gener
eu
reserv
eu
spend
expenditur
howev
pandem
provid
cover
illeg
deforest
environment
diplomaci
combin
late
capit
econom
predict
slow
invest
green
energi
prejudic
xenophobia
racism
around
world
toward
peopl
east
descent
confirm
confin
china
racist
express
peopl
deserv
viru
peopl
unit
kingdom
unit
increas
racist
abus
former
us
presid
trump
viru
kung
flu
condemn
racist
march
famili
girl
relat
hate
crime
follow
progress
outbreak
new
peopl
first
countri
experi
seriou
outbreak
subject
suspicion
xenophobia
peopl
discrimin
public
health
missionari
group
gather
new
earli
march
sourc
spread
late
seen
break
polic
treatment
ethnic
racism
xenophobia
toward
southern
south
east
gulf
south
commun
blame
spread
china
peopl
descent
told
leav
china
within
due
spread
viru
racism
xenophobia
foreign
diplomat
corp
ambassador
zimbabw
discrimin
older
alreadi
present
pandem
preval
pandem
vulner
viru
subsequ
physic
social
isol
coupl
alreadi
reduc
social
activ
depend
similarli
limit
digit
literaci
left
elderli
vulner
effect
isol
depress
loneli
pandem
mani
peopl
massiv
life
commerc
activ
job
market
social
larg
us
post
billion
increas
billion
year
trend
home
deliveri
due
pandem
indoor
dine
shut
due
low
peopl
due
massiv
part
differ
educ
increasingli
physic
attend
video
zoom
forc
shut
due
pandem
mass
travel
hospit
perman
recoveri
updat
ongo
research
index
searchabl
portfolio
newspap
remov
scientif
made
scientif
relat
outbreak
avail
open
access
chose
share
quickli
preprint
key
role
inform
concern
spatial
distribut
diseas
especi
develop
present
data
near
data
drawn
critic
howev
oversimplif
geograph
adopt
nation
rather
local
map
scale
pandem
misinform
conspiraci
scale
pandem
origin
prevent
diagnosi
treatment
diseas
fals
inform
intent
spread
social
media
text
mass
media
allegedli
spread
fake
news
pandem
fals
inform
promin
public
spread
misinform
signific
commerci
offer
suppos
miracl
sever
religi
faith
protect
viru
without
evid
peopl
viru
accident
deliber
laboratori
popul
control
scheme
result
spi
oper
side
effect
cellular
templat
pandem
group
relat
caus
caus
respiratori
tract
rang
mild
lethal
mild
includ
common
cold
predominantli
lethal
caus
caus
diarrhea
mice
caus
hepat
encephalomyel
constitut
subfamili
famili
order
realm
genom
helic
symmetri
genom
size
approxim
one
among
characterist
project
surfac
electron
creat
imag
reminisc
solar
corona
name
name
coronaviru
deriv
corona
mean
crown
wreath
borrow
garland
wreath
name
june
first
studi
human
word
first
use
print
inform
group
journal
natur
design
new
famili
name
characterist
appear
infect
form
viru
electron
microscopi
fring
larg
bulbou
surfac
imag
reminisc
solar
corona
halo
morpholog
viral
spike
surfac
viru
scientif
name
coronaviru
accept
genu
name
intern
committe
nomenclatur
later
intern
committe
taxonomi
number
new
speci
genu
split
four
genera
name
common
name
coronaviru
use
refer
member
subfamili
speci
offici
coronaviru
infect
late
acut
respiratori
infect
north
made
first
detail
report
new
respiratori
infect
north
infect
gasp
listless
high
mortal
carl
isol
viru
infect
viru
known
infecti
bronchiti
viru
cultiv
viru
first
time
specimen
came
known
strain
late
two
anim
brain
diseas
murin
enceph
mous
hepat
viru
hepat
mice
discov
time
three
differ
relat
human
discov
two
differ
unit
kingdom
unit
work
common
cold
unit
medic
research
council
collect
uniqu
common
cold
viru
viru
cultiv
standard
success
cultiv
known
common
cold
success
cultiv
novel
viru
serial
pass
organ
cultur
human
embryon
trachea
new
method
lab
isol
viru
cold
ether
envelop
univers
isol
novel
cold
medic
isol
grew
viru
kidney
tissu
cultur
novel
viru
cold
ether
virologist
june
st
hospit
electron
microscopi
three
shown
morpholog
relat
gener
shape
distinct
research
group
nation
institut
health
year
abl
isol
anoth
member
new
group
organ
cultur
one
organ
cultur
novel
cold
viru
distinct
electron
microscop
novel
cold
soon
shown
morpholog
relat
mous
hepat
viru
new
group
distinct
morpholog
appear
human
coronaviru
human
coronaviru
continu
studi
subsequ
coronaviru
strain
lost
known
present
human
coronaviru
human
sinc
larg
number
anim
sinc
larg
roughli
spheric
uniqu
surfac
size
highli
variabl
averag
extrem
size
known
diamet
total
molecular
mass
averag
envelop
number
protein
envelop
membran
protect
viru
outsid
host
cell
viral
envelop
made
membran
envelop
e
spike
structur
anchor
molar
ratio
e
approxim
e
protein
structur
combin
shape
viral
envelop
maintain
size
interact
host
human
coronaviru
peculiar
protein
bind
site
host
cell
protein
diamet
envelop
envelop
viru
electron
distinct
pair
rel
opaqu
electron
beam
use
scan
viru
particl
protein
main
structur
protein
envelop
overal
shape
type
membran
protein
amino
acid
layer
thick
three
short
domain
domain
lattic
envelop
differ
speci
either
n
protein
domain
protein
crucial
assembl
bud
envelop
format
pathogenesi
viru
e
minor
structur
highli
variabl
differ
speci
e
protein
molecul
coronaviru
particl
size
compos
amino
integr
ie
layer
two
name
domain
domain
almost
fulli
singl
domain
form
ion
respons
assembl
intracellular
morphogenesi
bud
distinguish
featur
respons
corona
halolik
surfac
averag
coronaviru
particl
surfac
spike
long
compos
trimer
protein
protein
turn
compos
subunit
protein
class
fusion
protein
receptor
bind
membran
fusion
viru
host
cell
subunit
head
spike
domain
subunit
stem
spike
viral
envelop
proteas
activ
fusion
two
remain
link
expos
viral
surfac
attach
host
cell
membran
function
activ
state
three
attach
two
subunit
complex
split
individu
viru
host
cell
action
cathepsin
famili
proteas
serin
host
cell
critic
infect
variabl
respons
host
cell
specif
possess
two
major
domain
domain
serv
recogn
bind
surfac
host
cell
except
protein
receptor
cell
adhes
molecul
respons
differ
protein
enzym
n
peptidas
subset
specif
subgroup
shorter
spikelik
surfac
protein
hemagglutinin
esteras
occur
compos
amino
acid
size
appear
tini
surfac
long
help
attach
detach
host
cell
insid
envelop
form
multipl
n
protein
bound
genom
continu
type
conform
n
protein
phosphoprotein
size
divid
three
major
protein
made
typic
rich
domain
short
carboxi
termin
end
net
neg
charg
due
excess
acid
basic
amino
acid
contain
genom
genom
size
genom
size
one
among
genom
cap
tail
genom
organ
coronaviru
spike
envelop
e
membran
n
tail
open
read
occupi
first
genom
encod
self
form
nonstructur
later
read
encod
four
major
structur
spike
envelop
membran
read
read
accessori
number
accessori
function
uniqu
depend
specif
coronaviru
infect
viral
spike
protein
complementari
host
cell
receptor
attach
proteas
host
cell
spike
protein
depend
host
cell
proteas
avail
cleavag
activ
viru
enter
host
cell
direct
fusion
viral
envelop
host
membran
entri
host
cell
viru
particl
uncoat
genom
cell
cytoplasm
coronaviru
genom
cap
tail
act
messeng
directli
host
cell
host
translat
initi
open
read
viru
genom
two
larg
result
slipperi
sequenc
downstream
end
open
read
frame
continu
translat
cleav
differ
specif
cleavag
nonstructur
product
includ
variou
replic
number
nonstructur
coalesc
form
complex
main
protein
directli
involv
replic
transcript
strand
nonstructur
complex
assist
replic
transcript
process
nonstructur
protein
instanc
extra
fidel
replic
provid
proofread
function
replic
one
main
complex
replic
viral
genom
directli
synthesi
genom
genom
replic
genom
genom
transcript
import
function
complex
transcrib
viral
genom
directli
synthesi
genom
process
transcript
correspond
form
set
common
partial
duplic
recombin
complex
capabl
genet
recombin
least
two
viral
present
infect
cell
recombin
major
drive
forc
genet
variabl
within
coronaviru
speci
capabl
coronaviru
speci
jump
one
host
anoth
infrequ
emerg
novel
exact
mechan
recombin
unclear
like
templat
switch
genom
replic
replic
genom
becom
genom
progeni
gene
last
third
viru
genom
initi
read
frame
host
structur
mani
accessori
translat
insid
endoplasm
reticulum
viral
structur
e
move
along
secretori
pathway
intermedi
compart
direct
assembl
follow
bind
progeni
host
cell
secretori
infect
host
infect
abl
shed
environ
interact
coronaviru
spike
protein
complementari
cell
receptor
central
tissu
tropism
infect
speci
rang
viru
mainli
target
epitheli
one
host
anoth
host
depend
coronaviru
speci
either
aerosol
rout
human
infect
epitheli
respiratori
tract
anim
gener
infect
epitheli
digest
tract
coronaviru
exampl
human
epitheli
via
aerosol
rout
bind
enzym
receptor
transmiss
gastroenter
coronaviru
pig
epitheli
digest
tract
via
rout
bind
alanin
receptor
form
subfamili
one
two
famili
order
realm
divid
four
genera
infect
primarili
infect
recent
common
ancestor
recent
although
place
common
ancestor
far
back
million
long
term
bat
avian
speci
recent
common
ancestor
line
line
line
line
bat
fli
ideal
natur
reservoir
coronaviru
gene
pool
bat
reservoir
reservoir
larg
number
global
rang
bat
avian
speci
host
extens
evolut
dissemin
mani
human
origin
bat
human
coronaviru
common
ancestor
bat
coronaviru
ce
human
coronaviru
common
ancestor
bat
coronaviru
ce
recent
alpaca
coronaviru
human
coronaviru
sometim
bat
intermedi
host
although
relat
sever
bat
coronaviru
speci
sever
ago
close
relat
bat
coronaviru
first
infect
bat
genu
subsequ
spread
horsesho
bat
speci
palm
final
unlik
bovin
coronaviru
speci
subgenu
thought
bat
equin
coronaviru
bovin
coronaviru
jump
later
human
coronaviru
bovin
coronaviru
anoth
event
flu
pandem
event
influenza
viru
relat
time
neurolog
unknown
caus
agent
pandem
besid
caus
respiratori
human
coronaviru
suspect
role
neurolog
human
coronaviru
diverg
present
phylogenet
mous
hepat
viru
murin
coronaviru
mous
liver
central
nervou
system
relat
human
coronaviru
bovin
coronaviru
human
coronaviru
vari
significantli
risk
factor
kill
infect
rel
harmless
common
cold
caus
major
fever
sore
throat
swollen
caus
pneumonia
either
direct
viral
pneumonia
secondari
bacteri
pneumonia
bronchiti
either
direct
viral
bronchiti
secondari
bacteri
bronchiti
human
coronaviru
discov
sever
acut
respiratori
syndrom
uniqu
pathogenesi
upper
lower
respiratori
tract
six
speci
human
known
one
speci
two
differ
make
seven
human
altogeth
four
human
produc
gener
mild
even
though
aggress
past
three
human
produc
potenti
sever
caus
commonli
respect
although
common
cold
usual
caus
coronaviru
human
continu
circul
human
popul
produc
gener
mild
common
cold
four
mild
season
incid
winter
temper
preponder
season
tropic
follow
outbreak
sever
acut
respiratori
syndrom
begun
prior
year
secondari
elsewher
world
world
health
organ
press
releas
novel
coronaviru
sever
caus
agent
viru
offici
coronaviru
peopl
differ
infect
least
new
type
coronaviru
initi
novel
coronaviru
offici
middl
east
respiratori
syndrom
coronaviru
world
health
organ
global
alert
soon
updat
viru
seem
pass
easili
person
person
howev
case
transmiss
confirm
ministri
social
health
addit
transmiss
ministri
health
two
confirm
involv
peopl
caught
diseas
late
father
ill
visit
despit
viru
troubl
spread
human
human
infect
transmit
viru
dutch
medic
viru
viru
given
new
name
human
medic
final
name
viru
middl
east
respiratori
syndrom
coronaviru
us
outbreak
republ
man
travel
middl
east
four
area
treat
ill
one
outsid
middl
east
infect
confirm
laboratori
fatal
mortal
rate
approxim
pneumonia
outbreak
wuhan
china
outbreak
novel
strain
coronaviru
given
interim
name
world
health
organ
later
intern
committe
taxonomi
june
least
confirm
confirm
pandem
wuhan
strain
new
strain
group
approxim
genet
similar
viru
similar
bat
coronaviru
wide
suspect
origin
bat
well
surveil
studi
viral
pneumonia
strain
canin
coronaviru
infect
caus
patholog
veterinari
medicin
sinc
infect
rang
swine
cattl
dog
bat
major
anim
relat
infect
intestin
tract
rout
signific
research
viral
pathogenesi
anim
especi
interest
veterinari
zoonot
infect
infecti
bronchiti
viru
type
coronaviru
avian
infecti
bronchiti
viru
concern
poultri
industri
high
mortal
infect
rapid
spread
effect
product
viru
meat
product
egg
product
substanti
econom
loss
infecti
bronchiti
viru
respiratori
tract
urogenit
tract
viru
spread
differ
throughout
chicken
viru
aerosol
food
fece
differ
exist
limit
spread
viru
infecti
bronchiti
viru
one
number
speci
avian
coronaviru
anoth
strain
avian
coronaviru
turkey
coronaviru
enter
affect
anim
husbandri
pig
farm
cattl
rais
swine
acut
diarrhea
syndrom
coronaviru
relat
bat
coronaviru
diarrhea
porcin
epidem
diarrhea
viru
coronaviru
recent
similarli
diarrhea
transmiss
gastroenter
viru
member
speci
anoth
coronaviru
diarrhea
young
cattl
industri
bovin
coronaviru
member
speci
relat
respons
sever
profus
enter
young
calv
infect
domest
dog
two
felin
coronaviru
speci
felin
enter
coronaviru
pathogen
minor
clinic
signific
spontan
mutat
viru
result
felin
infecti
periton
fip
diseas
high
mortal
two
differ
infect
dog
canin
coronaviru
member
speci
mild
gastrointestin
diseas
canin
respiratori
coronaviru
member
speci
relat
caus
respiratori
diseas
similarli
two
coronaviru
infect
ferret
enter
coronaviru
gastrointestin
syndrom
known
epizoot
catarrh
enter
lethal
system
version
viru
fip
known
ferret
system
coronaviru
infect
laboratori
mous
hepat
viru
member
speci
murin
coronaviru
epidem
murin
ill
high
mortal
especi
among
laboratori
mice
prior
discoveri
coronaviru
well
molecular
level
caus
progress
enceph
mice
use
murin
model
multipl
sclerosi
viru
strain
speci
murin
coronaviru
highli
infecti
coronaviru
laboratori
direct
contact
indirectli
aerosol
rabbit
enter
coronaviru
acut
gastrointestin
diseas
diarrhea
young
mortal
high
number
differ
human
coronaviru
antivir
human
viral
entri
develop
target
differ
viral
replic
avail
anim
canin
although
effect
limit
case
highli
contagi
anim
destruct
entir
use
prevent
transmiss
convey
deploy
countri
industri
coronaviru
diseas
contagi
diseas
sever
acut
respiratori
syndrom
coronaviru
first
known
case
wuhan
china
diseas
sinc
spread
lead
ongo
pandem
variabl
often
includ
fever
cough
headach
fatigu
breath
loss
smell
tast
begin
one
fourteen
day
exposur
viru
least
third
peopl
infect
develop
notic
peopl
develop
notic
enough
class
develop
mild
moder
mild
pneumonia
develop
sever
dyspnea
lung
involv
suffer
critic
respiratori
failur
shock
dysfunct
older
peopl
higher
risk
sever
peopl
continu
experi
rang
effect
long
covid
recoveri
damag
underway
investig
effect
diseas
transmiss
peopl
expos
respiratori
infect
person
reach
mouth
nose
person
touch
direct
deposit
ie
risk
infect
highest
peopl
close
proxim
long
time
longer
particularli
indoor
poorli
crowd
small
remain
suspend
air
touch
surfac
object
lead
infect
although
contribut
substanti
transmiss
peopl
infect
transmit
viru
anoth
person
two
day
show
peopl
experi
peopl
remain
infecti
ten
day
onset
moder
twenti
day
sever
sever
test
diagnos
diseas
standard
diagnost
method
detect
viru
acid
revers
transcript
chain
reaction
amplif
revers
transcript
isotherm
amplif
nasopharyng
swab
prevent
includ
physic
social
ventil
indoor
cover
hand
wash
keep
unwash
away
face
use
face
public
minim
risk
work
underway
develop
inhibit
viru
sever
distribut
variou
sinc
mass
vaccin
primari
treatment
symptomat
manag
treatment
support
care
isol
experiment
initi
outbreak
wuhan
viru
diseas
commonli
coronaviru
wuhan
coronaviru
diseas
sometim
wuhan
pneumonia
past
mani
geograph
flu
middl
east
respiratori
syndrom
viru
acut
respiratori
diseas
interim
viru
diseas
per
guidanc
intern
geograph
wuhan
china
anim
speci
peopl
diseas
viru
part
prevent
social
stigma
offici
corona
viru
diseas
outbreak
first
addit
viru
viru
respons
public
variabl
rang
mild
sever
ill
common
includ
headach
loss
smell
tast
nasal
congest
runni
nose
cough
muscl
pain
sore
throat
fever
diarrhea
breath
peopl
infect
differ
chang
time
three
common
one
respiratori
symptom
cluster
cough
sputum
short
breath
fever
symptom
cluster
muscl
joint
pain
headach
fatigu
cluster
digest
abdomin
pain
vomit
diarrhea
peopl
without
prior
ear
nose
throat
loss
tast
combin
loss
smell
associ
peopl
show
develop
mild
moder
mild
pneumonia
develop
sever
dyspnea
lung
involv
suffer
critic
respiratori
failur
shock
dysfunct
least
third
peopl
infect
viru
develop
notic
point
time
asymptomat
tend
get
test
spread
diseas
infect
peopl
develop
later
presymptomat
mild
spread
viru
common
delay
moment
person
first
becom
infect
appear
first
median
delay
four
five
day
symptomat
peopl
experi
within
two
seven
day
exposur
almost
experi
least
one
symptom
within
day
infect
sever
acut
respiratori
syndrom
coronaviru
viru
strain
citat
diseas
mainli
via
respiratori
rout
peopl
inhal
infect
peopl
releas
breath
talk
cough
sneez
sing
infect
peopl
like
transmit
physic
close
howev
infect
occur
longer
particularli
indoor
infect
earli
three
day
appear
peopl
infecti
prior
onset
first
week
infect
peopl
remain
contagi
day
peopl
spread
diseas
even
asymptomat
infecti
rang
size
remain
suspend
air
long
time
remain
fall
ground
variou
droplet
technic
gener
way
lead
confus
around
terminolog
addit
research
tradit
understand
respiratori
transmit
respiratori
fluid
travel
far
land
mucou
nose
mouth
infect
highest
concentr
peopl
close
proxim
easier
viral
transmiss
peopl
physic
close
transmiss
occur
longer
mainli
poorli
small
remain
suspend
air
sever
acut
respiratori
syndrom
coronaviru
novel
sever
acut
respiratori
syndrom
coronaviru
first
isol
three
peopl
pneumonia
connect
cluster
acut
respiratori
ill
wuhan
structur
novel
viru
particl
occur
relat
natur
outsid
human
bodi
viru
household
soap
protect
bubbl
close
relat
origin
thought
anim
zoonot
origin
genet
analysi
reveal
coronaviru
genet
genu
subgenu
lineag
b
togeth
two
ident
whole
genom
level
bat
coronaviru
structur
includ
membran
glycoprotein
envelop
protein
e
protein
n
spike
protein
protein
similar
protein
bat
around
homolog
pangolin
homolog
protein
wherea
similar
around
protein
structur
protein
sugar
transport
mani
group
either
standard
nomenclatur
five
seven
l
v
g
tool
mani
class
lineag
sever
notabl
late
citat
cluster
among
mink
citat
strict
mink
euthanasia
campaign
medic
citat
updat
three
spread
among
global
variant
first
found
kent
variant
discov
south
variant
discov
brazil
whole
genom
epidemiolog
suggest
variant
first
variant
investig
lineag
easili
affect
upper
respiratori
tract
nose
throat
lower
respiratori
tract
windpip
affect
viru
host
via
receptor
enzym
enzym
abund
surfac
type
alveolar
viru
special
surfac
glycoprotein
spike
connect
receptor
enter
host
cell
whether
abl
invad
nervou
system
remain
unknown
howev
clear
mani
peopl
exhibit
neurolog
mental
health
viru
major
peopl
neurolog
howev
low
brain
need
confirm
loss
smell
infect
support
olfactori
epithelium
subsequ
damag
olfactori
caus
respiratori
failur
affect
brain
stem
found
invad
viru
cerebrospin
fluid
exact
mechan
remain
unclear
first
involv
invas
peripher
given
low
brain
viru
enter
cross
barrier
gain
access
possibl
within
infect
white
blood
cell
viru
gastrointestin
abundantli
express
glandular
gastric
duoden
rectal
epithelium
well
endotheli
small
intestin
viru
caus
acut
myocardi
injuri
chronic
damag
cardiovascular
system
acut
cardiac
injuri
found
infect
peopl
admit
hospit
wuhan
china
frequent
sever
diseas
cardiovascular
high
owe
system
inflammatori
respons
immun
system
diseas
progress
acut
myocardi
relat
heart
highli
express
heart
involv
heart
function
high
incid
thrombosi
venou
found
peopl
transfer
intens
care
unit
relat
poor
prognosi
blood
vessel
dysfunct
clot
format
high
blood
thought
play
signific
role
mortal
lead
pulmonari
within
brain
note
lead
death
peopl
infect
infect
set
chain
vasoconstrict
within
bodi
constrict
blood
within
pulmonari
circul
mechan
oxygen
alongsid
present
viral
pneumonia
furthermor
blood
vessel
damag
small
number
tissu
brain
without
olfactori
anoth
common
caus
death
relat
earli
show
china
new
york
experienc
injuri
previou
kidney
peopl
found
diffus
alveolar
damag
inflammatori
within
lung
although
tropism
epitheli
respiratori
tract
peopl
sever
system
clinic
laboratori
elev
factor
protein
monocyt
protein
macrophag
inflammatori
protein
necrosi
factor
indic
releas
syndrom
suggest
underli
addit
peopl
acut
respiratori
distress
syndrom
classic
serum
elev
protein
lactat
dehydrogenas
system
inflamm
vasodil
inflammatori
lymphocyt
monocyt
infiltr
lung
heart
particular
pathogen
shown
correl
recruit
inflammatori
sever
lung
patholog
peopl
lymphocyt
autopsi
multipl
viral
host
affect
pathogenesi
viru
otherwis
known
spike
protein
viral
compon
host
receptor
via
two
rang
cellular
tropism
via
domain
membran
fusion
viru
potenti
cell
host
via
heptad
repeat
shown
domain
induc
antibodi
much
higher
capac
focu
spike
express
involv
mani
effect
protein
viral
protein
respons
transport
caus
bud
releas
format
viral
envelop
n
e
protein
accessori
interfer
host
immun
respons
human
convert
enzym
host
factor
viru
caus
theoret
usag
receptor
ace
express
increas
morbid
though
anim
data
suggest
potenti
protect
effect
howev
clinic
proven
suscept
data
avail
hypertens
remain
effect
viru
cell
infiltr
blood
vessel
permeabl
alveolar
wall
permeabl
well
secret
lung
effect
caus
major
respiratori
howev
aggrav
local
inflamm
storm
eventu
lead
system
inflammatori
respons
syndrom
among
healthi
expos
recogn
protein
particularli
subunit
react
viru
suggest
previou
common
sever
inflamm
sever
known
storm
protein
monocyt
protein
associ
diseas
sever
treatment
combat
storm
remain
one
lead
morbid
mortal
diseas
storm
due
acut
respons
respons
clinic
ill
array
relat
wors
prognosi
fatal
storm
acut
respiratori
distress
syndrom
blood
myocardi
infarct
enceph
acut
kidney
injuri
vascul
product
crucial
normal
immun
inadvert
becom
storm
central
nervou
system
microglia
involv
releas
affect
nervou
system
effect
toward
uncommon
pregnanc
respons
nowaday
mani
pregnant
pandem
given
prone
suffer
sever
diseas
infect
vulner
group
advis
take
supplementari
prevent
physiolog
pregnanc
includ
howev
evid
base
difficult
conclud
whether
pregnant
risk
grave
viru
addit
clinic
prove
affect
period
pregnanc
differ
way
one
hand
littl
evid
impact
gestat
hand
infect
caus
unfavor
cours
pregnanc
fetal
growth
restrict
birth
mortal
fetal
death
past
pregnanc
well
death
among
liveborn
seven
day
life
provision
basi
confirm
revers
transcript
chain
reaction
acid
test
infect
along
laboratori
test
chest
help
diagnos
high
clinic
suspicion
infect
detect
past
infect
possibl
serolog
detect
produc
bodi
respons
infect
standard
test
presenc
acid
presenc
viral
detect
infecti
viru
abil
determin
durat
infect
limit
test
typic
done
respiratori
nasopharyng
swab
howev
nasal
swab
sputum
sampl
use
gener
avail
within
sever
test
diseas
sever
serolog
detect
produc
bodi
respons
infect
sever
public
health
use
univers
point
mount
evid
good
proport
new
mild
peopl
quarantin
discharg
hospit
infecti
simpli
clear
harmless
viru
immun
system
effici
dealt
intern
effort
standard
period
calibr
test
govern
guidanc
provid
assur
posit
low
preval
reduct
predict
valu
posit
test
chest
help
diagnos
high
clinic
suspicion
infect
routin
screen
bilater
multilobar
peripher
asymmetr
posterior
distribut
common
earli
infect
subpleur
domin
crazi
pave
lobular
septal
thicken
variabl
alveolar
fill
consolid
appear
diseas
characterist
chest
tomographi
peopl
symptomat
includ
asymmetr
peripher
without
pleural
mani
includ
imageri
radiolog
societi
intern
confirm
due
overlap
without
confirm
limit
specif
larg
studi
china
chest
though
less
specif
infect
faster
sensit
late
assign
emerg
diseas
infect
clinic
without
infect
main
patholog
autopsi
prevent
reduc
infect
includ
get
home
wear
mask
public
crowd
keep
distanc
ventil
indoor
potenti
exposur
wash
soap
water
often
least
twenti
good
respiratori
hygien
touch
nose
mouth
unwash
believ
infect
advis
stay
home
except
get
medic
care
call
ahead
visit
provid
wear
face
mask
enter
provid
offic
room
vehicl
anoth
person
cover
tissu
regularli
wash
soap
water
avoid
person
household
first
vaccin
regulatori
approv
regul
emerg
use
author
statu
us
sever
initi
us
nation
health
recommend
medic
prevent
exposur
viru
outsid
set
clinic
trial
without
vaccin
prophylact
effect
key
part
tri
decreas
delay
epidem
peak
known
flatten
curv
done
infect
rate
decreas
risk
health
better
treatment
activ
delay
addit
effect
vaccin
becom
avail
vaccin
vaccin
intend
provid
acquir
immun
sever
acut
respiratori
syndrom
coronaviru
viru
coronaviru
diseas
wide
celebr
role
reduc
spread
sever
death
prior
pandem
establish
bodi
knowledg
structur
function
caus
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
knowledg
acceler
develop
variou
vaccin
earli
genet
sequenc
data
march
global
pharmaceut
industri
major
commit
address
phase
sever
efficaci
high
symptomat
june
updat
author
least
one
nation
regulatori
author
public
use
two
nine
convent
academi
medic
covaxin
five
viral
vector
sputnik
light
sputnik
v
johnson
johnson
two
protein
subunit
verif
total
march
updat
vaccin
variou
develop
clinic
research
phase
phase
phase
develop
mani
distribut
highest
risk
elderli
high
risk
exposur
transmiss
singl
dose
interim
use
consider
extend
vaccin
mani
peopl
possibl
vaccin
avail
us
recommend
wear
nonmed
face
public
risk
transmiss
social
difficult
maintain
recommend
meant
reduc
spread
diseas
asymptomat
presymptomat
complementari
establish
prevent
social
face
limit
volum
travel
distanc
expiratori
dispers
talk
breath
face
cover
without
filter
viru
air
reduc
infect
mask
includ
exhal
valv
wearer
infect
mayb
without
asymptomat
would
transmit
viru
outward
despit
certif
exhal
valv
infect
reliabl
stop
pandem
larg
scale
mani
local
encourag
mandat
use
face
cloth
face
public
limit
spread
viru
strongli
infect
take
care
someon
diseas
wear
mask
cover
mouth
nose
tissu
sneez
insid
elbow
tissu
avail
proper
hand
hygien
cough
sneez
directli
peopl
advis
use
least
protect
equival
addit
person
protect
equip
crowd
indoor
indoor
increas
rate
air
chang
decreas
recircul
air
increas
use
outdoor
air
reduc
transmiss
ventil
air
filtrat
public
help
clear
infecti
respiratori
buildup
within
inadequ
ventil
risk
infect
especi
peopl
engag
physic
exert
rais
voic
shout
sing
exhal
respiratori
exposur
typic
higher
risk
infect
thorough
hand
hygien
cough
sneez
wash
often
soap
water
least
twenti
especi
go
toilet
visibl
dirti
eat
blow
one
nose
soap
water
avail
hand
least
alcohol
commerci
hand
readili
avail
two
local
product
activ
ethanol
hydrogen
peroxid
use
help
elimin
bacteri
alcohol
activ
substanc
hand
antisepsi
glycerol
ad
humect
social
known
physic
infect
control
intend
slow
spread
diseas
close
contact
includ
travel
shop
appli
social
home
limit
travel
crowd
physic
mani
social
affect
outbreak
due
inabl
enforc
adequ
social
unit
prison
popul
age
mani
high
risk
poor
due
high
heart
lung
diseas
poor
access
bodi
surviv
day
person
dirti
surfac
deposit
viru
nose
mouth
enter
bodi
caus
infect
evid
contact
infect
main
driver
lead
disinfect
avoid
increas
resist
use
inappropri
clean
deep
clean
surfac
sanit
hygien
theater
give
fals
sens
secur
someth
primarili
spread
air
amount
time
viru
surviv
significantli
type
surfac
temperatur
humid
die
quickli
expos
light
sunlight
temperatur
room
temperatur
lower
rel
humid
low
mani
glass
plastic
stainless
steel
skin
viru
remain
infect
sever
day
indoor
room
temperatur
even
week
ideal
cotton
fabric
copper
viru
usual
viru
faster
porou
nonpor
due
capillari
action
within
faster
aerosol
droplet
evapor
howev
mani
test
two
surviv
time
respir
surgic
consid
porou
clean
soap
deterg
enough
reduc
risk
transmiss
case
suspect
confirm
facil
offic
day
care
common
electron
equip
touch
remot
use
ill
percent
ethanol
percent
percent
sodium
hypochlorit
percent
hydrogen
peroxid
percent
chlorid
less
effect
ultraviolet
germicid
irradi
use
disinfect
food
industri
suspens
surfac
test
kind
surfac
use
dilut
disinfect
seen
supplementari
materi
home
suspect
infect
health
detail
proper
mani
entir
expos
someon
recent
travel
countri
region
widespread
transmiss
advis
day
time
last
possibl
exposur
citat
th
school
public
health
healthi
diet
physic
activ
psycholog
stress
get
enough
sleep
consist
meet
scientif
per
week
exercis
similar
physic
activ
shown
associ
smaller
risk
death
due
even
consid
like
risk
elev
march
evid
vitamin
statu
relationship
health
clinic
trial
subject
dosag
regim
near
set
conclud
rapid
review
found
base
upon
evid
intern
control
travel
help
contain
spread
addit
screen
miss
mani
posit
border
screen
effect
miss
mani
posit
upon
arriv
without
review
minimum
quarantin
benefici
spread
effect
combin
addit
control
measur
border
screen
specif
effect
treatment
cure
coronaviru
diseas
diseas
viru
need
updat
thu
cornerston
manag
support
care
treatment
reliev
fluid
therapi
oxygen
support
prone
support
affect
vital
mild
support
care
medic
reliev
fever
bodi
cough
proper
intak
rest
nasal
breath
good
person
hygien
healthi
diet
us
diseas
control
prevent
recommend
suspect
carri
viru
isol
home
wear
face
mask
peopl
sever
need
treatment
hospit
low
oxygen
use
strongli
reduc
risk
death
ventil
ultim
admiss
intens
care
unit
mechan
ventil
support
breath
extracorpor
membran
oxygen
use
address
issu
respiratori
failur
still
consider
sever
diseas
take
mild
cours
common
upper
respiratori
common
cold
age
sever
enough
caus
hospit
mild
typic
recov
within
two
sever
critic
take
three
six
recov
among
time
symptom
onset
death
rang
two
eight
di
median
time
onset
death
twelv
day
seven
howev
peopl
transfer
median
time
ten
day
death
prothrombin
time
elev
protein
admiss
hospit
associ
sever
cours
transfer
earli
suggest
peopl
experi
last
longer
month
major
admit
hospit
sever
diseas
report
fatigu
short
breath
chief
signific
number
peopl
covid
viru
rang
seriou
effect
vast
spectrum
fluctuat
time
realli
concern
rang
fatigu
cough
short
breath
inflamm
injuri
major
heart
neurolog
psycholog
effect
often
overlap
affect
system
bodi
infect
peopl
cyclic
fatigu
complet
exhaust
mood
therefor
herd
immun
moral
unconscion
unfeas
hospit
return
hospit
treatment
within
two
discharg
averag
readmit
eight
day
sinc
first
hospit
visit
sever
risk
caus
multipl
hospit
facil
among
advanc
age
age
presenc
chronic
condit
diabet
heart
failur
chronic
kidney
diseas
accord
scientif
like
requir
intens
care
die
air
pollut
similarli
associ
risk
heart
lung
obes
health
risk
assum
higher
risk
get
sever
sick
one
research
kidney
transplant
found
mortal
rate
genet
import
role
abil
fight
diseas
instanc
produc
detect
type
produc
get
much
sicker
genet
screen
abl
detect
effector
pregnant
higher
risk
sever
infect
base
data
similar
data
young
experienc
lower
infect
older
rate
infect
similar
popul
whole
like
milder
lower
risk
sever
diseas
us
roughli
third
admit
multin
studi
june
found
admit
hospit
intens
care
four
studi
actual
mortal
rate
substanti
lower
sinc
milder
seek
medic
help
includ
studi
includ
pneumonia
acut
respiratori
distress
syndrom
failur
septic
shock
death
cardiovascular
includ
heart
failur
atrial
fibril
heart
inflamm
thrombosi
particularli
venou
approxim
peopl
present
elev
liver
reflect
liver
injuri
includ
seizur
stroke
enceph
syndrom
loss
motor
follow
infect
develop
inflammatori
syndrom
similar
diseas
fatal
rare
acut
encephalopathi
occur
consid
mental
statu
case
pregnant
import
note
accord
diseas
control
prevent
pregnant
risk
becom
serious
ill
pregnant
appear
like
develop
respiratori
obstetr
lead
miscarriag
prematur
deliveri
growth
restrict
rare
includ
mucormycosi
earli
suggest
ten
twenti
percent
peopl
experi
last
longer
month
major
admit
hospit
sever
diseas
report
fatigu
short
breath
admit
hospit
progress
sever
critic
diseas
pneumonia
acut
respiratori
failur
varieti
affect
major
show
lung
peopl
test
day
ill
peopl
advanc
age
sever
diseas
stay
smoke
like
effect
pulmonari
fibrosi
overal
approxim
four
pulmonari
fibrosi
reduc
lung
function
measur
even
asymptomat
peopl
suggest
improv
pass
time
immun
respons
viru
combin
immun
antibodi
product
sinc
human
popul
sinc
remain
unknown
immun
peopl
recov
diseas
presenc
blood
strongli
protect
infect
level
antibodi
time
asymptomat
mild
diseas
undetect
antibodi
two
infect
anoth
studi
level
fell
fourfold
one
four
onset
howev
lack
blood
mean
rapidli
produc
upon
memori
b
specif
spike
last
least
six
appear
nevertheless
reinfect
stringent
criteria
identif
differ
variant
second
infect
like
mani
peopl
viru
herd
immun
elimin
viru
reinfect
common
peopl
capabl
reinfect
roughli
year
nonetheless
march
much
contagi
variant
lineag
first
japan
subsequ
found
brazil
well
sever
unit
associ
diseas
reinfect
recoveri
infect
sever
commonli
use
quantifi
mortal
vari
region
time
volum
test
system
qualiti
treatment
time
sinc
initi
outbreak
popul
age
sex
overal
health
mortal
rate
number
within
specif
demograph
group
divid
popul
demograph
group
consequ
mortal
rate
preval
well
sever
diseas
within
given
popul
mortal
highli
correl
age
rel
low
young
peopl
rel
high
among
elderli
fact
one
relev
factor
mortal
age
structur
exampl
case
fatal
rate
lower
us
sinc
younger
popul
percentag
us
case
fatal
rate
number
divid
number
within
given
time
interv
base
univers
statist
global
ratio
june
number
region
reflect
true
sever
diseas
infect
remain
asymptomat
experi
mild
henc
includ
offici
case
moreov
vari
markedli
time
across
due
avail
live
viru
total
confirm
time
total
confirm
per
million
peopl
total
time
total
confirm
due
per
million
peopl
key
metric
gaug
sever
infect
fatal
rate
infect
fatal
ratio
infect
fatal
risk
metric
calcul
divid
total
number
diseas
total
number
infect
henc
contrast
asymptomat
undiagnos
well
systemat
review
popul
first
wave
pandem
mani
new
studi
found
reflect
correspond
age
composit
popul
infect
particular
estim
low
younger
age
age
progress
age
age
age
age
report
analysi
hazard
elderli
fatal
infect
two
magnitud
like
risk
fatal
automobil
accid
far
danger
season
influenza
earli
stage
pandem
world
health
organ
chief
scientist
averag
estim
expert
forum
august
found
data
broad
serolog
test
converg
approxim
firm
lower
establish
number
new
york
citi
sinc
less
popul
fatal
rate
new
york
citi
popul
million
confirm
probabl
popul
antibodi
test
new
york
citi
provinc
popul
us
center
diseas
control
prevent
preliminari
public
health
case
fatal
higher
among
men
howev
fatal
higher
men
global
men
like
admit
like
die
one
found
global
men
like
get
approxim
men
per
center
diseas
control
prevent
death
rate
men
later
june
signific
differ
suscept
one
review
differ
mortal
men
suggest
attribut
smoke
drink
alcohol
rather
genet
smoke
china
mainli
male
activ
habit
increas
significantli
case
fatal
among
men
immunolog
lesser
preval
smoke
men
hypertens
younger
age
higher
mortal
men
infect
peopl
men
men
us
govern
data
research
shown
viral
influenza
affect
men
differ
us
greater
proport
due
among
minor
structur
prevent
social
includ
concentr
crowd
substandard
hous
essenti
retail
groceri
public
transit
custodi
staff
greater
preval
health
insur
care
underli
diabet
hypertens
heart
diseas
increas
risk
death
similar
affect
nativ
one
hand
republ
clear
exampl
gender
ethnic
inequ
territori
great
inequ
precari
especi
greater
emphasi
descent
accord
us
health
polici
nonprofit
nativ
peopl
risk
seriou
ill
white
sourc
disproportion
high
mani
health
put
higher
risk
well
live
lack
access
clean
water
research
address
greater
proport
due
black
ethnic
minor
background
sever
upon
rel
incid
necess
hospit
vulner
diseas
associ
via
analysi
express
genet
chromosom
region
associ
heritag
structur
greater
affect
develop
sever
form
diseas
professor
institut
evolutionari
anthropolog
admixtur
modern
human
roughli
ago
southern
biolog
immun
respons
gener
behaviour
strongli
determin
die
underli
hypertens
diabet
cardiovascular
diseas
accord
march
data
unit
di
medic
avail
peopl
least
one
averag
person
accord
report
common
hypertens
type
diabet
ischem
heart
diseas
atrial
fibril
chronic
renal
failur
critic
respiratori
accord
moder
sever
asthma
pulmonari
fibrosi
cystic
fibrosi
evid
stem
sever
smaller
research
smoke
associ
wors
someon
respiratori
infect
greater
risk
sever
greater
risk
peopl
misus
insofar
drug
use
lung
damag
august
caution
tuberculosi
increas
risk
sever
ill
death
peopl
respiratori
screen
test
posit
rule
reduc
detect
due
pandem
result
million
addit
million
viru
thought
natur
anim
origin
infect
sever
first
case
patient
zero
origin
pandem
ongo
aros
phylogenet
algorithm
analysi
viru
wuhan
although
one
studi
present
earli
evid
coronaviru
wild
bat
spread
intermediari
wildlif
host
possibl
viru
accident
laboratori
increasingli
activ
consider
first
confirm
human
wuhan
china
studi
first
confirm
lancet
date
onset
offici
onset
transmiss
confirm
accord
offici
mostli
link
wholesal
market
sold
live
director
anim
collect
market
test
neg
viru
market
site
earli
event
site
initi
outbreak
viru
found
collect
spread
infect
almost
entir
driven
transmiss
number
coronaviru
gradual
reach
sixti
least
wuhan
central
hospit
sent
bronchoalveolar
lavag
fluid
bal
sampl
unresolv
clinic
case
compani
vision
vision
inform
wuhan
central
hospit
test
show
new
coronaviru
pneumonia
cluster
unknown
caus
doctor
provinci
hospit
inform
wuhan
test
report
wuhan
central
hospit
compani
state
erron
posit
result
caus
group
wuhan
central
hospit
alert
relev
hospit
result
wuhan
municip
health
commiss
notic
variou
medic
treatment
pneumonia
unknown
caus
even
eight
li
later
polic
spread
fals
anoth
ai
fen
rais
alarm
wuhan
municip
health
commiss
made
first
public
announc
pneumonia
outbreak
unknown
caus
confirm
enough
trigger
investig
earli
outbreak
number
doubl
approxim
everi
seven
half
day
earli
viru
spread
new
year
migrat
wuhan
transport
hub
major
rail
interchang
china
nearli
new
one
day
two
peopl
one
later
offici
data
peopl
alreadi
infect
report
lancet
human
transmiss
strongli
person
protect
equip
health
test
viru
essenti
due
pandem
potenti
declar
coronaviru
public
health
emerg
intern
concern
time
outbreak
spread
factor
time
first
confirm
two
china
china
countri
march
march
unit
china
highest
number
confirm
world
research
coronaviru
major
new
york
came
rather
directli
china
countri
prior
found
person
viru
person
unit
diseas
test
untreat
brazil
detect
earli
respect
sewag
mani
often
miss
risk
fals
due
contamin
one
gene
target
review
journal
articl
possibl
infect
alreadi
spread
end
last
year
abund
even
partial
circumstanti
evid
pneumonia
case
radiolog
initi
outbreak
misinform
regard
origin
scale
prevent
treatment
diseas
rapidli
spread
us
preliminari
risk
death
age
unit
wide
misunderstood
appear
capabl
spread
viru
type
diseas
transmiss
especi
catch
viru
infect
includ
respiratori
cough
digest
spread
viru
abl
spread
viru
transmiss
proven
dog
less
suscept
infect
increas
risk
transmiss
includ
kiss
lick
anim
viru
appear
abl
infect
mice
infect
unlik
involv
spread
viru
becom
infect
result
contact
infect
great
ape
speci
infect
viru
famili
infect
asymptomat
spread
viru
multipl
infect
mink
major
produc
mink
order
slaughter
viral
vaccin
mink
intern
research
underway
govern
academ
industri
classifi
requir
grade
laboratori
great
deal
research
acceler
research
meet
global
demand
updat
clinic
research
happen
everi
contin
except
antarctica
updat
possibl
studi
far
research
sever
dynam
transmiss
diagnosi
prognosi
infect
estim
impact
alloc
mostli
base
epidemiolog
number
infect
peopl
time
given
sever
use
comput
fluid
dynam
studi
flow
physic
crowd
movement
studi
occup
exposur
base
investig
transmiss
use
assess
econom
impact
pandem
conceptu
crisi
manag
research
appli
better
understand
effect
antivir
make
research
includ
immun
acid
enzym
march
world
health
organ
solidar
trial
assess
treatment
effect
promis
experiment
drug
antimalari
chloroquin
two
activ
clinic
underway
research
antimalari
chloroquin
ineffect
best
reduc
antivir
activ
updat
use
treatment
june
initi
recoveri
trial
unit
kingdom
reduc
mortal
one
third
peopl
critic
ill
one
fifth
supplement
oxygen
wide
avail
treatment
process
treatment
includ
base
preliminari
treatment
mechan
requir
supplement
oxygen
requir
supplement
oxygen
guidanc
system
rather
system
treatment
peopl
sever
critic
strong
recommend
base
moder
certainti
evid
use
treatment
peopl
condit
recommend
base
low
certainti
evid
guidanc
base
clinic
critic
ill
agenc
endors
use
twelv
age
weigh
least
requir
supplement
oxygen
therapi
taken
mouth
given
inject
infus
drip
vein
us
food
drug
administr
emerg
use
author
investig
antibodi
therapi
treatment
author
peopl
posit
direct
viral
test
twelv
age
older
weigh
least
high
risk
sever
hospit
age
older
chronic
medic
emerg
use
author
togeth
treatment
mild
moder
peopl
twelv
age
older
weigh
least
test
posit
high
risk
sever
author
use
treatment
age
older
certain
chronic
medic
emerg
use
author
investig
antibodi
therapi
alon
use
treatment
certain
pediatr
storm
complic
later
sever
storm
potenti
deadli
immun
reaction
larg
amount
quickli
storm
lead
multipl
organ
failur
data
collect
hospit
wuhan
china
sever
greater
system
milder
high
indic
presenc
storm
includ
treatment
china
nation
health
commiss
small
studi
undergo
phase
trial
nation
level
show
posit
peopl
sever
diseas
combin
serum
blood
test
identifi
storm
storm
syndrom
confus
releas
syndrom
meant
counter
thought
caus
death
affect
peopl
receptor
antagonist
undergo
phase
clinic
trial
effect
base
retrospect
case
treatment
releas
syndrom
induc
differ
caus
car
cell
therapi
date
evid
efficaci
treatment
prophylact
shown
increas
serum
drive
across
barrier
effect
incid
antibodi
protect
murin
car
viabl
therapeut
option
due
increas
pathogen
transfer
concentr
produc
immun
peopl
need
method
passiv
viral
neutral
mechan
action
passiv
antibodi
therapi
mediat
defenc
spike
protein
primari
target
august
eight
spike
protein
clinic
select
use
treat
futur
howev
cellular
phagocytosi
possibl
passiv
antibodi
therapi
exampl
develop
use
passiv
treat
peopl
activ
studi
product
convalesc
serum
liquid
portion
blood
peopl
infect
specif
viru
activ
strategi
tri
inconclus
review
found
high
certainti
evid
treatment
peopl
moder
sever
convalesc
plasma
reduc
mortal
bring
symptom
improv
uncertainti
safeti
convalesc
plasma
administr
peopl
measur
differ
use
efficaci
report
march
social
common
wear
surgic
similar
common
precaut
drop
spread
rate
common
cold
flu
sale
cough
throat
half
sale
year
public
health
flu
year
date
rise
vitamin
tri
boost
immun
pandem
part
pandem
coronaviru
diseas
sever
acut
respiratori
syndrom
coronaviru
first
case
china
current
number
confirm
june
number
confirm
world
unit
million
infect
number
unit
brazil
first
state
among
three
medic
return
wuhan
march
rest
countri
march
five
around
half
countri
thane
june
activ
first
time
infect
drop
along
number
new
activ
daili
peak
drop
second
wave
begin
march
much
first
hospit
oxygen
countri
late
led
world
new
activ
first
countri
report
new
period
health
believ
due
sever
vaccin
million
day
vaccin
covishield
covaxin
vaccin
sputnik
v
vaccin
emerg
use
updat
countri
million
vaccin
confirm
novel
coronaviru
caus
respiratori
ill
cluster
peopl
wuhan
china
first
case
rose
three
wuhan
apart
signific
rise
march
new
infect
tourist
group
month
sever
peopl
travel
histori
affect
test
posit
march
man
travel
histori
first
fatal
preacher
travel
histori
turn
festiv
sahib
march
peopl
march
contain
spread
march
religi
congreg
event
taken
place
march
around
return
sahib
mani
test
posit
bu
part
transport
arrang
base
antibodi
least
infect
point
govern
panel
state
pandem
peak
come
control
predict
base
mathemat
simul
assum
herd
immun
month
new
variant
lineag
countri
vaccin
nearli
year
first
case
countri
last
region
report
first
case
daili
fallen
howev
major
second
wave
took
hold
countri
million
activ
brazil
late
million
activ
averag
new
fear
new
one
day
multipl
potenti
sudden
spike
concern
lineag
lack
temporari
often
declin
new
built
health
safeti
enforc
march
mela
link
link
least
posit
sport
state
local
sever
public
econom
slowdown
put
pressur
govern
lift
feel
base
hope
young
popul
childhood
scheme
would
blunt
impact
viru
due
countri
due
high
demand
vaccin
hit
suppli
vaccin
suspend
meet
domest
demand
raw
manufactur
domest
hesit
lack
knowledg
among
rural
impact
second
wave
major
strain
system
shortag
liquid
medic
oxygen
due
first
wave
logist
lack
cryogen
met
via
liquid
oxygen
acknowledg
need
provid
short
time
acknowledg
product
use
rail
air
transport
deliv
oxygen
larg
number
new
oxygen
instal
burden
center
foreign
regard
oxygen
receiv
form
aid
number
sent
emerg
aid
form
oxygen
raw
materi
reflect
polici
shift
compar
aid
past
sixteen
number
new
begun
steadili
drop
countri
new
daili
increas
sinc
howev
mortal
rate
high
around
last
day
last
declar
two
first
found
delta
kappa
union
health
ministri
war
room
polici
make
team
new
decid
coronaviru
tackl
countri
ministri
emerg
medic
respons
unit
central
surveil
unit
nation
diseas
control
three
govern
among
march
strategi
similar
previou
well
break
chain
transmiss
capabl
viru
test
march
march
nation
institut
virolog
isol
strain
novel
coronaviru
fifth
countri
success
obtain
pure
sampl
viru
isol
viru
would
help
toward
develop
rapid
diagnost
countri
two
genom
anoth
test
kit
rapid
test
initi
test
travel
histori
come
contact
anyon
test
posit
coronaviru
show
per
govern
march
govern
decid
includ
pneumonia
regardless
travel
contact
histori
test
strategi
test
peopl
show
week
countri
regardless
travel
histori
local
contact
patient
health
ministri
enough
disagre
say
commun
transmiss
go
undetect
march
health
ministri
decid
allow
accredit
privat
patholog
test
person
get
test
privat
lab
qualifi
physician
govern
facil
test
ultim
result
correct
current
increas
confirm
addit
test
function
march
march
discoveri
first
compani
receiv
regulatori
valid
institut
integr
biolog
low
cost
test
detect
within
hour
test
would
cost
us
advis
pool
test
low
infect
increas
capac
test
save
process
maximum
five
test
test
individu
pool
posit
faulti
test
china
subsequ
return
futur
test
function
follow
test
nonaccredit
privat
accredit
given
permiss
test
coronaviru
highest
number
daili
world
test
govern
privat
function
total
daili
nation
test
capac
test
commun
transmiss
march
govern
test
random
peopl
exhibit
without
travel
histori
contact
infect
march
evid
commun
transmiss
found
random
test
neg
sari
sever
acut
respiratori
test
throughout
countri
test
posit
union
travel
histori
histori
contact
posit
patient
advis
contain
posit
among
sari
commun
transmiss
stage
howev
june
health
minist
admit
commun
transmiss
limit
nationwid
commun
transmiss
legend
avoid
display
center
solid
black
transpar
color
black
new
per
day
combin
antimalaria
flu
recoveri
three
march
march
nation
task
forc
use
treatment
month
institut
chemic
technolog
council
scientif
industri
research
joint
ventur
develop
anoth
firm
introduc
stem
agent
treat
critic
research
continu
fund
number
prevent
initi
research
cellular
molecular
biolog
work
genom
earli
accord
march
around
public
sector
govern
doubl
capac
june
assist
electron
led
creation
world
product
manufactur
gener
full
bodi
nil
near
past
around
per
day
second
half
month
world
second
produc
bodi
coveral
sever
control
gener
start
clinic
convalesc
plasma
therapi
plasma
exchang
therapi
initi
optim
around
plasma
therapi
robust
evid
support
convalesc
plasma
therapi
routin
therapi
experiment
therapi
convalesc
plasma
therapi
form
treatment
protocol
mid
june
gener
antivir
medic
treatment
institut
chemic
technolog
limit
firm
receiv
emerg
use
drug
chronic
plaqu
psoriasi
one
diseas
receiv
emerg
repurpos
medic
use
treat
hepat
c
treatment
moder
gave
permiss
emerg
use
drug
collabor
reddi
adjunct
altern
therapi
treat
moder
sever
initi
vaccin
serum
institut
trade
name
covishield
covaxin
vaccin
associ
council
medic
research
nation
institut
virolog
approv
covaxin
met
concern
vaccin
phase
due
statu
covaxin
sign
consent
form
chose
releg
covaxin
buffer
stock
primarili
distribut
vaccin
follow
conclus
trial
standard
emerg
use
covaxin
march
sputnik
v
vaccin
reddi
initi
shipment
million
sputnik
v
domest
sputnik
v
begin
august
russia
use
phase
covaxin
among
june
govern
confirm
first
death
case
covid
vaccin
man
due
anaphylaxi
vaccin
polici
million
peopl
base
occup
age
group
time
period
six
august
march
health
minist
state
necessari
scientif
give
everi
person
countri
vaccin
everi
person
world
process
dynam
process
procur
vaccin
polici
differenti
complic
situat
global
vaccin
sever
affect
associ
administr
vaccin
popul
earli
set
vaccin
task
forc
follow
nation
expert
group
vaccin
administr
form
set
state
level
vaccin
prepar
cold
govern
covid
mission
covid
secur
mission
crore
us
million
depart
aid
develop
covid
vaccin
budget
crore
us
billion
vaccin
procur
commun
strategi
vaccin
reveal
health
ministri
vaccin
eager
hesit
one
month
vaccin
wastag
across
reduc
march
stimulu
packag
crore
us
billion
help
state
overcom
epidem
econom
hardship
march
us
daili
wage
march
us
regist
construct
number
union
went
announc
free
ration
card
crore
us
million
relief
flower
construct
auto
cab
govern
doctor
nurs
hygien
worker
treatment
famili
provid
million
us
union
govern
distribut
food
secur
scheme
part
econom
relief
packag
crore
us
billion
center
march
includ
direct
cash
transfer
primarili
migrant
daili
wage
free
ga
three
cut
liquid
provid
moratorium
three
payment
relax
provid
short
term
credit
via
way
pend
wage
daili
wage
scheme
prime
minist
econom
packag
crore
us
billion
includ
previou
govern
financ
announc
march
govern
two
econom
stimulu
total
econom
stimulu
crore
us
billion
crore
us
billion
health
respons
june
financ
minist
reduc
tax
treatment
epidem
act
disast
manag
act
commerci
domest
intern
suspend
march
number
would
restrict
public
order
closur
variou
nonessenti
march
slow
spread
march
prime
minist
observ
curfew
peopl
curfew
march
thank
essenti
clap
ring
outsid
curfew
use
evalu
feasibl
nation
march
confirm
countri
prime
minist
would
total
least
three
noncrit
order
close
except
groceri
total
ban
leav
home
nonessenti
public
transport
suspend
divid
tier
system
base
incid
classifi
red
orang
green
littl
transmiss
zone
major
fell
red
begin
agricultur
sell
farm
resum
oper
well
public
work
cargo
transport
govern
phase
extend
till
increment
countri
lift
june
lift
continu
seri
extend
govern
prepar
health
system
would
impos
curfew
late
earli
weekend
night
curfew
among
earli
union
form
restrict
second
wave
pandem
seen
nationwid
unlock
start
june
number
covid
respons
number
advisori
task
form
pandem
nation
technic
advisori
group
apex
advisori
bodi
immun
diseas
surveil
nation
diseas
control
brought
earli
follow
onset
pandem
task
forc
nation
expert
group
vaccin
administr
form
august
would
guid
nation
vaccin
deliveri
strategi
advic
format
state
level
mechan
implement
vaccin
strategi
overal
respons
led
prime
minist
offic
least
review
militari
govern
respons
pandem
second
wave
taken
militari
help
fight
pandem
set
covid
set
oxygen
provid
domest
intern
air
water
transport
assist
provid
medic
assist
provid
nurs
assist
truck
provid
support
rope
retir
militari
provid
rope
nation
cadet
corp
three
arm
oper
oper
offici
repatri
oxygen
relat
transport
sever
donat
pandem
relat
sever
larg
busi
fund
lead
come
forward
provid
support
across
countri
set
cryogen
medic
equip
busi
set
chief
execut
us
set
global
task
forc
collabor
equip
support
provid
doorstep
deliveri
medic
oxygen
govern
provid
around
million
covid
late
march
million
gift
commerci
intern
support
provid
sinc
begin
pandem
late
intern
relief
transport
sent
pandem
relat
aid
oxygen
sent
oxygen
sent
armi
oper
oxygen
relat
equip
ship
unit
kingdom
russia
unit
sent
variou
relief
materi
oxygen
sent
oxygen
oxygen
govern
electr
voltag
provid
support
includ
extern
minist
describ
aid
call
friendship
respons
foreign
support
pandem
china
sent
test
use
view
low
accuraci
intern
relat
support
sent
use
receiv
aid
support
includ
oxygen
oxygen
oxygen
gener
govern
support
sent
role
nation
diseas
control
pandem
subdu
data
collect
diseas
surveil
perpetu
shortag
fund
result
weak
nationwid
data
collect
system
track
take
place
outsid
due
test
one
mani
built
system
lack
senior
decis
make
relat
evid
absenc
number
health
ministri
go
spree
fill
council
medic
research
treatment
protocol
nation
task
forc
meet
march
despit
obviou
second
wave
make
number
pertain
surg
march
lifesav
equip
second
wave
went
unheed
number
found
forecast
nation
committe
independ
earli
committe
abl
predict
second
wave
accur
lot
fail
respons
second
wave
gener
long
term
public
health
system
princip
scientif
advisor
govern
phase
inevit
clear
phase
occur
prepar
new
take
strong
third
wave
happen
anywher
well
guidanc
local
level
state
viru
intern
push
independ
inquiri
push
inquiri
led
union
back
viru
subcontin
origin
diseas
left
million
migrant
unemploy
shut
mani
migrant
left
livelihood
thu
decid
walk
go
back
nativ
mani
respons
central
state
took
variou
help
central
govern
state
set
immedi
relief
migrant
nativ
later
protect
report
suprem
court
march
central
govern
state
migrant
apprehens
surviv
panic
fake
news
would
last
three
earli
central
govern
permit
launch
special
migrant
move
suprem
court
admit
still
order
provid
free
food
shelter
transport
migrant
rais
issu
drug
hit
pandem
situat
china
wors
pharmaceut
china
march
restrict
export
pharmaceut
restrict
point
impend
global
second
wave
pandem
certain
go
black
market
import
relat
face
stock
sharp
rise
cost
raw
march
union
govern
order
closur
march
central
board
secondari
educ
examin
social
march
technolog
engin
colleg
across
countri
school
younger
either
automat
base
prior
perform
union
public
servic
commiss
interview
civil
examin
educ
abl
effect
adapt
remot
learn
digit
divid
impact
seriou
electr
lack
connect
due
limit
social
movement
second
wave
rel
first
wave
econom
impact
second
wave
date
less
sever
first
wave
socioeconom
power
demand
labour
particip
railway
freight
traffic
fell
less
second
wave
first
wave
first
wave
domest
econom
resili
visibl
second
wave
despit
sever
second
wave
financ
ministri
monthli
econom
review
wrote
econom
activ
learnt
oper
covid
sinc
begin
pandem
poverti
affect
stock
flash
crash
march
back
union
health
ministri
announc
two
new
confirm
march
stock
worst
crash
sinc
june
declar
outbreak
pandem
march
stock
post
worst
histori
fell
nifti
fell
howev
march
one
day
complet
prime
minist
post
biggest
gain
decad
domest
stock
posit
ralli
govern
confirm
made
emerg
order
least
social
media
remov
twitter
includ
misinform
panic
among
public
respons
pandem
includ
critic
west
minist
labour
law
journalist
reddi
actor
case
regard
govern
respons
pandem
suprem
court
bench
head
justic
free
flow
inform
restrict
contempt
court
free
flow
inform
hear
nation
crisi
presumpt
rais
alway
fals
kind
ministri
electron
inform
technolog
order
social
media
remov
content
variant
coronaviru
justif
misinform
world
health
organ
offici
use
term
relat
lineag
attent
given
fight
reduct
attent
given
tuberculosi
result
ten
setback
fight
tuberculosi
decad
fall
tuberculosi
countri
fell
due
pandem
relat
impact
institut
deliveri
august
medic
associ
due
number
howev
health
ministri
respect
due
base
insur
scheme
health
fight
put
number
ten
health
infect
covid
provid
covid
first
start
includ
major
given
second
dose
march
prime
minist
would
due
pandem
subsequ
numer
religi
larg
celebr
within
see
less
normal
public
social
char
manner
previou
year
seen
mani
religi
connect
via
radio
televis
religi
natur
includ
mela
state
took
place
saw
increas
period
saw
numer
religi
ignor
social
popul
ie
million
peopl
live
rural
share
covid
rural
semirur
august
increas
covid
larg
movement
covid
infect
migrant
urban
back
nativ
aggrav
situat
rural
semirur
includ
sever
lack
human
health
field
second
wave
saw
come
back
sharp
rise
employ
gener
half
rural
anoth
indic
situat
rush
semiurban
urban
search
per
cent
small
within
radiu
stori
govern
offici
confirm
report
peopl
viru
rural
river
due
lack
fund
follow
report
state
govern
pay
us
poor
cremat
buri
dead
march
onward
privat
indigo
go
air
march
govern
intern
land
march
march
union
govern
suspens
domest
countri
start
march
mission
mass
evacu
program
govern
repatri
around
world
august
air
express
flight
repatri
flight
intern
airport
kill
two
test
posit
took
variou
fight
pandem
initi
includ
remov
platform
across
suspend
march
train
countri
bare
good
around
nonessenti
passeng
transport
interst
transport
prime
minist
extend
nationwid
suspend
passeng
ticket
indefinit
railway
accid
due
confus
relat
pandem
public
transport
across
nation
affect
march
sever
panic
relat
pandem
consum
good
saw
averag
daili
doubl
march
rush
buy
ahead
address
nation
assur
enough
food
ration
advis
panic
food
trigger
food
crisi
first
week
essenti
grow
food
oper
number
sport
suspend
behind
close
open
badminton
tournament
super
leagu
final
world
gold
label
road
race
world
cup
qualif
match
versu
world
cup
commenc
march
new
march
board
control
cricket
open
march
tournament
eventu
suspend
indefinit
eventu
play
unit
south
march
origin
without
march
border
secur
forc
decid
conduct
border
ceremoni
without
ceremoni
march
histor
countri
would
remain
close
public
intern
film
academi
take
place
march
cinema
shut
film
decid
stop
product
web
seri
till
march
march
major
video
stream
countri
jointli
would
restrict
stream
high
definit
video
cellular
preserv
network
capac
infrastructur
union
total
death
first
wave
offici
death
number
burial
ground
ad
suspect
final
count
contrari
similar
second
wave
larg
note
offici
death
sudden
increas
number
buri
sever
disus
brought
back
oper
keep
demand
seri
newspap
previou
number
addit
pandem
known
excess
mortal
four
time
offici
covid
death
toll
ten
time
higher
state
howev
clear
proport
due
covid
due
medic
vaccin
vaccin
intend
provid
acquir
immun
sever
acut
respiratori
syndrom
coronaviru
viru
coronaviru
diseas
wide
celebr
role
reduc
spread
sever
death
prior
pandem
establish
bodi
knowledg
structur
function
caus
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
knowledg
acceler
develop
variou
vaccin
earli
genet
sequenc
data
march
global
pharmaceut
industri
major
commit
address
phase
sever
efficaci
high
symptomat
june
updat
author
least
one
nation
regulatori
author
public
use
two
nine
convent
academi
medic
covaxin
five
viral
vector
sputnik
light
sputnik
v
johnson
johnson
two
protein
subunit
verif
total
march
updat
vaccin
variou
develop
clinic
research
phase
phase
phase
develop
mani
distribut
highest
risk
elderli
high
risk
exposur
transmiss
singl
dose
interim
use
consider
extend
vaccin
mani
peopl
possibl
vaccin
avail
june
updat
billion
vaccin
base
offici
nation
health
billion
billion
sputnik
v
johnson
johnson
billion
million
million
billion
vaccin
half
world
popul
prior
vaccin
infecti
diseas
never
produc
less
sever
vaccin
coronaviru
infect
howev
produc
sever
anim
infecti
bronchiti
viru
canin
coronaviru
felin
coronaviru
previou
develop
famili
affect
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
test
nonhuman
accord
identif
develop
novel
treat
prioriti
public
health
around
world
time
cure
protect
vaccin
proven
safe
effect
proven
vaccin
preval
research
provid
use
templat
therapeut
infect
march
one
vaccin
phase
clinic
three
progress
two
one
sinc
vaccin
develop
expedit
via
unpreced
collabor
multin
pharmaceut
industri
multipl
along
entir
develop
path
sever
uniqu
vaccin
develop
urgenc
creat
vaccin
led
compress
standard
vaccin
develop
combin
clinic
trial
process
typic
sequenti
clinic
research
normal
sequenti
process
compress
safeti
efficaci
run
simultan
potenti
compromis
safeti
assur
exampl
vaccin
govern
center
diseas
control
prevent
march
numer
short
goal
showcas
technolog
unit
reassur
peopl
qualiti
produc
china
rapid
develop
urgenc
vaccin
pandem
increas
failur
rate
safe
effect
vaccin
addit
research
physic
must
progress
sever
phase
clinic
test
safeti
immunogen
effect
dose
advers
effect
candid
vaccin
vaccin
invest
intern
find
enough
phase
clinic
viru
prove
move
target
transmiss
across
within
forc
compet
trial
clinic
trial
encount
peopl
unwil
due
vaccin
hesit
disbelief
scienc
vaccin
technolog
abil
prevent
infect
new
pandem
licensur
vaccin
submiss
full
dossier
inform
develop
qualiti
intern
access
acceler
world
health
organ
initi
support
structur
enabl
share
knowledg
four
two
three
diagnost
therapeut
health
connector
r
blueprint
novel
coronaviru
larg
intern
individu
clinic
trial
allow
concurr
evalu
promis
candid
vaccin
within
made
avail
trial
vaccin
coalit
go
phase
clinic
determin
phase
pivot
trial
stage
nation
involv
vaccin
develop
canada
research
vaccin
research
establish
vaccin
bank
use
anoth
coronaviru
outbreak
support
clinic
develop
suppli
china
provid
one
vaccin
develop
central
bank
quickli
made
land
avail
compani
build
product
three
vaccin
research
govern
research
clinic
great
form
vaccin
task
forc
stimul
local
acceler
develop
vaccin
industri
govern
everi
phase
develop
research
unit
advanc
research
develop
author
feder
agenc
technolog
support
vaccin
develop
manufactur
promis
govern
program
oper
warp
speed
larg
pharmaceut
experi
make
scale
johnson
johnson
form
acceler
progress
toward
effect
caus
viru
sever
acut
respiratori
syndrom
coronaviru
isol
late
genet
sequenc
urgent
intern
respons
prepar
outbreak
hasten
develop
prevent
vaccin
sinc
earli
vaccin
develop
expedit
via
unpreced
collabor
multin
pharmaceut
industri
june
intern
health
univers
research
develop
vaccin
prepar
global
vaccin
immun
infect
accord
coalit
epidem
prepared
geograph
distribut
vaccin
develop
north
activ
south
expect
vaccin
becom
avail
less
rapidli
grow
infect
rate
earli
intern
govern
urgent
organ
make
multipl
four
vaccin
enter
human
evalu
march
see
vaccin
trial
author
statu
june
china
vaccin
limit
use
militari
two
viru
emerg
use
august
russia
approv
sputnik
v
vaccin
emerg
use
though
one
month
later
small
vaccin
distribut
use
outsid
phase
trial
partnership
request
vaccin
activ
ingredi
unit
kingdom
regulatori
agenc
gave
temporari
regulatori
approv
vaccin
becom
first
countri
approv
vaccin
first
countri
western
world
approv
use
vaccin
mani
union
author
vaccin
unit
emerg
market
author
unit
food
drug
administr
emerg
use
author
vaccin
week
later
vaccin
june
report
reveal
vaccin
ventur
blackwat
founder
princ
seri
text
close
associ
project
princ
sell
provid
data
clinic
safeti
efficaci
respons
distribut
assign
abu
entiti
windward
capit
letterhead
actual
windward
sole
sharehold
firm
handl
profession
scientif
technic
princ
march
rais
billion
privat
placement
nine
differ
technolog
technolog
numer
undefin
clarif
research
develop
creat
effect
vaccin
vaccin
clinic
coronaviru
spike
protein
primari
antigen
infect
involv
acid
messeng
viral
live
mani
vaccin
alreadi
use
prevent
influenza
rather
precis
infect
sever
synthet
use
mutat
lock
spike
protein
configur
immun
respons
viru
human
cell
vaccin
develop
improv
flexibl
antigen
manipul
effect
infect
suscept
popul
elderli
pregnant
peopl
immun
vaccin
tissu
messeng
caus
build
foreign
protein
stimul
adapt
immun
respons
bodi
identifi
destroy
correspond
pathogen
cancer
often
alway
use
messeng
deliveri
molecul
protect
help
absorpt
first
author
unit
kingdom
unit
union
updat
author
type
vaccin
vaccin
updat
vaccin
author
eu
sever
allerg
rare
first
vaccin
administr
sever
allerg
reaction
anaphylaxi
vaccin
dose
ten
anaphylaxi
like
respons
allerg
viral
vector
shell
protein
viral
mean
make
new
viru
rather
produc
antigen
system
immun
respons
updat
author
type
vaccin
sputnik
v
vaccin
johnson
johnson
vaccin
johnson
johnson
vaccin
offer
less
complic
logist
ordinari
refriger
sever
sputnik
v
vaccin
first
dose
johnson
johnson
vaccin
dose
second
dose
dose
consist
viru
grown
cultur
method
heat
formaldehyd
lose
diseas
capac
still
immun
respons
author
type
covaxin
clinic
includ
vaccin
unreli
sourc
subunit
present
one
without
whole
pathogen
involv
often
protein
molecul
fragment
pathogen
two
author
type
peptid
vaccin
pend
includ
vaccin
conjug
vaccin
vaccin
vaccin
previous
clinic
found
vaccin
potenti
caus
incorrect
subsequ
test
addit
clinic
includ
particl
multipl
least
two
vector
conjug
vaccin
vesicular
stomat
viru
spike
protein
oral
intranas
studi
whether
unrel
prime
immun
system
lessen
sever
infect
experiment
evid
vaccin
tuberculosi
nonspecif
effect
immun
system
evid
vaccin
effect
vaccin
efficaci
risk
get
diseas
trial
risk
get
diseas
unvaccin
efficaci
vaccin
work
ident
placebo
efficaci
half
mani
infect
unvaccin
vaccin
efficaci
advers
arm
improperli
vaccin
subcutan
instead
muscl
current
guidanc
repeat
subcutan
straightforward
compar
differ
run
differ
viru
case
vaccin
efficaci
enough
slow
pandem
vaccin
immun
necessari
prevent
transmiss
vaccin
efficaci
diseas
prevent
poor
indic
transmiss
sinc
asymptomat
peopl
highli
infecti
us
food
drug
administr
agenc
set
cutoff
efficaci
approv
vaccin
aim
realist
popul
vaccin
coverag
rate
depend
actual
basic
reproduct
number
necessari
effect
vaccin
need
least
prevent
epidem
least
extinguish
without
social
confid
unless
otherwis
regardless
age
accord
definit
absenc
confid
interv
accuraci
without
associ
confid
interv
unknown
public
efficaci
sever
import
sinc
public
health
burden
whose
prevent
prioriti
author
shown
follow
vaccin
effect
measur
extent
certain
vaccin
infect
hospit
death
larg
popul
routin
less
ideal
immedi
goal
vaccin
pandem
protect
diseas
goal
eventu
erad
proport
popul
must
must
greater
critic
vaccin
coverag
assum
effect
transmiss
would
greater
realist
coverag
level
imposs
coverag
level
less
effect
would
abl
erad
diseas
june
sever
alreadi
effect
asymptomat
infect
prevent
infect
impact
transmiss
particularli
asymptomat
presymptomat
exact
extent
effect
still
investig
transmiss
precis
effect
reproduct
number
basic
reproduct
number
greater
vaccin
coverag
greater
vaccin
effect
transmiss
combin
interplay
viru
human
initi
natur
prompt
avail
potenti
emerg
variant
moder
fulli
resist
antibodi
respons
current
gener
necessit
modif
indic
mani
initi
strain
lower
efficaci
symptomat
updat
us
food
drug
administr
author
effect
protect
limit
evid
variou
preliminari
diseas
alpha
vaccin
data
yet
relev
end
pandem
asymptomat
infect
antibodi
neutral
alpha
wide
distribut
sputnik
v
covaxin
minim
moder
reduct
data
yet
new
variant
alpha
variant
lineag
earli
suggest
protect
variant
pfizerbiontech
one
studi
vaccin
efficaci
alpha
versu
preliminari
data
clinic
trial
vaccin
effect
origin
variant
alpha
limit
evid
variou
preliminari
reduc
diseas
beta
vaccin
possibl
substanti
moder
johnson
johnson
minim
data
yet
relev
end
pandem
asymptomat
infect
possibl
reduc
antibodi
neutral
beta
wide
distribut
sputnik
v
johnson
johnson
minim
substanti
reduct
except
minim
modest
reduct
data
yet
trial
vaccin
tackl
beta
variant
lineag
pfizer
neutral
activ
reduc
variant
efficaci
vaccin
ill
variant
yet
made
activ
sera
pfizerbiontech
beta
later
confirm
sever
updat
pfizerbiontech
south
vaccin
trial
state
vaccin
effect
far
ie
saw
six
nine
placebo
control
group
beta
johnson
johnson
vaccin
south
level
protect
moder
sever
infect
unit
south
financi
time
provision
trial
data
studi
south
univers
conjunct
univers
reduc
efficaci
vaccin
variant
studi
found
sampl
size
vaccin
minim
protect
sever
minist
health
south
suspend
deploy
million
vaccin
whilst
examin
data
await
advic
proceed
march
preliminari
efficaci
vaccin
beta
mild
moder
sever
medic
citat
limit
evid
variou
preliminari
like
diseas
gamma
data
yet
relev
end
pandem
asymptomat
infect
antibodi
neutral
gamma
minim
reduct
slightli
reduc
neutral
minim
moder
reduct
data
yet
gamma
variant
lineag
variant
known
initi
brazil
partial
escap
vaccin
pfizerbiontech
vaccin
limit
evid
variou
preliminari
like
diseas
delta
vaccin
data
yet
relev
end
pandem
asymptomat
infect
reduc
antibodi
neutral
delta
substanti
reduct
covaxin
modest
moder
reduct
data
yet
new
variant
discov
lineag
spread
least
except
antarctica
south
among
spike
synonym
medic
citat
latter
two
caus
easili
avoid
variant
frequent
doubl
mutant
even
though
respect
unusu
updat
lineag
variant
investig
public
health
lineag
variant
investig
variant
concern
base
assess
transmiss
least
equival
alpha
variant
phase
test
primarili
safeti
preliminari
dozen
healthi
phase
follow
success
phase
evalu
immunogen
dose
efficaci
base
advers
effect
candid
vaccin
typic
peopl
phase
trial
preliminari
safeti
immunogen
test
typic
precis
effect
phase
typic
involv
multipl
includ
control
group
test
effect
vaccin
prevent
diseas
intervent
pivot
trial
advers
effect
optim
dose
definit
vaccin
safeti
efficaci
clinic
phase
trial
vari
differ
degre
side
effect
infect
amount
transmiss
whether
vaccin
moder
sever
infect
clinic
trial
design
progress
adapt
design
data
trial
provid
earli
posit
neg
efficaci
treatment
adapt
within
ongo
phase
clinic
candid
shorten
trial
use
possibl
earli
termin
success
duplic
research
design
solidar
trial
across
intern
nation
regulatori
emerg
use
fifteen
six
emerg
full
use
least
one
stringent
regulatori
author
biolog
licens
us
food
drug
administr
updat
eleven
vaccin
clinic
develop
use
enhanc
immunogen
immunolog
adjuv
substanc
vaccin
elev
immun
respons
antigen
viru
influenza
viru
specif
adjuv
use
vaccin
candid
boost
immunogen
efficaci
reduc
prevent
infect
use
vaccin
formul
particularli
effect
viru
aluminum
known
alum
first
adjuv
use
licens
adjuv
choic
alum
adjuv
divers
molecular
cellular
enhanc
immunogen
releas
june
updat
billion
vaccin
base
offici
nation
health
world
data
pandem
rapid
scale
intern
world
health
organ
coalit
epidem
prepared
vaccin
industri
distribut
eventu
vaccin
individu
vaccin
persuad
favor
highest
bidder
provid
countri
emphas
licens
avail
afford
peopl
need
agre
work
global
find
vaccin
share
would
get
preferenti
access
new
sever
plan
initi
manufactur
vaccin
artifici
low
increas
profit
later
annual
build
stock
futur
need
report
state
strong
intern
vaccin
public
health
ensur
promis
vaccin
suffici
equit
affect
particularli
financi
global
deploy
sever
safe
effect
need
differ
across
popul
exampl
success
would
like
first
personnel
risk
sever
ill
death
infect
elderli
peopl
meet
world
health
organ
emerg
committe
persist
inequ
global
vaccin
distribut
although
percent
world
popul
receiv
local
articl
march
brazil
twice
white
black
peopl
fact
mortal
bigger
black
popul
liabil
place
protect
pharmaceut
pfizer
neglig
relat
liabil
took
effect
us
secretari
health
human
notic
declar
public
readi
emerg
prepared
act
prep
act
medic
cover
vaccin
use
treat
diagnos
cure
prevent
mitig
transmiss
viru
therefrom
declar
liabil
neglig
manufactur
vaccin
neglig
health
care
provid
wrong
dose
absent
will
misconduct
absent
will
misconduct
money
damag
occur
administr
relat
declar
effect
unit
govern
pfizer
legal
indemn
vaccin
union
licens
condit
market
exempt
civil
administr
liabil
vaccin
remain
secret
contain
liabil
even
known
time
licensur
bureau
investig
journal
nonprofit
news
organ
investig
unnam
brazil
pfizer
legal
due
advers
effect
form
liabil
sovereign
asset
feder
bank
embassi
militari
base
go
beyond
us
pandem
parliamentari
inquiri
brazil
pfizer
repres
brazil
substanti
reduc
probabl
infect
still
possibl
fulli
peopl
contract
spread
public
health
peopl
continu
prevent
wear
face
social
distanc
wash
avoid
especi
vulner
peopl
particularli
high
commun
spread
reduc
vaccin
increas
commun
spread
buy
vaccin
avail
though
repres
global
popul
contract
buy
bought
would
necessari
vaccin
entir
equit
distribut
million
vaccin
least
given
one
countri
million
thousand
march
reveal
us
convinc
brazil
purchas
sputnik
v
vaccin
influenc
involv
territori
reportedli
access
block
accus
block
vaccin
deliveri
china
procur
vaccin
singl
dose
vaccin
would
cost
sell
report
endow
intern
peac
current
poverti
rate
around
percent
approxim
million
peopl
million
would
unabl
gain
access
luxuri
vaccin
human
lawyer
lawsuit
govern
forc
provid
vaccin
free
cost
public
accord
immunologist
mutant
viru
limit
vaccin
distribut
pose
get
entir
world
countri
call
global
vaccin
effort
wrote
mental
ultim
backfir
spread
viru
would
lead
current
less
effect
march
unit
union
block
push
eighti
waiv
vaccin
patent
effort
boost
product
poor
administr
intellectu
properti
parliament
back
motion
demand
temporari
lift
intellectu
commiss
eu
readi
discuss
issu
patent
includ
limit
export
product
look
compulsori
capac
increas
scheme
made
urgent
appeal
pool
excess
vaccin
capac
make
gap
program
program
mostli
vaccin
produc
sri
face
seriou
suppli
due
domest
vaccin
need
march
june
current
limit
amount
distribut
effici
shortfal
south
due
lack
expedi
intern
aid
point
sri
well
brazil
problem
short
suppli
critic
toward
pfizer
sinc
deliveri
second
half
earli
public
unsaf
unnecessari
refus
vaccin
global
health
threat
vaccin
hesit
risk
viral
spread
lead
two
peopl
us
would
accept
new
vaccin
wide
dispar
educ
level
employ
statu
geographi
march
us
get
effort
demonstr
vaccin
safeti
promin
receiv
camera
mani
public
publicli
declar
peopl
get
mani
made
video
otherwis
vaccin
partli
counteract
vaccin
hesit
vaccin
conspiraci
sever
current
former
state
govern
encourag
joe
w
bush
bill
lama
nanci
kamala
princ
vaccin
break
protocol
keep
royal
famili
health
privat
pope
pope
emeritu
benedict
dolli
get
vaccin
fund
peopl
get
new
version
song
vaccin
smith
king
toni
mavi
grey
willi
nelson
grey
state
got
vaccin
want
safe
lost
mani
peopl
covid
lost
heartbreak
frighten
ami
rosario
hall
l
stone
jeff
jane
kim
alan
harbour
get
encourag
dame
collin
van
ness
roker
dan
rather
get
fri
photograph
wrote
wonder
moment
feel
help
health
know
like
less
contagi
happen
carri
symbol
part
societi
part
group
want
protect
get
thing
done
sir
magic
johnson
get
find
new
way
keep
safe
ray
khan
produc
video
specif
encourag
ethnic
minor
conspiraci
scientif
evid
suggest
work
differ
peopl
ethnic
includ
pork
materi
fetal
anim
origin
spoken
black
trial
volunt
larg
part
reason
volunt
vaccin
research
black
peopl
peopl
color
need
part
divers
reap
medic
research
tri
tell
us
think
learn
articl
peer
learn
see
preprint
comput
medicin
univers
michigan
ann
arbor
mi
laboratori
anim
medicin
depart
microbiolog
immunolog
univers
michigan
ann
arbor
mi
comput
medicin
univers
michigan
ann
arbor
mi
comput
medicin
univers
michigan
ann
arbor
mi
laboratori
anim
medicin
depart
microbiolog
immunolog
univers
michigan
ann
arbor
mi
ultim
combat
pandem
desir
develop
effect
safe
vaccin
highli
contagi
diseas
coronaviru
literatur
clinic
trial
survey
whole
viru
well
spike
protein
n
protein
membran
protein
test
vaccin
develop
use
revers
tool
newli
machin
learn
tool
predict
vaccin
n
protein
found
pathogen
human
mostli
caus
mild
investig
entir
six
protein
five
nonstructur
crucial
viral
host
invas
induc
high
protect
antigen
besid
commonli
use
protein
protein
test
coronaviru
vaccin
select
investig
found
among
among
human
protein
contain
promiscu
linear
specif
function
protein
vaccin
provid
new
effect
safe
vaccin
coronaviru
diseas
pandem
massiv
crisi
global
public
health
march
confirm
accord
world
health
organ
declar
pandem
day
caus
agent
diseas
sever
acut
respiratori
syndrom
coronaviru
caus
anim
avian
infecti
bronchiti
infecti
bronchiti
viru
pig
transmiss
gastroenter
porcin
bat
commonli
natur
reservoir
genet
seven
known
human
novel
four
human
popul
caus
mild
coronaviru
promin
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
diseas
coronaviru
infect
peopl
summer
share
high
sequenc
diseas
infect
peopl
coronaviru
first
spread
sever
sinc
human
vaccin
market
prevent
urgent
need
develop
safe
effect
vaccin
prevent
highli
infecti
diseas
genom
insid
n
protein
membran
protein
envelop
e
protein
spike
mani
coronaviru
vaccin
differ
structur
eventu
soon
outbreak
recent
pandem
outbreak
urgent
resum
coronaviru
vaccin
research
immedi
respons
ongo
pandem
first
test
vaccin
protein
identifi
type
text
tabl
march
superfici
protrus
protein
protein
crucial
role
mediat
viru
entri
vaccin
develop
protein
subunit
receptor
bind
domain
frequent
use
vaccin
due
abil
induc
prevent
host
cell
entri
infect
howev
vaccin
provid
full
protect
sometim
rais
safeti
mani
research
great
manufactur
vaccin
clinic
recent
develop
vaccin
design
revers
first
identifi
promis
vaccin
candid
analysi
pathogen
genom
success
appli
vaccin
discoveri
group
b
meningococcu
led
licens
among
current
predict
first
use
success
predict
vaccin
differ
bacteri
viral
recent
machin
learn
approach
enhanc
predict
studi
first
coronaviru
vaccin
develop
statu
appli
predict
protein
vaccin
develop
six
possibl
structur
protein
five
nonstructur
three
induc
high
protect
immun
protein
highest
protect
antigen
score
extens
studi
target
coronaviru
select
protein
altern
vaccin
candid
protect
antigen
score
yet
consid
vaccin
sequenc
conserv
immunogen
protein
vaccin
better
understand
current
statu
coronaviru
vaccin
develop
systemat
develop
coronaviru
literatur
march
extens
effort
made
develop
safe
effect
vaccin
advanc
clinic
trial
studi
current
phase
tabl
task
quickli
develop
safe
effect
vaccin
ongo
two
primari
design
coronaviru
vaccin
develop
usag
whole
viru
genet
vaccin
differ
whole
viru
includ
live
tabl
two
live
envelop
protein
reduc
virul
replic
capabl
overal
whole
viru
induc
strong
immun
respons
protect
coronaviru
genet
target
specif
coronaviru
protein
often
use
improv
vaccin
safeti
efficaci
coronaviru
protein
n
protein
protein
vaccin
viral
vector
vaccin
tabl
test
surfac
glycoprotein
n
phosphoprotein
membran
glycoprotein
exon
domain
receptor
bind
first
use
analysi
compar
full
seven
human
coronaviru
use
seed
compar
analysi
analysi
n
protein
high
sequenc
similar
among
sever
form
coronaviru
low
sequenc
similar
among
typic
mild
sequenc
conserv
potenti
n
protein
candid
vaccin
n
protein
use
vaccin
develop
tabl
n
protein
coronaviru
form
helic
assembl
protein
protein
induc
immun
respons
neutral
coronaviru
howev
studi
linkag
n
protein
sever
pneumonia
seriou
liver
relat
pathogenesi
analysi
six
protein
adhes
tabl
critic
role
viru
host
cell
viru
entri
host
signific
associ
protein
match
primari
role
viru
entri
structur
protein
contribut
host
cell
entri
enzym
besid
protein
five
adhes
nonstructur
particular
nonstructur
protein
variou
function
predict
probabl
pipelin
protect
antigen
score
induct
protect
immun
vaccin
train
data
viral
protect
test
protect
least
one
anim
challeng
perform
tabl
figur
best
model
weight
model
three
protein
vaccin
signific
tabl
protein
highest
score
consist
experiment
literatur
protein
second
promis
vaccin
candid
besid
protein
current
studi
vaccin
target
structur
protein
variou
coronaviru
infect
replic
pathogenesi
immun
evas
viru
surviv
therefor
select
investig
multipl
sequenc
align
result
phylogeni
protein
protein
close
relat
human
bat
studi
genet
conserv
protein
figur
seven
human
eight
tabl
five
human
belong
belong
human
coronaviru
mild
cluster
togeth
murin
sever
form
human
coronaviru
group
three
bat
phylogeni
sequenc
conserv
coronaviru
phylogeni
base
protein
sequenc
align
phylogeni
analysi
b
conserv
among
differ
coronaviru
red
line
conserv
among
four
blue
line
bottom
part
size
phylogenet
close
four
amino
acid
rel
function
protein
except
region
marker
higher
conserv
figur
amino
acid
conserv
major
human
coronaviru
plot
use
gener
phylogenet
protein
figur
plot
figur
rel
posit
multipl
sequenc
align
tabl
figur
immunogen
protein
cell
linear
b
cell
promiscu
bind
refer
cover
major
world
popul
respect
tabl
linear
b
cell
least
ten
amino
length
tabl
structur
protein
plot
cell
linear
b
cell
figur
b
cell
like
distal
region
protein
structur
insid
protein
slide
cell
linear
b
cell
plot
respect
tent
protein
protein
refer
figur
domain
domain
preced
domain
b
cell
particular
helic
high
cell
pass
endoplasm
reticulum
er
membran
bind
domain
nab
domain
b
cell
final
framework
posit
domain
domain
high
sequenc
similar
human
type
text
structur
protein
cell
red
b
blue
cell
c
linear
b
cell
green
mix
b
shown
region
four
conserv
red
cell
b
blue
cell
c
linear
b
cell
green
predict
potenti
induc
protect
immun
time
analysi
vaccin
develop
current
coronaviru
vaccin
use
whole
viru
target
structur
spike
protein
n
protein
membran
protein
tabl
whole
viru
vaccin
induc
strong
advers
hand
structur
induc
strong
immun
structur
n
associ
pathogenesi
rais
safeti
concern
studi
shown
liver
patholog
vaccinia
although
advers
anim
safeti
efficaci
vaccin
test
human
clinic
studi
appli
reserv
machin
learn
entir
structur
nonstructur
vaccin
candid
predict
indic
first
time
mani
nonstructur
use
potenti
vaccin
protein
analysi
favor
vaccin
candid
first
framework
protein
like
consist
role
protein
invas
host
second
protein
high
protect
antigen
score
confirm
role
protein
import
target
howev
protein
mani
mani
nonpathogen
human
use
protein
cell
invas
exampl
despit
markedli
weak
pathogen
protein
enzym
cellular
protein
factor
infect
level
human
coronaviru
addit
protein
induc
high
antibodi
induc
suffici
protect
thu
altern
vaccin
protein
potenti
vaccin
candid
shown
protect
antigen
score
properti
promiscu
cell
b
cell
nonstructur
protein
multipl
function
support
viral
multipl
sequenc
align
higher
sequenc
conserv
function
coronaviru
fig
induct
immun
would
like
help
host
fight
infect
besid
studi
four
addit
vaccin
protein
signific
protect
antigen
nonstructur
part
viral
structur
particl
none
nonstructur
vaccin
vaccin
far
target
structur
still
nonstructur
use
effect
vaccin
stimul
protect
immun
mani
exampl
nonstructur
protein
found
induc
protect
immun
nonstructur
hepat
c
viru
induc
vigor
nonstructur
gene
shown
valuabl
prophylact
therapeut
therefor
reason
consid
nonstructur
possibl
vaccin
present
singl
protein
vaccin
antigen
would
propos
develop
cocktail
vaccin
effect
strategi
vaccin
develop
typic
cocktail
vaccin
one
antigen
cover
differ
licens
group
b
meningococcu
vaccin
via
revers
three
protein
develop
effici
safe
cocktail
vaccin
possibl
mix
structur
protein
nonstructur
viral
studi
consid
possibl
vaccin
benefit
cocktail
vaccin
strategi
induc
immun
protect
host
interact
viral
entri
host
protect
accessari
nonstructur
vital
viral
entri
replic
usag
one
antigen
us
reduc
volum
antigen
thu
reduc
induct
advers
nonetheless
nonstructur
protein
vaccin
develop
need
experiment
ration
vaccin
develop
critic
understand
fundament
interact
protect
immun
understand
provid
us
guidanc
antigen
select
facilit
design
vaccin
exampl
import
foundat
predict
studi
base
understand
critic
role
virul
factor
well
protect
antigen
choic
vaccin
vaccin
vector
anoth
method
vaccin
formul
deepli
root
understand
immun
respons
induct
differ
experiment
affect
therefor
crucial
understand
underli
molecular
cellular
ration
vaccin
journal
coronaviru
vaccin
experiment
studi
found
induc
protect
antibodi
provid
immun
virul
pathogen
sequenc
six
known
human
coronaviru
extract
full
seven
revers
program
serval
biolog
protein
predict
model
build
follow
similar
methodolog
specif
posit
train
data
includ
bacteri
viral
protect
remov
homolog
sequenc
ident
neg
extract
correspond
sequenc
dissimilar
previou
homolog
neg
remov
result
biolog
physicochem
biolog
includ
physicochem
includ
variou
physicochem
charg
polar
solvent
five
classif
logist
regress
support
vector
machin
neighbor
random
extrem
gradient
train
perform
fivefold
base
area
receiv
oper
characterist
curv
precis
recal
weight
correl
coeffici
best
model
select
predict
score
isol
id
type
text
protein
score
consid
strong
vaccin
immun
induct
weight
protein
select
investig
besid
tabl
multipl
sequenc
align
via
phylogenet
tree
amino
acid
conserv
diverg
score
use
gener
sequenc
conserv
line
protein
immunogen
protein
predict
cell
linear
b
cell
cell
consensu
method
use
promiscu
bind
refer
consensu
percentil
less
cell
consensu
method
use
promiscu
bind
half
refer
consensu
percentil
less
refer
cover
wide
rang
human
genet
variat
major
world
linear
b
cell
cutoff
linear
b
cell
least
ten
amino
structur
protein
via
count
cell
score
linear
b
cell
slide
window
size
ten
amino
protein
structur
avail
lab
work
grant
financi
declar
financi
financi
declar
financi
first
us
joint
vaccin
readi
credit
full
access
articl
via
seek
vaccin
coronaviru
earli
care
promis
quick
success
vaccin
previous
viral
sampl
approv
four
mump
hope
one
even
summer
highli
start
sever
excel
larg
show
promis
vaccin
made
drug
giant
pfizer
german
firm
first
immun
emerg
speed
advanc
whole
paradigm
possibl
vaccin
develop
dean
univers
tempt
hope
made
compar
sore
malaria
tuberculosi
pneumonia
togeth
kill
million
peopl
year
anticip
lethal
experi
almost
certainli
chang
futur
vaccin
scienc
dan
director
center
virolog
vaccin
research
medic
school
boston
fast
vaccin
develop
proceed
true
global
emerg
suffici
new
way
make
messeng
respons
shown
develop
process
acceler
substanti
without
compromis
safeti
first
fulli
test
vaccin
given
earli
dan
world
abl
develop
quickli
previou
research
relat
faster
way
manufactur
enorm
run
multipl
parallel
move
quickli
normal
translat
vaccin
particularli
guarante
repeat
rapid
success
requir
similar
massiv
develop
like
come
compar
sens
social
polit
urgenc
depend
natur
pathogen
viru
rel
slowli
belong
famili
strang
got
research
develop
new
coronaviru
start
pay
attent
relat
caus
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
work
new
vaccin
effort
vaccin
product
line
contain
viral
disabl
viru
stimul
bodi
immun
infect
live
viru
first
two
efficaci
phase
clinic
use
string
insid
coat
key
protein
insid
produc
protein
antigen
foreign
molecul
immun
respons
made
pfizer
us
pharmaceut
compani
use
spike
protein
human
cell
coronaviru
invad
cell
lot
went
platform
today
immunologist
yale
school
medicin
new
work
base
two
basic
research
least
ago
strong
research
cancer
approach
right
time
five
ago
technolog
would
instanc
us
nation
institut
allergi
infecti
knew
research
best
tune
sequenc
stabil
result
spike
protein
form
host
cell
trap
origin
state
becom
much
better
vaccin
antigen
barney
graham
deputi
director
vaccin
research
work
gave
team
work
head
start
fact
peopl
pay
close
attent
realli
whole
process
acceler
graham
deputi
director
vaccin
research
center
left
us
presid
trump
second
right
visit
march
research
far
right
earli
pictur
director
collin
second
left
director
third
left
credit
third
vaccin
show
efficaci
phase
clinic
made
pharmaceut
firm
univers
use
instead
viral
vector
carrier
extra
genet
materi
spike
protein
research
select
vector
case
firm
chose
form
isol
chimpanze
stool
convent
come
research
malaria
director
vaccin
school
hygien
tropic
medicin
remain
fortun
mani
viru
mutat
lot
effect
foil
human
immun
system
unlik
herp
even
influenza
herp
viru
contrast
evas
capabl
activ
bind
harder
find
effect
agent
fast
mutat
flu
differ
vaccin
formul
everi
flu
part
vaccin
develop
find
candid
test
often
see
vaccin
innov
run
efficaci
safeti
human
test
three
phase
involv
increas
peopl
proportion
went
process
made
possibl
take
financi
run
time
see
vaccin
year
world
data
natur
larg
given
vaccin
public
privat
preclin
phase
well
parallel
instead
sequenti
chief
scientist
divis
meant
gambl
start
test
work
total
entir
develop
process
vaccin
scienc
would
produc
fast
without
happen
devast
accordingli
took
longer
develop
money
time
wealthi
face
econom
devast
suggest
develop
futur
malaria
speedi
unless
put
money
way
acceler
peter
colleg
medicin
larg
pharmaceut
desir
stop
pandem
opportun
fund
research
develop
public
invest
around
us
billion
us
oper
warp
speed
vaccin
govern
stimulu
packag
ever
seen
impetu
come
urgenc
pandem
previou
infecti
lethal
creation
nation
global
promot
faster
vaccin
develop
saw
begin
better
global
respond
crisi
graham
spread
vaccin
technolog
much
difficult
time
natur
particular
coalit
epidem
prepared
goal
creat
technolog
infrastructur
rapid
afford
develop
sever
known
epidem
potenti
partli
fund
work
final
everywher
need
show
work
hard
run
efficaci
preval
especi
dean
diseas
patchi
low
infect
experi
prompt
regulatori
rethink
although
stringent
criteria
vaccin
approv
first
mostli
faster
requir
conduct
look
side
effect
efficaci
nation
inform
vaccin
auspic
global
bodi
intern
coalit
regulatori
set
reach
consensu
best
vaccin
harmon
side
effect
roll
see
natur
pandem
see
perman
vaccin
develop
start
establish
use
previous
gener
use
peopl
speedi
approach
technolog
candid
chemic
day
contrast
complic
involv
technolog
nimbl
approach
respond
futur
lot
use
facil
make
differ
invest
ramp
still
make
measl
polio
even
produc
help
meet
demand
vaccin
made
firm
larg
clinic
develop
provid
data
wide
use
understand
immun
given
differ
detail
inform
collect
clinic
volunt
antibodi
cellular
learn
much
human
vaccin
year
previou
human
make
quantum
leap
still
probabl
compar
speed
infect
high
make
possibl
run
massiv
rel
quickli
huge
harder
target
turn
need
know
say
least
viru
infect
graham
rather
wait
sink
fight
next
viru
money
would
better
spent
set
monitor
gener
data
prototyp
amount
money
help
without
solid
platform
basic
scienc
build
extraordinari
success
good
exampl
scienc
quickli
happen
overnight
natur
featur
ga
unit
ga
unit
ga
unit
univers
school
medicin
mo
unit
essenti
roundup
scienc
news
opinion
analysi
everi
full
access
articl
via
essenti
roundup
scienc
news
opinion
analysi
everi
natur
brief
newslett
scienc
free
daili
springer
natur
public
sever
acut
respiratori
syndrom
coronaviru
genet
sequenc
research
collabor
among
quickli
use
vaccin
discoveri
new
york
time
coronaviru
vaccin
tracker
author
emerg
use
unit
sever
full
use
outsid
unit
phase
clinic
global
numer
antivir
investig
coronaviru
diseas
us
food
drug
administr
emerg
use
sinc
two
pfizer
wherea
third
viral
vector
vaccin
johnson
johnson
phase
vaccin
older
nurs
alreadi
profoundli
reduc
sever
higher
risk
older
vaccin
alreadi
provid
reliabl
way
build
infect
receiv
vaccin
acut
ill
symptomat
meet
criteria
discontinu
isol
receiv
convalesc
plasma
wait
day
provid
substanti
higher
protect
infect
immun
previou
infect
higher
antibodi
time
higher
convalesc
natur
infect
earli
found
vaccin
prior
infect
immun
memori
respons
effect
data
emphas
import
uninfect
previous
infect
elicit
unit
vaccin
age
older
earli
extend
vaccin
pfizer
includ
younger
age
phase
trial
data
includ
vaccin
effect
infect
age
group
diseas
age
receiv
vaccin
n
receiv
placebo
n
vaccin
effect
day
age
addit
vaccin
efficaci
seroneg
start
day
first
dose
secondari
case
definit
test
milder
diseas
phase
trial
includ
june
expand
current
includ
popul
trial
age
enrol
clinic
ongo
addit
complex
find
effect
vaccin
product
process
import
vaccin
scale
global
increas
complex
distribut
includ
storag
frozen
whether
singl
inject
optim
immun
sever
technolog
viral
vector
protein
subunit
avail
vaccin
develop
vaccin
number
speed
develop
depend
type
technolog
method
employ
use
develop
previou
wherea
newli
exampl
influenza
rabi
viru
previous
test
variou
vaccin
includ
tabl
tabl
vaccin
platform
open
tabl
new
window
pfizer
univers
johnson
johnson
abil
quickli
produc
larg
pfizer
messeng
vaccin
domain
antigen
seri
given
day
multin
phase
trial
randomli
assign
receiv
vaccin
placebo
vaccin
group
placebo
group
inject
approxim
global
us
racial
ethnic
divers
global
us
age
vaccin
efficaci
origin
strain
day
dose
seriou
safeti
confirm
placebo
group
vaccin
group
sever
first
dose
placebo
group
vaccin
group
grade
advers
event
frequenc
greater
fatigu
headach
pain
inject
site
common
reaction
sever
pain
less
across
age
efficaci
data
ongo
phase
assess
efficaci
day
second
vaccin
dose
among
confirm
symptomat
placebo
group
vaccin
group
effect
sever
diseas
diseas
control
prevent
definit
sever
diseas
placebo
group
observ
studi
data
employ
larg
medic
center
first
vaccin
dose
among
elig
staff
receiv
first
dose
receiv
second
dose
symptomat
rate
per
unvaccin
diseas
per
day
day
first
vaccin
dose
respect
rate
diseas
day
day
first
dose
anoth
observ
studi
use
data
health
care
organ
evalu
mass
immun
effect
infect
symptomat
hospit
sever
ill
death
suggest
vaccin
effect
wide
rang
consist
trial
polack
vaccin
antigen
seri
given
day
apart
us
phase
trial
cove
trial
nation
institut
allergi
infecti
includ
receiv
two
placebo
day
overal
efficaci
origin
viral
strain
confirm
placebo
group
vaccin
group
among
placebo
group
sever
death
cove
studi
n
includ
older
younger
chronic
identifi
identifi
black
second
dose
efficaci
greater
infect
greater
sever
data
sever
ongo
phase
trial
adult
age
high
antibodi
activ
second
dose
booster
singl
booster
dose
concern
previous
clinic
trial
booster
dose
candid
higher
booster
dose
evalu
multival
vaccin
booster
ancestr
singl
vaccin
ongo
vaccin
johnson
johnson
singl
inject
phase
trial
ensembl
unit
south
south
fulli
enrol
interim
phase
trial
antibodi
day
day
trial
randomli
assign
receiv
inject
either
n
placebo
n
moder
onset
least
day
administr
vaccin
placebo
group
efficaci
least
day
administr
efficaci
vaccin
higher
efficaci
onset
day
onset
day
vaccin
effect
hospit
death
day
placebo
group
consist
protect
across
race
age
older
age
older
vaccin
arm
across
studi
south
nearli
due
infect
variant
lineag
fact
sheet
health
care
vaccin
safeti
efficaci
older
studi
overal
younger
least
day
post
vaccin
efficaci
moder
diseas
studi
ie
unit
south
age
older
unit
efficaci
least
day
vaccin
chimpanze
vector
vaccin
surfac
glycoprotein
antigen
spike
protein
gene
seri
day
apart
vaccin
immun
system
attack
viru
later
bodi
owe
test
differ
coronaviru
vaccin
develop
faster
viral
vector
interim
analysi
phase
clinic
trial
unit
kingdom
brazil
south
one
regimen
n
vaccin
efficaci
given
half
dose
full
dose
least
month
later
anoth
regimen
n
efficaci
given
full
least
month
apart
combin
analysi
n
averag
efficaci
p
day
first
dose
control
arm
sever
death
clinic
trial
implement
data
analysi
regimen
studi
design
regulatori
await
public
trial
data
anoth
trial
studi
second
vaccin
dose
first
dose
instead
month
initi
exclus
period
vaccin
group
control
group
vaccin
efficaci
singl
standard
dose
vaccin
day
day
analysi
protect
wane
initi
period
similarli
antibodi
period
minim
wane
day
group
receiv
standard
dose
vaccin
efficaci
higher
longer
interv
interv
less
respect
nasal
trial
everi
week
studi
regardless
assess
overal
impact
vaccin
risk
infect
thu
surrog
potenti
onward
transmiss
singl
standard
dose
reduc
posit
second
dose
reduc
posit
overal
data
indic
use
author
substanti
impact
transmiss
reduc
number
infect
popul
thrombosi
thrombocytopenia
syndrom
thrombosi
thrombocytopenia
johnson
johnson
temporarili
use
allow
advisori
committe
immun
evalu
rare
cerebr
venou
sinu
thrombosi
vaccin
interim
recommend
use
vaccin
age
older
warn
rare
occur
vaccin
primarili
among
age
risk
death
seriou
thrombosi
far
outweigh
risk
possibl
associ
highli
efficaci
rare
syndrom
acut
venou
arteri
thrombosi
thrombocytopenia
known
recent
exposur
heparin
although
mechan
fulli
understood
similar
thrombocytopenia
rare
reaction
heparin
treatment
unit
vaccin
thrombocytopenia
societi
hematolog
heart
stroke
associ
awar
diagnosi
urgent
treatment
suspect
diagnosi
follow
criteria
follow
associ
emerg
day
vaccin
technolog
genet
sequenc
gener
spike
protein
combin
adjuv
preclin
effici
human
target
viru
seri
given
day
apart
phase
clinic
trial
overal
efficaci
base
symptomat
among
trial
among
approxim
receiv
placebo
among
approxim
receiv
investig
vaccin
placebo
group
classifi
moder
sever
moder
sever
diseas
investig
vaccin
group
phase
trial
unit
kingdom
enrol
phase
trial
south
final
time
new
viral
unit
kingdom
south
phase
studi
enrol
age
older
south
phase
among
underw
screen
receiv
least
inject
vaccin
placebo
begin
august
time
tripl
mutant
variant
critic
multipl
outsid
wide
south
natur
occur
anywher
genom
unlik
human
genom
slow
mutat
abl
readili
quickli
mutat
mutat
alter
viral
function
enhanc
receptor
bind
function
new
viru
variant
viru
differenti
predomin
viru
popul
surveil
us
site
associ
particular
genom
surveil
dashboard
us
case
alter
extent
protect
avail
concern
reduc
vaccin
effect
evid
high
number
vaccin
breakthrough
low
protect
sever
diseas
variant
unit
variant
first
unit
kingdom
march
domin
strain
unit
remain
domin
strain
account
approxim
new
june
delta
variant
variant
concern
unit
delta
variant
new
unit
enhanc
genom
surveil
includ
first
south
brazil
routin
screen
airport
chang
variant
mutat
discov
earli
immun
respons
protect
antigen
unit
kingdom
south
late
multipl
ie
spike
protein
key
current
avail
reduc
neutral
variant
shown
refer
viral
strain
sera
antibodi
vaccin
use
sera
vaccin
reduct
neutral
bear
variant
ie
variant
variant
ie
south
variant
howev
anoth
studi
primari
infect
vaccin
like
maintain
protect
efficaci
partial
resist
viru
spike
protein
render
less
well
support
rational
develop
mutat
delta
variant
rapidli
spread
unit
predomin
variant
unit
kingdom
spring
found
variant
resist
neutral
sera
convalesc
howev
studi
public
health
found
vaccin
slightli
reduc
variant
delta
variant
second
dose
anoth
analysi
found
significantli
lower
rel
although
singl
dose
still
afford
consider
protect
vaccin
like
less
data
stress
import
typic
regimen
approxim
apart
vaccin
assess
south
signific
impact
neutral
variant
first
phase
test
contrast
month
later
variant
variant
variant
variant
well
subset
factor
test
panel
effect
neutral
reduct
factor
measur
variant
delta
variant
first
resist
neutral
sera
convalesc
slight
neutral
consid
clinic
signific
regard
vaccin
efficaci
owe
high
efficaci
vaccin
ie
approxim
wuhan
refer
viral
strain
continu
variant
surveil
nonhuman
allow
foresight
vaccin
develop
futur
booster
warrant
advanc
vaccin
candid
variant
first
south
preclin
phase
studi
unit
multival
booster
candid
singl
vaccin
third
vaccin
nation
health
phase
clinic
test
confirm
preliminari
efficaci
vaccin
phase
trial
unit
kingdom
n
final
analysi
vaccin
efficaci
origin
strain
final
analysi
phase
trial
n
south
efficaci
among
south
escap
variant
predomin
variant
johnson
phase
trial
n
viral
vector
vaccin
late
trial
geograph
time
sever
analysi
data
day
determin
vaccin
effect
unit
south
infect
importantli
vaccin
effect
sever
diseas
provid
complet
protect
hospit
death
geograph
addit
consist
protect
across
studi
south
nearli
due
infect
variant
lineag
studi
unit
kingdom
determin
efficaci
variant
similar
efficaci
vaccin
minim
protect
infect
variant
south
follow
infect
young
n
placebo
vaccin
efficaci
among
variant
incid
seriou
advers
balanc
vaccin
placebo
south
halt
roll
vaccin
earli
studi
public
health
found
dose
effect
reduc
variant
variant
delta
first
domin
variant
unit
kingdom
spring
accord
data
pregnant
risk
sever
ill
coronaviru
diseas
death
nonpregn
addit
pregnant
risk
advers
deliveri
interim
clinic
use
limit
data
avail
regard
administr
pregnant
owe
sever
infect
essenti
mother
fetu
cohort
studi
n
gray
found
humor
immun
pregnant
similarli
nonpregn
serum
vaccin
significantli
higher
induc
infect
pregnanc
p
importantli
present
umbil
cord
blood
show
immun
transfer
vial
placenta
anoth
studi
matern
cord
blood
sera
collect
receiv
vaccin
posit
anti
addit
support
cord
blood
provid
inform
regard
potenti
time
matern
vaccin
one
studi
n
mean
placent
transfer
ratio
follow
vaccin
equal
infant
antibodi
level
matern
level
increas
latenc
vaccin
suggest
vaccin
third
trimest
produc
greater
infant
immun
similar
studi
n
lead
matern
antibodi
product
soon
day
first
dose
passiv
immun
neonat
soon
day
placent
transfer
ratio
time
collier
bind
function
antibodi
well
present
pregnant
nonpregn
follow
vaccin
bind
infant
cord
blood
breast
milk
bind
antibodi
concern
reduc
viral
studi
pregnant
deliveri
induc
immun
respons
activ
link
decidu
arteriopathi
growth
restrict
deliveri
fetal
loss
mous
placent
examin
vaccin
incid
decidu
arteriopathi
fetal
vascular
chronic
villiti
chronic
histiocyt
control
group
incid
chronic
villiti
higher
control
group
group
colleg
regard
vaccin
pregnant
key
consid
vaccin
access
inform
vaccin
safeti
efficaci
inform
data
avail
convers
patient
clinic
team
provid
care
assist
regard
use
emerg
use
author
prevent
pregnant
import
includ
preliminari
regard
safeti
pregnant
registri
show
obviou
safeti
addit
pregnanc
determin
matern
pregnanc
infant
phase
clinic
pregnant
vaccin
vaccin
spring
vaccin
variou
develop
clinic
test
provid
tabl
investig
open
tabl
new
window
vaccin
stabl
room
temperatur
frozen
shipment
phase
trial
innov
ongo
phase
evalu
regimen
placebo
interim
phase
n
strong
antibodi
compar
natur
infect
singl
inject
high
antibodi
evid
prior
infect
suggest
strong
potenti
develop
booster
vaccin
phase
trial
start
target
enrol
amino
acid
receptor
bind
domain
design
th
deriv
subunit
membran
nucleoprotein
structur
induct
memori
recal
activ
effector
start
phase
trial
phase
trial
brazil
sister
compani
unit
form
new
compani
call
includ
vaccin
covaxin
vaccin
candid
level
facil
us
market
receiv
fulli
enrol
phase
trial
n
interim
phase
march
efficaci
second
interim
analysi
phase
late
found
efficaci
infect
efficaci
sever
pursu
full
us
approv
licens
applic
instead
upon
recommend
phase
trial
ongo
vaccin
inner
n
outer
spike
protein
activ
dual
offer
possibl
vaccin
candid
provid
durabl
immun
potent
antibodi
stimul
n
trial
expand
includ
initi
prime
vaccin
oral
sublingu
booster
induc
comprehens
immun
protect
gener
system
mucos
vaccin
vaccin
administr
inject
undergo
investig
open
tabl
new
window
vaccin
inner
n
outer
spike
protein
activ
respect
phase
trial
safeti
immunogen
oral
supplement
vaccin
enhanc
cell
base
immunogen
alreadi
receiv
vaccin
author
emerg
use
avail
vaccin
coronaviru
diseas
like
avail
first
technolog
use
develop
coronaviru
diseas
coronaviru
diseas
vaccin
coronaviru
diseas
vaccin
associ
thrombosi
thrombocytopenia
syndrom
coronaviru
diseas
vaccin
coronaviru
diseas
vaccin
coronaviru
diseas
vaccin
viral
affect
vaccin
immun
clinic
relat
vaccin
regard
pregnanc
lactat
coronaviru
diseas
still
phase
develop
coronaviru
diseas
develop
coronaviru
vaccin
tracker
new
york
time
avail
self
effect
pfizerbiontech
among
age
unit
mortal
rep
full
text
assi
r
r
palma
substanti
antibodi
natur
infect
vaccin
full
text
c
butler
otter
ad
k
prior
infect
b
cell
first
vaccin
dose
scienc
full
text
ta
x
lee
previous
infect
broadli
neutral
full
text
l
j
wan
v
h
vaccin
infect
scienc
mar
full
text
z
r
vaccin
develop
landscap
nat
rev
drug
full
text
n
r
j
pandem
speed
n
j
full
text
c
current
state
play
rev
full
text
f
miller
z
immunolog
vaccin
nat
rev
full
text
polack
n
clinic
trial
group
safeti
efficaci
vaccin
n
j
full
text
pfizer
confirm
high
efficaci
seriou
safeti
follow
second
dose
toplin
analysi
landmark
vaccin
studi
pfizer
avail
g
e
earli
rate
infect
vaccin
lancet
mar
full
text
n
n
e
vaccin
nationwid
mass
vaccin
set
n
j
full
text
el
b
cove
studi
group
efficaci
safeti
vaccin
n
j
full
text
clinic
suppli
vaccin
program
ahead
annual
day
avail
n
studi
group
antibodi
persist
second
dose
vaccin
n
j
full
text
posit
initi
booster
data
concern
avail
j
de
groot
c
immunogen
vaccin
jama
full
text
j
gray
g
ensembl
studi
group
safeti
efficaci
vaccin
n
j
full
text
sac
sa
covid
vaccin
trial
group
safeti
efficaci
vaccin
interim
analysi
four
brazil
south
lancet
full
text
r
b
mistak
difficult
vaccin
new
york
time
avail
costa
sa
sa
covid
vaccin
trial
group
administr
influenc
time
booster
dose
immunogen
efficaci
vaccin
analysi
four
lancet
mar
full
text
ay
advisori
committe
immun
use
johnson
johnson
vaccin
thrombosi
thrombocytopenia
syndrom
among
vaccin
unit
mortal
rep
full
text
us
clinic
trial
show
vaccin
safe
nation
health
avail
high
efficaci
origin
variant
unit
kingdom
south
mar
avail
v
z
studi
group
efficaci
vaccin
variant
n
j
full
text
galloway
se
p
emerg
lineag
unit
mortal
rep
full
text
x
j
h
ka
cutler
neutral
mutant
sera
full
text
j
h
x
ka
activ
serum
preliminari
report
n
j
full
text
ak
b
ka
j
w
neutral
lineag
human
sera
scienc
full
text
mulligan
neutral
south
unit
variant
spike
convalesc
sera
full
text
lai
l
k
infect
antibodi
variant
full
text
n
c
e
r
effect
variant
public
health
full
text
wall
r
kelli
g
sawyer
c
antibodi
activ
vaccin
lancet
full
text
k
e
serum
activ
vaccin
n
j
mar
full
text
consortium
project
efficaci
vaccin
variant
concern
exploratori
analysi
trial
lancet
mar
full
text
sa
v
group
covid
group
efficaci
vaccin
variant
n
j
mar
full
text
gray
ea
c
e
b
young
n
vaccin
respons
pregnant
cohort
studi
j
mar
full
text
g
e
r
wolf
effici
transfer
anti
spike
antenat
vaccin
infect
di
full
text
miller
es
cord
blood
follow
matern
vaccin
pregnanc
j
full
text
prabhu
murphi
ea
yee
j
singh
antibodi
respons
pregnant
full
text
collier
ay
k
j
immunogen
pregnant
jama
ca
miller
es
sever
acut
respiratori
syndrom
coronaviru
vaccin
pregnanc
immun
placent
histopatholog
kim
pregnanc
registri
preliminari
vaccin
safeti
pregnant
n
j
full
text
safeti
immunogen
efficaci
healthi
seroneg
high
risk
exposur
avail
studi
determin
safeti
efficaci
vaccin
avail
vaccin
candid
strong
immun
across
adult
age
phase
trial
avail
phase
studi
trimer
vaccin
prevent
avail
phase
clinic
trial
vaccin
candid
avail
studi
evalu
safeti
toler
immunogen
vaccin
avail
therapeut
avail
vaccin
solut
avail
pipelin
overview
infecti
diseas
avail
announc
start
phase
clinic
vaccin
candid
avail
pursu
path
us
vaccin
candid
avail
guan
li
immunogen
safeti
vaccin
healthi
age
older
phase
trial
lancet
full
text
piecem
data
threaten
undermin
vaccin
avail
ai
safeti
efficaci
heterolog
vaccin
interim
analysi
phase
trial
russia
lancet
full
text
subcutan
oral
supplement
vaccin
boost
enhanc
cell
protect
alreadi
receiv
avail
vaccin
candid
readi
year
avail
announc
collabor
agreement
develop
novel
vaccin
candid
us
avail
spike
vaccin
adjuv
prevent
healthi
avail
mar
develop
vaccin
develop
two
investig
therapeut
avail
immunogen
healthi
vaccin
studi
avail
present
world
vaccin
congress
oral
vaccin
hold
ice
needl
avail
e
g
array
coronaviru
immunogen
rapid
translat
develop
full
text
safeti
immunogen
intranas
vaccin
spike
protein
vaccin
avail
pfizer
univers
johnson
johnson
abil
quickli
produc
larg
vaccin
stabl
room
temperatur
frozen
shipment
phase
trial
innov
ongo
phase
evalu
regimen
placebo
interim
phase
n
strong
antibodi
compar
natur
infect
singl
inject
high
antibodi
evid
prior
infect
suggest
strong
potenti
develop
booster
vaccin
phase
trial
start
target
enrol
amino
acid
receptor
bind
domain
design
th
deriv
subunit
membran
nucleoprotein
structur
induct
memori
recal
activ
effector
start
phase
trial
phase
trial
brazil
sister
compani
unit
form
new
compani
call
includ
vaccin
covaxin
vaccin
candid
level
facil
us
market
receiv
fulli
enrol
phase
trial
n
interim
phase
march
efficaci
second
interim
analysi
phase
late
found
efficaci
infect
efficaci
sever
pursu
full
us
approv
licens
applic
instead
upon
recommend
phase
trial
ongo
vaccin
inner
n
outer
spike
protein
activ
dual
offer
possibl
vaccin
candid
provid
durabl
immun
potent
antibodi
stimul
n
trial
expand
includ
initi
prime
vaccin
oral
sublingu
booster
induc
comprehens
immun
protect
gener
system
mucos
vaccin
vaccin
inner
n
outer
spike
protein
activ
respect
phase
trial
safeti
immunogen
oral
supplement
vaccin
enhanc
cell
base
immunogen
alreadi
receiv
vaccin
author
emerg
use
j
associ
professor
medicin
pediatr
adult
pediatr
infecti
new
jersey
medic
school
j
member
follow
medic
academi
medicin
academi
pediatr
colleg
medic
associ
medicin
associ
infecti
societi
medic
societi
new
jersey
pediatr
infecti
noth
j
stewardship
program
infecti
pharmaci
resid
program
director
depart
pharmaceut
nutrit
care
divis
infecti
medicin
clinic
associ
professor
depart
pharmaci
practic
colleg
pharmaci
univers
medic
center
j
member
follow
medic
associ
pharmaci
colleg
clinic
pharmaci
associ
societi
microbiolog
societi
infecti
societi
societi
infecti
receiv
research
grant
l
windl
adjunct
associ
professor
univers
medic
center
colleg
pharmaci
drug
noth
visit
browser
version
limit
support
obtain
best
experi
recommend
use
date
browser
turn
compat
mode
explor
ensur
continu
support
site
without
cell
death
differenti
volum
cite
articl
eleven
sinc
identif
viru
genom
except
effort
scientif
commun
led
develop
vaccin
undergo
clinic
evalu
ten
phase
clinic
three
end
phase
posit
new
emerg
use
data
suggest
new
vaccin
instrument
protect
reduc
spread
pandem
conceptu
technolog
divers
like
differ
show
better
distinct
human
popul
moreov
remain
whether
extent
capac
evalu
unrel
increas
immunolog
fit
train
innat
immun
protect
due
short
develop
time
novelti
adopt
sever
unresolv
passag
time
permit
clarifi
technic
connect
product
ethic
connect
avail
immin
face
us
tenet
long
run
one
vaccin
ensur
equit
global
access
protect
divers
immun
viral
outbreak
around
world
design
free
avail
basic
scienc
data
base
innov
direct
toward
well
defin
sensibl
financi
support
privat
sever
made
possibl
develop
new
extrem
possibl
numer
base
differ
allow
us
select
effect
specif
phase
pandem
differ
product
distribut
new
difficult
creativ
technolog
effort
lead
develop
way
think
design
new
new
abl
control
pandem
abl
protect
fragil
human
popul
develop
short
time
necessarili
yet
possibl
know
efficaci
possibl
side
possibl
overcom
financi
polit
allow
avail
equiti
entir
popul
world
hope
media
public
larg
soon
possibl
vaccin
result
great
control
infecti
howev
long
seri
infecti
partial
effect
seri
sensat
vaccin
inde
diseas
immunolog
problem
even
today
data
one
dispos
difficult
predict
kind
vaccin
truli
effect
difficulti
even
greater
new
diseas
ongo
new
data
tremend
pace
coronaviru
respons
viru
gener
high
mutat
rate
genet
instabl
long
consid
repres
challeng
develop
effect
mani
recoveri
viral
diseas
combin
action
biolog
neutral
viral
killer
activ
track
kill
howev
viral
whose
heal
mainli
exclus
antibodi
respons
destruct
action
killer
fundament
case
yet
clearli
defin
although
sever
data
suggest
major
protect
effect
spike
protein
particular
domain
often
display
high
data
role
mucos
immun
secretori
scarc
furthermor
yet
know
long
protect
acquir
last
point
interest
sinc
often
durat
protect
heal
somewhat
durat
protect
provid
impress
amount
carri
sinc
viru
first
still
larg
number
diseas
precis
fulli
justifi
differ
conceptu
technolog
current
prepar
diversif
essenti
precis
mani
particularli
new
diseas
difficult
predict
type
immun
respons
therefor
vaccin
shown
major
tradit
vaccin
develop
develop
pressur
rampant
epidem
pressur
pandem
multipl
carri
financi
without
know
whether
candid
vaccin
safe
effect
earli
commerci
scale
establish
clinic
proof
concept
howev
mani
financi
risk
mainli
taken
public
provid
financi
support
develop
eleven
definit
genom
offici
vaccin
fifti
alreadi
human
experiment
current
gener
popul
differ
candid
whole
express
viru
surfac
differ
candid
group
base
technolog
platform
elicit
protect
immun
respons
howev
almost
everi
vaccin
project
make
uniqu
signific
regard
efficaci
durat
induc
protect
safeti
vaccin
select
vaccin
current
phase
trial
base
whole
varieti
determin
speed
carri
one
help
amaz
human
scientif
creativ
even
variou
compet
technic
formul
come
basic
scientif
research
structur
open
world
inde
numer
freeli
avail
basic
research
data
infect
convinc
innov
vaccin
focu
immun
respons
spike
protein
fig
new
data
phase
show
base
spike
protein
carri
elicit
effect
protect
respons
four
impress
press
provid
first
evid
base
previous
unproven
significantli
contribut
control
pandem
date
million
within
identif
new
freeli
avail
data
made
numer
around
world
provid
defin
pictur
viru
structur
human
cell
infect
oili
spheric
particl
wrap
coil
protein
viru
outer
shell
three
structur
spike
envelop
membran
coat
surfac
three
spike
aggreg
outsid
interact
high
affin
enzym
normal
present
outer
surfac
wide
varieti
human
b
spike
protein
two
extern
domain
region
known
domain
bind
domain
progress
elucid
critic
role
interact
provid
key
spur
sever
innov
vaccin
target
spike
protein
recent
protect
efficaci
base
differ
spike
protein
suggest
freeli
avail
basic
scienc
data
make
win
bet
import
compar
intens
durat
protect
four
induc
base
technolog
develop
vaccin
come
work
better
first
provid
longer
immun
cost
side
effect
offer
specif
elderli
pregnant
peopl
histori
vaccin
base
live
microb
caus
diseas
sinc
retain
abil
replic
give
rise
limit
diseas
effect
immun
system
strong
persist
immun
memori
efficaci
infect
million
peopl
fatal
tradit
technolog
construct
live
grow
viru
unfavor
gener
genet
version
viru
howev
attenu
complex
delic
associ
major
produc
storag
handl
requir
care
experi
viru
rare
signific
side
effect
sinc
caus
diseas
even
minor
one
oral
rout
case
polio
vaccin
intranas
rout
induc
mucos
immun
base
secretori
three
activ
preclin
develop
follow
serum
collabor
new
york
privat
collabor
univers
vaccin
yet
stage
clinic
base
belong
tradit
technolog
platform
led
numer
produc
method
stabl
live
limit
mainli
relat
short
durat
immun
memori
inocul
higher
vaccin
associ
microorgan
adjuv
immun
respons
direct
spike
protein
mani
induc
respons
gener
concern
induc
vaccin
easili
handl
less
expens
much
differ
chemic
candid
vaccin
base
various
clinic
four
phase
alreadi
limit
use
fig
avail
phase
suggest
vaccin
safe
high
titer
seven
clinic
run
china
vaccin
phase
trial
interim
late
meanwhil
alreadi
limit
use
among
gener
popul
fig
china
two
distinct
limit
use
gener
popul
fig
wuhan
china
vaccin
limit
use
gener
popul
fig
china
vaccin
covaxin
late
stage
phase
trial
sever
human
base
present
surfac
initi
today
produc
larg
trimer
spike
protein
protrud
outsid
play
essenti
role
human
therefor
spike
protein
even
mostli
nucleoprotein
n
target
activ
robust
immun
respons
often
exploit
either
bacteri
synthet
numer
vaccin
base
combin
least
sixteen
candid
alreadi
human
two
phase
trial
fig
probabl
immunogen
thank
combin
new
exploit
spike
protein
allow
product
larg
vaccin
extrem
low
protein
plu
russia
vector
russia
clover
plu
adjuv
us
de
vaccin
plu
adjuv
plu
adjuv
plu
adjuv
plu
adjuv
west
china
china
china
plu
carri
us
us
south
plu
adjuv
fig
oral
tablet
spike
protein
skin
patch
spike
protein
insert
institut
viru
plu
adjuv
us
fig
offer
great
flexibl
manipul
antigen
great
potenti
speed
current
regist
human
use
howev
commonli
use
veterinari
medicin
stabl
easili
produc
larg
muscl
skin
enter
human
abil
enter
enhanc
short
local
electr
puls
cell
produc
temporarili
target
protein
way
vaccin
product
activ
killer
enter
human
code
spike
protein
japan
plu
us
messeng
yet
produc
regist
vaccin
sever
vaccin
exploit
technolog
creation
unlik
must
transport
variou
way
enter
human
cell
vaccin
temporarili
cell
produc
antigen
protein
vaccin
carri
case
target
antigen
mostli
spike
protein
vaccin
kept
mani
vaccin
base
spike
protein
two
finish
phase
fig
vaccin
carri
first
test
time
write
pfizer
regulatori
histor
vaccin
approv
way
mass
immun
western
sputnik
v
alreadi
limit
author
popul
despit
excel
preliminari
immunogen
phase
trial
vaccin
provid
provoc
somewhat
contradictori
requir
studi
china
us
fig
pfizer
us
two
candid
test
parallel
one
finish
phase
trial
fig
fig
form
vaccin
test
yet
phase
spike
protein
viral
viru
possibl
exploit
viru
great
abil
infect
deliv
human
viru
insid
insert
lose
abil
replic
sinc
immun
viru
vector
affect
vaccin
efficaci
primat
chimpanze
often
insert
replic
activ
viru
propag
extent
induc
robust
immun
respons
vaccin
target
antigen
mostli
spike
protein
commonli
intramuscularli
howev
numer
interest
aim
vaccin
nose
inhal
effect
candid
vaccin
induc
mucos
immun
capabl
viru
thu
abil
enter
human
numer
vaccin
base
viral
alreadi
advanc
clinic
four
current
phase
trial
limit
use
fig
vaccin
insert
insid
viru
fig
test
vaccin
yet
phase
trial
gorilla
china
fig
johnson
us
fig
mil
russia
vaccin
base
two
human
one
limit
use
fig
specif
nasal
spray
enterpris
china
mil
china
two
viru
intramuscularli
measl
viru
us
vesicular
stomat
viru
nasal
spray
influenza
viru
hong
china
canada
phase
human
trial
underway
oral
carri
spike
canada
phase
human
trial
underway
plasma
us
phase
human
trial
underway
patient
dendrit
express
medic
china
phase
human
trial
underway
dendrit
express
report
eleven
candid
advanc
phase
clinic
assess
five
phase
made
avail
briefli
comment
avail
inform
base
number
enrol
rang
studi
design
usual
singl
arm
phase
trial
includ
irrelev
meningococcu
vaccin
vaccin
select
common
includ
activ
innat
immun
reveal
local
system
inflamm
induct
induct
type
cell
product
type
immun
consid
cornerston
antivir
immun
least
extens
studi
vaccin
trial
induct
type
potenti
deleteri
cell
collect
encourag
suffer
extens
limit
day
durat
persist
immunolog
memori
remain
determin
actual
signific
immunolog
protect
remain
defin
age
associ
loss
immunolog
memori
reduc
repertoir
inflammatori
tone
consequ
instanc
design
elderli
influenza
therefor
particular
interest
phase
trial
age
older
vaccin
abl
elicit
effect
product
elicit
reactiv
even
age
inde
age
group
reduc
moreov
assist
interpret
data
full
trial
oper
procedur
made
avail
phase
trial
compar
immunogen
reactiv
pfizer
vaccin
similar
antibodi
young
age
phase
trial
liposom
vaccin
older
stratifi
accord
age
antibodi
similar
previous
among
vaccin
interim
analysi
ongo
larg
phase
brazil
confirm
vaccin
accept
safeti
profil
enrol
brazil
receiv
vaccin
standard
dose
consist
vaccin
efficaci
contrast
subset
trial
receiv
half
vaccin
dose
first
dose
standard
dose
booster
dose
vaccin
efficaci
despit
enthusiasm
find
vaccin
efficaci
level
pfizerbiontech
fig
interpret
ore
yet
establish
uncommon
differ
first
second
vaccin
potenti
intens
induc
immun
respons
altern
lower
first
dose
vaccin
elicit
strong
reaction
chimpanze
fig
absenc
strong
antibodi
respons
effect
deliv
booster
vaccin
rational
sputnik
v
vaccin
differ
type
first
vaccin
booster
inject
puzzl
data
vaccin
task
forc
plan
mix
match
trial
combin
vaccin
evalu
two
togeth
produc
immun
respons
two
trigger
slightli
differ
immun
mutual
enhanc
avail
clinic
document
sputnik
v
vaccin
prepar
research
institut
regist
russia
base
small
clinic
studi
howev
larg
clinic
trial
peopl
russia
current
ongo
join
pfizerbiontech
press
research
institut
interim
analysi
base
receiv
first
second
dose
sputnik
v
vaccin
efficaci
seven
day
second
dose
two
later
protect
efficaci
vaccin
subset
inflammatori
occur
soon
vaccin
safeti
appear
relat
administr
pfizer
vaccin
administr
frequenc
inflammatori
higher
commonli
flu
two
candid
initi
test
pfizer
domain
spike
protein
see
fig
sinc
entir
spike
protein
candid
vaccin
induc
similar
immun
respons
across
age
less
older
younger
earli
humor
innat
immun
molecul
help
earli
assess
activ
innat
immun
associ
fraction
develop
block
pathway
thrombosi
although
major
suffer
assess
impact
autoimmun
myasthenia
even
incomplet
list
ongo
clinic
shown
idea
grandios
scientif
technic
organiz
effort
current
underway
administr
new
vaccin
possibl
understand
whether
vaccin
signific
immun
respons
whether
administr
clear
advers
candid
consid
worthi
studi
complex
phase
human
limit
number
phase
clinic
minor
side
effect
good
product
capabl
infect
signific
cell
activ
even
evalu
immun
respons
vari
vastli
appear
elicit
antibodi
respons
real
evalu
effect
new
vaccin
base
phase
compar
incid
larg
peopl
evalu
determin
whether
one
sever
none
new
effect
margin
administr
associ
import
collater
situat
aris
scientif
huge
result
develop
fifteen
regist
gener
use
compet
mirror
wall
data
phase
provid
excel
indic
efficaci
safeti
candid
howev
long
list
directli
put
forward
solidar
efficaci
open
everi
countri
made
public
detail
criteria
vaccin
efficaci
includ
oper
warp
speed
us
govern
partnership
support
efficaci
streamlin
oversight
run
immunolog
analys
central
direct
data
comparison
although
vaccin
regist
assess
long
seri
data
efficaci
safeti
like
long
time
industri
nation
polit
allow
solid
compar
assess
efficaci
variou
quantit
efficaci
differ
immun
lack
intern
instanc
intern
standard
moment
serum
let
alon
neutral
cell
current
technolog
limit
difficult
compar
immun
differ
conceiv
best
vaccin
exist
distinct
technolog
induc
differ
immun
appropri
differ
environment
human
polio
vaccin
interest
exampl
inject
vaccin
turn
appropri
world
safe
effect
world
polio
longer
contrast
vaccin
effect
easier
oral
appropri
world
wild
viru
still
thu
evolut
pandem
make
appropri
differ
geograph
differ
elderli
human
popul
quit
possibl
sequenti
arriv
subsequ
wage
increas
make
appropri
protect
initi
induc
first
first
made
avail
significantli
contribut
normal
social
life
even
arriv
long
list
inher
associ
dramat
pressur
brought
pandem
reactiv
speed
passag
time
along
luxuri
abl
develop
detail
lead
clarif
mani
left
open
first
phase
time
tell
long
protect
last
frequent
booster
keep
protect
fulli
activ
time
popul
data
better
clarifi
kind
protect
variou
induc
vaccin
protect
peopl
form
one
seriou
mortal
often
phase
design
test
whether
reduc
symptomat
sever
requir
hospit
end
death
anoth
crucial
question
detail
answer
phase
current
underway
mainli
healthi
popul
vaccin
effect
popul
work
equal
well
elderli
frail
even
group
reopen
transmiss
viru
take
place
among
school
staff
help
reopen
societi
becom
hot
current
phase
includ
pregnant
anoth
group
sinc
higher
risk
admit
intens
care
unit
mechan
ventil
abl
prevent
spread
diseas
effect
protect
clinic
diseas
reduc
viru
transmiss
among
mani
time
question
whether
arriv
abl
creat
herd
immun
capabl
spread
complex
social
polici
accept
reject
vaccin
popul
significantli
affect
possibl
crucial
administr
new
vaccin
must
alway
care
associ
rigor
studi
safeti
particularli
import
vaccin
drug
sick
peopl
risk
die
rather
treatment
given
well
prevent
risk
fall
ill
race
develop
vaccin
necessari
howev
time
evalu
aris
new
vaccin
must
includ
develop
prepar
diseas
induc
helper
must
care
new
vaccin
distribut
combat
pandem
subsequ
basic
take
special
import
inappropri
polit
lead
evalu
vaccin
safeti
race
develop
vaccin
distribut
candid
vaccin
popul
data
clinic
care
danger
erod
trust
vaccin
regulatori
weird
contest
put
forward
pharmaceut
director
us
object
warp
speed
keep
rigor
efficaci
safeti
absolut
central
issu
vaccin
develop
time
write
complet
data
viral
least
three
avail
rel
stabl
evid
viru
spread
global
instanc
viru
region
shown
spike
protein
undergo
rel
stabil
unlik
strong
rational
vaccin
develop
howev
follow
introduct
effect
vaccin
mutant
viru
appear
select
advantag
thu
pose
issu
vaccin
strong
evid
select
protect
infecti
unrel
one
specif
target
instanc
measl
strongli
associ
reduc
incid
unrel
respiratori
tract
protect
complex
includ
avoid
effect
train
innat
immun
evid
protect
train
innat
immun
strong
moreov
intens
vaccin
calendar
yet
unexplain
resist
base
sever
prospect
clinic
ongo
assess
valu
instanc
protect
health
care
stage
usag
prevent
measur
outsid
clinic
howev
avail
inform
influenza
pneumococcu
herp
elderli
repres
gener
train
strategi
innat
adapt
immun
moreov
import
assess
whether
increas
immunolog
fit
relev
fight
escap
new
vaccin
subsequ
relat
product
distribut
technolog
organiz
regulatori
econom
overcom
industri
technolog
scale
product
billion
depend
kind
vaccin
work
best
initi
physic
possibl
make
enough
world
popul
although
variou
alreadi
product
without
sure
regist
distribut
besid
polit
econom
limit
vaccin
access
countri
afford
pay
make
new
avail
global
popul
problem
fair
distribut
vaccin
world
much
variou
sever
intern
ensur
equit
access
futur
coalit
epidem
prepared
global
allianc
immun
global
access
facil
global
mechan
procur
equit
distribut
eventu
enthusiasm
design
differ
commun
biolog
somewhat
romant
social
movement
small
involv
transform
life
inform
low
cost
independ
academ
corpor
recent
sever
taken
part
biolog
help
investig
potenti
innov
test
often
vaccin
hunt
free
open
scienc
coronaviru
vaccin
along
progress
develop
modern
opinion
vaccin
western
world
current
news
opposit
addit
openli
oppos
vaccin
sever
show
signific
percentag
peopl
western
would
hesit
contrari
take
vaccin
chief
concern
among
vaccin
approv
process
would
move
quickli
without
take
time
properli
establish
safeti
effect
certainli
intrus
polit
pace
vaccin
evalu
process
help
build
confid
new
howev
time
regist
made
avail
data
efficaci
safeti
care
sever
nation
intern
hand
short
document
histori
elicit
hypothet
side
effect
long
time
previous
howev
conjectur
situat
instead
like
efficaci
vaccin
much
hesit
vaccin
quickli
vanish
commonli
appar
mark
reduct
risk
die
larg
risk
hypothet
late
side
obtain
cost
almost
vaccin
mistrust
illeg
purchas
probabl
fake
start
certainli
possibl
eastern
citi
involv
essenti
work
buy
vaccin
made
still
phase
trial
favor
control
danger
trade
fig
pandem
drama
mani
around
world
design
possibl
altern
thu
addit
larg
number
offici
enlist
numer
univers
small
fresh
clever
intellectu
technolog
effort
divers
becom
import
front
runner
partial
protect
work
poorli
certain
popul
high
make
front
runner
unsuit
deploy
exampl
infect
nose
throat
make
produc
spike
protein
nasal
insuffl
mouth
appear
would
realli
great
achiev
develop
vaccin
induc
effect
immun
mucos
imped
viral
infect
viru
spread
respiratori
success
approv
first
detract
enthusiasm
practic
possibl
new
lead
develop
product
second
well
design
differ
clinic
inde
erad
go
long
wind
road
finish
first
vaccin
brief
way
current
fresh
data
phase
vaccin
registr
soon
base
differ
mandatori
made
avail
select
popul
china
russia
unit
landscap
pandem
take
complet
differ
know
efficaci
control
viru
spread
remain
far
goal
alreadi
latter
case
next
burn
issu
vaccin
avail
equit
distribut
world
predatori
nation
polit
first
vaccin
made
avail
popul
nation
clash
mani
intern
set
fair
distribut
world
nobl
effort
sever
polit
signific
vaccin
assum
polit
leader
countri
first
salvif
vaccin
exploit
affirm
abil
protect
well
friendli
vaccin
thu
becom
inappropri
measur
power
mani
diseas
despair
death
difficult
access
vaccin
sow
among
peopl
earth
cynic
relentless
predatori
rush
grab
first
vaccin
produc
fair
distribut
surplu
less
rich
rel
short
time
final
tenet
long
run
one
vaccin
ensur
equit
global
access
protect
divers
immun
viral
g
l
g
l
park
n
c
spike
domain
serolog
cell
n
r
j
pandem
speed
n
j
acut
respiratori
syndrom
coronaviru
new
type
coronaviru
coronaviru
diseas
pandem
centuri
consid
high
mortal
rapid
spread
effect
vaccin
urgent
control
pandem
result
industri
govern
work
tightli
togeth
develop
test
varieti
unpreced
pace
review
outlin
essenti
coronaviru
biolog
import
vaccin
design
addit
summar
key
previou
vaccin
sever
acut
respiratori
syndrom
coronaviru
middl
east
respiratori
syndrom
coronaviru
immun
strategi
final
base
prior
vaccin
discuss
recent
progress
potenti
vaccin
group
relat
caus
respiratori
tract
infect
rang
mild
lethal
seven
genera
known
infect
four
genera
human
coronaviru
human
coronaviru
human
coronaviru
human
coronaviru
caus
rel
mild
respiratori
altern
three
sever
acut
respiratori
syndrom
coronaviru
middl
east
respiratori
syndrom
coronaviru
sever
acut
respiratori
syndrom
coronaviru
highli
pathogen
lead
sever
respiratori
fatal
outcom
infect
first
lethal
coronaviru
provinc
china
outbreak
infect
peopl
mortal
rate
across
two
south
still
ongo
sporad
nowaday
confirm
mortal
rate
across
new
type
caus
sever
respiratori
ill
wuhan
china
world
health
organ
novel
viru
diseas
coronaviru
diseas
clinic
manifest
vari
asymptomat
mild
acut
respiratori
distress
syndrom
death
pulmonari
cardiolog
neurolog
highli
contagi
reproduct
number
one
case
caus
averag
new
addit
abil
spread
asymptomat
great
challeng
contain
infect
million
million
mortal
rate
needless
say
becom
seriou
public
health
crisi
gener
profound
impact
global
economi
geopolit
although
understand
pathogen
steadili
two
effect
vaccin
yet
prevent
human
infect
consid
rapid
spread
high
mortal
effect
vaccin
urgent
control
pandem
review
summar
relev
biolog
immun
recent
vaccin
develop
hope
review
provid
essenti
knowledg
research
interest
vaccin
whose
name
characterist
appear
electron
microscop
diamet
approxim
genom
molecul
genom
known
genom
two
open
read
orf
orf
genom
length
fig
orf
orf
two
nonstructur
involv
viral
genom
replic
synthesi
genom
four
major
structur
order
spike
envelop
e
membran
n
fig
e
protein
envelop
n
protein
capsid
pack
genom
fig
genom
multipl
accessori
usual
help
evad
immun
system
increas
virul
instanc
accessori
protein
orf
orf
orf
fig
genom
structur
genom
structur
genom
two
open
read
orf
orf
genom
length
orf
orf
two
nonstructur
genom
four
major
structur
order
spike
envelop
e
membran
n
accessori
genom
b
structur
spike
envelop
e
membran
form
envelop
n
form
capsid
pack
genom
spike
protein
convert
enzym
cell
membran
viru
enter
cell
mani
viral
essenti
life
cycl
enter
target
protein
first
cellular
domain
complex
subsequ
fig
bind
enzym
protein
cellular
receptor
fig
endosom
protein
subunit
fusion
viral
envelop
host
cell
membran
enter
cell
sever
particularli
mediat
replic
genom
transcript
differ
nonstructur
structur
n
bind
genom
form
viral
e
form
envelop
assembl
viral
bud
endoplasm
reticulum
er
pathway
exit
fig
life
cycl
upon
bind
membran
receptor
host
cell
genom
multipl
nonstructur
genom
genom
templat
gener
genom
genom
replic
mani
differ
transcript
major
structur
n
e
assembl
genom
form
matur
lumen
er
final
whole
viru
leav
cell
coronaviru
replic
cycl
protein
particularli
import
receptor
bind
membran
fusion
suggest
effect
target
vaccin
design
fact
shown
protein
addit
sever
antibodi
neutral
protect
effect
moreov
mani
shown
elicit
potent
immun
protect
effect
preclin
corrobor
protein
ideal
vaccin
target
induc
protect
immun
besid
protein
structur
test
vaccin
n
usual
induc
like
due
fact
n
protein
display
surfac
howev
n
protein
advantag
across
speci
protein
make
potenti
target
univers
vaccin
one
recent
studi
shown
viral
vector
vaccin
n
protein
induc
protect
suggest
feasibl
n
hand
induc
high
titer
antibodi
respons
howev
neutral
antibodi
protect
immun
data
preclin
final
e
immun
far
none
induct
protect
immun
associ
requir
optim
one
advers
effect
induct
enhanc
ade
effect
usual
suboptim
viral
entri
host
studi
found
vaccin
base
protein
infect
human
cell
addit
two
shown
protein
serum
viral
infect
rais
safeti
one
potenti
strategi
overcom
ade
problem
design
contain
major
subunit
domain
protein
strategi
decreas
induct
therefor
reduc
ade
effect
anoth
potenti
advers
effect
eosinophil
unwant
immun
respons
vaccin
least
two
whole
viru
vaccin
eosinophil
pulmonari
respons
mice
addit
one
studi
immun
particl
vaccin
eosinophil
lung
viral
challeng
order
prevent
work
adjuv
optim
found
appropri
receptor
agonist
polysaccharid
increas
serum
antibodi
reduc
lung
eosinophil
provid
promis
strategi
deal
immun
respons
induc
test
preclin
howev
clinic
none
includ
protein
subunit
particl
viral
vector
follow
outlin
variou
vaccin
develop
tabl
latest
preclin
clinic
tabl
protein
subunit
consist
viral
antigen
produc
protein
easi
produc
rel
safe
whole
viru
viral
vector
drawback
protein
subunit
low
immunogen
therefor
fusion
usual
use
togeth
subunit
overcom
develop
protein
subunit
initi
surround
later
protein
none
protein
subunit
clinic
induc
potent
antibodi
protect
effect
preclin
shown
protein
extracellular
domain
protein
trimer
immunogen
elicit
protect
infect
howev
found
vaccin
caus
receptor
depend
infect
human
b
hand
protein
abl
induc
without
caus
obviou
pathogen
effect
probabl
contain
addit
protein
one
studi
shown
protect
mice
detect
viral
lung
induc
furthermor
shown
induc
cellular
immun
mice
result
becom
main
target
final
subunit
base
subunit
n
structur
test
howev
evid
shown
induc
protect
effect
viral
previou
subunit
gener
show
great
immunogen
elicit
potent
immun
protect
effect
infect
one
studi
tai
found
trimer
protein
induc
anoth
studi
tai
differ
induc
diverg
human
camel
indic
promis
vaccin
target
abil
induc
infect
subunit
shown
induc
protect
notabl
domain
protein
sialic
acid
import
infect
certain
cell
immun
vaccin
protect
potent
humor
immun
howev
sinc
sialic
function
strategi
generaliz
vaccin
antigen
design
sever
affect
efficaci
protein
subunit
express
system
protein
qualiti
quantiti
protein
subunit
protein
express
mammalian
antibodi
express
insect
e
coli
probabl
due
nativ
conform
modif
mammalian
cellular
system
addit
play
import
role
immunogen
protein
subunit
multipl
aluminum
conjug
found
best
potenti
protein
elicit
protect
effect
data
provid
good
start
point
subunit
moreov
immun
rout
subunit
vaccin
affect
potenc
combin
differ
antigen
vaccin
pathway
chang
exampl
li
subunit
vaccin
intramuscular
rout
antibodi
subcutan
rout
lan
rout
prefer
inject
vaccin
therefor
ideal
rout
need
subunit
viral
structur
mimic
conform
nativ
lack
viral
genom
protein
subunit
present
conform
similar
nativ
viru
lead
better
immun
addit
whole
viru
product
involv
live
viru
inactiv
vaccin
highli
repetit
antigen
surfac
help
induc
antibodi
respons
effici
surfac
protect
human
hepat
b
viru
far
chimer
compos
protein
mous
hepat
viru
e
n
induc
antibodi
reduc
viru
titer
mice
lung
viral
challeng
addit
anoth
studi
chimer
protein
influenza
viru
protein
induc
provid
protect
lethal
challeng
mice
howev
one
studi
use
chimer
vaccin
lead
pulmonari
challeng
therefor
potenti
advers
effect
coronaviru
wang
shown
e
induc
specif
antibodi
respons
cellular
immun
rhesu
research
group
anoth
chimer
vaccin
fusion
domain
protein
canin
structur
protein
vaccin
antibodi
respons
immun
mice
hold
potenti
clinic
effect
coronaviru
contain
viral
antigen
express
vaccin
offer
fast
flexibl
platform
vaccin
develop
product
make
attract
technolog
combat
addit
antigen
product
target
recapitul
nativ
conform
modif
viral
howev
import
drawback
limit
immunogen
due
inabl
spread
amplifi
therefor
import
consid
enhanc
potenc
adjuv
regimen
besid
genom
integr
host
chromosom
anoth
concern
lead
even
though
previou
shown
risk
vaccin
insert
host
chromosom
pretti
low
still
integr
includ
part
safeti
program
sever
vaccin
n
although
gener
certain
level
antibodi
vaccin
shown
induc
protect
effect
infect
probabl
due
indispens
role
protein
receptor
bind
yang
immun
protein
protein
part
cytoplasm
domain
protein
cytoplasm
induc
immun
well
provid
protect
effect
mice
promis
result
follow
phase
clinic
trial
base
protein
vaccin
vaccin
induc
cell
healthi
furthermor
two
made
use
strategi
enhanc
potenc
vaccin
combin
increas
magnitud
antibodi
respons
well
desir
immun
respons
woo
vaccin
prime
plu
e
coli
express
protein
booster
induc
higher
neutral
protein
subunit
vaccin
alon
similar
sever
optimist
vaccin
induc
potent
cellular
immun
mice
vaccin
challeng
without
clinic
radiograph
pneumonia
build
encourag
data
phase
clinic
trial
base
vaccin
well
seriou
advers
immun
durabl
immun
two
data
support
develop
vaccin
notabl
vaccin
candid
base
design
vaccin
phase
clinic
trial
addit
anoth
vaccin
studi
protein
prime
plu
protein
subunit
booster
robust
activ
sever
mice
rhesu
rhesu
boost
vaccin
protect
radiograph
pneumonia
support
strategi
promis
approach
vaccin
develop
asid
subunit
good
target
vaccin
one
studi
immunogen
vaccin
express
vector
found
immun
balanc
respons
gener
higher
vaccin
fact
subunit
effici
extracellular
space
therefor
result
greater
uptak
studi
better
target
vaccin
taken
togeth
protein
encourag
fight
strategi
like
generaliz
vaccin
consid
biolog
vector
encod
interest
unrel
viru
deliv
antigen
natur
infect
induc
strong
cellular
humor
immun
per
se
therebi
need
addit
addit
viral
abl
accept
larg
genom
provid
flexibl
platform
antigen
design
despit
sever
process
viral
vector
complic
optim
cellular
exclus
greatli
affect
effici
viral
moreov
carri
risk
genom
human
host
addit
assess
enter
clinic
final
chosen
viral
vector
infect
gener
immun
viral
vector
dampen
induc
immun
respons
seen
measl
similar
protein
subunit
viral
vector
coronaviru
target
antigen
numer
viral
use
develop
detail
previou
review
follow
highlight
base
vaccinia
viru
equin
enceph
viru
well
studi
viral
vector
coronaviru
briefli
introduc
viral
activ
coronaviru
popular
viral
vector
vaccin
test
clinic
wide
varieti
sever
efficaci
vaccin
feasibl
vector
vaccin
first
two
studi
vector
fragment
induc
respect
neither
protect
challeng
later
see
efficaci
protein
vaccin
whole
vaccin
found
induc
protect
effect
mice
challeng
though
antibodi
respons
vaccin
viru
vaccin
besid
test
regimen
human
type
chimpanze
deriv
vaccin
substanti
reduct
viral
load
pneumonia
challeng
subsequ
develop
vaccinia
viru
anoth
vaccin
platform
combat
infecti
shown
intranas
intramuscular
immun
highli
gene
antibodi
protect
immun
mice
evid
reduc
viru
titer
mice
lung
post
challeng
anoth
studi
protein
mice
show
protect
experi
data
studi
howev
anoth
two
vaccin
protein
provid
protect
effect
even
inflammatori
focal
necrosi
liver
therefor
potenti
advers
effect
need
consid
protein
equin
enceph
vee
vaccin
vee
viru
protein
complet
short
protect
homolog
strain
challeng
young
senesc
mice
improv
efficaci
vee
vaccin
heterolog
challeng
immunogen
protein
vaccin
substitut
vee
glycoprotein
counterpart
result
protein
vaccin
protect
age
mice
heterolog
challeng
sever
addit
viral
shown
promis
two
use
viru
vector
express
protein
show
vaccin
induc
antibodi
protect
effect
challeng
besid
vesicular
stomat
viru
test
vaccin
immun
protein
induc
abl
protect
mice
infect
sever
human
type
type
protein
shown
induc
mice
howev
protect
effect
notabl
vaccin
use
combin
protein
heterolog
immun
prime
spike
protein
protect
effect
mice
challeng
balanc
homolog
vector
alreadi
appli
vaccin
develop
promis
phase
clinic
besid
chimpanze
employ
viral
vector
aim
overcom
immun
problem
human
protein
vaccin
base
chimpanze
vector
shown
induc
high
immun
mice
protect
mice
lethal
challeng
addit
vaccin
reduc
viral
load
dromedari
provid
protect
immun
rhesu
given
promis
preclin
vaccin
phase
clinic
trial
trial
result
safe
well
test
singl
dose
capabl
humor
cellular
notabl
research
team
appli
platform
vaccin
develop
product
lead
player
vaccin
race
vaccin
vaccinia
viru
protein
induc
antibodi
cell
respons
provid
protect
effect
mice
furthermor
dromedari
protein
vaccin
gener
show
less
viru
excret
infect
sinc
camel
major
anim
reservoir
vaccin
opportun
effect
control
transmiss
final
phase
clinic
trial
vaccin
favor
safeti
profil
homolog
immun
vaccin
humor
immun
test
vaccin
popul
depend
equin
enceph
vee
viru
studi
vee
viru
protein
induc
young
age
mice
anoth
studi
found
n
protein
vaccin
induc
memori
immun
respons
provid
protect
immun
mice
sinc
n
protein
protein
across
differ
coronaviru
speci
approach
hold
potenti
develop
univers
coronaviru
vaccin
sever
vaccin
appli
develop
vaccin
measl
viru
rabi
protein
shown
induc
provid
protect
effect
mice
diseas
viru
vesicular
stomat
viru
employ
howev
neutral
data
provid
protect
data
two
summari
base
mani
viral
vaccinia
viru
equin
enceph
viru
viru
vesicular
stomat
viru
measl
viru
rabi
viru
shown
elicit
protect
immun
viral
viral
alreadi
becom
promis
candid
develop
compos
chemic
contain
full
repertoir
immunogen
origin
viru
carri
risk
viral
reactiv
properli
although
live
immunogen
structur
deform
inactiv
process
undermin
protect
provid
moreov
whole
induc
lung
patholog
make
whole
less
attract
strategi
coronaviru
vaccin
earli
develop
whole
viru
lead
strategi
shown
induc
antibodi
respons
phase
clinic
trial
vaccin
safe
elicit
howev
later
found
doubli
vaccin
either
incomplet
protect
mice
eosinophil
pulmonari
inflammatori
respons
upon
challeng
similarli
vaccin
alum
lung
patholog
viru
challeng
despit
abil
induc
enthusiasm
coronaviru
nevertheless
recent
two
reveal
receptor
alum
unmethyl
reduc
even
prevent
lung
patholog
challeng
appropri
combin
inactiv
method
whole
viru
still
viabl
option
coronaviru
vaccin
live
pathogen
compon
viral
genom
similar
whole
possess
nearli
full
immunogen
origin
viru
furthermor
preserv
nativ
conform
viral
present
immun
system
natur
therefor
live
immunogen
kind
vaccin
long
histori
success
varieti
infecti
howev
live
carri
higher
risk
possibl
revers
virul
state
danger
persist
infect
therefor
live
need
care
proceed
clinic
live
efficaci
anim
none
clinic
envelop
e
protein
besid
structur
major
role
activ
associ
inflamm
lung
result
delet
e
protein
lead
virul
coronaviru
e
gene
induc
protect
effect
challeng
addit
nonstructur
protein
anoth
viabl
target
coronaviru
vaccin
ribos
cap
viral
methyl
coronaviru
avoid
activ
type
innat
immun
respons
viral
therefor
delet
virul
mutant
provid
protect
challeng
moreov
nonstructur
protein
exon
involv
proofread
replic
use
target
live
coronaviru
vaccin
loss
exon
caus
profound
decreas
replic
fidel
lead
attenu
coronaviru
pathogenesi
graham
shown
exon
delet
reduc
virul
young
age
mice
vaccin
induc
protect
effect
challeng
mice
sum
serv
potenti
develop
live
resolv
spontan
region
outbreak
magnitud
pandem
made
develop
vaccin
unpreced
urgenc
urgent
need
led
mani
differ
vaccin
develop
first
unconvent
vaccin
acid
viral
vector
becom
lead
race
vaccin
develop
due
abil
sequenc
inform
alon
new
therefor
highli
adapt
safeti
alreadi
well
recent
influenza
secondli
clinic
develop
process
vaccin
acceler
parallel
rather
follow
linear
sequenc
exampl
multipl
vaccin
directli
clinic
preclin
data
anim
mani
vaccin
adopt
phase
phase
approach
save
time
last
least
order
meet
massiv
global
need
vaccin
vaccin
especi
front
ramp
capac
scale
billion
per
year
unit
sever
import
role
potenti
effect
section
discuss
latest
preclin
clinic
develop
highlight
repres
major
vaccin
platform
clinic
data
tabl
protein
subunit
enter
clinic
among
lead
compani
vaccin
phase
trial
south
phase
trial
spike
protein
proprietari
adjuv
preclin
trial
vaccin
induc
viral
replic
respiratori
tract
viru
vaccin
induc
bind
phase
trial
phase
trial
dose
spare
effect
adjuv
found
ug
ug
dose
induc
significantli
high
antibodi
placebo
group
ug
dose
without
adjuv
group
anoth
vaccin
phase
trial
new
coronaviru
vaccin
instead
protein
vaccin
protein
howev
design
data
provid
far
candid
protein
subunit
util
either
protein
protein
vaccin
antigen
notabl
one
recent
studi
generaliz
strategi
enhanc
immunogen
protein
subunit
coronaviru
dimer
form
significantli
immunogen
protect
convent
monomer
counterpart
appli
strategi
enhanc
antibodi
therefor
framework
immunogen
design
univers
applic
protein
subunit
coronaviru
current
clinic
among
lead
compani
vaccin
full
length
protein
intraderm
devic
skin
cell
experi
phase
trial
vaccin
platform
vaccin
vaccin
immun
anim
mice
guinea
rhesu
vaccin
two
phase
trial
interim
analysi
two
phase
induc
humor
cell
immun
two
advers
grade
although
vaccin
past
two
alreadi
novel
reach
clinic
sinc
outbreak
consist
viral
messeng
human
produc
antigen
stimul
immun
system
usual
complex
addit
protamin
increas
efficaci
similar
highli
adapt
new
abl
recapitul
nativ
conform
antigen
furthermor
addit
unlik
interact
therefor
obviat
genom
integr
besid
given
multipl
tradit
intraven
inject
wherea
need
via
special
gene
gun
nevertheless
exogen
activ
antivir
immun
respons
lead
translat
degrad
suppress
efficaci
addit
associ
inflamm
potenti
autoimmun
even
though
sever
import
care
evalu
potenti
advers
two
lead
vaccin
vaccin
spike
trimer
substitut
amino
prolin
stabil
spike
protein
conform
increas
translat
prevent
activ
upon
enter
cell
preliminari
report
phase
clinic
trial
two
immun
antibodi
higher
convalesc
serum
two
vaccin
immun
system
advers
second
dose
vaccin
grade
advers
ug
induc
satisfactori
immun
respons
thu
continu
use
ug
dosag
phase
clinic
trial
addit
expand
phase
trial
includ
elderli
age
older
old
result
ug
dose
induc
higher
bind
ug
dose
advers
associ
mild
moder
elderli
reveal
first
interim
analysi
phase
trial
result
among
peopl
symptomat
trial
group
rest
placebo
group
result
vaccin
efficaci
addit
sever
analysi
placebo
group
none
group
concurr
safeti
review
notic
signific
safeti
concern
therefor
promis
result
vaccin
safe
effect
symptomat
pfizer
vaccin
four
nucleosid
vaccin
spike
protein
spike
protein
hand
urna
base
vaccin
sarna
base
vaccin
pfizer
two
phase
trial
us
respect
regimen
convalesc
human
serum
analysi
immun
respons
detect
assay
although
german
trial
us
trial
use
differ
vaccin
two
agre
regimen
ug
day
day
abl
elicit
favor
immun
respons
without
sever
advers
effect
follow
two
anoth
studi
vaccin
shown
induc
similar
younger
older
howev
less
system
older
therefor
decid
move
forward
instead
phase
clinic
trial
pfizer
efficaci
analysi
phase
clinic
trial
meet
primari
efficaci
evalu
effect
result
base
confirm
placebo
group
group
addit
among
sever
trial
placebo
group
group
notabl
efficaci
elderli
peopl
would
help
protect
vulner
popul
seriou
safeti
concern
among
enrol
data
anoth
efficaci
viral
vector
clinic
addit
viral
vector
preclin
develop
mani
viral
vector
test
human
nonhuman
measl
viru
vaccinia
viru
viru
rabi
viru
vesicular
stomat
viru
surprisingli
equin
enceph
vee
viru
extens
studi
vaccin
test
vaccin
yet
hand
influenza
viru
vector
viral
vector
gain
popular
develop
viral
vector
vaccin
viral
vector
clinic
base
four
lead
platform
univers
sputnik
v
research
institut
biolog
institut
johnson
johnson
beth
deaco
medic
center
chimpanze
viral
vector
vaccin
spike
protein
platform
use
develop
vaccin
promis
preclin
phase
clinic
trial
data
vaccin
team
phase
trial
interim
report
elicit
antibodi
respons
induc
antibodi
regimen
sever
advers
effect
base
promis
data
phase
phase
brazil
unit
russia
phase
trial
put
hold
safeti
review
particip
unexplain
ill
follow
later
independ
review
determin
trial
still
safe
therefor
clinic
trial
interim
analysi
clinic
trial
brazil
result
averag
efficaci
base
total
interestingli
one
dose
regimen
efficaci
given
half
first
dose
full
second
dose
n
hand
two
full
dose
regimen
efficaci
n
due
respons
discrep
differ
addit
better
determin
efficaci
suitabl
regimen
addit
vaccin
team
phase
trial
two
differ
one
frozen
formul
formul
vaccin
phase
test
heterolog
immun
type
vector
spike
glycoprotein
plu
type
vector
spike
glycoprotein
frozen
formul
vaccin
induc
potent
immun
immun
respons
frozen
formul
slightli
formul
safe
vaccin
enter
phase
trial
russia
research
institut
second
interim
analysi
sputnik
v
phase
clinic
trial
result
efficaci
day
first
dose
base
confirm
among
reveal
day
first
dose
day
second
dose
vaccin
efficaci
even
unexpect
advers
effect
trial
promis
safe
effect
furthermor
vaccin
team
whose
vaccin
base
human
clinic
data
phase
studi
vaccin
signific
immun
respons
singl
immun
test
two
dosag
viral
dose
less
sever
advers
without
compromis
immunogen
vaccin
advanc
two
phase
global
clinic
final
johnson
johnson
vaccin
phase
clinic
trial
data
trial
whole
vaccin
clinic
previou
experi
vaccin
develop
whole
viru
induc
advers
effect
lung
preclin
even
though
seriou
advers
effect
vaccin
import
research
commun
keep
mind
care
evalu
potenti
advers
effect
ongo
whole
vaccin
three
publicli
preclin
clinic
data
known
cell
line
whole
viru
vaccin
viru
strain
preclin
studi
broad
repres
mice
nonhuman
three
protect
immun
challeng
without
caus
enhanc
effect
follow
preclin
studi
two
phase
result
yet
start
phase
clinic
trial
brazil
turkey
addit
wuhan
institut
biolog
differ
viru
vaccin
specif
product
name
vaccin
strain
isol
patient
wuhan
two
inactiv
test
three
differ
dosag
three
differ
inject
phase
phase
phase
interim
report
differ
vaccin
regimen
low
rate
advers
phase
clinic
trial
unit
final
institut
biolog
develop
anoth
viru
vaccin
process
similar
vaccin
produc
except
use
differ
strain
rather
strain
test
preclin
immun
protect
rhesu
challeng
follow
clinic
phase
trial
safe
test
two
age
furthermor
immunogen
result
humor
induc
vaccin
day
immun
vaccin
phase
clinic
trial
unit
sever
vaccin
differ
vaccin
induc
humor
immun
preclin
one
candid
vaccin
phase
clinic
trial
vaccin
preclin
develop
howev
none
group
publicli
vaccin
yet
live
vaccin
shown
provid
protect
effect
mice
preclin
ongo
higher
risk
advers
effect
made
live
vaccin
less
appeal
choic
race
vaccin
develop
nevertheless
success
live
vaccin
provid
potent
protect
effect
due
high
similar
natur
addit
tradit
unconvent
autolog
dendrit
vaccin
load
deriv
peripher
blood
dendrit
back
blood
compani
phase
clinic
trial
evalu
safeti
efficaci
profil
besid
corpor
live
vaccin
deliv
synthet
spike
protein
regist
phase
clinic
trial
examin
safeti
vaccin
moreov
group
univers
found
plant
target
bind
block
protein
translat
data
replic
acceler
neg
convers
infect
follow
studi
phase
clinic
trial
china
evalu
safeti
toler
peopl
test
licens
tri
repurpos
combat
shown
tuberculosi
vaccin
bacillu
train
innat
immun
induc
nonspecif
host
defens
reaction
viral
respiratori
syncyti
viru
influenza
viru
herp
simplex
viru
type
addit
interest
studi
nation
differ
impact
correl
nation
vaccin
polici
found
without
univers
vaccin
sever
affect
univers
base
least
phase
clinic
test
whether
vaccin
reduc
morbid
mortal
given
rapid
transmiss
asymptomat
spread
clear
effect
vaccin
global
immun
coverag
bring
peopl
back
normalci
howev
even
effect
vaccin
becom
avail
durat
immun
still
larg
unknown
previou
shown
approxim
infect
result
perman
immun
less
like
case
regular
vaccin
polici
futur
addit
still
unclear
minim
antibodi
titer
provid
protect
effect
infect
higher
antibodi
vaccin
better
protect
effect
consist
observ
reinfect
experi
mild
symptom
first
infect
suffici
induc
strong
therefor
great
import
character
correl
antibodi
protect
effect
guid
vaccin
develop
last
least
variou
genom
mutat
preval
one
point
mutat
protein
infect
decreas
shed
increas
protein
incorpor
fortun
mutat
prevent
bind
thu
provid
resist
vaccin
howev
possibl
futur
vaccin
develop
even
discoveri
human
new
kept
gradual
becom
seriou
threat
global
public
health
even
though
almost
two
sinc
first
coronaviru
outbreak
scientif
medic
commun
well
prepar
effect
combat
one
lesson
learn
financi
regulatori
mechan
current
pharmaceut
market
provid
enough
incent
encourag
vaccin
develop
deadli
outbreak
make
academ
world
explos
vaccin
highli
compress
clinic
trial
fortun
biolog
clinic
learn
togeth
vaccin
develop
experi
alreadi
us
come
multipl
promis
candid
besid
multipl
therapeut
life
cycl
human
immun
respons
rapidli
two
lead
promis
clinic
shorten
time
recoveri
decreas
mortal
treatment
complementari
achiev
overal
mitig
pandem
conclus
hope
world
regardless
polit
unit
work
togeth
achiev
fast
success
vaccin
develop
near
diseas
acut
respiratori
syndrom
east
respiratori
syndrom
acut
respiratori
syndrom
coronaviru
bind
enzym
equin
heart
risk
among
manag
anxieti
pregnanc
weight
loss
sport
exercis
yet
readi
cataract
surgeri
tri
futur
yet
rise
new
prep
help
care
scari
health
news
harm
weight
loss
behavior
therapi
insomnia
good
treatment
gotten
wear
mask
need
keep
distanc
like
still
wear
mask
protect
exactli
physic
help
need
know
new
follow
help
prevent
spread
well
fulli
everyon
chart
protect
limit
travel
social
thorough
frequent
slow
develop
new
reduc
risk
overwhelm
health
care
new
guidanc
fulli
peopl
particip
indoor
outdoor
without
mask
without
physic
peopl
fulli
recommend
mask
wear
prevent
outdoor
indoor
immun
system
due
medic
condit
take
less
vaccin
thu
risk
around
talk
doctor
find
safeti
continu
need
follow
feder
state
tribal
local
workplac
busi
around
mask
wear
physic
help
chart
protect
vaccin
outdoor
indoor
prevent
still
need
take
view
chart
click
often
soap
water
least
especi
go
bathroom
eat
blow
nose
sneez
handl
anyth
come
outsid
coronaviru
mainli
person
person
person
infect
coronaviru
even
one
emit
talk
breath
infecti
viral
float
drift
around
air
three
anoth
person
breath
becom
infect
happen
peopl
close
contact
one
anoth
produc
infect
person
land
peopl
nearbi
possibl
less
like
happen
outdoor
air
scatter
dilut
viru
home
offic
confin
space
limit
air
circul
even
outdoor
peopl
fulli
follow
guidanc
physic
reduc
risk
even
risk
spread
contact
consid
extrem
low
accord
contact
surfac
less
chanc
caus
viru
shed
saliva
semen
fece
whether
shed
vagin
known
kiss
transmit
viru
transmiss
viru
fece
vagin
anal
intercours
oral
sex
extrem
unlik
come
close
contact
someon
risk
becom
infect
potenti
contact
trace
help
prevent
transmiss
viru
quickli
peopl
infect
contagi
take
infect
trace
everyon
person
recent
contact
sinc
contagi
case
person
contagi
experi
notifi
exposur
told
look
advis
isol
period
time
seek
medic
attent
start
experi
viru
primarili
one
person
produc
infect
person
taken
stop
slow
spread
contagi
diseas
individu
enough
distanc
anoth
person
avoid
get
infect
someon
els
work
home
help
enforc
physic
commun
expand
close
someon
point
defin
close
contact
someon
spent
consecut
within
six
someon
accord
new
definit
close
contact
someon
within
six
person
period
risk
infect
person
posit
contact
identifi
close
urg
quarantin
prevent
spread
base
new
definit
peopl
consid
close
affect
infect
spread
one
person
anoth
includ
whether
one
peopl
wear
whether
infect
person
show
whether
encount
indoor
outdoor
though
within
six
rule
help
guidelin
alway
best
minim
close
peopl
new
definit
case
morbid
mortal
weekli
report
correct
offic
infect
within
six
nonconsecut
six
asymptomat
later
test
posit
stock
least
suppli
insur
even
better
make
sure
health
health
coronaviru
primarili
viru
viral
float
air
viru
breath
directli
spread
person
surfac
object
viru
mouth
nose
current
evid
viru
help
avoid
breath
coronaviru
touch
surfac
touch
groceri
store
maintain
least
six
distanc
wipe
frequent
touch
groceri
basket
disinfect
avoid
touch
face
wear
cloth
mask
remind
touch
face
help
reduc
spread
viru
use
hand
leav
store
wash
soon
get
older
risk
reason
yet
limit
groceri
store
ask
neighbor
friend
pick
leav
outsid
hous
see
groceri
store
special
older
underli
advis
physic
distanc
social
outdoor
avoid
crowd
indoor
wash
frequent
fulli
essenti
take
reduc
risk
catch
spread
take
help
let
go
let
take
need
wear
run
true
person
get
infect
touch
surfac
object
viral
touch
mouth
nose
main
way
viru
wo
prevent
type
transmiss
even
make
like
touch
face
instead
wash
leav
hous
use
hand
wash
get
back
home
tri
avoid
touch
need
disinfect
risk
infect
food
food
small
disinfect
intend
hard
cardboard
groceri
absorb
concern
transfer
food
serv
wash
disinfect
away
handl
mail
come
quarantin
mail
pose
larg
risk
mail
asid
sever
day
open
unnecessari
best
bet
wash
handl
anyth
bring
invit
back
home
fulli
request
wear
entir
time
home
fulli
leav
hous
present
otherwis
move
differ
part
hous
close
door
open
increas
throughout
go
swim
rel
safe
coronaviru
spread
water
chlorin
disinfect
tri
maintain
physic
crowd
wear
cloth
water
difficult
breath
wet
wear
mask
minim
time
often
crowd
well
look
period
social
opportun
get
mean
gym
right
mean
ca
exercis
take
long
run
outsid
best
maintain
least
six
nonfamili
outsid
yoga
indoor
exercis
weather
need
exercis
tri
get
outsid
everi
day
famili
soccer
game
rememb
time
invit
neighborhood
play
pull
board
gather
dust
famili
movi
night
catch
mean
read
famili
everi
import
stay
connect
even
though
person
keep
touch
virtual
phone
zoom
video
social
media
enjoy
leisur
chat
old
friend
mean
els
go
bed
earli
get
extra
sleep
coronaviru
primarili
viral
float
air
viru
even
peopl
infect
yet
infect
help
minim
spread
long
advis
mask
wear
addit
physic
guidanc
mask
wear
tailor
advic
depend
person
vaccin
statu
along
natur
locat
activ
coupl
first
learn
transmiss
much
less
like
occur
outdoor
air
like
scatter
dilut
viru
addit
peopl
protect
infect
appear
less
like
infect
accord
new
guidanc
fulli
peopl
particip
indoor
outdoor
without
mask
without
physic
peopl
fulli
recommend
mask
wear
prevent
outdoor
indoor
help
chart
protect
vaccin
outdoor
indoor
prevent
still
need
take
view
chart
click
kind
mask
wear
made
two
washabl
breathabl
fabric
surgic
effect
make
sure
mask
complet
nose
mouth
snugli
side
face
without
leav
effect
reserv
prefer
someon
inform
make
wear
clean
nonsurg
use
need
wear
mask
doubl
still
good
idea
lab
studi
mask
unmask
aerosol
mouthpiec
cough
breath
studi
found
wear
cloth
mask
surgic
mask
wear
tightli
fit
surgic
mask
substanti
level
protect
mask
wearer
doubl
wear
snug
cloth
mask
surgic
mask
surgic
provid
better
filtrat
tend
fit
loos
cloth
close
provid
anoth
layer
protect
surgic
sometim
medic
medic
procedur
surgic
mask
fit
method
knot
tuck
good
protect
knot
tuck
surgic
mask
knot
ear
face
mask
join
edg
mask
fold
tuck
unneed
materi
video
knot
tuck
surgic
mask
click
mask
fitter
mask
brace
worn
cloth
surgic
mask
improv
mask
lab
studi
doubl
surgic
reduc
transmiss
exposur
know
wear
help
prevent
spread
coronaviru
block
someon
best
worst
duke
univers
simpl
setup
count
number
droplet
peopl
spoke
phrase
stay
healthi
peopl
five
time
row
first
studi
spoke
without
mask
repeat
time
wear
one
differ
face
medic
grade
best
mean
number
got
surgic
sever
made
blend
cotton
sewn
differ
rank
dead
last
neck
tend
made
lightweight
fabric
often
worn
rank
coupl
simpl
help
gaug
effect
mask
see
mask
hold
light
breath
easili
probabl
much
prevent
known
time
help
prevent
peopl
spread
coronaviru
base
analysi
inform
new
studi
protect
mask
becom
infect
studi
author
block
viral
lead
lower
viru
peopl
becom
infect
milder
china
experi
test
effect
put
healthi
infect
coronaviru
cage
healthi
infect
barrier
made
surgic
mani
mask
healthi
get
infect
got
less
sick
previous
healthi
similar
experi
ethic
done
studi
flu
viru
found
peopl
higher
dose
flu
viru
like
get
sick
experi
coronaviru
cruis
support
idea
help
protect
mask
research
ca
certain
protect
wearer
know
hurt
protect
studi
journal
natur
medicin
widespread
use
prevent
nearli
occur
march
base
epidemiolog
model
consid
state
state
number
peopl
suscept
coronaviru
infect
mani
get
expos
mani
becom
infect
infecti
mani
recov
variou
mask
wear
assum
social
would
go
effect
number
per
million
base
exact
less
import
differ
studi
scenario
peopl
alway
wore
public
mani
scenario
peopl
nation
averag
mask
alway
wore
studi
messag
help
prevent
covid
wear
better
meet
famili
outdoor
know
coronaviru
someon
viru
infect
person
talk
breath
research
shown
confin
laboratori
set
viral
remain
afloat
eight
smaller
infecti
viral
drift
around
air
even
air
like
scatter
dilut
viru
make
transmiss
less
like
home
offic
confin
space
limit
air
circul
even
outdoor
fulli
follow
guidanc
physic
reduc
risk
even
know
certain
viru
air
know
hot
humid
peopl
like
stay
indoor
close
give
viru
opportun
infect
person
smaller
infecti
viral
drift
around
air
sever
outdoor
air
scatter
dilut
viru
make
transmiss
less
like
like
inhal
viru
indoor
close
whether
air
must
indoor
anyon
outsid
household
increas
air
circul
keep
open
much
evid
suggest
vitamin
help
protect
becom
infect
seriou
know
exampl
peopl
low
vitamin
suscept
upper
respiratori
tract
one
found
peopl
took
vitamin
particularli
low
vitamin
less
like
develop
acut
respiratori
tract
protect
two
way
first
help
boost
natur
defens
bacteria
second
help
prevent
exagger
inflammatori
respons
shown
contribut
sever
ill
peopl
make
vitamin
expos
sunshin
five
sun
exposur
day
week
arm
back
without
enabl
make
enough
vitamin
good
food
vitamin
includ
fatti
fish
tuna
mackerel
salmon
vitamin
dairi
soy
milk
chees
egg
dietari
dose
vitamin
day
younger
day
daili
supplement
vitamin
like
safe
peopl
risk
harm
effect
per
fulli
peopl
travel
freeli
within
us
need
get
covid
test
travel
need
quarantin
unless
local
state
cautiou
intern
travel
risk
even
peopl
fulli
gener
rule
travel
increas
chanc
spread
get
unvaccin
get
test
domest
travel
day
travel
discourag
unvaccin
peopl
outsid
wear
mask
nose
mouth
maintain
physic
distanc
six
avoid
wash
often
anyon
sick
test
posit
fli
current
travel
regulatori
emerg
use
author
vaccin
pfizer
first
vaccin
author
use
us
one
week
later
vaccin
evid
pfizerbiontech
vaccin
effect
new
coronaviru
test
vaccin
new
two
new
contagi
previou
appear
one
first
unit
kingdom
south
around
contain
viru
spike
protein
spike
surfac
viru
bind
allow
viru
enter
human
interestingli
share
key
mutat
spike
protein
viru
bind
tightli
human
mutat
new
contagi
previou
test
effect
pfizerbiontech
vaccin
new
viru
mutat
took
blood
enrol
vaccin
trial
expos
viru
blood
human
well
made
respons
pfizerbiontech
vaccin
found
block
viru
human
effect
block
viru
without
studi
see
hold
real
world
known
long
protect
last
whether
work
found
emerg
use
author
vaccin
collabor
vaccin
use
peopl
older
second
vaccin
author
use
us
pfizerbiontech
vaccin
receiv
prior
week
base
analysi
efficaci
safeti
data
well
recommend
made
relat
biolog
advisori
committe
group
outsid
infecti
diseas
microbiolog
immunolog
relat
brief
vaccin
overal
efficaci
studi
enrol
half
receiv
vaccin
half
receiv
placebo
shot
among
studi
placebo
group
vaccin
group
sever
covid
placebo
group
strongli
suggest
vaccin
risk
sever
vaccin
similarli
effect
peopl
older
younger
men
peopl
without
medic
put
high
risk
sever
ill
differ
racial
ethnic
common
vaccin
side
effect
pain
inject
site
fatigu
headach
muscl
pain
joint
pain
vaccin
two
space
four
apart
yet
know
long
immun
vaccin
vaccin
synthet
messeng
genet
materi
human
produc
spike
protein
found
surfac
viru
bodi
spike
protein
invad
soon
cell
harmless
later
encount
actual
viru
readi
recogn
destroy
pfizer
vaccin
storag
vaccin
normal
freezer
allow
distribut
emerg
use
author
vaccin
pfizer
vaccin
use
peopl
older
first
vaccin
author
use
base
analysi
efficaci
safeti
data
well
recommend
made
relat
biolog
advisori
committe
group
outsid
infecti
diseas
microbiolog
immunolog
relat
pfizerbiontech
vaccin
trial
new
journal
medicin
data
vaccin
reduc
risk
trial
enrol
nearli
got
two
space
three
apart
half
receiv
vaccin
half
got
placebo
shot
studi
placebo
group
eight
vaccin
group
nine
sever
covid
placebo
group
suggest
vaccin
reduc
risk
mild
sever
articl
vaccin
similarli
effect
studi
differ
bodi
weight
presenc
absenc
medic
younger
older
worth
felt
comfort
vaccin
even
though
number
teen
enrol
studi
studi
experienc
seriou
side
effect
howev
pain
inject
site
half
vaccin
mild
moder
fatigu
headach
fever
fairli
common
almost
alway
resolv
within
vaccin
two
space
three
apart
although
vaccin
provid
reason
protect
first
dose
protect
two
yet
know
long
immun
vaccin
pfizerbiontech
vaccin
vaccin
vaccin
synthet
messeng
genet
materi
make
insid
bodi
human
produc
singl
compon
viru
spike
protein
found
viru
surfac
bodi
spike
protein
invad
later
encount
actual
viru
readi
recogn
destroy
ill
must
cold
improperli
becom
staff
care
first
get
peopl
alreadi
gotten
sick
benefit
vaccin
accord
know
lead
seriou
ill
even
younger
peopl
without
underli
medic
know
possibl
someon
alreadi
though
hand
know
long
natur
immun
protect
sick
clear
strength
durat
natur
immun
base
sever
initi
ill
know
long
immun
initi
deploy
vaccin
front
line
peopl
care
nurs
peopl
elig
vaccin
get
regardless
whether
previous
infect
test
prior
learn
natur
immun
covid
ill
vaccin
criteria
base
presenc
play
role
answer
pfizerbiontech
found
good
job
symptomat
diseas
sever
howev
measur
whether
person
less
like
spread
viru
someon
possibl
protect
diseas
person
becom
infect
first
place
howev
possibl
vaccin
person
ill
prevent
person
becom
infect
person
viru
nose
throat
even
becom
mean
enough
viru
nose
throat
infect
someon
els
necessarili
possibl
immun
respons
trigger
vaccin
becom
sick
amount
viru
nose
throat
point
unlik
spread
someon
els
need
research
know
bottom
line
among
first
peopl
get
best
continu
wear
physic
distanc
order
protect
yet
gotten
vaccin
protect
get
sick
prevent
least
continu
wear
mask
physic
even
get
pfizerbiontech
found
good
job
symptomat
diseas
sever
howev
measur
whether
person
less
like
spread
viru
someon
possibl
protect
diseas
person
becom
infect
howev
possibl
vaccin
person
get
sick
prevent
viru
person
nose
mean
enough
viru
nose
throat
infect
someon
els
necessarili
need
research
know
leav
us
among
first
peopl
get
best
continu
wear
physic
distanc
order
protect
yet
gotten
success
vaccin
safe
effect
stimul
bodi
immun
system
creat
protect
coronaviru
emerg
use
author
vaccin
pfizer
one
week
later
anoth
vaccin
one
least
two
vaccin
close
behind
possibl
variou
develop
vaccin
complet
follow
messeng
genet
materi
make
contain
synthet
insid
bodi
human
produc
spike
protein
found
surfac
viru
bodi
spike
protein
invad
soon
cell
harmless
later
encount
actual
viru
readi
recogn
destroy
one
pfizer
anoth
emerg
use
author
vaccin
first
vaccin
emerg
use
author
chang
messeng
genet
materi
make
contain
insid
bodi
human
produc
spike
protein
found
surfac
viru
soon
cell
spike
protein
cell
harmless
point
enter
cell
nucleu
genet
materi
immun
system
spike
protein
invad
later
encount
actual
viru
readi
recogn
destroy
colleg
obstetr
gynecolog
societi
medicin
agre
new
pfizerbiontech
pregnant
breastfeed
lot
still
know
safeti
doctor
best
posit
advis
base
person
health
consid
first
although
actual
risk
sever
ill
death
among
pregnant
low
higher
nonpregn
age
group
addit
research
increas
risk
prematur
birth
particularli
sever
ill
transmiss
viru
mother
babi
pregnanc
possibl
rare
vaccin
deliber
includ
pregnant
knowledg
regard
safeti
pregnanc
limit
anim
affect
fertil
caus
pregnanc
contain
viru
caus
woman
babi
quickli
break
elimin
use
vaccin
unlik
reach
cross
placenta
hand
immun
woman
vaccin
cross
placenta
help
keep
babi
safe
believ
like
safe
get
vaccin
breastfeed
although
breastfeed
peopl
includ
vaccin
person
breastfeed
immun
system
protect
breast
milk
babi
like
help
protect
caus
varieti
common
cold
use
two
lead
vaccin
scientif
term
deliv
coronaviru
spike
protein
bodi
spike
protein
immun
system
produc
bodi
attack
viru
later
promis
vaccin
univers
studi
journal
lancet
analysi
vaccin
efficaci
base
adult
studi
receiv
full
dose
coronaviru
vaccin
four
later
anoth
full
dose
nearli
receiv
half
dose
coronaviru
vaccin
four
later
full
dose
control
group
receiv
mening
vaccin
second
mening
vaccin
placebo
salt
water
shot
least
two
second
coronaviru
vaccin
reduc
risk
averag
control
group
surprisingli
half
dose
vaccin
combin
effect
reduc
risk
full
dose
combin
reduc
risk
none
receiv
coronaviru
vaccin
sever
reduct
asymptomat
studi
white
addit
studi
healthi
stabl
underli
medic
data
understand
effect
vaccin
peopl
older
peopl
color
peopl
underli
medic
vaccin
clinic
around
world
us
analysi
base
data
unit
kingdom
use
vaccin
harmless
form
chimpanze
vaccin
safe
sever
staff
care
first
group
us
start
get
vaccin
age
older
essenti
next
age
peopl
age
medic
put
high
risk
sever
essenti
local
follow
order
distribut
million
us
varieti
outpati
emerg
medic
public
health
anoth
three
million
peopl
resid
work
care
includ
nurs
residenti
care
taken
heavi
toll
care
essenti
work
home
abl
physic
distanc
work
includ
first
polic
day
care
postal
peopl
work
groceri
guidanc
base
recommend
advisori
committe
immun
made
immunolog
virolog
public
health
relat
work
limit
vaccin
broadli
advis
immun
world
current
differ
variou
test
develop
phase
safeti
phase
optim
dose
schedul
proof
concept
phase
effect
side
effect
emerg
use
author
two
one
pfizerbiontech
anoth
use
type
molecul
messeng
rapidli
human
make
protein
spike
protein
surfac
coronaviru
enter
human
bodi
spike
protein
invad
later
encount
actual
viru
readi
recogn
destroy
vaccin
show
central
question
long
protect
immun
protect
sick
know
long
natur
immun
strong
count
natur
immun
protect
us
reinfect
long
unfortun
know
answer
either
confirm
reinfect
person
got
sick
infect
rare
peopl
alreadi
gotten
sick
benefit
vaccin
possibl
even
peopl
previous
infect
peopl
elig
get
vaccin
whether
previous
infect
vaccin
criteria
chang
futur
learn
natur
immun
covid
immun
enough
peopl
becom
immun
diseas
make
spread
unlik
result
entir
commun
even
immun
herd
immun
usual
vaccin
occur
natur
initi
somewher
popul
need
immun
order
achiev
herd
immun
recent
rais
estim
near
nowher
close
achiev
herd
immun
herd
immun
natur
infect
mani
peopl
would
becom
ill
mani
would
die
fall
develop
effect
howev
still
know
long
peopl
recov
remain
immun
achiev
herd
immun
peopl
around
world
receiv
last
pneumonia
pneumococc
vaccin
influenza
type
b
vaccin
help
protect
peopl
specif
bacteri
protect
coronaviru
pneumonia
pneumonia
part
howev
even
though
specif
protect
coronaviru
highli
protect
respiratori
present
consid
unlik
dog
spread
viru
howev
spread
caus
ill
e
coli
salmonella
wash
thoroughli
soap
water
viru
appear
spread
peopl
accord
research
found
like
becom
infect
pet
follow
reduc
risk
infect
becom
sick
restrict
contact
would
around
peopl
forgo
food
bed
pet
feel
better
possibl
anoth
member
household
care
sick
must
care
pet
sick
wash
interact
wear
face
immun
system
bodi
defens
system
harm
invad
cold
flu
viru
coronaviru
bodi
immun
system
attack
known
immun
respons
attack
sequenc
variou
gener
health
best
step
take
toward
keep
immun
system
strong
healthi
everi
part
bodi
immun
system
better
environment
mani
medic
dental
comprehens
safeti
help
protect
doctor
offic
staff
feel
anxiou
visit
person
call
doctor
increasingli
provid
mean
phone
call
virtual
video
chat
servic
ask
schedul
appoint
doctor
new
ongo
nonurg
matter
speak
doctor
would
see
person
let
urgent
fall
categori
exampl
advis
period
cancer
remiss
doctor
regularli
monitor
condit
risk
treatment
base
recent
test
similar
call
doctor
avail
elect
throughout
unit
fluid
reflect
number
infect
rate
given
area
rise
area
quit
possibl
alreadi
hospit
medic
center
procedur
consid
procedur
keep
mind
elect
rel
term
instanc
immedi
surgeri
sciatica
herniat
disc
pain
sever
would
abl
endur
surgeri
perhap
case
doctor
make
decis
proceed
new
pfizer
seem
remark
good
seriou
ill
unclear
well
curb
spread
pfizer
track
mani
peopl
sick
leav
open
possibl
peopl
get
infect
without
silent
transmit
viru
especi
come
close
contact
stop
wear
peopl
silent
viru
keep
unvaccin
peopl
risk
lot
peopl
think
get
go
wear
tal
immunologist
univers
realli
go
critic
know
keep
wear
still
contagi
respiratori
new
coronaviru
nose
main
port
entri
viru
rapidli
jolt
immun
system
produc
type
specif
mucosa
moist
tissu
line
nose
mouth
stomach
person
expos
viru
second
time
well
immun
rememb
viru
rapidli
shut
viru
nose
chanc
take
hold
elsewher
coronaviru
contrast
deep
stimul
immun
system
produc
enough
protect
keep
person
get
circul
blood
nasal
mucosa
stand
guard
clear
much
antibodi
pool
quickli
answer
much
bloom
nose
breath
infect
race
whether
viru
replic
faster
immun
system
control
faster
pepper
immunologist
univers
realli
import
question
mucos
nasal
spray
oral
polio
vaccin
better
intramuscular
respiratori
next
gener
coronaviru
elicit
immun
nose
rest
respiratori
tract
peopl
get
intramuscular
inject
mucos
boost
protect
nose
coronaviru
prove
power
sever
ill
guarante
efficaci
nose
site
sever
much
access
nose
throat
make
easier
safeguard
sever
diseas
easiest
mild
diseas
harder
immunologist
univers
percent
effect
symptomat
diseas
go
someth
less
sure
still
optimist
would
suppress
viru
enough
even
nose
throat
prevent
peopl
spread
feel
develop
form
immun
vaccin
abil
get
infect
go
immunologist
yale
univers
even
infect
level
viru
replic
nose
reduc
vaccin
produc
data
mani
peopl
infect
viru
trial
test
regularli
viru
vaccin
prevent
test
subset
trial
viral
protein
n
noth
protein
n
would
reveal
whether
becom
infect
viru
immun
spokeswoman
analyz
blood
test
n
take
sever
expect
see
colleen
spokeswoman
far
blood
test
mucosa
would
confirm
travel
nose
mouth
tal
team
analyz
blood
saliva
johnson
johnson
trial
see
two
antibodi
recent
work
show
peopl
receiv
intramuscular
flu
vaccin
abund
nose
studi
found
antibodi
saliva
blood
close
suggest
strong
immun
respons
blood
would
protect
mucos
peopl
viru
teem
nose
throat
would
transmit
viru
lack
peopl
infect
vaccin
kept
viru
even
peopl
high
coronaviru
nose
note
academi
pediatr
feder
advisori
committe
immun
first
person
confirm
coronaviru
man
hong
enough
viru
infect
peopl
high
viral
load
would
actual
way
even
wors
fals
sens
secur
tal
concern
monkey
show
get
ill
still
viru
intent
expos
massiv
viru
still
less
viru
unvaccin
virologist
medicin
new
york
reduc
viral
load
less
like
transmiss
data
theori
need
data
point
countri
achiev
herd
immun
portion
popul
must
acquir
resist
coronaviru
either
infect
vaccin
order
diseas
fade
away
life
return
normal
sinc
start
pandem
figur
mani
percent
rang
still
world
health
organ
often
repeat
futur
cours
imposs
know
certainti
limit
reach
transmiss
good
estim
import
sens
hope
breath
freeli
figur
million
look
guidanc
advis
trump
administr
incom
administr
begun
rais
pandem
earli
day
cite
percent
estim
month
ago
say
percent
televis
last
week
interview
news
percent
percent
telephon
interview
next
day
acknowledg
slowli
deliber
move
goal
partli
base
new
scienc
partli
gut
feel
countri
final
readi
hear
realli
hear
take
close
percent
immun
bring
viru
halt
almost
much
stop
measl
promin
proven
right
earli
rang
percent
almost
undoubtedli
low
viru
becom
transmiss
take
greater
herd
immun
stop
ago
publicli
rais
estim
mani
hesit
would
need
accept
almost
univers
order
countri
achiev
herd
show
mani
readi
even
eager
felt
deliv
tough
messag
return
normal
take
longer
half
would
take
vaccin
say
herd
immun
would
take
percent
percent
would
take
thought
nudg
bit
went
need
humil
ad
realli
know
real
number
think
real
rang
somewher
percent
go
say
percent
discourag
sure
enough
voluntari
accept
reach
goal
although
year
sever
current
suggest
percent
say
unwil
accept
note
figur
percent
rang
infecti
measl
bet
hous
covid
contagi
measl
thought
world
contagi
diseas
linger
air
drift
infect
peopl
crowd
militari
student
kept
percent
regard
degre
herd
immun
defeat
coronaviru
produc
rang
line
came
warn
mere
tell
put
give
answer
marc
epidemiologist
th
school
public
health
tell
nobodi
truli
accur
herd
immun
done
actual
come
anim
rinderpest
diseas
senior
advis
epidemiolog
nation
institut
allergi
infecti
cattl
easi
measur
fast
diseas
one
anim
anoth
move
around
diseas
spread
among
far
origin
assumpt
would
take
percent
immun
stop
diseas
base
earli
data
china
health
watch
fast
doubl
calcul
viru
reproduct
number
mani
new
carrier
infect
two
three
potenti
would
becom
immun
carrier
infect
one
carrier
one
new
victim
outbreak
slowli
three
percent
establish
rang
percent
herd
notion
studi
militari
crew
aircraft
carrier
de
outbreak
late
march
director
univers
institut
health
metric
studi
found
aboard
percent
test
posit
carrier
return
port
outbreak
still
progress
crew
went
quarantin
unclear
whether
viru
finish
new
even
percent
caught
aboard
poor
land
move
much
faster
close
quarter
vessel
civilian
popul
e
dean
univers
import
earli
wuhan
later
upward
note
number
first
wave
took
two
certain
mani
asymptomat
peopl
spread
clearer
later
one
person
even
larg
role
spread
normal
one
everyon
basketbal
broadway
push
reproduct
number
upward
even
consequ
call
higher
herd
immun
exampl
four
five
peopl
percent
must
immun
slow
grow
consensu
among
viru
becom
transmiss
variant
strain
mutat
known
spread
much
faster
origin
wuhan
variant
newli
mutat
sometim
make
viru
even
infecti
recent
south
transmiss
pathogen
peopl
must
becom
immun
order
stop
agre
level
herd
immun
stop
percent
higher
toni
read
tea
leav
diseas
control
prevent
herd
immun
estim
say
know
although
still
sometim
cite
older
percent
estim
agenc
director
immun
thought
rang
low
declin
estim
correct
higher
one
lean
thin
tri
say
level
vaccin
coverag
would
achiev
say
know
world
even
nation
number
depend
commun
live
dean
note
stop
transmiss
crowd
citi
new
york
peopl
would
achiev
immun
would
necessari
less
crowd
place
right
take
even
percent
herd
immun
complet
stop
coronaviru
transmiss
still
viru
sooner
ad
zero
transmiss
order
decent
societi
lot
flu
time
shut
societi
vaccin
almost
peopl
risk
sever
would
becom
milder
diseas
scienc
time
page
sign
scienc
time
newslett
coronaviru
pandem
surg
initi
vaccin
limit
unit
hard
choic
countri
immun
program
focu
earli
elderli
peopl
seriou
medic
die
viru
highest
essenti
expans
categori
born
risk
infect
health
care
elderli
almost
certainli
get
first
diseas
control
prevent
vaccin
start
month
debat
among
feder
state
health
goe
next
outsid
includ
grow
question
increasingli
laid
bare
pandem
disproportion
high
infect
death
among
poor
peopl
peopl
color
dispar
access
test
child
care
technolog
school
damnabl
even
posit
make
rev
j
barber
cochairman
poor
peopl
campaign
nation
coalit
attent
work
poor
make
choic
leav
poor
essenti
last
ultim
choic
come
whether
death
curb
spread
viru
semblanc
normalci
highest
prioriti
goal
maxim
preserv
human
life
would
bia
vaccin
toward
older
former
food
drug
administr
commission
recent
goal
reduc
rate
infect
would
essenti
impact
tri
achiev
two
fact
definit
essenti
use
nearli
percent
work
forc
sweep
groceri
store
emerg
tugboat
nuclear
energi
labor
public
health
consid
categori
say
interact
person
publican
independ
committe
medic
immun
soon
vote
recommend
second
phase
vaccin
phase
meet
last
month
vote
committe
support
essenti
ahead
peopl
older
health
committe
scientif
evid
inform
weigh
social
justic
well
note
professor
health
polici
decis
univers
michigan
issu
ethic
signific
import
countri
peter
committe
member
pediatr
professor
univers
time
clearli
essenti
worker
group
high
proport
minor
among
essenti
posit
counter
world
health
organ
nation
engin
medicin
mani
say
reduc
unequivoc
prioriti
older
sicker
peopl
thu
go
view
mani
public
health
director
nation
top
public
health
offici
advisori
committe
import
older
peopl
say
statement
forward
futur
base
vaccin
avail
demonstr
nation
elderli
committe
decid
whether
accept
offici
guidanc
agenc
rare
director
reject
recommend
committe
whose
select
health
human
secretari
serv
never
task
high
profil
ultim
decis
state
local
health
follow
though
histor
done
million
essenti
nationwid
defin
divis
depart
homeland
secur
roster
help
maintain
critic
infrastructur
pandem
list
long
enough
reach
everyon
first
make
tough
preliminari
plan
exampl
prison
food
ahead
groceri
educ
public
transit
retail
food
earli
point
mani
state
put
least
peopl
older
live
independ
peopl
medic
ahead
essenti
though
chang
committe
formal
recommend
next
occup
whose
prioriti
hotli
teach
essenti
everyon
epidemiologist
th
school
public
health
includ
essenti
central
goal
committe
reduc
health
often
white
colleg
cours
better
among
senior
economist
econom
polici
institut
disagre
ensur
fall
behind
educ
critic
work
forc
larg
talk
disproportion
impact
concern
peopl
get
back
labor
forc
mani
harder
time
reliabl
place
go
think
gener
peopl
disproportion
black
brown
challeng
child
care
issu
academ
depart
homeland
secur
list
essenti
found
broadli
mirror
labor
forc
narrow
vulner
categori
food
emerg
medic
must
work
face
face
thu
greater
risk
definit
labor
economist
univers
author
studi
belong
categori
essenti
howev
work
rather
remot
would
fit
group
individu
categor
short
subset
essenti
given
natur
must
provid
labor
person
sens
given
risk
face
analysi
work
paper
nation
bureau
econom
research
line
say
list
essenti
larg
realli
b
omer
director
yale
institut
global
health
work
vaccin
nation
essenti
feder
list
make
nearli
percent
labor
forc
percent
made
percent
certain
far
educ
lower
wage
averag
hour
proport
black
higher
categori
essenti
health
polici
rather
reduc
viru
transmiss
simpli
pragmat
choic
enough
vaccin
initi
avail
make
meaning
dent
contagion
effect
use
limit
say
save
vaccin
trial
far
show
protect
receiv
yet
person
would
infect
though
believ
like
case
yet
expert
ethic
health
polici
univers
reason
put
essenti
ahead
older
given
disproportion
older
societi
structur
way
live
longer
instead
give
addit
health
alreadi
start
level
field
bit
protect
older
peopl
risk
committe
integr
agenc
social
vulner
index
index
deriv
censu
overcrowd
hous
lack
vehicl
access
poverti
determin
urgent
commun
need
health
support
goal
reduc
new
analysi
preliminari
vaccin
found
least
intend
appli
index
one
reserv
earli
peopl
believ
wrong
give
racial
socioeconom
equiti
weight
like
die
need
bombproof
one
group
goe
ahead
anoth
chuck
former
senat
aid
industri
lobbyist
essenti
ahead
older
peopl
committe
provid
explan
withstand
public
scrutini
differ
prioriti
committe
mani
essenti
older
essenti
come
face
face
public
peopl
whose
allegi
one
group
made
case
claim
vaccin
marc
presid
unit
food
commerci
union
million
groceri
food
despit
high
rate
infect
among
thought
older
go
first
thing
everybodi
got
grandmoth
grandfath
believ
almost
everybodi
countri
would
want
protect
age
shah
top
public
health
offici
respect
disagre
explan
given
older
good
health
abl
social
told
know
sorri
need
get
vaccin
first
get
world
come
back
readi
receiv
cours
essenti
inform
still
state
emerg
fulli
expect
uncertainti
given
high
apprehens
around
vaccin
mani
peopl
earli
actual
line
high
proport
essenti
declin
get
vaccin
quickli
move
onto
next
group
anyway
univers
michigan
health
analyst
arriv
use
certain
amount
time
degrad
earli
vaccin
studi
suggest
differ
provok
protect
immun
respons
trial
produc
high
immun
get
one
dose
pfizerbiontech
vaccin
one
dose
either
order
like
provid
potent
protect
snape
vaccin
expert
univers
news
confer
think
would
effect
snape
trial
first
wave
studi
gave
one
four
got
two
either
pfizer
shown
effect
got
dose
one
pfizer
vice
first
wave
four
found
vaccin
protect
second
dose
run
separ
trial
deliv
next
found
muscl
pain
peopl
get
two
vaccin
side
effect
snape
drew
blood
measur
immun
respons
found
got
two
pfizerbiontech
produc
time
high
got
two
got
pfizer
antibodi
five
time
high
two
got
pfizer
antibodi
high
got
two
snape
would
like
narrow
get
second
dose
vaccin
time
strengthen
studi
found
differ
produc
higher
level
immun
attack
coronaviru
give
two
vaccin
snape
clear
yet
advantag
intrigu
let
say
much
snape
begun
similar
trial
list
best
cours
action
remain
get
two
vaccin
larg
clinic
clearli
strategi
get
default
proven
work
snape
mani
possibl
vaccin
sometim
exampl
younger
peopl
advis
get
second
dose
small
risk
blood
import
know
whether
peopl
switch
anoth
vaccin
reassur
evid
work
snape
research
first
link
market
center
wuhan
china
new
analysi
earli
coronaviru
point
elsewher
citi
world
starv
fresh
data
help
clarifi
origin
pandem
studi
unearth
earli
deliber
hidden
bound
ignit
sizzl
debat
unreview
paper
evolutionari
biologist
bloom
cancer
research
center
team
wuhan
china
post
viral
wide
use
us
later
genet
inform
remov
obscur
exist
reinforc
china
someth
hide
pandem
preprint
post
yesterday
say
bloom
detect
work
much
ado
noth
later
viral
inform
differ
form
add
littl
known
bloom
support
evid
pandem
origin
wuhan
market
initi
came
light
health
tie
market
outbreak
unexplain
pneumonia
month
later
becom
clear
mani
link
locat
paper
three
found
collect
link
market
unearth
coronaviru
rel
wuhan
institut
virolog
discov
bat
explos
assert
data
bound
intensifi
debat
whether
viru
origin
unknown
anim
somehow
laboratori
bloom
bia
toward
particular
origin
hypothesi
viral
small
piec
larg
unfinish
puzzl
think
either
lab
origin
zoonosi
hypothesi
think
addit
evid
viru
probabl
wuhan
certainli
probabl
less
complet
pictur
earli
bloom
viral
evolut
studi
controversi
report
pandem
origin
march
joint
commiss
foreign
organ
world
health
organ
bloom
organ
much
letter
report
extrem
unlik
laboratori
letter
scienc
dispassion
discours
difficult
import
issu
report
heavili
found
tie
market
bloom
go
tri
repeat
number
analys
joint
report
bloom
led
studi
list
march
sequenc
read
archiv
overseen
nation
center
inform
divis
us
nation
health
check
one
list
find
project
inform
found
anoth
studi
led
ming
wang
wuhan
univers
hospit
post
preprint
march
later
june
small
journal
chemistri
virolog
paper
wuhan
specif
give
full
sequenc
data
led
bloom
discov
inform
cloud
platform
search
turn
wang
team
data
paper
small
mention
viral
explain
remov
led
bloom
conclud
preprint
trust
scienc
obscur
relev
earli
spread
wuhan
bloom
lack
three
seen
market
wang
team
found
like
repres
sequenc
bat
viru
found
must
pandem
speci
well
infect
bat
viru
made
final
jump
peopl
great
differ
evolutionari
biologist
univers
use
bloom
look
back
time
see
famili
tree
ask
remov
data
repli
scienc
receiv
repli
lead
statement
today
say
remov
request
investig
agenc
data
scientist
sequenc
inform
anoth
data
remov
avoid
version
control
bloom
find
virolog
sharpli
divid
valu
bloom
resurrect
data
creativ
rigor
approach
investig
proven
microbiologist
univers
mailman
school
public
health
two
viru
outbreak
link
wuhan
market
activ
suppress
epidemiolog
sequenc
data
track
origin
leav
asid
mean
bloom
found
demonstr
potenti
find
new
data
cloud
excit
advanc
research
templ
univers
analysi
earli
mani
peopl
feel
lot
data
access
year
evolutionari
virologist
univers
understand
reason
small
paper
simpli
good
studi
unfortun
flew
radar
small
paper
remov
data
idea
group
tri
hide
someth
farcic
cover
someth
sure
would
paper
malfeas
bloom
zero
knowledg
paper
remov
data
member
origin
commiss
univers
medic
center
report
need
find
data
circul
good
see
addit
data
sure
point
preprint
harm
futur
origin
tone
view
rather
suggest
wish
scienc
would
stay
away
bloom
piec
togeth
coronaviru
data
found
small
paper
way
field
conduct
evolutionari
analys
one
knew
way
peopl
find
go
sequenc
look
bloom
divis
discuss
origin
come
price
mani
peopl
preconceiv
topic
open
mouth
topic
someon
go
take
support
reject
particular
narr
either
say
anyth
think
use
product
tri
draw
make
transpar
possibl
matter
much
peopl
new
studi
agre
interpret
disagre
interpret
least
go
repeat
kai
coronaviru
variant
delta
first
state
seem
remark
new
later
impact
devast
almost
daili
late
suddenli
domin
complet
away
alpha
preval
citi
institut
integr
biolog
new
unlik
suffer
big
new
outbreak
mani
alreadi
infect
bare
slow
delta
transmiss
evad
immun
went
wall
around
citi
wall
walk
new
variant
quickli
spread
set
sweep
globe
devast
new
wave
unit
kingdom
delta
alreadi
driven
case
dramat
declin
led
govern
last
week
postpon
final
stage
plan
resurg
govern
enact
travel
ban
citi
rest
countri
variant
account
union
end
august
head
diseas
prevent
control
today
like
delta
variant
circul
extens
summer
particularli
among
younger
target
vaccin
caus
risk
vulner
infect
experi
sever
ill
death
fulli
delta
caus
russia
mani
unit
preval
least
diseas
control
prevent
declar
delta
variant
concern
surg
set
frenzi
research
understand
delta
spread
much
faster
three
concern
whether
danger
way
uniqu
pattern
caus
subtl
wreak
havoc
delta
arriv
brought
fresh
attent
potenti
evolv
adapt
ahead
moment
delta
particular
threat
littl
access
chief
scienc
advis
world
health
organ
immedi
worri
happen
delta
end
explos
research
public
health
delta
abil
spread
alpha
unit
kingdom
get
transmiss
model
school
hygien
tropic
reduc
protect
play
role
well
data
indic
pfizerbiontech
offer
slightli
less
protect
symptomat
new
variant
alpha
peopl
receiv
one
shot
mani
especi
vulner
two
either
vaccin
still
offer
high
level
protect
hospit
delta
well
mani
use
around
world
protect
unclear
data
protect
result
prior
bout
spike
protein
domain
left
power
latch
viru
middl
right
prevent
two
transmiss
immun
hard
disentangl
would
argu
delta
variant
driven
transmiss
abil
escap
immun
head
trust
alpha
realli
approxim
transmiss
wild
type
strain
delta
transmiss
alpha
talk
viru
twice
transmiss
initi
strain
evolutionari
virologist
univers
would
mean
low
vaccin
like
see
big
new
inde
faster
spread
entir
viru
catastroph
news
rest
world
top
delta
like
put
unvaccin
peopl
hospit
alpha
earli
data
unit
kingdom
suggest
risk
hospit
twice
high
togeth
caus
huge
go
enough
oxygen
go
enough
hospit
alreadi
know
peopl
wors
realli
lead
higher
mortal
even
among
younger
peopl
begin
probe
delta
danger
suit
nine
gene
spike
protein
viru
surfac
invad
human
one
import
mutat
amino
acid
spot
directli
besid
cleavag
site
human
enzym
protein
key
step
viru
invad
human
alpha
variant
mutat
site
made
cleavag
effici
preprint
late
delta
differ
chang
cleavag
even
easier
suggest
make
viru
made
carri
mutat
found
infect
lab
howev
coronaviru
includ
mutat
far
less
success
delta
evolutionari
virologist
univers
must
interact
someth
els
genom
delta
help
thwart
immun
alter
spike
domain
protein
surfac
recent
cell
paper
one
spot
unfailingli
target
delta
uniqu
delet
amino
amino
acid
arginin
glycin
latter
direct
contact
point
antibodi
bind
structur
biologist
univers
think
mutat
one
hallmark
delta
given
phenotyp
comput
biologist
cancer
research
mutat
help
rebuff
start
examin
role
delta
variant
molecular
biologist
univers
san
much
know
everi
level
dark
delta
sever
protein
exampl
mani
swiss
armi
knife
protein
virologist
crick
institut
bring
clariti
take
agre
urgent
action
stop
spread
new
variant
delta
galvan
us
realli
ramp
vaccin
surg
delta
tick
virologist
univers
us
presid
joe
get
fulli
protect
delta
today
acceler
fulli
vaccin
vulner
kept
place
keep
new
variant
spread
caus
anoth
surg
littl
access
vaccin
need
resort
physic
keep
place
push
fulli
vaccin
vulner
goal
save
immedi
give
viru
less
room
evolv
delta
success
shown
abl
identifi
danger
new
time
stop
spread
emma
virologist
univers
despit
unpreced
global
effort
track
evolut
real
time
would
danger
assum
much
better
anyth
least
twice
evolut
part
pattern
would
unsurpris
saw
equival
come
year
two
ago
transplant
surgeon
despond
donat
organ
take
power
suppress
immun
system
one
dose
highli
effect
messeng
vaccin
exampl
protect
pandem
coronaviru
standard
two
took
protect
organ
mount
healthi
immun
respons
vaccin
even
peopl
make
antivir
often
low
rais
well
shield
univers
becom
cautious
optimist
found
third
dose
vaccin
help
among
organ
transplant
two
eight
peopl
protect
sought
third
six
peopl
coronaviru
two
wound
high
third
shot
today
annal
intern
medicin
although
conduct
systemat
got
differ
differ
time
hope
critic
right
encourag
evid
abl
help
immun
system
need
organ
transplant
research
project
run
vaccin
peopl
immun
case
got
peopl
say
hey
get
third
dose
want
blood
opportun
unit
determin
secur
extra
vaccin
despit
current
author
two
studi
first
report
third
dose
vaccin
part
discuss
whether
offer
extra
vulner
health
third
dose
countri
organ
polici
shift
kidney
transplant
univers
hospit
receiv
third
dose
vaccin
antibodi
although
yet
roughli
match
small
cohort
percent
two
third
shot
weak
reaction
two
respons
third
nephrologist
unit
peopl
organ
number
worri
well
work
includ
peopl
cancer
got
immun
system
suppress
chemotherapi
surpris
see
higher
work
systemat
find
director
transplant
infecti
gener
clinic
third
crucial
provid
clariti
ideal
time
potenti
vulner
one
whether
extra
dose
vaccin
immun
system
induc
reject
donat
organ
studi
heart
transplant
patient
mild
reject
episod
week
third
dose
though
say
whether
link
addit
dose
without
clinic
trial
run
transplant
two
vaccin
trial
provid
third
dose
second
shot
rest
got
placebo
run
vaccin
studi
recruit
rang
natur
affect
immun
peopl
organ
kidney
dialysi
studi
second
dose
vaccin
eventu
offer
third
vaccin
dose
sander
infecti
diseas
expert
univers
hospit
berlin
help
lead
work
nation
health
start
trial
summer
transplant
strong
biolog
rational
third
dose
specif
health
polici
research
medic
univers
yet
third
imagin
support
strategi
somewhen
come
peopl
cancer
deepli
worri
effect
two
last
month
studi
jama
oncolog
group
cancer
chemotherapi
produc
two
pfizer
vaccin
commentari
paper
anoth
studi
cancer
cell
month
cancer
vaccin
excel
news
salomon
stemmer
medic
medic
center
led
jama
oncolog
stemmer
cohort
treatment
antibodi
healthi
famili
got
vaccin
differ
strongli
concern
stemmer
level
natur
time
whether
drop
worryingli
low
cancer
sooner
start
lower
level
big
question
know
quickli
antibodi
go
fall
follow
cohort
test
antibodi
everi
learn
small
group
produc
includ
three
breast
cancer
get
chemotherapi
less
time
third
vaccin
help
stemmer
would
offer
part
clinic
inform
help
come
soon
right
lack
guidanc
lack
knowledg
peopl
prefer
take
wherea
would
eagerli
join
clinic
anyon
consid
third
vaccin
dose
speak
doctor
first
whatev
happen
go
learn
much
possibl
safeti
health
regulatori
agenc
revers
last
week
allow
trickl
sputnik
v
vaccin
countri
fraction
total
group
state
agenc
stringent
reduc
suppos
health
monitor
vaccin
safeti
brazil
face
massiv
surg
scarciti
vaccin
previou
import
request
vaccin
replic
harm
peopl
decis
spark
lawsuit
threat
sputnik
v
manufactur
research
institut
epidemiolog
microbiolog
drew
critic
june
four
five
decid
allow
import
sputnik
v
sway
new
law
brazil
worsen
crisi
health
context
countri
go
us
face
need
make
number
avail
one
four
brazil
one
world
highest
peopl
first
v
two
use
two
differ
deliv
spike
protein
pandem
coronaviru
suppos
unabl
make
gener
manag
biolog
latest
agenc
receiv
analys
health
minist
put
number
per
dose
document
still
accept
clear
us
rational
use
approv
specif
presenc
safe
outsid
fray
previous
document
argu
indic
presenc
live
viru
rather
detect
law
march
countri
select
import
alreadi
emerg
use
certain
russia
sever
discuss
way
get
time
minim
associ
vaccin
restrict
sputnik
v
number
suffici
cover
popul
six
northern
origin
vaccin
request
million
undergo
analysi
lab
show
safe
contain
healthi
elig
vaccin
must
disclos
popul
regulatori
agenc
clear
qualiti
safeti
efficaci
step
conduct
sputnik
v
efficaci
studi
supervis
victori
us
go
work
togeth
follow
brazil
former
scienc
minist
part
scientif
board
support
vaccin
origin
import
polit
presid
especi
communist
china
v
temporari
use
permit
suspend
time
either
world
health
organ
formal
emerg
use
author
still
evalu
brazil
aris
laboratori
vaccin
predict
arriv
manufactur
alreadi
vaccin
immunologist
vaccin
expert
feder
univers
main
campu
compromis
clever
strategi
posit
discard
good
solut
see
effect
vaccin
work
well
distribut
whole
popul
dark
hors
vaccin
compani
strong
today
pivot
trial
pandem
coronaviru
vaccin
unit
vaccin
protein
differ
technolog
author
far
overal
efficaci
symptomat
protect
moder
sever
diseas
eight
viral
interest
concern
efficaci
vaccin
safe
vaccin
phenomen
infecti
diseas
physician
epidemiologist
univers
san
clinic
trial
highli
divers
nonwhit
vaccin
straightforward
storag
speed
access
remot
around
differ
percentag
efficaci
efficaci
pfizerbiontech
part
later
trial
pit
vaccin
viral
immunologist
medicin
particip
trial
compos
messeng
wide
vaccin
whose
efficaci
least
par
pfizer
essenti
protect
diseas
one
expert
less
howev
data
noth
spectacular
former
chief
oper
offic
vaccin
divis
efficaci
overal
coupl
pfizer
vaccin
best
appli
us
food
drug
administr
emerg
use
author
third
quarter
compani
regulatori
product
consist
vaccin
use
clinic
presid
announc
end
long
begin
compani
develop
vaccin
billion
us
govern
oper
warp
speed
compani
product
launch
north
clinic
trial
late
trial
unit
six
initi
receiv
two
vaccin
day
receiv
placebo
experienc
placebo
group
similar
trial
peopl
unit
kingdom
trial
vaccin
efficaci
overal
alpha
variant
first
unit
kingdom
origin
viru
strain
separ
trial
south
worrisom
beta
variant
aros
wide
vaccin
overal
efficaci
sank
new
trial
ill
half
found
culprit
alpha
variant
us
late
compani
provid
specif
efficaci
data
alpha
variant
two
beta
variant
trial
realli
address
well
vaccin
would
work
escap
beta
dean
univers
far
author
major
western
regulatori
deliv
genet
materi
recipi
make
spike
surfac
protein
immun
system
respond
viru
vaccin
instead
spike
protein
carri
soaplik
given
extra
punch
substanc
adjuv
protein
technolog
use
hepat
bin
clinic
far
vaccin
produc
somewhat
power
though
transient
side
effect
headach
muscl
pain
fatigu
mani
pfizerbiontech
experienc
instanc
receiv
vaccin
part
trial
least
one
effect
trial
unit
kingdom
number
second
dose
vaccin
north
trial
receiv
activ
vaccin
degre
headach
muscl
pain
fatigu
seriou
rel
mild
side
effect
plu
analyst
b
riley
vaccin
go
less
cancel
afterward
jab
find
nich
booster
vaccin
unit
countri
love
choic
contract
oper
warp
speed
deliv
million
us
govern
although
countri
need
initi
reach
capac
million
per
month
end
third
quarter
million
per
month
fourth
quarter
year
compani
million
anoth
five
western
last
month
deal
suppli
vaccin
allianc
million
global
access
facil
global
partnership
serum
institut
make
vaccin
deliv
anoth
million
serum
start
vaccin
provid
regulatori
author
told
product
substanti
back
compani
would
ship
billion
year
compani
struggl
scale
partner
particularli
product
wrote
note
invest
last
need
frozen
protein
vaccin
refriger
remov
remain
viabl
new
version
vaccin
beta
variant
use
booster
compani
posit
vaccin
mice
work
vaccin
whose
ago
make
small
compani
climb
market
share
profit
tough
new
clinic
trial
test
messeng
pregnant
one
care
center
south
urgent
place
highli
million
clinic
trial
meant
test
efficaci
novel
messeng
key
variant
pandem
coronaviru
well
peopl
live
pregnant
readi
launch
eight
yet
neither
maker
pfizer
even
provid
group
promin
south
written
letter
delay
us
govern
director
nation
institut
allergi
infecti
agre
pay
studi
stress
peopl
live
especi
hard
danger
evolv
mani
immun
believ
landmark
studi
region
world
wrote
respect
ask
power
enabl
studi
take
place
efficaci
trial
yield
littl
given
rapid
spread
region
import
studi
entir
portfolio
adult
vaccin
fund
us
govern
date
cancer
research
center
organ
trial
follow
protect
coronaviru
variant
first
seen
south
origin
beta
world
health
organ
new
name
system
variant
wide
preval
critic
antibodi
lab
shown
lower
efficaci
see
tabl
two
johnson
johnson
offer
modest
protect
peopl
real
problem
gray
south
medic
research
council
studi
sponsor
whether
current
protect
pregnant
remain
uncertain
initi
efficaci
new
trial
would
organ
prevent
network
previous
stage
efficaci
vaccin
four
vaccin
part
us
govern
oper
warp
speed
program
posit
would
strengthen
case
scarc
world
wide
avail
pfizer
studi
unnecessari
evid
vaccin
work
well
beta
variant
compani
intern
studi
underway
pregnant
protect
variant
escap
key
antibodi
widespread
pfizer
messeng
vaccin
best
trial
small
efficaci
measur
symptomat
sever
diseas
trial
turn
compani
initi
would
provid
vaccin
although
trial
compar
current
version
version
develop
ago
trial
launch
back
compani
say
complex
mix
liabil
reluct
help
oversight
known
design
studi
led
chang
heartsom
trial
howev
suspect
busi
factor
wari
new
data
would
complic
get
full
approv
regulatori
receiv
emerg
use
author
unit
trial
would
involv
peopl
south
zimbabw
adult
preval
half
studi
would
receiv
current
vaccin
surfac
protein
spike
initi
would
receiv
placebo
soon
clear
evid
current
vaccin
placebo
group
would
new
bival
vaccin
origin
spike
protein
well
slightli
version
beta
variant
long
whether
vaccin
trial
still
given
proven
product
south
research
design
studi
receiv
multipl
intens
ethic
moment
director
tutu
investig
vaccin
peopl
region
trial
like
receiv
would
otherwis
becom
elig
author
vaccin
trial
drop
work
close
compani
design
vaccin
warp
speed
gave
firm
billion
relat
r
efficaci
pfizer
receiv
govern
support
develop
test
vaccin
request
us
govern
drug
compani
help
answer
critic
question
gray
weird
howev
move
new
formul
believ
scienc
public
health
better
investig
safeti
efficaci
multival
vaccin
sequenc
activ
potenti
conduct
studi
gray
studi
say
compani
express
concern
liabil
vaccin
side
effect
case
new
trial
remain
strong
add
south
trial
pfizer
vaccin
work
well
beta
variant
nine
peopl
placebo
group
symptomat
among
small
mean
find
far
conclus
bigger
studi
critic
scienc
polici
data
show
efficaci
region
hard
exclud
access
type
vaccin
medic
inappropri
trial
hope
deal
still
note
theori
us
govern
assum
liabil
provid
trial
vaccin
us
govern
offici
familiar
hitch
public
readi
emerg
prepared
act
vaccin
unit
act
provid
intern
indemn
would
requir
action
highest
govern
altern
south
govern
indemnifi
compani
gray
vaccin
trial
goe
forward
current
vaccin
work
beta
variant
gray
pfizer
still
move
forward
differ
well
origin
viru
lead
windfal
contin
rich
embrac
new
would
whole
lot
origin
vaccin
lie
around
nobodi
place
acquir
staff
writer
scienc
peopl
yet
still
nervou
pitch
allur
drool
tube
provid
mail
see
like
among
peopl
end
hospit
die
infect
promis
test
compani
last
week
unit
genet
data
someon
age
sex
medic
predict
risk
becom
extrem
ill
test
base
genet
link
sever
along
risk
compani
data
unit
kingdom
forerunn
similar
risk
academ
team
recent
detail
simpler
genet
test
help
determin
aggress
peopl
infect
sever
genet
tell
scienc
person
influenc
cours
remain
murki
deploy
risk
think
prematur
use
genet
test
predict
person
like
sever
understand
exactli
genet
mean
affect
diseas
genet
epidemiologist
univers
think
would
chang
treat
infect
person
base
unvaccin
peopl
would
adopt
behavior
compani
test
less
vulner
say
compani
test
pointless
time
peopl
unit
get
highli
effect
even
get
shot
chief
scientif
offic
compani
behind
test
genet
peopl
heed
public
test
use
immun
later
previous
cancer
risk
test
draw
comb
genet
help
explain
sick
got
influenc
person
resist
viru
exampl
suscept
deadli
immun
global
effort
host
genet
initi
found
tent
link
common
genet
base
singl
nucleotid
higher
risk
infect
person
develop
sever
doubl
risk
small
say
risk
seven
unearth
initi
form
basi
new
test
narrow
list
genet
turn
data
research
mostli
white
current
age
provid
medic
inform
known
compani
viru
end
mild
ill
combin
inform
risk
old
male
obes
result
substanti
improv
predict
power
age
sex
alon
compani
preprint
post
march
wherea
averag
risk
sever
diseas
coronaviru
person
older
low
peopl
age
compani
model
genet
first
author
dite
risk
realli
realli
high
much
mean
unvaccin
person
infect
almost
develop
sever
genet
us
partner
offer
test
understand
among
us
greater
risk
sever
diseas
thought
safeti
person
will
take
compani
even
roll
corpor
would
find
valuabl
tool
among
yet
come
back
workplac
test
regulatori
gray
zone
howev
two
seek
us
food
drug
administr
approv
valid
test
product
review
custom
feder
consult
physician
sometim
author
genet
risk
sever
person
compani
respond
request
comment
sever
compani
preprint
told
scienc
test
need
divers
one
detail
wonder
whether
reliabl
peopl
infect
new
good
start
suffici
say
test
would
take
wife
take
cancer
geneticist
us
nation
cancer
institut
work
similar
difficult
find
larg
data
clinic
inform
compani
decid
go
ahead
know
valid
possibl
import
rapid
respons
ongo
pandem
test
whether
someon
ancestri
data
suggest
risk
sever
dite
relev
us
host
genet
initi
singl
chromosom
predict
risk
sever
diseas
infect
peopl
age
seek
medic
care
one
copi
person
risk
report
preprint
post
march
declin
discuss
studi
journal
studi
gener
hospit
polygen
risk
tri
assess
person
common
yet
mean
chromosom
test
quickli
find
medic
use
almost
emerg
room
staff
give
rapid
genet
test
guid
treatment
think
like
practic
still
mani
look
genet
risk
believ
worth
way
test
go
use
still
much
open
question
staff
writer
scienc
magazin
citi
serrana
line
vaccin
small
commut
town
surround
southeastern
brazil
one
hit
shown
even
vaccin
low
efficaci
clinic
dramat
control
pandem
part
unusu
experi
track
effect
vaccin
made
compani
almost
adult
serrana
state
receiv
two
long
would
otherwis
becom
elig
vaccin
dramat
symptomat
sinc
start
mass
vaccin
relat
fell
plummet
research
team
charg
experi
press
confer
risen
control
nearbi
serrana
oasi
epidemiologist
institut
research
center
vaccin
brazil
shown
us
sure
possibl
control
epidem
vaccin
greater
effect
seriou
diseas
bring
low
concern
copi
stimul
immun
clinic
sever
came
differ
efficaci
vaccin
threshold
establish
world
health
organ
emerg
use
vaccin
later
brazil
tri
assess
vaccin
effect
similar
data
serrana
reassur
mani
brazil
vaccin
encourag
ethel
epidemiologist
feder
univers
part
studi
especi
reliev
vaccin
town
variant
brazil
preval
countri
common
variant
serrana
period
studi
lab
recent
delta
elud
protect
today
emerg
use
list
step
speed
vaccin
use
mani
brazil
world
second
outbreak
offici
unit
ahead
brazil
vaccin
campaign
slow
get
ground
scarc
vaccin
still
elderli
popul
least
one
vaccin
mass
vaccin
experi
serrana
project
town
secret
initi
kept
quiet
avoid
massiv
migrat
town
one
serrana
infect
previous
expos
viru
high
made
town
attract
test
site
along
modest
popul
peopl
proxim
campu
univers
team
local
health
first
detail
censu
divid
serrana
peopl
interact
exampl
live
group
shop
four
vaccin
group
week
apart
second
first
older
suffer
chronic
pregnant
elig
total
receiv
two
town
never
close
isol
neighbor
say
see
reduct
transmiss
almost
immedi
first
group
got
second
dose
time
third
group
receiv
second
dose
elig
popul
outbreak
effect
suggest
vaccin
campaign
combin
popul
previou
gotten
town
herd
immun
point
coronaviru
difficulti
find
new
peopl
infect
mani
alreadi
immun
day
last
vaccin
two
among
peopl
amaz
plummet
among
none
receiv
sever
side
effect
team
soon
journal
public
post
preprint
virologist
school
medicin
mount
experi
interest
outcom
sens
data
studi
necessari
draw
presid
immunolog
societi
good
news
analysi
short
research
team
track
serrana
year
see
whether
immun
quickli
end
pandem
hard
brazil
would
probabl
need
start
give
booster
even
fulli
entir
popul
vaccin
efficaci
period
short
keep
current
pace
vaccin
herd
immun
never
popul
larg
group
immun
associ
advanc
scienc
reserv
partner
agora
choru
research
dose
pfizerbiontech
vaccin
vaccin
made
pfizer
put
young
men
elev
risk
heart
muscl
inflamm
myocard
say
report
today
ministri
health
conclud
one
one
men
receiv
vaccin
rare
condit
mild
resolv
within
typic
myocard
imagin
go
anyth
would
caus
medic
peopl
say
vaccin
pediatrician
health
first
issu
mostli
young
men
receiv
second
dose
vaccin
day
around
time
us
depart
defens
track
us
diseas
control
prevent
myocard
agenc
receiv
myocard
follow
pfizerbiontech
vaccin
one
rel
peopl
age
panel
come
mani
debat
whether
younger
older
sinc
ministri
health
announc
tomorrow
whether
older
unit
canada
older
parent
perspect
realli
come
risk
percept
assess
data
studi
even
link
myocard
vaccin
condit
usual
mild
treatment
wherea
infect
caus
seriou
diseas
side
effect
even
young
peopl
suspicion
possibl
connect
know
mani
almost
exclus
pfizerbiontech
vaccin
earli
fast
vaccin
drive
ministri
health
panel
led
head
intern
medicin
univers
medic
center
investig
issu
scienc
myocard
among
million
peopl
receiv
two
pfizerbiontech
vaccin
month
diagnosi
one
vaccin
number
concern
given
background
rate
myocard
gener
popul
typic
trigger
viral
bacteri
rate
myocard
follow
vaccin
among
young
men
higher
nineti
percent
pick
men
although
myocard
normal
common
among
young
men
rate
among
somewher
five
time
background
rate
report
two
fatal
myocard
panel
inconclus
one
patient
gener
inflammatori
syndrom
diagnosi
report
new
analysi
suggest
causal
natur
vaccin
myocard
convinc
relationship
suggest
least
statist
real
phenomenon
peter
cardiologist
chief
scientif
offic
univers
heart
institut
import
investig
even
hint
signal
report
suggest
valid
certain
link
play
back
sport
hospit
emerg
room
see
viral
seen
year
result
would
expect
see
littl
bump
myocard
versu
year
ago
ideal
compar
unvaccin
time
gear
follow
vaccin
use
unit
clear
two
reli
messeng
heighten
risk
one
possibl
high
antibodi
gener
young
peopl
rare
lead
sort
immun
heart
question
extrem
role
innat
immun
system
part
bodi
defens
think
actual
kind
natur
adjuv
immun
respons
medic
commun
alert
chest
pain
soon
quickli
health
awar
among
import
prompt
effect
treatment
import
question
whether
delay
second
vaccin
dose
reduc
potenti
risk
opportun
find
sever
interv
two
test
pfizer
even
want
give
mani
peopl
possibl
least
one
shot
drop
myocard
among
whose
second
dose
show
data
ahead
lower
dose
young
peopl
worth
consid
pfizer
test
lower
come
link
myocard
vaccin
even
young
peopl
gener
lower
risk
sever
diseas
differ
given
extrem
low
new
yesterday
ministri
health
leav
decis
whether
vaccin
younger
teen
moment
longer
emerg
updat
june
text
ad
stori
two
fatal
myocard
expert
panel
correspond
scienc
magazin
base
berlin
writer
read
research
secur
personnel
stood
guard
outsid
wuhan
institut
virolog
china
visit
world
health
organ
team
investig
viru
joe
today
grow
choru
call
yet
fuller
transpar
investig
whether
viru
behind
pandem
laboratori
wuhan
china
outlin
unit
would
take
tri
resolv
question
appar
even
china
allow
thorough
investig
scenario
world
health
organ
team
year
presid
move
came
sever
top
feder
senat
hear
morn
hypothesi
credibl
explan
emerg
although
less
like
scenario
viru
wild
written
statement
intellig
commun
redoubl
collect
analyz
inform
bring
us
closer
definit
conclus
report
back
day
part
report
inquiri
specif
china
effort
includ
work
nation
govern
augment
intellig
commun
pronounc
came
head
us
depart
health
human
annual
world
health
assembl
yesterday
push
forward
initi
investig
trip
china
phase
two
covid
studi
must
refer
transpar
give
intern
independ
fulli
assess
sourc
viru
earli
day
outbreak
notion
viru
wuhan
institut
virolog
coronaviru
research
gotten
attent
sinc
mission
china
uncov
inform
significantli
advanc
natur
hypothesi
anim
reservoir
new
viru
intermedi
host
peopl
often
immens
toll
ad
urgenc
search
spark
notabl
former
new
york
time
wade
promin
sever
previous
express
idea
endors
closer
scrutini
idea
part
appar
lack
seriou
attent
given
mission
team
report
devot
three
hypothesi
mission
qualifi
abl
conduct
thorough
investig
hypothesi
letter
scienc
month
mix
investig
write
accident
releas
lab
zoonot
remain
viabl
know
critic
global
mitig
risk
futur
statement
intellig
report
nation
secur
advis
compil
elect
report
sourc
wide
articl
wall
street
journal
last
week
reveal
three
wuhan
lab
coronaviru
research
receiv
hospit
care
unspecifi
ill
two
natur
origin
laboratori
statement
today
us
intellig
commun
around
two
like
definit
conclus
question
current
posit
two
toward
former
scenario
one
toward
latter
low
moder
confid
major
believ
suffici
inform
assess
one
like
part
today
senat
hear
budget
request
nation
health
agenc
director
collin
nation
institut
allergi
infecti
director
still
believ
like
scenario
natur
occurr
one
sure
sinc
lot
concern
lot
specul
sinc
one
absolut
believ
need
kind
investig
open
transpar
inform
avail
made
avail
scrutin
collin
much
desir
transpar
possibl
situat
realli
tri
find
agre
like
viru
aros
natur
exclud
possibl
kind
lab
accid
strongli
need
go
back
tri
first
phase
investig
realli
satisfi
nobodi
time
need
realli
collect
inform
mostli
realli
go
find
travi
news
editor
scienc
news
coverag
biolog
read
research
million
us
led
possibl
side
effect
govern
fox
news
host
tucker
monologu
cast
doubt
safeti
show
tucker
tonight
almost
peopl
get
ad
data
come
vaccin
advers
event
system
us
govern
program
side
effect
possibl
mislead
statement
death
noth
diseas
control
prevent
subsequ
found
indic
save
small
subset
extrem
rare
disord
link
one
vaccin
segment
earli
warn
system
wide
even
cultur
vaccin
broadcast
new
phalanx
plumb
data
scare
public
vaccin
presid
media
nonprofit
vaccin
activ
social
media
sinc
one
differ
way
tucker
hit
distress
watch
use
detect
real
vaccin
side
rare
disord
link
johnson
johnson
j
j
rule
thu
provid
safeti
reassur
public
believ
peopl
tri
form
antivaccin
argument
eric
ear
surgeon
turn
run
food
drug
administr
hear
anecdot
sudden
hear
loss
vaccin
analysi
data
hear
loss
frequent
possibl
less
frequent
among
vaccin
popul
whole
jama
otolaryngolog
last
week
data
probe
whether
rare
caus
heart
inflamm
yet
potenti
weak
era
anyon
vaccin
author
unit
report
advers
event
famili
open
plenti
alon
sinc
four
time
number
receiv
last
year
worri
make
easi
post
fals
data
clearli
fake
recent
report
presid
advers
event
beach
volleybal
deliber
fals
feder
crimin
offens
rare
evid
widespread
fraud
game
system
deputi
director
immun
safeti
offic
balanc
keep
open
system
get
much
inform
vaccin
safeti
potenti
data
qualiti
even
honest
use
spook
public
promin
disclaim
includ
incomplet
inaccur
coincident
unverifi
inform
peopl
misinterpret
easili
searchabl
actual
side
effect
rather
possibl
suspect
easi
pull
data
context
scare
lot
materi
director
vaccin
confid
project
school
hygien
tropic
fear
fox
news
host
mention
among
approxim
vaccin
time
broadcast
nearli
peopl
older
whose
mortal
substanti
higher
younger
peopl
review
avail
clinic
inform
death
autopsi
medic
establish
causal
link
counter
misinterpret
data
promin
impli
causal
event
coincid
number
vaccin
million
vaccin
given
agenc
continu
track
vaccin
misinform
worri
imprimatur
mislead
sheen
credibl
moment
need
persuad
peopl
someth
incred
compel
advers
tucker
segment
catalyst
analysi
fals
kill
episod
particular
traction
social
media
translat
day
later
fals
caus
infertil
attent
although
neither
data
newscast
address
system
critic
keep
histori
work
say
data
crucial
abil
quickli
detect
guid
public
rare
allerg
pfizerbiontech
even
problem
j
j
jab
physician
team
within
immun
safeti
offic
keep
system
open
anyon
report
suspect
side
effect
consult
data
essenti
public
health
commun
need
make
seriou
invest
right
aggress
counter
misus
data
exampl
quickli
possibl
new
gain
traction
languag
rather
arcan
medic
least
make
sure
get
right
inform
soon
possibl
watch
peopl
misinterpret
data
clearli
kai
world
health
organ
blunt
warn
world
brink
catastroph
moral
failur
wealthi
avail
leav
tini
replay
influenza
pandem
price
failur
world
right
today
rich
young
old
extrem
low
risk
sever
even
enough
health
care
nearli
vaccin
date
gone
peopl
upper
gross
domest
product
per
scandal
inequ
open
speech
world
health
assembl
least
popul
everi
countri
global
health
noth
new
lifesav
unavail
larg
world
even
cost
make
reach
million
peopl
need
crisi
expos
distinct
acut
way
normal
vaccin
unit
kingdom
unit
health
system
buckl
soar
case
world
still
record
almost
million
everi
moral
argument
asid
practic
reason
tri
distribut
equit
part
world
feel
safe
pandem
elsewher
pose
risk
reintroduct
spawn
potenti
danger
viral
get
better
global
access
facil
nonprofit
bulk
discount
world
although
major
troubl
part
main
supplier
base
reason
hope
mani
rich
soon
big
superflu
billion
one
donat
capac
increas
rapidli
suggest
enough
vaccin
avail
year
give
everi
person
world
least
one
dose
although
get
everi
countri
everi
arm
would
still
major
challeng
longer
term
afoot
build
vaccin
product
world
pump
pandem
futur
look
offer
form
avoid
exactli
scenario
jointli
run
coalit
epidem
prepared
vaccin
allianc
organ
bring
togeth
invest
sever
vaccin
would
distribut
equit
among
philanthrop
would
foot
bill
first
work
almost
everi
countri
world
deliv
first
vaccin
money
compet
rich
corner
market
earli
strike
purchas
anyon
would
make
us
director
real
frustrat
anoth
major
blow
came
march
home
led
serum
institut
bank
main
halt
vaccin
made
collabor
univers
resum
end
year
bit
crisi
seth
million
short
end
june
tri
fill
hole
receiv
million
vaccin
resum
short
billion
end
year
thought
would
prevent
happen
chief
scientist
rapidli
receiv
far
rich
help
unclear
work
mani
made
major
multipl
unit
union
advanc
enough
vaccin
three
time
exampl
although
unit
alreadi
surplu
enough
vaccin
donat
billion
anoth
billion
report
earli
independ
panel
pandem
prepared
respons
mark
former
head
us
govern
presid
emerg
plan
relief
member
urgent
need
realli
press
acceler
get
excess
surplu
rapidli
possibl
rich
concern
viral
new
hesit
give
still
need
lot
moment
make
peopl
nervou
alreadi
begun
new
given
vaccin
elig
receiv
back
facil
readi
donat
stock
whose
use
recent
restrict
older
age
caus
rare
seriou
disord
biggest
pledg
far
come
administr
donat
million
end
june
million
hope
add
arsen
heavili
vaccin
cheap
unlik
messeng
transport
regular
still
pfizer
partner
agre
sell
million
vaccin
year
deal
sell
million
shot
year
million
give
discount
reveal
world
health
assembl
made
bold
call
offer
new
product
market
commit
date
combin
distribut
billion
requir
two
much
vaccin
way
mani
author
continu
build
new
contract
iron
product
hope
produc
billion
year
end
plan
offer
directli
low
ramp
billion
three
billion
come
conglomer
organ
serum
sever
three
say
collect
pump
billion
year
johnson
johnson
add
anoth
billion
vaccin
million
sputnik
v
vaccin
come
research
institut
epidemiolog
microbiolog
contract
clover
efficaci
market
told
billion
leav
year
accord
document
written
advanc
march
summit
step
product
pace
startl
pandem
world
togeth
produc
billion
document
best
set
make
unlik
meet
aspir
organ
dispos
line
media
biggest
challeng
raw
materi
nowher
near
kept
demand
travel
made
difficult
move
around
world
almost
everi
vaccin
produc
deliv
initi
viral
evad
immun
limit
use
safeti
shot
fell
favor
south
variant
union
phase
vaccin
rare
disord
china
far
lower
efficaci
requir
third
short
sever
drop
work
well
easi
modifi
new
larg
world
come
seen
injustic
viral
immunologist
cancer
research
center
go
human
util
follow
vaccin
sometim
fierc
boost
output
provid
licens
vaccin
serum
compani
learn
manufactur
intens
process
known
technolog
transfer
vaccin
shi
away
chang
technolog
access
pool
system
proven
would
voluntarili
share
intellectu
properti
hope
new
pluck
whatev
either
reason
fee
free
start
make
yet
attract
say
want
hold
see
threat
drastic
take
away
cornerston
south
world
trade
organ
issu
waiver
intellectu
pertain
prevent
contain
treatment
idea
made
littl
headway
although
us
trade
repres
tai
statement
explicitli
support
waiver
global
health
crisi
extraordinari
pandem
call
extraordinari
tai
shipment
vaccin
slow
pharmaceut
industri
decri
statement
give
away
would
remov
incent
innov
inexperienc
new
vaccin
would
drain
limit
suppli
raw
pfizer
recent
letter
safeti
secur
risk
wrong
question
new
would
abl
produc
year
next
critic
time
pandem
although
enforc
pandem
make
vaccin
still
patent
critic
one
univers
import
vaccin
research
patent
useless
new
would
still
need
set
train
staff
learn
produc
patent
recip
make
chef
got
lot
kitchen
want
come
hous
cook
tri
creat
train
center
low
learn
set
industri
process
go
back
facil
instead
spend
set
run
matter
love
nongovernment
organ
knowledg
ecolog
intern
would
process
mani
illeg
year
half
even
work
love
go
invest
someth
illeg
say
threat
patent
act
cudgel
compel
big
pharmaceut
share
wrote
report
fail
negoti
voluntari
technolog
within
work
past
lifesav
long
expens
peopl
threat
would
led
big
share
knowledg
gener
plummet
reaction
today
drug
back
let
us
produc
know
complic
done
difficult
produc
pfizer
play
ball
us
help
set
train
facil
solicit
help
patent
yet
regulatori
allow
produc
long
term
addit
serv
need
pandem
futur
well
wane
immun
viru
creat
annual
need
sever
billion
vaccin
new
diseas
world
find
need
new
inequit
way
roll
system
power
without
access
campaign
southeast
bulk
vaccin
far
made
unit
china
felt
vaccin
peopl
first
done
give
argument
much
face
subtext
whole
convers
head
trust
global
enterpris
produc
small
costa
provid
vaccin
domest
quickli
world
get
togeth
make
pay
new
presid
union
confer
countri
alreadi
construct
plant
sever
one
blueprint
vaccin
world
small
modular
build
ship
anywher
singl
product
room
roughli
size
four
ship
make
raw
crank
million
per
month
million
compani
provid
plant
clean
room
hous
compani
one
run
littl
year
agreement
leapfrog
abil
fight
intern
vaccin
initi
idea
mani
larg
scale
reliabl
suppli
raw
stringent
qualiti
control
regular
amaz
place
public
health
commit
innov
snap
sudden
highli
capabl
peopl
know
everi
detail
process
ensur
oper
unclear
vaccin
staff
would
year
half
pandem
bright
light
huge
complic
challeng
taken
unpreced
want
vaccin
everyon
planet
never
done
say
accomplish
unpreced
histori
human
race
actual
think
tragedi
covid
impos
realli
long
long
time
staff
writer
correspond
scienc
magazin
base
berlin
author
book
color
blue
martin
wrestl
dilemma
past
stay
vaccin
trial
enrol
much
hope
drop
take
alreadi
proven
vaccin
protect
sooner
question
trial
face
past
hear
much
knew
face
dilemma
sinc
day
drove
behemoth
academ
center
southeastern
part
enrol
herald
studi
larg
efficaci
trial
candid
vaccin
produc
compani
sat
small
basement
room
infecti
physician
provid
basic
inform
studi
gave
consent
form
sign
carri
physic
came
import
moment
go
randomli
assign
receiv
either
experiment
vaccin
placebo
research
button
comput
read
messag
screen
thank
subject
success
half
hour
later
nurs
gave
inject
neither
us
knew
tini
fatti
save
get
sick
wheel
fortun
gambl
chanc
candid
vaccin
time
case
high
transmiss
variant
first
unit
kingdom
take
mani
elig
proven
vaccin
scarc
chanc
protect
asid
happi
play
tini
part
one
great
scientif
luck
help
anoth
vaccin
cross
finish
promis
enough
shown
work
phase
studi
found
mostli
moder
side
effect
dose
trigger
good
immun
respons
human
although
latecom
immun
race
vaccin
potenti
advantag
two
messeng
pfizerbiontech
collabor
requir
extrem
low
remain
stabl
contrast
kept
temperatur
ordinari
refriger
least
day
room
temperatur
huge
advantag
especi
pfizer
work
less
fragil
well
set
play
big
role
well
win
author
agenc
quickli
commiss
order
million
option
anoth
million
help
meet
demand
compani
first
trial
would
show
work
herald
ultim
enrol
peopl
four
six
research
subject
unev
side
effect
first
shot
second
one
later
particip
trial
lead
take
phenomenon
vaccin
time
even
use
test
vaccin
abil
prevent
infect
given
low
exposur
risk
work
home
cautiou
social
go
back
hospit
test
mild
test
came
back
written
inform
receiv
studi
discuss
particip
becom
elig
proven
vaccin
initi
choic
vaccin
slowli
studi
would
like
report
first
data
within
studi
team
told
elig
author
vaccin
final
analysi
studi
confirm
accord
clinic
trial
protocol
first
interim
analysi
take
long
efficaci
calcul
number
symptomat
diseas
vaccin
placebo
trial
clear
conclus
would
shown
work
would
essenti
two
receiv
placebo
would
vaccin
safe
receiv
safe
along
need
anyth
still
post
compani
first
data
interim
analysi
first
quarter
year
deadlin
came
went
pace
vaccin
countri
pick
peopl
older
municip
health
work
way
birth
went
increasingli
like
year
would
come
announc
would
open
differ
set
turn
receiv
altruist
stay
trial
complet
knock
wood
vaccin
work
well
err
side
safeti
drop
get
whatev
govern
turn
placebo
two
would
still
would
complet
unprotect
trial
would
give
vaccin
case
valu
yet
shown
two
vaccin
advic
virologist
school
medicin
mount
subject
pfizer
efficaci
trial
whether
analysi
trial
data
pfizer
vaccin
highli
effect
blind
cours
data
point
lot
back
besid
turn
placebo
pfizer
would
offer
shot
would
remain
data
point
part
trial
arm
chose
learn
placebo
receiv
vaccin
still
situat
differ
efficaci
data
yet
would
nobl
think
trial
alreadi
help
thing
nobodi
expect
stay
avail
protect
get
sever
diseas
die
point
drop
would
void
particip
altogeth
past
alreadi
part
data
ad
stay
placebo
group
get
infect
infect
somebodi
els
person
virologist
medic
colleg
face
slightli
differ
dilemma
efficaci
studi
unit
vaccin
produc
late
decid
stay
studi
even
elig
proven
vaccin
hospit
point
data
studi
unit
kingdom
late
shot
efficaci
compani
would
switch
crossov
design
mean
would
two
first
receiv
placebo
would
receiv
vaccin
vice
everybodi
would
remain
blind
advantag
know
compani
way
keep
peopl
trial
exampl
better
durat
immun
correl
accept
offer
cross
receiv
two
last
one
confid
unvaccin
longer
would
think
delay
would
cost
much
cours
dynam
would
differ
whether
move
crossov
design
fact
much
face
make
decis
base
leav
trial
prison
age
group
elig
vaccin
went
right
away
lock
first
second
yet
make
decis
figur
alway
cancel
appoint
trial
team
day
later
physic
exam
day
enrol
visit
fourth
told
research
turn
come
briefli
ran
possibl
unblind
swivel
comput
screen
direct
see
suddenli
placebo
think
much
longer
look
forward
safe
want
life
someth
summer
come
even
two
take
earli
fulli
drop
trial
physician
understood
would
one
makeshift
vaccin
insid
massiv
empti
confer
center
receiv
first
pfizerbiontech
shot
wheel
fortun
given
hope
still
felt
scienc
intern
news
editor
base
pneumonia
sever
ago
evid
novel
coronaviru
similar
one
found
dog
research
team
today
seven
previous
known
infect
peopl
latest
spark
pandem
discoveri
like
new
human
pathogen
along
report
instanc
coronaviru
peopl
mani
ago
significantli
expand
viral
famili
pose
anoth
global
threat
think
look
find
cross
speci
everywher
virologist
univers
involv
new
definit
link
either
new
viru
human
diseas
evid
two
new
transmit
infect
jump
person
nonhuman
host
mani
worri
evolv
abil
within
person
normal
infect
complet
genom
sequenc
viru
found
one
patient
today
clinic
infecti
chimera
four
two
previous
canin
one
known
infect
pig
first
report
suggest
coronaviru
replic
peopl
need
confirm
abil
grown
viru
dog
tumor
yet
human
known
human
clear
evid
particular
coronaviru
strain
better
spike
structur
veterinari
virologist
state
univers
lead
author
studi
human
dog
occur
much
higher
frequenc
previous
thought
particular
viru
transmit
peopl
know
sure
eight
whose
tissu
studi
mainli
live
tradit
rural
suburban
like
frequent
exposur
domest
jungl
wildlif
among
pneumonia
screen
nasopharyng
upper
part
larg
varieti
human
nonhuman
hospit
diagnost
pneumonia
respiratori
ill
would
dog
cat
one
look
recent
canin
felin
everywher
world
entir
novel
viru
sequenc
canin
coronaviru
howev
sequenc
spike
protein
host
cell
initi
infect
close
relat
spike
sequenc
canin
coronaviru
type
one
porcin
coronaviru
known
transmiss
gastroenter
viru
one
part
spike
protein
similar
spike
felin
coronaviru
chimera
unlik
arisen
instead
involv
repeat
genet
differ
time
mosaic
sever
differ
happen
nobodi
watch
boom
get
monstros
virologist
benjamin
univers
colleg
anim
actual
novel
viru
peopl
cat
pig
dog
wild
veterinari
virologist
univers
bari
screen
fecal
acut
gastroenter
see
whether
find
someth
alreadi
knew
three
canin
coronaviru
mix
readili
felin
porcin
surpris
anim
actual
caus
diseas
person
one
would
expect
lack
import
well
eight
whose
viru
younger
old
four
mostli
indigen
ethnic
day
divid
four
beta
gamma
new
one
alpha
third
alpha
coronaviru
infect
peopl
two
caus
common
peopl
expos
earli
life
pattern
explain
perhap
new
one
ralph
baric
virologist
univers
north
chapel
hill
immun
newli
discov
alpha
coronaviru
repeat
exposur
far
danger
human
seen
trigger
outbreak
seriou
diseas
feel
much
comfort
wild
world
march
univers
preprint
first
evid
porcin
delta
coronaviru
peopl
serum
three
transfer
serum
monkey
abl
grow
genet
known
porcin
work
journal
delta
thought
infect
delta
coronaviru
infect
swine
hong
went
isol
viru
swine
cell
viru
major
fatal
diarrheal
diseas
outbreak
babi
unit
sinc
shown
infect
cell
lab
shown
viru
persist
infect
diarrheal
diseas
put
poultri
left
viru
avian
mammalian
speci
baric
know
hong
delta
pandem
threat
viru
consider
want
test
local
abil
infect
peopl
confirm
pandem
threat
two
point
import
anim
public
health
need
coronaviru
research
clearli
desper
evalu
critic
regard
frequenc
coronaviru
transmiss
potenti
spread
baric
gray
duke
univers
senior
author
chimer
coronaviru
studi
surveil
among
pneumonia
known
hot
novel
larg
mix
live
anim
larg
take
gray
go
differ
infect
far
chimer
viru
transmit
effici
peopl
divis
infecti
depart
pediatr
depart
epidemiolog
public
health
yale
univers
school
medicin
new
pediatr
infecti
hospit
medic
school
boston
first
respons
substanti
proport
upper
respiratori
tract
sinc
least
new
human
sever
acut
respiratori
syndrom
coronaviru
signific
morbid
mortal
group
newli
group
new
coronaviru
associ
upper
lower
respiratori
tract
diseas
like
common
human
global
distribut
newli
group
coronaviru
yet
establish
advanc
significantli
past
epidem
put
anim
spotlight
background
histori
rel
import
expand
research
area
histori
human
found
passag
viru
found
human
embryon
tracheal
organ
respiratori
tract
adult
common
cold
presenc
infecti
agent
medium
human
produc
signific
proport
unabl
grow
agent
tissu
cultur
time
time
abl
grow
viru
unusu
tissu
cultur
medic
viru
therefor
presum
coat
infect
relat
known
myxo
work
laboratori
nation
health
recoveri
multipl
human
respiratori
tract
techniqu
similar
design
grown
organ
time
frame
electron
microscopi
organ
infect
found
infecti
bronchiti
viru
medium
size
pleomorph
cover
wide
space
surfac
agent
previou
similar
morpholog
fig
late
lead
group
work
human
number
anim
includ
infecti
bronchiti
viru
mous
hepat
viru
transmiss
gastroenter
viru
swine
morpholog
seen
electron
new
group
coronaviru
corona
appear
surfac
later
offici
accept
new
genu
research
serolog
consider
amount
inform
regard
epidemiolog
human
respiratori
found
temper
respiratori
coronaviru
occur
often
winter
spring
summer
fall
data
reveal
coronaviru
contribut
much
total
respiratori
viral
activ
overal
proport
adult
produc
discoveri
human
studi
exclus
larg
easiest
work
growth
suckl
mous
brain
subsequ
tissu
cultur
found
close
relat
mous
hepat
viru
strain
grown
tissu
cultur
directli
clinic
period
larg
strain
epidem
throughout
unit
wherea
strain
predispos
mani
respiratori
reinfect
infect
occur
age
common
extens
focu
exclus
clear
coronaviru
well
shown
coronaviru
strain
serolog
ident
either
variou
strain
famili
found
previous
distantli
relat
volunt
inocul
found
respiratori
associ
varieti
respiratori
howev
pathogen
consid
predomin
ill
associ
upper
respiratori
infect
occasion
pneumonia
young
shown
abl
produc
asthma
well
chronic
bronchiti
research
proceed
explor
pathogen
epidemiolog
human
number
import
anim
grow
rapidli
diseas
multipl
anim
speci
mice
calv
dog
anim
includ
limit
research
respiratori
studi
focu
includ
gastroenter
hepat
enceph
mice
pneumon
infecti
periton
interest
peak
particularli
regard
enceph
produc
mous
hepat
viru
periton
produc
infecti
periton
viru
pathogenesi
diseas
variou
complex
genu
whole
capabl
wide
varieti
diseas
human
anim
broad
base
antigen
genet
group
viru
group
viru
group
made
avian
infecti
bronchiti
viru
number
relat
avian
enorm
varieti
anim
surpris
caus
new
sever
acut
respiratori
syndrom
coronaviru
southern
china
spread
throughout
world
quantifi
viru
grew
fairli
easili
tissu
cultur
quick
genom
suffici
known
human
anim
place
viru
new
group
along
viru
subsequ
cultur
palm
presum
outbreak
infect
north
south
overal
infect
still
unclear
viru
human
popul
whether
palm
natur
reservoir
viru
sequenc
analysi
viru
isol
palm
reveal
viru
sequenc
found
human
particular
involv
spread
anim
nucleotid
sequenc
integr
open
read
frame
orf
wherea
human
absenc
motif
function
anim
human
unknown
unclear
whether
delet
sequenc
role
jump
capac
epidem
strain
spread
virul
viru
curious
data
among
food
market
epidem
like
wild
anim
slaughter
seroposit
although
none
histori
suggest
expos
occup
viru
frequent
asymptomat
infect
infect
control
halt
epidem
last
seri
date
epidem
gave
world
enorm
infus
energi
activ
larg
amount
alreadi
known
virolog
pathogenesi
coronaviru
expand
area
veterinari
characterist
appear
electron
neg
fig
acid
long
posit
sens
singl
known
viral
larg
form
follow
surfac
protein
present
sever
group
larg
surfac
glycoprotein
protein
surfac
small
envelop
protein
e
protein
membran
glycoprotein
protein
protein
n
protein
complex
sever
clear
strategi
replic
set
messeng
common
uniqu
portion
common
natur
addit
capabl
genet
recombin
infect
cell
develop
cytoplasm
infect
fig
bud
cytoplasm
endoplasm
reticulum
either
cell
within
time
frame
cell
group
use
human
n
cellular
mous
hepat
viru
group
coronaviru
member
antigen
famili
receptor
known
sever
cell
surfac
acid
coronaviru
enzym
cellular
new
human
discov
tabl
three
group
close
relat
like
repres
viral
speci
van
discoveri
new
human
coronaviru
isol
girl
coryza
conjunct
fever
bronchiol
novel
genom
amplif
techniqu
abl
sequenc
entir
viral
genom
phylogenet
analysi
viru
group
coronaviru
relat
transmiss
gastroenter
viru
viru
screen
respiratori
collect
turn
addit
test
posit
upper
lower
respiratori
tract
diseas
identif
coronaviru
isol
boy
pneumonia
grown
clinic
specimen
genom
amplif
base
arbitrarili
revers
chain
reaction
use
identifi
viral
full
genom
sequenc
analysi
viru
group
coronaviru
close
relat
four
respiratori
collect
test
posit
respiratori
tract
diseas
whose
rang
discoveri
propag
cell
use
molecular
target
coronaviru
genom
later
found
evid
human
respiratori
coronaviru
respiratori
younger
age
new
coronaviru
approach
base
theori
gene
viral
genet
encod
indispens
essenti
target
viru
identif
discoveri
approach
requir
propag
viru
cell
cultur
organ
experiment
directli
respiratori
initi
identif
novel
specif
use
screen
respiratori
collect
younger
age
whose
respiratori
specimen
test
neg
respiratori
syncyti
viru
influenza
test
posit
major
winter
spring
sequenc
phylogenet
analysi
base
gene
close
relat
although
full
genom
sequenc
cough
rhinorrhea
tachypnea
present
infect
eleven
intens
care
unit
time
sampl
sinc
birth
suggest
either
nosocomi
infect
less
like
caus
vertic
child
test
posit
carri
diagnosi
diseas
vascul
earli
childhood
subsequ
studi
diseas
test
posit
age
test
posit
p
presenc
peptid
correspond
spike
glycoprotein
close
relat
viru
tissu
diseas
summat
play
role
pathogenesi
diseas
research
necessari
determin
whether
caus
man
recent
return
china
previous
area
hong
fever
product
cough
although
screen
neg
novel
group
coronaviru
sequenc
respiratori
specimen
use
target
viral
novel
viru
genet
distinct
known
human
group
coronaviru
viru
cell
cultur
base
human
infect
howev
unclear
whether
western
blot
use
detect
antibodi
antibodi
human
field
advanc
significantli
recent
epidem
dramat
remind
anim
potenti
human
popul
although
exact
mechan
spread
coronaviru
remain
obscur
mani
viru
relat
like
caus
substanti
proport
respiratori
tract
diseas
impact
yet
known
clear
caus
respiratori
diseas
heterogen
quit
wide
distribut
among
repres
similar
origin
addit
human
coronaviru
like
discov
need
investig
virolog
etiolog
infecti
actual
clinic
impact
infecti
diseas
preval
sever
child
adult
popul
common
gener
relat
upper
respiratori
tract
famili
trigger
asthma
sever
respiratori
diseas
elderli
curv
respiratori
infect
probabl
caus
pneumonia
bronchiol
infant
child
popul
clinic
impact
yet
fulli
determin
much
still
remain
discov
despit
recent
research
overwhelmingli
adult
popul
probabl
lot
human
popul
spread
present
much
problem
interestingli
enough
seem
much
threat
infect
less
sever
less
infecti
evid
look
trend
secondari
mark
contrast
sever
respiratori
viral
data
consider
interest
discuss
good
explan
surfac
theori
fact
almost
respiratori
viral
occur
background
partial
immun
theoret
took
viru
first
time
human
popul
infect
immun
develop
sever
diseas
howev
research
verifi
seen
strain
coronaviru
human
respiratori
coronaviru
sever
acut
respiratori
syndrom
new
coronaviru
open
safe
new
viru
sever
acut
respiratori
syndrom
coronaviru
caus
diseas
outbreak
china
diseas
coronaviru
diseas
march
world
health
organ
declar
pandem
public
health
us
diseas
control
prevent
pandem
post
spread
shown
viru
coronaviru
diseas
mainli
person
person
among
close
contact
within
viru
respiratori
someon
infect
viru
land
mouth
nose
person
viru
spread
person
expos
small
stay
air
sever
transmiss
yet
known
common
viru
spread
spread
person
surfac
viru
mouth
nose
main
way
mild
sever
peopl
common
fever
cough
includ
short
breath
muscl
sore
throat
headach
chest
pain
loss
tast
smell
list
inclus
less
common
appear
two
day
us
food
drug
administr
given
emerg
use
author
us
vaccin
prevent
get
prevent
becom
serious
ill
get
gotten
vaccin
mani
take
prevent
get
viru
spread
recommend
follow
chronic
medic
condit
higher
risk
seriou
ill
check
doctor
way
protect
recommend
peopl
wear
cloth
face
public
social
difficult
peopl
continu
wear
face
indoor
public
outdoor
high
risk
transmiss
crowd
event
larg
gather
advic
base
evid
peopl
transmit
viru
realiz
public
help
reduc
spread
peopl
nonmed
cloth
public
surgic
use
avail
surgic
short
suppli
reserv
health
care
fulli
wear
mask
except
role
law
consid
fulli
get
second
dose
vaccin
get
singl
dose
johnson
us
everyon
need
wear
mask
public
travel
first
check
travel
use
appropri
public
want
talk
doctor
health
make
suscept
respiratori
develop
expos
viru
contact
doctor
medic
advic
need
go
doctor
hospit
call
ahead
health
care
take
ensur
follow
avoid
spread
viru
featur
take
right
keep
healthi
fulli
viru
coronaviru
diseas
mainli
person
person
respiratori
someon
viru
less
commonli
transmiss
occur
small
viru
linger
air
potenti
area
even
infect
person
far
away
left
space
viru
spread
infect
peopl
touch
less
common
transmiss
yet
known
far
risk
get
viru
common
food
evid
anyon
viru
touch
food
food
mani
offer
deliveri
lessen
risk
concern
reason
follow
gener
food
safeti
wash
least
soap
water
handl
transfer
food
clean
dish
clean
wash
eat
clean
disinfect
store
produc
possibl
coronaviru
linger
handl
person
viru
whether
make
sick
practic
follow
food
safeti
wash
thoroughli
eat
run
water
soap
scrub
produc
rind
thick
skin
clean
produc
brush
wash
well
soap
water
soon
get
home
groceri
disinfect
carri
store
cloth
go
washer
disinfect
wipe
unvaccin
wear
mask
groceri
shop
difficult
maintain
social
distanc
certain
wear
mask
contact
peopl
especi
peopl
live
household
get
close
vaccin
keep
rule
social
distanc
mind
tri
stay
away
viru
spread
person
closer
someon
viru
put
risk
within
circl
dog
infect
viru
close
contact
peopl
viru
often
viru
mainli
person
person
consid
signific
way
coronaviru
area
ongo
peopl
keep
least
away
peopl
outsid
household
home
hot
water
evid
viru
swim
hot
water
good
idea
keep
physic
distanc
peopl
live
least
public
pool
water
park
unvaccin
set
face
mask
asid
water
wet
mask
breath
difficult
wear
face
mask
water
help
minim
potenti
viru
spread
stay
home
feel
urin
bodi
respiratori
main
sourc
spread
viru
viru
stool
peopl
sick
know
yet
risk
transmiss
stool
viru
potenti
spread
untreat
sewag
unknown
whether
viru
spread
bodi
urin
vomit
breast
milk
semen
follow
social
local
public
health
wear
face
mask
go
help
lower
risk
infect
unvaccin
get
vaccin
prevent
get
viru
becom
serious
ill
get
viru
fulli
return
mani
abl
pandem
wear
mask
social
except
rule
enough
data
recommend
use
vitamin
prevent
infect
viru
treat
accord
nation
health
world
health
recent
impact
vitamin
one
studi
peopl
found
vitamin
defici
like
test
posit
viru
peopl
normal
vitamin
research
high
vitamin
defici
peopl
experienc
acut
respiratori
failur
peopl
significantli
higher
risk
die
small
studi
found
peopl
given
high
dose
type
vitamin
one
treatment
intens
care
unit
contrast
among
peopl
given
intens
care
addit
vitamin
defici
common
unit
particularli
among
black
peopl
disproportion
affect
vitamin
defici
common
peopl
older
peopl
bodi
mass
index
higher
obes
peopl
high
blood
pressur
hypertens
increas
risk
sever
recent
two
clinic
studi
effect
vitamin
supplement
less
hope
high
vitamin
given
peopl
vitamin
serious
ill
vitamin
reduc
length
hospit
stay
mortal
given
research
determin
role
vitamin
vitamin
defici
play
prevent
treatment
vitamin
defici
talk
doctor
whether
supplement
right
concern
vitamin
level
ask
doctor
get
f
use
site
agreement
privaci
polici
link
featur
plasma
therapi
blood
peopl
ill
help
us
food
drug
administr
given
emerg
author
convalesc
plasma
therapi
high
antibodi
treat
use
peopl
ill
either
earli
ill
immun
donat
peopl
viru
donat
blood
remov
blood
leav
behind
liquid
plasma
given
peopl
boost
abil
fight
plasma
therapi
given
peopl
hospit
earli
ill
immun
plasma
therapi
help
peopl
recov
lessen
sever
shorten
length
use
treat
mani
usual
safe
risk
get
convalesc
plasma
test
yet
believ
risk
low
fulli
plasma
therapi
risk
low
donat
blood
must
test
safeti
peopl
mild
none
peopl
sever
doctor
consid
convalesc
plasma
therapi
hospit
earli
ill
immun
system
convalesc
plasma
therapi
ask
doctor
order
convalesc
plasma
compat
blood
type
hospit
local
blood
convalesc
plasma
therapi
health
care
team
procedur
health
care
team
member
steril
needl
connect
tube
intraven
line
vein
one
plasma
steril
plasma
bag
attach
tube
plasma
bag
tube
complet
close
receiv
convalesc
plasma
doctor
record
respons
treatment
record
long
need
stay
hospit
need
yet
known
convalesc
plasma
therapi
effect
treatment
experi
benefit
howev
therapi
help
recov
sever
clinic
nation
access
program
suggest
convalesc
plasma
high
antibodi
lessen
sever
shorten
durat
peopl
given
earli
diseas
immun
howev
research
determin
convalesc
plasma
therapi
effect
treatment
take
protect
find
safe
visit
go
gym
visit
public
commun
import
understand
take
protect
coronaviru
diseas
need
best
way
protect
viru
get
vaccin
consid
fulli
get
second
dose
vaccin
get
singl
dose
johnson
vaccin
fulli
return
abl
pandem
stop
wear
mask
social
set
except
rule
law
howev
still
wear
mask
public
transport
travel
within
us
well
train
vaccin
continu
close
contact
within
wear
face
mask
indoor
public
outdoor
high
risk
transmiss
crowd
event
larg
addit
practic
good
hygien
feel
sick
stay
home
help
check
venu
safeti
ahead
time
consid
specif
safeti
visit
restaur
bar
consid
visit
place
worship
visit
gym
visit
hair
nail
salon
visit
groceri
store
consid
pickup
visit
bank
visit
ga
station
afraid
ask
feel
confid
busi
safeti
postpon
visit
protect
health
worth
hot
vaccin
use
site
agreement
privaci
polici
link
featur
famili
caus
respiratori
common
cold
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
coronaviru
famili
caus
respiratori
common
cold
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
famili
caus
common
cold
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
new
coronaviru
caus
diseas
outbreak
viru
known
sever
acut
respiratori
syndrom
coronaviru
diseas
coronaviru
diseas
march
world
health
organ
declar
outbreak
health
us
diseas
control
prevent
pandem
post
treat
coronaviru
diseas
appear
two
day
exposur
time
exposur
incub
period
common
includ
earli
includ
loss
tast
includ
list
inclus
similar
gener
mild
sever
rang
mild
sever
peopl
peopl
peopl
experi
short
breath
pneumonia
week
older
higher
risk
seriou
ill
risk
age
peopl
medic
higher
risk
seriou
ill
certain
medic
increas
risk
seriou
ill
includ
list
inclus
underli
medic
increas
risk
seriou
ill
contact
someon
contact
doctor
clinic
right
away
medic
advic
tell
health
care
team
possibl
exposur
go
emerg
seek
care
immedi
emerg
includ
list
inclus
let
doctor
know
older
adult
chronic
medic
heart
diseas
lung
diseas
greater
risk
becom
serious
ill
pandem
import
make
sure
health
care
avail
need
combin
inform
health
inform
treat
inform
health
inform
use
disclos
inform
set
forth
notic
privaci
time
link
new
coronaviru
sever
acut
respiratori
syndrom
coronaviru
coronaviru
diseas
viru
easili
among
peopl
discov
time
data
shown
mainli
person
person
among
close
contact
within
viru
respiratori
someon
viru
land
mouth
nose
person
viru
spread
person
expos
small
stay
air
sever
transmiss
yet
known
common
viru
spread
spread
person
surfac
object
viru
mouth
nose
risk
viru
appear
includ
although
peopl
mild
moder
diseas
caus
sever
medic
lead
death
peopl
older
peopl
medic
greater
risk
becom
serious
ill
includ
us
food
drug
administr
given
emerg
use
author
us
vaccin
prevent
get
viru
prevent
becom
serious
ill
get
viru
fulli
return
mani
abl
pandem
wear
mask
social
except
rule
vaccin
take
mani
reduc
risk
infect
recommend
follow
exposur
viru
chronic
medic
condit
higher
risk
seriou
ill
check
doctor
way
protect
travel
first
check
advic
prepar
wear
mask
use
appropri
hand
hygien
public
want
talk
doctor
health
make
suscept
respiratori
consid
deal
grief
loss
normal
coronaviru
diseas
pandem
peopl
mani
way
addit
feel
grief
loss
life
like
griev
loss
normal
prevent
spread
past
year
affect
peopl
peopl
work
way
go
school
play
abil
gather
person
famili
peopl
shop
worship
exercis
eat
seek
entertain
celebr
special
result
pandem
major
psycholog
impact
caus
peopl
lose
sens
safeti
predict
control
freedom
loss
routin
upset
realiz
feel
peopl
probabl
feel
power
work
certain
experi
lose
howev
unexpect
caus
strong
make
hard
deal
move
find
brought
pandem
affect
sens
self
instanc
ident
close
tie
job
lose
job
trigger
ident
caus
feel
numb
empti
angri
unabl
feel
joy
sad
physic
troubl
sleep
eat
excess
fatigu
muscl
weak
shaki
social
mind
howev
grief
posit
effect
exampl
feel
grate
brave
peopl
commun
appreci
desir
help
similar
aw
feel
grief
import
purpos
grief
recogn
experienc
loss
go
need
deal
grief
focu
present
control
adjust
grief
like
troubl
cope
grief
pandem
consid
seek
help
mental
health
hot
vaccin
use
site
agreement
privaci
polici
link
coupl
drew
widespread
critic
fli
small
indigen
commun
get
guilti
local
coronaviru
accord
court
coupl
rodney
baker
virtual
territori
court
guilti
territori
civil
emerg
act
pandem
peopl
isol
day
enter
face
jail
time
plu
surcharg
coupl
fortun
noth
physic
case
one
got
covid
result
judg
court
accord
corpor
harm
harm
anyon
catch
covid
certainli
psycholog
travel
capit
two
day
later
two
quarantin
coupl
charter
flight
beaver
creek
northwest
motel
area
receiv
later
day
coupl
return
found
day
baker
chief
execut
great
game
corpor
across
canada
resign
posit
baker
case
part
legal
branch
immedi
respond
request
comment
creek
heavili
traffic
highway
econom
amid
travel
pandem
commun
made
prioriti
part
remot
made
avail
identif
coupl
global
vaccin
vaccin
distribut
made
complic
disproportion
high
infect
death
among
poor
peopl
peopl
color
especi
fraught
amid
vaccin
distribut
coupl
lawyer
immedi
respond
request
comment
commun
minist
time
coupl
selfish
behavior
similarli
demit
chief
white
river
first
nation
privileg
clear
predominantli
indigen
commun
assum
must
clear
signal
sent
behavior
unaccept
news
health
social
media
sound
alarm
anoth
variant
coronaviru
time
delta
much
contagi
perhap
lethal
variant
seen
far
easi
understand
new
viru
continu
emerg
rise
mani
whether
new
pose
uniqu
substanti
risk
still
unknown
concern
misunderstand
risk
pose
caus
confus
coronaviru
spread
global
genom
viru
affect
viru
fit
abil
reproduc
spread
weaken
viru
measur
effect
make
viru
becom
fit
less
fit
delta
first
variant
beat
certain
alpha
variant
first
domin
gamma
variant
first
domin
brazil
uniqu
coronaviru
viral
fit
everi
flu
season
flu
circul
wide
variant
anoth
necessarili
mean
infecti
deadli
peopl
becom
infect
true
past
year
half
human
behavior
far
import
shape
cours
pandem
mani
way
viru
mutat
increas
fit
much
focu
viru
spike
allow
coronaviru
invad
viru
sustain
allow
viru
replic
easili
evad
immun
system
exampl
even
allow
viru
persist
longer
nasal
impact
given
mutat
substanti
laboratori
research
sometim
earli
particular
mutat
incorrect
first
variant
note
last
winter
viru
spike
protein
made
viru
contagi
subsequ
research
case
even
time
new
chang
spike
protein
mani
presum
variant
virul
concern
whether
variant
biolog
transmiss
sever
ill
rigor
variant
transmiss
base
larg
widespread
variant
variant
contagi
higher
proport
new
delta
common
variant
account
percent
new
percent
new
unit
us
agre
suffici
declar
variant
transmiss
contagi
clear
delta
fitter
domin
variant
determin
transmiss
abil
viru
one
person
anoth
measur
infect
requir
peopl
uneth
peopl
contribut
rise
travel
failur
mask
adher
physic
import
right
insuffici
vaccin
often
consid
public
discuss
huge
infect
necessarili
particular
variant
larg
part
contain
crowd
poor
public
health
peopl
infect
coronaviru
highli
like
infect
variant
area
right
mani
import
understand
peopl
infect
necessarili
develop
sever
diseas
die
frequent
coronaviru
essenti
get
coronaviru
effect
sever
diseas
death
delta
alway
prevent
make
substanti
impact
reduc
viru
spread
risk
seriou
health
peopl
unvaccin
great
risk
infect
harm
variant
pandem
time
peopl
want
immedi
question
mutat
mean
provid
correct
requir
research
littl
evid
viru
endless
trajectori
transmiss
virul
today
still
end
becom
wide
avail
peopl
unit
travel
mani
peopl
vaccin
social
media
new
cruis
alreadi
provid
proof
vaccin
keep
record
key
new
york
exampl
proof
vaccin
recent
neg
test
entri
larg
unvaccin
instruct
wear
mask
practic
social
depend
venu
assign
section
specif
vaccin
statu
alreadi
number
vaccin
passport
underway
would
make
vaccin
statu
easi
share
digit
clear
biometr
screen
program
use
across
countri
technolog
compani
instanc
march
new
york
first
state
introduc
digit
tool
excelsior
pass
allow
peopl
easili
show
either
test
neg
viru
order
gain
entri
taken
wide
across
countri
want
onto
littl
everyth
need
know
vaccin
record
import
keep
vaccin
card
given
first
shot
vaccin
second
one
vaccin
manufactur
dose
date
locat
accord
brown
spokeswoman
made
digit
brown
access
vaccin
via
compani
mobil
sam
club
alreadi
offer
digit
access
vaccin
health
pass
clear
nonprofit
common
project
foundat
goal
give
free
secur
digit
access
vaccin
record
enabl
share
inform
third
seek
confirm
vaccin
statu
furner
chief
execut
offic
presid
us
new
card
easi
enough
got
pharmaci
brown
anyon
card
return
pharmaci
employe
print
new
card
patient
electron
track
state
health
reach
state
agenc
get
replac
card
accord
diseas
control
prevent
agenc
contact
inform
immun
inform
system
state
take
pictur
phone
inform
photo
librari
backup
assist
professor
gener
intern
medicin
infecti
yale
card
make
durabl
carri
around
wallet
though
concern
lamin
would
prevent
inform
futur
booster
ad
moot
point
new
booster
shot
would
seem
like
number
offer
free
lamin
offer
free
lamin
vaccin
gotten
accord
spokeswoman
offic
good
retail
offer
valid
compani
unit
offer
code
end
seek
way
protect
vaccin
record
know
like
import
hand
futur
vice
presid
print
market
store
felt
natur
way
provid
free
solut
peopl
get
vaccin
lamin
free
offic
depot
nationwid
code
keep
card
safe
place
would
passport
rather
carri
around
necessarili
need
person
time
ye
border
entri
set
intern
air
transport
associ
trade
associ
world
cruis
fulli
travel
march
fulli
present
proof
vaccin
visit
iceland
exampl
avoid
border
test
countri
govern
cruis
line
royal
crew
older
order
board
virgin
crystal
well
restart
cruis
spring
summer
moment
travel
intern
vaccin
entri
idea
much
industri
interview
nightli
news
chief
execut
offic
delta
air
proof
vaccin
like
eventu
intern
whether
paper
proof
digit
vaccin
passport
flint
spokesman
agenc
support
mandatori
vaccin
requir
air
travel
discrimin
take
longer
becom
wide
avail
abl
get
medic
unwil
owe
ethic
still
agenc
vaccin
pass
travel
pass
use
share
health
inform
requir
flint
march
launch
excelsior
pass
free
allow
scan
code
confirm
whether
someon
test
neg
coronaviru
sign
new
york
visit
excelsior
pass
enter
name
date
birth
zip
code
pass
code
automat
data
state
vaccin
test
lab
one
excelsior
pass
accord
spokesman
governor
offic
pass
print
show
vaccin
card
evid
neg
test
result
administr
execut
curb
pandem
one
govern
assess
feasibl
digit
vaccin
govern
involv
administr
would
pass
feder
mandat
vaccin
white
hous
news
confer
march
senior
white
hous
pandem
advis
unlik
world
govern
role
place
creat
passport
place
hold
data
view
someth
privat
sector
import
us
lead
interag
process
right
go
import
criteria
met
equit
access
privaci
secur
asid
health
get
vaccin
come
vaccin
card
across
countri
marijuana
offer
vaccin
card
instanc
rest
year
would
give
one
free
glaze
doughnut
per
day
anyon
proof
compani
chief
execut
told
fox
news
acceler
across
countri
made
decis
hey
support
next
act
joy
come
show
us
vaccin
card
get
doughnut
time
day
everi
day
choos
follow
new
york
time
travel
twitter
sign
weekli
travel
dispatch
newslett
receiv
expert
travel
inspir
next
vacat
futur
getaway
armchair
travel
check
list
much
celebr
vaccin
govern
bet
big
million
even
vaccin
percent
unit
popul
fulli
far
mani
struggl
obtain
stop
unit
surplu
sinc
begin
peopl
viru
sinc
vaccin
distribut
well
underway
mani
infect
face
medic
nation
emerg
investig
learn
pandem
new
york
time
dozen
public
health
reflect
vaccin
approach
effect
anyth
done
differ
trump
numer
rais
univers
agreement
done
way
know
certainti
whether
differ
vaccin
tactic
would
still
benefit
hindsight
point
sever
unit
taken
anoth
approach
five
altern
peopl
familiar
pfizer
initi
dose
vaccin
second
shot
three
four
suggest
unit
second
vaccin
sever
instead
given
first
wide
high
risk
peopl
order
give
protect
peopl
one
dose
pfizer
vaccin
percent
protect
two
percent
two
accord
feder
report
efficaci
real
world
johnson
johnson
vaccin
author
later
come
singl
shot
spent
lot
provid
lot
second
peopl
gotten
first
shot
ton
high
risk
peopl
get
infect
die
singl
shot
would
made
big
differ
dean
brown
univers
school
public
shot
approach
rigor
test
particularli
time
viru
hotli
feder
ultim
riski
top
infecti
diseas
expert
approach
though
experiment
use
second
organ
larg
age
start
like
die
viru
descend
order
plummet
countri
recent
day
zero
new
recent
studi
intrigu
find
peopl
receiv
second
shot
later
actual
produc
receiv
second
shot
three
still
seen
rise
recent
second
order
combat
outbreak
delta
variant
contagi
like
infect
peopl
one
shot
peopl
nation
peopl
like
spread
viru
rather
vulner
die
tri
younger
peopl
first
spoke
gener
unit
wise
older
peopl
covid
much
higher
goal
save
need
think
like
die
nanci
professor
univers
school
medicin
age
pretti
reliabl
predictor
inde
sinc
among
peopl
older
fallen
substanti
particular
progress
nurs
initi
short
suppli
mani
face
vaccin
open
slightli
group
brought
equiti
higher
age
white
longer
life
expect
black
elig
gener
popul
threshold
mani
went
cutoff
older
even
begin
least
omer
director
yale
institut
global
recent
peopl
age
made
grow
share
covid
risk
slightli
younger
group
faden
founder
institut
favor
lower
age
limit
protect
older
peopl
color
lower
mani
whose
rais
issu
vaccin
equiti
area
unit
fell
much
log
highest
per
covid
vaccin
black
higher
risk
infect
die
white
receiv
vaccin
lower
accord
us
censu
survey
last
month
among
open
higher
person
household
incom
like
person
receiv
shot
million
will
yet
peopl
percent
colleg
degre
accord
analysi
censu
address
socioeconom
equiti
essenti
groceri
transit
prove
complic
mani
direct
approach
tactic
tri
limit
number
intent
avoid
jewel
associ
dean
health
equiti
dell
medic
school
last
spring
summer
peopl
die
good
enough
say
know
need
go
one
data
analysi
univers
would
possibl
save
simpli
earli
zip
mani
zip
strategi
polit
tenabl
epidem
model
studi
like
would
across
whole
pass
trillion
three
separ
march
congress
legisl
address
pandem
need
across
countri
final
packag
vaccin
distribut
becom
law
pfizer
alreadi
author
emerg
use
money
come
ye
health
scale
made
differ
assist
professor
medic
school
pulmonari
time
earli
chaotic
critic
moment
peopl
die
everi
day
logist
meant
avail
immedi
peopl
arm
physician
public
health
research
medicin
tantamount
lose
compound
interest
account
polio
vaccin
avail
unit
march
organ
presid
franklin
made
major
advertis
push
young
risk
infect
editor
histori
project
colleg
boost
public
interest
vaccin
got
backstag
show
seen
patriot
thing
today
govern
public
educ
issu
fragment
divis
former
presid
j
trump
whose
administr
biggest
success
pandem
quickli
use
polit
stardom
convinc
skeptic
base
got
privat
leav
white
hous
today
remain
less
like
get
administr
vocal
support
unabl
overcom
hesit
part
mani
skeptic
govern
author
suspici
medic
establish
record
racial
inequ
countri
like
fall
short
presid
goal
percent
least
partli
associ
dean
public
health
integr
michigan
state
univers
least
resist
start
oper
warp
speed
feder
effort
develop
coronaviru
vaccin
quickli
peopl
warp
speed
know
corner
cut
quick
dirti
unit
mass
literaci
campaign
long
produc
made
far
easier
get
avail
peopl
front
basic
inform
vaccin
deliveri
fact
feder
govern
foot
bill
often
short
suppli
vaccin
assist
professor
medic
school
peopl
would
constantli
come
pile
identif
cash
massiv
begin
vaccin
free
need
id
cool
factor
everyon
convinc
health
testimoni
wood
market
professor
north
state
univers
market
peopl
disinterest
oppos
vaccin
instead
top
give
varieti
even
convinc
everyon
white
hous
unit
would
send
three
million
johnson
johnson
vaccin
brazil
countri
viru
surg
death
toll
third
countri
popul
least
one
shot
averag
new
per
day
countri
last
week
increas
percent
averag
two
set
arriv
near
part
presid
pledg
dispatch
million
oversea
end
month
white
hous
offici
offici
ad
scientif
legal
regulatori
unit
brazil
work
secur
shipment
brazil
one
last
weekend
million
vaccin
intens
pressur
increas
vaccin
abroad
month
administr
would
buy
million
pfizerbiontech
vaccin
distribut
among
next
last
week
pandem
news
confer
whether
administr
would
send
brazil
white
hous
respons
unit
work
complic
logist
needl
syring
alcohol
would
accompani
johnson
johnson
vaccin
high
level
protect
viru
face
sag
demand
unit
diseas
control
prevent
food
drug
administr
paus
use
rare
disord
small
number
peopl
receiv
vaccin
decis
state
interest
plant
subcontractor
emerg
johnson
johnson
abl
deliv
half
million
feder
govern
end
month
littl
half
johnson
johnson
far
accord
us
send
brazil
feder
pool
choos
order
white
hous
around
third
produc
emerg
recent
special
review
facil
produc
month
around
million
use
unit
export
proviso
guarante
emerg
week
agenc
anoth
million
emerg
still
vaccin
determin
safe
decis
peopl
brazil
miss
second
vaccin
campaign
alreadi
suppli
million
return
second
shot
june
accord
data
follow
vaccin
nearli
percent
elig
second
peopl
miss
second
dose
vari
warn
larg
number
peopl
partial
protect
set
back
brazil
alreadi
vaccin
effort
coronaviru
peopl
brazil
known
toll
world
unit
daili
new
third
popul
receiv
least
one
dose
less
percent
fulli
mani
peopl
like
first
dose
public
health
specialist
feder
univers
rio
de
one
lead
studi
fall
one
reason
mani
peopl
second
shot
brazil
chaotic
vaccin
mani
local
state
quickli
high
risk
infect
enough
avail
euphoria
vaccin
line
realiti
suppli
speed
say
peopl
left
behind
brazil
much
vaccin
suppli
domest
ship
china
churn
vaccin
compani
march
brazil
health
ministri
initi
reserv
second
prioriti
health
older
peopl
china
badli
peopl
brazil
due
receiv
second
peopl
get
second
dose
eventu
gave
vice
presid
societi
infecti
lost
opportun
brazil
ad
believ
one
shot
health
warn
singl
dose
enough
especi
brazil
countri
mostli
vaccin
effect
seriou
studi
chile
percent
effect
one
shot
receiv
two
ill
anyway
least
inocul
mount
across
countri
halt
dri
feder
investig
last
week
govern
deal
buy
million
covaxin
vaccin
produc
inflat
investig
presid
handl
pandem
decis
ignor
multipl
earli
buy
pfizer
danger
viru
miracl
proven
staff
hospit
fire
resign
follow
polici
hospit
methodist
told
june
face
suspens
two
nearli
suspend
hospit
resign
accord
gale
smith
spokeswoman
smith
vaccin
polici
suspens
period
return
work
day
hospit
specifi
mani
return
hesit
high
among
health
care
nearli
half
unvaccin
despit
among
first
becom
elig
march
survey
kaiser
famili
foundat
found
health
care
new
possibl
side
effect
common
wait
month
methodist
deadlin
outsid
hospit
mandatori
vaccin
protest
lawsuit
last
month
methodist
employ
vaccin
polici
lawsuit
accus
hospit
forc
human
guinea
condit
continu
employ
nurs
led
methodist
protest
lack
full
approv
reason
get
district
judg
n
southern
district
claim
lead
plaintiff
lawsuit
avail
use
unit
experiment
danger
hospit
human
trial
judg
wrote
methodist
tri
busi
save
without
give
viru
choic
made
keep
staff
professor
medic
ethic
new
york
univers
school
medicin
vaccin
requir
differ
health
care
get
annual
flu
shot
keep
wear
note
health
care
fire
past
refus
get
flu
new
york
requir
health
care
three
special
ethic
one
protect
vulner
peopl
realli
risk
diseas
secondli
put
patient
first
say
put
choic
first
third
suppos
harm
condemn
comparison
lead
plaintiff
case
hospit
concentr
camp
hospit
get
would
better
differ
line
work
wrong
job
buddi
warrant
record
recommend
firm
emerg
board
agre
nearli
million
cash
stock
five
compani
spring
even
congress
investig
compani
product
million
unus
forc
shutdown
nonetheless
best
financi
year
histori
thank
larg
govern
largess
decis
usual
previous
undisclos
seek
competit
feder
reserv
product
space
plant
book
two
emerg
nearbi
bottl
packag
coronaviru
qualiti
recent
accord
previous
unreport
one
health
found
factori
take
adequ
prevent
two
addit
seen
littl
use
compani
collect
million
keep
product
larg
minim
compani
emerg
chief
financi
offic
last
lucr
agreement
emerg
earli
chaotic
day
pandem
trump
administr
engag
one
govern
offici
panic
littl
outsid
good
posit
benefit
feder
contractor
base
compani
effect
corner
market
feder
build
success
busi
past
two
atop
anthrax
nation
emerg
medic
stockpil
new
york
time
though
never
regulatori
approv
anyth
main
plant
polit
connect
compani
make
two
time
previous
disclos
contamin
vaccin
product
new
show
govern
enlist
two
emerg
despit
record
qualiti
taken
togeth
three
compani
banner
depart
health
human
told
time
gener
deal
meant
compens
emerg
give
work
three
govern
cost
base
compar
reserv
commerci
will
pay
emerg
contract
compani
statement
emerg
improperli
inflat
accur
review
compani
file
exchang
commiss
entir
contract
busi
three
elsewher
never
brought
anyth
close
amount
feder
govern
revenu
compani
contract
previou
three
agreement
govern
among
recent
made
public
congression
emerg
million
reserv
three
rang
three
last
week
suspend
factori
section
deliv
singl
usabl
vaccin
dose
distribut
unit
special
warn
food
drug
administr
addit
product
two
section
mostli
sat
memo
june
last
year
govern
reserv
substanti
capac
plant
emerg
use
previou
year
commerci
de
trump
top
expert
pandem
respons
wrote
plant
bottl
three
million
govern
reserv
enough
space
bottl
million
annual
basi
percent
increas
industri
emerg
deal
would
highli
unusu
among
privat
typic
custom
part
cost
front
rest
job
done
emerg
case
govern
agre
pay
full
cost
even
none
took
similar
bottl
work
competit
bid
process
feder
health
skirt
regular
new
busi
deal
emerg
made
eight
show
norm
sometim
use
expedit
agreement
trump
administr
agre
set
asid
million
reserv
two
product
plant
de
soon
date
capabl
handl
small
two
book
end
year
use
sparingli
accord
senior
health
depart
offici
spoke
condit
anonym
discuss
agenc
sensit
depart
declin
specifi
mani
emerg
bottl
govern
say
work
million
reserv
small
bottl
line
five
plant
line
never
use
appar
vaccin
prefer
handl
bigger
accord
two
feder
addit
govern
million
emerg
build
new
product
line
nearli
million
reserv
last
three
year
cornerston
oper
warp
speed
trump
administr
initi
pay
promis
therapeut
even
fail
clinic
govern
went
beyond
emerg
deal
howev
agre
pay
compani
regardless
whether
produc
senior
health
depart
speak
condit
anonym
deal
necessari
prepar
unexpect
throughout
pandem
least
one
compani
backup
capac
turn
unnecessari
emerg
contract
trump
administr
tradit
sought
competit
addit
bottl
known
industri
work
show
olog
base
agre
provid
essenti
emerg
nearli
cost
accord
calcul
base
agreement
august
olog
would
charg
govern
per
vial
comparison
emerg
would
cost
health
depart
spokeswoman
olog
part
bottl
singl
batch
much
five
time
emerg
handl
per
vial
price
spread
fix
olog
govern
continu
agreement
emerg
higher
cost
ensur
addit
capac
avail
fill
therapeut
time
contract
former
current
feder
govern
secur
much
power
possibl
commerci
snap
emerg
grown
get
govern
fund
amass
compani
plan
doubl
revenu
part
expand
contract
busi
senior
vice
presid
outlin
game
plan
includ
addit
feder
govern
six
later
emerg
struck
deal
govern
contract
includ
work
former
trump
administr
offici
agenc
previous
work
consult
emerg
negoti
emerg
deal
approv
emerg
agreement
career
govern
case
govern
stood
despit
rais
de
visit
plant
last
year
wrote
product
obsolet
heavili
manual
labor
instead
risk
contamin
govern
turn
plant
wrote
new
line
construct
use
exclus
two
senior
health
depart
de
note
warrant
contract
walk
site
say
oh
wow
equip
state
art
ago
one
walk
mani
mani
say
exactli
thing
unduli
concern
inspect
qualiti
control
plagu
emerg
factori
process
far
less
notic
product
therapeut
highli
sophist
tightli
regul
pose
risk
regulatori
time
detail
seri
plant
past
seven
seriou
one
pharmaceut
product
within
state
control
found
recur
issu
broken
wrote
facil
good
state
repair
crowd
setup
risk
inspect
found
emerg
correct
return
factori
note
similar
crack
follow
meant
prevent
similar
plant
emerg
fail
properli
control
contamin
discov
tri
identifi
underli
inspector
note
two
hair
found
equip
firm
correct
continu
found
within
facil
inspector
wrote
almost
verbatim
find
previou
year
inspect
health
depart
none
dramat
assess
fit
purpos
state
complianc
spokesman
emerg
compani
serious
work
expediti
address
time
two
former
enforc
qualiti
control
plant
emerg
regularli
qualiti
investig
june
last
year
would
even
go
far
say
know
one
root
end
plant
tri
mitig
make
look
issu
bad
take
minimum
correct
anoth
former
qualiti
engin
spoke
condit
anonym
fear
emerg
told
better
disclos
less
detail
written
rais
among
comment
rais
former
time
benefit
hindsight
qualiti
control
moment
emerg
plant
behind
mount
last
year
seri
confidenti
seriou
time
previous
broke
public
view
march
accident
batch
johnson
johnson
vaccin
key
ingredi
feder
order
plant
paus
product
strip
emerg
respons
produc
vaccin
instruct
johnson
johnson
assert
direct
control
vaccin
decid
equival
million
johnson
johnson
vaccin
produc
emerg
use
possibl
contamin
brought
number
johnson
johnson
ruin
emerg
poor
agenc
million
johnson
johnson
distribut
million
warn
guarante
emerg
equival
million
addit
johnson
johnson
produc
plant
review
determin
inspect
ensur
factori
correct
pattern
still
progress
decis
whether
reopen
later
emerg
anoth
year
record
larg
part
compani
recent
told
revenu
contract
busi
would
probabl
million
million
less
previous
shortfal
like
made
next
mass
vaccin
campaign
month
ago
unproven
wager
would
prove
effect
enough
blunt
rapid
spread
coronaviru
gambl
pay
health
countri
vaccin
prove
percent
effect
coronaviru
clinic
pandem
declin
import
foreign
strive
develop
countri
world
announc
among
effect
covid
world
accord
data
clinic
par
pfizerbiontech
percent
rate
percent
russia
sputnik
v
corpor
anoth
sovereign
percent
efficaci
two
three
full
three
next
vaccin
news
seen
rare
caus
celebr
island
pandem
tourism
industri
econom
current
worst
coronaviru
outbreak
sinc
start
pandem
new
health
mass
vaccin
campaign
complet
phase
assess
vaccin
effect
safeti
emerg
step
intend
help
combat
beta
variant
first
south
spread
rapidli
capit
close
one
million
percent
nation
popul
receiv
three
either
sovereign
accord
offici
say
see
viru
spread
concentr
express
interest
coronaviru
high
rate
efficaci
reinforc
help
lift
econom
made
pfizerbiontech
set
persist
immun
reaction
bodi
protect
coronaviru
add
grow
evid
peopl
need
long
viru
evolv
much
beyond
current
peopl
need
even
viru
make
signific
transform
good
sign
durabl
immun
vaccin
immunologist
univers
st
led
studi
journal
studi
consid
coronaviru
vaccin
made
johnson
johnson
immun
respons
less
durabl
produc
last
month
peopl
immun
recogn
viru
lie
quiescent
bone
marrow
least
eight
infect
studi
anoth
team
memori
b
continu
matur
strengthen
least
year
immun
last
possibl
lifetim
peopl
infect
coronaviru
later
unclear
whether
vaccin
alon
similarli
team
sought
address
question
look
sourc
memori
lymph
immun
train
recogn
fight
infect
vaccin
special
structur
germin
center
lymph
structur
elit
school
b
boot
camp
becom
increasingli
sophist
learn
recogn
divers
set
viral
genet
rang
longer
practic
like
abl
thwart
viru
emerg
everyon
alway
viru
show
b
thing
pepper
immunologist
univers
go
protect
ongo
evolut
viru
realli
encourag
infect
coronaviru
germin
center
vaccin
educ
place
lymph
within
reach
peopl
eight
histori
infect
viru
two
pfizerbiontech
vaccin
peopl
team
extract
lymph
three
four
five
seven
first
painstak
work
heroic
studi
immunologist
yale
kind
care
analysi
difficult
team
found
first
dose
vaccin
germin
center
still
highli
activ
number
memori
coronaviru
declin
fact
continu
almost
four
vaccin
good
sign
germin
typic
peak
one
two
immun
wane
usual
four
six
much
left
immunologist
univers
germin
still
go
lot
declin
peopl
note
know
persist
germin
base
anim
research
new
studi
first
show
peopl
suggest
vast
major
peopl
long
term
least
coronaviru
older
peopl
weak
immun
take
suppress
immun
need
peopl
later
never
need
long
protect
last
hard
predict
absenc
immun
theori
immun
last
lifetim
viru
clearli
anyth
would
actual
requir
booster
would
base
wane
immun
see
happen
peopl
infect
coronaviru
see
major
boost
antibodi
like
memori
b
produc
mani
evolv
good
news
booster
vaccin
probabl
effect
prior
infect
peopl
give
anoth
chanc
engag
massiv
respons
memori
b
immun
system
vaccin
probabl
better
actual
infect
repertoir
memori
b
produc
vaccin
divers
infect
suggest
protect
better
natur
immun
persist
immun
reaction
alon
oppos
made
tradit
johnson
johnson
unfair
comparison
johnson
johnson
vaccin
given
singl
dose
j
j
booster
mayb
induc
kind
respons
elig
intern
fierc
debat
across
unit
whether
digit
health
certif
often
somewhat
misleadingli
vaccin
passport
prove
immun
white
paper
card
evid
easili
forg
alreadi
sell
fals
stolen
vaccin
feder
govern
introduc
digit
vaccin
feder
mandat
grow
number
cruis
sport
say
requir
proof
entri
digit
health
pass
scrambl
launch
provid
electron
record
neg
coronaviru
test
streamlin
drive
rais
privaci
equiti
vaccin
argu
digit
infrastructur
secur
help
speed
process
societi
reviv
technolog
test
differ
digit
health
tri
come
common
compat
system
health
safe
process
come
great
technic
especi
sheer
number
underway
use
must
agre
common
infrastructur
use
need
compat
unit
ad
complex
get
individu
share
immun
data
differ
certif
privaci
know
current
statu
digit
health
face
unit
march
new
york
first
state
unit
launch
digit
health
certif
excelsior
pass
person
neg
coronaviru
test
result
fulli
one
million
free
voluntari
new
york
code
print
verifi
person
health
data
pass
use
new
enter
stadium
squar
garden
smaller
public
requir
peopl
show
state
id
along
excelsior
pass
prevent
potenti
half
popul
fulli
must
show
electron
green
pass
attend
wed
dine
indoor
union
endors
electron
vaccin
certif
number
begun
individu
member
countri
abl
set
travel
test
certif
system
help
reopen
virgin
atlant
jet
blue
use
digit
health
common
pass
verifi
passeng
test
board
intern
air
transport
associ
health
pass
use
health
necessari
intern
state
administr
feder
vaccin
system
mandat
individu
hold
primari
public
health
unit
author
requir
expect
vaccin
passport
whatev
want
call
driven
privat
sector
white
hous
press
secretari
brief
march
univers
feder
feder
mandat
everyon
obtain
singl
vaccin
credenti
execut
order
ban
govern
privat
receiv
state
peopl
show
proof
governor
similar
order
say
proof
vaccin
would
reduc
individu
freedom
harm
patient
privaci
well
creat
two
class
base
stick
shaki
legal
ground
director
institut
nation
global
health
law
univers
certainli
legislatur
author
regul
state
local
issu
vaccin
governor
act
inher
power
regul
emerg
health
legislatur
unit
feder
vaccin
instead
collect
inform
except
new
immun
new
york
share
diseas
control
prevent
data
public
anyon
digit
vaccin
certif
unit
would
obtain
immun
data
individu
problemat
oppos
health
pass
terminolog
passport
govern
person
data
person
legal
name
date
birth
mani
peopl
fear
one
relat
coronaviru
person
sensit
health
data
privat
stolen
use
whole
lot
valid
privaci
technolog
would
work
especi
silicon
valley
great
histori
privaci
execut
director
foundat
public
health
organ
concept
privaci
complic
ultim
tri
prove
somebodi
receiv
someth
keep
secret
challeng
present
prove
someth
without
chain
traceabl
forev
use
foundat
work
network
technolog
initi
develop
set
privaci
use
vaccin
main
aim
initi
establish
verifi
credenti
much
card
one
wallet
set
individu
digit
nativ
cryptograph
argu
credenti
would
intrud
person
privat
health
vaccin
must
stop
former
repres
wrote
tweet
last
week
fals
idea
govern
life
bodi
freedom
worri
exclus
digit
system
would
leav
behind
especi
access
area
simpl
free
open
sourc
access
peopl
digit
paper
design
start
protect
peopl
privaci
jeff
white
hous
coronaviru
world
health
organ
back
vaccin
travel
yet
uncertainti
whether
inocul
transmiss
viru
well
equiti
organ
work
number
commiss
establish
possibl
global
digit
vaccin
new
york
time
travel
twitter
sign
weekli
travel
dispatch
newslett
receiv
expert
travel
inspir
next
vacat
futur
getaway
armchair
travel
check
list
peopl
summer
would
return
normal
life
tini
island
nation
three
put
faith
least
part
easili
access
would
allow
roll
ambiti
inocul
much
world
go
instead
freedom
coronaviru
three
surg
vaccin
diplomaci
campaign
last
year
provid
shot
would
safe
effect
sever
less
certain
time
success
would
curb
sever
suggest
effect
spread
viru
particularli
new
lay
bare
harsh
realiti
face
world
degre
recoveri
depend
give
chile
percent
fulli
unit
accord
world
data
data
project
four
rank
among
top
worst
covid
recent
last
week
accord
data
new
york
time
four
mostli
made
two
vaccin
suffici
good
see
pattern
virologist
univers
hong
respons
remedi
know
certain
rel
high
inocul
suffer
new
social
quickli
careless
behavior
first
regimen
breakthrough
last
unit
percent
popul
fulli
mostli
made
pfizerbiontech
percent
six
provid
pfizer
vaccin
rate
world
number
new
daili
confirm
per
million
around
mostli
number
per
creat
world
three
emerg
pandem
wealthi
use
secur
pfizerbiontech
far
away
major
fulli
partli
well
receiv
end
third
group
contend
roll
test
life
come
remain
back
question
efficaci
unvaccin
peopl
line
becom
month
second
dose
fell
ill
test
posit
miner
spent
nine
day
hospit
capit
use
shot
peopl
convinc
summer
free
covid
turn
true
saw
vaccin
diplomaci
opportun
emerg
pandem
influenti
global
power
china
top
leader
xi
deliv
shot
easili
transport
million
peopl
around
world
global
public
good
beneficiari
chanc
score
million
small
countri
quickli
roll
inocul
program
percent
popul
new
month
statement
china
foreign
ministri
see
link
recent
world
health
organ
say
vaccin
certain
suffici
prevent
continu
maintain
relev
data
show
mani
use
express
safe
reliabl
good
role
epidem
prevent
ministri
china
target
sever
diseas
rather
vaccin
fulli
transmiss
peopl
still
fall
ill
rel
low
efficaci
possibl
caus
recent
pfizerbiontech
efficaci
percent
varieti
johnson
johnson
efficaci
around
percent
vaccin
institut
biolog
efficaci
rate
percent
vaccin
efficaci
rate
much
clinic
data
show
work
transmiss
epidemiologist
center
diseas
control
prevent
china
fulli
vaccin
percent
popul
achiev
herd
immun
previou
offici
estim
breakthrough
made
avail
either
though
studi
chile
vaccin
less
effect
pfizerbiontech
infect
among
repres
hung
phone
comment
respond
request
medic
director
nation
foundat
infecti
univers
efficaci
low
enough
sustain
transmiss
well
creat
ill
substanti
amount
highli
popul
even
though
peopl
larg
hospit
despit
spike
say
effect
sever
head
research
scientif
advisori
group
ministri
health
made
right
decis
go
shot
part
keep
mortal
rate
low
countri
data
vaccin
actual
protect
sputnik
vaccin
accord
health
reason
surg
countri
quickli
mani
peopl
one
dose
think
say
celebr
earli
advic
start
full
lesson
learn
much
confid
health
less
professor
colleg
medicin
public
health
univers
evid
would
reason
assum
vaccin
minim
effect
curb
transmiss
major
risk
inocul
peopl
still
spread
viru
think
complex
lost
decis
around
world
new
variant
spread
health
care
recent
came
despit
fulli
accord
risk
mitig
team
medic
associ
across
countri
june
ten
taken
vaccin
associ
enough
make
director
medic
question
use
problem
associ
pfizer
news
confer
actual
problem
associ
vaccin
unit
first
two
approv
shot
even
clinic
trial
data
sinc
extens
peopl
fall
ill
statement
govern
media
offic
kingdom
vaccin
effici
success
date
still
last
month
unit
would
offer
third
booster
shot
pfizer
midst
summer
celebr
coronaviru
declin
collect
relief
well
deserv
countri
remain
vulner
spotti
vaccin
even
risk
futur
loss
life
almost
entir
prevent
given
avail
yet
reason
believ
caus
nation
fall
short
presid
target
percent
coverag
among
elig
despit
fact
overwhelm
major
among
reason
unit
settl
patchwork
vaccin
easili
prevent
death
way
overcom
low
vaccin
demand
research
persuad
peopl
get
health
care
sourc
vaccin
inform
even
among
vaccin
nation
need
talk
everi
seem
obviou
yet
train
effect
talk
peopl
exampl
assum
need
offer
inform
order
persuad
research
often
lack
knowledg
main
problem
mani
peopl
refus
mistrust
health
system
peopl
fenc
vaccin
inform
help
make
mind
earli
stage
inform
frame
vaccin
default
choic
time
get
versu
mayb
think
covid
vaccin
effect
take
away
someon
autonomi
still
verbal
nudg
toward
nation
ensur
use
need
medic
educ
program
tool
use
keep
knowledg
medicin
maintain
licens
train
effect
vaccin
commun
recent
program
way
ensur
health
care
spend
suffici
time
sometim
make
vaccin
reimburs
right
vaccin
patient
get
patient
refus
alway
know
persuad
convers
first
place
mani
exampl
recent
gener
provid
peopl
get
often
multipl
ideal
part
appoint
urg
unvaccin
get
vaccin
talk
physician
three
similar
threshold
smoke
cessat
doctor
seek
reimburs
abl
bill
multipl
session
patient
reason
limit
three
time
per
increas
vaccin
access
make
vaccin
process
simpl
remain
import
day
mani
peopl
concern
cost
even
though
free
vaccin
stop
insur
effect
vaccin
messag
one
come
sourc
get
encourag
around
well
need
peopl
becom
complac
get
health
care
hold
sway
health
need
push
toward
higher
vaccin
requir
coronaviru
enter
new
york
next
conting
morgan
new
york
citi
counti
must
attest
fulli
person
familiar
matter
memo
crawley
bank
chief
human
offic
staff
work
remot
ad
person
spoke
condit
anonym
discuss
requir
honor
system
rather
proof
vaccin
allow
bank
lift
pandem
face
physic
offic
morgan
institut
invest
wealth
manag
alreadi
allow
receiv
work
across
grappl
question
whether
ask
vaccin
statu
requir
equal
employ
opportun
commiss
last
month
legal
still
senior
worri
month
unit
would
report
vaccin
statu
big
wall
street
chase
bank
encourag
disclos
vaccin
statu
voluntarili
asset
manag
allow
staff
return
offic
begin
next
month
howev
stop
short
attest
financi
time
morgan
vaccin
coronaviru
hit
serum
institut
uniqu
posit
help
world
vaccin
maker
billion
year
polio
tetanu
strike
deal
make
deliv
billion
vaccin
low
year
howev
second
wave
coronaviru
hit
hard
prime
minist
decid
ban
ban
meant
million
serum
institut
new
across
intens
care
unit
golden
hospit
two
dozen
breath
arm
cri
help
choke
come
mainten
room
see
wrong
small
plastic
fill
critic
ill
enough
golden
hospit
run
medic
oxygen
next
seven
coronaviru
nobodi
forget
night
hospit
nurs
superintend
total
breakdown
across
amid
devast
second
wave
ran
critic
untold
peopl
worsen
alreadi
tragic
outbreak
one
count
oxygen
alon
least
peopl
past
two
knew
countri
vulner
yet
prime
minist
govern
local
alik
prepar
second
wave
accord
review
govern
new
york
major
produc
compress
oxygen
govern
late
distribut
oxygen
citi
build
produc
store
oxygen
alloc
tight
govern
led
oxygen
run
golden
hospit
comprehens
coronaviru
plan
govern
left
much
burden
even
oxygen
crisi
tragic
reveal
approach
test
though
vaccin
shortag
risk
third
wave
without
adequ
second
wave
return
effect
surg
plan
director
health
initi
world
health
organ
avert
fever
check
golden
veteran
schoolteach
test
posit
along
husband
two
golden
good
reput
privat
hospit
orthoped
pediatr
gastroenterolog
motto
care
care
fill
golden
sick
peopl
recept
area
lean
ward
extra
husband
lawyer
lie
back
hall
plastic
oxygen
mask
strap
face
healthi
strong
swimmer
hold
breath
ate
wholesom
diet
whole
grain
flour
northern
medic
oxygen
run
short
one
month
daili
count
nurs
shut
leav
peopl
die
curb
tragic
oxygen
still
unprepar
metric
liquid
oxygen
day
mostli
industri
use
pandem
peak
demand
metric
oxygen
wrong
place
produc
near
steel
eastern
hot
parliamentari
committe
ensur
oxygen
inventori
place
plan
unveil
eventu
build
pull
oxygen
atmospher
hospit
use
expand
oxygen
storag
capac
accord
govern
second
wave
clear
enough
oxygen
built
extra
storag
quarter
emerg
need
oxygen
still
concentr
specif
govern
essenti
medic
oxygen
state
allot
air
forc
would
airlift
empti
cryogen
tanker
truck
steel
plant
state
would
fill
liquid
oxygen
put
special
train
much
burden
meet
harsh
health
minist
state
health
plan
advanc
increas
medic
infrastructur
deal
surg
central
govern
give
enough
govern
metric
oxygen
day
capit
twice
court
accus
govern
citi
alloc
need
central
govern
desper
need
sick
peopl
golden
golden
father
seeth
insid
manag
whose
father
admit
earli
younger
father
soil
bed
nobodi
go
bathroom
father
cri
take
away
hospit
declin
nation
govern
limit
oxygen
grew
increasingli
worri
built
one
small
plant
previous
littl
need
deputi
chief
minist
store
one
day
worth
pandem
need
tank
neighborhood
suppli
long
adequ
problem
came
regularli
apport
central
govern
twitter
say
major
enough
oxygen
increasingli
state
stop
tanker
oxygen
briefli
reason
simpl
peopl
die
lack
oxygen
left
anil
health
minist
local
media
give
sent
polic
border
tanker
day
receiv
metric
liquid
oxygen
half
central
govern
quarter
citi
court
order
central
govern
stop
interf
oxygen
make
sure
send
polic
oxygen
fill
hastili
incompat
oxygen
emerg
respons
team
differ
one
frenzi
effort
went
manag
oxygen
distribut
offic
sir
abl
save
peopl
tonight
central
govern
sent
metric
oxygen
less
half
golden
full
outsid
emerg
room
school
princip
north
bed
ventil
feed
sent
text
famili
fine
soon
tri
strong
morn
chief
fear
big
tragedi
happen
due
oxygen
shortag
never
abl
forgiv
chief
minist
told
video
taken
citi
oxygen
distribut
day
accord
need
hospit
desper
dispatch
two
truck
stopgap
anguish
twitter
doctor
patient
rel
though
system
would
eventu
oxygen
distribut
offici
initi
use
golden
typic
receiv
daili
oxygen
shipment
medic
director
time
though
truck
appear
oxygen
suppli
compani
nobodi
pick
time
distribut
oxygen
per
govern
would
suppli
oxygen
command
center
golden
nearli
told
famili
would
sought
street
husband
heart
attack
oxygen
ventil
writh
bed
gasp
air
bear
watch
ventil
rang
across
oxygen
later
golden
backup
system
oxygen
ran
check
father
right
phone
receiv
put
hello
hello
background
hear
ventil
someon
mutter
om
om
om
god
father
probabl
die
moment
brother
golden
around
chao
peopl
dash
carri
oxygen
distraught
kill
one
man
pace
around
shout
leav
alon
someth
mother
two
close
midnight
larg
one
seven
late
smaller
one
raj
singh
singh
next
morn
televis
weep
respons
came
faith
golden
hospit
put
faith
govern
govern
next
week
govern
committe
form
look
natur
virul
cours
diseas
shortag
oxygen
caus
death
acknowledg
done
better
done
team
save
golden
face
lawsuit
sever
declin
comment
blame
nation
local
hospit
sever
demand
crimin
portrait
husband
day
incens
stick
miss
everi
live
moment
new
air
peak
covid
devast
leader
advis
peopl
breath
bit
yoga
advic
came
one
mani
social
media
prime
minist
use
power
oratori
digit
savvi
becom
domin
leader
tweet
master
public
percept
increasingli
get
messag
across
abil
control
omnipres
larg
public
view
govern
prove
powerless
stop
mount
critic
perform
poll
drop
alli
strain
make
case
talk
increasingli
posit
campaign
connect
sit
comfort
medit
postur
read
tweet
one
mani
project
divers
set
one
wise
yoga
guru
keep
spine
erect
place
gentli
close
rais
face
slightli
breath
normal
one
comment
rub
salt
wound
turn
tri
quash
dissent
govern
lock
messi
showdown
social
media
take
critic
content
polic
capit
least
peopl
critic
handl
popul
state
oxygen
offici
death
infect
fall
tri
seiz
moment
chang
narr
rare
address
sinc
second
wave
declar
central
govern
would
help
million
get
free
revers
polici
forc
state
chaotic
competit
limit
spokesman
busi
silent
work
work
work
appear
public
posit
push
attempt
drown
dissatisfact
one
survey
found
disapprov
rise
percentag
sinc
second
wave
anoth
survey
one
six
peopl
lost
one
blame
central
govern
first
destini
loss
much
death
much
despair
lost
overnight
elderli
lost
young
peopl
lost
entrepreneur
relief
work
state
goa
dare
tell
posit
approv
rate
still
percent
accord
one
poll
grow
dissatisfact
prime
minist
easili
abl
chang
public
sentiment
push
emot
nationalist
shift
imag
done
past
rather
politician
increasingli
abil
deliv
templat
want
focu
convinc
rest
popul
visibl
part
entir
part
work
past
founder
institut
percept
new
catastroph
actual
notic
govern
absent
perhap
tell
critic
come
power
organ
million
long
turn
state
recent
tri
help
posit
campaign
hold
seri
influenti
posit
unlimit
speech
chief
entir
deflect
blame
administr
govern
peopl
guard
pick
mani
commun
volunt
social
historian
polit
analyst
written
extens
group
languag
mobil
storytel
load
symbol
histori
train
pedagogi
oratori
came
learn
use
storytel
bigger
train
way
emerg
pandem
depend
becom
prime
minist
reput
involv
fan
religi
violenc
chief
minist
state
two
ago
time
enter
unit
ground
religi
success
nationalist
develop
champion
soon
win
elect
travel
new
york
spoke
hour
squar
garden
seven
prime
minist
tightli
imag
select
news
vulner
offer
plenti
content
social
media
apparatu
network
celebr
face
crisi
display
talent
new
narr
switch
comb
nation
champion
digit
leader
spiritu
guid
time
seem
deepli
relat
opposit
abil
take
messag
elect
economi
weaken
threat
comment
made
parti
nation
watchman
boast
size
chest
sign
vote
templ
went
medit
cave
religi
devot
path
cover
red
carpet
surround
even
footag
medit
insid
small
last
year
first
wave
viru
declar
victori
say
approach
save
entir
human
big
tragedi
imag
wise
man
servic
nation
grew
beard
offic
post
video
feed
babi
adult
one
second
wave
struck
campaign
trail
boast
crowd
size
rip
say
social
alli
tri
drown
neg
scrambl
address
catastroph
oxygen
shortag
vaccin
main
tactic
threat
labyrinthin
judici
central
govern
polic
peopl
last
month
critic
handl
vaccin
drive
made
parti
parti
simpl
act
protest
nation
capit
sent
shock
less
rhetor
ideolog
abil
provid
historian
debat
go
shift
toward
polit
safeti
bodi
talk
prime
minist
talk
deliveri
new
pilot
air
came
year
flew
san
southern
citi
among
mani
work
one
humanitarian
bring
home
transport
essenti
one
least
coronaviru
accord
guild
union
countri
almost
half
flew
air
rest
privat
indigo
go
air
air
reduc
pandem
union
mani
came
aid
peopl
transport
even
though
countri
especi
work
air
prime
minist
govern
better
compens
crew
die
feder
organ
public
interest
lawsuit
high
court
seek
better
compens
insur
vaccin
crew
feder
petit
year
nearli
air
staff
test
posit
hospit
howev
scheme
adequ
compens
case
demis
feder
ad
insur
scheme
scheme
provid
safeti
net
letter
chairman
director
air
last
month
guild
countri
lost
three
span
five
day
state
carrier
point
long
servic
nation
taken
consid
pay
cut
lack
recognit
contribut
throughout
pandem
union
air
pay
million
compens
famili
pilot
number
fraction
enough
take
care
deceas
colleagu
hospit
indigo
privat
pay
million
union
one
union
sent
repeat
govern
flight
letter
health
minist
harsh
union
govern
recogn
crew
essenti
urg
vaccin
aircrew
air
anonym
govern
way
better
compens
salari
fallen
deaf
fear
expos
new
viru
nearli
percent
less
receiv
pandem
pay
came
effect
last
year
global
travel
came
singh
civil
aviat
minist
countri
mission
evacu
world
repatri
drive
transport
million
peopl
far
cower
face
health
crisi
centuri
tweet
neither
air
ministri
civil
aviat
new
immedi
respond
request
union
wrote
letter
air
compani
show
similar
kind
show
duti
rescu
world
unit
china
need
hour
immedi
provid
befit
compens
alreadi
ultim
price
daughter
pain
think
father
declin
interview
ganga
believ
dip
bodi
purifi
soul
second
wave
pandem
hit
spring
river
exhibit
administr
northern
state
recent
death
toll
privat
coronaviru
mela
religi
festiv
northern
million
turn
coronaviru
event
reportedli
second
wave
countri
struggl
process
stagger
toll
nearli
peopl
dead
vast
major
sinc
march
obfusc
local
central
holi
district
found
bloat
float
river
fish
district
upstream
local
senior
polic
offic
travel
popul
nation
editor
newspap
five
half
million
day
across
mostli
small
get
clearer
sens
devast
pandem
among
sent
walk
major
alon
travel
along
river
float
day
wash
yet
base
offici
data
state
claim
peopl
small
villag
southern
consid
holi
associ
lord
deiti
protagonist
epic
poem
saw
mani
buri
yard
apart
saffron
wrap
around
poke
ground
poor
afford
buy
wood
cremat
kin
sought
solac
buri
near
sacr
shallow
river
along
stretch
less
one
never
tragedi
weather
earli
swell
toss
river
surfac
onto
wash
dirt
buri
laid
bare
govern
coloss
failur
strengthen
rural
health
care
ensur
adequ
vaccin
take
respons
parti
prime
minist
sinc
march
chief
minist
yogi
monk
turn
politician
respons
grave
oxygen
intens
care
throughout
state
overcrowd
issu
direct
state
invok
seiz
properti
peopl
accus
spread
govern
yet
mani
peopl
access
health
care
limit
die
doctor
town
doctor
told
one
peopl
test
posit
coronaviru
told
around
peopl
poor
peopl
lost
three
famili
told
report
bare
manag
earn
enough
eat
money
medic
treatment
rural
poverti
effect
second
wave
govern
callou
disregard
trigger
latest
surg
mela
pilgrimag
one
world
religi
spring
well
sever
percent
fulli
good
reason
fear
devast
third
becom
prime
minist
ran
parliamentari
seat
holi
citi
feel
mother
ganga
today
call
coronaviru
hit
serum
institut
uniqu
posit
help
world
vaccin
maker
billion
year
polio
tetanu
strike
deal
make
deliv
billion
vaccin
low
year
howev
second
wave
coronaviru
hit
hard
prime
minist
decid
ban
ban
meant
million
serum
institut
million
covid
set
nation
record
first
day
new
polici
free
energ
lacklust
inocul
slow
start
suppli
central
govern
say
vaccin
product
procur
acceler
ensur
roughli
million
fulli
end
total
covid
given
singl
day
countri
besid
china
surg
partli
wide
avail
free
first
time
younger
news
record
made
possibl
hold
back
run
govern
parti
prime
minist
one
state
number
shrunk
day
start
new
polici
million
suddenli
boost
probabl
temporari
avail
suggest
would
difficult
sustain
pace
come
avail
million
month
million
million
avail
inocul
drive
almost
entir
two
govern
behind
serum
institut
deliv
total
billion
august
end
year
come
still
assess
nation
billion
peopl
task
ahead
remain
enorm
although
countri
nearli
million
far
accord
govern
data
less
percent
popul
fulli
less
percent
peopl
receiv
least
one
govern
work
iron
suppli
eas
registr
vaccin
access
especi
countri
avail
spotti
still
vaccin
hesit
born
local
well
misinform
spread
polit
religi
anoth
hurdl
ambiti
goal
end
effort
ramp
come
worst
devast
second
wave
major
eas
economi
new
peak
earli
weekli
test
posit
rate
percent
two
consecut
sign
undetect
popul
least
peopl
covid
accord
offici
although
believ
signific
global
nearli
million
afar
help
back
home
health
system
buckl
weight
devast
coronaviru
wave
one
us
resid
come
sometim
day
oppress
sever
ill
peopl
buzz
dolli
arjun
physician
assist
ago
arjun
program
provid
free
health
care
indigen
cast
system
long
face
discrimin
typic
last
receiv
assist
humanitarian
often
live
rural
medic
care
devast
wave
coronaviru
surg
across
face
new
peril
arjun
desper
help
even
though
emot
exhaust
year
work
peopl
die
arjun
human
human
need
focu
rariti
among
medic
unit
come
urban
reason
know
person
servant
home
arjun
program
health
translat
local
find
medic
unit
join
effort
easi
still
arjun
two
contact
group
medic
call
back
video
often
first
task
reassur
littl
understand
coronaviru
appropri
medic
arjun
part
happen
told
covid
go
kill
panick
arjun
note
one
state
govern
broadli
treat
regardless
whether
test
posit
show
howev
detect
late
arjun
log
onto
video
call
young
man
father
home
breath
central
state
around
midnight
know
told
us
oxygen
avail
seen
doctor
man
arjun
famili
check
see
whether
hospit
avail
instead
assum
full
took
lot
convinc
next
day
admit
improv
hospit
run
oxygen
arjun
put
call
sever
oxygen
cylind
though
famili
know
name
hospit
fell
later
learn
man
concern
increas
number
potenti
fatal
fungal
affect
either
peopl
recent
condit
known
mucormycosi
high
mortal
rate
present
pandem
mold
wet
attack
respiratori
tract
potenti
facial
condit
rel
rare
medic
say
covid
whose
immun
underli
particularli
diabet
leav
attribut
fungal
use
treat
anoth
factor
second
wave
pandem
mani
oxygen
therapi
home
without
proper
hygien
western
state
commerci
hub
badli
pandem
local
news
media
around
covid
mucormycosi
eight
western
state
north
state
govern
order
alloc
separ
treatment
infect
put
purchas
b
medicin
use
treat
countri
capit
new
keep
close
situat
peopl
suffer
mucormycosi
big
outbreak
covid
task
forc
last
week
watch
fungu
strong
relat
diabet
ad
person
diabet
uncommon
person
would
mucormycosi
mani
higher
diabet
one
china
popul
even
billion
higher
raw
number
percent
adult
popul
condit
million
peopl
china
million
adult
percent
accord
intern
diabet
foundat
k
reddi
public
health
foundat
larg
number
recent
mucormycosi
coronaviru
recoveri
reduc
hyperimmun
respons
covid
reddi
reduc
resist
new
twitter
back
increasingli
heavyhand
control
speech
call
govern
respect
freedom
express
intimid
tactic
countri
statement
come
govern
prime
minist
mount
pressur
handl
devast
second
wave
coronaviru
mani
twitter
elsewher
govern
reclaim
narr
free
speech
twitter
receiv
notic
noncompli
inform
technolog
notic
compani
remov
content
critic
govern
handl
coronaviru
post
law
twitter
face
seven
prison
compani
abid
govern
remov
content
subvers
threat
public
order
nation
statement
san
social
media
servic
push
chang
new
given
greater
say
right
concern
recent
regard
potenti
threat
freedom
express
peopl
serv
statement
new
inform
technolog
ad
alongsid
mani
civil
societi
around
world
use
intimid
tactic
polic
respons
enforc
global
servic
well
core
new
day
belong
elit
polic
unit
twitter
new
bear
notic
way
compani
senior
within
rule
parti
post
twitter
provid
proof
opposit
use
countri
coronaviru
crisi
polit
cudgel
twitter
media
respons
coronaviru
hit
govern
taken
increasingli
strong
curb
dissent
countri
twitter
block
remov
unspecifi
number
govern
accus
make
inflammatori
connect
angri
outsid
new
least
six
protest
agricultur
take
action
media
believ
block
consist
law
compani
acknowledg
withheld
unverifi
view
even
though
content
legitim
free
speech
intern
law
compani
last
week
verif
process
allow
govern
media
appli
blue
check
mark
marker
credibl
process
hold
sinc
govern
order
twitter
take
social
media
critic
handl
pandem
order
roughli
opposit
includ
new
appli
wide
varieti
media
digit
news
stream
social
media
give
govern
sweep
quickli
take
materi
specif
social
media
appoint
crimin
liabl
well
creat
trace
identifi
first
origin
govern
offens
social
media
given
deadlin
name
requir
danger
overreach
inconsist
open
democrat
govern
highli
unusu
step
platform
unconstitut
digit
say
threaten
fundament
chang
way
use
democrat
framework
constitut
apar
execut
director
freedom
foundat
group
sever
suffer
unconstitution
undermin
free
express
privaci
million
countri
sought
enforc
balanc
free
speech
safeti
unit
taken
aim
big
technolog
influenc
peopl
buy
read
well
handl
person
data
work
new
would
provid
govern
greater
author
remov
misinform
materi
consid
ministri
electron
inform
technolog
govern
arm
twitter
take
materi
post
respons
statement
servic
new
design
prevent
abus
misus
social
media
minist
electron
inform
technolog
statement
govern
critic
right
ask
separ
statement
ministri
twitter
call
total
baseless
fals
attempt
defam
protect
free
speech
compani
prerog
last
week
govern
social
media
twitter
remov
content
relat
coronaviru
particularli
spread
twitter
confirm
receiv
request
remov
even
immedi
respond
request
least
one
first
seen
known
viru
unit
kingdom
present
least
govern
request
assert
complet
fals
govern
legal
basi
ask
social
media
remov
content
appli
news
import
scientif
viru
kill
peopl
day
countri
health
care
system
far
beyond
limit
new
choke
collar
lawyer
work
govern
tug
sri
tap
japan
unit
look
rest
world
inocul
sinc
vaccin
deal
catastroph
second
coronaviru
wave
ad
approach
decis
world
biggest
vaccin
manufactur
left
much
global
suppli
even
unit
global
pledg
donat
billion
poor
world
health
organ
billion
defeat
south
elsewher
mani
continu
scrambl
health
say
vaccin
pledg
group
vagu
incorpor
real
littl
address
immedi
need
million
peopl
year
combin
donat
serum
institut
vaccin
univers
brand
local
coronaviru
rose
sharpli
march
prime
minist
govern
block
forc
serum
reneg
bilater
global
program
world
million
peopl
age
older
second
shot
first
dose
march
govern
south
unit
help
director
health
ministri
substant
progress
far
first
million
vaccin
administr
seven
million
capit
clear
kind
mani
nationwid
nearli
one
three
coronaviru
come
back
posit
less
percent
countri
million
peopl
fulli
sri
receiv
china
vaccin
sri
angl
provid
second
dose
peopl
wait
nearli
four
presid
met
japan
ambassador
appeal
govern
donat
across
given
bit
green
light
sri
gen
silva
head
sri
covid
task
forc
told
new
york
govern
inocul
rest
popul
donat
sputnik
v
second
wave
coronaviru
continu
rise
count
us
rais
pressur
administr
help
secretari
countri
covid
vaccin
manag
committe
short
roughli
million
second
donat
million
bulk
china
sputnik
v
russia
million
million
peopl
fulli
world
act
end
covid
pandem
come
horribl
form
herd
immun
transmiss
take
hold
around
world
kill
troubl
new
evid
variant
first
far
transmiss
even
variant
first
around
widespread
vaccin
unit
expect
covid
continu
declin
stay
low
especi
lab
real
world
experi
show
appear
defend
well
sever
effect
much
rest
world
though
even
transmiss
new
variant
evid
yet
conclus
data
preliminari
variant
transmiss
easi
spread
rapidli
area
chanc
mayb
got
found
suscept
popul
got
lucki
seed
variant
seen
frequent
countri
genom
often
test
routin
anoth
countri
alreadi
key
measur
use
previou
figur
variant
transmiss
look
secondari
attack
mani
peopl
come
close
contact
infect
person
get
viru
greater
number
get
viru
averag
greater
likelihood
variant
transmiss
secondari
attack
public
health
agenc
similar
diseas
control
prevent
variant
first
seen
substanti
transmiss
among
close
even
alreadi
highli
transmiss
report
agenc
last
week
earli
data
rais
later
inform
confirm
earli
epidemiologist
school
hygien
tropic
medicin
told
faster
spread
higher
variant
higher
transmiss
point
back
terribl
neighbor
widespread
given
limit
genet
identif
data
particularli
use
variant
higher
transmiss
huge
danger
peopl
without
immun
either
vaccin
prior
infect
even
variant
deadli
previou
viru
almost
complet
kept
pandem
rel
well
recent
fairli
littl
immun
larg
unvaccin
transmiss
variant
burn
immunolog
popul
transmiss
exponenti
threat
viru
previous
infect
three
peopl
averag
infect
four
small
increas
yet
start
two
infect
peopl
total
infect
transmiss
variant
would
caus
million
oppos
less
transmiss
practic
emerg
immedi
action
widespread
vaccin
vulner
threat
vaccin
fine
unless
tie
process
actual
suppli
littl
tragedi
produc
need
gather
emerg
meet
immedi
decid
command
whatev
excess
capac
produc
whatev
necessari
threat
transmiss
sinc
evid
hand
even
appear
highli
effect
sever
diseas
wors
focu
highest
number
possibl
fast
choic
vaccin
vaccin
preced
go
whatev
regardless
nation
origin
alli
need
crisi
worst
necessari
away
wealthi
suppli
cours
understand
everi
nation
vaccin
first
countri
high
vaccin
especi
among
vulner
hold
especi
big
addit
excess
go
without
even
vaccin
global
allianc
vaccin
equiti
enough
distribut
suppli
get
accord
nation
popul
serious
need
chang
fire
depart
need
water
direct
fire
burn
everi
hous
vari
elderli
health
care
wherev
crisi
worst
appli
delay
success
canada
face
decid
global
health
reason
possibl
world
mount
threat
best
interven
earli
aggress
possibl
even
delay
make
huge
differ
wait
definit
evid
transmiss
allow
variant
rampag
besid
prove
unfound
world
would
still
better
solut
even
imperfect
better
wait
perfect
setup
conclus
told
entir
possibl
covid
occur
enough
protect
risk
global
daili
surg
first
wave
less
understand
treat
diseas
far
therapeut
later
cut
mortal
even
vaccin
campaign
kept
spread
rapidli
among
unvaccin
similar
pattern
much
eastern
determin
transmiss
bad
fear
emerg
still
kind
catastroph
outbreak
one
caus
mani
needless
simpli
overwhelm
alreadi
rang
south
face
supplement
oxygen
kind
seen
pathogen
one
fatal
rate
oxygen
avail
therapi
one
would
unspeak
tragedi
suffer
latter
second
year
one
end
either
million
mayb
infect
time
world
choic
littl
time
make
choic
made
ram
singh
first
wave
pandem
board
crowd
bu
cross
border
home
later
rate
new
fell
return
job
print
press
new
sustain
famili
two
pay
school
three
swept
second
wave
infect
last
month
new
oxygen
level
manag
ambul
take
back
border
cross
carri
cloth
back
consid
health
emerg
viru
virtual
uncheck
across
nation
million
peopl
carri
migrant
viciou
second
wave
countri
medic
system
beyond
meager
half
million
covid
believ
deepli
toll
test
remain
limit
one
figur
indic
true
sever
percent
govern
disarray
troubl
embattl
prime
minist
push
elect
countri
parliament
month
event
worsen
past
week
minist
health
popul
govern
consid
health
emerg
declar
caught
polit
move
would
allow
limit
peopl
level
control
opposit
worri
use
quell
capit
peopl
store
food
least
week
stay
impact
rippl
beyond
infect
migrant
tourism
economi
million
peopl
continu
feel
increas
pressur
direct
health
impact
food
medic
school
mental
pressur
much
resid
repres
unit
develop
program
close
relationship
make
vulner
long
import
trade
transit
partner
two
share
deep
cultur
bond
across
porou
border
devast
big
neighbor
hospit
onto
long
oxygen
govern
unprepar
say
forc
come
home
second
wave
brought
viru
along
border
worst
hit
health
ministri
percent
sent
genom
show
variant
found
world
health
organ
classifi
variant
global
concern
unprepar
first
wave
last
year
one
million
migrant
return
home
test
quarantin
border
spring
second
wave
littl
late
time
shut
border
earli
made
back
trickl
without
proper
test
quarantin
continu
return
govern
attent
elsewher
viru
retreat
opposit
last
year
health
peopl
would
deter
govern
say
pandem
global
problem
best
intern
aid
though
enough
meet
need
china
donat
vaccin
oxygen
unit
sent
medic
equip
oxygen
antigen
face
surgic
unit
provid
million
month
scale
covid
test
migrant
gulf
oxygen
sent
fight
pandem
without
help
alreadi
vaccin
manufactur
told
deliv
one
million
depend
half
medic
equip
need
accord
chemic
medic
associ
latter
countri
keep
everyth
urgent
domest
need
equip
china
alreadi
costli
becom
difficult
obtain
pandem
month
stop
suppli
medic
equip
medicin
associ
experienc
return
mani
migrant
run
district
main
provinci
hospit
admit
small
outli
quietli
mourn
dead
test
slow
except
mani
unabl
come
daili
agricultur
work
ram
ward
chief
villag
nine
peopl
covid
day
month
worri
thing
even
symptomat
peopl
readi
covid
recent
remot
health
along
team
conduct
antigen
turn
health
plea
covid
would
dispirit
found
posit
situat
control
hopeless
helpless
print
press
worker
villag
municip
western
corner
area
peopl
offici
accord
health
chief
joshi
lack
border
data
fulli
measur
sever
peopl
return
one
two
border
district
sinc
second
wave
joshi
hard
manag
high
school
dropout
went
work
labor
still
wife
home
twice
year
life
crack
make
fun
month
sent
home
cover
famili
household
well
privat
school
two
teenag
last
year
meant
stuck
home
earn
continu
privat
school
would
repay
print
press
see
eldest
daughter
talent
grow
doctor
complet
husband
say
let
eat
less
send
better
school
educ
receiv
husband
border
around
frail
energi
even
stand
taken
nearbi
hospit
everyth
go
home
husband
told
never
came
home
govern
pfizer
obtain
million
compani
coronaviru
vaccin
start
summer
still
consid
drug
manufactur
demand
indemn
relat
sever
side
effect
given
indemn
protect
legal
liabil
manufactur
coronaviru
govern
like
grant
pfizer
request
drug
compani
indemn
sever
vaccin
alreadi
use
unit
examin
request
take
interest
peopl
govern
vaccin
program
told
pfizer
prepar
suppli
million
vaccin
compani
inform
relat
drug
efficaci
health
struggl
inocul
popul
second
wave
coronaviru
countri
kill
day
overwhelm
medic
peopl
viru
toll
world
unit
brazil
believ
offici
data
signific
percent
billion
peopl
fulli
accord
new
york
time
say
slow
reach
rural
outbreak
grow
pace
nationwid
slip
two
million
day
three
million
ago
health
say
run
mani
countri
say
find
place
say
expand
way
outbreak
unlik
mani
govern
prime
minist
declin
sign
advanc
purchas
vaccin
believ
year
viru
say
guard
left
defenseless
coronaviru
larg
vaccin
industri
keep
demand
leav
countri
reliant
short
suppli
global
would
work
pfizer
make
avail
soon
vaccin
shortag
begin
eas
capit
new
begin
end
next
week
chief
minist
capit
ago
devast
forc
coronaviru
new
daili
funer
burn
day
night
take
first
back
toward
construct
activ
return
six
home
avoid
infect
move
came
sharp
drop
new
least
offici
hospit
strain
medicin
street
return
normal
immedi
still
close
system
last
year
nationwid
suspend
servic
citi
govern
eas
allow
peopl
ram
begin
work
broadli
start
repair
ail
economi
construct
compani
owner
must
replac
migrant
fled
second
wave
coronaviru
struck
confid
busi
would
return
normal
soon
immedi
abl
start
work
slowli
six
day
abl
mobil
labor
materi
start
work
presid
associ
least
one
million
peopl
construct
sector
abl
return
job
small
open
gambl
citi
percent
billion
peopl
fulli
limit
health
infrastructur
public
state
pandem
rural
outsid
larg
unknown
alreadi
third
wave
lull
respit
end
second
ago
number
new
soar
reach
peak
new
nearli
one
three
coronaviru
came
back
posit
full
beyond
capac
turn
away
peopl
seek
treatment
die
outsid
cremat
prefer
last
rite
empti
lot
mani
burn
sky
turn
ash
nightmar
capit
least
even
rise
elsewher
countri
citi
new
intens
care
unit
around
feel
need
strike
balanc
pandem
econom
new
set
countri
economi
grew
percent
period
end
march
say
reflect
activ
full
impact
feroci
second
wave
like
unsustain
current
quarter
june
broadli
predict
growth
full
fiscal
year
end
march
pace
point
two
main
vaccin
rate
fallen
million
day
four
million
last
month
countri
limit
vaccin
slow
surg
say
need
remain
place
least
percent
countri
billion
peopl
receiv
one
vaccin
shot
estim
reach
vaccin
threshold
mid
late
august
accordingli
expect
extend
third
quarter
head
southeast
econom
research
brief
last
week
consequ
growth
forecast
ad
suppli
vaccin
hesit
prevent
countri
reach
percent
threshold
august
result
econom
economist
econom
hit
would
even
pronounc
rural
stand
scale
speed
spread
covid
given
push
back
economi
princip
economist
research
credit
agenc
ad
countri
neg
growth
previou
financi
year
ever
eas
nowher
near
sever
nationwid
prime
minist
last
year
million
peopl
rural
often
foot
rail
transport
suspend
mani
director
us
nation
institut
allergi
infecti
reinstitut
similar
nod
chao
last
year
throughout
second
wave
core
infrastructur
across
countri
employ
million
domest
migrant
highway
along
rail
citi
privat
construct
howev
close
carpent
extrem
precari
usual
per
day
sat
home
idli
last
day
unabl
pay
rent
increasingli
impati
landlord
hope
close
quarter
abl
secur
dose
one
citi
public
close
intermitt
vaccin
first
prioriti
stomach
stomach
fill
die
even
corona
meet
citi
disast
manag
author
chief
minist
would
phase
accord
econom
need
prioriti
econom
start
particularli
migrant
mani
work
construct
peopl
alreadi
danger
slide
middl
class
poverti
countri
economi
fray
well
pandem
deep
structur
sometim
impetu
polici
gener
govern
approach
lift
low
infect
repres
repriev
end
capit
terrifi
second
wave
decis
merit
obvious
take
maximum
care
k
reddi
presid
public
health
foundat
per
day
last
week
drop
percent
peak
death
toll
fell
though
less
precipit
overal
toll
wide
consid
vast
fallen
peopl
cautious
left
even
daytim
summer
heat
pick
normal
bustl
quiet
neighborhood
pandem
far
rise
remot
rural
scant
health
state
home
industri
hub
extend
tight
least
anoth
week
southern
daili
case
remain
high
offici
resum
met
resist
question
life
versu
livelihood
gener
secretari
union
auto
plant
yet
name
latest
coronaviru
variant
set
edg
evolutionari
call
fear
world
health
organ
group
less
technic
easili
pronounc
system
name
viru
driven
new
around
assign
alphabet
order
potenti
exampl
deadli
surg
delta
new
system
variant
spread
even
quickli
variant
discov
devast
global
new
name
alpha
keep
long
new
hope
roll
motiv
system
complic
mani
peopl
discov
instead
variant
exampl
worri
inform
inaccur
genom
necessari
sound
alarm
new
well
somewher
stick
anoth
matter
sinc
issu
variant
south
variant
prolifer
news
consid
number
take
make
new
mani
syllabl
alreadi
recogniz
freed
anoth
task
world
meteorolog
organ
march
would
longer
use
name
san
govern
order
tech
take
critic
handl
coronaviru
pandem
social
network
chat
ask
prime
minist
stifl
dissent
one
intern
post
new
york
time
employe
famili
accus
afraid
would
ban
compani
busi
countri
act
make
fear
later
broke
remov
promin
briefli
relat
violenc
took
messag
ask
compani
content
er
side
govern
make
due
polit
one
worker
wrote
intern
messag
recent
handl
intern
accord
half
dozen
current
former
compani
grill
top
one
case
form
group
intern
report
content
believ
wrongli
remov
week
open
letter
call
audit
treatment
accord
person
saw
anoth
sign
intern
unrest
employe
critic
beyond
domest
past
larg
mark
chief
execut
handl
inflammatori
former
presid
j
trump
sinc
trump
left
offic
attent
global
compani
acquiesc
continu
profit
feel
among
peopl
systemat
approach
one
strong
govern
right
correct
ashraf
former
head
polici
middl
east
north
region
left
increasingli
caught
vise
russia
elsewher
remov
content
tri
corral
platform
power
speech
takedown
upset
say
social
network
authoritarian
repress
quash
silenc
result
kind
intern
cultur
clash
grow
movement
dissent
versu
global
public
polici
team
directli
current
former
mani
polici
team
will
acced
polici
team
appreci
delic
danc
intern
lever
spokeswoman
compani
made
appeas
everyon
goal
give
voic
mani
peopl
around
world
possibl
push
back
overreach
govern
wherev
ad
remov
content
accord
compani
local
intern
human
employe
discont
lever
peopl
platform
debat
import
peopl
work
news
financi
time
employe
dissatisfact
divid
global
polici
team
compos
roughli
current
former
polici
team
chief
oper
subscrib
idea
stand
see
dictatori
polici
team
often
weigh
likelihood
govern
shut
social
servic
compani
takedown
sometim
speech
better
none
face
mani
tricki
intern
russia
consid
whether
would
shut
work
led
employe
dissent
begun
public
evid
countri
govern
roughli
social
media
twitter
mani
includ
govern
opposit
remov
briefli
block
compani
later
mistak
part
govern
intern
damag
done
chat
human
global
polici
disappoint
famili
worri
month
violenc
broke
surfac
eras
content
briefli
refer
mosqu
one
later
confus
milit
group
bristl
peopl
one
wrote
intern
messag
time
wrote
offic
head
cutler
previous
work
prime
minist
benjamin
cutler
respond
request
comment
push
agenda
favor
govern
take
content
role
public
polici
team
one
jordan
well
around
world
help
make
sure
local
commun
understand
lever
spokeswoman
local
knowledg
understand
charg
serv
former
execut
cast
net
feel
signific
tilt
within
manag
system
approach
benefit
peopl
mad
see
emblemat
mani
employe
meet
virtual
session
one
worker
nick
public
explain
compani
role
remov
content
tie
conflict
accord
employe
situat
fraught
go
get
right
content
ran
list
polici
go
forward
assur
staff
moder
would
fair
respons
two
peopl
familiar
meet
discuss
cordial
one
peopl
chat
box
besid
respons
larg
dissatisfi
peopl
spoke
broke
privat
workplac
known
discuss
later
form
group
flag
content
suppress
intern
content
moder
two
goal
polici
team
tri
intern
memo
time
two
polici
team
wrote
hope
intern
commun
resist
divis
side
brutal
one
alway
agre
wrote
howev
best
work
assum
good
intent
recogn
side
tri
serv
commun
best
possibl
way
student
suppos
start
master
degre
fall
univers
school
intern
public
coronaviru
receiv
two
covaxin
made
manufactur
current
world
health
organ
told
need
differ
vaccin
campu
one
say
sure
safe
concern
take
two
differ
wrote
via
applic
process
would
part
cycl
realli
uncertain
sinc
march
unit
vaccin
coronaviru
design
primarili
domest
mind
leav
intern
scrambl
particularli
covaxin
sputnik
v
vaccin
russia
howev
access
pfizerbiontech
johnson
johnson
three
eight
author
health
agenc
accord
dispar
hinder
made
major
prioriti
retain
intern
brought
close
billion
tuition
year
pandem
accord
one
analysi
want
enrol
intern
add
divers
campu
commun
bring
money
terri
w
senior
vice
presid
council
educ
subject
intens
discuss
situat
particularli
approxim
intern
everi
year
second
china
subcontin
one
sever
pandem
burial
ground
run
space
funer
nearli
constantli
burn
vaccin
acut
percent
popul
fulli
get
appoint
tax
turn
black
market
pay
hire
peopl
spend
tri
line
vaccin
hard
enough
get
appoint
even
secur
one
vaccin
accept
everi
day
get
say
mean
impact
program
new
york
univers
last
year
run
north
associ
work
help
fellow
flood
get
vaccin
time
still
matricul
fall
vaccin
get
local
colleg
univers
vaccin
requir
less
two
ago
work
overtim
answer
roughli
phone
pour
everi
day
univers
roughli
oversea
vice
presid
intern
ring
hook
begin
describ
volum
oversea
tri
navig
vaccin
bureaucraci
home
well
host
flight
question
anxieti
concern
among
intern
diseas
control
prevent
tri
provid
guidanc
agenc
peopl
fulli
sever
receiv
requisit
author
spokeswoman
three
current
avail
unit
emerg
author
world
bodi
accord
three
vaccin
one
made
one
made
vaccin
china
week
vaccin
made
appear
follow
student
vaccin
rose
presid
colleg
student
consid
student
bodi
oversea
intern
present
either
booklet
letter
physician
confirm
receiv
requisit
one
world
bodi
donna
chief
oper
offic
univers
medic
center
campu
leav
two
face
complic
potenti
problemat
succeed
vaccin
start
fall
semest
mani
say
plan
campu
offer
one
three
trick
two
pfizer
requir
first
second
dose
space
three
apart
someon
consid
fulli
two
last
dose
process
minimum
five
time
quarantin
rest
campu
goe
back
normal
need
undergo
routin
test
differ
say
need
dorm
attend
class
remot
say
wear
mask
undergo
complic
scenario
receiv
vaccin
sputnik
covaxin
mani
student
need
medic
logist
data
whether
combin
differ
safe
sinc
interchang
safeti
effect
two
differ
studi
spokeswoman
wrote
ad
peopl
outsid
unit
vaccin
author
wait
minimum
day
take
first
dose
one
vagu
plan
deal
logist
complex
space
unrel
beyond
say
accommod
undergo
much
remain
flux
least
one
major
univers
system
state
public
univers
system
countri
nearli
accept
vaccin
student
receiv
author
regulatori
agenc
countri
origin
chancellor
abl
satisfi
requir
long
vaccin
receiv
someth
similar
entiti
face
mount
pressur
confus
anxiou
least
six
region
emerg
past
week
vaccin
head
state
although
move
came
late
sinc
alreadi
inject
accept
instead
futur
cours
studi
fret
whether
vaccin
need
get
upon
caus
advers
reaction
truth
easier
get
admit
handl
process
world
lead
produc
past
week
global
leader
clear
countri
vaccin
answer
question
matter
urgent
interest
second
wave
infect
left
tableau
death
despair
big
critic
supplier
global
effort
vaccin
peopl
coronaviru
roll
enough
vaccin
billion
peopl
close
watch
especi
crisi
alreadi
contin
count
vaccin
learn
ago
prime
minist
suspend
nearli
million
vaccin
produc
daili
top
vaccin
compani
serum
institut
use
even
shift
well
scrambl
pharmaceut
industri
ramp
product
agreement
make
sputnik
vaccin
russia
effort
get
mani
possibl
terribl
speed
viru
countri
vaccin
way
surg
infecti
diseas
expert
professor
new
york
univers
school
somehow
solv
vaccin
suppli
problem
quickli
help
least
short
term
take
two
first
dose
effect
requir
interv
four
first
second
median
incub
period
viru
contrast
four
five
day
mean
necessarili
avert
health
ministri
new
death
toll
alreadi
put
critic
ventil
medic
oxygen
lifesav
feroc
second
wave
take
everyon
surpris
k
princip
scientif
advis
govern
interview
express
newspap
awar
second
hand
model
scale
surg
new
york
time
vaccin
progress
million
peopl
percent
popul
fulli
better
rate
mostli
poor
practic
one
still
among
world
unit
contrast
govern
spent
secur
figur
percent
even
brazil
viru
especi
acut
health
hunger
crisi
percent
popul
fulli
goal
million
peopl
summer
look
increasingli
peter
j
molecular
virolog
professor
colleg
medicin
one
basic
simpli
suppli
vaccin
need
never
scale
level
serum
institut
vaccin
must
produc
million
long
take
vaccin
ramp
product
talk
longer
infecti
diseas
expert
host
two
epidem
diagnosi
new
clear
frustrat
among
vaccin
shaikh
one
serum
institut
week
receiv
stun
respons
compani
demand
take
five
six
center
get
per
month
read
mass
front
shaikh
shut
center
govern
chip
unit
govern
author
leav
advis
leav
soon
safe
grim
coronaviru
warn
death
toll
signific
vaccin
program
suppos
bright
pandem
ran
world
immun
program
routin
million
peopl
year
coronaviru
bean
spread
serum
institut
becom
vaccin
manufactur
world
million
western
citi
initi
fast
three
million
day
vaccin
drive
health
ministri
million
previou
cash
govern
major
vaccin
struggl
increas
serum
institut
million
month
anoth
compani
make
million
month
covaxin
shot
third
compani
agreement
produc
russia
sputnik
v
vaccin
later
fraction
need
inocul
everi
adult
million
peopl
invit
peopl
home
lunch
cook
epidemiologist
health
say
run
mani
receiv
one
shot
say
troubl
get
second
feel
new
businessman
turn
away
two
went
get
second
dose
vulner
day
portal
govern
regist
demand
million
eventu
got
shortag
everywher
singh
health
minist
state
struggl
obtain
three
million
vaccin
health
ministri
suppli
shortag
tri
acceler
privat
purchas
directli
say
polici
lead
rais
privat
new
shaikh
vaccin
center
would
soon
unabl
offer
even
averag
day
think
abl
help
vaccin
center
cri
task
forc
meet
health
minist
assur
public
march
pandem
prime
minist
global
nation
save
human
big
disast
corona
effect
told
virtual
gather
world
econom
forum
late
three
tricolor
display
second
wave
made
countri
day
run
short
lifesav
oxygen
run
day
cremat
ground
burn
send
ash
turn
sky
gray
biggest
stark
revers
victori
suffer
emerg
forc
nation
reckon
around
world
countri
worst
pandem
entertain
rel
youth
health
popul
govern
even
say
hit
global
phenomenon
time
trace
second
independ
health
polit
say
overconfid
domin
leadership
style
bear
huge
share
respons
say
administr
determin
cast
imag
back
track
open
busi
despit
one
point
popul
vulner
herd
immun
administr
suggest
peopl
familiar
grow
distress
across
countri
aura
polit
invulner
opposit
person
charisma
becom
power
politician
opposit
attack
central
hold
power
increasingli
made
target
scath
critic
parliamentari
three
away
govern
power
secur
govern
step
get
desper
elig
scarc
age
still
say
domin
peopl
hold
person
respons
sick
death
across
countri
bulk
blame
govern
style
top
chosen
loyalti
rather
secreci
imag
manag
privileg
transpar
research
scholar
center
polici
research
new
govern
framework
ad
ball
covid
disastr
variou
recent
made
come
back
haunt
vaccin
powerhous
protect
world
purchas
enough
protect
instead
vaccin
low
home
new
million
bolster
stand
world
rose
decid
let
big
gather
help
rule
parti
burnish
nationalist
govern
festiv
million
take
place
state
without
mask
surround
alli
rather
felt
point
call
doubt
pandem
parti
alli
silenc
twitter
take
critic
threaten
arrest
ordinari
peopl
plead
parti
known
govern
declin
answer
specif
list
govern
taken
hold
dozen
air
forc
pharmaceut
mani
statement
govern
steadi
pace
consult
prepar
adequ
respons
ad
administr
advis
maintain
strict
vigil
let
guard
leader
would
face
million
poor
peopl
live
cheek
jowl
easi
highli
contagi
viru
long
public
health
spend
less
per
per
year
world
bank
less
mani
problem
countri
new
viru
evid
offici
vastli
underst
toll
countri
biggest
citi
essenti
ran
say
much
better
first
wave
politician
humbl
penchant
dramat
social
march
total
order
countri
one
world
four
notic
anxiou
guidanc
peopl
duti
stay
indoor
stand
bang
solidar
health
care
million
credit
though
flaw
spread
econom
devast
million
work
mani
turn
global
power
fear
lock
mani
rose
reach
almost
per
day
health
care
system
begin
economi
stagger
life
team
made
concert
effort
signal
shed
return
even
set
first
wave
parti
leadership
declar
covid
abl
sensit
visionari
leadership
prime
minist
earli
march
harsh
health
minist
pandem
sure
task
forc
around
health
meet
least
twice
month
task
forc
meet
accord
three
peopl
knowledg
two
govern
simpli
threat
grew
concern
offici
line
nation
billion
approach
herd
immun
point
enough
peopl
popul
immun
either
infect
viru
longer
spread
easili
head
task
forc
highli
run
pandem
concern
back
accord
three
peopl
serolog
necessarili
back
idea
two
peopl
familiar
research
govern
move
toward
herd
vaccin
program
lost
steam
complac
set
administr
gain
favor
take
china
new
region
rival
govern
two
use
made
countri
less
two
percent
popul
receiv
two
spokesman
govern
govern
expand
product
procur
altern
hit
campaign
trail
sever
hold
specif
west
state
opposit
parti
shah
home
minist
relentlessli
draw
mani
wear
close
togeth
vote
health
energet
campaign
draw
strength
told
one
top
new
daili
happi
see
peopl
peopl
noth
els
west
stagger
posit
rate
percent
mean
half
peopl
test
infect
hold
see
sever
play
new
danger
viru
involv
mani
peopl
blame
recent
hear
judg
told
lawyer
elect
commiss
book
murder
anoth
court
hear
lawyer
local
govern
administr
enough
help
acut
oxygen
shortag
countri
solicitor
gener
let
tri
crybabi
like
hold
power
thank
weak
opposit
abil
fire
nationalist
base
even
imag
lost
basebal
cap
chic
wore
year
ago
grown
hair
beard
long
reminisc
sage
uniqu
polit
anim
director
south
program
endow
intern
peac
charisma
allur
magnet
compel
person
stori
enorm
person
credibl
averag
voter
even
ad
peopl
find
way
justifi
new
within
world
worst
coronaviru
outbreak
empti
oxygen
canist
desper
need
metal
store
transport
lifesav
ga
across
countri
gasp
local
chariti
outrag
one
supplier
doubl
price
nearli
chariti
polic
discov
one
brazen
danger
countri
awash
fraud
polic
say
supplier
busi
varsha
engin
essenti
fire
sell
oxygen
deadli
fire
explod
fill
oxygen
guy
homicid
volunt
chariti
owner
jail
comment
coronaviru
second
wave
medic
system
confid
abil
prime
minist
govern
treat
peopl
quell
diseas
wide
far
day
full
oxygen
run
fill
gap
medicin
oxygen
phone
mani
prey
desper
grief
peopl
alreadi
special
commission
polic
moment
got
opportun
switch
sometim
good
fraudul
potenti
harm
last
week
polic
state
accus
one
group
steal
use
funer
sell
new
day
state
discov
fake
antivir
drug
mani
despit
predatori
top
court
new
month
moral
fabric
societi
dismemb
past
month
new
polic
peopl
cheat
hoard
crimin
conspiraci
fraud
connect
similarli
polic
peopl
seen
deprav
singh
former
polic
chief
level
predat
deprav
seen
career
life
profit
repres
flip
side
huge
help
system
fill
void
left
govern
across
countri
connect
need
lifesav
ad
system
vital
oxygen
still
stuck
peopl
keep
die
run
vaccin
pharmaceut
keep
threaten
peopl
publicli
plead
black
market
exorbit
good
mani
peopl
feel
graduat
student
new
grandmoth
late
neighbor
state
ambul
driver
ride
hospit
cremat
ground
time
normal
price
famili
firewood
cost
demand
account
price
everyon
tri
profit
pandem
know
peopl
egregi
found
countri
struggl
hospit
system
wide
mani
time
numer
offici
indic
across
fill
peopl
die
lack
oxygen
one
doctor
gone
viral
doctor
tri
stop
local
activist
govern
parti
sell
access
govern
hospit
work
know
get
bed
big
struggl
around
interview
govern
distribut
equit
becom
properti
one
person
activist
local
investig
know
doctor
accus
brisk
market
contraband
plasma
mani
use
treat
polic
citi
two
men
accus
sell
plasma
per
unit
accord
polic
one
men
plasma
need
social
media
sold
plasma
tri
help
social
media
find
univers
student
twitter
post
advertis
drug
drug
sometim
use
treat
pneumonia
hard
find
seller
advanc
post
possibl
scam
receiv
flurri
peopl
desper
drug
kind
helpless
peopl
face
day
antivir
drug
focu
number
polic
new
recent
four
peopl
work
medic
unus
dead
sold
drug
scarc
charg
famili
citi
recent
middleman
six
lucki
event
manag
famili
littl
choic
mother
serious
sick
mother
sinc
doctor
buy
jaw
khan
owner
hospit
drug
provid
procur
would
check
tri
get
around
polic
western
state
month
discov
fake
bust
tipster
led
factori
fill
glucos
water
alreadi
sold
mayb
even
put
polic
pose
public
health
risk
unknown
scale
turn
black
market
often
know
take
singh
cloth
trader
new
desper
seek
ill
wife
acquir
two
price
four
social
media
found
seller
will
part
four
five
time
price
first
two
second
two
differ
first
batch
made
differ
seller
oxygen
drop
desper
gave
without
abl
determin
whether
real
fake
polic
report
one
guilt
regret
probabl
wife
would
save
origin
polic
sent
test
peopl
crisi
period
benefit
moral
crisi
suspend
vaccin
cut
sri
econom
reviv
horrif
surg
coronaviru
effect
nearbi
seal
sever
count
plead
china
russia
question
whether
enough
region
mani
risk
made
vulner
dens
heavi
air
pollut
fragil
health
care
larg
poor
must
weigh
threat
viru
possibl
link
across
region
express
grow
dread
easili
follow
neighbor
feel
world
war
situat
physician
district
along
border
turn
away
hospit
everi
day
enforc
two
ago
close
migrant
better
situat
ad
still
wait
worst
clearli
crisi
initi
wave
last
year
nation
million
new
year
last
month
migrant
return
go
year
search
new
surg
rage
across
mani
return
across
porou
border
came
border
district
come
back
day
test
posit
ram
chief
district
offic
therein
mani
return
last
week
worker
percent
test
lack
capac
percent
even
govern
close
border
decis
necessari
ensur
return
late
transit
capit
possibl
loophol
seek
get
around
travel
record
mani
per
day
percent
come
back
posit
peopl
even
say
like
reason
crisi
govern
expand
health
coronaviru
control
last
year
slow
enforc
social
clear
point
huge
prime
minist
even
rose
likewis
rule
opposit
larg
polit
prime
minist
parliament
viru
everi
corner
countri
director
epidemiolog
diseas
control
divis
health
minist
told
situat
control
acknowledg
polit
instabl
led
night
lost
vote
confid
parliament
throw
continu
turn
critic
ill
away
medic
oxygen
run
short
govern
hospit
say
far
adequ
die
insuffici
oxygen
spread
happen
right
preview
futur
contain
latest
covid
surg
chairwoman
red
cross
statement
last
unlik
help
immedi
two
million
serum
institut
world
produc
crisi
govern
essenti
leav
million
paus
vaccin
late
last
month
would
temporarili
stop
new
serum
institut
cut
short
roughli
million
need
administ
second
let
alon
first
turn
china
russia
new
shortfal
otherwis
better
mani
rapidli
sinc
surg
even
though
mani
crowd
continu
work
warn
luck
hold
first
case
variant
first
discov
present
infect
death
situat
situat
fall
heavi
storm
public
health
expert
rise
along
border
even
though
countri
least
partial
percent
elig
popul
last
month
suspend
entri
foreign
come
border
close
even
pandem
polit
rise
offici
lead
coronaviru
respons
fact
entir
region
explain
new
spring
surg
directli
link
outbreak
rippl
effect
fresh
sri
new
wave
brought
highest
daili
yet
domest
holiday
travel
last
month
crisi
led
suspens
travel
two
dash
air
travel
bubbl
would
reviv
sri
tourism
industri
countri
sourc
account
nearli
director
tour
compani
mostli
seen
hand
year
suburb
laid
percent
sinc
start
pandem
cut
least
half
travel
bubbl
great
initi
unfortun
reap
situat
stagger
new
surg
like
take
month
peak
health
care
system
even
strain
govern
coronaviru
respons
plan
last
local
would
insuffici
activ
mani
anger
sorrow
mix
utter
businessman
border
district
watch
anxieti
sorrow
migrant
return
crowd
everi
day
test
mani
simpli
return
viru
travel
safeti
matter
go
stifl
tightli
medic
ward
civil
hospit
ear
nose
throat
specialist
briskli
one
bed
next
shine
flashlight
one
patient
mouth
examin
anoth
specialist
bela
treatment
nearli
mucormycosi
rare
often
deadli
fungal
diseas
explod
across
coronaviru
pandem
unprepar
spring
devast
second
wave
mani
took
desper
save
door
yet
anoth
deadli
diseas
pandem
precipit
epidem
three
number
diseas
known
misnom
black
fungu
found
dead
tissu
shot
neglig
accord
news
feder
health
ministri
new
nationwid
allot
scarc
expens
medicin
coronaviru
pandem
drawn
stark
rich
poor
mucormycosi
epidem
latest
manifest
second
wave
struck
creaki
medic
system
oxygen
mucormycosi
epidem
even
urgenc
difficult
task
protect
billion
peopl
small
fraction
coronaviru
remain
vulner
third
wave
follow
mucormycosi
tail
go
back
covid
subsid
epidemiologist
come
back
third
wave
unless
find
happen
mani
think
know
fungu
attack
gastrointestin
tract
skin
often
eye
socket
brain
left
untreat
treatment
diseas
complex
often
surgeri
uncommon
expens
drug
mortal
rate
person
person
commonplac
sometim
build
believ
crowd
dire
lack
medic
oxygen
left
fungu
enough
oxygen
go
around
mani
standard
treatment
covid
global
reduc
inflamm
help
covid
breath
far
exceed
world
health
organ
microbiologist
coauthor
studi
examin
mucormycosi
outbreak
patient
immun
made
suscept
fungal
danger
blood
sugar
leav
peopl
diabet
vulner
mucormycosi
increas
chanc
blood
lead
malnourish
tissu
fungu
chanc
ask
whether
diabet
hardli
time
patient
manag
look
take
care
respiratori
tract
accord
health
ministri
four
five
mucormycosi
half
engin
surgic
tape
left
eye
hook
drip
civil
hospit
one
mucormycosi
first
came
civil
servic
exam
new
second
wave
hit
test
posit
coronaviru
hospit
oxygen
scarc
onto
train
older
brother
home
rural
oxygen
plummet
potenti
lethal
two
oxygen
support
local
hospit
acut
headach
left
side
brain
thought
would
go
away
suddenli
vision
left
eye
went
blank
mucormycosi
would
remov
went
civil
hospit
second
opinion
five
surgeri
involv
scrape
away
dead
tissu
sinu
tract
clear
infect
receiv
cours
b
kept
eye
still
lose
life
sinc
remov
thin
layer
infect
behind
eye
without
remov
eye
lost
vision
left
eye
definit
want
know
mucor
form
faulti
treatment
someon
respons
wrath
god
studi
month
us
diseas
control
prevent
heavi
use
correl
diabet
unsanitari
pandem
mucormycosi
year
averag
singl
case
everi
two
unit
western
environment
play
part
incid
diabet
twice
mani
peopl
condit
unit
mucormycosi
peopl
diabet
either
unawar
condit
take
insulin
properli
current
outbreak
mani
histori
diabet
common
denomin
infect
govern
declar
mucormycosi
epidem
whether
live
die
often
quickli
undergo
surgeri
fungu
start
cours
minist
fungal
diseas
new
challeng
import
creat
tackl
small
b
free
charg
public
limit
unit
per
vial
patient
need
manufactur
donat
effect
toxic
pose
risk
kidney
damag
pain
choic
patel
infecti
specialist
privat
sterl
hospit
mucormycosi
patel
anoth
studi
commonli
routin
diarrhea
fever
mild
need
case
one
patel
patel
matriarch
farm
famili
rural
pay
day
treatment
steep
cost
patel
seen
patel
relat
previou
health
relat
diabet
mucormycosi
want
take
hospit
intens
headach
facial
numb
patel
earli
june
privat
room
sterl
hospit
felt
healthi
first
time
patel
god
soar
whole
govern
powerless
grip
coronaviru
crisi
agre
spread
probabl
even
wors
offici
statist
suggest
mani
countri
hospit
supplement
oxygen
vital
run
western
roll
mass
vaccin
percent
popul
fulli
though
slowli
improv
new
viru
spread
larg
uncheck
rest
new
york
time
describ
midst
pandem
wrote
fear
loss
anxieti
boredom
wrote
anger
stumbl
respons
govern
prime
minist
wrote
famili
cope
made
help
alik
lot
peopl
age
help
peopl
find
hospit
oxygen
medic
social
media
whatev
float
around
send
whoever
need
work
one
group
realiz
necessari
job
time
incred
sign
complet
broken
system
band
togeth
work
exhaust
tri
answer
desper
twitter
get
harder
day
worsen
get
exhaust
quickli
time
end
call
lot
get
respons
usual
peopl
say
noth
us
heartbreak
peopl
around
suffer
die
littl
help
burnt
unsustain
system
get
peopl
access
health
care
leav
bear
brunt
health
care
system
new
miss
spontan
hate
plan
everyth
even
feel
disappear
tri
focu
instead
determin
stay
social
media
amplifi
volunt
respons
center
assist
choic
help
made
loud
clear
go
life
moment
experi
hard
imagin
actual
real
happen
everi
social
media
feed
everi
group
full
peopl
look
oxygen
hospit
critic
lifesav
worst
part
almost
noth
help
anyon
immedi
call
beg
help
actual
find
even
time
feel
almost
call
back
find
help
still
fear
hear
inevit
person
without
get
adequ
care
die
covid
treatment
care
got
covid
lost
mother
yesterday
father
ventil
support
reason
lost
mother
get
treatment
live
way
get
bed
hospit
help
line
never
work
take
transfer
call
help
complet
helpless
took
mother
hospit
sure
even
legitim
money
train
staff
oxygen
alway
short
suppli
felt
helpless
take
anywher
knew
kept
would
surviv
bring
father
condit
due
lack
oxygen
take
differ
hospit
late
ventil
submiss
receiv
maintain
mood
log
throughout
day
encourag
famili
post
mood
meter
social
media
peopl
repli
feel
talk
help
food
temperatur
sinc
differ
realli
import
keep
record
along
chart
vital
extend
famili
help
time
remain
connect
remind
us
lose
faith
sinc
go
work
everi
day
realli
experienc
insid
stress
year
come
work
last
year
peopl
immedi
rush
bank
work
difficult
almost
imposs
rural
part
make
peopl
understand
import
social
govern
done
littl
make
peopl
awar
situat
initi
televis
stunt
rather
precautionari
measur
lot
duti
leav
even
sick
precautionari
paper
nowher
close
realiti
past
dumb
someth
clearli
saw
come
type
four
lay
ajar
wide
open
home
three
us
covid
old
dad
take
care
cook
clean
day
dad
day
night
interrupt
food
tea
hoars
pain
frustrat
cope
night
lie
weather
unbear
hot
fever
rare
make
posit
mind
get
job
earn
enough
secur
famili
cruel
world
bold
less
hesit
fight
peopl
see
warn
corrupt
inept
distribut
slap
complac
power
ruthless
demagogu
fear
resent
dud
come
tough
leadership
send
submiss
famili
mani
infect
call
everi
day
share
joke
stay
posit
make
meet
futur
still
frighten
cope
tri
help
peopl
overcom
keep
tell
peopl
us
infect
recov
ask
peopl
avoid
panic
seek
unvalid
sinc
last
year
regularli
continu
even
infect
isol
pistol
shooter
state
mental
import
part
train
medit
day
stay
posit
raj
frighten
half
peopl
know
test
posit
previous
infect
step
hous
past
two
taken
greater
toll
physic
mental
health
rule
avoid
contact
want
keep
close
safe
need
keep
away
mother
essenti
worker
seen
groceri
shop
mani
needi
peopl
someth
time
need
hold
human
faith
whatev
believ
atheist
faith
scienc
